data_1e68_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1e68 _Structure_validation_residue.Date_analyzed 2016-10-06 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.495 ' HE3' HD13 ' A' ' 32' ' ' LEU . 33.3 mtp . . . . . 0 N--CA 1.48 1.06 0 N-CA-C 111.988 0.366 . . . . 0.0 111.988 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . 0.442 ' HA ' ' O ' ' A' ' 7' ' ' ILE . . . -55.19 -50.75 68.57 Favored 'General case' 0 CA--C 1.543 0.68 0 O-C-N 124.475 1.109 . . . . 0.0 112.511 178.343 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 54.7 tttp -73.25 -59.95 2.47 Favored 'General case' 0 CA--C 1.543 0.7 0 CA-C-N 112.695 -2.048 . . . . 0.0 114.097 -176.717 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 14.0 tt0 -67.93 -42.54 80.85 Favored 'General case' 0 N--CA 1.481 1.075 0 N-CA-C 115.009 1.485 . . . . 0.0 115.009 -168.831 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . 0.409 ' HB2' HD11 ' A' ' 7' ' ' ILE . 70.4 m-85 -100.32 -18.71 16.67 Favored 'General case' 0 N--CA 1.468 0.467 0 N-CA-C 116.824 2.157 . . . . 0.0 116.824 -173.913 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 83.28 57.82 2.42 Favored Glycine 0 CA--C 1.544 1.892 0 O-C-N 124.688 1.242 . . . . 0.0 111.519 -173.652 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . 0.442 ' O ' ' HA ' ' A' ' 2' ' ' ALA . 0.4 OUTLIER -115.67 150.17 44.31 Favored Pre-proline 0 N--CA 1.481 1.106 0 CA-C-N 113.384 -1.408 . . . . 0.0 110.638 177.888 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_endo -88.37 151.99 6.6 Favored 'Trans proline' 0 CA--C 1.53 0.312 0 N-CA-C 109.513 -0.995 . . . . 0.0 109.513 159.587 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -51.19 -26.97 7.73 Favored 'General case' 0 N--CA 1.476 0.86 0 N-CA-C 115.217 1.562 . . . . 0.0 115.217 176.156 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -41.94 -56.16 2.86 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 126.298 1.839 . . . . 0.0 112.312 169.948 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.793 HG11 HG21 ' A' ' 31' ' ' ILE . 21.3 m -88.91 -29.45 5.23 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.004 0 N-CA-C 114.371 1.249 . . . . 0.0 114.371 -173.7 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -64.92 -32.16 73.75 Favored 'General case' 0 N--CA 1.477 0.877 0 N-CA-C 112.964 0.727 . . . . 0.0 112.964 173.564 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -65.96 -40.37 95.29 Favored Glycine 0 CA--C 1.542 1.736 0 O-C-N 124.161 0.913 . . . . 0.0 112.809 173.581 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' THR . . . . . 0.594 HG21 HG13 ' A' ' 28' ' ' ILE . 1.0 OUTLIER -60.75 -40.6 93.07 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 123.969 0.908 . . . . 0.0 112.554 173.378 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.827 HG12 HD12 ' A' ' 55' ' ' LEU . 18.3 t -54.73 -43.34 66.05 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.086 0 C-N-CA 124.22 1.008 . . . . 0.0 112.86 168.776 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 81.5 mt -60.28 -38.72 84.46 Favored 'General case' 0 N--CA 1.481 1.096 0 N-CA-C 114.03 1.122 . . . . 0.0 114.03 177.115 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 24.7 t-20 -51.94 -48.64 64.17 Favored 'General case' 0 N--CA 1.481 1.077 0 O-C-N 124.512 1.132 . . . . 0.0 111.869 173.089 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -49.39 -49.39 18.08 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.182 0 CA-C-N 114.428 -1.26 . . . . 0.0 112.559 174.638 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.719 HG11 ' HA ' ' A' ' 56' ' ' LYS . 3.4 t -66.2 -51.27 61.16 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.975 0 O-C-N 125.071 1.482 . . . . 0.0 110.446 -177.069 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 25.3 mt-10 -60.45 -38.86 85.54 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 125.231 1.412 . . . . 0.0 114.215 -175.792 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -103.7 -16.21 15.53 Favored 'General case' 0 N--CA 1.472 0.645 0 N-CA-C 116.948 2.203 . . . . 0.0 116.948 -174.159 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 69.16 46.72 56.94 Favored Glycine 0 CA--C 1.545 1.926 0 N-CA-C 111.991 -0.443 . . . . 0.0 111.991 -169.885 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -102.71 167.82 17.82 Favored Glycine 0 CA--C 1.542 1.74 0 CA-C-N 114.036 -1.082 . . . . 0.0 114.384 -167.425 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' TRP . . . . . 0.503 ' HB3' HG21 ' A' ' 26' ' ' THR . 75.8 m95 -62.71 106.51 0.8 Allowed 'General case' 0 N--CA 1.476 0.84 0 CA-C-N 113.054 -1.573 . . . . 0.0 112.2 -178.849 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.486 HG22 HG21 ' A' ' 51' ' ' ILE . 2.6 p -57.46 -23.68 20.15 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.835 0 CA-C-N 113.624 -1.626 . . . . 0.0 113.723 168.698 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' THR . . . . . 0.503 HG21 ' HB3' ' A' ' 24' ' ' TRP . 1.7 t -55.4 -43.84 75.59 Favored 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 113.329 0.863 . . . . 0.0 113.329 -179.96 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' THR . . . . . 0.439 ' O ' HG12 ' A' ' 31' ' ' ILE . 0.0 OUTLIER -65.46 -45.06 85.24 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 123.883 0.873 . . . . 0.0 112.242 174.868 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.594 HG13 HG21 ' A' ' 14' ' ' THR . 1.6 mp -59.78 -44.89 94.92 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.89 0 CA-C-N 114.598 -1.183 . . . . 0.0 111.796 177.398 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.477 HG11 HD13 ' A' ' 43' ' ' LEU . 53.2 t -53.77 -43.79 57.18 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.999 0 C-N-CA 124.126 0.97 . . . . 0.0 112.434 178.544 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 1.1 m -59.62 -43.08 93.93 Favored 'General case' 0 N--CA 1.485 1.317 0 N-CA-C 112.693 0.627 . . . . 0.0 112.693 176.078 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.793 HG21 HG11 ' A' ' 11' ' ' VAL . 35.5 mm -68.71 -38.8 79.4 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.138 0 CA-C-N 115.319 -0.855 . . . . 0.0 109.572 -176.544 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.676 HD23 ' HB ' ' A' ' 11' ' ' VAL . 3.7 mm? -63.89 -51.78 62.95 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 125.906 1.683 . . . . 0.0 112.624 176.35 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 27.7 p -70.19 -28.94 65.7 Favored 'General case' 0 N--CA 1.472 0.67 0 N-CA-C 114.28 1.215 . . . . 0.0 114.28 -179.733 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -52.57 -27.58 17.39 Favored 'General case' 0 N--CA 1.482 1.133 0 N-CA-C 113.951 1.093 . . . . 0.0 113.951 170.881 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 46.6 t . . . . . 0 N--CA 1.482 1.15 0 C-N-CA 125.433 1.493 . . . . 0.0 111.785 170.592 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . 0.467 ' O ' ' HG ' ' A' ' 43' ' ' LEU . . . . . . . . 0 CA--C 1.538 1.495 0 N-CA-C 112.271 -0.332 . . . . 0.0 112.271 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 12.2 mt -62.84 -44.16 96.89 Favored 'General case' 0 N--CA 1.478 0.93 0 CA-C-N 113.641 -1.28 . . . . 0.0 114.035 -178.065 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 28.6 p -61.53 -39.82 92.42 Favored 'General case' 0 N--CA 1.481 1.076 0 N-CA-C 113.234 0.827 . . . . 0.0 113.234 175.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 12.4 tp -62.21 -47.76 83.02 Favored 'General case' 0 N--CA 1.484 1.245 0 C-N-CA 122.863 0.465 . . . . 0.0 110.531 171.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.477 HD13 HG11 ' A' ' 29' ' ' VAL . 63.7 mt -60.5 -32.62 71.62 Favored 'General case' 0 N--CA 1.481 1.113 0 N-CA-C 114.86 1.43 . . . . 0.0 114.86 -179.606 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -66.53 -31.23 71.81 Favored 'General case' 0 N--CA 1.482 1.156 0 N-CA-C 113.732 1.012 . . . . 0.0 113.732 174.51 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -53.5 -48.52 68.88 Favored 'General case' 0 N--CA 1.477 0.875 0 N-CA-C 115.155 1.539 . . . . 0.0 115.155 -170.648 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -144.48 50.16 1.3 Allowed 'General case' 0 N--CA 1.482 1.129 0 CA-C-O 122.482 1.134 . . . . 0.0 113.503 174.271 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -51.37 -50.39 41.24 Favored Glycine 0 N--CA 1.487 2.076 0 CA-C-N 113.473 -1.694 . . . . 0.0 113.349 -176.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 79.4 ttt180 -58.83 -48.95 79.52 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 126.125 1.77 . . . . 0.0 113.974 -179.855 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 5.6 tm-20 -80.03 18.92 0.76 Allowed 'General case' 0 N--CA 1.476 0.838 0 N-CA-C 114.001 1.111 . . . . 0.0 114.001 -179.06 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 52.2 p 53.14 124.95 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 127.213 2.205 . . . . 0.0 111.911 -168.786 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.486 HG21 HG22 ' A' ' 25' ' ' VAL . 29.5 mm -52.44 -31.18 15.07 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.055 0 CA-C-N 115.081 -0.963 . . . . 0.0 112.816 170.419 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 71.1 tttt -57.14 -64.96 0.71 Allowed 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 124.36 1.064 . . . . 0.0 111.436 177.347 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -62.73 -35.17 78.89 Favored 'General case' 0 N--CA 1.472 0.659 0 N-CA-C 113.4 0.889 . . . . 0.0 113.4 178.694 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 15.7 t80 -51.17 -67.68 0.23 Allowed 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 124.984 1.314 . . . . 0.0 111.758 173.651 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.827 HD12 HG12 ' A' ' 15' ' ' VAL . 39.6 mt -61.97 -38.18 87.58 Favored 'General case' 0 N--CA 1.479 1.003 0 N-CA-C 113.084 0.772 . . . . 0.0 113.084 -177.115 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . 0.719 ' HA ' HG11 ' A' ' 19' ' ' VAL . 96.2 mttt -54.88 -52.3 63.27 Favored 'General case' 0 C--O 1.219 -0.502 0 CA-C-N 114.353 -1.294 . . . . 0.0 113.609 177.433 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 2.3 ttpm? -74.99 -45.22 43.52 Favored 'General case' 0 N--CA 1.476 0.828 0 CA-C-N 114.945 -1.025 . . . . 0.0 112.392 176.026 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . 0.432 ' O ' ' HB2' ' A' ' 62' ' ' LYS . 44.4 tt0 -58.67 -49.93 75.72 Favored 'General case' 0 N--CA 1.471 0.596 0 O-C-N 123.384 0.428 . . . . 0.0 111.199 -174.918 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.721 HG22 HG23 ' A' ' 67' ' ' VAL . 3.2 mm -76.33 -27.4 17.55 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.162 0 CA-C-O 118.934 -0.555 . . . . 0.0 112.258 -177.924 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . 0.473 ' HB2' ' O ' ' A' ' 56' ' ' LYS . 19.9 ttmm -59.5 -27.83 66.5 Favored 'General case' 0 N--CA 1.469 0.508 0 N-CA-C 114.422 1.267 . . . . 0.0 114.422 172.005 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 75.0 mttt -93.92 -41.87 9.37 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-N 113.283 -1.781 . . . . 0.0 113.432 176.76 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . 0.432 ' HB2' ' O ' ' A' ' 58' ' ' GLU . 30.6 tttt -67.05 -60.94 2.2 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 126.511 1.924 . . . . 0.0 113.828 -175.301 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 104.09 110.21 3.46 Favored Glycine 0 CA--C 1.54 1.631 0 CA-C-N 114.795 -1.093 . . . . 0.0 112.448 -169.572 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.521 ' HZ1' HG21 ' A' ' 59' ' ' ILE . 0.0 OUTLIER -36.79 -43.36 0.43 Allowed 'General case' 0 N--CA 1.477 0.918 0 N-CA-C 119.577 3.177 . . . . 0.0 119.577 -175.668 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . 0.406 ' O ' ' HB ' ' A' ' 68' ' ' ILE . 1.8 ttp180 -56.56 -47.12 80.16 Favored 'General case' 0 N--CA 1.477 0.883 0 N-CA-C 114.146 1.165 . . . . 0.0 114.146 179.356 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -64.58 -26.13 68.27 Favored 'General case' 0 N--CA 1.475 0.798 0 CA-C-N 114.509 -1.223 . . . . 0.0 113.62 175.157 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.721 HG23 HG22 ' A' ' 59' ' ' ILE . 30.4 t -72.12 -36.9 58.15 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.042 0 C-N-CA 123.671 0.788 . . . . 0.0 110.707 179.95 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.406 ' HB ' ' O ' ' A' ' 65' ' ' ARG . 19.9 mm -51.76 -46.79 39.65 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.171 0 C-N-CA 124.12 0.968 . . . . 0.0 110.748 167.934 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -69.99 -49.46 51.3 Favored 'General case' 0 N--CA 1.477 0.913 0 N-CA-C 113.802 1.038 . . . . 0.0 113.802 177.019 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' TRP . . . . . 0.425 ' CE3' ' HG3' ' A' ' 1' ' ' MET . 32.2 t90 . . . . . 0 N--CA 1.48 1.031 0 C-N-CA 126.412 1.885 . . . . 0.0 112.98 -178.049 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.637 ' HE2' HG22 ' A' ' 15' ' ' VAL . 56.8 mtp . . . . . 0 CA--C 1.542 0.651 0 N-CA-C 112.238 0.459 . . . . 0.0 112.238 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . 0.404 ' HA ' ' O ' ' A' ' 7' ' ' ILE . . . -57.46 -52.37 65.66 Favored 'General case' 0 N--CA 1.488 1.471 0 CA-C-N 114.806 -1.088 . . . . 0.0 112.96 176.772 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . 0.424 ' HZ1' ' HG3' ' A' ' 3' ' ' LYS . 10.7 tptp -66.04 -58.35 5.68 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 127.491 2.316 . . . . 0.0 112.461 -177.425 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . 0.447 ' HB2' ' O ' ' A' ' 70' ' ' TRP . 0.7 OUTLIER -74.41 -47.54 33.22 Favored 'General case' 0 N--CA 1.477 0.883 0 N-CA-C 115.972 1.841 . . . . 0.0 115.972 -171.796 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . 0.636 ' HB2' HD13 ' A' ' 7' ' ' ILE . 47.8 m-85 -100.14 -11.2 20.67 Favored 'General case' 0 N--CA 1.473 0.683 0 N-CA-C 115.747 1.758 . . . . 0.0 115.747 -169.021 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 75.79 61.01 3.0 Favored Glycine 0 N--CA 1.478 1.443 0 O-C-N 124.614 1.197 . . . . 0.0 111.245 -173.413 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . 0.636 HD13 ' HB2' ' A' ' 5' ' ' PHE . 1.0 OUTLIER -117.76 145.53 36.73 Favored Pre-proline 0 N--CA 1.478 0.951 0 C-N-CA 125.287 1.435 . . . . 0.0 111.941 179.696 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_endo -89.78 154.17 5.06 Favored 'Trans proline' 0 CA--C 1.535 0.548 0 N-CA-C 109.176 -1.125 . . . . 0.0 109.176 158.383 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -48.77 -29.78 4.92 Favored 'General case' 0 CA--C 1.544 0.73 0 N-CA-C 115.23 1.567 . . . . 0.0 115.23 176.774 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -39.67 -44.91 1.59 Allowed 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 126.388 1.875 . . . . 0.0 114.503 172.069 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.849 HG11 HG21 ' A' ' 31' ' ' ILE . 22.6 m -101.05 -29.51 3.17 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.93 0 N-CA-C 114.959 1.466 . . . . 0.0 114.959 -176.219 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . 0.418 ' O ' ' HG ' ' A' ' 16' ' ' LEU . . . -68.48 -31.21 70.32 Favored 'General case' 0 CA--C 1.546 0.817 0 N-CA-C 112.547 0.573 . . . . 0.0 112.547 175.631 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -61.06 -42.87 99.94 Favored Glycine 0 CA--C 1.543 1.84 0 CA-C-O 122.186 0.881 . . . . 0.0 112.393 170.485 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' THR . . . . . 0.752 HG21 HG13 ' A' ' 28' ' ' ILE . 1.4 m -62.62 -36.89 84.22 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 124.928 1.291 . . . . 0.0 113.562 176.02 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.637 HG22 ' HE2' ' A' ' 1' ' ' MET . 2.4 t -58.05 -41.05 79.53 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 C-N-CA 124.03 0.932 . . . . 0.0 112.443 170.691 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.453 HD21 ' HG3' ' A' ' 64' ' ' LYS . 53.2 mt -60.04 -37.31 79.43 Favored 'General case' 0 N--CA 1.476 0.837 0 N-CA-C 112.73 0.641 . . . . 0.0 112.73 177.497 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 27.5 t-20 -56.96 -44.57 82.72 Favored 'General case' 0 N--CA 1.474 0.756 0 CA-C-N 115.765 -0.652 . . . . 0.0 112.527 175.864 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 3.7 t -48.49 -48.79 14.15 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.155 0 C-N-CA 123.086 0.555 . . . . 0.0 111.699 172.131 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.774 HG11 ' HA ' ' A' ' 56' ' ' LYS . 5.8 t -67.5 -50.46 61.5 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.389 0 CA-C-N 113.997 -1.456 . . . . 0.0 110.789 -176.351 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 29.2 mt-10 -65.81 -42.02 91.15 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 126.478 1.911 . . . . 0.0 115.606 -177.728 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -99.62 -22.91 15.23 Favored 'General case' 0 N--CA 1.477 0.919 0 N-CA-C 116.219 1.933 . . . . 0.0 116.219 -173.0 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . 0.839 ' HA3' ' HZ2' ' A' ' 56' ' ' LYS . . . 77.39 34.02 41.89 Favored Glycine 0 N--CA 1.481 1.68 0 N-CA-C 112.02 -0.432 . . . . 0.0 112.02 -171.248 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -99.85 172.53 24.8 Favored Glycine 0 N--CA 1.47 0.949 0 CA-C-N 113.263 -1.468 . . . . 0.0 114.102 -165.458 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 89.4 m95 -57.67 100.6 0.06 Allowed 'General case' 0 N--CA 1.476 0.866 0 CA-C-N 111.764 -2.218 . . . . 0.0 114.148 -176.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.57 HG22 HG13 ' A' ' 51' ' ' ILE . 4.3 p -56.72 -25.53 21.79 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 CA-C-N 112.553 -2.112 . . . . 0.0 113.779 169.244 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 11.5 p -61.34 -46.36 90.58 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 124.176 0.99 . . . . 0.0 112.277 -178.547 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' THR . . . . . 0.427 ' O ' HG12 ' A' ' 31' ' ' ILE . 0.2 OUTLIER -60.8 -44.88 96.27 Favored 'General case' 0 N--CA 1.478 0.945 0 CA-C-N 114.01 -1.45 . . . . 0.0 110.994 175.039 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.752 HG13 HG21 ' A' ' 14' ' ' THR . 1.7 mp -62.63 -47.67 91.84 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.084 0 C-N-CA 124.073 0.949 . . . . 0.0 111.749 179.023 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.48 HG11 HD13 ' A' ' 43' ' ' LEU . 39.8 t -52.41 -43.5 41.34 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.067 0 C-N-CA 124.379 1.072 . . . . 0.0 111.325 179.064 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 90.4 p -65.79 -32.09 73.43 Favored 'General case' 0 N--CA 1.478 0.965 0 N-CA-C 115.391 1.626 . . . . 0.0 115.391 176.324 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.849 HG21 HG11 ' A' ' 11' ' ' VAL . 40.5 mm -70.9 -40.47 76.5 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.33 0 C-N-CA 123.7 0.8 . . . . 0.0 109.583 177.235 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.667 ' HB3' ' HA3' ' A' ' 39' ' ' GLY . 3.8 mm? -61.59 -52.07 65.94 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 125.365 1.466 . . . . 0.0 112.745 174.606 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 7.5 p -65.76 -27.1 68.05 Favored 'General case' 0 N--CA 1.484 1.243 0 N-CA-C 114.159 1.17 . . . . 0.0 114.159 179.317 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -53.0 -29.36 28.79 Favored 'General case' 0 N--CA 1.483 1.225 0 N-CA-C 113.892 1.071 . . . . 0.0 113.892 166.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 54.5 t . . . . . 0 N--CA 1.491 1.619 0 C-N-CA 124.238 1.015 . . . . 0.0 112.411 172.192 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . 0.667 ' HA3' ' HB3' ' A' ' 32' ' ' LEU . . . . . . . . 0 N--CA 1.475 1.25 0 N-CA-C 111.413 -0.675 . . . . 0.0 111.413 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 44.7 mt -58.86 -48.46 81.28 Favored 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 115.26 1.578 . . . . 0.0 115.26 -176.222 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' SER . . . . . 0.434 ' HB2' ' HD1' ' A' ' 5' ' ' PHE . 29.6 p -60.69 -39.49 88.66 Favored 'General case' 0 N--CA 1.475 0.791 0 N-CA-C 114.488 1.292 . . . . 0.0 114.488 175.669 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.427 HD11 ' HE1' ' A' ' 1' ' ' MET . 13.8 tp -63.79 -48.46 76.79 Favored 'General case' 0 N--CA 1.483 1.2 0 C-N-CA 122.505 0.322 . . . . 0.0 110.888 173.839 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.48 HD13 HG11 ' A' ' 29' ' ' VAL . 80.5 mt -61.98 -27.57 68.94 Favored 'General case' 0 N--CA 1.482 1.131 0 N-CA-C 114.843 1.423 . . . . 0.0 114.843 -176.344 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -70.81 -45.4 64.7 Favored 'General case' 0 CA--C 1.549 0.905 0 N-CA-C 112.839 0.681 . . . . 0.0 112.839 173.933 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -65.12 -40.47 94.53 Favored 'General case' 0 N--CA 1.477 0.917 0 CA-C-O 122.715 1.245 . . . . 0.0 111.999 179.902 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.525 ' HB3' ' HA ' ' A' ' 51' ' ' ILE . . . -59.18 -26.76 65.07 Favored 'General case' 0 CA--C 1.537 0.447 0 N-CA-C 116.438 2.014 . . . . 0.0 116.438 179.131 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -47.78 -40.62 18.81 Favored Glycine 0 N--CA 1.482 1.73 0 C-N-CA 125.598 1.57 . . . . 0.0 113.641 -177.942 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 35.4 ttp-105 -53.62 -47.78 69.91 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 125.184 1.394 . . . . 0.0 113.931 -173.937 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 11.8 tt0 -126.0 37.32 4.36 Favored 'General case' 0 N--CA 1.478 0.968 0 N-CA-C 114.285 1.217 . . . . 0.0 114.285 -177.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 72.0 p 50.77 127.49 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.502 0 C-N-CA 125.603 1.561 . . . . 0.0 112.792 -172.057 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.57 HG13 HG22 ' A' ' 25' ' ' VAL . 6.3 tp -39.04 -51.65 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 N-CA-C 117.728 2.492 . . . . 0.0 117.728 -172.791 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 56.3 tttt -65.95 -57.17 8.44 Favored 'General case' 0 N--CA 1.469 0.516 0 N-CA-C 113.618 0.97 . . . . 0.0 113.618 179.877 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -60.59 -38.17 83.75 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 124.591 1.156 . . . . 0.0 112.763 178.497 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . 0.4 ' HB3' ' O ' ' A' ' 51' ' ' ILE . 90.4 t80 -47.66 -63.51 1.04 Allowed 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 125.961 1.704 . . . . 0.0 109.861 170.233 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 79.1 mt -64.24 -41.98 96.74 Favored 'General case' 0 N--CA 1.473 0.721 0 N-CA-C 113.894 1.072 . . . . 0.0 113.894 -176.575 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . 0.839 ' HZ2' ' HA3' ' A' ' 22' ' ' GLY . 29.2 mtpp -55.97 -44.73 78.79 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 114.653 -1.158 . . . . 0.0 113.447 177.466 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . 0.42 ' O ' ' HG2' ' A' ' 61' ' ' LYS . 66.7 tttt -77.3 -50.13 13.51 Favored 'General case' 0 N--CA 1.475 0.787 0 CA-C-N 115.292 -0.867 . . . . 0.0 112.051 172.947 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . 0.5 ' O ' ' HB2' ' A' ' 62' ' ' LYS . 4.2 tp10 -54.51 -51.38 65.29 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 123.979 0.912 . . . . 0.0 111.831 -173.51 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.707 HG22 HG22 ' A' ' 67' ' ' VAL . 1.3 mm -75.87 -26.32 17.69 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.05 0 CA-C-N 115.623 -0.717 . . . . 0.0 111.846 -175.255 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 6.7 mtpp -60.07 -39.05 84.72 Favored 'General case' 0 CA--C 1.538 0.487 0 N-CA-C 115.336 1.606 . . . . 0.0 115.336 170.285 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . 0.42 ' HG2' ' O ' ' A' ' 57' ' ' LYS . 70.4 mmtt -79.32 -46.24 18.09 Favored 'General case' 0 N--CA 1.476 0.834 0 O-C-N 126.188 2.18 . . . . 0.0 110.93 176.977 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . 0.5 ' HB2' ' O ' ' A' ' 58' ' ' GLU . 5.7 tptp -66.53 -52.22 48.17 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 126.728 2.011 . . . . 0.0 114.822 -175.561 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 96.6 117.87 3.47 Favored Glycine 0 N--CA 1.483 1.828 0 CA-C-N 114.593 -1.185 . . . . 0.0 110.332 -173.94 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.706 ' HD2' ' H ' ' A' ' 64' ' ' LYS . 9.8 mptt -36.18 -46.78 0.53 Allowed 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 117.782 2.512 . . . . 0.0 117.782 -177.422 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.22 -51.63 69.14 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 125.538 1.535 . . . . 0.0 114.958 176.89 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -64.83 -27.3 68.78 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-N 114.423 -1.262 . . . . 0.0 112.907 174.771 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.707 HG22 HG22 ' A' ' 59' ' ' ILE . 98.7 t -67.13 -41.78 87.43 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.251 0 C-N-CA 123.191 0.597 . . . . 0.0 110.942 175.19 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 35.1 mm -51.15 -42.66 25.87 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.856 0 O-C-N 124.18 0.925 . . . . 0.0 110.764 172.061 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . 0.414 ' O ' ' HB2' ' A' ' 3' ' ' LYS . . . -71.38 -52.62 17.62 Favored 'General case' 0 N--CA 1.473 0.725 0 O-C-N 124.683 1.239 . . . . 0.0 112.585 176.117 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' TRP . . . . . 0.447 ' O ' ' HB2' ' A' ' 4' ' ' GLU . 30.9 t90 . . . . . 0 N--CA 1.485 1.277 0 C-N-CA 127.034 2.134 . . . . 0.0 112.646 -178.449 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.47 ' HE2' HD11 ' A' ' 42' ' ' LEU . 72.3 mtp . . . . . 0 N--CA 1.472 0.63 0 N-CA-C 112.184 0.439 . . . . 0.0 112.184 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -56.79 -49.6 74.83 Favored 'General case' 0 CA--C 1.547 0.828 0 CA-C-N 115.541 -0.754 . . . . 0.0 112.602 177.499 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 50.2 tttm -76.32 -51.65 11.54 Favored 'General case' 0 N--CA 1.475 0.799 0 CA-C-N 113.407 -1.724 . . . . 0.0 113.303 -173.195 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . 0.429 ' HB2' ' O ' ' A' ' 70' ' ' TRP . 1.8 mp0 -79.03 -33.33 44.91 Favored 'General case' 0 N--CA 1.47 0.536 0 N-CA-C 115.94 1.83 . . . . 0.0 115.94 -173.411 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . 0.408 ' HB2' HD11 ' A' ' 7' ' ' ILE . 26.7 m-85 -113.41 -14.13 12.79 Favored 'General case' 0 N--CA 1.474 0.774 0 N-CA-C 117.621 2.452 . . . . 0.0 117.621 -171.556 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 82.33 58.84 2.36 Favored Glycine 0 CA--C 1.538 1.506 0 C-N-CA 124.133 0.873 . . . . 0.0 111.159 -179.155 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . 0.546 HG23 ' HB3' ' A' ' 12' ' ' ALA . 0.8 OUTLIER -120.39 146.71 43.51 Favored Pre-proline 0 N--CA 1.479 1.009 0 CA-C-N 112.747 -1.726 . . . . 0.0 113.307 -176.102 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -91.51 161.12 3.59 Favored 'Trans proline' 0 CA--C 1.537 0.662 0 C-N-CA 121.123 1.215 . . . . 0.0 110.745 160.535 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -52.75 -32.08 41.44 Favored 'General case' 0 CA--C 1.544 0.716 0 N-CA-C 114.07 1.137 . . . . 0.0 114.07 174.312 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -40.84 -39.46 1.13 Allowed 'General case' 0 N--CA 1.485 1.323 0 C-N-CA 126.784 2.033 . . . . 0.0 114.976 172.879 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.943 HG11 HG21 ' A' ' 31' ' ' ILE . 17.3 m -110.95 -31.63 2.25 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.354 0 N-CA-C 114.939 1.459 . . . . 0.0 114.939 -177.162 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . 0.546 ' HB3' HG23 ' A' ' 7' ' ' ILE . . . -65.94 -36.91 84.65 Favored 'General case' 0 N--CA 1.476 0.864 0 N-CA-C 112.61 0.596 . . . . 0.0 112.61 174.016 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . 0.515 ' O ' ' HB2' ' A' ' 16' ' ' LEU . . . -58.18 -41.95 95.02 Favored Glycine 0 CA--C 1.54 1.603 0 C-N-CA 124.033 0.825 . . . . 0.0 112.563 171.813 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' THR . . . . . 0.739 HG21 HG13 ' A' ' 28' ' ' ILE . 0.2 OUTLIER -62.14 -34.05 75.65 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 125.546 1.538 . . . . 0.0 114.045 176.719 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.436 HG21 HD22 ' A' ' 32' ' ' LEU . 5.2 t -58.15 -46.93 88.34 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.29 0 C-N-CA 123.846 0.858 . . . . 0.0 112.798 171.045 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.515 ' HB2' ' O ' ' A' ' 13' ' ' GLY . 9.5 mp -52.5 -38.61 59.94 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 124.912 1.285 . . . . 0.0 113.384 173.026 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 15.3 t-20 -57.4 -49.13 77.18 Favored 'General case' 0 N--CA 1.485 1.279 0 O-C-N 123.873 0.733 . . . . 0.0 110.815 177.768 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 2.4 t -50.19 -50.89 19.21 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.767 0 O-C-N 124.366 1.041 . . . . 0.0 112.77 173.31 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.523 HG11 ' HA ' ' A' ' 56' ' ' LYS . 9.0 t -65.34 -48.97 81.22 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.235 0 CA-C-N 114.647 -1.16 . . . . 0.0 112.411 -175.075 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -71.39 -46.72 59.59 Favored 'General case' 0 CA--C 1.548 0.872 0 N-CA-C 114.692 1.367 . . . . 0.0 114.692 -177.425 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -96.04 -9.18 31.59 Favored 'General case' 0 N--CA 1.475 0.807 0 N-CA-C 115.733 1.753 . . . . 0.0 115.733 -170.352 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 65.19 33.13 86.1 Favored Glycine 0 CA--C 1.542 1.773 0 C-N-CA 124.327 0.965 . . . . 0.0 112.494 -171.523 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -78.31 167.66 53.39 Favored Glycine 0 N--CA 1.476 1.357 0 C-N-CA 125.372 1.463 . . . . 0.0 115.698 -175.044 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' TRP . . . . . 0.423 ' HB3' HG21 ' A' ' 26' ' ' THR . 2.5 m-90 -68.2 106.39 2.42 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-N 113.454 -1.373 . . . . 0.0 111.999 -178.666 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 2.8 p -57.58 -24.84 23.14 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.781 0 CA-C-N 114.122 -1.399 . . . . 0.0 114.07 173.65 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' THR . . . . . 0.423 HG21 ' HB3' ' A' ' 24' ' ' TRP . 10.0 t -60.0 -44.54 94.48 Favored 'General case' 0 N--CA 1.483 1.214 0 C-N-CA 124.053 0.941 . . . . 0.0 113.239 -179.823 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' THR . . . . . 0.453 ' O ' HG12 ' A' ' 31' ' ' ILE . 0.0 OUTLIER -65.28 -42.76 92.81 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 124.254 1.021 . . . . 0.0 111.787 175.657 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.739 HG13 HG21 ' A' ' 14' ' ' THR . 1.8 mp -62.3 -46.1 97.22 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 C-N-CA 124.427 1.091 . . . . 0.0 111.037 178.235 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.478 HG11 HD13 ' A' ' 43' ' ' LEU . 39.6 t -56.11 -45.27 80.62 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.837 0 C-N-CA 124.344 1.058 . . . . 0.0 111.978 174.009 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 36.9 m -58.34 -37.03 74.32 Favored 'General case' 0 N--CA 1.486 1.344 0 N-CA-C 113.855 1.057 . . . . 0.0 113.855 175.256 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.943 HG21 HG11 ' A' ' 11' ' ' VAL . 43.5 mm -75.9 -39.34 37.56 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.41 0 C-N-CA 123.926 0.891 . . . . 0.0 110.434 179.737 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.665 HD23 ' HB ' ' A' ' 11' ' ' VAL . 3.7 mm? -60.57 -50.94 71.51 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 125.564 1.546 . . . . 0.0 112.251 174.003 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 18.0 p -67.25 -30.55 70.47 Favored 'General case' 0 N--CA 1.484 1.229 0 N-CA-C 114.609 1.337 . . . . 0.0 114.609 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -49.1 -40.6 32.66 Favored 'General case' 0 N--CA 1.485 1.291 0 N-CA-C 113.52 0.933 . . . . 0.0 113.52 170.37 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 57.7 t . . . . . 0 N--CA 1.487 1.382 0 C-N-CA 125.139 1.376 . . . . 0.0 112.934 173.008 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . 0.543 ' HA3' ' HB3' ' A' ' 32' ' ' LEU . . . . . . . . 0 CA--C 1.535 1.307 0 N-CA-C 111.57 -0.612 . . . . 0.0 111.57 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 30.3 mt -59.34 -45.71 90.62 Favored 'General case' 0 N--CA 1.48 1.03 0 N-CA-C 114.983 1.475 . . . . 0.0 114.983 -177.789 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 51.9 p -66.2 -37.58 85.93 Favored 'General case' 0 N--CA 1.48 1.033 0 N-CA-C 113.926 1.084 . . . . 0.0 113.926 176.132 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.47 HD11 ' HE2' ' A' ' 1' ' ' MET . 12.7 tp -65.98 -44.16 85.71 Favored 'General case' 0 N--CA 1.482 1.149 0 CA-C-O 120.963 0.411 . . . . 0.0 110.217 173.033 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.478 HD13 HG11 ' A' ' 29' ' ' VAL . 82.6 mt -64.9 -22.74 67.05 Favored 'General case' 0 N--CA 1.476 0.874 0 N-CA-C 115.031 1.493 . . . . 0.0 115.031 178.997 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -72.98 -47.85 41.69 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-N 115.706 -0.679 . . . . 0.0 112.16 170.15 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -60.22 -35.56 75.71 Favored 'General case' 0 N--CA 1.487 1.391 0 C-N-CA 124.221 1.009 . . . . 0.0 111.739 177.08 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -52.74 -26.87 15.43 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 127.209 2.204 . . . . 0.0 115.821 174.855 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -46.46 -43.22 14.62 Favored Glycine 0 N--CA 1.483 1.769 0 C-N-CA 125.676 1.608 . . . . 0.0 114.249 -175.5 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 66.6 ttp85 -47.48 -55.8 8.33 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 126.01 1.724 . . . . 0.0 113.486 -176.597 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 10.5 tt0 -136.38 38.54 2.69 Favored 'General case' 0 N--CA 1.483 1.198 0 N-CA-C 113.656 0.984 . . . . 0.0 113.656 -174.216 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 23.2 t 45.86 125.77 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 125.313 1.445 . . . . 0.0 114.096 -173.849 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 10.5 tp -31.3 -49.74 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.481 1.083 0 N-CA-C 118.355 2.724 . . . . 0.0 118.355 -174.32 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 52.2 tptt -55.77 -70.05 0.12 Allowed 'General case' 0 N--CA 1.483 1.215 0 C-N-CA 124.575 1.15 . . . . 0.0 111.848 176.525 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -61.3 -38.44 86.83 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 124.377 1.071 . . . . 0.0 113.525 179.709 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 85.9 t80 -46.8 -60.43 2.42 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 124.84 1.256 . . . . 0.0 111.587 173.359 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 67.4 mt -67.05 -43.81 81.76 Favored 'General case' 0 N--CA 1.478 0.952 0 N-CA-C 113.992 1.108 . . . . 0.0 113.992 -177.085 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . 0.523 ' HA ' HG11 ' A' ' 19' ' ' VAL . 6.5 mmmt -52.24 -43.37 64.29 Favored 'General case' 0 N--CA 1.478 0.947 0 CA-C-N 113.995 -1.457 . . . . 0.0 114.438 177.911 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 33.4 tttm -80.53 -55.25 4.99 Favored 'General case' 0 N--CA 1.476 0.847 0 CA-C-N 114.583 -1.189 . . . . 0.0 111.67 172.235 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . 0.555 ' O ' ' HB2' ' A' ' 62' ' ' LYS . 34.3 tt0 -54.06 -51.43 64.09 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-O 117.038 -1.458 . . . . 0.0 110.895 -170.478 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.791 HG22 HG22 ' A' ' 67' ' ' VAL . 3.4 mm -78.92 -23.51 12.86 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.349 0 CA-C-O 118.719 -0.658 . . . . 0.0 112.335 -174.707 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 1.2 tppm? -61.52 -37.64 84.47 Favored 'General case' 0 N--CA 1.466 0.368 0 N-CA-C 113.997 1.11 . . . . 0.0 113.997 172.436 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 45.1 mttt -90.93 -37.86 13.25 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-N 112.465 -2.152 . . . . 0.0 113.419 -178.453 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . 0.555 ' HB2' ' O ' ' A' ' 58' ' ' GLU . 24.1 tttm -67.51 -45.44 75.78 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 126.562 1.945 . . . . 0.0 113.574 -176.994 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 98.32 102.97 2.29 Favored Glycine 0 CA--C 1.534 1.229 0 CA-C-O 122.11 0.839 . . . . 0.0 111.409 -177.155 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.47 ' HD2' ' H ' ' A' ' 64' ' ' LYS . 2.2 mptp? -31.58 -47.6 0.12 Allowed 'General case' 0 N--CA 1.477 0.909 0 N-CA-C 119.136 3.013 . . . . 0.0 119.136 -178.076 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 4.8 ttp-105 -62.27 -47.81 82.68 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 124.76 1.224 . . . . 0.0 113.628 179.56 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -60.98 -26.95 67.94 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-N 114.642 -1.163 . . . . 0.0 113.952 172.489 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.791 HG22 HG22 ' A' ' 59' ' ' ILE . 63.9 t -68.6 -40.38 81.76 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.291 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.635 176.442 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 45.5 mm -53.52 -45.83 59.09 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.08 0 C-N-CA 123.485 0.714 . . . . 0.0 109.895 172.145 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -64.8 -52.58 56.05 Favored 'General case' 0 N--CA 1.482 1.134 0 N-CA-C 112.79 0.663 . . . . 0.0 112.79 176.111 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' TRP . . . . . 0.429 ' O ' ' HB2' ' A' ' 4' ' ' GLU . 33.9 t90 . . . . . 0 N--CA 1.479 1.018 0 C-N-CA 126.051 1.74 . . . . 0.0 112.336 178.36 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.535 ' HE2' HG22 ' A' ' 15' ' ' VAL . 46.1 mtp . . . . . 0 N--CA 1.471 0.577 0 N-CA-C 112.457 0.54 . . . . 0.0 112.457 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . 0.474 ' HA ' ' O ' ' A' ' 7' ' ' ILE . . . -52.22 -51.83 55.92 Favored 'General case' 0 N--CA 1.47 0.538 0 O-C-N 124.568 1.167 . . . . 0.0 112.73 176.708 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 14.7 tttt -79.93 -51.75 8.72 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 112.717 -2.038 . . . . 0.0 114.578 -173.555 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 10.6 mt-10 -73.04 -35.15 66.69 Favored 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 115.382 1.623 . . . . 0.0 115.382 -173.772 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . 0.403 ' HD1' ' HB2' ' A' ' 41' ' ' SER . 50.6 m-85 -109.04 -13.85 14.64 Favored 'General case' 0 N--CA 1.478 0.933 0 N-CA-C 117.356 2.354 . . . . 0.0 117.356 -173.997 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 82.75 60.49 2.07 Favored Glycine 0 CA--C 1.542 1.765 0 O-C-N 124.342 1.027 . . . . 0.0 110.65 -177.83 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . 0.474 ' O ' ' HA ' ' A' ' 2' ' ' ALA . 0.8 OUTLIER -125.23 143.38 44.2 Favored Pre-proline 0 N--CA 1.481 1.12 0 CA-C-N 113.63 -1.285 . . . . 0.0 112.457 -175.924 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_endo -87.92 159.54 7.4 Favored 'Trans proline' 0 CA--C 1.538 0.675 0 C-N-CA 120.94 1.094 . . . . 0.0 109.376 163.797 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -50.58 -33.2 21.1 Favored 'General case' 0 N--CA 1.476 0.874 0 N-CA-C 114.253 1.205 . . . . 0.0 114.253 174.895 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -37.03 -41.85 0.38 Allowed 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 127.45 2.3 . . . . 0.0 115.917 169.725 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.898 HG11 HG21 ' A' ' 31' ' ' ILE . 19.0 m -111.37 -28.53 2.57 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 N-CA-C 115.395 1.628 . . . . 0.0 115.395 -176.749 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . 0.463 ' O ' ' HG ' ' A' ' 16' ' ' LEU . . . -66.28 -33.61 76.14 Favored 'General case' 0 N--CA 1.477 0.891 0 N-CA-C 112.71 0.633 . . . . 0.0 112.71 171.433 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -59.62 -37.41 92.22 Favored Glycine 0 CA--C 1.539 1.59 0 C-N-CA 124.448 1.023 . . . . 0.0 112.674 171.349 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' THR . . . . . 0.611 HG21 HG13 ' A' ' 28' ' ' ILE . 0.2 OUTLIER -71.98 -37.15 69.93 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 125.188 1.395 . . . . 0.0 112.598 177.908 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.646 HG21 HD22 ' A' ' 32' ' ' LEU . 20.9 t -55.93 -41.65 68.23 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.237 0 C-N-CA 123.423 0.689 . . . . 0.0 111.88 166.366 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.463 ' HG ' ' O ' ' A' ' 12' ' ' ALA . 77.6 mt -61.25 -37.1 81.91 Favored 'General case' 0 N--CA 1.486 1.347 0 N-CA-C 114.518 1.303 . . . . 0.0 114.518 177.929 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 12.0 t-20 -52.35 -49.2 64.8 Favored 'General case' 0 CA--C 1.545 0.767 0 CA-C-N 114.395 -1.275 . . . . 0.0 112.065 173.424 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.435 ' HB ' ' O ' ' A' ' 15' ' ' VAL . 5.0 t -52.08 -50.57 34.8 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 CA-C-N 113.295 -1.775 . . . . 0.0 111.502 175.848 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.576 HG11 ' HA ' ' A' ' 56' ' ' LYS . 13.0 t -66.86 -48.62 79.21 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.255 0 O-C-N 123.991 0.807 . . . . 0.0 111.043 -176.124 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -63.73 -44.01 94.81 Favored 'General case' 0 CA--C 1.542 0.656 0 N-CA-C 114.446 1.276 . . . . 0.0 114.446 -176.638 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -103.06 -19.94 14.37 Favored 'General case' 0 N--CA 1.479 1.005 0 N-CA-C 115.559 1.689 . . . . 0.0 115.559 -171.194 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 71.17 39.69 62.33 Favored Glycine 0 N--CA 1.481 1.66 0 N-CA-C 109.905 -1.278 . . . . 0.0 109.905 -166.767 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -83.82 162.8 39.58 Favored Glycine 0 CA--C 1.527 0.806 0 N-CA-C 109.168 -1.573 . . . . 0.0 109.168 -178.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' TRP . . . . . 0.439 ' O ' HD11 ' A' ' 28' ' ' ILE . 31.5 m95 -64.76 104.6 0.85 Allowed 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 112.365 -1.918 . . . . 0.0 112.48 -175.132 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.56 HG22 HG13 ' A' ' 51' ' ' ILE . 3.1 p -57.35 -24.91 22.51 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.927 0 CA-C-N 113.147 -1.842 . . . . 0.0 113.39 171.395 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 3.1 p -61.34 -47.21 86.95 Favored 'General case' 0 N--CA 1.484 1.246 0 N-CA-C 113.786 1.032 . . . . 0.0 113.786 -179.516 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -62.4 -40.83 97.79 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 123.24 0.616 . . . . 0.0 111.357 173.862 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.611 HG13 HG21 ' A' ' 14' ' ' THR . 1.8 mp -60.02 -48.69 86.88 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 C-N-CA 124.878 1.271 . . . . 0.0 112.253 177.504 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.52 HG21 ' O ' ' A' ' 25' ' ' VAL . 53.5 t -49.59 -45.68 20.34 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 C-N-CA 124.406 1.082 . . . . 0.0 112.264 178.356 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -62.27 -41.72 98.71 Favored 'General case' 0 N--CA 1.485 1.314 0 N-CA-C 112.917 0.71 . . . . 0.0 112.917 178.38 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.898 HG21 HG11 ' A' ' 11' ' ' VAL . 36.7 mm -70.9 -38.86 74.19 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.145 0 C-N-CA 123.436 0.695 . . . . 0.0 109.805 -179.057 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.765 HD23 ' HB ' ' A' ' 11' ' ' VAL . 3.2 mm? -58.05 -53.44 58.18 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 125.475 1.51 . . . . 0.0 112.039 173.78 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 11.0 m -71.86 -21.19 61.7 Favored 'General case' 0 N--CA 1.477 0.916 0 N-CA-C 113.496 0.924 . . . . 0.0 113.496 179.473 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -58.89 -28.83 66.53 Favored 'General case' 0 N--CA 1.484 1.26 0 C-N-CA 123.967 0.907 . . . . 0.0 113.402 172.425 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 74.8 t . . . . . 0 N--CA 1.484 1.256 0 C-N-CA 124.045 0.938 . . . . 0.0 111.495 170.916 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . 0.436 ' O ' ' HG ' ' A' ' 43' ' ' LEU . . . . . . . . 0 N--CA 1.478 1.493 0 N-CA-C 114.901 0.72 . . . . 0.0 114.901 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 43.9 mt -67.05 -44.93 78.89 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 124.242 1.017 . . . . 0.0 113.42 -177.143 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' SER . . . . . 0.403 ' HB2' ' HD1' ' A' ' 5' ' ' PHE . 0.0 OUTLIER -55.44 -39.79 70.74 Favored 'General case' 0 N--CA 1.481 1.082 0 O-C-N 124.079 0.862 . . . . 0.0 112.838 171.903 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 16.8 tp -64.09 -48.17 77.2 Favored 'General case' 0 N--CA 1.477 0.884 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.042 175.859 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.436 ' HG ' ' O ' ' A' ' 39' ' ' GLY . 44.1 mt -61.05 -30.94 70.62 Favored 'General case' 0 N--CA 1.479 0.999 0 N-CA-C 114.603 1.334 . . . . 0.0 114.603 179.078 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -66.62 -50.39 63.15 Favored 'General case' 0 N--CA 1.478 0.96 0 CA-C-N 115.882 -0.599 . . . . 0.0 112.211 171.402 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -61.16 -34.73 75.49 Favored 'General case' 0 N--CA 1.485 1.301 0 CA-C-O 121.743 0.782 . . . . 0.0 112.345 176.273 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -67.35 -22.57 65.58 Favored 'General case' 0 N--CA 1.478 0.934 0 N-CA-C 116.191 1.923 . . . . 0.0 116.191 179.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -49.42 -34.58 19.44 Favored Glycine 0 CA--C 1.549 2.208 0 C-N-CA 124.688 1.137 . . . . 0.0 112.741 177.123 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 18.5 ttm180 -52.32 -50.87 61.39 Favored 'General case' 0 CA--C 1.549 0.906 0 C-N-CA 126.455 1.902 . . . . 0.0 114.977 -175.427 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 16.0 tt0 -133.5 40.58 3.13 Favored 'General case' 0 N--CA 1.479 0.977 0 N-CA-C 113.283 0.846 . . . . 0.0 113.283 -175.529 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 89.0 p 44.86 115.14 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.499 0 C-N-CA 125.303 1.441 . . . . 0.0 113.727 -172.445 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.56 HG13 HG22 ' A' ' 25' ' ' VAL . 8.0 tp -23.88 -56.82 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.483 1.177 0 N-CA-C 119.131 3.012 . . . . 0.0 119.131 -175.484 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 54.2 tttt -64.11 -55.52 21.35 Favored 'General case' 0 N--CA 1.48 1.045 0 N-CA-C 112.835 0.68 . . . . 0.0 112.835 -179.86 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -62.9 -38.66 91.81 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 124.936 1.294 . . . . 0.0 112.158 177.759 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 69.1 t80 -51.75 -58.42 6.45 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 125.617 1.567 . . . . 0.0 111.18 174.791 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.602 HD12 HG12 ' A' ' 15' ' ' VAL . 60.6 mt -70.47 -41.12 73.19 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 114.811 1.411 . . . . 0.0 114.811 -179.346 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . 0.576 ' HA ' HG11 ' A' ' 19' ' ' VAL . 50.4 tptt -55.26 -49.96 70.72 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-N 114.004 -1.453 . . . . 0.0 113.174 178.076 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 52.8 tttp -74.55 -54.62 7.14 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-N 114.759 -1.109 . . . . 0.0 112.1 174.656 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . 0.409 ' O ' ' HB2' ' A' ' 62' ' ' LYS . 16.1 mt-10 -61.36 -41.78 97.63 Favored 'General case' 0 N--CA 1.472 0.625 0 N-CA-C 113.972 1.101 . . . . 0.0 113.972 -169.156 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.826 HG22 HG23 ' A' ' 67' ' ' VAL . 2.8 mm -78.09 -26.56 14.51 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.851 0 C-N-CA 120.13 -0.628 . . . . 0.0 112.192 -179.346 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 10.3 tppt? -61.94 -27.6 68.94 Favored 'General case' 0 CA--C 1.542 0.643 0 N-CA-C 114.332 1.234 . . . . 0.0 114.332 170.247 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 42.3 mmtm -89.18 -43.15 11.23 Favored 'General case' 0 N--CA 1.483 1.215 0 CA-C-N 113.647 -1.615 . . . . 0.0 111.387 178.475 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . 0.457 ' HD3' HG21 ' A' ' 67' ' ' VAL . 2.7 tttm -68.88 -51.02 44.66 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 125.965 1.706 . . . . 0.0 114.89 -176.274 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 100.46 112.79 3.49 Favored Glycine 0 CA--C 1.534 1.273 0 N-CA-C 110.547 -1.021 . . . . 0.0 110.547 -172.654 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.44 ' HB3' HD12 ' A' ' 16' ' ' LEU . 10.5 mptt -41.99 -43.84 3.29 Favored 'General case' 0 N--CA 1.479 1.015 0 N-CA-C 118.139 2.644 . . . . 0.0 118.139 -172.643 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . 0.435 ' O ' ' HB ' ' A' ' 68' ' ' ILE . 0.0 OUTLIER -61.3 -42.78 99.24 Favored 'General case' 0 N--CA 1.477 0.905 0 N-CA-C 114.995 1.48 . . . . 0.0 114.995 177.552 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -68.78 -22.33 64.29 Favored 'General case' 0 N--CA 1.479 1.022 0 CA-C-N 114.878 -1.055 . . . . 0.0 113.171 173.742 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.826 HG23 HG22 ' A' ' 59' ' ' ILE . 61.8 t -75.53 -32.71 25.5 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.919 0 C-N-CA 123.725 0.81 . . . . 0.0 111.34 176.72 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.435 ' HB ' ' O ' ' A' ' 65' ' ' ARG . 18.6 mm -51.78 -47.47 39.51 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.153 0 C-N-CA 123.639 0.776 . . . . 0.0 109.814 165.714 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -68.22 -48.83 64.11 Favored 'General case' 0 N--CA 1.472 0.641 0 O-C-N 124.225 0.953 . . . . 0.0 113.406 178.038 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' TRP . . . . . 0.4 ' HE3' HG11 ' A' ' 67' ' ' VAL . 34.1 t90 . . . . . 0 N--CA 1.476 0.859 0 C-N-CA 125.587 1.555 . . . . 0.0 112.407 178.482 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.449 ' HB3' HG23 ' A' ' 7' ' ' ILE . 53.9 mtp . . . . . 0 N--CA 1.478 0.946 0 N-CA-C 112.367 0.506 . . . . 0.0 112.367 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -55.47 -50.82 68.87 Favored 'General case' 0 N--CA 1.472 0.643 0 O-C-N 124.67 1.231 . . . . 0.0 112.711 177.291 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 52.7 tttp -72.91 -58.81 3.06 Favored 'General case' 0 CA--C 1.543 0.686 0 CA-C-N 114.257 -1.338 . . . . 0.0 113.573 -178.78 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -66.16 -43.74 86.09 Favored 'General case' 0 N--CA 1.471 0.601 0 N-CA-C 116.474 2.027 . . . . 0.0 116.474 -168.901 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . 0.562 ' HB2' HD13 ' A' ' 7' ' ' ILE . 38.4 m-85 -101.41 -18.06 16.19 Favored 'General case' 0 N--CA 1.476 0.857 0 N-CA-C 115.953 1.835 . . . . 0.0 115.953 -170.509 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 81.41 63.06 1.89 Allowed Glycine 0 N--CA 1.484 1.855 0 O-C-N 124.532 1.145 . . . . 0.0 110.714 -169.464 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . 0.562 HD13 ' HB2' ' A' ' 5' ' ' PHE . 0.4 OUTLIER -122.55 145.93 46.23 Favored Pre-proline 0 N--CA 1.471 0.613 0 C-N-CA 125.587 1.555 . . . . 0.0 108.998 179.775 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_endo -86.44 152.1 9.12 Favored 'Trans proline' 0 CA--C 1.537 0.645 0 N-CA-C 108.173 -1.51 . . . . 0.0 108.173 161.13 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -47.69 -33.94 7.54 Favored 'General case' 0 N--CA 1.47 0.55 0 N-CA-C 115.663 1.727 . . . . 0.0 115.663 175.486 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -37.69 -57.37 0.98 Allowed 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 126.964 2.106 . . . . 0.0 113.931 173.374 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.868 HG11 HG21 ' A' ' 31' ' ' ILE . 23.9 m -83.97 -33.16 9.01 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.214 0 N-CA-C 113.728 1.01 . . . . 0.0 113.728 -175.259 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -64.09 -32.39 73.93 Favored 'General case' 0 CA--C 1.545 0.787 0 N-CA-C 112.303 0.483 . . . . 0.0 112.303 173.38 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -59.36 -44.62 96.45 Favored Glycine 0 CA--C 1.538 1.473 0 CA-C-O 122.497 1.054 . . . . 0.0 113.071 171.277 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' THR . . . . . 0.651 HG21 HG13 ' A' ' 28' ' ' ILE . 0.3 OUTLIER -63.17 -35.7 81.17 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 125.276 1.43 . . . . 0.0 113.586 176.542 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.459 HG21 HD22 ' A' ' 32' ' ' LEU . 5.1 t -58.15 -41.53 80.97 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 C-N-CA 124.205 1.002 . . . . 0.0 111.992 170.747 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 24.6 mt -61.32 -38.93 88.64 Favored 'General case' 0 N--CA 1.472 0.638 0 N-CA-C 113.222 0.823 . . . . 0.0 113.222 178.681 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -52.81 -48.06 67.18 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 124.798 1.239 . . . . 0.0 112.526 173.038 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.413 HG22 ' HA ' ' A' ' 25' ' ' VAL . 1.1 t -54.4 -54.0 25.55 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.984 0 CA-C-N 115.057 -0.974 . . . . 0.0 111.501 174.735 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.782 HG11 ' HA ' ' A' ' 56' ' ' LYS . 6.8 t -59.87 -47.58 90.98 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.014 0 O-C-N 123.803 0.689 . . . . 0.0 110.458 -177.505 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . 0.594 ' HG3' ' HE2' ' A' ' 64' ' ' LYS . 17.4 mt-10 -60.34 -36.74 78.69 Favored 'General case' 0 CA--C 1.542 0.666 0 N-CA-C 115.992 1.849 . . . . 0.0 115.992 -178.49 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -106.8 -9.97 16.22 Favored 'General case' 0 N--CA 1.477 0.876 0 N-CA-C 116.303 1.964 . . . . 0.0 116.303 -175.409 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 64.42 42.01 97.8 Favored Glycine 0 CA--C 1.549 2.196 0 N-CA-C 110.298 -1.121 . . . . 0.0 110.298 -168.12 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -92.53 175.24 37.23 Favored Glycine 0 CA--C 1.534 1.275 0 C-N-CA 124.27 0.938 . . . . 0.0 113.872 -167.436 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' TRP . . . . . 0.598 ' HB3' HG21 ' A' ' 26' ' ' THR . 81.5 m95 -67.29 104.83 1.58 Allowed 'General case' 0 N--CA 1.468 0.464 0 CA-C-O 122.55 1.167 . . . . 0.0 113.3 179.763 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.546 HG22 HG13 ' A' ' 51' ' ' ILE . 2.2 p -60.74 -22.08 25.36 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.971 0 CA-C-N 113.665 -1.607 . . . . 0.0 113.693 170.795 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' THR . . . . . 0.598 HG21 ' HB3' ' A' ' 24' ' ' TRP . 4.4 t -56.57 -46.38 80.8 Favored 'General case' 0 N--CA 1.485 1.316 0 N-CA-C 113.811 1.041 . . . . 0.0 113.811 -179.982 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' THR . . . . . 0.405 ' O ' HG12 ' A' ' 31' ' ' ILE . 0.0 OUTLIER -64.09 -41.01 97.45 Favored 'General case' 0 N--CA 1.479 1.016 0 O-C-N 123.972 0.795 . . . . 0.0 112.006 176.91 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.651 HG13 HG21 ' A' ' 14' ' ' THR . 2.0 mp -68.59 -44.37 82.8 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 C-N-CA 125.255 1.422 . . . . 0.0 111.904 -179.114 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.686 HG12 HD13 ' A' ' 43' ' ' LEU . 38.2 t -51.95 -48.88 39.74 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.349 0 C-N-CA 124.386 1.074 . . . . 0.0 111.069 174.52 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 42.3 m -52.34 -41.78 63.31 Favored 'General case' 0 N--CA 1.483 1.198 0 N-CA-C 114.555 1.317 . . . . 0.0 114.555 176.59 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.868 HG21 HG11 ' A' ' 11' ' ' VAL . 36.9 mm -75.35 -40.81 42.99 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.981 0 C-N-CA 124.407 1.083 . . . . 0.0 109.719 -177.766 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.657 HD23 ' HB ' ' A' ' 11' ' ' VAL . 3.9 mm? -55.96 -53.14 60.43 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 124.493 1.117 . . . . 0.0 112.294 171.565 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 1.2 p -66.4 -29.62 69.82 Favored 'General case' 0 N--CA 1.481 1.103 0 N-CA-C 115.974 1.842 . . . . 0.0 115.974 178.865 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -57.29 -27.94 62.59 Favored 'General case' 0 N--CA 1.477 0.882 0 O-C-N 124.303 1.002 . . . . 0.0 113.188 171.862 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 83.7 t . . . . . 0 N--CA 1.485 1.297 0 C-N-CA 124.019 0.928 . . . . 0.0 111.628 172.898 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . 0.446 ' HA3' ' HB3' ' A' ' 32' ' ' LEU . . . . . . . . 0 N--CA 1.477 1.38 0 N-CA-C 111.032 -0.827 . . . . 0.0 111.032 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 94.8 mt -65.02 -49.14 71.35 Favored 'General case' 0 N--CA 1.48 1.028 0 N-CA-C 114.291 1.219 . . . . 0.0 114.291 -179.22 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 27.8 p -59.2 -38.83 80.85 Favored 'General case' 0 N--CA 1.48 1.065 0 N-CA-C 114.167 1.173 . . . . 0.0 114.167 175.873 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 13.8 tp -62.32 -50.61 70.93 Favored 'General case' 0 N--CA 1.48 1.047 0 CA-C-O 120.853 0.358 . . . . 0.0 111.11 170.275 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.686 HD13 HG12 ' A' ' 29' ' ' VAL . 0.7 OUTLIER -61.43 -30.89 70.85 Favored 'General case' 0 N--CA 1.473 0.706 0 N-CA-C 114.835 1.421 . . . . 0.0 114.835 -179.284 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -70.36 -43.79 69.45 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 123.568 0.747 . . . . 0.0 112.562 173.239 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -64.77 -31.43 72.65 Favored 'General case' 0 N--CA 1.475 0.798 0 N-CA-C 112.977 0.732 . . . . 0.0 112.977 174.074 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -60.22 -21.24 61.56 Favored 'General case' 0 N--CA 1.476 0.842 0 N-CA-C 115.817 1.784 . . . . 0.0 115.817 177.124 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -49.63 -33.63 18.94 Favored Glycine 0 CA--C 1.542 1.781 0 C-N-CA 126.198 1.856 . . . . 0.0 114.423 179.631 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 66.3 ttp85 -49.61 -60.2 3.08 Favored 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 125.602 1.561 . . . . 0.0 112.339 179.84 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 12.5 tt0 -129.15 32.08 4.77 Favored 'General case' 0 N--CA 1.48 1.069 0 CA-C-N 114.61 -1.177 . . . . 0.0 113.586 -172.571 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 8.0 t 49.75 123.55 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.295 0 C-N-CA 124.642 1.177 . . . . 0.0 113.692 -173.458 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.546 HG13 HG22 ' A' ' 25' ' ' VAL . 8.7 tp -29.01 -49.8 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.482 1.136 0 N-CA-C 117.947 2.573 . . . . 0.0 117.947 -174.713 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 33.8 ttmt -57.97 -68.67 0.22 Allowed 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 123.849 0.86 . . . . 0.0 111.93 177.383 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -62.61 -33.96 76.05 Favored 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 124.743 1.217 . . . . 0.0 113.397 179.588 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 88.5 t80 -49.5 -63.48 1.09 Allowed 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 125.11 1.364 . . . . 0.0 111.786 175.15 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.424 HD12 HG11 ' A' ' 15' ' ' VAL . 59.9 mt -65.09 -39.87 93.78 Favored 'General case' 0 N--CA 1.475 0.802 0 N-CA-C 114.469 1.285 . . . . 0.0 114.469 -178.299 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . 0.782 ' HA ' HG11 ' A' ' 19' ' ' VAL . 97.8 mttt -58.66 -41.15 85.44 Favored 'General case' 0 N--CA 1.475 0.803 0 N-CA-C 114.34 1.237 . . . . 0.0 114.34 179.44 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 22.1 tttt -80.64 -49.66 10.96 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-N 114.628 -1.169 . . . . 0.0 111.983 173.753 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . 0.425 ' O ' ' HB2' ' A' ' 62' ' ' LYS . 31.2 tt0 -58.62 -49.29 78.05 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-N 115.672 -0.694 . . . . 0.0 112.421 -173.454 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.63 HD11 HG22 ' A' ' 67' ' ' VAL . 2.7 mm -75.53 -25.35 17.64 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.937 0 C-N-CA 120.658 -0.417 . . . . 0.0 111.91 -177.261 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . 0.548 ' HB2' ' O ' ' A' ' 56' ' ' LYS . 2.5 tttt -62.85 -32.95 74.28 Favored 'General case' 0 N--CA 1.472 0.641 0 N-CA-C 114.599 1.333 . . . . 0.0 114.599 169.485 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 3.0 mptp? -81.36 -43.31 19.22 Favored 'General case' 0 N--CA 1.482 1.137 0 CA-C-N 114.132 -1.395 . . . . 0.0 112.373 173.271 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . 0.425 ' HB2' ' O ' ' A' ' 58' ' ' GLU . 17.4 tptt -71.59 -52.52 17.66 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 126.636 1.974 . . . . 0.0 114.038 -171.72 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 97.6 114.63 3.28 Favored Glycine 0 N--CA 1.475 1.246 0 CA-C-O 122.602 1.112 . . . . 0.0 110.895 -170.216 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.594 ' HE2' ' HG3' ' A' ' 20' ' ' GLU . 11.8 mptt -32.25 -52.11 0.27 Allowed 'General case' 0 N--CA 1.474 0.747 0 N-CA-C 119.251 3.056 . . . . 0.0 119.251 177.024 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . 1.025 HH21 HG13 ' A' ' 68' ' ' ILE . 0.0 OUTLIER -59.74 -45.31 92.59 Favored 'General case' 0 N--CA 1.476 0.827 0 N-CA-C 114.318 1.229 . . . . 0.0 114.318 -179.354 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -63.36 -29.85 71.08 Favored 'General case' 0 N--CA 1.474 0.751 0 CA-C-N 114.026 -1.443 . . . . 0.0 113.871 172.413 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.63 HG22 HD11 ' A' ' 59' ' ' ILE . 95.4 t -71.13 -33.12 50.06 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 N-CA-C 112.527 0.566 . . . . 0.0 112.527 178.175 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 1.025 HG13 HH21 ' A' ' 65' ' ' ARG . 27.0 mm -51.57 -47.49 37.05 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.333 0 O-C-N 123.902 0.751 . . . . 0.0 109.669 167.347 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -69.19 -51.48 37.59 Favored 'General case' 0 N--CA 1.483 1.21 0 CA-C-N 114.898 -1.046 . . . . 0.0 113.326 178.881 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 29.3 t90 . . . . . 0 N--CA 1.479 0.99 0 C-N-CA 124.657 1.183 . . . . 0.0 113.096 179.703 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.783 ' HE2' HD13 ' A' ' 32' ' ' LEU . 2.4 mmm . . . . . 0 CA--C 1.537 0.449 0 N-CA-C 111.442 0.164 . . . . 0.0 111.442 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -62.14 -58.78 6.5 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-N 113.65 -1.614 . . . . 0.0 112.261 177.871 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 15.5 ttpp -65.49 -54.05 33.73 Favored 'General case' 0 N--CA 1.476 0.832 0 CA-C-N 113.486 -1.688 . . . . 0.0 113.391 -173.478 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 12.1 tt0 -71.88 -37.47 70.16 Favored 'General case' 0 N--CA 1.477 0.911 0 N-CA-C 114.319 1.229 . . . . 0.0 114.319 -171.165 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . 0.446 ' HD1' ' HB2' ' A' ' 41' ' ' SER . 71.9 m-85 -102.84 -10.66 18.89 Favored 'General case' 0 N--CA 1.475 0.783 0 N-CA-C 117.473 2.397 . . . . 0.0 117.473 -172.944 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 74.36 50.9 9.13 Favored Glycine 0 CA--C 1.539 1.581 0 CA-C-O 122.459 1.033 . . . . 0.0 111.461 -174.604 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -113.86 146.84 36.43 Favored Pre-proline 0 N--CA 1.476 0.873 0 CA-C-N 112.998 -1.601 . . . . 0.0 109.767 179.405 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 97.4 Cg_endo -88.58 152.64 6.34 Favored 'Trans proline' 0 C--O 1.236 0.378 0 N-CA-C 109.733 -0.91 . . . . 0.0 109.733 165.498 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -48.77 -29.31 4.39 Favored 'General case' 0 N--CA 1.474 0.75 0 N-CA-C 115.119 1.525 . . . . 0.0 115.119 171.342 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -38.97 -47.75 1.5 Allowed 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 126.392 1.877 . . . . 0.0 114.498 170.092 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.732 HG11 HG21 ' A' ' 31' ' ' ILE . 33.0 m -99.04 -39.06 7.51 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.0 0 N-CA-C 113.791 1.034 . . . . 0.0 113.791 -176.892 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -62.8 -38.02 89.02 Favored 'General case' 0 CA--C 1.547 0.865 0 N-CA-C 112.814 0.672 . . . . 0.0 112.814 176.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -58.5 -47.45 89.85 Favored Glycine 0 N--CA 1.486 1.995 0 O-C-N 124.535 1.147 . . . . 0.0 112.394 173.551 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 16.4 m -59.06 -39.57 82.48 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 124.625 1.17 . . . . 0.0 113.918 173.967 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.475 ' O ' HG22 ' A' ' 19' ' ' VAL . 40.6 t -57.04 -44.73 83.38 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.116 0 C-N-CA 123.682 0.793 . . . . 0.0 111.239 172.824 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.65 HD13 HG12 ' A' ' 68' ' ' ILE . 37.0 mt -60.97 -45.96 92.67 Favored 'General case' 0 N--CA 1.481 1.116 0 N-CA-C 112.831 0.678 . . . . 0.0 112.831 178.782 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 24.6 t-20 -50.14 -50.22 49.53 Favored 'General case' 0 N--CA 1.48 1.051 0 O-C-N 124.612 1.195 . . . . 0.0 111.067 174.475 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 56.5 t -57.65 -50.41 77.46 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 CA-C-N 113.056 -1.884 . . . . 0.0 111.841 178.624 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.59 HG12 ' HB ' ' A' ' 59' ' ' ILE . 24.3 t -59.31 -45.68 93.03 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.291 0 O-C-N 123.681 0.613 . . . . 0.0 110.943 -179.937 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . 0.559 ' HG3' ' HE2' ' A' ' 64' ' ' LYS . 14.3 mt-10 -57.69 -44.39 85.78 Favored 'General case' 0 N--CA 1.477 0.875 0 C-N-CA 125.153 1.381 . . . . 0.0 114.232 179.921 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -77.36 -17.46 58.22 Favored 'General case' 0 CA--C 1.541 0.609 0 N-CA-C 113.97 1.1 . . . . 0.0 113.97 178.35 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 71.61 51.45 16.06 Favored Glycine 0 N--CA 1.477 1.382 0 O-C-N 124.138 0.898 . . . . 0.0 111.86 -170.277 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -109.75 167.31 12.75 Favored Glycine 0 N--CA 1.48 1.597 0 CA-C-O 122.844 1.247 . . . . 0.0 112.634 -177.415 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' TRP . . . . . 0.693 ' HB3' HG21 ' A' ' 26' ' ' THR . 77.1 m95 -78.19 105.95 9.77 Favored 'General case' 0 N--CA 1.479 0.997 0 CA-C-N 113.252 -1.474 . . . . 0.0 111.818 -178.524 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.799 HG23 ' HB2' ' A' ' 55' ' ' LEU . 0.4 OUTLIER -62.58 -16.5 16.89 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.948 0 CA-C-N 113.897 -1.501 . . . . 0.0 112.825 171.021 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' THR . . . . . 0.693 HG21 ' HB3' ' A' ' 24' ' ' TRP . 15.3 t -67.74 -27.71 67.02 Favored 'General case' 0 N--CA 1.48 1.045 0 N-CA-C 114.513 1.301 . . . . 0.0 114.513 -178.993 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' THR . . . . . 0.596 ' HB ' HD11 ' A' ' 28' ' ' ILE . 0.7 OUTLIER -71.11 -48.86 49.85 Favored 'General case' 0 N--CA 1.48 1.054 0 CA-C-O 121.445 0.64 . . . . 0.0 110.813 170.111 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.596 HD11 ' HB ' ' A' ' 27' ' ' THR . 3.4 mp -65.84 -25.36 36.08 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 C-N-CA 125.956 1.702 . . . . 0.0 112.86 -179.474 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.522 HG23 HD23 ' A' ' 43' ' ' LEU . 7.9 t -36.48 -44.21 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.409 0 C-N-CA 124.101 0.96 . . . . 0.0 112.013 162.255 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 85.2 p -59.01 -39.05 80.7 Favored 'General case' 0 N--CA 1.486 1.359 0 N-CA-C 113.831 1.048 . . . . 0.0 113.831 178.688 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.732 HG21 HG11 ' A' ' 11' ' ' VAL . 39.6 mm -76.65 -35.66 25.85 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.814 0 C-N-CA 124.51 1.124 . . . . 0.0 110.178 -177.557 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.783 HD13 ' HE2' ' A' ' 1' ' ' MET . 3.8 mm? -59.71 -54.38 47.08 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 125.161 1.384 . . . . 0.0 112.973 170.884 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -68.83 -24.2 64.35 Favored 'General case' 0 N--CA 1.476 0.833 0 N-CA-C 114.765 1.394 . . . . 0.0 114.765 177.066 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -53.54 -28.17 30.0 Favored 'General case' 0 N--CA 1.482 1.131 0 N-CA-C 113.4 0.889 . . . . 0.0 113.4 167.092 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.42 ' HB ' ' O ' ' A' ' 32' ' ' LEU . 70.0 t . . . . . 0 N--CA 1.481 1.111 0 C-N-CA 125.087 1.355 . . . . 0.0 112.354 169.807 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . 0.432 ' O ' ' HG ' ' A' ' 43' ' ' LEU . . . . . . . . 0 CA--C 1.539 1.588 0 N-CA-C 111.433 -0.667 . . . . 0.0 111.433 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 79.4 mt -60.4 -49.7 76.52 Favored 'General case' 0 N--CA 1.479 1.022 0 N-CA-C 114.594 1.331 . . . . 0.0 114.594 179.594 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' SER . . . . . 0.446 ' HB2' ' HD1' ' A' ' 5' ' ' PHE . 2.1 p -57.34 -37.33 72.38 Favored 'General case' 0 N--CA 1.479 1.021 0 N-CA-C 114.344 1.239 . . . . 0.0 114.344 177.337 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.766 HD11 ' SD ' ' A' ' 1' ' ' MET . 18.8 tp -62.94 -49.2 75.7 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 123.692 0.797 . . . . 0.0 110.436 171.396 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.522 HD23 HG23 ' A' ' 29' ' ' VAL . 49.5 mt -58.38 -33.74 69.95 Favored 'General case' 0 N--CA 1.476 0.855 0 N-CA-C 114.7 1.37 . . . . 0.0 114.7 178.087 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -65.1 -43.95 90.37 Favored 'General case' 0 N--CA 1.476 0.838 0 N-CA-C 112.324 0.491 . . . . 0.0 112.324 172.581 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -63.18 -43.17 98.98 Favored 'General case' 0 N--CA 1.484 1.251 0 C-N-CA 122.849 0.46 . . . . 0.0 111.729 173.276 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -57.34 -26.49 61.06 Favored 'General case' 0 N--CA 1.472 0.665 0 N-CA-C 115.645 1.72 . . . . 0.0 115.645 -176.597 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -45.86 -42.43 11.31 Favored Glycine 0 CA--C 1.546 2.029 0 C-N-CA 125.764 1.65 . . . . 0.0 114.052 178.589 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . 0.501 ' CZ ' ' HH ' ' A' ' 54' ' ' TYR . 29.0 ttm180 -48.54 -53.25 18.94 Favored 'General case' 0 N--CA 1.476 0.844 0 CA-C-N 112.558 -1.821 . . . . 0.0 113.673 -175.723 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 17.2 tt0 -126.84 36.72 4.41 Favored 'General case' 0 N--CA 1.474 0.77 0 N-CA-C 113.258 0.836 . . . . 0.0 113.258 178.024 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 18.4 t 48.33 120.96 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.421 0 C-N-CA 126.17 1.788 . . . . 0.0 113.821 -178.031 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 7.8 tp -31.31 -51.42 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 N-CA-C 116.595 2.072 . . . . 0.0 116.595 -176.319 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 70.3 mttt -48.68 -67.03 0.3 Allowed 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 125.477 1.511 . . . . 0.0 112.927 176.113 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -74.47 -30.86 62.03 Favored 'General case' 0 N--CA 1.466 0.352 0 N-CA-C 114.735 1.384 . . . . 0.0 114.735 -179.198 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . 0.541 ' HD2' ' HG ' ' A' ' 55' ' ' LEU . 72.9 t80 -49.0 -63.82 0.99 Allowed 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 124.933 1.293 . . . . 0.0 112.291 -178.133 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.799 ' HB2' HG23 ' A' ' 25' ' ' VAL . 42.4 mt -73.29 -34.44 65.76 Favored 'General case' 0 N--CA 1.477 0.885 0 N-CA-C 114.884 1.438 . . . . 0.0 114.884 -174.595 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . 0.56 ' HA ' HG11 ' A' ' 19' ' ' VAL . 57.8 mtpt -58.59 -46.17 87.53 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 114.438 -1.256 . . . . 0.0 112.67 177.052 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 61.6 tttm -77.44 -50.77 11.99 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 114.903 -1.044 . . . . 0.0 111.873 174.409 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 58.8 tt0 -59.1 -44.99 92.0 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-O 118.225 -0.893 . . . . 0.0 111.515 -170.404 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.762 HG22 HG23 ' A' ' 67' ' ' VAL . 4.0 mm -79.32 -20.08 12.61 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.789 0 C-N-CA 119.841 -0.744 . . . . 0.0 112.712 -175.262 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . 0.462 ' HD2' ' HZ2' ' A' ' 64' ' ' LYS . 23.1 tptt -65.57 -37.28 86.22 Favored 'General case' 0 CA--C 1.549 0.909 0 CA-C-O 122.449 1.119 . . . . 0.0 113.454 170.545 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 21.6 ttpp -84.53 -37.78 20.82 Favored 'General case' 0 CA--C 1.554 1.101 0 CA-C-N 112.355 -2.202 . . . . 0.0 111.415 -178.601 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 6.9 tttt -77.21 -43.62 33.0 Favored 'General case' 0 CA--C 1.541 0.626 0 N-CA-C 116.603 2.075 . . . . 0.0 116.603 -177.432 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 91.35 111.5 1.7 Allowed Glycine 0 N--CA 1.478 1.445 0 CA-C-O 122.584 1.102 . . . . 0.0 111.332 -177.48 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.623 ' HB3' HD12 ' A' ' 16' ' ' LEU . 10.4 mptt -43.87 -41.21 4.99 Favored 'General case' 0 N--CA 1.487 1.377 0 N-CA-C 117.863 2.542 . . . . 0.0 117.863 -171.778 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . 0.477 ' O ' ' HB ' ' A' ' 68' ' ' ILE . 0.0 OUTLIER -56.16 -49.41 74.06 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 124.583 1.153 . . . . 0.0 113.386 178.402 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -67.65 -23.98 65.39 Favored 'General case' 0 N--CA 1.477 0.904 0 N-CA-C 114.61 1.337 . . . . 0.0 114.61 174.961 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.762 HG23 HG22 ' A' ' 59' ' ' ILE . 45.6 t -75.16 -32.23 26.05 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.083 0 CA-C-N 114.86 -1.064 . . . . 0.0 110.822 176.325 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.65 HG12 HD13 ' A' ' 16' ' ' LEU . 8.0 mm -51.7 -46.71 38.88 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.951 0 C-N-CA 123.355 0.662 . . . . 0.0 110.075 168.491 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -68.87 -48.91 62.24 Favored 'General case' 0 N--CA 1.482 1.143 0 O-C-N 124.542 1.152 . . . . 0.0 113.345 176.585 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' TRP . . . . . 0.411 ' HE3' HG11 ' A' ' 67' ' ' VAL . 34.6 t90 . . . . . 0 N--CA 1.477 0.88 0 C-N-CA 124.799 1.24 . . . . 0.0 113.6 -178.846 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.434 ' HE1' HG22 ' A' ' 7' ' ' ILE . 22.5 mtp . . . . . 0 N--CA 1.48 1.036 0 N-CA-C 112.553 0.575 . . . . 0.0 112.553 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -60.56 -51.31 69.98 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-N 115.213 -0.903 . . . . 0.0 113.259 177.629 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 57.8 tttp -70.32 -51.44 30.15 Favored 'General case' 0 CA--C 1.551 0.987 0 CA-C-N 113.568 -1.651 . . . . 0.0 112.978 -173.42 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -77.22 -38.57 51.05 Favored 'General case' 0 N--CA 1.482 1.166 0 N-CA-C 116.577 2.065 . . . . 0.0 116.577 -170.361 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . 0.685 ' HD1' ' HB2' ' A' ' 41' ' ' SER . 53.3 m-85 -99.7 -30.99 11.78 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-N 112.914 -1.948 . . . . 0.0 115.356 -168.395 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 93.88 50.73 2.24 Favored Glycine 0 CA--C 1.541 1.682 0 O-C-N 125.277 1.611 . . . . 0.0 110.964 -171.174 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . 0.434 HG22 ' HE1' ' A' ' 1' ' ' MET . 0.6 OUTLIER -117.83 147.76 41.82 Favored Pre-proline 0 N--CA 1.475 0.823 0 CA-C-N 113.4 -1.4 . . . . 0.0 109.287 -178.528 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_endo -89.42 155.04 5.42 Favored 'Trans proline' 0 C--N 1.332 -0.327 0 N-CA-C 108.861 -1.246 . . . . 0.0 108.861 161.307 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -50.18 -26.04 4.19 Favored 'General case' 0 CA--C 1.54 0.58 0 N-CA-C 115.208 1.558 . . . . 0.0 115.208 173.516 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -47.32 -59.38 3.23 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 125.237 1.415 . . . . 0.0 112.678 172.626 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.889 HG11 HG21 ' A' ' 31' ' ' ILE . 33.5 m -81.9 -27.6 9.61 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.988 0 N-CA-C 114.181 1.178 . . . . 0.0 114.181 -175.278 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -67.94 -33.84 75.44 Favored 'General case' 0 N--CA 1.478 0.932 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.651 172.863 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -61.24 -42.54 99.81 Favored Glycine 0 CA--C 1.537 1.451 0 C-N-CA 124.073 0.844 . . . . 0.0 112.833 173.263 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' THR . . . . . 0.429 HG21 HG13 ' A' ' 28' ' ' ILE . 0.8 OUTLIER -58.85 -41.63 87.41 Favored 'General case' 0 N--CA 1.478 0.966 0 N-CA-C 114.166 1.173 . . . . 0.0 114.166 173.792 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.543 HG12 HD11 ' A' ' 55' ' ' LEU . 22.2 t -53.87 -43.18 56.16 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.265 0 C-N-CA 123.514 0.725 . . . . 0.0 112.915 170.67 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 25.0 mt -60.74 -40.87 94.05 Favored 'General case' 0 N--CA 1.476 0.857 0 N-CA-C 113.278 0.844 . . . . 0.0 113.278 178.102 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -52.43 -45.5 66.0 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 124.405 1.082 . . . . 0.0 111.977 174.698 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -60.44 -51.65 70.57 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.682 0 CA-C-N 114.283 -1.326 . . . . 0.0 112.339 175.52 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.648 HG11 ' HA ' ' A' ' 56' ' ' LYS . 17.9 t -58.85 -45.0 91.82 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.388 0 O-C-N 124.265 0.978 . . . . 0.0 111.002 -178.876 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 21.0 mt-10 -66.88 -39.52 87.53 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 125.97 1.708 . . . . 0.0 115.418 -177.705 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -101.93 -24.19 14.04 Favored 'General case' 0 N--CA 1.474 0.753 0 N-CA-C 115.82 1.785 . . . . 0.0 115.82 -172.01 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . 0.617 ' HA3' ' HE2' ' A' ' 56' ' ' LYS . . . 77.7 44.21 13.1 Favored Glycine 0 N--CA 1.484 1.897 0 N-CA-C 110.742 -0.943 . . . . 0.0 110.742 -166.75 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -85.67 169.29 42.7 Favored Glycine 0 N--CA 1.474 1.208 0 C-N-CA 124.294 0.95 . . . . 0.0 112.995 -175.451 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 66.6 m95 -67.43 99.8 0.78 Allowed 'General case' 0 C--O 1.243 0.751 0 CA-C-O 123.257 1.503 . . . . 0.0 111.728 176.75 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.75 HG23 ' HA ' ' A' ' 52' ' ' LYS . 16.0 t -56.32 -24.46 18.38 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.939 0 CA-C-N 113.521 -1.672 . . . . 0.0 112.481 174.091 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 11.7 p -58.55 -45.68 88.42 Favored 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 123.735 0.814 . . . . 0.0 112.71 176.528 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -61.65 -45.22 94.96 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 124.095 0.958 . . . . 0.0 111.211 176.023 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.429 HG13 HG21 ' A' ' 14' ' ' THR . 1.7 mp -56.96 -48.43 81.62 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.915 0 CA-C-N 114.701 -1.136 . . . . 0.0 112.951 175.225 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.419 HG11 HD13 ' A' ' 43' ' ' LEU . 54.4 t -52.38 -41.83 36.34 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.059 0 C-N-CA 123.85 0.86 . . . . 0.0 111.937 176.948 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 73.2 m -55.96 -47.2 78.05 Favored 'General case' 0 N--CA 1.486 1.327 0 N-CA-C 113.625 0.972 . . . . 0.0 113.625 174.349 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.889 HG21 HG11 ' A' ' 11' ' ' VAL . 36.5 mm -69.47 -38.17 76.44 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.964 0 CA-C-N 115.149 -0.932 . . . . 0.0 109.349 -175.906 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.527 HD23 ' HB ' ' A' ' 11' ' ' VAL . 4.3 mm? -61.81 -52.66 63.29 Favored 'General case' 0 N--CA 1.48 1.026 0 CA-C-N 113.813 -1.54 . . . . 0.0 113.496 175.508 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 8.3 p -68.01 -31.72 71.6 Favored 'General case' 0 N--CA 1.476 0.834 0 N-CA-C 114.76 1.393 . . . . 0.0 114.76 177.36 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -52.46 -29.62 25.65 Favored 'General case' 0 N--CA 1.479 0.981 0 N-CA-C 113.714 1.005 . . . . 0.0 113.714 172.117 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 85.6 t . . . . . 0 N--CA 1.492 1.652 0 C-N-CA 124.179 0.992 . . . . 0.0 112.453 171.789 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . 0.438 ' O ' ' HG ' ' A' ' 43' ' ' LEU . . . . . . . . 0 N--CA 1.478 1.49 0 N-CA-C 110.875 -0.89 . . . . 0.0 110.875 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 18.9 mt -59.07 -48.94 79.77 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 124.594 1.157 . . . . 0.0 114.097 177.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' SER . . . . . 0.685 ' HB2' ' HD1' ' A' ' 5' ' ' PHE . 0.0 OUTLIER -58.63 -41.46 86.03 Favored 'General case' 0 N--CA 1.479 1.014 0 N-CA-C 113.824 1.046 . . . . 0.0 113.824 174.927 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 15.3 tp -60.25 -44.44 95.26 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 122.477 0.311 . . . . 0.0 110.87 174.07 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.438 ' HG ' ' O ' ' A' ' 39' ' ' GLY . 79.6 mt -62.01 -36.25 80.97 Favored 'General case' 0 N--CA 1.477 0.891 0 N-CA-C 115.017 1.488 . . . . 0.0 115.017 178.103 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -63.12 -50.02 72.12 Favored 'General case' 0 N--CA 1.472 0.635 0 O-C-N 123.962 0.789 . . . . 0.0 112.076 172.2 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -62.67 -33.57 75.34 Favored 'General case' 0 N--CA 1.486 1.347 0 N-CA-C 112.571 0.582 . . . . 0.0 112.571 177.558 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -65.29 -19.72 66.09 Favored 'General case' 0 N--CA 1.474 0.732 0 N-CA-C 115.702 1.741 . . . . 0.0 115.702 178.289 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -52.61 -38.29 51.95 Favored Glycine 0 N--CA 1.477 1.412 0 O-C-N 124.665 1.228 . . . . 0.0 112.696 178.006 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 65.1 ttp85 -54.12 -47.03 72.29 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 125.541 1.536 . . . . 0.0 113.805 -174.744 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 15.8 tt0 -132.25 36.11 3.64 Favored 'General case' 0 N--CA 1.477 0.899 0 N-CA-C 114.903 1.446 . . . . 0.0 114.903 -174.722 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 78.2 p 49.37 116.99 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.823 0 C-N-CA 124.06 0.944 . . . . 0.0 113.073 -174.798 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.526 HG13 HG12 ' A' ' 25' ' ' VAL 0.256 8.2 tp -31.5 -49.54 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 N-CA-C 117.974 2.583 . . . . 0.0 117.974 -173.58 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . 0.75 ' HA ' HG23 ' A' ' 25' ' ' VAL . 0.3 OUTLIER -64.98 -66.57 0.53 Allowed 'General case' 0 N--CA 1.489 1.518 0 CA-C-N 118.214 0.461 . . . . 0.0 111.885 178.132 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -50.74 -40.02 53.53 Favored 'General case' 0 C--O 1.236 0.349 0 O-C-N 124.868 1.355 . . . . 0.0 112.522 178.804 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 91.6 t80 -48.84 -62.82 1.32 Allowed 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 126.108 1.763 . . . . 0.0 111.23 174.212 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.543 HD11 HG12 ' A' ' 15' ' ' VAL . 92.4 mt -64.98 -39.62 93.74 Favored 'General case' 0 N--CA 1.478 0.956 0 N-CA-C 115.354 1.613 . . . . 0.0 115.354 -178.792 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . 0.648 ' HA ' HG11 ' A' ' 19' ' ' VAL . 29.1 mttt -58.78 -48.07 82.55 Favored 'General case' 0 C--N 1.319 -0.717 0 N-CA-C 115.444 1.646 . . . . 0.0 115.444 176.7 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 71.4 tttt -74.48 -50.71 17.18 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-N 115.039 -0.982 . . . . 0.0 112.039 173.547 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . 0.484 ' O ' ' HB2' ' A' ' 62' ' ' LYS . 31.3 tt0 -63.28 -47.37 82.63 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-O 118.433 -0.794 . . . . 0.0 111.549 -168.542 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.71 HG22 HG22 ' A' ' 67' ' ' VAL . 3.2 mm -77.66 -19.62 13.96 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.928 0 N-CA-C 112.117 0.414 . . . . 0.0 112.117 -176.334 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 2.7 ttmp? -68.62 -41.61 79.24 Favored 'General case' 0 CA--C 1.547 0.835 0 CA-C-N 115.511 -0.768 . . . . 0.0 112.643 170.069 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 25.4 ttpp -72.6 -41.91 65.1 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 125.651 1.58 . . . . 0.0 112.91 175.223 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . 0.484 ' HB2' ' O ' ' A' ' 58' ' ' GLU . 0.0 OUTLIER -70.68 -53.45 15.69 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 126.674 1.99 . . . . 0.0 113.855 -177.034 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 99.37 106.24 2.69 Favored Glycine 0 N--CA 1.477 1.405 0 N-CA-C 110.399 -1.08 . . . . 0.0 110.399 -174.246 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.765 ' HD2' ' H ' ' A' ' 64' ' ' LYS . 10.8 mptt -30.87 -50.21 0.14 Allowed 'General case' 0 N--CA 1.485 1.319 0 N-CA-C 118.769 2.878 . . . . 0.0 118.769 -175.738 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . 0.467 ' O ' ' HB ' ' A' ' 68' ' ' ILE . 0.0 OUTLIER -59.22 -42.1 90.2 Favored 'General case' 0 N--CA 1.474 0.73 0 N-CA-C 114.517 1.303 . . . . 0.0 114.517 178.759 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -69.56 -26.62 64.57 Favored 'General case' 0 N--CA 1.478 0.927 0 CA-C-N 114.55 -1.205 . . . . 0.0 113.65 174.729 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.71 HG22 HG22 ' A' ' 59' ' ' ILE . 72.6 t -69.63 -34.38 61.09 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.048 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.448 175.711 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.467 ' HB ' ' O ' ' A' ' 65' ' ' ARG . 19.8 mm -52.58 -41.57 37.52 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.941 0 O-C-N 124.223 0.952 . . . . 0.0 110.934 170.045 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -70.21 -53.84 15.37 Favored 'General case' 0 N--CA 1.48 1.042 0 N-CA-C 113.247 0.832 . . . . 0.0 113.247 174.535 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 46.7 t90 . . . . . 0 CA--C 1.545 0.76 0 C-N-CA 126.321 1.848 . . . . 0.0 114.325 -176.497 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.703 ' HE3' HG22 ' A' ' 15' ' ' VAL . 70.0 mtp . . . . . 0 N--CA 1.475 0.803 0 N-CA-C 112.98 0.733 . . . . 0.0 112.98 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . 0.447 ' HA ' ' O ' ' A' ' 7' ' ' ILE . . . -61.52 -56.28 21.78 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-N 114.546 -1.206 . . . . 0.0 112.112 172.685 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 95.1 mttt -64.06 -62.86 1.36 Allowed 'General case' 0 CA--C 1.541 0.621 0 CA-C-N 114.015 -1.448 . . . . 0.0 114.453 -177.555 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 3.9 mp0 -75.21 -40.54 59.1 Favored 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 115.016 1.488 . . . . 0.0 115.016 -170.065 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . 0.481 ' HD2' ' HA ' ' A' ' 1' ' ' MET . 41.3 m-85 -101.85 -11.68 18.85 Favored 'General case' 0 N--CA 1.476 0.851 0 N-CA-C 116.557 2.058 . . . . 0.0 116.557 -174.005 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 67.39 37.37 90.33 Favored Glycine 0 CA--C 1.538 1.528 0 CA-C-O 121.855 0.697 . . . . 0.0 111.359 -173.731 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . 0.664 HG22 HG22 ' A' ' 11' ' ' VAL . 0.7 OUTLIER -110.06 115.31 55.06 Favored Pre-proline 0 N--CA 1.474 0.73 0 C-N-CA 124.547 1.139 . . . . 0.0 109.086 179.016 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 96.3 Cg_endo -65.2 154.92 71.22 Favored 'Trans proline' 0 CA--C 1.536 0.602 0 C-N-CA 120.614 0.876 . . . . 0.0 111.019 -177.165 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -46.49 -30.11 2.05 Favored 'General case' 0 N--CA 1.472 0.662 0 N-CA-C 115.833 1.79 . . . . 0.0 115.833 174.478 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -40.4 -60.76 1.03 Allowed 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 126.337 1.855 . . . . 0.0 112.875 171.116 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.975 HG13 HG21 ' A' ' 31' ' ' ILE . 34.6 m -86.86 -31.11 5.99 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.915 0 CA-C-N 114.58 -1.191 . . . . 0.0 113.679 -174.793 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -59.63 -33.81 71.98 Favored 'General case' 0 CA--C 1.547 0.843 0 N-CA-C 113.24 0.829 . . . . 0.0 113.24 171.611 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -63.68 -44.18 96.77 Favored Glycine 0 N--CA 1.481 1.69 0 C-N-CA 124.044 0.831 . . . . 0.0 112.229 174.641 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' THR . . . . . 0.918 HG21 HG13 ' A' ' 28' ' ' ILE . 1.7 m -61.33 -36.87 81.34 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 125.368 1.467 . . . . 0.0 113.674 174.175 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.703 HG22 ' HE3' ' A' ' 1' ' ' MET . 6.1 t -58.16 -45.36 88.7 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.359 0 N-CA-C 113.044 0.757 . . . . 0.0 113.044 170.187 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.405 HD12 ' HB3' ' A' ' 64' ' ' LYS . 39.0 mt -57.07 -38.56 73.47 Favored 'General case' 0 N--CA 1.482 1.173 0 CA-C-N 115.352 -0.84 . . . . 0.0 112.868 177.102 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -53.01 -46.17 68.25 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-N 113.355 -1.748 . . . . 0.0 113.384 176.268 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.42 HG22 ' HA ' ' A' ' 25' ' ' VAL . 1.7 t -55.52 -49.47 73.25 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.124 0 C-N-CA 124.696 1.198 . . . . 0.0 113.042 172.26 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.765 HG11 ' HA ' ' A' ' 56' ' ' LYS . 11.6 t -63.45 -45.44 97.9 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.227 0 C-N-CA 123.635 0.774 . . . . 0.0 111.483 -174.961 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . 0.432 ' HG3' ' HE2' ' A' ' 64' ' ' LYS . 19.0 mt-10 -65.14 -40.98 95.17 Favored 'General case' 0 CA--C 1.541 0.6 0 N-CA-C 115.843 1.794 . . . . 0.0 115.843 -179.6 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -101.12 -20.9 15.13 Favored 'General case' 0 N--CA 1.479 1.007 0 N-CA-C 116.287 1.958 . . . . 0.0 116.287 -174.716 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 71.57 39.63 60.5 Favored Glycine 0 N--CA 1.481 1.634 0 N-CA-C 110.894 -0.882 . . . . 0.0 110.894 -164.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -82.17 164.52 44.2 Favored Glycine 0 N--CA 1.478 1.444 0 C-N-CA 124.388 0.994 . . . . 0.0 113.006 -174.123 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' TRP . . . . . 0.525 ' HB3' HG21 ' A' ' 26' ' ' THR . 2.3 m-90 -62.33 103.9 0.44 Allowed 'General case' 0 N--CA 1.475 0.787 0 CA-C-O 123.166 1.46 . . . . 0.0 112.107 179.603 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.42 ' HA ' HG22 ' A' ' 18' ' ' VAL . 3.0 p -55.57 -24.56 16.36 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.718 0 CA-C-N 112.89 -1.959 . . . . 0.0 112.851 172.87 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' THR . . . . . 0.525 HG21 ' HB3' ' A' ' 24' ' ' TRP . 9.8 t -62.49 -45.92 90.82 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-O 118.002 -0.999 . . . . 0.0 113.441 177.951 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -60.09 -42.06 93.85 Favored 'General case' 0 N--CA 1.484 1.26 0 O-C-N 124.416 1.072 . . . . 0.0 110.454 175.642 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.918 HG13 HG21 ' A' ' 14' ' ' THR . 1.9 mp -65.62 -47.53 85.92 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.649 0 C-N-CA 124.634 1.174 . . . . 0.0 112.583 -179.534 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 72.7 t -50.37 -42.7 21.29 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 O-C-N 123.755 0.66 . . . . 0.0 111.232 174.426 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 5.5 m -55.55 -40.95 72.57 Favored 'General case' 0 N--CA 1.481 1.106 0 N-CA-C 113.919 1.081 . . . . 0.0 113.919 175.948 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.975 HG21 HG13 ' A' ' 11' ' ' VAL . 34.9 mm -71.45 -38.86 70.07 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.957 0 C-N-CA 124.14 0.976 . . . . 0.0 109.932 179.802 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.513 HD23 ' HB ' ' A' ' 11' ' ' VAL . 3.4 mm? -61.15 -40.42 93.77 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 124.716 1.207 . . . . 0.0 112.184 171.491 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 10.0 m -67.63 -36.88 81.61 Favored 'General case' 0 N--CA 1.476 0.84 0 N-CA-C 114.05 1.13 . . . . 0.0 114.05 175.813 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -53.64 -31.55 47.89 Favored 'General case' 0 N--CA 1.488 1.437 0 C-N-CA 124.325 1.05 . . . . 0.0 113.797 175.2 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 42.9 t . . . . . 0 N--CA 1.478 0.94 0 C-N-CA 125.802 1.641 . . . . 0.0 113.402 174.167 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . 0.433 ' HA2' ' HB3' ' A' ' 32' ' ' LEU . . . . . . . . 0 N--CA 1.484 1.837 0 N-CA-C 111.805 -0.518 . . . . 0.0 111.805 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 5.3 mt -56.97 -37.38 71.53 Favored 'General case' 0 N--CA 1.481 1.1 0 N-CA-C 115.954 1.835 . . . . 0.0 115.954 -167.869 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 12.3 p -59.15 -48.33 82.02 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 124.139 0.976 . . . . 0.0 112.661 176.335 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.435 HD21 ' HE2' ' A' ' 1' ' ' MET . 15.0 tp -62.75 -49.39 75.21 Favored 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 122.983 0.513 . . . . 0.0 110.572 173.062 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 77.8 mt -60.47 -31.22 70.25 Favored 'General case' 0 N--CA 1.475 0.81 0 N-CA-C 113.972 1.101 . . . . 0.0 113.972 -177.462 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -69.36 -46.14 67.7 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 123.463 0.705 . . . . 0.0 111.826 173.94 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -60.74 -30.85 70.24 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 123.833 0.853 . . . . 0.0 112.563 177.317 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.499 ' HB3' ' HA ' ' A' ' 51' ' ' ILE . . . -67.38 -27.82 67.42 Favored 'General case' 0 N--CA 1.471 0.608 0 N-CA-C 115.931 1.826 . . . . 0.0 115.931 178.276 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -45.76 -45.54 13.23 Favored Glycine 0 CA--C 1.544 1.851 0 C-N-CA 126.105 1.812 . . . . 0.0 114.295 -170.811 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 24.6 tpt180 -45.79 -48.43 15.56 Favored 'General case' 0 CA--C 1.544 0.736 0 CA-C-N 111.948 -2.126 . . . . 0.0 114.328 -179.221 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 18.9 tt0 -123.74 25.89 7.91 Favored 'General case' 0 N--CA 1.481 1.107 0 N-CA-C 114.499 1.296 . . . . 0.0 114.499 -176.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 33.2 t 50.21 133.18 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.486 0 C-N-CA 125.626 1.57 . . . . 0.0 111.83 -167.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.499 ' HA ' ' HB3' ' A' ' 46' ' ' ALA . 7.4 tp -43.13 -45.4 1.36 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.027 0 N-CA-C 115.536 1.68 . . . . 0.0 115.536 -175.599 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 5.6 tmtm? -53.84 -71.2 0.08 Allowed 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 125.061 1.344 . . . . 0.0 111.941 177.733 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -65.47 -29.18 69.81 Favored 'General case' 0 N--CA 1.471 0.576 0 N-CA-C 115.135 1.531 . . . . 0.0 115.135 179.385 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . 0.46 ' O ' ' HB2' ' A' ' 58' ' ' GLU . 86.9 t80 -51.1 -64.64 0.75 Allowed 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 125.417 1.487 . . . . 0.0 111.579 176.565 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.464 HD12 HG12 ' A' ' 15' ' ' VAL . 75.4 mt -60.77 -37.86 83.3 Favored 'General case' 0 N--CA 1.478 0.95 0 N-CA-C 114.617 1.34 . . . . 0.0 114.617 -176.18 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . 0.765 ' HA ' HG11 ' A' ' 19' ' ' VAL . 94.0 mttt -61.3 -45.23 95.31 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 113.201 -1.818 . . . . 0.0 114.055 -179.335 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 81.4 tttt -77.25 -47.06 21.12 Favored 'General case' 0 CA--C 1.543 0.71 0 CA-C-N 115.275 -0.875 . . . . 0.0 112.703 171.463 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . 0.461 ' O ' ' HB2' ' A' ' 62' ' ' LYS . 4.1 mm-40 -57.22 -51.05 70.91 Favored 'General case' 0 C--O 1.219 -0.522 0 N-CA-C 113.743 1.016 . . . . 0.0 113.743 -175.105 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.716 HG22 HG22 ' A' ' 67' ' ' VAL . 2.6 mm -80.01 -21.1 11.91 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.484 0 N-CA-C 112.206 0.447 . . . . 0.0 112.206 -177.603 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . 0.522 ' HB2' ' O ' ' A' ' 56' ' ' LYS . 6.9 tppt? -60.65 -42.79 97.71 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-O 123.783 1.754 . . . . 0.0 112.296 171.599 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . 0.277 19.5 tttm -81.32 -45.03 16.8 Favored 'General case' 0 CA--C 1.55 0.951 0 CA-C-N 111.132 -2.758 . . . . 0.0 111.74 -179.797 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . 0.461 ' HB2' ' O ' ' A' ' 58' ' ' GLU . 15.5 tptt -58.51 -50.66 72.95 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 126.036 1.734 . . . . 0.0 113.605 -179.135 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 86.66 108.31 0.82 Allowed Glycine 0 N--CA 1.478 1.47 0 CA-C-N 113.582 -1.644 . . . . 0.0 109.911 -169.079 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.685 ' HD2' ' H ' ' A' ' 64' ' ' LYS . 10.0 mptt -28.48 -48.38 0.06 Allowed 'General case' 0 N--CA 1.481 1.083 0 N-CA-C 119.776 3.25 . . . . 0.0 119.776 -176.625 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . 0.4 ' O ' ' HB ' ' A' ' 68' ' ' ILE . 1.2 ttp85 -54.5 -44.03 72.35 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 125.625 1.57 . . . . 0.0 113.321 178.804 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -69.25 -23.25 63.84 Favored 'General case' 0 N--CA 1.474 0.761 0 N-CA-C 114.702 1.371 . . . . 0.0 114.702 176.116 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.716 HG22 HG22 ' A' ' 59' ' ' ILE . 63.9 t -75.67 -35.88 32.48 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.31 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.893 178.752 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.4 ' HB ' ' O ' ' A' ' 65' ' ' ARG . 17.3 mm -50.39 -42.56 21.2 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 C-N-CA 124.124 0.969 . . . . 0.0 111.107 169.304 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -74.9 -52.8 10.35 Favored 'General case' 0 N--CA 1.484 1.238 0 N-CA-C 113.718 1.007 . . . . 0.0 113.718 174.789 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 33.3 t90 . . . . . 0 N--CA 1.488 1.47 0 C-N-CA 125.704 1.602 . . . . 0.0 114.118 -178.301 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.711 ' HE1' HG23 ' A' ' 7' ' ' ILE . 68.1 mtp . . . . . 0 N--CA 1.478 0.969 0 N-CA-C 112.137 0.421 . . . . 0.0 112.137 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . 0.569 ' HA ' ' O ' ' A' ' 7' ' ' ILE . . . -58.26 -52.78 64.14 Favored 'General case' 0 N--CA 1.475 0.825 0 CA-C-N 114.819 -1.082 . . . . 0.0 112.129 173.902 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.99 -65.11 0.84 Allowed 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 112.518 -2.128 . . . . 0.0 115.997 -174.962 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . 0.42 ' HB2' ' O ' ' A' ' 70' ' ' TRP . 1.8 mp0 -73.79 -26.34 60.58 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-N 112.877 -1.965 . . . . 0.0 113.496 -170.718 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . 0.421 ' HD1' ' HB2' ' A' ' 41' ' ' SER . 31.6 m-85 -118.02 -6.92 10.92 Favored 'General case' 0 N--CA 1.478 0.937 0 N-CA-C 118.025 2.602 . . . . 0.0 118.025 -174.167 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 63.13 37.22 94.56 Favored Glycine 0 CA--C 1.543 1.806 0 O-C-N 124.007 0.817 . . . . 0.0 112.551 -175.866 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . 0.711 HG23 ' HE1' ' A' ' 1' ' ' MET . 0.5 OUTLIER -114.0 121.51 36.63 Favored Pre-proline 0 N--CA 1.475 0.778 0 CA-C-N 114.448 -0.876 . . . . 0.0 108.708 -179.833 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 96.6 Cg_endo -67.28 160.87 45.59 Favored 'Trans proline' 0 CA--C 1.532 0.411 0 C-N-CA 120.971 1.114 . . . . 0.0 111.334 -177.558 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -53.62 -27.62 28.05 Favored 'General case' 0 CA--C 1.545 0.772 0 N-CA-C 114.713 1.375 . . . . 0.0 114.713 173.048 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -45.43 -43.9 11.7 Favored 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 126.191 1.796 . . . . 0.0 114.357 174.216 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.528 ' HB ' HD23 ' A' ' 32' ' ' LEU . 34.5 m -102.65 -33.59 3.36 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.893 0 N-CA-C 114.306 1.225 . . . . 0.0 114.306 -176.947 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -61.45 -34.17 74.97 Favored 'General case' 0 N--CA 1.475 0.776 0 CA-C-N 114.8 -1.091 . . . . 0.0 112.181 173.686 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -59.71 -49.97 72.82 Favored Glycine 0 N--CA 1.478 1.434 0 C-N-CA 124.799 1.19 . . . . 0.0 112.775 173.57 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' THR . . . . . 0.43 HG23 HG13 ' A' ' 31' ' ' ILE . 9.1 m -62.13 -36.39 81.65 Favored 'General case' 0 N--CA 1.479 1.001 0 N-CA-C 114.612 1.338 . . . . 0.0 114.612 175.596 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.66 HG22 ' HE3' ' A' ' 1' ' ' MET . 72.0 t -56.94 -40.11 69.96 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.133 0 C-N-CA 123.213 0.605 . . . . 0.0 111.481 173.109 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.628 HD12 ' HB3' ' A' ' 64' ' ' LYS . 27.6 mt -61.36 -43.57 98.65 Favored 'General case' 0 N--CA 1.479 1.023 0 N-CA-C 113.418 0.896 . . . . 0.0 113.418 178.636 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 56.6 t-20 -54.77 -49.77 70.08 Favored 'General case' 0 CA--C 1.548 0.901 0 O-C-N 124.614 1.197 . . . . 0.0 111.055 173.443 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 96.8 t -54.9 -52.35 44.0 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.954 0 CA-C-N 114.6 -1.182 . . . . 0.0 111.204 175.823 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.656 HG12 ' HB ' ' A' ' 59' ' ' ILE . 81.7 t -53.88 -56.14 10.61 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.307 0 O-C-N 124.05 0.844 . . . . 0.0 111.124 179.788 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 14.5 tt0 -57.13 -37.69 72.38 Favored 'General case' 0 N--CA 1.476 0.829 0 O-C-N 124.972 1.42 . . . . 0.0 113.191 -176.825 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -88.12 -16.64 32.91 Favored 'General case' 0 N--CA 1.473 0.699 0 N-CA-C 116.294 1.961 . . . . 0.0 116.294 179.15 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 70.58 33.65 67.36 Favored Glycine 0 N--CA 1.487 2.099 0 C-N-CA 124.5 1.048 . . . . 0.0 112.143 -170.012 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -77.32 -177.12 45.69 Favored Glycine 0 CA--C 1.539 1.583 0 CA-C-O 124.155 1.975 . . . . 0.0 115.542 -170.954 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' TRP . . . . . 0.419 ' HB3' ' OG1' ' A' ' 26' ' ' THR . 74.0 m95 -63.7 122.65 16.9 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 110.717 -2.741 . . . . 0.0 116.73 -176.296 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 11.9 p -42.76 -37.75 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.379 0 CA-C-N 112.492 -2.14 . . . . 0.0 113.802 164.561 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' THR . . . . . 0.419 ' OG1' ' HB3' ' A' ' 24' ' ' TRP . 8.4 p -60.1 -44.26 94.97 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 123.782 0.833 . . . . 0.0 111.483 176.927 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -60.72 -29.54 69.42 Favored 'General case' 0 N--CA 1.485 1.317 0 N-CA-C 112.835 0.68 . . . . 0.0 112.835 176.321 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.496 ' O ' HD21 ' A' ' 32' ' ' LEU . 30.4 mt -72.75 -68.28 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.028 0 N-CA-C 109.36 -0.607 . . . . 0.0 109.36 167.239 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 85.7 t -54.39 -48.49 68.57 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.054 0 CA-C-O 118.159 -0.924 . . . . 0.0 112.896 -170.45 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 67.2 m -64.83 -26.15 68.21 Favored 'General case' 0 N--CA 1.477 0.897 0 N-CA-C 115.172 1.545 . . . . 0.0 115.172 179.349 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.492 HG21 HG11 ' A' ' 11' ' ' VAL . 35.7 mm -85.23 -42.41 16.3 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.921 0 C-N-CA 123.047 0.539 . . . . 0.0 110.166 174.659 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.528 HD23 ' HB ' ' A' ' 11' ' ' VAL . 3.5 mm? -62.18 -30.12 70.84 Favored 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 125.107 1.363 . . . . 0.0 114.328 176.015 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 2.8 p -68.54 -30.84 69.72 Favored 'General case' 0 N--CA 1.488 1.448 0 N-CA-C 116.424 2.009 . . . . 0.0 116.424 170.472 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -58.63 -25.46 62.71 Favored 'General case' 0 N--CA 1.475 0.82 0 O-C-N 124.654 1.221 . . . . 0.0 112.868 177.16 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.419 HG21 HG13 ' A' ' 11' ' ' VAL . 98.4 t . . . . . 0 N--CA 1.481 1.077 0 C-N-CA 126.592 1.957 . . . . 0.0 112.597 175.408 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . 0.511 ' HA2' ' HB3' ' A' ' 32' ' ' LEU . . . . . . . . 0 CA--C 1.541 1.686 0 CA-C-O 119.109 -0.828 . . . . 0.0 113.48 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 20.8 mt -55.79 -43.16 76.54 Favored 'General case' 0 N--CA 1.477 0.908 0 N-CA-C 115.15 1.537 . . . . 0.0 115.15 -173.442 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' SER . . . . . 0.421 ' HB2' ' HD1' ' A' ' 5' ' ' PHE . 8.8 p -60.0 -46.39 89.61 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 123.861 0.864 . . . . 0.0 113.063 173.937 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 12.0 tp -60.91 -51.3 69.88 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 124.002 0.921 . . . . 0.0 110.366 172.096 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 52.1 mt -57.8 -33.06 68.17 Favored 'General case' 0 N--CA 1.476 0.84 0 N-CA-C 114.345 1.239 . . . . 0.0 114.345 -179.692 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -65.39 -48.43 72.9 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-N 115.765 -0.652 . . . . 0.0 112.529 172.697 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -64.7 -36.63 84.9 Favored 'General case' 0 N--CA 1.482 1.155 0 CA-C-O 121.892 0.853 . . . . 0.0 111.829 177.595 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.535 ' HB3' ' HA ' ' A' ' 51' ' ' ILE . . . -65.16 -15.74 62.75 Favored 'General case' 0 N--CA 1.476 0.843 0 N-CA-C 116.107 1.891 . . . . 0.0 116.107 179.071 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -51.77 -42.81 53.51 Favored Glycine 0 CA--C 1.544 1.87 0 C-N-CA 124.725 1.155 . . . . 0.0 112.988 177.914 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 44.9 ttp180 -49.58 -49.89 44.68 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 125.123 1.369 . . . . 0.0 113.817 -174.158 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . 0.411 ' HB3' ' HD1' ' A' ' 54' ' ' TYR . 29.1 tt0 -129.64 36.06 4.13 Favored 'General case' 0 CA--C 1.547 0.849 0 N-CA-C 113.605 0.965 . . . . 0.0 113.605 -174.518 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 96.0 p 50.31 123.68 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.372 0 C-N-CA 126.527 1.931 . . . . 0.0 113.877 -175.524 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.535 ' HA ' ' HB3' ' A' ' 46' ' ' ALA 0.274 3.9 tp -35.23 -63.99 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.545 0.779 0 N-CA-C 117.547 2.425 . . . . 0.0 117.547 -170.134 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 16.0 ttpp -52.52 -58.49 6.6 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 123.387 0.675 . . . . 0.0 112.791 177.359 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -64.05 -38.37 90.83 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 124.518 1.127 . . . . 0.0 113.485 -178.147 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . 0.411 ' HD1' ' HB3' ' A' ' 49' ' ' GLU . 72.8 t80 -51.9 -65.6 0.53 Allowed 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 126.056 1.742 . . . . 0.0 109.625 175.441 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 48.1 mt -64.36 -37.27 86.93 Favored 'General case' 0 N--CA 1.474 0.765 0 N-CA-C 114.33 1.233 . . . . 0.0 114.33 -177.8 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . 0.579 ' HA ' HG11 ' A' ' 19' ' ' VAL . 9.0 tmtm? -57.58 -48.86 78.21 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 114.594 -1.185 . . . . 0.0 112.598 178.602 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 41.2 tttm -77.88 -49.83 13.44 Favored 'General case' 0 N--CA 1.476 0.854 0 CA-C-N 115.18 -0.918 . . . . 0.0 112.601 175.171 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . 0.442 ' O ' ' HB2' ' A' ' 62' ' ' LYS . 39.5 tt0 -58.25 -49.2 77.93 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-O 118.523 -0.751 . . . . 0.0 110.53 -173.164 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.764 HG22 HG22 ' A' ' 67' ' ' VAL . 2.8 mm -75.89 -25.53 17.22 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.893 0 CA-C-O 119.18 -0.438 . . . . 0.0 111.902 -176.503 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . 0.567 ' HB2' ' O ' ' A' ' 56' ' ' LYS . 0.9 OUTLIER -61.38 -34.03 74.65 Favored 'General case' 0 CA--C 1.546 0.796 0 O-C-N 124.56 1.162 . . . . 0.0 113.812 171.867 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -86.26 -43.34 13.02 Favored 'General case' 0 N--CA 1.481 1.098 0 CA-C-N 113.094 -1.866 . . . . 0.0 112.228 179.02 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . 0.442 ' HB2' ' O ' ' A' ' 58' ' ' GLU . 22.8 tttm -67.06 -51.06 59.17 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 127.507 2.323 . . . . 0.0 112.34 -173.742 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 102.42 108.38 3.2 Favored Glycine 0 N--CA 1.476 1.325 0 N-CA-C 109.621 -1.392 . . . . 0.0 109.621 -173.048 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.628 ' HB3' HD12 ' A' ' 16' ' ' LEU . 10.9 mptt -40.04 -43.57 1.6 Allowed 'General case' 0 N--CA 1.487 1.375 0 N-CA-C 117.558 2.429 . . . . 0.0 117.558 -175.171 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . 0.445 ' O ' ' HB ' ' A' ' 68' ' ' ILE . 11.2 mmp_? -57.4 -43.39 83.66 Favored 'General case' 0 N--CA 1.478 0.931 0 N-CA-C 116.003 1.853 . . . . 0.0 116.003 178.749 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -67.65 -27.7 67.09 Favored 'General case' 0 N--CA 1.482 1.157 0 CA-C-N 114.15 -1.386 . . . . 0.0 113.209 173.104 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.764 HG22 HG22 ' A' ' 59' ' ' ILE . 78.8 t -70.92 -33.18 51.06 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.048 0 C-N-CA 123.337 0.655 . . . . 0.0 111.972 177.794 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.445 ' HB ' ' O ' ' A' ' 65' ' ' ARG . 14.1 mm -51.07 -44.38 28.23 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.022 0 C-N-CA 123.805 0.842 . . . . 0.0 110.894 166.831 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -71.96 -48.61 43.93 Favored 'General case' 0 N--CA 1.478 0.957 0 O-C-N 124.263 0.977 . . . . 0.0 112.697 176.727 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' TRP . . . . . 0.42 ' O ' ' HB2' ' A' ' 4' ' ' GLU . 40.6 t90 . . . . . 0 N--CA 1.48 1.041 0 C-N-CA 126.045 1.738 . . . . 0.0 113.519 -178.469 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.579 ' HE2' HG22 ' A' ' 15' ' ' VAL . 67.2 mtp . . . . . 0 N--CA 1.479 1.013 0 N-CA-C 112.615 0.598 . . . . 0.0 112.615 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . 0.542 ' HA ' ' O ' ' A' ' 7' ' ' ILE . . . -53.67 -52.53 59.68 Favored 'General case' 0 CA--C 1.542 0.653 0 O-C-N 124.658 1.224 . . . . 0.0 112.691 172.407 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 39.7 ttmt -73.76 -55.32 6.37 Favored 'General case' 0 N--CA 1.472 0.675 0 CA-C-N 112.617 -2.083 . . . . 0.0 114.765 -175.637 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -74.86 -35.83 62.33 Favored 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 114.804 1.409 . . . . 0.0 114.804 -170.154 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . 0.532 ' HB2' HD11 ' A' ' 7' ' ' ILE . 61.1 m-85 -113.89 -23.23 9.73 Favored 'General case' 0 N--CA 1.48 1.045 0 N-CA-C 116.92 2.192 . . . . 0.0 116.92 -170.999 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 87.23 59.12 1.79 Allowed Glycine 0 N--CA 1.488 2.121 0 O-C-N 125.151 1.532 . . . . 0.0 111.878 -176.472 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . 0.542 ' O ' ' HA ' ' A' ' 2' ' ' ALA . 1.0 OUTLIER -119.07 139.74 27.81 Favored Pre-proline 0 N--CA 1.48 1.031 0 C-N-CA 125.061 1.344 . . . . 0.0 110.412 178.85 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_endo -83.2 151.86 13.93 Favored 'Trans proline' 0 N--CA 1.455 -0.757 0 N-CA-C 108.714 -1.302 . . . . 0.0 108.714 162.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -42.76 -38.28 2.05 Favored 'General case' 0 N--CA 1.471 0.597 0 N-CA-C 116.403 2.001 . . . . 0.0 116.403 -179.629 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -30.62 -59.26 0.2 Allowed 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 127.081 2.153 . . . . 0.0 113.99 168.594 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.897 HG13 HG21 ' A' ' 31' ' ' ILE . 17.2 m -87.98 -31.01 5.61 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.668 0 N-CA-C 114.627 1.344 . . . . 0.0 114.627 -170.903 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -67.3 -29.27 68.81 Favored 'General case' 0 CA--C 1.549 0.927 0 CA-C-N 116.302 -0.408 . . . . 0.0 112.092 169.757 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . 0.523 ' HA3' HD11 ' A' ' 16' ' ' LEU . . . -67.56 -41.81 89.42 Favored Glycine 0 CA--C 1.545 1.908 0 C-N-CA 125.368 1.461 . . . . 0.0 112.936 171.209 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' THR . . . . . 0.527 HG21 HG13 ' A' ' 28' ' ' ILE . 8.6 m -65.84 -35.87 81.87 Favored 'General case' 0 N--CA 1.475 0.778 0 N-CA-C 113.046 0.758 . . . . 0.0 113.046 173.503 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.659 HG21 HD23 ' A' ' 32' ' ' LEU . 2.3 t -49.24 -38.48 11.75 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.066 0 C-N-CA 124.47 1.108 . . . . 0.0 113.599 166.126 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.641 HD21 ' HG3' ' A' ' 64' ' ' LYS . 84.6 mt -61.0 -38.12 84.91 Favored 'General case' 0 N--CA 1.475 0.822 0 N-CA-C 113.602 0.964 . . . . 0.0 113.602 178.648 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 35.2 t-20 -52.23 -42.72 63.83 Favored 'General case' 0 CA--C 1.547 0.838 0 O-C-N 124.0 0.813 . . . . 0.0 111.421 172.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -60.43 -56.3 18.61 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.816 0 CA-C-N 115.046 -0.979 . . . . 0.0 113.045 173.14 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.765 HG11 ' HA ' ' A' ' 56' ' ' LYS . 5.5 t -58.96 -49.69 82.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 124.026 0.829 . . . . 0.0 112.698 -177.53 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . 0.444 ' OE1' ' HB3' ' A' ' 16' ' ' LEU . 24.5 mt-10 -72.35 -42.4 65.38 Favored 'General case' 0 N--CA 1.473 0.696 0 N-CA-C 116.57 2.063 . . . . 0.0 116.57 -175.236 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -103.92 -25.87 12.88 Favored 'General case' 0 N--CA 1.481 1.125 0 N-CA-C 115.231 1.567 . . . . 0.0 115.231 -173.022 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 77.4 41.23 21.36 Favored Glycine 0 CA--C 1.541 1.699 0 N-CA-C 110.467 -1.053 . . . . 0.0 110.467 -165.71 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -76.44 173.86 54.01 Favored Glycine 0 CA--C 1.535 1.316 0 C-N-CA 124.914 1.245 . . . . 0.0 112.689 -173.439 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' TRP . . . . . 0.406 ' HB3' HG21 ' A' ' 26' ' ' THR . 3.6 m-90 -69.16 101.79 1.53 Allowed 'General case' 0 N--CA 1.473 0.72 0 CA-C-O 123.341 1.544 . . . . 0.0 110.93 -178.92 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.401 HG22 HG22 ' A' ' 51' ' ' ILE . 9.8 p -48.51 -29.44 2.53 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.821 0 CA-C-N 112.658 -2.064 . . . . 0.0 114.86 172.736 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' THR . . . . . 0.406 HG21 ' HB3' ' A' ' 24' ' ' TRP . 11.1 t -60.04 -46.62 88.93 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 123.73 0.812 . . . . 0.0 112.929 179.745 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' THR . . . . . 0.535 ' O ' HG12 ' A' ' 31' ' ' ILE . 2.0 m -60.09 -48.13 82.98 Favored 'General case' 0 N--CA 1.481 1.08 0 CA-C-N 114.144 -1.389 . . . . 0.0 109.992 175.913 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.527 HG13 HG21 ' A' ' 14' ' ' THR . 1.8 mp -58.32 -53.03 51.81 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.023 0 C-N-CA 123.912 0.885 . . . . 0.0 110.771 179.301 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 65.5 t -53.98 -47.81 64.62 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.744 0 CA-C-O 118.118 -0.944 . . . . 0.0 111.474 177.551 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 20.9 m -61.04 -36.91 80.83 Favored 'General case' 0 N--CA 1.481 1.119 0 N-CA-C 114.446 1.276 . . . . 0.0 114.446 178.672 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.897 HG21 HG13 ' A' ' 11' ' ' VAL . 42.2 mm -72.98 -42.44 59.77 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.93 0 C-N-CA 124.246 1.018 . . . . 0.0 109.463 178.88 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.659 HD23 HG21 ' A' ' 15' ' ' VAL . 4.2 mm? -57.83 -53.06 62.48 Favored 'General case' 0 N--CA 1.484 1.259 0 C-N-CA 125.097 1.359 . . . . 0.0 112.897 173.796 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -65.57 -28.11 68.91 Favored 'General case' 0 N--CA 1.481 1.104 0 N-CA-C 115.406 1.632 . . . . 0.0 115.406 178.329 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -52.37 -32.0 36.48 Favored 'General case' 0 N--CA 1.486 1.358 0 N-CA-C 113.907 1.077 . . . . 0.0 113.907 171.949 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 50.7 t . . . . . 0 N--CA 1.49 1.561 0 C-N-CA 126.169 1.788 . . . . 0.0 112.41 173.816 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . 0.5 ' HA3' ' HB3' ' A' ' 32' ' ' LEU . . . . . . . . 0 N--CA 1.482 1.765 0 N-CA-C 111.435 -0.666 . . . . 0.0 111.435 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 72.0 mt -57.54 -45.6 84.88 Favored 'General case' 0 N--CA 1.476 0.861 0 N-CA-C 115.937 1.828 . . . . 0.0 115.937 -176.297 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 79.5 p -62.54 -42.36 99.47 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-N 115.384 -0.825 . . . . 0.0 112.938 176.148 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 11.9 tp -63.59 -43.42 96.98 Favored 'General case' 0 N--CA 1.474 0.762 0 N-CA-C 110.026 -0.361 . . . . 0.0 110.026 175.731 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 94.7 mt -62.95 -35.97 81.91 Favored 'General case' 0 N--CA 1.475 0.784 0 N-CA-C 114.414 1.265 . . . . 0.0 114.414 -179.808 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -69.68 -40.69 76.24 Favored 'General case' 0 N--CA 1.473 0.691 0 O-C-N 123.83 0.706 . . . . 0.0 112.782 174.176 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -68.57 -36.17 78.39 Favored 'General case' 0 N--CA 1.475 0.817 0 CA-C-O 121.286 0.565 . . . . 0.0 112.128 177.508 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -53.95 -21.76 8.71 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 126.58 1.952 . . . . 0.0 115.587 173.197 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -50.01 -32.89 20.42 Favored Glycine 0 N--CA 1.478 1.49 0 C-N-CA 125.144 1.354 . . . . 0.0 114.007 178.936 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 68.0 ttp85 -55.36 -55.32 32.9 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 124.918 1.287 . . . . 0.0 113.33 178.573 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 8.2 tt0 -133.29 34.79 3.5 Favored 'General case' 0 CA--C 1.548 0.869 0 N-CA-C 114.803 1.408 . . . . 0.0 114.803 -173.931 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 32.8 t 44.31 127.09 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.041 0 N-CA-C 114.147 1.165 . . . . 0.0 114.147 -172.646 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.401 HG22 HG22 ' A' ' 25' ' ' VAL 0.266 8.8 tp -30.47 -57.28 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 N-CA-C 119.036 2.976 . . . . 0.0 119.036 -169.812 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 81.9 tttt -60.99 -56.0 26.25 Favored 'General case' 0 N--CA 1.478 0.927 0 N-CA-C 112.065 0.394 . . . . 0.0 112.065 -179.477 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -61.16 -38.44 86.44 Favored 'General case' 0 N--CA 1.486 1.363 0 C-N-CA 123.94 0.896 . . . . 0.0 113.203 177.603 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 89.9 t80 -52.41 -60.24 3.47 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 125.618 1.567 . . . . 0.0 112.253 175.479 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.406 HD12 HG12 ' A' ' 15' ' ' VAL . 64.5 mt -65.9 -38.88 89.89 Favored 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 114.053 1.131 . . . . 0.0 114.053 -179.929 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . 0.765 ' HA ' HG11 ' A' ' 19' ' ' VAL . 30.9 mttm -53.81 -54.04 43.92 Favored 'General case' 0 N--CA 1.48 1.039 0 CA-C-N 114.029 -1.441 . . . . 0.0 113.377 178.482 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 55.2 tttp -68.93 -47.23 66.23 Favored 'General case' 0 CA--C 1.541 0.621 0 CA-C-N 115.294 -0.866 . . . . 0.0 112.537 176.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . 0.467 ' O ' ' HB2' ' A' ' 62' ' ' LYS . 66.8 mt-10 -56.61 -51.66 67.8 Favored 'General case' 0 N--CA 1.477 0.898 0 N-CA-C 112.26 0.467 . . . . 0.0 112.26 -175.351 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.48 ' HA ' ' HB2' ' A' ' 62' ' ' LYS . 6.3 mm -81.02 -20.61 11.21 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.258 0 N-CA-C 112.99 0.737 . . . . 0.0 112.99 -176.218 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . 0.424 ' HD3' ' HA ' ' A' ' 60' ' ' LYS . 10.2 tppt? -62.44 -34.02 75.95 Favored 'General case' 0 CA--C 1.542 0.657 0 CA-C-O 121.985 0.898 . . . . 0.0 112.865 170.234 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 93.0 mttt -84.95 -44.67 12.91 Favored 'General case' 0 CA--C 1.546 0.806 0 CA-C-N 112.814 -1.994 . . . . 0.0 113.556 175.507 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . 0.48 ' HB2' ' HA ' ' A' ' 59' ' ' ILE . 0.2 OUTLIER -65.06 -45.04 86.98 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-N 113.529 -1.669 . . . . 0.0 115.329 -172.929 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 85.91 111.72 0.79 Allowed Glycine 0 N--CA 1.47 0.949 0 N-CA-C 108.356 -1.898 . . . . 0.0 108.356 -172.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.813 ' HD2' ' H ' ' A' ' 64' ' ' LYS . 9.9 mptt -23.41 -46.53 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.437 0 N-CA-C 119.516 3.154 . . . . 0.0 119.516 -174.829 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . 0.284 8.9 ttt180 -48.92 -44.22 40.14 Favored 'General case' 0 N--CA 1.471 0.618 0 N-CA-C 115.365 1.617 . . . . 0.0 115.365 173.052 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -58.74 -31.25 68.15 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 116.243 -1.837 . . . . 0.0 113.124 174.575 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.534 HG13 ' O ' ' A' ' 64' ' ' LYS . 0.5 OUTLIER -64.06 -41.84 93.76 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.259 0 CA-C-N 119.393 0.997 . . . . 0.0 111.573 178.766 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 35.8 mm -57.82 -39.06 69.16 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.887 0 CA-C-N 113.251 -1.795 . . . . 0.0 110.471 177.141 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -80.24 -49.18 11.96 Favored 'General case' 0 N--CA 1.475 0.805 0 N-CA-C 114.288 1.218 . . . . 0.0 114.288 175.05 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 24.3 t90 . . . . . 0 N--CA 1.484 1.265 0 C-N-CA 127.055 2.142 . . . . 0.0 112.708 -179.363 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.747 ' HE2' HG22 ' A' ' 15' ' ' VAL . 52.3 mtp . . . . . 0 N--CA 1.479 0.979 0 N-CA-C 113.417 0.895 . . . . 0.0 113.417 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -61.31 -49.27 77.68 Favored 'General case' 0 N--CA 1.474 0.757 0 CA-C-N 115.018 -0.992 . . . . 0.0 112.287 173.974 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 57.4 tttm -75.82 -60.46 2.31 Favored 'General case' 0 N--CA 1.478 0.948 0 CA-C-N 114.046 -1.434 . . . . 0.0 114.085 -176.428 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . 0.403 ' HB2' ' O ' ' A' ' 70' ' ' TRP . 2.1 mp0 -75.96 -29.07 58.16 Favored 'General case' 0 N--CA 1.474 0.744 0 N-CA-C 115.656 1.724 . . . . 0.0 115.656 -169.751 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . 0.417 ' HD1' ' HB2' ' A' ' 41' ' ' SER . 43.4 m-85 -115.11 -18.21 11.23 Favored 'General case' 0 N--CA 1.48 1.051 0 N-CA-C 117.496 2.406 . . . . 0.0 117.496 -173.243 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 72.82 40.67 51.94 Favored Glycine 0 CA--C 1.542 1.756 0 O-C-N 124.543 1.152 . . . . 0.0 112.11 -171.126 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . 0.79 HG22 HG22 ' A' ' 11' ' ' VAL . 0.6 OUTLIER -121.91 106.23 36.89 Favored Pre-proline 0 N--CA 1.474 0.73 0 C-N-CA 124.566 1.146 . . . . 0.0 110.288 179.425 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_endo -63.93 168.23 12.5 Favored 'Trans proline' 0 CA--C 1.54 0.791 0 C-N-CA 122.567 2.178 . . . . 0.0 112.582 -172.825 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -51.34 -33.32 28.91 Favored 'General case' 0 N--CA 1.477 0.914 0 CA-C-N 113.617 -1.629 . . . . 0.0 114.212 172.493 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -49.87 -34.45 20.13 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 125.9 1.68 . . . . 0.0 114.567 176.099 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 1.066 HG13 HG21 ' A' ' 31' ' ' ILE . 30.4 m -112.0 -29.4 2.37 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.407 0 N-CA-C 114.145 1.165 . . . . 0.0 114.145 179.819 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . 0.406 ' O ' ' HG ' ' A' ' 16' ' ' LEU . . . -66.77 -37.35 84.41 Favored 'General case' 0 N--CA 1.475 0.794 0 N-CA-C 113.393 0.886 . . . . 0.0 113.393 174.791 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -61.09 -37.9 94.68 Favored Glycine 0 CA--C 1.544 1.871 0 C-N-CA 123.92 0.771 . . . . 0.0 112.287 170.62 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -70.32 -32.91 70.87 Favored 'General case' 0 N--CA 1.487 1.407 0 C-N-CA 125.051 1.34 . . . . 0.0 113.363 179.44 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.747 HG22 ' HE2' ' A' ' 1' ' ' MET . 10.4 t -61.2 -36.11 70.47 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.255 0 C-N-CA 123.895 0.878 . . . . 0.0 111.982 169.469 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.58 HD12 ' HB3' ' A' ' 64' ' ' LYS . 48.3 mt -66.09 -37.73 86.5 Favored 'General case' 0 N--CA 1.471 0.61 0 N-CA-C 113.242 0.83 . . . . 0.0 113.242 177.423 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 11.0 t30 -55.12 -44.59 75.13 Favored 'General case' 0 N--CA 1.478 0.934 0 CA-C-N 115.341 -0.845 . . . . 0.0 111.339 172.798 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.514 ' HB ' ' O ' ' A' ' 15' ' ' VAL . 12.8 t -50.64 -52.56 15.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 C-N-CA 124.642 1.177 . . . . 0.0 112.182 171.67 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.721 HG11 ' HA ' ' A' ' 56' ' ' LYS . 11.4 t -61.91 -52.66 57.88 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.191 0 C-N-CA 124.568 1.147 . . . . 0.0 111.479 -178.452 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 10.1 mt-10 -54.82 -44.04 73.51 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 125.692 1.597 . . . . 0.0 115.057 -178.401 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -93.17 -17.1 24.13 Favored 'General case' 0 CA--C 1.546 0.822 0 N-CA-C 115.701 1.741 . . . . 0.0 115.701 -175.376 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 68.39 40.96 86.69 Favored Glycine 0 CA--C 1.544 1.889 0 N-CA-C 110.438 -1.065 . . . . 0.0 110.438 -165.489 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -100.46 164.11 18.95 Favored Glycine 0 CA--C 1.537 1.428 0 C-N-CA 124.827 1.203 . . . . 0.0 114.145 -167.259 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' TRP . . . . . 0.495 ' HD1' ' HZ2' ' A' ' 52' ' ' LYS . 5.8 m-90 -67.69 104.53 1.66 Allowed 'General case' 0 C--O 1.24 0.583 0 CA-C-O 122.577 1.179 . . . . 0.0 113.831 -175.341 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.456 HG13 HG13 ' A' ' 51' ' ' ILE . 5.5 p -55.59 -25.13 17.43 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.825 0 CA-C-N 113.369 -1.741 . . . . 0.0 113.847 169.191 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 1.7 t -60.51 -40.33 91.04 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 114.305 1.224 . . . . 0.0 114.305 179.727 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 1.9 m -68.54 -39.1 81.26 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 122.928 0.491 . . . . 0.0 110.653 175.811 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 2.8 mp -72.23 -31.07 37.9 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.077 0 C-N-CA 124.854 1.262 . . . . 0.0 112.576 177.9 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.442 HG21 ' O ' ' A' ' 25' ' ' VAL . 55.6 t -55.54 -36.42 41.74 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.826 0 C-N-CA 123.104 0.562 . . . . 0.0 112.201 171.737 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 29.8 p -60.98 -26.15 67.37 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 114.813 1.412 . . . . 0.0 114.813 173.788 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 1.066 HG21 HG13 ' A' ' 11' ' ' VAL . 34.7 mm -85.01 -37.84 12.69 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.914 0 C-N-CA 123.901 0.88 . . . . 0.0 109.85 176.493 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.613 HD23 ' HB ' ' A' ' 11' ' ' VAL . 4.3 mm? -60.54 -34.49 74.21 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 124.835 1.254 . . . . 0.0 112.255 172.636 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 9.1 p -75.2 -36.24 61.43 Favored 'General case' 0 N--CA 1.474 0.775 0 N-CA-C 115.413 1.634 . . . . 0.0 115.413 174.057 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -52.88 -25.24 11.04 Favored 'General case' 0 N--CA 1.482 1.155 0 O-C-N 124.64 1.212 . . . . 0.0 114.183 172.236 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.408 HG22 HG23 ' A' ' 11' ' ' VAL . 93.0 t . . . . . 0 N--CA 1.482 1.133 0 C-N-CA 126.32 1.848 . . . . 0.0 113.238 171.225 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . 0.508 ' HA2' ' HB3' ' A' ' 32' ' ' LEU . . . . . . . . 0 N--CA 1.487 2.069 0 CA-C-O 119.6 -0.555 . . . . 0.0 113.461 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 9.7 mt -54.6 -46.83 73.88 Favored 'General case' 0 N--CA 1.481 1.106 0 N-CA-C 116.563 2.06 . . . . 0.0 116.563 -168.501 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' SER . . . . . 0.417 ' HB2' ' HD1' ' A' ' 5' ' ' PHE . 11.6 p -60.11 -44.83 94.56 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 114.823 -1.08 . . . . 0.0 113.397 177.636 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.531 HD21 ' HE1' ' A' ' 1' ' ' MET . 10.8 tp -63.09 -50.31 71.04 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 123.887 0.875 . . . . 0.0 110.287 171.923 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 82.9 mt -60.77 -28.64 68.88 Favored 'General case' 0 N--CA 1.477 0.887 0 N-CA-C 114.875 1.435 . . . . 0.0 114.875 -177.23 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -67.3 -47.64 69.99 Favored 'General case' 0 N--CA 1.474 0.736 0 O-C-N 123.805 0.691 . . . . 0.0 112.798 170.785 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -62.46 -33.61 75.18 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 123.375 0.67 . . . . 0.0 112.44 179.247 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.424 ' HB3' ' HA ' ' A' ' 51' ' ' ILE . . . -57.18 -23.75 49.75 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 126.885 2.074 . . . . 0.0 115.546 174.655 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -52.11 -35.03 40.64 Favored Glycine 0 CA--C 1.538 1.486 0 C-N-CA 125.068 1.318 . . . . 0.0 113.91 -177.904 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 40.0 ttp180 -51.57 -53.51 37.33 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 125.0 1.32 . . . . 0.0 112.958 -176.233 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 20.6 tt0 -128.76 36.8 4.18 Favored 'General case' 0 N--CA 1.478 0.963 0 CA-C-N 115.166 -0.924 . . . . 0.0 113.153 -176.247 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 8.0 t 43.36 128.4 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 125.68 1.592 . . . . 0.0 114.474 -172.07 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.456 HG13 HG13 ' A' ' 25' ' ' VAL . 8.0 tp -32.25 -52.47 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.258 0 N-CA-C 118.156 2.65 . . . . 0.0 118.156 -171.161 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . 0.495 ' HZ2' ' HD1' ' A' ' 24' ' ' TRP . 2.3 ttmt -60.37 -67.46 0.39 Allowed 'General case' 0 N--CA 1.472 0.631 0 N-CA-C 114.461 1.282 . . . . 0.0 114.461 178.441 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -56.62 -34.64 67.46 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 124.276 1.03 . . . . 0.0 113.667 177.817 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 66.7 t80 -50.86 -62.27 1.71 Allowed 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 124.875 1.27 . . . . 0.0 110.589 174.541 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.624 HD12 HG11 ' A' ' 15' ' ' VAL . 60.7 mt -65.26 -37.91 88.66 Favored 'General case' 0 N--CA 1.475 0.783 0 N-CA-C 115.001 1.482 . . . . 0.0 115.001 -176.123 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . 0.721 ' HA ' HG11 ' A' ' 19' ' ' VAL . 93.9 mttt -61.94 -37.15 83.62 Favored 'General case' 0 N--CA 1.473 0.7 0 CA-C-N 113.445 -1.707 . . . . 0.0 114.732 178.523 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . 0.469 ' HE3' ' HE3' ' A' ' 61' ' ' LYS . 80.2 tttt -85.64 -52.55 5.73 Favored 'General case' 0 CA--C 1.535 0.395 0 O-C-N 124.514 1.134 . . . . 0.0 111.241 173.03 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . 0.416 ' O ' ' HB2' ' A' ' 62' ' ' LYS . 29.0 tt0 -55.19 -51.08 67.67 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-O 118.687 -0.673 . . . . 0.0 111.771 -173.014 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.725 HG22 HG23 ' A' ' 67' ' ' VAL . 3.7 mm -75.96 -27.1 17.99 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.281 0 N-CA-C 112.769 0.655 . . . . 0.0 112.769 -173.64 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . 0.458 ' HB2' ' O ' ' A' ' 56' ' ' LYS . 14.9 tttp -60.28 -36.32 77.56 Favored 'General case' 0 CA--C 1.544 0.749 0 CA-C-O 122.643 1.211 . . . . 0.0 113.496 174.02 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . 0.469 ' HE3' ' HE3' ' A' ' 57' ' ' LYS . 9.7 mttm -85.01 -33.17 22.6 Favored 'General case' 0 N--CA 1.474 0.757 0 CA-C-N 112.023 -2.353 . . . . 0.0 112.236 -179.412 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . 0.416 ' HB2' ' O ' ' A' ' 58' ' ' GLU . 66.8 tttt -85.33 -60.13 2.12 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-N 112.744 -2.026 . . . . 0.0 111.561 -168.484 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . 0.46 ' O ' HG22 ' A' ' 67' ' ' VAL . . . 113.11 126.03 4.45 Favored Glycine 0 CA--C 1.532 1.122 0 N-CA-C 110.08 -1.208 . . . . 0.0 110.08 -172.297 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.58 ' HB3' HD12 ' A' ' 16' ' ' LEU . 0.0 OUTLIER -59.4 -42.04 90.81 Favored 'General case' 0 N--CA 1.482 1.135 0 N-CA-C 115.59 1.7 . . . . 0.0 115.59 -173.128 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -58.13 -47.3 83.73 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 125.251 1.42 . . . . 0.0 113.648 179.353 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -62.94 -32.05 73.28 Favored 'General case' 0 N--CA 1.475 0.777 0 CA-C-N 114.534 -1.212 . . . . 0.0 113.769 173.002 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.725 HG23 HG22 ' A' ' 59' ' ' ILE . 48.5 t -68.8 -35.97 72.07 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.989 0 C-N-CA 122.872 0.469 . . . . 0.0 111.179 179.497 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 18.0 mt -53.42 -48.5 57.08 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.01 0 C-N-CA 124.267 1.027 . . . . 0.0 109.722 169.385 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -67.08 -47.49 71.1 Favored 'General case' 0 N--CA 1.477 0.907 0 CA-C-N 115.581 -0.736 . . . . 0.0 112.901 178.808 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' TRP . . . . . 0.403 ' O ' ' HB2' ' A' ' 4' ' ' GLU . 43.0 t90 . . . . . 0 N--CA 1.477 0.891 0 C-N-CA 125.78 1.632 . . . . 0.0 112.22 -179.512 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.5 ' HB3' HG23 ' A' ' 7' ' ' ILE . 76.6 mtp . . . . . 0 C--O 1.238 0.487 0 N-CA-C 113.039 0.755 . . . . 0.0 113.039 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . 0.439 ' HA ' ' O ' ' A' ' 7' ' ' ILE . . . -55.78 -54.13 48.14 Favored 'General case' 0 N--CA 1.475 0.814 0 CA-C-N 114.988 -1.005 . . . . 0.0 111.649 172.882 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 51.1 tttp -72.86 -61.02 1.96 Allowed 'General case' 0 N--CA 1.481 1.08 0 CA-C-N 113.952 -1.476 . . . . 0.0 113.982 -174.246 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -71.0 -37.25 72.66 Favored 'General case' 0 N--CA 1.475 0.815 0 N-CA-C 115.48 1.659 . . . . 0.0 115.48 -171.388 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . 0.413 ' HD2' ' HA ' ' A' ' 1' ' ' MET . 52.1 m-85 -107.95 -15.92 14.42 Favored 'General case' 0 N--CA 1.477 0.885 0 N-CA-C 116.532 2.049 . . . . 0.0 116.532 -172.063 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 79.65 54.25 4.02 Favored Glycine 0 CA--C 1.541 1.701 0 CA-C-O 122.311 0.95 . . . . 0.0 112.508 -176.023 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . 0.5 HG23 ' HB3' ' A' ' 1' ' ' MET . 0.5 OUTLIER -112.73 147.99 38.34 Favored Pre-proline 0 N--CA 1.482 1.128 0 CA-C-N 113.526 -1.337 . . . . 0.0 111.645 -178.839 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 91.0 Cg_endo -86.06 153.39 9.69 Favored 'Trans proline' 0 CA--C 1.538 0.723 0 C-N-CA 121.685 1.59 . . . . 0.0 109.365 163.309 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -49.7 -33.67 16.55 Favored 'General case' 0 N--CA 1.47 0.574 0 N-CA-C 114.966 1.469 . . . . 0.0 114.966 176.346 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -39.08 -43.73 1.06 Allowed 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 127.792 2.437 . . . . 0.0 115.174 171.626 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.969 HG11 HG21 ' A' ' 31' ' ' ILE . 20.0 m -102.31 -29.09 3.04 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.914 0 N-CA-C 114.269 1.211 . . . . 0.0 114.269 -173.626 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -67.48 -30.65 70.41 Favored 'General case' 0 N--CA 1.489 1.483 0 CA-C-N 115.727 -0.67 . . . . 0.0 112.197 171.526 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . 0.446 ' O ' ' HB2' ' A' ' 16' ' ' LEU . . . -63.57 -43.05 98.6 Favored Glycine 0 CA--C 1.553 2.44 0 C-N-CA 124.278 0.942 . . . . 0.0 112.625 168.814 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' THR . . . . . 0.793 HG21 HG13 ' A' ' 28' ' ' ILE . 3.9 m -62.78 -37.49 86.87 Favored 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 113.371 0.878 . . . . 0.0 113.371 176.792 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.468 HG22 ' HE3' ' A' ' 1' ' ' MET . 2.4 t -50.52 -37.73 15.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 C-N-CA 124.155 0.982 . . . . 0.0 113.337 168.254 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.714 HD21 ' HG3' ' A' ' 64' ' ' LYS . 84.8 mt -61.98 -37.28 84.22 Favored 'General case' 0 N--CA 1.479 0.996 0 N-CA-C 113.989 1.107 . . . . 0.0 113.989 177.446 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 14.6 t-20 -53.99 -47.06 71.82 Favored 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 123.223 0.609 . . . . 0.0 110.864 173.417 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 3.1 t -52.01 -56.26 6.87 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.256 0 CA-C-N 114.996 -1.002 . . . . 0.0 112.67 170.556 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.745 HG11 ' HA ' ' A' ' 56' ' ' LYS . 3.8 t -60.11 -51.17 76.04 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 O-C-N 124.549 1.156 . . . . 0.0 111.523 -176.307 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -66.49 -44.37 82.83 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 126.166 1.786 . . . . 0.0 115.705 -175.636 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -101.59 -12.41 18.49 Favored 'General case' 0 CA--C 1.548 0.891 0 N-CA-C 115.413 1.635 . . . . 0.0 115.413 -170.492 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . 0.423 ' HA3' ' HE2' ' A' ' 56' ' ' LYS . . . 66.69 41.53 93.79 Favored Glycine 0 N--CA 1.482 1.762 0 N-CA-C 110.137 -1.185 . . . . 0.0 110.137 -161.734 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -74.53 158.92 51.98 Favored Glycine 0 N--CA 1.471 0.984 0 C-N-CA 125.151 1.358 . . . . 0.0 114.266 -169.3 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' TRP . . . . . 0.433 ' HB3' HG21 ' A' ' 26' ' ' THR . 88.7 m95 -61.68 102.99 0.29 Allowed 'General case' 0 N--CA 1.473 0.724 0 CA-C-N 113.277 -1.462 . . . . 0.0 111.785 175.538 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.56 HG22 HG13 ' A' ' 51' ' ' ILE . 2.7 p -54.49 -24.19 12.25 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.625 0 CA-C-N 114.279 -1.328 . . . . 0.0 114.58 175.331 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' THR . . . . . 0.433 HG21 ' HB3' ' A' ' 24' ' ' TRP . 3.6 t -60.29 -44.24 95.55 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 124.261 1.024 . . . . 0.0 113.632 -179.915 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' THR . . . . . 0.566 ' O ' HG12 ' A' ' 31' ' ' ILE . 0.8 OUTLIER -65.68 -46.34 79.43 Favored 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 123.799 0.84 . . . . 0.0 110.212 176.49 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.793 HG13 HG21 ' A' ' 14' ' ' THR . 2.0 mp -58.98 -51.49 71.87 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.979 0 C-N-CA 124.438 1.095 . . . . 0.0 111.622 177.375 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 50.6 t -53.11 -48.73 53.07 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.826 0 CA-C-O 117.037 -1.459 . . . . 0.0 111.556 176.59 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . 0.284 1.5 p -61.99 -29.85 70.54 Favored 'General case' 0 N--CA 1.479 1.016 0 N-CA-C 115.438 1.644 . . . . 0.0 115.438 179.712 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.969 HG21 HG11 ' A' ' 11' ' ' VAL . 21.2 mm -76.65 -43.26 34.51 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.006 0 C-N-CA 124.174 0.99 . . . . 0.0 110.115 176.38 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.629 HD23 ' HB ' ' A' ' 11' ' ' VAL . 4.2 mm? -55.52 -56.02 25.06 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 124.951 1.3 . . . . 0.0 112.427 172.796 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 3.1 p -64.0 -30.88 71.92 Favored 'General case' 0 N--CA 1.475 0.814 0 N-CA-C 114.825 1.417 . . . . 0.0 114.825 177.599 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -53.31 -25.41 14.74 Favored 'General case' 0 N--CA 1.482 1.134 0 N-CA-C 114.649 1.351 . . . . 0.0 114.649 172.355 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 61.7 t . . . . . 0 N--CA 1.486 1.356 0 C-N-CA 124.547 1.139 . . . . 0.0 111.574 172.669 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . 0.468 ' HA3' ' HB3' ' A' ' 32' ' ' LEU . . . . . . . . 0 N--CA 1.479 1.507 0 N-CA-C 111.76 -0.536 . . . . 0.0 111.76 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 78.4 mt -60.25 -41.65 93.65 Favored 'General case' 0 N--CA 1.482 1.142 0 N-CA-C 115.434 1.642 . . . . 0.0 115.434 -177.754 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 42.7 p -63.69 -43.28 97.1 Favored 'General case' 0 N--CA 1.476 0.863 0 N-CA-C 113.294 0.85 . . . . 0.0 113.294 174.922 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.443 HD11 ' HE2' ' A' ' 1' ' ' MET . 12.4 tp -61.7 -46.8 88.13 Favored 'General case' 0 N--CA 1.474 0.741 0 CA-C-O 121.22 0.534 . . . . 0.0 110.435 174.002 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 94.8 mt -59.96 -39.15 84.64 Favored 'General case' 0 N--CA 1.482 1.153 0 CA-C-N 114.457 -1.247 . . . . 0.0 114.328 179.983 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -61.93 -44.94 95.73 Favored 'General case' 0 N--CA 1.477 0.911 0 N-CA-C 112.362 0.504 . . . . 0.0 112.362 173.289 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -65.96 -33.29 75.47 Favored 'General case' 0 N--CA 1.479 0.992 0 N-CA-C 113.564 0.95 . . . . 0.0 113.564 177.339 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -75.65 -21.56 57.57 Favored 'General case' 0 CA--C 1.543 0.698 0 N-CA-C 116.888 2.181 . . . . 0.0 116.888 179.766 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -50.99 -39.8 41.57 Favored Glycine 0 N--CA 1.474 1.185 0 O-C-N 124.308 1.005 . . . . 0.0 113.914 -173.031 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . 0.461 ' HA ' ' HD2' ' A' ' 48' ' ' ARG . 0.3 OUTLIER -59.51 -49.74 76.61 Favored 'General case' 0 CA--C 1.542 0.643 0 CA-C-N 111.239 -2.48 . . . . 0.0 115.876 -176.479 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 5.4 tt0 -114.5 28.86 8.43 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-N 115.29 -0.868 . . . . 0.0 112.982 -175.242 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 94.2 p 48.33 121.45 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 125.9 1.68 . . . . 0.0 113.373 -172.796 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.56 HG13 HG22 ' A' ' 25' ' ' VAL . 7.6 tp -41.47 -46.14 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.42 0 N-CA-C 117.298 2.332 . . . . 0.0 117.298 -173.64 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 34.6 tttm -60.36 -62.6 1.75 Allowed 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 124.582 1.153 . . . . 0.0 112.266 177.035 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -59.66 -38.7 82.17 Favored 'General case' 0 N--CA 1.48 1.044 0 N-CA-C 113.96 1.096 . . . . 0.0 113.96 177.598 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 84.3 t80 -49.84 -62.11 1.75 Allowed 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 125.432 1.493 . . . . 0.0 111.071 177.343 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.418 HD21 HG12 ' A' ' 15' ' ' VAL . 45.0 mt -61.87 -38.98 90.28 Favored 'General case' 0 N--CA 1.484 1.234 0 N-CA-C 114.477 1.288 . . . . 0.0 114.477 -176.829 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . 0.745 ' HA ' HG11 ' A' ' 19' ' ' VAL . 92.3 mttt -55.19 -54.64 40.73 Favored 'General case' 0 N--CA 1.472 0.638 0 O-C-N 124.83 1.331 . . . . 0.0 112.483 177.705 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . 0.571 ' HG2' ' HD2' ' A' ' 61' ' ' LYS . 78.0 tttt -71.76 -45.75 60.66 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-N 114.622 -1.172 . . . . 0.0 112.575 178.452 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 7.7 mm-40 -52.55 -55.36 22.73 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 122.824 0.45 . . . . 0.0 111.087 -177.617 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 5.9 mm -80.1 -23.51 11.68 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 CA-C-N 114.652 -1.158 . . . . 0.0 112.957 -172.635 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . 0.452 ' HB2' ' O ' ' A' ' 56' ' ' LYS . 16.7 tttp -59.08 -38.0 78.43 Favored 'General case' 0 CA--C 1.544 0.73 0 N-CA-C 114.195 1.183 . . . . 0.0 114.195 170.362 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . 0.571 ' HD2' ' HG2' ' A' ' 57' ' ' LYS . 23.4 mtpt -86.2 -43.59 12.87 Favored 'General case' 0 N--CA 1.479 0.994 0 CA-C-N 113.681 -1.599 . . . . 0.0 111.174 -179.518 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 17.3 tttt -72.14 -40.34 68.13 Favored 'General case' 0 N--CA 1.473 0.709 0 CA-C-N 112.664 -2.062 . . . . 0.0 115.048 -173.391 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 85.49 130.22 2.34 Favored Glycine 0 CA--C 1.538 1.5 0 N-CA-C 109.743 -1.343 . . . . 0.0 109.743 -171.817 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.721 ' HD2' ' H ' ' A' ' 64' ' ' LYS . 11.9 mptt -40.7 -45.16 2.33 Favored 'General case' 0 N--CA 1.486 1.348 0 N-CA-C 116.501 2.038 . . . . 0.0 116.501 -179.496 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -53.64 -43.89 69.14 Favored 'General case' 0 N--CA 1.468 0.441 0 N-CA-C 112.174 0.435 . . . . 0.0 112.174 179.391 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -64.55 -29.73 70.76 Favored 'General case' 0 N--CA 1.48 1.044 0 CA-C-N 113.632 -1.622 . . . . 0.0 114.566 174.787 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.658 HG13 ' O ' ' A' ' 64' ' ' LYS . 1.4 p -64.57 -43.07 96.76 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.342 0 CA-C-N 119.629 1.104 . . . . 0.0 111.759 175.137 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 45.1 mm -55.86 -42.64 71.51 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.276 0 CA-C-N 114.082 -1.417 . . . . 0.0 110.023 176.148 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -72.63 -51.43 19.6 Favored 'General case' 0 N--CA 1.48 1.056 0 N-CA-C 113.951 1.093 . . . . 0.0 113.951 175.573 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 25.9 t90 . . . . . 0 N--CA 1.478 0.952 0 C-N-CA 126.752 2.021 . . . . 0.0 112.176 -178.305 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.604 ' HE2' HG22 ' A' ' 15' ' ' VAL . 53.1 mtp . . . . . 0 N--CA 1.469 0.479 0 N-CA-C 112.592 0.59 . . . . 0.0 112.592 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . 0.499 ' HA ' ' O ' ' A' ' 7' ' ' ILE . . . -56.51 -57.05 14.01 Favored 'General case' 0 N--CA 1.473 0.695 0 CA-C-N 114.823 -1.081 . . . . 0.0 112.12 175.873 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 18.6 ttpp -67.37 -49.2 64.94 Favored 'General case' 0 CA--C 1.547 0.841 0 CA-C-N 112.985 -1.916 . . . . 0.0 113.385 -172.014 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 10.2 tt0 -81.17 -48.08 12.58 Favored 'General case' 0 N--CA 1.477 0.903 0 N-CA-C 114.203 1.186 . . . . 0.0 114.203 -170.088 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . 0.614 ' HB2' HD13 ' A' ' 7' ' ' ILE . 48.0 m-85 -95.86 -17.06 21.41 Favored 'General case' 0 N--CA 1.474 0.733 0 N-CA-C 117.402 2.371 . . . . 0.0 117.402 -170.717 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 83.97 54.9 2.92 Favored Glycine 0 CA--C 1.539 1.564 0 CA-C-O 122.575 1.097 . . . . 0.0 111.052 -174.671 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . 0.614 HD13 ' HB2' ' A' ' 5' ' ' PHE . 1.0 OUTLIER -117.65 142.65 30.91 Favored Pre-proline 0 N--CA 1.475 0.811 0 CA-C-N 113.665 -1.268 . . . . 0.0 110.777 -178.092 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 90.9 Cg_endo -87.82 158.98 7.53 Favored 'Trans proline' 0 CA--C 1.541 0.845 0 C-N-CA 121.26 1.307 . . . . 0.0 109.164 164.844 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -49.09 -32.33 9.55 Favored 'General case' 0 N--CA 1.48 1.07 0 N-CA-C 114.297 1.221 . . . . 0.0 114.297 171.829 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -43.8 -37.1 2.58 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 127.047 2.139 . . . . 0.0 115.615 174.618 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.922 HG11 HG21 ' A' ' 31' ' ' ILE . 26.9 m -109.22 -31.6 2.37 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.074 0 N-CA-C 114.13 1.159 . . . . 0.0 114.13 -179.537 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -69.39 -32.1 70.91 Favored 'General case' 0 N--CA 1.483 1.198 0 N-CA-C 113.354 0.872 . . . . 0.0 113.354 178.301 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -65.81 -36.67 92.52 Favored Glycine 0 N--CA 1.484 1.855 0 CA-C-O 122.717 1.176 . . . . 0.0 112.232 173.953 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' THR . . . . . 0.473 HG21 HG13 ' A' ' 28' ' ' ILE . 0.2 OUTLIER -68.44 -36.19 78.68 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 126.557 1.943 . . . . 0.0 113.356 176.877 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.604 HG22 ' HE2' ' A' ' 1' ' ' MET . 17.4 t -56.11 -39.82 60.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 C-N-CA 124.093 0.957 . . . . 0.0 112.065 168.167 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 39.6 mt -65.59 -41.18 93.11 Favored 'General case' 0 N--CA 1.476 0.829 0 N-CA-C 113.398 0.888 . . . . 0.0 113.398 179.599 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 25.5 t-20 -50.34 -47.54 55.85 Favored 'General case' 0 N--CA 1.475 0.783 0 O-C-N 124.317 1.011 . . . . 0.0 111.593 171.469 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 2.4 t -50.79 -48.69 27.87 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.993 0 C-N-CA 123.991 0.916 . . . . 0.0 112.106 177.183 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.791 HG11 ' HA ' ' A' ' 56' ' ' LYS . 9.7 t -64.84 -55.56 20.31 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.116 0 O-C-N 124.139 0.9 . . . . 0.0 109.806 -179.13 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 37.7 mt-10 -58.75 -49.71 76.62 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 125.897 1.679 . . . . 0.0 114.585 -177.586 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -77.66 -17.99 57.15 Favored 'General case' 0 N--CA 1.473 0.724 0 N-CA-C 114.904 1.446 . . . . 0.0 114.904 -176.282 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . 0.532 ' HA3' ' HE3' ' A' ' 56' ' ' LYS . . . 67.0 44.78 87.78 Favored Glycine 0 N--CA 1.486 1.969 0 N-CA-C 109.588 -1.405 . . . . 0.0 109.588 -162.309 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -96.79 157.65 21.24 Favored Glycine 0 N--CA 1.474 1.22 0 CA-C-N 113.661 -1.27 . . . . 0.0 114.777 -161.701 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 85.4 m95 -68.47 100.56 1.11 Allowed 'General case' 0 N--CA 1.473 0.691 0 CA-C-N 113.004 -1.598 . . . . 0.0 110.581 -178.562 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.512 HG22 HG13 ' A' ' 51' ' ' ILE . 0.6 OUTLIER -53.48 -26.15 12.3 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.799 0 CA-C-N 113.828 -1.533 . . . . 0.0 113.609 172.39 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 4.7 t -59.44 -43.92 93.03 Favored 'General case' 0 N--CA 1.481 1.076 0 CA-C-O 118.715 -0.659 . . . . 0.0 112.71 -176.364 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' THR . . . . . 0.443 ' HB ' HD13 ' A' ' 28' ' ' ILE . 2.7 m -57.82 -42.46 84.33 Favored 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 124.144 0.978 . . . . 0.0 111.855 174.218 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.473 HG13 HG21 ' A' ' 14' ' ' THR . 2.0 mp -73.73 -42.54 54.55 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.058 0 C-N-CA 125.98 1.712 . . . . 0.0 112.59 -178.124 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.577 HG11 HD13 ' A' ' 43' ' ' LEU . 40.1 t -49.64 -46.35 21.1 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.322 0 C-N-CA 124.815 1.246 . . . . 0.0 110.719 178.625 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -55.46 -35.86 65.95 Favored 'General case' 0 N--CA 1.486 1.364 0 C-N-CA 124.749 1.219 . . . . 0.0 113.906 176.366 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.922 HG21 HG11 ' A' ' 11' ' ' VAL . 22.3 mm -78.96 -39.36 21.65 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.071 0 C-N-CA 124.171 0.988 . . . . 0.0 109.083 -176.477 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.685 ' HB3' ' HA3' ' A' ' 39' ' ' GLY . 4.3 mm? -57.04 -49.38 75.98 Favored 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 124.553 1.141 . . . . 0.0 111.804 171.506 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 1.4 p -67.71 -27.38 66.77 Favored 'General case' 0 N--CA 1.474 0.734 0 N-CA-C 115.371 1.619 . . . . 0.0 115.371 178.018 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -55.71 -29.45 59.46 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 113.098 0.777 . . . . 0.0 113.098 169.95 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 23.0 t . . . . . 0 N--CA 1.483 1.187 0 C-N-CA 125.166 1.386 . . . . 0.0 111.065 174.486 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . 0.685 ' HA3' ' HB3' ' A' ' 32' ' ' LEU . . . . . . . . 0 N--CA 1.472 1.05 0 CA-C-O 121.287 0.382 . . . . 0.0 113.542 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 14.6 mt -62.53 -44.71 95.69 Favored 'General case' 0 N--CA 1.477 0.892 0 CA-C-N 113.149 -1.525 . . . . 0.0 113.96 -178.46 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 6.9 m -55.9 -47.12 77.99 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 123.745 0.818 . . . . 0.0 112.174 173.65 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.441 HD11 ' HE1' ' A' ' 1' ' ' MET . 12.3 tp -63.23 -45.22 92.63 Favored 'General case' 0 N--CA 1.48 1.035 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.763 177.691 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.577 HD13 HG11 ' A' ' 29' ' ' VAL . 46.8 mt -64.15 -21.46 66.56 Favored 'General case' 0 N--CA 1.477 0.909 0 N-CA-C 115.732 1.753 . . . . 0.0 115.732 -178.987 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -78.35 -42.4 30.62 Favored 'General case' 0 CA--C 1.545 0.767 0 CA-C-N 115.493 -0.776 . . . . 0.0 112.954 171.33 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -61.77 -29.48 70.16 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 123.752 0.821 . . . . 0.0 112.245 172.874 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -59.03 -23.87 62.34 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 125.581 1.552 . . . . 0.0 115.011 177.709 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -52.76 -34.42 44.39 Favored Glycine 0 CA--C 1.543 1.83 0 C-N-CA 125.474 1.512 . . . . 0.0 113.763 -176.147 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 65.5 ttp85 -55.04 -52.64 62.55 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 124.662 1.185 . . . . 0.0 112.937 -178.974 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . 0.414 ' HB3' ' HA ' ' A' ' 54' ' ' TYR . 12.5 tt0 -137.37 38.13 2.49 Favored 'General case' 0 N--CA 1.477 0.906 0 N-CA-C 115.404 1.631 . . . . 0.0 115.404 -175.621 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 21.0 t 42.15 121.26 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.293 0 C-N-CA 125.325 1.45 . . . . 0.0 114.846 -174.08 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.512 HG13 HG22 ' A' ' 25' ' ' VAL 0.278 9.8 tp -27.42 -57.75 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.481 1.096 0 N-CA-C 118.654 2.835 . . . . 0.0 118.654 -169.231 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 39.4 tttm -57.75 -61.11 2.76 Favored 'General case' 0 N--CA 1.486 1.344 0 C-N-CA 123.703 0.801 . . . . 0.0 111.771 178.56 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -63.47 -39.17 93.75 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 124.843 1.257 . . . . 0.0 112.836 178.236 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . 0.414 ' HA ' ' HB3' ' A' ' 49' ' ' GLU . 79.3 t80 -48.22 -59.35 3.48 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 125.203 1.401 . . . . 0.0 111.932 176.684 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 64.0 mt -65.74 -39.61 91.3 Favored 'General case' 0 N--CA 1.478 0.973 0 CA-C-N 114.597 -1.183 . . . . 0.0 114.123 -179.883 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . 0.791 ' HA ' HG11 ' A' ' 19' ' ' VAL . 43.7 mttp -57.9 -42.76 85.37 Favored 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 114.955 1.465 . . . . 0.0 114.955 179.869 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 55.7 tttp -78.9 -52.55 8.14 Favored 'General case' 0 N--CA 1.478 0.941 0 CA-C-N 115.256 -0.884 . . . . 0.0 111.54 170.984 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . 0.466 ' O ' ' HB2' ' A' ' 62' ' ' LYS . 28.0 tt0 -56.57 -49.94 73.39 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-O 118.558 -0.734 . . . . 0.0 111.975 -171.051 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.721 HG22 HG22 ' A' ' 67' ' ' VAL . 2.8 mm -75.86 -27.91 18.79 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 O-C-N 121.306 -0.872 . . . . 0.0 112.683 -175.959 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . 0.469 ' HB2' ' O ' ' A' ' 56' ' ' LYS . 11.9 mttt -62.51 -34.12 76.24 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 116.935 2.198 . . . . 0.0 116.935 171.008 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 62.3 pttt -92.96 -25.36 18.05 Favored 'General case' 0 CA--C 1.546 0.825 0 CA-C-N 113.879 -1.51 . . . . 0.0 112.515 176.358 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . 0.466 ' HB2' ' O ' ' A' ' 58' ' ' GLU . 29.1 tttm -80.27 -46.14 16.71 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 125.967 1.707 . . . . 0.0 113.594 -176.573 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 93.89 105.6 1.83 Allowed Glycine 0 N--CA 1.477 1.405 0 N-CA-C 110.589 -1.004 . . . . 0.0 110.589 -177.818 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.584 ' HD2' ' H ' ' A' ' 64' ' ' LYS . 5.6 mptt -32.01 -45.57 0.1 Allowed 'General case' 0 N--CA 1.489 1.479 0 C-N-CA 127.587 2.355 . . . . 0.0 116.266 -178.131 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . 0.403 ' CA ' ' HE ' ' A' ' 65' ' ' ARG 0.3 0.0 OUTLIER -46.94 -56.11 6.94 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 127.568 2.347 . . . . 0.0 114.105 175.781 . . . . . . . . 4 4 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -71.12 -23.24 62.05 Favored 'General case' 0 N--CA 1.478 0.957 0 CA-C-N 113.994 -1.457 . . . . 0.0 114.298 175.072 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.721 HG22 HG22 ' A' ' 59' ' ' ILE . 61.1 t -70.82 -39.11 75.08 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.174 0 C-N-CA 123.423 0.689 . . . . 0.0 110.838 177.91 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.412 HD12 ' HA ' ' A' ' 68' ' ' ILE . 19.0 mm -51.15 -44.24 28.94 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.87 0 C-N-CA 123.902 0.881 . . . . 0.0 111.089 169.682 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -68.91 -51.4 40.46 Favored 'General case' 0 N--CA 1.481 1.097 0 N-CA-C 113.559 0.948 . . . . 0.0 113.559 174.574 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 31.1 t90 . . . . . 0 N--CA 1.479 1.0 0 C-N-CA 125.419 1.487 . . . . 0.0 112.621 -179.302 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 62.9 mtp . . . . . 0 N--CA 1.477 0.879 0 N-CA-C 113.321 0.86 . . . . 0.0 113.321 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -60.19 -48.92 79.71 Favored 'General case' 0 N--CA 1.477 0.89 0 O-C-N 124.104 0.877 . . . . 0.0 112.959 177.269 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 42.2 tttm -72.5 -58.36 3.44 Favored 'General case' 0 N--CA 1.479 0.998 0 CA-C-N 114.404 -1.271 . . . . 0.0 113.624 -174.59 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . 0.459 ' HB2' ' O ' ' A' ' 70' ' ' TRP . 0.8 OUTLIER -70.29 -36.24 74.24 Favored 'General case' 0 CA--C 1.538 0.485 0 N-CA-C 114.327 1.232 . . . . 0.0 114.327 -171.658 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . 0.549 ' HB2' HD11 ' A' ' 7' ' ' ILE . 29.8 m-85 -108.86 -10.09 15.12 Favored 'General case' 0 N--CA 1.47 0.55 0 N-CA-C 117.014 2.227 . . . . 0.0 117.014 -170.36 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 68.08 56.65 10.08 Favored Glycine 0 CA--C 1.541 1.678 0 O-C-N 123.965 0.791 . . . . 0.0 111.351 -174.634 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . 0.549 HD11 ' HB2' ' A' ' 5' ' ' PHE . 0.4 OUTLIER -111.95 140.37 23.34 Favored Pre-proline 0 N--CA 1.476 0.874 0 CA-C-N 113.466 -1.367 . . . . 0.0 110.149 -179.841 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -85.27 160.78 11.31 Favored 'Trans proline' 0 C--O 1.243 0.752 0 C-N-CA 121.161 1.241 . . . . 0.0 110.057 166.551 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -52.21 -32.76 38.0 Favored 'General case' 0 N--CA 1.484 1.225 0 N-CA-C 115.262 1.579 . . . . 0.0 115.262 175.807 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -41.0 -38.26 0.95 Allowed 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 126.688 1.995 . . . . 0.0 115.815 172.412 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.711 ' HB ' HD23 ' A' ' 32' ' ' LEU . 33.6 m -105.4 -41.24 6.24 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.95 0 N-CA-C 114.754 1.391 . . . . 0.0 114.754 -176.67 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . 0.461 ' HB3' HG23 ' A' ' 7' ' ' ILE . . . -67.29 -39.85 86.03 Favored 'General case' 0 N--CA 1.479 1.023 0 N-CA-C 112.992 0.738 . . . . 0.0 112.992 178.541 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -58.52 -41.9 95.69 Favored Glycine 0 CA--C 1.547 2.048 0 C-N-CA 123.923 0.773 . . . . 0.0 111.877 175.532 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 10.4 m -66.52 -39.88 88.88 Favored 'General case' 0 N--CA 1.484 1.232 0 CA-C-N 113.644 -1.278 . . . . 0.0 114.158 176.986 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 71.4 t -52.77 -43.36 44.86 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.017 0 N-CA-C 112.042 0.386 . . . . 0.0 112.042 169.445 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.591 HD13 HG12 ' A' ' 68' ' ' ILE . 38.3 mt -60.63 -43.84 97.07 Favored 'General case' 0 N--CA 1.481 1.095 0 N-CA-C 113.161 0.8 . . . . 0.0 113.161 179.75 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 20.4 t-20 -52.95 -50.78 63.35 Favored 'General case' 0 N--CA 1.48 1.05 0 O-C-N 124.934 1.396 . . . . 0.0 110.731 173.909 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.547 HG12 HD12 ' A' ' 28' ' ' ILE . 70.6 t -63.05 -41.62 93.54 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.088 0 CA-C-N 114.306 -1.315 . . . . 0.0 113.746 178.24 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.647 HG11 ' HA ' ' A' ' 56' ' ' LYS . 37.0 t -61.25 -45.75 97.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 123.845 0.716 . . . . 0.0 110.427 175.689 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . 0.422 ' HG3' ' HE2' ' A' ' 64' ' ' LYS . 31.3 mt-10 -60.67 -39.54 88.77 Favored 'General case' 0 CA--C 1.551 0.981 0 C-N-CA 124.914 1.286 . . . . 0.0 113.744 177.605 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -87.06 -15.98 36.97 Favored 'General case' 0 CA--C 1.543 0.68 0 N-CA-C 117.398 2.37 . . . . 0.0 117.398 -178.551 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 63.6 37.14 94.3 Favored Glycine 0 N--CA 1.484 1.851 0 C-N-CA 124.216 0.912 . . . . 0.0 112.219 -172.021 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -90.01 -166.23 41.29 Favored Glycine 0 N--CA 1.482 1.712 0 CA-C-O 122.808 1.227 . . . . 0.0 113.365 -172.694 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' TRP . . . . . 0.647 ' HB3' HG21 ' A' ' 26' ' ' THR . 5.4 m-90 -82.74 111.44 18.68 Favored 'General case' 0 N--CA 1.478 0.957 0 CA-C-O 122.328 1.061 . . . . 0.0 111.032 -179.891 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.423 ' HB ' ' HG2' ' A' ' 52' ' ' LYS . 39.6 t -65.02 -20.18 27.07 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.209 0 CA-C-N 114.669 -1.15 . . . . 0.0 112.307 168.278 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' THR . . . . . 0.647 HG21 ' HB3' ' A' ' 24' ' ' TRP . 10.9 t -64.26 -32.96 74.75 Favored 'General case' 0 N--CA 1.482 1.129 0 N-CA-C 113.96 1.096 . . . . 0.0 113.96 179.587 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -66.74 -33.68 76.16 Favored 'General case' 0 N--CA 1.485 1.313 0 N-CA-C 113.672 0.99 . . . . 0.0 113.672 173.875 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.547 HD12 HG12 ' A' ' 18' ' ' VAL . 0.0 OUTLIER -87.4 -38.0 11.57 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.165 0 CA-C-O 118.737 -0.649 . . . . 0.0 111.363 -178.798 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 14.0 t -44.82 -44.23 2.63 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.213 0 C-N-CA 124.225 1.01 . . . . 0.0 111.981 175.288 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 6.4 p -63.28 -31.76 72.99 Favored 'General case' 0 N--CA 1.484 1.229 0 N-CA-C 114.706 1.373 . . . . 0.0 114.706 175.92 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.684 HG21 HG11 ' A' ' 11' ' ' VAL . 15.3 mm -82.44 -37.94 14.83 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.152 0 C-N-CA 123.661 0.784 . . . . 0.0 109.732 179.006 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.711 HD23 ' HB ' ' A' ' 11' ' ' VAL . 3.7 mm? -53.72 -52.97 58.39 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 125.341 1.456 . . . . 0.0 111.283 170.356 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 17.2 p -70.18 -30.87 68.1 Favored 'General case' 0 N--CA 1.475 0.825 0 N-CA-C 114.277 1.214 . . . . 0.0 114.277 179.159 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -53.64 -33.47 55.27 Favored 'General case' 0 N--CA 1.483 1.184 0 N-CA-C 113.554 0.946 . . . . 0.0 113.554 170.022 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.489 ' HB ' ' O ' ' A' ' 32' ' ' LEU . 74.7 t . . . . . 0 N--CA 1.488 1.426 0 C-N-CA 124.675 1.19 . . . . 0.0 112.899 170.934 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . 0.5 ' HA3' ' HB3' ' A' ' 32' ' ' LEU . . . . . . . . 0 N--CA 1.479 1.527 0 N-CA-C 111.753 -0.539 . . . . 0.0 111.753 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 52.5 mt -60.21 -47.38 86.23 Favored 'General case' 0 N--CA 1.478 0.949 0 N-CA-C 115.126 1.528 . . . . 0.0 115.126 -176.529 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 75.5 p -61.76 -41.29 97.5 Favored 'General case' 0 CA--C 1.544 0.715 0 N-CA-C 113.139 0.792 . . . . 0.0 113.139 176.665 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 9.8 tp -63.88 -47.37 80.91 Favored 'General case' 0 N--CA 1.482 1.135 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.405 173.87 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.476 ' HG ' ' O ' ' A' ' 39' ' ' GLY . 75.8 mt -60.6 -30.48 69.85 Favored 'General case' 0 N--CA 1.474 0.768 0 N-CA-C 114.783 1.401 . . . . 0.0 114.783 -178.916 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -70.3 -44.68 67.83 Favored 'General case' 0 N--CA 1.477 0.917 0 O-C-N 123.842 0.714 . . . . 0.0 112.724 172.897 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -68.64 -37.14 79.45 Favored 'General case' 0 N--CA 1.479 0.994 0 CA-C-O 121.607 0.717 . . . . 0.0 112.305 177.242 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.475 ' HB3' ' HA ' ' A' ' 51' ' ' ILE . . . -60.74 -25.24 66.33 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 126.45 1.9 . . . . 0.0 115.371 176.364 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -48.77 -36.83 20.05 Favored Glycine 0 CA--C 1.545 1.934 0 O-C-N 124.657 1.223 . . . . 0.0 113.564 176.642 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . 0.587 ' CZ ' ' HH ' ' A' ' 54' ' ' TYR . 25.0 ttm180 -43.64 -52.57 6.31 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 128.256 2.622 . . . . 0.0 113.228 -177.698 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 11.2 tt0 -128.55 36.12 4.29 Favored 'General case' 0 CA--C 1.545 0.761 0 N-CA-C 112.957 0.725 . . . . 0.0 112.957 -178.599 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 60.3 p 51.5 123.62 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.664 0 C-N-CA 125.065 1.346 . . . . 0.0 112.17 -169.101 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.475 ' HA ' ' HB3' ' A' ' 46' ' ' ALA . 5.8 tp -33.57 -50.51 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.164 0 N-CA-C 117.082 2.253 . . . . 0.0 117.082 -176.952 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . 0.423 ' HG2' ' HB ' ' A' ' 25' ' ' VAL . 7.1 mttt -59.76 -62.86 1.56 Allowed 'General case' 0 N--CA 1.471 0.623 0 N-CA-C 114.388 1.255 . . . . 0.0 114.388 178.123 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -63.28 -34.1 76.94 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 113.24 -1.8 . . . . 0.0 112.662 -179.388 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . 0.587 ' HH ' ' CZ ' ' A' ' 48' ' ' ARG . 72.4 t80 -51.52 -63.61 1.08 Allowed 'General case' 0 C--O 1.224 -0.277 0 C-N-CA 125.955 1.702 . . . . 0.0 110.654 176.969 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 43.5 mt -65.96 -39.62 90.59 Favored 'General case' 0 N--CA 1.477 0.925 0 N-CA-C 115.265 1.58 . . . . 0.0 115.265 -175.859 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . 0.647 ' HA ' HG11 ' A' ' 19' ' ' VAL . 1.8 mptm? -58.94 -44.38 91.41 Favored 'General case' 0 N--CA 1.472 0.644 0 N-CA-C 114.859 1.429 . . . . 0.0 114.859 177.767 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 15.6 tttm -79.39 -52.68 7.76 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-N 114.467 -1.242 . . . . 0.0 112.542 173.284 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . 0.547 ' O ' ' HB2' ' A' ' 62' ' ' LYS . 0.8 OUTLIER -59.22 -45.17 91.82 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-O 116.488 -1.72 . . . . 0.0 113.039 -171.62 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.667 HG22 HG22 ' A' ' 67' ' ' VAL . 3.2 mm -76.37 -26.64 17.05 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.04 0 C-N-CA 119.994 -0.682 . . . . 0.0 111.697 -179.637 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . 0.524 ' HB2' ' O ' ' A' ' 56' ' ' LYS . 0.7 OUTLIER -59.22 -34.51 72.27 Favored 'General case' 0 CA--C 1.543 0.7 0 CA-C-O 122.162 0.982 . . . . 0.0 113.566 173.144 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 5.0 mttm -87.97 -44.97 10.62 Favored 'General case' 0 N--CA 1.479 0.985 0 CA-C-N 112.536 -2.12 . . . . 0.0 110.853 179.363 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . 0.547 ' HB2' ' O ' ' A' ' 58' ' ' GLU . 19.9 tttt -68.51 -41.23 80.27 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 127.348 2.259 . . . . 0.0 114.41 -171.554 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 93.24 110.57 2.02 Favored Glycine 0 CA--C 1.534 1.231 0 N-CA-C 110.358 -1.097 . . . . 0.0 110.358 -177.719 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.728 ' HD2' ' H ' ' A' ' 64' ' ' LYS . 10.0 mptt -39.3 -47.61 1.73 Allowed 'General case' 0 N--CA 1.481 1.093 0 N-CA-C 117.395 2.369 . . . . 0.0 117.395 -176.189 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . 0.463 ' O ' ' HB ' ' A' ' 68' ' ' ILE . 4.6 ttp180 -58.51 -50.22 74.55 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 124.18 0.992 . . . . 0.0 113.436 179.448 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -61.96 -28.03 69.26 Favored 'General case' 0 N--CA 1.476 0.843 0 N-CA-C 114.118 1.155 . . . . 0.0 114.118 173.669 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.667 HG22 HG22 ' A' ' 59' ' ' ILE . 90.3 t -70.62 -33.15 51.98 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 N-CA-C 112.333 0.494 . . . . 0.0 112.333 176.509 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.591 HG12 HD13 ' A' ' 16' ' ' LEU . 4.1 mm -49.5 -47.28 20.38 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.332 0 C-N-CA 123.28 0.632 . . . . 0.0 109.718 167.719 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -66.95 -51.81 50.59 Favored 'General case' 0 N--CA 1.485 1.286 0 CA-C-N 114.811 -1.086 . . . . 0.0 112.751 177.807 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' TRP . . . . . 0.459 ' O ' ' HB2' ' A' ' 4' ' ' GLU . 39.6 t90 . . . . . 0 N--CA 1.484 1.263 0 C-N-CA 125.055 1.342 . . . . 0.0 113.121 -179.201 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.789 ' HE1' HG23 ' A' ' 7' ' ' ILE . 72.4 mtp . . . . . 0 N--CA 1.476 0.832 0 N-CA-C 112.814 0.672 . . . . 0.0 112.814 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . 0.63 ' HA ' ' O ' ' A' ' 7' ' ' ILE . . . -60.91 -54.84 40.15 Favored 'General case' 0 N--CA 1.471 0.601 0 N-CA-C 113.584 0.957 . . . . 0.0 113.584 173.961 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 9.7 tptp -74.08 -57.05 4.22 Favored 'General case' 0 CA--C 1.543 0.711 0 CA-C-N 113.559 -1.655 . . . . 0.0 114.456 -174.597 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 11.3 tt0 -77.88 -43.74 29.27 Favored 'General case' 0 N--CA 1.477 0.88 0 N-CA-C 113.631 0.974 . . . . 0.0 113.631 -171.967 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 41.7 m-85 -95.35 -8.08 36.75 Favored 'General case' 0 CA--C 1.542 0.652 0 N-CA-C 117.396 2.369 . . . . 0.0 117.396 -173.749 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 63.48 38.53 96.48 Favored Glycine 0 N--CA 1.478 1.47 0 O-C-N 124.38 1.05 . . . . 0.0 112.848 -177.773 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . 0.789 HG23 ' HE1' ' A' ' 1' ' ' MET . 0.8 OUTLIER -114.06 128.6 25.62 Favored Pre-proline 0 N--CA 1.479 1.005 0 C-N-CA 124.51 1.124 . . . . 0.0 108.474 -179.808 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -66.89 156.37 66.46 Favored 'Trans proline' 0 CA--C 1.54 0.785 0 CA-C-N 120.169 1.096 . . . . 0.0 110.943 179.721 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -51.8 -30.0 21.4 Favored 'General case' 0 N--CA 1.483 1.177 0 N-CA-C 115.077 1.51 . . . . 0.0 115.077 173.988 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -44.64 -46.98 10.44 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 126.332 1.853 . . . . 0.0 114.007 175.159 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.98 HG11 HG21 ' A' ' 31' ' ' ILE . 34.9 m -96.14 -32.43 4.31 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.345 0 N-CA-C 114.016 1.117 . . . . 0.0 114.016 -177.824 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . 0.411 ' O ' ' HG ' ' A' ' 16' ' ' LEU . . . -59.99 -34.61 73.55 Favored 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 112.483 0.549 . . . . 0.0 112.483 173.43 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -58.69 -46.73 92.95 Favored Glycine 0 CA--C 1.546 1.978 0 C-N-CA 124.823 1.201 . . . . 0.0 113.048 169.463 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -62.32 -39.98 94.82 Favored 'General case' 0 N--CA 1.487 1.391 0 C-N-CA 124.46 1.104 . . . . 0.0 113.633 176.822 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.655 HG22 ' HE3' ' A' ' 1' ' ' MET . 30.9 t -51.76 -39.37 24.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 C-N-CA 124.286 1.034 . . . . 0.0 112.768 169.338 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.582 HD21 ' HG3' ' A' ' 64' ' ' LYS . 56.3 mt -62.75 -38.35 90.23 Favored 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 113.773 1.027 . . . . 0.0 113.773 177.408 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 18.2 t-20 -51.84 -47.48 64.36 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 123.792 0.837 . . . . 0.0 111.762 173.338 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.44 HG22 ' HA ' ' A' ' 25' ' ' VAL . 2.1 t -52.33 -51.49 32.03 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.118 0 CA-C-N 115.366 -0.833 . . . . 0.0 113.039 173.507 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.579 HG11 ' HA ' ' A' ' 56' ' ' LYS . 4.1 t -63.28 -46.41 95.73 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.065 0 O-C-N 124.299 0.999 . . . . 0.0 110.982 -179.116 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 33.0 mt-10 -62.21 -45.72 92.08 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 125.075 1.35 . . . . 0.0 114.279 -178.09 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -94.9 -22.01 18.28 Favored 'General case' 0 N--CA 1.48 1.056 0 N-CA-C 116.34 1.978 . . . . 0.0 116.34 -172.035 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 73.89 45.54 26.73 Favored Glycine 0 N--CA 1.481 1.663 0 N-CA-C 109.042 -1.623 . . . . 0.0 109.042 -163.352 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -94.71 164.13 25.13 Favored Glycine 0 N--CA 1.477 1.401 0 C-N-CA 124.898 1.237 . . . . 0.0 113.829 -169.438 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 2.8 m-90 -66.86 102.12 0.92 Allowed 'General case' 0 N--CA 1.475 0.818 0 CA-C-O 122.568 1.175 . . . . 0.0 112.045 -178.542 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.633 HG22 HG13 ' A' ' 51' ' ' ILE . 5.5 p -53.45 -25.59 11.1 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.996 0 CA-C-N 112.979 -1.918 . . . . 0.0 115.225 170.881 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 10.6 t -62.42 -36.42 82.33 Favored 'General case' 0 N--CA 1.478 0.951 0 N-CA-C 113.434 0.902 . . . . 0.0 113.434 179.756 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 1.3 m -67.11 -42.7 84.07 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 124.082 0.953 . . . . 0.0 110.65 173.226 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.462 ' O ' HD21 ' A' ' 32' ' ' LEU . 1.6 mp -63.34 -44.7 99.16 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.759 0 C-N-CA 124.227 1.011 . . . . 0.0 112.633 178.272 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 77.2 t -52.38 -44.17 42.58 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.152 0 C-N-CA 123.816 0.846 . . . . 0.0 111.049 174.842 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 20.3 p -60.83 -33.59 73.27 Favored 'General case' 0 N--CA 1.482 1.15 0 N-CA-C 114.999 1.481 . . . . 0.0 114.999 175.944 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.98 HG21 HG11 ' A' ' 11' ' ' VAL . 27.7 mm -75.18 -40.73 44.1 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.692 0 C-N-CA 124.226 1.01 . . . . 0.0 109.319 178.891 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.619 ' HB3' ' HA2' ' A' ' 39' ' ' GLY . 3.6 mm? -59.68 -32.89 70.91 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 124.743 1.217 . . . . 0.0 111.391 169.236 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 2.9 m -73.38 -35.88 65.98 Favored 'General case' 0 N--CA 1.475 0.801 0 N-CA-C 113.984 1.105 . . . . 0.0 113.984 174.532 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -53.8 -30.38 44.64 Favored 'General case' 0 N--CA 1.487 1.383 0 N-CA-C 113.374 0.879 . . . . 0.0 113.374 175.94 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 55.5 t . . . . . 0 N--CA 1.481 1.093 0 C-N-CA 126.823 2.049 . . . . 0.0 113.213 173.567 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . 0.619 ' HA2' ' HB3' ' A' ' 32' ' ' LEU . . . . . . . . 0 CA--C 1.55 2.28 0 N-CA-C 110.784 -0.926 . . . . 0.0 110.784 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 10.8 mt -55.81 -37.34 68.52 Favored 'General case' 0 N--CA 1.483 1.216 0 N-CA-C 116.363 1.986 . . . . 0.0 116.363 -169.657 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 16.6 p -56.87 -43.64 81.44 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 124.376 1.07 . . . . 0.0 113.652 176.506 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 14.9 tp -66.68 -45.8 77.7 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 123.12 0.568 . . . . 0.0 110.845 175.316 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 88.4 mt -60.65 -30.77 70.09 Favored 'General case' 0 N--CA 1.477 0.89 0 CA-C-N 114.293 -1.321 . . . . 0.0 114.19 179.116 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -66.79 -48.18 69.82 Favored 'General case' 0 N--CA 1.474 0.726 0 N-CA-C 112.943 0.72 . . . . 0.0 112.943 173.546 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -64.36 -29.21 70.29 Favored 'General case' 0 N--CA 1.485 1.316 0 N-CA-C 113.029 0.752 . . . . 0.0 113.029 176.815 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -77.99 -9.53 59.15 Favored 'General case' 0 CA--C 1.543 0.683 0 N-CA-C 117.259 2.318 . . . . 0.0 117.259 -177.236 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -56.6 -57.06 21.41 Favored Glycine 0 CA--C 1.542 1.75 0 C-N-CA 124.321 0.962 . . . . 0.0 113.216 -166.881 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.71 -44.93 90.5 Favored 'General case' 0 CA--C 1.541 0.601 0 N-CA-C 115.681 1.734 . . . . 0.0 115.681 -177.321 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . 0.493 ' OE1' ' HA ' ' A' ' 54' ' ' TYR . 13.0 tt0 -103.1 25.49 9.37 Favored 'General case' 0 N--CA 1.478 0.947 0 N-CA-C 114.749 1.389 . . . . 0.0 114.749 -175.058 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 91.8 p 46.63 118.85 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 125.756 1.622 . . . . 0.0 112.919 -174.594 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.633 HG13 HG22 ' A' ' 25' ' ' VAL . 8.0 tp -35.86 -52.18 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.263 0 N-CA-C 116.883 2.179 . . . . 0.0 116.883 -174.134 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 23.6 tptp -55.51 -67.98 0.24 Allowed 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 124.703 1.201 . . . . 0.0 112.863 174.518 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -57.73 -36.31 71.86 Favored 'General case' 0 N--CA 1.482 1.16 0 N-CA-C 113.993 1.108 . . . . 0.0 113.993 179.586 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . 0.493 ' HA ' ' OE1' ' A' ' 49' ' ' GLU . 94.3 t80 -50.0 -64.6 0.76 Allowed 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 125.533 1.533 . . . . 0.0 111.738 173.641 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.555 HD11 HG12 ' A' ' 15' ' ' VAL . 46.2 mt -63.16 -41.2 99.21 Favored 'General case' 0 N--CA 1.472 0.675 0 N-CA-C 114.023 1.12 . . . . 0.0 114.023 -178.357 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . 0.579 ' HA ' HG11 ' A' ' 19' ' ' VAL . 54.1 tptt -53.57 -54.15 41.56 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-N 113.751 -1.568 . . . . 0.0 112.303 179.076 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 58.9 tttp -68.79 -54.42 15.96 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 115.127 -0.942 . . . . 0.0 111.943 173.895 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 8.9 tt0 -59.25 -48.23 82.4 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-N 115.655 -0.702 . . . . 0.0 111.845 -167.34 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.742 HG22 HG23 ' A' ' 67' ' ' VAL . 3.1 mm -75.99 -23.95 16.35 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.124 0 O-C-N 123.288 0.367 . . . . 0.0 111.359 -176.051 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . 0.422 ' HB2' ' O ' ' A' ' 56' ' ' LYS . 24.3 mttt -65.92 -21.6 66.45 Favored 'General case' 0 C--O 1.222 -0.362 0 N-CA-C 117.3 2.333 . . . . 0.0 117.3 169.095 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 60.4 mtpt -91.26 -50.24 5.93 Favored 'General case' 0 N--CA 1.481 1.091 0 CA-C-N 112.831 -1.986 . . . . 0.0 110.614 172.481 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 36.9 tttp -65.19 -50.29 66.49 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 126.957 2.103 . . . . 0.0 114.909 -171.957 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 95.77 121.61 3.84 Favored Glycine 0 CA--C 1.533 1.181 0 CA-C-O 122.384 0.991 . . . . 0.0 110.888 -171.86 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.582 ' HG3' HD21 ' A' ' 16' ' ' LEU . 12.3 mptt -45.08 -39.38 5.8 Favored 'General case' 0 N--CA 1.48 1.054 0 N-CA-C 117.396 2.369 . . . . 0.0 117.396 -175.777 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . 0.415 ' O ' ' HB ' ' A' ' 68' ' ' ILE . 0.0 OUTLIER -59.66 -46.97 87.42 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 124.545 1.138 . . . . 0.0 112.805 178.208 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -63.26 -28.27 69.91 Favored 'General case' 0 N--CA 1.479 1.023 0 N-CA-C 114.54 1.311 . . . . 0.0 114.54 174.723 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.742 HG23 HG22 ' A' ' 59' ' ' ILE . 26.2 t -70.75 -36.9 66.82 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.868 0 C-N-CA 123.594 0.758 . . . . 0.0 111.282 178.536 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.415 ' HB ' ' O ' ' A' ' 65' ' ' ARG . 21.6 mm -52.95 -46.75 53.55 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.95 0 C-N-CA 123.926 0.89 . . . . 0.0 110.384 170.781 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -70.37 -50.88 34.3 Favored 'General case' 0 N--CA 1.479 1.009 0 CA-C-N 114.783 -1.099 . . . . 0.0 113.172 177.072 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 31.6 t90 . . . . . 0 N--CA 1.484 1.248 0 C-N-CA 125.611 1.564 . . . . 0.0 112.77 -179.494 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.533 ' HE2' HG22 ' A' ' 15' ' ' VAL . 74.2 mtp . . . . . 0 N--CA 1.471 0.577 0 N-CA-C 112.215 0.45 . . . . 0.0 112.215 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . 0.428 ' HA ' ' O ' ' A' ' 7' ' ' ILE . . . -54.96 -58.38 7.85 Favored 'General case' 0 N--CA 1.472 0.664 0 O-C-N 124.734 1.271 . . . . 0.0 113.255 173.395 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 22.1 tptm -71.81 -50.75 26.91 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 113.684 -1.598 . . . . 0.0 113.104 -173.763 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 8.3 tt0 -78.1 -42.76 31.03 Favored 'General case' 0 N--CA 1.479 0.99 0 N-CA-C 114.674 1.361 . . . . 0.0 114.674 -170.254 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . 0.463 ' HD1' ' HB2' ' A' ' 41' ' ' SER . 58.3 m-85 -105.76 -15.15 15.03 Favored 'General case' 0 N--CA 1.474 0.738 0 N-CA-C 116.987 2.218 . . . . 0.0 116.987 -172.101 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 85.75 61.21 1.71 Allowed Glycine 0 N--CA 1.482 1.73 0 O-C-N 124.352 1.033 . . . . 0.0 112.331 -176.922 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . 0.572 HG22 ' HB3' ' A' ' 12' ' ' ALA . 1.0 OUTLIER -111.48 137.14 21.04 Favored Pre-proline 0 N--CA 1.475 0.789 0 CA-C-N 114.365 -0.918 . . . . 0.0 109.771 173.47 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo -82.04 38.45 0.75 Allowed 'Trans proline' 0 CA--C 1.537 0.673 0 C-N-CA 122.861 2.374 . . . . 0.0 113.2 175.522 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . 53.85 -34.04 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.518 0 C-N-CA 129.69 3.196 . . . . 0.0 117.243 -169.959 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -37.23 -63.53 0.43 Allowed 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 128.735 2.814 . . . . 0.0 113.564 174.023 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.522 HG11 HG21 ' A' ' 31' ' ' ILE . 26.9 m -74.77 -21.43 16.99 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.862 0 N-CA-C 113.896 1.073 . . . . 0.0 113.896 -176.248 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . 0.572 ' HB3' HG22 ' A' ' 7' ' ' ILE . . . -67.6 -32.88 73.91 Favored 'General case' 0 N--CA 1.475 0.785 0 N-CA-C 112.356 0.502 . . . . 0.0 112.356 169.991 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -59.37 -38.04 92.84 Favored Glycine 0 CA--C 1.541 1.706 0 C-N-CA 123.836 0.731 . . . . 0.0 113.44 172.284 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' THR . . . . . 0.487 HG21 HG13 ' A' ' 28' ' ' ILE . 0.2 OUTLIER -69.79 -27.67 65.1 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 126.189 1.796 . . . . 0.0 115.124 176.329 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.533 HG22 ' HE2' ' A' ' 1' ' ' MET . 2.8 t -67.01 -44.07 88.62 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.169 0 C-N-CA 124.884 1.273 . . . . 0.0 110.691 171.501 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.462 ' HG ' ' O ' ' A' ' 12' ' ' ALA . 60.2 mt -63.44 -42.83 98.67 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 114.408 -1.269 . . . . 0.0 112.348 179.076 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . 0.41 ' HB2' ' O ' ' A' ' 14' ' ' THR 0.444 0.6 OUTLIER -48.33 -52.86 19.63 Favored 'General case' 0 C--N 1.31 -1.123 0 CA-C-N 114.484 -1.235 . . . . 0.0 114.161 169.281 . . . . . . . . 4 4 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.45 ' HB ' ' O ' ' A' ' 15' ' ' VAL . 2.9 t -46.17 -54.2 2.09 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.416 0 O-C-N 125.629 1.831 . . . . 0.0 110.342 173.434 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.796 HG11 ' HA ' ' A' ' 56' ' ' LYS . 4.1 t -62.33 -49.99 81.73 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.08 0 CA-C-N 115.011 -0.995 . . . . 0.0 111.16 -174.453 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 25.8 mt-10 -66.28 -38.59 88.14 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 126.128 1.771 . . . . 0.0 115.012 -171.959 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -99.63 -11.45 20.93 Favored 'General case' 0 N--CA 1.473 0.688 0 N-CA-C 114.473 1.286 . . . . 0.0 114.473 -175.044 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 68.03 39.83 88.81 Favored Glycine 0 CA--C 1.545 1.912 0 N-CA-C 111.423 -0.671 . . . . 0.0 111.423 -166.903 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -91.69 159.45 25.85 Favored Glycine 0 CA--C 1.541 1.689 0 CA-C-O 122.948 1.304 . . . . 0.0 113.776 -173.251 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 83.8 m95 -63.81 108.03 1.35 Allowed 'General case' 0 N--CA 1.47 0.558 0 CA-C-N 112.863 -1.668 . . . . 0.0 113.564 -179.512 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.596 HG22 HG13 ' A' ' 51' ' ' ILE . 5.5 p -58.46 -26.86 31.87 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 CA-C-N 111.741 -2.481 . . . . 0.0 113.864 168.653 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 10.1 t -65.09 -36.51 84.53 Favored 'General case' 0 N--CA 1.482 1.125 0 N-CA-C 113.431 0.901 . . . . 0.0 113.431 -173.867 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -70.45 -43.7 69.33 Favored 'General case' 0 N--CA 1.47 0.544 0 N-CA-C 112.367 0.506 . . . . 0.0 112.367 172.029 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.487 HG13 HG21 ' A' ' 14' ' ' THR . 1.6 mp -61.27 -44.0 97.59 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.564 0 C-N-CA 124.92 1.288 . . . . 0.0 112.539 -179.214 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.526 HG12 HD12 ' A' ' 43' ' ' LEU . 23.7 t -46.04 -47.54 5.76 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.703 0 C-N-CA 124.632 1.173 . . . . 0.0 111.594 171.572 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 22.7 p -60.52 -33.98 73.43 Favored 'General case' 0 N--CA 1.482 1.128 0 N-CA-C 114.606 1.335 . . . . 0.0 114.606 177.808 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.522 HG21 HG11 ' A' ' 11' ' ' VAL . 21.7 mm -77.28 -35.66 22.87 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 C-N-CA 124.142 0.977 . . . . 0.0 109.235 -178.951 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.61 ' HB3' ' HA3' ' A' ' 39' ' ' GLY . 4.0 mm? -60.66 -52.38 65.36 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 124.198 0.999 . . . . 0.0 111.587 173.5 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 1.7 p -60.84 -30.05 69.87 Favored 'General case' 0 N--CA 1.482 1.169 0 N-CA-C 115.37 1.619 . . . . 0.0 115.37 177.156 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -53.62 -33.51 55.28 Favored 'General case' 0 N--CA 1.479 1.009 0 N-CA-C 114.81 1.411 . . . . 0.0 114.81 175.251 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 68.8 t . . . . . 0 N--CA 1.484 1.265 0 C-N-CA 125.916 1.686 . . . . 0.0 111.912 175.889 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . 0.61 ' HA3' ' HB3' ' A' ' 32' ' ' LEU . . . . . . . . 0 N--CA 1.473 1.143 0 N-CA-C 111.467 -0.653 . . . . 0.0 111.467 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 58.8 mt -57.89 -48.94 78.39 Favored 'General case' 0 N--CA 1.474 0.742 0 N-CA-C 115.452 1.649 . . . . 0.0 115.452 -175.971 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' SER . . . . . 0.463 ' HB2' ' HD1' ' A' ' 5' ' ' PHE . 13.1 p -61.91 -37.88 86.3 Favored 'General case' 0 CA--C 1.544 0.732 0 N-CA-C 114.828 1.418 . . . . 0.0 114.828 177.66 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 10.0 tp -69.74 -42.12 74.34 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 124.251 1.02 . . . . 0.0 111.005 175.183 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.526 HD12 HG12 ' A' ' 29' ' ' VAL . 51.2 mt -63.26 -25.79 68.48 Favored 'General case' 0 N--CA 1.469 0.506 0 N-CA-C 114.968 1.47 . . . . 0.0 114.968 178.516 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -72.09 -49.52 35.61 Favored 'General case' 0 N--CA 1.481 1.106 0 CA-C-N 115.909 -0.587 . . . . 0.0 112.286 171.273 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -60.9 -35.75 77.46 Favored 'General case' 0 N--CA 1.49 1.529 0 C-N-CA 124.847 1.259 . . . . 0.0 112.933 -179.229 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -52.4 -25.7 10.6 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 126.844 2.058 . . . . 0.0 114.347 174.293 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -45.7 -37.97 7.27 Favored Glycine 0 CA--C 1.539 1.561 0 C-N-CA 126.514 2.007 . . . . 0.0 114.101 178.868 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 4.5 tmm_? -62.96 -39.35 94.39 Favored 'General case' 0 CA--C 1.544 0.738 0 N-CA-C 114.802 1.408 . . . . 0.0 114.802 -173.079 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 11.5 tt0 -141.15 38.7 1.76 Allowed 'General case' 0 N--CA 1.479 0.981 0 N-CA-C 116.365 1.987 . . . . 0.0 116.365 -178.51 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 59.5 p 53.47 119.34 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.874 0 C-N-CA 125.184 1.394 . . . . 0.0 112.643 -177.131 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.596 HG13 HG22 ' A' ' 25' ' ' VAL 0.276 8.6 tp -36.7 -46.55 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 N-CA-C 117.89 2.552 . . . . 0.0 117.89 -171.945 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 24.7 tptt -55.86 -68.93 0.16 Allowed 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 126.107 1.763 . . . . 0.0 112.895 174.767 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -62.96 -32.3 73.59 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 124.904 1.282 . . . . 0.0 113.865 177.317 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 91.2 t80 -53.81 -62.91 1.35 Allowed 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 125.894 1.677 . . . . 0.0 110.88 -178.948 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 65.8 mt -65.09 -35.39 81.0 Favored 'General case' 0 N--CA 1.469 0.483 0 N-CA-C 114.134 1.161 . . . . 0.0 114.134 179.928 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . 0.796 ' HA ' HG11 ' A' ' 19' ' ' VAL . 58.7 mttp -61.36 -47.96 83.46 Favored 'General case' 0 N--CA 1.477 0.904 0 CA-C-N 113.982 -1.463 . . . . 0.0 114.445 178.476 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 85.7 tttt -76.78 -50.64 13.02 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-N 114.764 -1.107 . . . . 0.0 111.695 175.406 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . 0.434 ' O ' ' HB2' ' A' ' 62' ' ' LYS . 28.8 tt0 -59.08 -49.21 78.75 Favored 'General case' 0 N--CA 1.471 0.596 0 N-CA-C 111.922 0.341 . . . . 0.0 111.922 -173.152 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.734 HD13 HG22 ' A' ' 67' ' ' VAL . 2.7 mm -72.09 -25.03 23.08 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.038 0 CA-C-O 118.428 -0.796 . . . . 0.0 112.391 -178.669 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 63.9 tttm -62.77 -33.17 74.62 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 114.682 1.364 . . . . 0.0 114.682 172.045 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 55.1 mtmt -80.91 -48.58 12.14 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-N 114.055 -1.429 . . . . 0.0 110.729 173.941 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . 0.434 ' HB2' ' O ' ' A' ' 58' ' ' GLU . 5.9 tttm -64.51 -50.6 66.74 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 126.131 1.772 . . . . 0.0 115.77 -172.053 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 91.66 108.58 1.59 Allowed Glycine 0 N--CA 1.482 1.749 0 CA-C-N 114.932 -1.031 . . . . 0.0 110.747 -175.941 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.687 ' HD2' ' H ' ' A' ' 64' ' ' LYS . 8.6 mptt -31.95 -43.83 0.08 Allowed 'General case' 0 N--CA 1.482 1.153 0 N-CA-C 119.277 3.066 . . . . 0.0 119.277 -173.713 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.44 -47.94 82.34 Favored 'General case' 0 N--CA 1.475 0.78 0 N-CA-C 113.396 0.888 . . . . 0.0 113.396 178.865 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -60.77 -28.12 68.49 Favored 'General case' 0 N--CA 1.473 0.723 0 CA-C-N 115.015 -0.993 . . . . 0.0 113.402 172.937 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.734 HG22 HD13 ' A' ' 59' ' ' ILE . 96.2 t -72.95 -36.09 50.56 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.662 0 N-CA-C 112.877 0.695 . . . . 0.0 112.877 179.276 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 33.5 mm -53.21 -46.77 56.63 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.996 0 O-C-N 123.637 0.586 . . . . 0.0 109.952 168.721 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -68.6 -43.15 77.05 Favored 'General case' 0 N--CA 1.476 0.844 0 N-CA-C 113.598 0.962 . . . . 0.0 113.598 178.57 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 29.3 t90 . . . . . 0 N--CA 1.477 0.886 0 CA-C-N 114.816 -1.084 . . . . 0.0 113.069 178.337 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.605 ' HE3' HG22 ' A' ' 15' ' ' VAL . 39.7 mtp . . . . . 0 N--CA 1.477 0.918 0 N-CA-C 111.8 0.296 . . . . 0.0 111.8 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . 0.419 ' HA ' ' O ' ' A' ' 7' ' ' ILE . . . -53.64 -55.19 28.04 Favored 'General case' 0 N--CA 1.475 0.789 0 CA-C-N 113.714 -1.585 . . . . 0.0 113.415 177.625 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -74.24 -44.11 54.32 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 113.639 -1.619 . . . . 0.0 114.156 -174.758 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 13.6 tt0 -78.52 -43.19 27.45 Favored 'General case' 0 N--CA 1.472 0.652 0 N-CA-C 114.241 1.2 . . . . 0.0 114.241 -170.898 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . 0.602 ' HB2' HD11 ' A' ' 7' ' ' ILE . 46.3 m-85 -105.34 -23.99 12.76 Favored 'General case' 0 N--CA 1.484 1.233 0 N-CA-C 116.258 1.947 . . . . 0.0 116.258 -170.16 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 95.72 58.38 1.12 Allowed Glycine 0 CA--C 1.534 1.276 0 C-N-CA 124.225 0.917 . . . . 0.0 111.77 -175.083 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . 0.602 HD11 ' HB2' ' A' ' 5' ' ' PHE . 1.3 mt -125.77 151.11 70.46 Favored Pre-proline 0 N--CA 1.478 0.944 0 C-N-CA 124.764 1.225 . . . . 0.0 111.069 -173.57 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo -97.27 162.63 0.97 Allowed 'Trans proline' 0 C--O 1.24 0.597 0 C-N-CA 121.162 1.241 . . . . 0.0 109.703 161.596 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -53.44 -29.38 35.11 Favored 'General case' 0 CA--C 1.538 0.481 0 N-CA-C 114.719 1.377 . . . . 0.0 114.719 177.176 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -43.61 -59.87 2.0 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 126.196 1.799 . . . . 0.0 112.953 173.146 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.776 ' HB ' HD23 ' A' ' 32' ' ' LEU . 29.6 m -84.42 -29.89 7.13 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.195 0 N-CA-C 114.321 1.23 . . . . 0.0 114.321 -175.231 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -67.26 -29.79 69.5 Favored 'General case' 0 N--CA 1.48 1.064 0 N-CA-C 112.759 0.651 . . . . 0.0 112.759 172.943 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -66.66 -40.01 93.89 Favored Glycine 0 CA--C 1.536 1.374 0 C-N-CA 124.317 0.96 . . . . 0.0 112.401 170.616 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' THR . . . . . 0.75 HG21 HD13 ' A' ' 28' ' ' ILE . 1.0 OUTLIER -67.7 -34.13 76.29 Favored 'General case' 0 N--CA 1.487 1.404 0 C-N-CA 124.183 0.993 . . . . 0.0 112.937 177.232 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.605 HG22 ' HE3' ' A' ' 1' ' ' MET . 10.8 t -54.15 -40.58 47.3 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 C-N-CA 124.707 1.203 . . . . 0.0 112.879 165.772 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.47 HD21 ' HG3' ' A' ' 64' ' ' LYS . 83.2 mt -61.27 -37.13 82.03 Favored 'General case' 0 N--CA 1.472 0.645 0 N-CA-C 114.261 1.208 . . . . 0.0 114.261 176.494 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 48.2 t-20 -53.62 -47.9 69.8 Favored 'General case' 0 N--CA 1.481 1.076 0 CA-C-N 115.179 -0.919 . . . . 0.0 111.355 173.353 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.567 HG21 HG13 ' A' ' 28' ' ' ILE . 22.6 t -48.11 -51.61 9.0 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.213 0 CA-C-N 115.28 -0.873 . . . . 0.0 112.021 174.596 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.827 HG11 ' HA ' ' A' ' 56' ' ' LYS . 5.1 t -64.3 -48.16 86.62 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.144 0 C-N-CA 124.155 0.982 . . . . 0.0 111.327 -176.774 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -74.13 -43.11 58.72 Favored 'General case' 0 N--CA 1.469 0.519 0 N-CA-C 116.767 2.136 . . . . 0.0 116.767 -176.127 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -103.17 -22.45 13.74 Favored 'General case' 0 N--CA 1.481 1.107 0 N-CA-C 115.814 1.783 . . . . 0.0 115.814 -169.796 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 68.87 39.61 85.34 Favored Glycine 0 N--CA 1.477 1.413 0 N-CA-C 110.639 -0.984 . . . . 0.0 110.639 -165.928 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -86.55 142.82 18.91 Favored Glycine 0 N--CA 1.48 1.57 0 N-CA-C 108.815 -1.714 . . . . 0.0 108.815 -177.513 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 9.2 m-90 -49.6 103.15 0.04 OUTLIER 'General case' 0 N--CA 1.477 0.883 0 CA-C-N 113.624 -1.288 . . . . 0.0 112.71 -172.498 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 3.2 p -56.44 -23.41 16.68 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.758 0 CA-C-N 114.028 -1.442 . . . . 0.0 114.414 176.368 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 5.0 t -62.43 -44.42 96.47 Favored 'General case' 0 N--CA 1.484 1.225 0 CA-C-N 115.648 -0.705 . . . . 0.0 112.558 178.389 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 1.6 m -60.86 -45.76 93.25 Favored 'General case' 0 N--CA 1.485 1.287 0 C-N-CA 123.871 0.868 . . . . 0.0 110.937 172.998 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.75 HD13 HG21 ' A' ' 14' ' ' THR . 8.4 mm -62.37 -46.58 96.09 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.152 0 C-N-CA 124.394 1.078 . . . . 0.0 111.867 -179.09 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 48.7 t -50.31 -45.77 25.02 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.386 0 C-N-CA 124.757 1.223 . . . . 0.0 111.129 176.964 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 64.8 m -63.81 -27.31 69.09 Favored 'General case' 0 N--CA 1.481 1.095 0 N-CA-C 115.867 1.802 . . . . 0.0 115.867 177.825 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.77 HG21 HG11 ' A' ' 11' ' ' VAL . 34.9 mm -82.21 -39.81 16.67 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.032 0 C-N-CA 123.857 0.863 . . . . 0.0 109.07 178.967 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.776 HD23 ' HB ' ' A' ' 11' ' ' VAL . 3.4 mm? -56.64 -50.58 71.61 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 125.142 1.377 . . . . 0.0 112.204 172.171 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 1.4 p -70.89 -29.69 65.83 Favored 'General case' 0 N--CA 1.481 1.079 0 N-CA-C 114.683 1.364 . . . . 0.0 114.683 177.837 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -52.4 -25.63 10.43 Favored 'General case' 0 N--CA 1.477 0.918 0 N-CA-C 114.006 1.113 . . . . 0.0 114.006 170.456 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 58.5 t . . . . . 0 N--CA 1.485 1.322 0 C-N-CA 124.327 1.051 . . . . 0.0 112.051 173.753 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . 0.529 ' O ' ' HG ' ' A' ' 43' ' ' LEU . . . . . . . . 0 N--CA 1.48 1.58 0 CA-C-O 120.34 -0.144 . . . . 0.0 113.018 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 22.3 mt -61.45 -48.27 81.91 Favored 'General case' 0 N--CA 1.479 0.981 0 CA-C-N 113.589 -1.306 . . . . 0.0 113.5 -178.845 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 17.0 m -57.92 -41.25 82.3 Favored 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 123.658 0.783 . . . . 0.0 112.758 176.188 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.494 HD11 ' HE2' ' A' ' 1' ' ' MET . 13.7 tp -60.5 -45.76 92.6 Favored 'General case' 0 N--CA 1.478 0.961 0 CA-C-N 115.554 -0.748 . . . . 0.0 111.393 173.969 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.529 ' HG ' ' O ' ' A' ' 39' ' ' GLY . 69.2 mt -61.85 -32.84 73.21 Favored 'General case' 0 N--CA 1.473 0.697 0 N-CA-C 113.66 0.985 . . . . 0.0 113.66 -179.269 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -63.9 -48.99 74.43 Favored 'General case' 0 N--CA 1.476 0.851 0 O-C-N 123.985 0.803 . . . . 0.0 112.102 171.802 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -62.52 -33.34 74.7 Favored 'General case' 0 N--CA 1.485 1.284 0 CA-C-O 122.239 1.019 . . . . 0.0 112.753 178.12 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -61.77 -14.33 31.64 Favored 'General case' 0 N--CA 1.478 0.933 0 N-CA-C 116.11 1.893 . . . . 0.0 116.11 176.559 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -48.54 -37.22 19.24 Favored Glycine 0 CA--C 1.542 1.771 0 O-C-N 124.718 1.261 . . . . 0.0 113.511 177.833 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 40.2 ttp180 -50.71 -50.76 54.46 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 125.671 1.588 . . . . 0.0 113.647 -173.602 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -145.52 37.98 1.12 Allowed 'General case' 0 N--CA 1.476 0.841 0 N-CA-C 114.064 1.135 . . . . 0.0 114.064 -175.013 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 27.6 t 52.96 133.37 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.504 0 C-N-CA 125.175 1.39 . . . . 0.0 112.855 -175.71 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.419 ' O ' ' HB3' ' A' ' 54' ' ' TYR 0.259 9.9 tp -37.79 -54.04 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.822 0 N-CA-C 117.89 2.552 . . . . 0.0 117.89 -168.186 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 38.4 tttt -61.98 -57.23 12.48 Favored 'General case' 0 CA--C 1.543 0.694 0 N-CA-C 114.096 1.147 . . . . 0.0 114.096 178.232 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -66.17 -30.0 70.39 Favored 'General case' 0 N--CA 1.479 1.011 0 O-C-N 123.925 0.765 . . . . 0.0 112.936 179.766 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . 0.419 ' HB3' ' O ' ' A' ' 51' ' ' ILE . 64.4 t80 -53.98 -61.42 2.31 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 124.893 1.277 . . . . 0.0 110.716 170.592 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.435 HD12 HG12 ' A' ' 15' ' ' VAL . 51.2 mt -65.01 -35.81 82.4 Favored 'General case' 0 N--CA 1.482 1.165 0 N-CA-C 113.622 0.971 . . . . 0.0 113.622 -174.662 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . 0.827 ' HA ' HG11 ' A' ' 19' ' ' VAL . 55.6 mttm -54.41 -56.58 17.26 Favored 'General case' 0 N--CA 1.473 0.693 0 O-C-N 125.34 1.65 . . . . 0.0 112.065 173.024 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 57.1 tttm -68.43 -45.47 72.47 Favored 'General case' 0 CA--C 1.542 0.635 0 CA-C-N 115.411 -0.813 . . . . 0.0 112.113 176.799 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . 0.451 ' O ' ' HB2' ' A' ' 62' ' ' LYS . 4.1 tp10 -56.81 -52.37 65.31 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-N 114.969 -1.014 . . . . 0.0 112.962 -175.969 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.551 HG22 HG22 ' A' ' 67' ' ' VAL . 1.2 mm -74.8 -26.7 19.75 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.261 0 CA-C-N 116.04 -0.527 . . . . 0.0 112.1 -177.713 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . 0.472 ' HB2' ' O ' ' A' ' 56' ' ' LYS . 3.8 tppt? -62.06 -42.2 98.94 Favored 'General case' 0 CA--C 1.539 0.543 0 O-C-N 124.383 1.052 . . . . 0.0 112.525 176.596 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 61.2 pttt -86.39 -26.99 24.49 Favored 'General case' 0 CA--C 1.547 0.86 0 CA-C-N 113.447 -1.706 . . . . 0.0 113.193 177.935 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . 0.451 ' HB2' ' O ' ' A' ' 58' ' ' GLU . 35.7 tptt -76.16 -58.37 3.32 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 125.714 1.606 . . . . 0.0 114.542 -178.008 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 103.32 110.72 3.48 Favored Glycine 0 CA--C 1.543 1.803 0 CA-C-N 114.628 -1.169 . . . . 0.0 112.189 -174.304 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.486 ' HD2' ' H ' ' A' ' 64' ' ' LYS . 11.2 mptt -34.75 -52.27 0.52 Allowed 'General case' 0 N--CA 1.481 1.077 0 N-CA-C 119.784 3.253 . . . . 0.0 119.784 -172.641 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -61.55 -45.59 93.52 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 123.779 0.831 . . . . 0.0 112.993 -179.778 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -65.48 -25.82 67.65 Favored 'General case' 0 N--CA 1.478 0.97 0 CA-C-N 113.924 -1.489 . . . . 0.0 112.949 174.12 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.551 HG22 HG22 ' A' ' 59' ' ' ILE . 71.7 t -63.77 -43.86 98.09 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.314 0 C-N-CA 123.319 0.648 . . . . 0.0 110.411 174.864 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -51.78 -44.48 36.52 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.966 0 C-N-CA 123.339 0.656 . . . . 0.0 111.671 173.562 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -70.43 -47.64 59.79 Favored 'General case' 0 N--CA 1.481 1.077 0 N-CA-C 113.222 0.823 . . . . 0.0 113.222 177.629 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 30.7 t90 . . . . . 0 N--CA 1.481 1.083 0 C-N-CA 126.382 1.873 . . . . 0.0 112.433 -178.69 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.664 ' HB3' HG21 ' A' ' 7' ' ' ILE . 68.4 mtp . . . . . 0 N--CA 1.474 0.757 0 N-CA-C 113.471 0.915 . . . . 0.0 113.471 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -64.37 -38.83 92.42 Favored 'General case' 0 N--CA 1.475 0.813 0 N-CA-C 114.111 1.152 . . . . 0.0 114.111 176.562 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 35.6 ttmt -91.25 -68.54 0.79 Allowed 'General case' 0 N--CA 1.471 0.605 0 N-CA-C 114.125 1.157 . . . . 0.0 114.125 -176.89 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 8.5 tt0 -61.66 -31.14 71.23 Favored 'General case' 0 CA--C 1.55 0.974 0 C-N-CA 125.188 1.395 . . . . 0.0 113.796 -173.623 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . 0.548 ' HD1' ' HB2' ' A' ' 41' ' ' SER . 45.1 m-85 -109.77 -11.93 14.67 Favored 'General case' 0 N--CA 1.474 0.74 0 N-CA-C 116.948 2.203 . . . . 0.0 116.948 -179.94 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 64.44 31.62 81.47 Favored Glycine 0 CA--C 1.538 1.511 0 C-N-CA 124.176 0.893 . . . . 0.0 113.856 -174.228 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . 0.664 HG21 ' HB3' ' A' ' 1' ' ' MET . 0.7 OUTLIER -104.21 118.01 57.97 Favored Pre-proline 0 N--CA 1.478 0.939 0 C-N-CA 123.418 0.687 . . . . 0.0 110.863 -177.524 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -64.27 161.61 33.52 Favored 'Trans proline' 0 CA--C 1.537 0.653 0 C-N-CA 122.506 2.137 . . . . 0.0 112.277 -171.807 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -55.75 -29.1 59.02 Favored 'General case' 0 N--CA 1.476 0.83 0 CA-C-N 113.278 -1.783 . . . . 0.0 114.137 173.141 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -49.03 -33.55 11.52 Favored 'General case' 0 N--CA 1.48 1.033 0 N-CA-C 114.853 1.427 . . . . 0.0 114.853 172.941 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.745 HG11 HG21 ' A' ' 31' ' ' ILE . 30.2 m -112.15 -35.45 2.43 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.016 0 N-CA-C 113.789 1.033 . . . . 0.0 113.789 179.895 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -64.57 -40.21 95.14 Favored 'General case' 0 N--CA 1.476 0.852 0 N-CA-C 113.651 0.982 . . . . 0.0 113.651 174.802 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -61.72 -40.67 99.09 Favored Glycine 0 CA--C 1.548 2.104 0 C-N-CA 124.172 0.891 . . . . 0.0 112.276 174.542 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' THR . . . . . 0.494 HG21 HD13 ' A' ' 28' ' ' ILE . 4.3 m -66.81 -40.99 88.25 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 125.139 1.376 . . . . 0.0 113.46 177.324 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.618 HG22 ' HE3' ' A' ' 1' ' ' MET . 54.4 t -52.54 -46.96 49.05 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.207 0 C-N-CA 123.126 0.57 . . . . 0.0 111.249 169.056 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.665 HD13 HG12 ' A' ' 68' ' ' ILE . 23.8 mt -57.28 -48.19 79.54 Favored 'General case' 0 N--CA 1.482 1.174 0 O-C-N 123.839 0.712 . . . . 0.0 112.904 179.205 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 11.8 t-20 -54.44 -44.68 72.67 Favored 'General case' 0 CA--C 1.542 0.665 0 CA-C-N 114.857 -1.065 . . . . 0.0 111.338 179.168 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.933 HG22 HD12 ' A' ' 28' ' ' ILE . 2.8 t -68.68 -40.96 82.35 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.762 0 CA-C-N 113.475 -1.693 . . . . 0.0 114.087 179.336 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.633 HG11 ' HA ' ' A' ' 56' ' ' LYS . 40.5 t -59.01 -52.48 60.16 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.357 0 O-C-N 124.392 1.058 . . . . 0.0 109.265 175.73 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . 0.543 ' HG3' ' HE2' ' A' ' 64' ' ' LYS . 36.0 mt-10 -55.01 -53.54 54.46 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 125.232 1.413 . . . . 0.0 113.35 178.099 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -77.24 -11.66 59.85 Favored 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 115.683 1.735 . . . . 0.0 115.683 -175.379 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 67.66 47.93 59.01 Favored Glycine 0 N--CA 1.478 1.472 0 C-N-CA 124.523 1.059 . . . . 0.0 111.424 -172.44 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -94.13 -160.1 34.44 Favored Glycine 0 N--CA 1.475 1.248 0 CA-C-O 123.163 1.424 . . . . 0.0 113.293 -173.958 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' TRP . . . . . 0.422 ' HB3' HG21 ' A' ' 26' ' ' THR . 9.1 m-90 -102.89 105.69 16.1 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-O 122.651 1.215 . . . . 0.0 113.305 179.16 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.473 HG21 ' HE3' ' A' ' 56' ' ' LYS . 77.4 t -55.67 -27.23 21.36 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.045 0 CA-C-N 114.057 -1.429 . . . . 0.0 112.899 168.338 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' THR . . . . . 0.422 HG21 ' HB3' ' A' ' 24' ' ' TRP . 3.1 t -60.28 -38.32 83.19 Favored 'General case' 0 N--CA 1.485 1.286 0 N-CA-C 113.349 0.87 . . . . 0.0 113.349 179.143 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 2.7 m -64.07 -41.03 97.49 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 125.09 1.356 . . . . 0.0 110.684 175.013 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.933 HD12 HG22 ' A' ' 18' ' ' VAL . 1.6 mm -73.65 -39.85 53.87 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.277 0 CA-C-N 115.508 -0.769 . . . . 0.0 111.411 -178.79 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 25.6 t -46.09 -44.77 5.5 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 C-N-CA 124.113 0.965 . . . . 0.0 111.639 175.589 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 20.0 m -57.1 -41.31 78.68 Favored 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 124.966 1.307 . . . . 0.0 114.472 174.287 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.745 HG21 HG11 ' A' ' 11' ' ' VAL . 16.4 mm -75.09 -37.62 40.79 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.272 0 C-N-CA 124.483 1.113 . . . . 0.0 110.196 -178.957 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.536 ' HB3' ' HA2' ' A' ' 39' ' ' GLY . 4.2 mm? -55.37 -41.17 72.23 Favored 'General case' 0 N--CA 1.49 1.573 0 C-N-CA 124.342 1.057 . . . . 0.0 110.926 168.805 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 25.5 m -68.53 -38.83 81.2 Favored 'General case' 0 N--CA 1.485 1.317 0 N-CA-C 114.232 1.197 . . . . 0.0 114.232 174.961 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -55.68 -30.12 60.53 Favored 'General case' 0 N--CA 1.481 1.115 0 O-C-N 124.7 1.25 . . . . 0.0 113.242 175.131 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.457 ' HB ' ' O ' ' A' ' 32' ' ' LEU . 54.5 t . . . . . 0 N--CA 1.48 1.034 0 C-N-CA 125.838 1.655 . . . . 0.0 113.423 172.916 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . 0.536 ' HA2' ' HB3' ' A' ' 32' ' ' LEU . . . . . . . . 0 CA--C 1.546 1.977 0 N-CA-C 111.899 -0.481 . . . . 0.0 111.899 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 9.4 mt -51.91 -40.03 60.07 Favored 'General case' 0 N--CA 1.485 1.303 0 N-CA-C 116.631 2.086 . . . . 0.0 116.631 -168.52 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' SER . . . . . 0.548 ' HB2' ' HD1' ' A' ' 5' ' ' PHE . 7.9 p -59.8 -49.04 79.26 Favored 'General case' 0 CA--C 1.546 0.792 0 N-CA-C 113.448 0.907 . . . . 0.0 113.448 178.792 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.496 HD21 ' HE2' ' A' ' 1' ' ' MET . 15.8 tp -61.16 -47.36 86.56 Favored 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 122.968 0.507 . . . . 0.0 110.43 172.684 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 43.9 mt -66.19 -26.64 67.5 Favored 'General case' 0 N--CA 1.476 0.863 0 CA-C-N 114.605 -1.179 . . . . 0.0 114.062 -175.215 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -69.75 -45.16 68.71 Favored 'General case' 0 N--CA 1.475 0.823 0 CA-C-N 115.694 -0.685 . . . . 0.0 111.82 171.57 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -63.54 -35.81 81.7 Favored 'General case' 0 N--CA 1.479 0.976 0 CA-C-O 121.005 0.431 . . . . 0.0 111.875 173.845 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -66.13 -28.59 68.91 Favored 'General case' 0 N--CA 1.474 0.774 0 N-CA-C 116.193 1.923 . . . . 0.0 116.193 179.654 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -53.14 -35.05 48.37 Favored Glycine 0 N--CA 1.482 1.717 0 C-N-CA 124.818 1.199 . . . . 0.0 113.39 -178.433 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 42.2 ttp180 -57.24 -41.92 80.48 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 126.233 1.813 . . . . 0.0 113.929 -176.177 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -138.57 57.43 1.69 Allowed 'General case' 0 N--CA 1.476 0.839 0 CA-C-O 121.887 0.851 . . . . 0.0 110.149 178.197 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 9.0 t 30.33 114.32 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.225 0 N-CA-C 116.84 2.163 . . . . 0.0 116.84 -178.868 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 7.0 tp -26.99 -54.04 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.349 0 N-CA-C 118.023 2.601 . . . . 0.0 118.023 -177.273 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . 0.49 ' NZ ' ' HZ3' ' A' ' 56' ' ' LYS . 24.1 tptp -57.65 -58.15 9.57 Favored 'General case' 0 N--CA 1.481 1.108 0 C-N-CA 124.494 1.118 . . . . 0.0 111.913 -177.762 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -72.01 -35.21 69.37 Favored 'General case' 0 N--CA 1.484 1.237 0 O-C-N 124.579 1.174 . . . . 0.0 113.831 177.847 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 67.8 t80 -45.78 -60.96 1.93 Allowed 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 125.445 1.498 . . . . 0.0 112.117 -179.695 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 59.4 mt -65.86 -36.14 82.61 Favored 'General case' 0 N--CA 1.475 0.811 0 N-CA-C 114.782 1.401 . . . . 0.0 114.782 -175.24 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . 0.633 ' HA ' HG11 ' A' ' 19' ' ' VAL . 35.5 mmtp -57.67 -56.2 25.02 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-N 114.211 -1.359 . . . . 0.0 112.311 177.386 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . 0.445 ' HE3' ' HE3' ' A' ' 61' ' ' LYS . 64.0 tttp -69.51 -51.15 38.4 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-N 115.054 -0.975 . . . . 0.0 111.968 175.673 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . 0.553 ' O ' ' HB2' ' A' ' 62' ' ' LYS . 3.6 mm-40 -54.93 -50.75 68.08 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-O 118.281 -0.866 . . . . 0.0 112.682 -173.377 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.615 HG22 HG22 ' A' ' 67' ' ' VAL . 2.7 mm -79.14 -25.68 12.94 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.077 0 CA-C-O 118.618 -0.706 . . . . 0.0 112.007 -175.824 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . 0.613 ' HA ' ' HZ3' ' A' ' 64' ' ' LYS . 8.7 tppt? -62.1 -32.42 72.98 Favored 'General case' 0 N--CA 1.473 0.698 0 N-CA-C 114.416 1.265 . . . . 0.0 114.416 171.894 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . 0.445 ' HE3' ' HE3' ' A' ' 57' ' ' LYS . 48.4 mttm -88.56 -45.7 9.68 Favored 'General case' 0 N--CA 1.476 0.838 0 CA-C-N 113.351 -1.75 . . . . 0.0 112.42 176.127 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . 0.553 ' HB2' ' O ' ' A' ' 58' ' ' GLU . 2.9 tttm -64.41 -45.55 87.07 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 126.448 1.899 . . . . 0.0 112.96 -172.512 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 95.45 113.66 2.75 Favored Glycine 0 N--CA 1.479 1.546 0 O-C-N 124.958 1.411 . . . . 0.0 109.65 -175.546 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.64 ' HD2' ' H ' ' A' ' 64' ' ' LYS . 10.7 mptt -44.66 -43.7 8.5 Favored 'General case' 0 N--CA 1.484 1.234 0 N-CA-C 116.801 2.148 . . . . 0.0 116.801 -172.636 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . 0.464 ' O ' ' HB ' ' A' ' 68' ' ' ILE . 0.0 OUTLIER -56.16 -48.53 76.11 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 125.381 1.472 . . . . 0.0 114.576 178.054 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -64.71 -28.05 69.33 Favored 'General case' 0 N--CA 1.473 0.718 0 N-CA-C 114.463 1.282 . . . . 0.0 114.463 172.526 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.615 HG22 HG22 ' A' ' 59' ' ' ILE . 95.3 t -72.96 -32.82 41.25 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.944 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.321 179.098 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.665 HG12 HD13 ' A' ' 16' ' ' LEU . 4.3 mm -50.05 -49.57 21.55 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.332 0 C-N-CA 123.494 0.718 . . . . 0.0 110.098 167.132 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -64.59 -50.0 68.92 Favored 'General case' 0 N--CA 1.481 1.076 0 CA-C-N 114.917 -1.038 . . . . 0.0 112.912 178.636 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 23.2 t90 . . . . . 0 CA--C 1.544 0.728 0 C-N-CA 126.489 1.915 . . . . 0.0 112.987 179.394 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.743 ' HE3' HG22 ' A' ' 15' ' ' VAL . 74.1 mtp . . . . . 0 N--CA 1.482 1.156 0 N-CA-C 113.327 0.862 . . . . 0.0 113.327 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -65.18 -56.12 14.68 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-N 114.915 -1.039 . . . . 0.0 112.67 175.474 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 14.4 ttmm -71.09 -52.96 16.4 Favored 'General case' 0 CA--C 1.549 0.935 0 CA-C-N 114.361 -1.291 . . . . 0.0 114.118 -172.967 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . 0.435 ' HB2' ' O ' ' A' ' 70' ' ' TRP . 1.8 mp0 -79.77 -38.45 33.15 Favored 'General case' 0 N--CA 1.476 0.829 0 N-CA-C 115.052 1.501 . . . . 0.0 115.052 -174.559 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . 0.517 ' HD2' ' HA ' ' A' ' 1' ' ' MET . 73.9 m-85 -106.28 -9.72 16.71 Favored 'General case' 0 N--CA 1.484 1.253 0 N-CA-C 117.041 2.237 . . . . 0.0 117.041 -172.236 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 66.73 36.92 91.94 Favored Glycine 0 CA--C 1.54 1.632 0 CA-C-O 121.971 0.762 . . . . 0.0 112.917 -176.055 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . 0.671 HG22 HG22 ' A' ' 11' ' ' VAL . 0.6 OUTLIER -116.12 112.87 41.81 Favored Pre-proline 0 N--CA 1.472 0.657 0 C-N-CA 124.327 1.051 . . . . 0.0 109.413 179.106 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_endo -63.86 164.05 23.02 Favored 'Trans proline' 0 N--CA 1.48 0.68 0 C-N-CA 121.184 1.256 . . . . 0.0 111.597 -174.471 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -55.76 -28.42 55.85 Favored 'General case' 0 N--CA 1.479 0.989 0 N-CA-C 114.674 1.361 . . . . 0.0 114.674 176.75 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -45.51 -43.98 12.21 Favored 'General case' 0 CA--C 1.549 0.917 0 C-N-CA 125.985 1.714 . . . . 0.0 113.753 174.628 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.962 HG13 HG21 ' A' ' 31' ' ' ILE . 33.6 m -100.24 -28.92 3.28 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.054 0 N-CA-C 114.766 1.395 . . . . 0.0 114.766 179.248 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -67.6 -34.97 78.07 Favored 'General case' 0 N--CA 1.477 0.895 0 N-CA-C 113.791 1.034 . . . . 0.0 113.791 176.76 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -61.47 -41.34 99.53 Favored Glycine 0 N--CA 1.478 1.44 0 CA-C-O 122.467 1.037 . . . . 0.0 112.304 172.357 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 3.1 m -64.1 -34.05 77.15 Favored 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 126.046 1.738 . . . . 0.0 112.893 175.524 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.743 HG22 ' HE3' ' A' ' 1' ' ' MET . 20.5 t -63.5 -36.64 77.06 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.065 0 C-N-CA 123.667 0.787 . . . . 0.0 112.083 172.039 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.635 HD12 ' HB3' ' A' ' 64' ' ' LYS . 31.6 mt -65.43 -40.36 93.21 Favored 'General case' 0 N--CA 1.485 1.305 0 N-CA-C 112.913 0.708 . . . . 0.0 112.913 174.234 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 4.6 m120 -57.62 -43.99 85.18 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 124.976 1.31 . . . . 0.0 112.448 174.384 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 4.1 t -48.11 -57.64 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.35 0 C-N-CA 123.835 0.854 . . . . 0.0 111.373 168.391 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.566 HG11 ' HA ' ' A' ' 56' ' ' LYS . 4.8 t -60.66 -44.78 97.76 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 123.935 0.772 . . . . 0.0 111.913 -176.16 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 27.6 mt-10 -63.93 -43.74 94.97 Favored 'General case' 0 N--CA 1.472 0.634 0 N-CA-C 115.301 1.593 . . . . 0.0 115.301 179.506 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -97.04 -11.51 24.39 Favored 'General case' 0 N--CA 1.478 0.934 0 N-CA-C 116.221 1.934 . . . . 0.0 116.221 -170.917 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . 0.494 ' HA3' ' HZ2' ' A' ' 56' ' ' LYS . . . 73.49 25.28 72.98 Favored Glycine 0 CA--C 1.544 1.866 0 O-C-N 123.521 0.513 . . . . 0.0 112.736 -169.002 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -78.76 149.94 33.8 Favored Glycine 0 N--CA 1.476 1.362 0 CA-C-O 122.419 1.01 . . . . 0.0 113.689 -171.054 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' TRP . . . . . 0.521 ' HB3' HG21 ' A' ' 26' ' ' THR . 2.9 m-90 -62.1 98.08 0.1 Allowed 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 125.31 1.444 . . . . 0.0 112.327 178.402 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 5.0 p -51.87 -27.84 9.19 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.868 0 CA-C-N 113.734 -1.575 . . . . 0.0 113.985 173.187 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' THR . . . . . 0.521 HG21 ' HB3' ' A' ' 24' ' ' TRP . 13.9 t -59.52 -40.72 88.05 Favored 'General case' 0 CA--C 1.546 0.827 0 C-N-CA 124.735 1.214 . . . . 0.0 112.937 -178.055 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -67.66 -47.07 70.57 Favored 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 124.101 0.96 . . . . 0.0 110.604 174.964 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 2.3 mp -60.21 -35.4 61.72 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.036 0 C-N-CA 125.259 1.424 . . . . 0.0 112.99 177.179 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.41 ' O ' ' HB2' ' A' ' 32' ' ' LEU . 15.9 t -48.97 -40.62 12.78 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.365 0 C-N-CA 124.403 1.081 . . . . 0.0 112.38 173.845 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 59.7 p -61.03 -30.3 70.22 Favored 'General case' 0 N--CA 1.477 0.888 0 N-CA-C 114.02 1.118 . . . . 0.0 114.02 176.255 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.962 HG21 HG13 ' A' ' 11' ' ' VAL . 42.6 mm -77.33 -36.47 23.96 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.989 0 C-N-CA 124.07 0.948 . . . . 0.0 109.191 179.965 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.56 ' HB3' ' HA2' ' A' ' 39' ' ' GLY . 3.9 mm? -60.13 -36.42 77.45 Favored 'General case' 0 N--CA 1.49 1.554 0 C-N-CA 123.741 0.817 . . . . 0.0 111.315 169.414 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 2.5 m -72.55 -34.31 67.42 Favored 'General case' 0 N--CA 1.483 1.176 0 N-CA-C 114.698 1.37 . . . . 0.0 114.698 175.403 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -54.49 -29.02 48.77 Favored 'General case' 0 N--CA 1.482 1.16 0 O-C-N 124.245 0.965 . . . . 0.0 113.459 174.317 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.403 ' HB ' ' O ' ' A' ' 32' ' ' LEU . 70.5 t . . . . . 0 N--CA 1.484 1.255 0 C-N-CA 126.313 1.845 . . . . 0.0 113.03 172.031 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . 0.56 ' HA2' ' HB3' ' A' ' 32' ' ' LEU . . . . . . . . 0 CA--C 1.543 1.815 0 N-CA-C 113.404 0.121 . . . . 0.0 113.404 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 14.3 mt -53.23 -41.74 65.7 Favored 'General case' 0 N--CA 1.48 1.059 0 N-CA-C 116.459 2.022 . . . . 0.0 116.459 -171.127 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' SER . . . . . 0.478 ' HB2' ' HD1' ' A' ' 5' ' ' PHE . 11.5 p -59.47 -51.62 69.1 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 125.327 1.451 . . . . 0.0 113.86 175.26 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 14.5 tp -60.74 -43.48 97.87 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 123.676 0.79 . . . . 0.0 110.31 174.157 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 82.7 mt -65.68 -27.37 68.3 Favored 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 114.618 1.34 . . . . 0.0 114.618 -178.23 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -70.33 -48.26 57.32 Favored 'General case' 0 N--CA 1.478 0.953 0 CA-C-N 115.43 -0.805 . . . . 0.0 112.323 169.91 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -59.19 -37.16 76.74 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 123.446 0.699 . . . . 0.0 112.697 176.292 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -57.87 -28.95 64.62 Favored 'General case' 0 C--N 1.321 -0.63 0 C-N-CA 126.546 1.938 . . . . 0.0 115.642 177.76 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -47.81 -41.78 20.67 Favored Glycine 0 CA--C 1.536 1.371 0 C-N-CA 125.438 1.494 . . . . 0.0 114.608 -174.514 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 41.0 ttp-105 -53.81 -47.02 71.27 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 126.0 1.72 . . . . 0.0 113.81 -174.797 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 5.0 tt0 -127.14 31.01 5.32 Favored 'General case' 0 CA--C 1.547 0.854 0 N-CA-C 113.787 1.032 . . . . 0.0 113.787 -177.553 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 24.5 t 45.85 126.8 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 125.353 1.461 . . . . 0.0 113.809 -171.545 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 9.8 tp -37.44 -42.25 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 N-CA-C 117.239 2.311 . . . . 0.0 117.239 -173.437 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 8.4 mmtt -57.41 -72.05 0.09 Allowed 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 124.31 1.044 . . . . 0.0 112.05 174.393 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -62.49 -34.8 77.57 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 125.196 1.398 . . . . 0.0 113.853 -177.842 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 87.6 t80 -48.62 -59.45 3.51 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 125.497 1.519 . . . . 0.0 111.646 175.715 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.516 HD12 HG11 ' A' ' 15' ' ' VAL . 75.0 mt -67.86 -41.67 82.54 Favored 'General case' 0 N--CA 1.482 1.149 0 N-CA-C 114.448 1.277 . . . . 0.0 114.448 -177.873 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . 0.566 ' HA ' HG11 ' A' ' 19' ' ' VAL . 33.2 mmtp -55.98 -42.16 75.92 Favored 'General case' 0 N--CA 1.479 0.993 0 CA-C-N 113.253 -1.794 . . . . 0.0 114.507 178.963 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 59.3 tttm -80.35 -54.97 5.23 Favored 'General case' 0 N--CA 1.473 0.715 0 O-C-N 124.843 1.34 . . . . 0.0 112.327 172.559 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 72.9 tt0 -58.68 -46.02 88.16 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-O 117.766 -1.111 . . . . 0.0 112.489 -168.694 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.684 HG22 HG23 ' A' ' 67' ' ' VAL . 3.7 mm -79.36 -20.02 12.59 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.895 0 C-N-CA 119.911 -0.716 . . . . 0.0 112.081 -173.814 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 22.9 tttp -72.55 -24.91 61.19 Favored 'General case' 0 CA--C 1.547 0.851 0 O-C-N 124.713 1.258 . . . . 0.0 114.147 172.638 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 45.3 mmtm -97.25 -38.8 9.54 Favored 'General case' 0 N--CA 1.477 0.886 0 CA-C-N 113.549 -1.66 . . . . 0.0 111.58 178.455 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . 0.438 ' HD3' HG21 ' A' ' 67' ' ' VAL . 31.6 tttp -71.54 -52.65 17.1 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 126.282 1.833 . . . . 0.0 114.514 -177.938 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 102.17 114.62 3.88 Favored Glycine 0 N--CA 1.483 1.79 0 O-C-N 124.361 1.038 . . . . 0.0 111.022 -173.289 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.643 ' HD2' ' H ' ' A' ' 64' ' ' LYS . 9.0 mptt -41.44 -44.37 2.86 Favored 'General case' 0 N--CA 1.486 1.354 0 N-CA-C 117.548 2.425 . . . . 0.0 117.548 -176.043 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . 0.373 0.0 OUTLIER -53.08 -51.76 60.78 Favored 'General case' 0 C--N 1.315 -0.912 0 C-N-CA 127.801 2.44 . . . . 0.0 114.124 177.216 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -65.71 -27.62 68.47 Favored 'General case' 0 N--CA 1.475 0.788 0 N-CA-C 114.111 1.152 . . . . 0.0 114.111 173.436 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.684 HG23 HG22 ' A' ' 59' ' ' ILE . 21.7 t -71.08 -36.16 61.88 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.966 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.502 179.876 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.402 HG12 HD13 ' A' ' 16' ' ' LEU . 14.2 mm -49.01 -44.61 15.99 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.847 0 C-N-CA 124.243 1.017 . . . . 0.0 110.939 167.696 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -70.77 -51.76 25.01 Favored 'General case' 0 N--CA 1.477 0.877 0 CA-C-N 115.004 -0.998 . . . . 0.0 112.331 179.088 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' TRP . . . . . 0.435 ' O ' ' HB2' ' A' ' 4' ' ' GLU . 36.2 t90 . . . . . 0 CA--C 1.553 1.073 0 C-N-CA 125.303 1.441 . . . . 0.0 113.352 -177.277 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.456 ' HE3' HG22 ' A' ' 15' ' ' VAL . 34.3 mtp . . . . . 0 CA--C 1.533 0.294 0 CA-C-O 119.718 -0.182 . . . . 0.0 110.738 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . 0.413 ' HA ' ' O ' ' A' ' 7' ' ' ILE . . . -60.29 -50.39 73.84 Favored 'General case' 0 N--CA 1.478 0.966 0 CA-C-N 114.374 -1.285 . . . . 0.0 112.863 178.844 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . 0.44 ' HA ' ' HD2' ' A' ' 3' ' ' LYS . 10.5 tptm -71.73 -58.92 3.05 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 113.543 -1.662 . . . . 0.0 114.55 -175.716 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -67.95 -43.58 78.77 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 116.263 1.949 . . . . 0.0 116.263 -170.209 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . 0.495 ' HB2' HD13 ' A' ' 7' ' ' ILE . 33.7 m-85 -102.0 -26.09 13.52 Favored 'General case' 0 N--CA 1.481 1.113 0 N-CA-C 116.665 2.098 . . . . 0.0 116.665 -170.408 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 92.47 58.64 1.34 Allowed Glycine 0 N--CA 1.477 1.384 0 O-C-N 124.931 1.394 . . . . 0.0 110.537 -174.975 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . 0.495 HD13 ' HB2' ' A' ' 5' ' ' PHE . 0.7 OUTLIER -120.47 140.48 30.38 Favored Pre-proline 0 N--CA 1.476 0.831 0 CA-C-N 114.365 -0.918 . . . . 0.0 110.309 -179.12 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 68.3 Cg_endo -89.47 152.71 5.36 Favored 'Trans proline' 0 CA--C 1.534 0.495 0 C-N-CA 121.27 1.313 . . . . 0.0 109.069 166.828 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -44.65 -34.37 2.17 Favored 'General case' 0 N--CA 1.47 0.532 0 N-CA-C 116.108 1.892 . . . . 0.0 116.108 177.03 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -36.2 -43.29 0.35 Allowed 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 125.984 1.714 . . . . 0.0 115.108 168.687 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.925 HG13 HG21 ' A' ' 31' ' ' ILE . 10.4 m -103.66 -37.28 4.49 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.1 0 N-CA-C 115.192 1.553 . . . . 0.0 115.192 -177.442 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . 0.483 ' O ' ' HG ' ' A' ' 16' ' ' LEU . . . -64.76 -36.28 83.8 Favored 'General case' 0 N--CA 1.482 1.15 0 N-CA-C 113.145 0.795 . . . . 0.0 113.145 177.758 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -64.12 -40.87 98.49 Favored Glycine 0 N--CA 1.479 1.567 0 C-N-CA 125.777 1.656 . . . . 0.0 112.35 176.13 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 2.1 m -63.98 -41.86 97.39 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 124.54 1.136 . . . . 0.0 112.404 174.308 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.652 HG11 HD11 ' A' ' 55' ' ' LEU . 32.1 t -53.75 -40.91 45.34 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.934 0 CA-C-O 121.174 0.512 . . . . 0.0 112.2 170.188 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.593 HD13 HG12 ' A' ' 68' ' ' ILE . 45.7 mt -64.99 -49.88 68.53 Favored 'General case' 0 N--CA 1.477 0.898 0 CA-C-N 115.699 -0.682 . . . . 0.0 112.725 178.825 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 1.7 t30 -42.8 -45.2 4.75 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-O 123.167 1.461 . . . . 0.0 113.839 172.657 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.739 HG11 ' O ' ' A' ' 23' ' ' GLY . 5.3 t -63.27 -50.99 76.72 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.746 0 CA-C-N 109.976 -3.284 . . . . 0.0 112.29 178.793 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.726 HG11 ' HA ' ' A' ' 56' ' ' LYS . 36.0 t -59.91 -46.39 93.98 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.889 0 O-C-N 124.77 1.294 . . . . 0.0 110.691 179.419 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -63.58 -39.82 95.37 Favored 'General case' 0 N--CA 1.466 0.369 0 N-CA-C 114.342 1.238 . . . . 0.0 114.342 -177.51 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -96.39 2.53 52.74 Favored 'General case' 0 N--CA 1.478 0.963 0 N-CA-C 115.616 1.71 . . . . 0.0 115.616 -177.593 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 56.97 47.08 89.95 Favored Glycine 0 CA--C 1.541 1.702 0 C-N-CA 123.644 0.64 . . . . 0.0 111.572 -174.39 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.739 ' O ' HG11 ' A' ' 18' ' ' VAL . . . -102.97 154.49 18.22 Favored Glycine 0 N--CA 1.476 1.313 0 CA-C-O 123.944 1.858 . . . . 0.0 112.594 -174.576 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 4.5 m-90 -73.43 101.11 3.4 Favored 'General case' 0 N--CA 1.473 0.689 0 CA-C-N 112.961 -1.619 . . . . 0.0 112.807 -175.69 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.706 ' HB ' HG12 ' A' ' 18' ' ' VAL . 7.6 p -62.37 -20.46 24.66 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 N-CA-C 114.171 1.174 . . . . 0.0 114.171 173.3 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 6.4 t -61.02 -28.62 69.18 Favored 'General case' 0 N--CA 1.481 1.09 0 N-CA-C 112.952 0.723 . . . . 0.0 112.952 178.942 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -74.91 -43.61 53.3 Favored 'General case' 0 N--CA 1.474 0.73 0 CA-C-O 119.625 -0.226 . . . . 0.0 111.118 174.669 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 3.2 mp -64.12 -30.93 51.4 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.053 0 C-N-CA 127.67 2.388 . . . . 0.0 112.853 178.15 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.577 HG11 HD12 ' A' ' 43' ' ' LEU . 31.2 t -44.96 -37.47 1.63 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.14 0 C-N-CA 124.616 1.166 . . . . 0.0 112.702 172.542 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 91.5 p -60.4 -35.39 75.65 Favored 'General case' 0 N--CA 1.476 0.873 0 N-CA-C 113.217 0.821 . . . . 0.0 113.217 176.415 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.925 HG21 HG13 ' A' ' 11' ' ' VAL . 33.8 mm -77.87 -34.08 19.28 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.775 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.304 -179.781 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.599 HD23 ' HB ' ' A' ' 11' ' ' VAL . 4.1 mm? -60.92 -50.03 75.08 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 124.127 0.971 . . . . 0.0 112.159 172.105 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -69.84 -26.14 64.08 Favored 'General case' 0 N--CA 1.482 1.132 0 N-CA-C 114.925 1.454 . . . . 0.0 114.925 -179.87 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -51.56 -38.38 54.09 Favored 'General case' 0 CA--C 1.545 0.758 0 O-C-N 124.139 0.899 . . . . 0.0 112.508 169.736 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 22.8 t . . . . . 0 N--CA 1.481 1.081 0 C-N-CA 125.346 1.458 . . . . 0.0 111.607 174.852 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . 0.471 ' HA3' ' HB3' ' A' ' 32' ' ' LEU . . . . . . . . 0 CA--C 1.535 1.302 0 N-CA-C 110.788 -0.925 . . . . 0.0 110.788 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 66.4 mt -60.32 -52.41 65.38 Favored 'General case' 0 N--CA 1.47 0.565 0 N-CA-C 116.388 1.996 . . . . 0.0 116.388 -179.675 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 23.4 p -62.78 -35.15 78.91 Favored 'General case' 0 N--CA 1.479 0.997 0 CA-C-O 118.092 -0.956 . . . . 0.0 113.16 177.939 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 13.4 tp -61.05 -50.62 72.59 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 123.007 0.523 . . . . 0.0 111.12 170.56 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.577 HD12 HG11 ' A' ' 29' ' ' VAL . 59.1 mt -61.92 -34.45 76.08 Favored 'General case' 0 N--CA 1.479 0.985 0 O-C-N 124.222 0.951 . . . . 0.0 113.439 -179.532 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -63.24 -46.03 88.8 Favored 'General case' 0 N--CA 1.473 0.692 0 N-CA-C 112.995 0.739 . . . . 0.0 112.995 172.895 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -65.07 -35.72 82.06 Favored 'General case' 0 N--CA 1.487 1.388 0 CA-C-N 115.268 -0.878 . . . . 0.0 112.483 175.437 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -60.81 -28.31 68.69 Favored 'General case' 0 N--CA 1.475 0.779 0 N-CA-C 115.122 1.527 . . . . 0.0 115.122 179.837 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -44.85 -35.53 4.45 Favored Glycine 0 N--CA 1.48 1.601 0 C-N-CA 126.679 2.085 . . . . 0.0 114.193 -175.789 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . 0.492 ' HE ' ' HE1' ' A' ' 54' ' ' TYR . 63.3 ttp85 -51.61 -54.99 21.85 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-N 112.875 -1.663 . . . . 0.0 112.732 -176.692 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 25.4 tt0 -127.71 36.73 4.31 Favored 'General case' 0 N--CA 1.473 0.71 0 N-CA-C 114.154 1.168 . . . . 0.0 114.154 -173.14 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 75.8 p 50.4 121.69 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 125.221 1.408 . . . . 0.0 111.974 -171.387 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.473 ' O ' ' HB3' ' A' ' 54' ' ' TYR 0.276 6.3 tp -31.35 -53.86 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.483 1.223 0 N-CA-C 117.16 2.282 . . . . 0.0 117.16 -173.438 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . 0.621 ' HG3' HG11 ' A' ' 25' ' ' VAL . 0.1 OUTLIER -59.11 -66.97 0.42 Allowed 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 115.561 1.689 . . . . 0.0 115.561 175.402 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -54.99 -34.17 63.15 Favored 'General case' 0 N--CA 1.475 0.788 0 O-C-N 124.776 1.298 . . . . 0.0 113.252 177.601 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . 0.492 ' HE1' ' HE ' ' A' ' 48' ' ' ARG . 87.5 t80 -54.36 -63.34 1.18 Allowed 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 126.141 1.776 . . . . 0.0 110.541 174.981 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.652 HD11 HG11 ' A' ' 15' ' ' VAL . 96.4 mt -66.98 -42.2 85.48 Favored 'General case' 0 N--CA 1.476 0.843 0 N-CA-C 115.379 1.622 . . . . 0.0 115.379 -177.453 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . 0.726 ' HA ' HG11 ' A' ' 19' ' ' VAL . 96.4 mttt -56.52 -43.21 79.58 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 113.109 -1.859 . . . . 0.0 114.092 178.522 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . 0.408 ' O ' ' HG3' ' A' ' 61' ' ' LYS . 15.6 tttt -82.64 -50.07 9.15 Favored 'General case' 0 C--N 1.318 -0.776 0 O-C-N 124.158 0.911 . . . . 0.0 112.997 174.306 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . 0.461 ' O ' ' HB2' ' A' ' 62' ' ' LYS . 31.1 tt0 -57.72 -47.49 82.26 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 118.2 -0.905 . . . . 0.0 112.397 -175.95 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.627 HG22 HG22 ' A' ' 67' ' ' VAL . 1.8 mm -75.84 -23.32 16.29 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.26 0 N-CA-C 112.266 0.469 . . . . 0.0 112.266 -175.49 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . 0.457 ' HA ' ' HZ2' ' A' ' 64' ' ' LYS . 32.2 tptt -64.01 -38.55 91.5 Favored 'General case' 0 CA--C 1.544 0.717 0 O-C-N 124.695 1.247 . . . . 0.0 112.284 170.354 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . 0.408 ' HG3' ' O ' ' A' ' 57' ' ' LYS . 26.5 mtpt -77.3 -45.44 26.25 Favored 'General case' 0 N--CA 1.481 1.108 0 CA-C-N 112.925 -1.943 . . . . 0.0 113.05 177.139 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . 0.461 ' HB2' ' O ' ' A' ' 58' ' ' GLU . 10.4 tttm -70.25 -47.32 61.84 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 126.699 1.999 . . . . 0.0 113.352 -172.468 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 96.05 99.58 1.85 Allowed Glycine 0 N--CA 1.467 0.708 0 CA-C-N 114.46 -1.245 . . . . 0.0 110.658 179.067 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.698 ' HD2' ' H ' ' A' ' 64' ' ' LYS . 10.8 mptt -22.42 -47.6 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.838 0 N-CA-C 119.673 3.212 . . . . 0.0 119.673 -175.673 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . 0.412 ' O ' ' HB ' ' A' ' 68' ' ' ILE . 0.1 OUTLIER -56.02 -49.5 73.5 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 124.687 1.195 . . . . 0.0 113.08 177.386 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -62.23 -26.12 68.2 Favored 'General case' 0 N--CA 1.471 0.61 0 N-CA-C 114.536 1.31 . . . . 0.0 114.536 174.514 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.627 HG22 HG22 ' A' ' 59' ' ' ILE . 99.1 t -72.97 -34.68 46.74 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.638 0 C-N-CA 123.094 0.558 . . . . 0.0 111.094 177.001 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.593 HG12 HD13 ' A' ' 16' ' ' LEU . 5.2 mm -51.06 -45.85 30.34 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.117 0 O-C-N 123.904 0.752 . . . . 0.0 110.468 169.689 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -64.83 -52.58 55.92 Favored 'General case' 0 CA--C 1.549 0.937 0 CA-C-N 114.368 -1.287 . . . . 0.0 113.033 175.906 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 35.3 t90 . . . . . 0 N--CA 1.484 1.228 0 C-N-CA 125.582 1.553 . . . . 0.0 115.007 -178.983 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.495 ' HE3' HD13 ' A' ' 32' ' ' LEU . 33.3 mtp . . . . . 0 N--CA 1.48 1.06 0 N-CA-C 111.988 0.366 . . . . 0.0 111.988 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . 0.442 ' HA ' ' O ' ' A' ' 7' ' ' ILE . . . -55.19 -50.75 68.57 Favored 'General case' 0 CA--C 1.543 0.68 0 O-C-N 124.475 1.109 . . . . 0.0 112.511 178.343 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 54.7 tttp -73.25 -59.95 2.47 Favored 'General case' 0 CA--C 1.543 0.7 0 CA-C-N 112.695 -2.048 . . . . 0.0 114.097 -176.717 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 14.0 tt0 -67.93 -42.54 80.85 Favored 'General case' 0 N--CA 1.481 1.075 0 N-CA-C 115.009 1.485 . . . . 0.0 115.009 -168.831 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . 0.409 ' HB2' HD11 ' A' ' 7' ' ' ILE . 70.4 m-85 -100.32 -18.71 16.67 Favored 'General case' 0 N--CA 1.468 0.467 0 N-CA-C 116.824 2.157 . . . . 0.0 116.824 -173.913 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 83.28 57.82 2.42 Favored Glycine 0 CA--C 1.544 1.892 0 O-C-N 124.688 1.242 . . . . 0.0 111.519 -173.652 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.442 ' O ' ' HA ' ' A' ' 2' ' ' ALA . 0.4 OUTLIER -115.67 150.17 44.31 Favored Pre-proline 0 N--CA 1.481 1.106 0 CA-C-N 113.384 -1.408 . . . . 0.0 110.638 177.888 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_endo -88.37 151.99 6.6 Favored 'Trans proline' 0 CA--C 1.53 0.312 0 N-CA-C 109.513 -0.995 . . . . 0.0 109.513 159.587 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -51.19 -26.97 7.73 Favored 'General case' 0 N--CA 1.476 0.86 0 N-CA-C 115.217 1.562 . . . . 0.0 115.217 176.156 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -41.94 -56.16 2.86 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 126.298 1.839 . . . . 0.0 112.312 169.948 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.793 HG11 HG21 ' A' ' 31' ' ' ILE . 21.3 m -88.91 -29.45 5.23 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.004 0 N-CA-C 114.371 1.249 . . . . 0.0 114.371 -173.7 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -64.92 -32.16 73.75 Favored 'General case' 0 N--CA 1.477 0.877 0 N-CA-C 112.964 0.727 . . . . 0.0 112.964 173.564 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -65.96 -40.37 95.29 Favored Glycine 0 CA--C 1.542 1.736 0 O-C-N 124.161 0.913 . . . . 0.0 112.809 173.581 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 0.594 HG21 HG13 ' A' ' 28' ' ' ILE . 1.0 OUTLIER -60.75 -40.6 93.07 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 123.969 0.908 . . . . 0.0 112.554 173.378 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.827 HG12 HD12 ' A' ' 55' ' ' LEU . 18.3 t -54.73 -43.34 66.05 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.086 0 C-N-CA 124.22 1.008 . . . . 0.0 112.86 168.776 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 81.5 mt -60.28 -38.72 84.46 Favored 'General case' 0 N--CA 1.481 1.096 0 N-CA-C 114.03 1.122 . . . . 0.0 114.03 177.115 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 24.7 t-20 -51.94 -48.64 64.17 Favored 'General case' 0 N--CA 1.481 1.077 0 O-C-N 124.512 1.132 . . . . 0.0 111.869 173.089 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -49.39 -49.39 18.08 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.182 0 CA-C-N 114.428 -1.26 . . . . 0.0 112.559 174.638 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.719 HG11 ' HA ' ' A' ' 56' ' ' LYS . 3.4 t -66.2 -51.27 61.16 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.975 0 O-C-N 125.071 1.482 . . . . 0.0 110.446 -177.069 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 25.3 mt-10 -60.45 -38.86 85.54 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 125.231 1.412 . . . . 0.0 114.215 -175.792 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -103.7 -16.21 15.53 Favored 'General case' 0 N--CA 1.472 0.645 0 N-CA-C 116.948 2.203 . . . . 0.0 116.948 -174.159 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 69.16 46.72 56.94 Favored Glycine 0 CA--C 1.545 1.926 0 N-CA-C 111.991 -0.443 . . . . 0.0 111.991 -169.885 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -102.71 167.82 17.82 Favored Glycine 0 CA--C 1.542 1.74 0 CA-C-N 114.036 -1.082 . . . . 0.0 114.384 -167.425 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' TRP . . . . . 0.503 ' HB3' HG21 ' A' ' 26' ' ' THR . 75.8 m95 -62.71 106.51 0.8 Allowed 'General case' 0 N--CA 1.476 0.84 0 CA-C-N 113.054 -1.573 . . . . 0.0 112.2 -178.849 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.486 HG22 HG21 ' A' ' 51' ' ' ILE . 2.6 p -57.46 -23.68 20.15 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.835 0 CA-C-N 113.624 -1.626 . . . . 0.0 113.723 168.698 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.503 HG21 ' HB3' ' A' ' 24' ' ' TRP . 1.7 t -55.4 -43.84 75.59 Favored 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 113.329 0.863 . . . . 0.0 113.329 -179.96 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' THR . . . . . 0.439 ' O ' HG12 ' A' ' 31' ' ' ILE . 0.0 OUTLIER -65.46 -45.06 85.24 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 123.883 0.873 . . . . 0.0 112.242 174.868 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.594 HG13 HG21 ' A' ' 14' ' ' THR . 1.6 mp -59.78 -44.89 94.92 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.89 0 CA-C-N 114.598 -1.183 . . . . 0.0 111.796 177.398 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.477 HG11 HD13 ' A' ' 43' ' ' LEU . 53.2 t -53.77 -43.79 57.18 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.999 0 C-N-CA 124.126 0.97 . . . . 0.0 112.434 178.544 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 1.1 m -59.62 -43.08 93.93 Favored 'General case' 0 N--CA 1.485 1.317 0 N-CA-C 112.693 0.627 . . . . 0.0 112.693 176.078 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.793 HG21 HG11 ' A' ' 11' ' ' VAL . 35.5 mm -68.71 -38.8 79.4 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.138 0 CA-C-N 115.319 -0.855 . . . . 0.0 109.572 -176.544 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.676 HD23 ' HB ' ' A' ' 11' ' ' VAL . 3.7 mm? -63.89 -51.78 62.95 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 125.906 1.683 . . . . 0.0 112.624 176.35 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 27.7 p -70.19 -28.94 65.7 Favored 'General case' 0 N--CA 1.472 0.67 0 N-CA-C 114.28 1.215 . . . . 0.0 114.28 -179.733 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -52.57 -27.58 17.39 Favored 'General case' 0 N--CA 1.482 1.133 0 N-CA-C 113.951 1.093 . . . . 0.0 113.951 170.881 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 46.6 t -68.36 -38.73 79.84 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.15 0 C-N-CA 125.433 1.493 . . . . 0.0 111.785 170.592 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 118.68 -123.53 5.72 Favored Glycine 0 N--CA 1.478 1.454 0 C-N-CA 124.77 1.176 . . . . 0.0 110.421 -175.472 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 13.3 p -59.26 -38.64 80.59 Favored 'General case' 0 N--CA 1.478 0.964 0 CA-C-N 112.739 -1.731 . . . . 0.0 115.181 -174.381 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -50.07 -43.13 40.82 Favored Glycine 0 N--CA 1.484 1.886 0 O-C-N 124.525 1.141 . . . . 0.0 114.209 177.308 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.467 ' O ' ' HG ' ' A' ' 43' ' ' LEU . . . -62.73 -49.78 69.97 Favored Glycine 0 CA--C 1.538 1.495 0 C-N-CA 123.393 0.52 . . . . 0.0 112.271 176.842 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 12.2 mt -62.84 -44.16 96.89 Favored 'General case' 0 N--CA 1.478 0.93 0 CA-C-N 113.641 -1.28 . . . . 0.0 114.035 -178.065 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 28.6 p -61.53 -39.82 92.42 Favored 'General case' 0 N--CA 1.481 1.076 0 N-CA-C 113.234 0.827 . . . . 0.0 113.234 175.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 12.4 tp -62.21 -47.76 83.02 Favored 'General case' 0 N--CA 1.484 1.245 0 C-N-CA 122.863 0.465 . . . . 0.0 110.531 171.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.477 HD13 HG11 ' A' ' 29' ' ' VAL . 63.7 mt -60.5 -32.62 71.62 Favored 'General case' 0 N--CA 1.481 1.113 0 N-CA-C 114.86 1.43 . . . . 0.0 114.86 -179.606 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -66.53 -31.23 71.81 Favored 'General case' 0 N--CA 1.482 1.156 0 N-CA-C 113.732 1.012 . . . . 0.0 113.732 174.51 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -53.5 -48.52 68.88 Favored 'General case' 0 N--CA 1.477 0.875 0 N-CA-C 115.155 1.539 . . . . 0.0 115.155 -170.648 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -144.48 50.16 1.3 Allowed 'General case' 0 N--CA 1.482 1.129 0 CA-C-O 122.482 1.134 . . . . 0.0 113.503 174.271 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -51.37 -50.39 41.24 Favored Glycine 0 N--CA 1.487 2.076 0 CA-C-N 113.473 -1.694 . . . . 0.0 113.349 -176.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 79.4 ttt180 -58.83 -48.95 79.52 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 126.125 1.77 . . . . 0.0 113.974 -179.855 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 5.6 tm-20 -80.03 18.92 0.76 Allowed 'General case' 0 N--CA 1.476 0.838 0 N-CA-C 114.001 1.111 . . . . 0.0 114.001 -179.06 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 52.2 p 53.14 124.95 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 127.213 2.205 . . . . 0.0 111.911 -168.786 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.486 HG21 HG22 ' A' ' 25' ' ' VAL . 29.5 mm -52.44 -31.18 15.07 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.055 0 CA-C-N 115.081 -0.963 . . . . 0.0 112.816 170.419 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 71.1 tttt -57.14 -64.96 0.71 Allowed 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 124.36 1.064 . . . . 0.0 111.436 177.347 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -62.73 -35.17 78.89 Favored 'General case' 0 N--CA 1.472 0.659 0 N-CA-C 113.4 0.889 . . . . 0.0 113.4 178.694 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 15.7 t80 -51.17 -67.68 0.23 Allowed 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 124.984 1.314 . . . . 0.0 111.758 173.651 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.827 HD12 HG12 ' A' ' 15' ' ' VAL . 39.6 mt -61.97 -38.18 87.58 Favored 'General case' 0 N--CA 1.479 1.003 0 N-CA-C 113.084 0.772 . . . . 0.0 113.084 -177.115 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.719 ' HA ' HG11 ' A' ' 19' ' ' VAL . 96.2 mttt -54.88 -52.3 63.27 Favored 'General case' 0 C--O 1.219 -0.502 0 CA-C-N 114.353 -1.294 . . . . 0.0 113.609 177.433 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 2.3 ttpm? -74.99 -45.22 43.52 Favored 'General case' 0 N--CA 1.476 0.828 0 CA-C-N 114.945 -1.025 . . . . 0.0 112.392 176.026 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . 0.432 ' O ' ' HB2' ' A' ' 62' ' ' LYS . 44.4 tt0 -58.67 -49.93 75.72 Favored 'General case' 0 N--CA 1.471 0.596 0 O-C-N 123.384 0.428 . . . . 0.0 111.199 -174.918 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.721 HG22 HG23 ' A' ' 67' ' ' VAL . 3.2 mm -76.33 -27.4 17.55 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.162 0 CA-C-O 118.934 -0.555 . . . . 0.0 112.258 -177.924 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.473 ' HB2' ' O ' ' A' ' 56' ' ' LYS . 19.9 ttmm -59.5 -27.83 66.5 Favored 'General case' 0 N--CA 1.469 0.508 0 N-CA-C 114.422 1.267 . . . . 0.0 114.422 172.005 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 75.0 mttt -93.92 -41.87 9.37 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-N 113.283 -1.781 . . . . 0.0 113.432 176.76 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.432 ' HB2' ' O ' ' A' ' 58' ' ' GLU . 30.6 tttt -67.05 -60.94 2.2 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 126.511 1.924 . . . . 0.0 113.828 -175.301 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 104.09 110.21 3.46 Favored Glycine 0 CA--C 1.54 1.631 0 CA-C-N 114.795 -1.093 . . . . 0.0 112.448 -169.572 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.521 ' HZ1' HG21 ' A' ' 59' ' ' ILE . 0.0 OUTLIER -36.79 -43.36 0.43 Allowed 'General case' 0 N--CA 1.477 0.918 0 N-CA-C 119.577 3.177 . . . . 0.0 119.577 -175.668 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . 0.406 ' O ' ' HB ' ' A' ' 68' ' ' ILE . 1.8 ttp180 -56.56 -47.12 80.16 Favored 'General case' 0 N--CA 1.477 0.883 0 N-CA-C 114.146 1.165 . . . . 0.0 114.146 179.356 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -64.58 -26.13 68.27 Favored 'General case' 0 N--CA 1.475 0.798 0 CA-C-N 114.509 -1.223 . . . . 0.0 113.62 175.157 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.721 HG23 HG22 ' A' ' 59' ' ' ILE . 30.4 t -72.12 -36.9 58.15 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.042 0 C-N-CA 123.671 0.788 . . . . 0.0 110.707 179.95 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.406 ' HB ' ' O ' ' A' ' 65' ' ' ARG . 19.9 mm -51.76 -46.79 39.65 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.171 0 C-N-CA 124.12 0.968 . . . . 0.0 110.748 167.934 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -69.99 -49.46 51.3 Favored 'General case' 0 N--CA 1.477 0.913 0 N-CA-C 113.802 1.038 . . . . 0.0 113.802 177.019 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' TRP . . . . . 0.425 ' CE3' ' HG3' ' A' ' 1' ' ' MET . 32.2 t90 . . . . . 0 N--CA 1.48 1.031 0 C-N-CA 126.412 1.885 . . . . 0.0 112.98 -178.049 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.637 ' HE2' HG22 ' A' ' 15' ' ' VAL . 56.8 mtp . . . . . 0 CA--C 1.542 0.651 0 N-CA-C 112.238 0.459 . . . . 0.0 112.238 . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . 0.404 ' HA ' ' O ' ' A' ' 7' ' ' ILE . . . -57.46 -52.37 65.66 Favored 'General case' 0 N--CA 1.488 1.471 0 CA-C-N 114.806 -1.088 . . . . 0.0 112.96 176.772 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.424 ' HZ1' ' HG3' ' A' ' 3' ' ' LYS . 10.7 tptp -66.04 -58.35 5.68 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 127.491 2.316 . . . . 0.0 112.461 -177.425 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . 0.447 ' HB2' ' O ' ' A' ' 70' ' ' TRP . 0.7 OUTLIER -74.41 -47.54 33.22 Favored 'General case' 0 N--CA 1.477 0.883 0 N-CA-C 115.972 1.841 . . . . 0.0 115.972 -171.796 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . 0.636 ' HB2' HD13 ' A' ' 7' ' ' ILE . 47.8 m-85 -100.14 -11.2 20.67 Favored 'General case' 0 N--CA 1.473 0.683 0 N-CA-C 115.747 1.758 . . . . 0.0 115.747 -169.021 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 75.79 61.01 3.0 Favored Glycine 0 N--CA 1.478 1.443 0 O-C-N 124.614 1.197 . . . . 0.0 111.245 -173.413 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.636 HD13 ' HB2' ' A' ' 5' ' ' PHE . 1.0 OUTLIER -117.76 145.53 36.73 Favored Pre-proline 0 N--CA 1.478 0.951 0 C-N-CA 125.287 1.435 . . . . 0.0 111.941 179.696 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_endo -89.78 154.17 5.06 Favored 'Trans proline' 0 CA--C 1.535 0.548 0 N-CA-C 109.176 -1.125 . . . . 0.0 109.176 158.383 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -48.77 -29.78 4.92 Favored 'General case' 0 CA--C 1.544 0.73 0 N-CA-C 115.23 1.567 . . . . 0.0 115.23 176.774 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -39.67 -44.91 1.59 Allowed 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 126.388 1.875 . . . . 0.0 114.503 172.069 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.849 HG11 HG21 ' A' ' 31' ' ' ILE . 22.6 m -101.05 -29.51 3.17 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.93 0 N-CA-C 114.959 1.466 . . . . 0.0 114.959 -176.219 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . 0.418 ' O ' ' HG ' ' A' ' 16' ' ' LEU . . . -68.48 -31.21 70.32 Favored 'General case' 0 CA--C 1.546 0.817 0 N-CA-C 112.547 0.573 . . . . 0.0 112.547 175.631 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -61.06 -42.87 99.94 Favored Glycine 0 CA--C 1.543 1.84 0 CA-C-O 122.186 0.881 . . . . 0.0 112.393 170.485 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 0.752 HG21 HG13 ' A' ' 28' ' ' ILE . 1.4 m -62.62 -36.89 84.22 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 124.928 1.291 . . . . 0.0 113.562 176.02 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.637 HG22 ' HE2' ' A' ' 1' ' ' MET . 2.4 t -58.05 -41.05 79.53 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 C-N-CA 124.03 0.932 . . . . 0.0 112.443 170.691 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.453 HD21 ' HG3' ' A' ' 64' ' ' LYS . 53.2 mt -60.04 -37.31 79.43 Favored 'General case' 0 N--CA 1.476 0.837 0 N-CA-C 112.73 0.641 . . . . 0.0 112.73 177.497 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 27.5 t-20 -56.96 -44.57 82.72 Favored 'General case' 0 N--CA 1.474 0.756 0 CA-C-N 115.765 -0.652 . . . . 0.0 112.527 175.864 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 3.7 t -48.49 -48.79 14.15 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.155 0 C-N-CA 123.086 0.555 . . . . 0.0 111.699 172.131 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.774 HG11 ' HA ' ' A' ' 56' ' ' LYS . 5.8 t -67.5 -50.46 61.5 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.389 0 CA-C-N 113.997 -1.456 . . . . 0.0 110.789 -176.351 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 29.2 mt-10 -65.81 -42.02 91.15 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 126.478 1.911 . . . . 0.0 115.606 -177.728 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -99.62 -22.91 15.23 Favored 'General case' 0 N--CA 1.477 0.919 0 N-CA-C 116.219 1.933 . . . . 0.0 116.219 -173.0 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . 0.839 ' HA3' ' HZ2' ' A' ' 56' ' ' LYS . . . 77.39 34.02 41.89 Favored Glycine 0 N--CA 1.481 1.68 0 N-CA-C 112.02 -0.432 . . . . 0.0 112.02 -171.248 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -99.85 172.53 24.8 Favored Glycine 0 N--CA 1.47 0.949 0 CA-C-N 113.263 -1.468 . . . . 0.0 114.102 -165.458 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 89.4 m95 -57.67 100.6 0.06 Allowed 'General case' 0 N--CA 1.476 0.866 0 CA-C-N 111.764 -2.218 . . . . 0.0 114.148 -176.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.57 HG22 HG13 ' A' ' 51' ' ' ILE . 4.3 p -56.72 -25.53 21.79 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 CA-C-N 112.553 -2.112 . . . . 0.0 113.779 169.244 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 11.5 p -61.34 -46.36 90.58 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 124.176 0.99 . . . . 0.0 112.277 -178.547 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' THR . . . . . 0.427 ' O ' HG12 ' A' ' 31' ' ' ILE . 0.2 OUTLIER -60.8 -44.88 96.27 Favored 'General case' 0 N--CA 1.478 0.945 0 CA-C-N 114.01 -1.45 . . . . 0.0 110.994 175.039 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.752 HG13 HG21 ' A' ' 14' ' ' THR . 1.7 mp -62.63 -47.67 91.84 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.084 0 C-N-CA 124.073 0.949 . . . . 0.0 111.749 179.023 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.48 HG11 HD13 ' A' ' 43' ' ' LEU . 39.8 t -52.41 -43.5 41.34 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.067 0 C-N-CA 124.379 1.072 . . . . 0.0 111.325 179.064 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 90.4 p -65.79 -32.09 73.43 Favored 'General case' 0 N--CA 1.478 0.965 0 N-CA-C 115.391 1.626 . . . . 0.0 115.391 176.324 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.849 HG21 HG11 ' A' ' 11' ' ' VAL . 40.5 mm -70.9 -40.47 76.5 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.33 0 C-N-CA 123.7 0.8 . . . . 0.0 109.583 177.235 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.667 ' HB3' ' HA3' ' A' ' 39' ' ' GLY . 3.8 mm? -61.59 -52.07 65.94 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 125.365 1.466 . . . . 0.0 112.745 174.606 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 7.5 p -65.76 -27.1 68.05 Favored 'General case' 0 N--CA 1.484 1.243 0 N-CA-C 114.159 1.17 . . . . 0.0 114.159 179.317 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -53.0 -29.36 28.79 Favored 'General case' 0 N--CA 1.483 1.225 0 N-CA-C 113.892 1.071 . . . . 0.0 113.892 166.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 54.5 t -75.34 -27.16 19.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 C-N-CA 124.238 1.015 . . . . 0.0 112.411 172.192 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 97.88 -100.4 2.37 Favored Glycine 0 N--CA 1.481 1.658 0 C-N-CA 124.727 1.156 . . . . 0.0 111.015 -176.797 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 2.7 p -55.41 -47.34 76.07 Favored 'General case' 0 N--CA 1.483 1.21 0 CA-C-N 113.628 -1.286 . . . . 0.0 113.569 -177.014 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.406 ' HA2' HG13 ' A' ' 7' ' ' ILE . . . -54.28 -40.97 69.7 Favored Glycine 0 CA--C 1.539 1.592 0 C-N-CA 124.875 1.226 . . . . 0.0 115.106 -178.58 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.667 ' HA3' ' HB3' ' A' ' 32' ' ' LEU . . . -60.18 -58.56 13.44 Favored Glycine 0 N--CA 1.475 1.25 0 O-C-N 124.604 0.826 . . . . 0.0 111.413 173.595 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 44.7 mt -58.86 -48.46 81.28 Favored 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 115.26 1.578 . . . . 0.0 115.26 -176.222 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' SER . . . . . 0.434 ' HB2' ' HD1' ' A' ' 5' ' ' PHE . 29.6 p -60.69 -39.49 88.66 Favored 'General case' 0 N--CA 1.475 0.791 0 N-CA-C 114.488 1.292 . . . . 0.0 114.488 175.669 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.427 HD11 ' HE1' ' A' ' 1' ' ' MET . 13.8 tp -63.79 -48.46 76.79 Favored 'General case' 0 N--CA 1.483 1.2 0 C-N-CA 122.505 0.322 . . . . 0.0 110.888 173.839 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.48 HD13 HG11 ' A' ' 29' ' ' VAL . 80.5 mt -61.98 -27.57 68.94 Favored 'General case' 0 N--CA 1.482 1.131 0 N-CA-C 114.843 1.423 . . . . 0.0 114.843 -176.344 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -70.81 -45.4 64.7 Favored 'General case' 0 CA--C 1.549 0.905 0 N-CA-C 112.839 0.681 . . . . 0.0 112.839 173.933 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -65.12 -40.47 94.53 Favored 'General case' 0 N--CA 1.477 0.917 0 CA-C-O 122.715 1.245 . . . . 0.0 111.999 179.902 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.525 ' HB3' ' HA ' ' A' ' 51' ' ' ILE . . . -59.18 -26.76 65.07 Favored 'General case' 0 CA--C 1.537 0.447 0 N-CA-C 116.438 2.014 . . . . 0.0 116.438 179.131 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -47.78 -40.62 18.81 Favored Glycine 0 N--CA 1.482 1.73 0 C-N-CA 125.598 1.57 . . . . 0.0 113.641 -177.942 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 35.4 ttp-105 -53.62 -47.78 69.91 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 125.184 1.394 . . . . 0.0 113.931 -173.937 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 11.8 tt0 -126.0 37.32 4.36 Favored 'General case' 0 N--CA 1.478 0.968 0 N-CA-C 114.285 1.217 . . . . 0.0 114.285 -177.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 72.0 p 50.77 127.49 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.502 0 C-N-CA 125.603 1.561 . . . . 0.0 112.792 -172.057 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.57 HG13 HG22 ' A' ' 25' ' ' VAL . 6.3 tp -39.04 -51.65 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 N-CA-C 117.728 2.492 . . . . 0.0 117.728 -172.791 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 56.3 tttt -65.95 -57.17 8.44 Favored 'General case' 0 N--CA 1.469 0.516 0 N-CA-C 113.618 0.97 . . . . 0.0 113.618 179.877 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -60.59 -38.17 83.75 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 124.591 1.156 . . . . 0.0 112.763 178.497 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . 0.4 ' HB3' ' O ' ' A' ' 51' ' ' ILE . 90.4 t80 -47.66 -63.51 1.04 Allowed 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 125.961 1.704 . . . . 0.0 109.861 170.233 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 79.1 mt -64.24 -41.98 96.74 Favored 'General case' 0 N--CA 1.473 0.721 0 N-CA-C 113.894 1.072 . . . . 0.0 113.894 -176.575 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.839 ' HZ2' ' HA3' ' A' ' 22' ' ' GLY . 29.2 mtpp -55.97 -44.73 78.79 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 114.653 -1.158 . . . . 0.0 113.447 177.466 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.42 ' O ' ' HG2' ' A' ' 61' ' ' LYS . 66.7 tttt -77.3 -50.13 13.51 Favored 'General case' 0 N--CA 1.475 0.787 0 CA-C-N 115.292 -0.867 . . . . 0.0 112.051 172.947 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . 0.5 ' O ' ' HB2' ' A' ' 62' ' ' LYS . 4.2 tp10 -54.51 -51.38 65.29 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 123.979 0.912 . . . . 0.0 111.831 -173.51 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.707 HG22 HG22 ' A' ' 67' ' ' VAL . 1.3 mm -75.87 -26.32 17.69 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.05 0 CA-C-N 115.623 -0.717 . . . . 0.0 111.846 -175.255 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 6.7 mtpp -60.07 -39.05 84.72 Favored 'General case' 0 CA--C 1.538 0.487 0 N-CA-C 115.336 1.606 . . . . 0.0 115.336 170.285 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . 0.42 ' HG2' ' O ' ' A' ' 57' ' ' LYS . 70.4 mmtt -79.32 -46.24 18.09 Favored 'General case' 0 N--CA 1.476 0.834 0 O-C-N 126.188 2.18 . . . . 0.0 110.93 176.977 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.5 ' HB2' ' O ' ' A' ' 58' ' ' GLU . 5.7 tptp -66.53 -52.22 48.17 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 126.728 2.011 . . . . 0.0 114.822 -175.561 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 96.6 117.87 3.47 Favored Glycine 0 N--CA 1.483 1.828 0 CA-C-N 114.593 -1.185 . . . . 0.0 110.332 -173.94 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.706 ' HD2' ' H ' ' A' ' 64' ' ' LYS . 9.8 mptt -36.18 -46.78 0.53 Allowed 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 117.782 2.512 . . . . 0.0 117.782 -177.422 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.22 -51.63 69.14 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 125.538 1.535 . . . . 0.0 114.958 176.89 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -64.83 -27.3 68.78 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-N 114.423 -1.262 . . . . 0.0 112.907 174.771 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.707 HG22 HG22 ' A' ' 59' ' ' ILE . 98.7 t -67.13 -41.78 87.43 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.251 0 C-N-CA 123.191 0.597 . . . . 0.0 110.942 175.19 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 35.1 mm -51.15 -42.66 25.87 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.856 0 O-C-N 124.18 0.925 . . . . 0.0 110.764 172.061 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . 0.414 ' O ' ' HB2' ' A' ' 3' ' ' LYS . . . -71.38 -52.62 17.62 Favored 'General case' 0 N--CA 1.473 0.725 0 O-C-N 124.683 1.239 . . . . 0.0 112.585 176.117 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' TRP . . . . . 0.447 ' O ' ' HB2' ' A' ' 4' ' ' GLU . 30.9 t90 . . . . . 0 N--CA 1.485 1.277 0 C-N-CA 127.034 2.134 . . . . 0.0 112.646 -178.449 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.47 ' HE2' HD11 ' A' ' 42' ' ' LEU . 72.3 mtp . . . . . 0 N--CA 1.472 0.63 0 N-CA-C 112.184 0.439 . . . . 0.0 112.184 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -56.79 -49.6 74.83 Favored 'General case' 0 CA--C 1.547 0.828 0 CA-C-N 115.541 -0.754 . . . . 0.0 112.602 177.499 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 50.2 tttm -76.32 -51.65 11.54 Favored 'General case' 0 N--CA 1.475 0.799 0 CA-C-N 113.407 -1.724 . . . . 0.0 113.303 -173.195 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . 0.429 ' HB2' ' O ' ' A' ' 70' ' ' TRP . 1.8 mp0 -79.03 -33.33 44.91 Favored 'General case' 0 N--CA 1.47 0.536 0 N-CA-C 115.94 1.83 . . . . 0.0 115.94 -173.411 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . 0.408 ' HB2' HD11 ' A' ' 7' ' ' ILE . 26.7 m-85 -113.41 -14.13 12.79 Favored 'General case' 0 N--CA 1.474 0.774 0 N-CA-C 117.621 2.452 . . . . 0.0 117.621 -171.556 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 82.33 58.84 2.36 Favored Glycine 0 CA--C 1.538 1.506 0 C-N-CA 124.133 0.873 . . . . 0.0 111.159 -179.155 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.546 HG23 ' HB3' ' A' ' 12' ' ' ALA . 0.8 OUTLIER -120.39 146.71 43.51 Favored Pre-proline 0 N--CA 1.479 1.009 0 CA-C-N 112.747 -1.726 . . . . 0.0 113.307 -176.102 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -91.51 161.12 3.59 Favored 'Trans proline' 0 CA--C 1.537 0.662 0 C-N-CA 121.123 1.215 . . . . 0.0 110.745 160.535 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -52.75 -32.08 41.44 Favored 'General case' 0 CA--C 1.544 0.716 0 N-CA-C 114.07 1.137 . . . . 0.0 114.07 174.312 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -40.84 -39.46 1.13 Allowed 'General case' 0 N--CA 1.485 1.323 0 C-N-CA 126.784 2.033 . . . . 0.0 114.976 172.879 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.943 HG11 HG21 ' A' ' 31' ' ' ILE . 17.3 m -110.95 -31.63 2.25 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.354 0 N-CA-C 114.939 1.459 . . . . 0.0 114.939 -177.162 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . 0.546 ' HB3' HG23 ' A' ' 7' ' ' ILE . . . -65.94 -36.91 84.65 Favored 'General case' 0 N--CA 1.476 0.864 0 N-CA-C 112.61 0.596 . . . . 0.0 112.61 174.016 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . 0.515 ' O ' ' HB2' ' A' ' 16' ' ' LEU . . . -58.18 -41.95 95.02 Favored Glycine 0 CA--C 1.54 1.603 0 C-N-CA 124.033 0.825 . . . . 0.0 112.563 171.813 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 0.739 HG21 HG13 ' A' ' 28' ' ' ILE . 0.2 OUTLIER -62.14 -34.05 75.65 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 125.546 1.538 . . . . 0.0 114.045 176.719 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.436 HG21 HD22 ' A' ' 32' ' ' LEU . 5.2 t -58.15 -46.93 88.34 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.29 0 C-N-CA 123.846 0.858 . . . . 0.0 112.798 171.045 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.515 ' HB2' ' O ' ' A' ' 13' ' ' GLY . 9.5 mp -52.5 -38.61 59.94 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 124.912 1.285 . . . . 0.0 113.384 173.026 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 15.3 t-20 -57.4 -49.13 77.18 Favored 'General case' 0 N--CA 1.485 1.279 0 O-C-N 123.873 0.733 . . . . 0.0 110.815 177.768 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 2.4 t -50.19 -50.89 19.21 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.767 0 O-C-N 124.366 1.041 . . . . 0.0 112.77 173.31 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.523 HG11 ' HA ' ' A' ' 56' ' ' LYS . 9.0 t -65.34 -48.97 81.22 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.235 0 CA-C-N 114.647 -1.16 . . . . 0.0 112.411 -175.075 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -71.39 -46.72 59.59 Favored 'General case' 0 CA--C 1.548 0.872 0 N-CA-C 114.692 1.367 . . . . 0.0 114.692 -177.425 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -96.04 -9.18 31.59 Favored 'General case' 0 N--CA 1.475 0.807 0 N-CA-C 115.733 1.753 . . . . 0.0 115.733 -170.352 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 65.19 33.13 86.1 Favored Glycine 0 CA--C 1.542 1.773 0 C-N-CA 124.327 0.965 . . . . 0.0 112.494 -171.523 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -78.31 167.66 53.39 Favored Glycine 0 N--CA 1.476 1.357 0 C-N-CA 125.372 1.463 . . . . 0.0 115.698 -175.044 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' TRP . . . . . 0.423 ' HB3' HG21 ' A' ' 26' ' ' THR . 2.5 m-90 -68.2 106.39 2.42 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-N 113.454 -1.373 . . . . 0.0 111.999 -178.666 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 2.8 p -57.58 -24.84 23.14 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.781 0 CA-C-N 114.122 -1.399 . . . . 0.0 114.07 173.65 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.423 HG21 ' HB3' ' A' ' 24' ' ' TRP . 10.0 t -60.0 -44.54 94.48 Favored 'General case' 0 N--CA 1.483 1.214 0 C-N-CA 124.053 0.941 . . . . 0.0 113.239 -179.823 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' THR . . . . . 0.453 ' O ' HG12 ' A' ' 31' ' ' ILE . 0.0 OUTLIER -65.28 -42.76 92.81 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 124.254 1.021 . . . . 0.0 111.787 175.657 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.739 HG13 HG21 ' A' ' 14' ' ' THR . 1.8 mp -62.3 -46.1 97.22 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 C-N-CA 124.427 1.091 . . . . 0.0 111.037 178.235 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.478 HG11 HD13 ' A' ' 43' ' ' LEU . 39.6 t -56.11 -45.27 80.62 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.837 0 C-N-CA 124.344 1.058 . . . . 0.0 111.978 174.009 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 36.9 m -58.34 -37.03 74.32 Favored 'General case' 0 N--CA 1.486 1.344 0 N-CA-C 113.855 1.057 . . . . 0.0 113.855 175.256 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.943 HG21 HG11 ' A' ' 11' ' ' VAL . 43.5 mm -75.9 -39.34 37.56 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.41 0 C-N-CA 123.926 0.891 . . . . 0.0 110.434 179.737 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.665 HD23 ' HB ' ' A' ' 11' ' ' VAL . 3.7 mm? -60.57 -50.94 71.51 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 125.564 1.546 . . . . 0.0 112.251 174.003 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 18.0 p -67.25 -30.55 70.47 Favored 'General case' 0 N--CA 1.484 1.229 0 N-CA-C 114.609 1.337 . . . . 0.0 114.609 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -49.1 -40.6 32.66 Favored 'General case' 0 N--CA 1.485 1.291 0 N-CA-C 113.52 0.933 . . . . 0.0 113.52 170.37 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 57.7 t -63.74 -20.32 26.18 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.382 0 C-N-CA 125.139 1.376 . . . . 0.0 112.934 173.008 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 91.38 -102.12 2.88 Favored Glycine 0 N--CA 1.473 1.141 0 C-N-CA 125.091 1.329 . . . . 0.0 110.416 -179.463 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 11.9 p -56.62 -45.3 81.58 Favored 'General case' 0 N--CA 1.479 0.992 0 CA-C-N 112.306 -1.947 . . . . 0.0 113.904 -175.774 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -51.02 -48.17 46.69 Favored Glycine 0 N--CA 1.477 1.401 0 C-N-CA 124.898 1.237 . . . . 0.0 114.76 179.345 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.543 ' HA3' ' HB3' ' A' ' 32' ' ' LEU . . . -60.04 -52.99 49.48 Favored Glycine 0 CA--C 1.535 1.307 0 N-CA-C 111.57 -0.612 . . . . 0.0 111.57 176.269 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 30.3 mt -59.34 -45.71 90.62 Favored 'General case' 0 N--CA 1.48 1.03 0 N-CA-C 114.983 1.475 . . . . 0.0 114.983 -177.789 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 51.9 p -66.2 -37.58 85.93 Favored 'General case' 0 N--CA 1.48 1.033 0 N-CA-C 113.926 1.084 . . . . 0.0 113.926 176.132 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.47 HD11 ' HE2' ' A' ' 1' ' ' MET . 12.7 tp -65.98 -44.16 85.71 Favored 'General case' 0 N--CA 1.482 1.149 0 CA-C-O 120.963 0.411 . . . . 0.0 110.217 173.033 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.478 HD13 HG11 ' A' ' 29' ' ' VAL . 82.6 mt -64.9 -22.74 67.05 Favored 'General case' 0 N--CA 1.476 0.874 0 N-CA-C 115.031 1.493 . . . . 0.0 115.031 178.997 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -72.98 -47.85 41.69 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-N 115.706 -0.679 . . . . 0.0 112.16 170.15 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -60.22 -35.56 75.71 Favored 'General case' 0 N--CA 1.487 1.391 0 C-N-CA 124.221 1.009 . . . . 0.0 111.739 177.08 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -52.74 -26.87 15.43 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 127.209 2.204 . . . . 0.0 115.821 174.855 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -46.46 -43.22 14.62 Favored Glycine 0 N--CA 1.483 1.769 0 C-N-CA 125.676 1.608 . . . . 0.0 114.249 -175.5 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 66.6 ttp85 -47.48 -55.8 8.33 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 126.01 1.724 . . . . 0.0 113.486 -176.597 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 10.5 tt0 -136.38 38.54 2.69 Favored 'General case' 0 N--CA 1.483 1.198 0 N-CA-C 113.656 0.984 . . . . 0.0 113.656 -174.216 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 23.2 t 45.86 125.77 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 125.313 1.445 . . . . 0.0 114.096 -173.849 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 10.5 tp -31.3 -49.74 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.481 1.083 0 N-CA-C 118.355 2.724 . . . . 0.0 118.355 -174.32 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 52.2 tptt -55.77 -70.05 0.12 Allowed 'General case' 0 N--CA 1.483 1.215 0 C-N-CA 124.575 1.15 . . . . 0.0 111.848 176.525 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -61.3 -38.44 86.83 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 124.377 1.071 . . . . 0.0 113.525 179.709 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 85.9 t80 -46.8 -60.43 2.42 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 124.84 1.256 . . . . 0.0 111.587 173.359 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 67.4 mt -67.05 -43.81 81.76 Favored 'General case' 0 N--CA 1.478 0.952 0 N-CA-C 113.992 1.108 . . . . 0.0 113.992 -177.085 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.523 ' HA ' HG11 ' A' ' 19' ' ' VAL . 6.5 mmmt -52.24 -43.37 64.29 Favored 'General case' 0 N--CA 1.478 0.947 0 CA-C-N 113.995 -1.457 . . . . 0.0 114.438 177.911 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 33.4 tttm -80.53 -55.25 4.99 Favored 'General case' 0 N--CA 1.476 0.847 0 CA-C-N 114.583 -1.189 . . . . 0.0 111.67 172.235 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . 0.555 ' O ' ' HB2' ' A' ' 62' ' ' LYS . 34.3 tt0 -54.06 -51.43 64.09 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-O 117.038 -1.458 . . . . 0.0 110.895 -170.478 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.791 HG22 HG22 ' A' ' 67' ' ' VAL . 3.4 mm -78.92 -23.51 12.86 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.349 0 CA-C-O 118.719 -0.658 . . . . 0.0 112.335 -174.707 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 1.2 tppm? -61.52 -37.64 84.47 Favored 'General case' 0 N--CA 1.466 0.368 0 N-CA-C 113.997 1.11 . . . . 0.0 113.997 172.436 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 45.1 mttt -90.93 -37.86 13.25 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-N 112.465 -2.152 . . . . 0.0 113.419 -178.453 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.555 ' HB2' ' O ' ' A' ' 58' ' ' GLU . 24.1 tttm -67.51 -45.44 75.78 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 126.562 1.945 . . . . 0.0 113.574 -176.994 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 98.32 102.97 2.29 Favored Glycine 0 CA--C 1.534 1.229 0 CA-C-O 122.11 0.839 . . . . 0.0 111.409 -177.155 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.47 ' HD2' ' H ' ' A' ' 64' ' ' LYS . 2.2 mptp? -31.58 -47.6 0.12 Allowed 'General case' 0 N--CA 1.477 0.909 0 N-CA-C 119.136 3.013 . . . . 0.0 119.136 -178.076 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 4.8 ttp-105 -62.27 -47.81 82.68 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 124.76 1.224 . . . . 0.0 113.628 179.56 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -60.98 -26.95 67.94 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-N 114.642 -1.163 . . . . 0.0 113.952 172.489 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.791 HG22 HG22 ' A' ' 59' ' ' ILE . 63.9 t -68.6 -40.38 81.76 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.291 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.635 176.442 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 45.5 mm -53.52 -45.83 59.09 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.08 0 C-N-CA 123.485 0.714 . . . . 0.0 109.895 172.145 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -64.8 -52.58 56.05 Favored 'General case' 0 N--CA 1.482 1.134 0 N-CA-C 112.79 0.663 . . . . 0.0 112.79 176.111 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' TRP . . . . . 0.429 ' O ' ' HB2' ' A' ' 4' ' ' GLU . 33.9 t90 . . . . . 0 N--CA 1.479 1.018 0 C-N-CA 126.051 1.74 . . . . 0.0 112.336 178.36 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.535 ' HE2' HG22 ' A' ' 15' ' ' VAL . 46.1 mtp . . . . . 0 N--CA 1.471 0.577 0 N-CA-C 112.457 0.54 . . . . 0.0 112.457 . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . 0.474 ' HA ' ' O ' ' A' ' 7' ' ' ILE . . . -52.22 -51.83 55.92 Favored 'General case' 0 N--CA 1.47 0.538 0 O-C-N 124.568 1.167 . . . . 0.0 112.73 176.708 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 14.7 tttt -79.93 -51.75 8.72 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 112.717 -2.038 . . . . 0.0 114.578 -173.555 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 10.6 mt-10 -73.04 -35.15 66.69 Favored 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 115.382 1.623 . . . . 0.0 115.382 -173.772 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . 0.403 ' HD1' ' HB2' ' A' ' 41' ' ' SER . 50.6 m-85 -109.04 -13.85 14.64 Favored 'General case' 0 N--CA 1.478 0.933 0 N-CA-C 117.356 2.354 . . . . 0.0 117.356 -173.997 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 82.75 60.49 2.07 Favored Glycine 0 CA--C 1.542 1.765 0 O-C-N 124.342 1.027 . . . . 0.0 110.65 -177.83 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.474 ' O ' ' HA ' ' A' ' 2' ' ' ALA . 0.8 OUTLIER -125.23 143.38 44.2 Favored Pre-proline 0 N--CA 1.481 1.12 0 CA-C-N 113.63 -1.285 . . . . 0.0 112.457 -175.924 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_endo -87.92 159.54 7.4 Favored 'Trans proline' 0 CA--C 1.538 0.675 0 C-N-CA 120.94 1.094 . . . . 0.0 109.376 163.797 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -50.58 -33.2 21.1 Favored 'General case' 0 N--CA 1.476 0.874 0 N-CA-C 114.253 1.205 . . . . 0.0 114.253 174.895 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -37.03 -41.85 0.38 Allowed 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 127.45 2.3 . . . . 0.0 115.917 169.725 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.898 HG11 HG21 ' A' ' 31' ' ' ILE . 19.0 m -111.37 -28.53 2.57 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 N-CA-C 115.395 1.628 . . . . 0.0 115.395 -176.749 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . 0.463 ' O ' ' HG ' ' A' ' 16' ' ' LEU . . . -66.28 -33.61 76.14 Favored 'General case' 0 N--CA 1.477 0.891 0 N-CA-C 112.71 0.633 . . . . 0.0 112.71 171.433 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -59.62 -37.41 92.22 Favored Glycine 0 CA--C 1.539 1.59 0 C-N-CA 124.448 1.023 . . . . 0.0 112.674 171.349 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 0.611 HG21 HG13 ' A' ' 28' ' ' ILE . 0.2 OUTLIER -71.98 -37.15 69.93 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 125.188 1.395 . . . . 0.0 112.598 177.908 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.646 HG21 HD22 ' A' ' 32' ' ' LEU . 20.9 t -55.93 -41.65 68.23 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.237 0 C-N-CA 123.423 0.689 . . . . 0.0 111.88 166.366 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.463 ' HG ' ' O ' ' A' ' 12' ' ' ALA . 77.6 mt -61.25 -37.1 81.91 Favored 'General case' 0 N--CA 1.486 1.347 0 N-CA-C 114.518 1.303 . . . . 0.0 114.518 177.929 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 12.0 t-20 -52.35 -49.2 64.8 Favored 'General case' 0 CA--C 1.545 0.767 0 CA-C-N 114.395 -1.275 . . . . 0.0 112.065 173.424 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.435 ' HB ' ' O ' ' A' ' 15' ' ' VAL . 5.0 t -52.08 -50.57 34.8 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 CA-C-N 113.295 -1.775 . . . . 0.0 111.502 175.848 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.576 HG11 ' HA ' ' A' ' 56' ' ' LYS . 13.0 t -66.86 -48.62 79.21 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.255 0 O-C-N 123.991 0.807 . . . . 0.0 111.043 -176.124 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -63.73 -44.01 94.81 Favored 'General case' 0 CA--C 1.542 0.656 0 N-CA-C 114.446 1.276 . . . . 0.0 114.446 -176.638 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -103.06 -19.94 14.37 Favored 'General case' 0 N--CA 1.479 1.005 0 N-CA-C 115.559 1.689 . . . . 0.0 115.559 -171.194 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 71.17 39.69 62.33 Favored Glycine 0 N--CA 1.481 1.66 0 N-CA-C 109.905 -1.278 . . . . 0.0 109.905 -166.767 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -83.82 162.8 39.58 Favored Glycine 0 CA--C 1.527 0.806 0 N-CA-C 109.168 -1.573 . . . . 0.0 109.168 -178.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' TRP . . . . . 0.439 ' O ' HD11 ' A' ' 28' ' ' ILE . 31.5 m95 -64.76 104.6 0.85 Allowed 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 112.365 -1.918 . . . . 0.0 112.48 -175.132 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.56 HG22 HG13 ' A' ' 51' ' ' ILE . 3.1 p -57.35 -24.91 22.51 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.927 0 CA-C-N 113.147 -1.842 . . . . 0.0 113.39 171.395 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 3.1 p -61.34 -47.21 86.95 Favored 'General case' 0 N--CA 1.484 1.246 0 N-CA-C 113.786 1.032 . . . . 0.0 113.786 -179.516 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -62.4 -40.83 97.79 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 123.24 0.616 . . . . 0.0 111.357 173.862 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.611 HG13 HG21 ' A' ' 14' ' ' THR . 1.8 mp -60.02 -48.69 86.88 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 C-N-CA 124.878 1.271 . . . . 0.0 112.253 177.504 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.52 HG21 ' O ' ' A' ' 25' ' ' VAL . 53.5 t -49.59 -45.68 20.34 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 C-N-CA 124.406 1.082 . . . . 0.0 112.264 178.356 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -62.27 -41.72 98.71 Favored 'General case' 0 N--CA 1.485 1.314 0 N-CA-C 112.917 0.71 . . . . 0.0 112.917 178.38 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.898 HG21 HG11 ' A' ' 11' ' ' VAL . 36.7 mm -70.9 -38.86 74.19 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.145 0 C-N-CA 123.436 0.695 . . . . 0.0 109.805 -179.057 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.765 HD23 ' HB ' ' A' ' 11' ' ' VAL . 3.2 mm? -58.05 -53.44 58.18 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 125.475 1.51 . . . . 0.0 112.039 173.78 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 11.0 m -71.86 -21.19 61.7 Favored 'General case' 0 N--CA 1.477 0.916 0 N-CA-C 113.496 0.924 . . . . 0.0 113.496 179.473 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -58.89 -28.83 66.53 Favored 'General case' 0 N--CA 1.484 1.26 0 C-N-CA 123.967 0.907 . . . . 0.0 113.402 172.425 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 74.8 t -59.16 -38.28 73.35 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.256 0 C-N-CA 124.045 0.938 . . . . 0.0 111.495 170.916 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 89.86 109.28 1.3 Allowed Glycine 0 CA--C 1.537 1.412 0 N-CA-C 110.313 -1.115 . . . . 0.0 110.313 -175.482 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 50.4 m 76.05 -38.55 0.34 Allowed 'General case' 0 N--CA 1.494 1.738 0 C-N-CA 127.649 2.379 . . . . 0.0 113.959 -176.557 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -51.76 -53.16 30.79 Favored Glycine 0 N--CA 1.485 1.953 0 C-N-CA 124.732 1.158 . . . . 0.0 113.262 -175.586 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.436 ' O ' ' HG ' ' A' ' 43' ' ' LEU . . . -58.19 -41.33 94.72 Favored Glycine 0 N--CA 1.478 1.493 0 CA-C-N 114.316 -0.942 . . . . 0.0 114.901 176.087 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 43.9 mt -67.05 -44.93 78.89 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 124.242 1.017 . . . . 0.0 113.42 -177.143 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' SER . . . . . 0.403 ' HB2' ' HD1' ' A' ' 5' ' ' PHE . 0.0 OUTLIER -55.44 -39.79 70.74 Favored 'General case' 0 N--CA 1.481 1.082 0 O-C-N 124.079 0.862 . . . . 0.0 112.838 171.903 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 16.8 tp -64.09 -48.17 77.2 Favored 'General case' 0 N--CA 1.477 0.884 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.042 175.859 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.436 ' HG ' ' O ' ' A' ' 39' ' ' GLY . 44.1 mt -61.05 -30.94 70.62 Favored 'General case' 0 N--CA 1.479 0.999 0 N-CA-C 114.603 1.334 . . . . 0.0 114.603 179.078 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -66.62 -50.39 63.15 Favored 'General case' 0 N--CA 1.478 0.96 0 CA-C-N 115.882 -0.599 . . . . 0.0 112.211 171.402 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -61.16 -34.73 75.49 Favored 'General case' 0 N--CA 1.485 1.301 0 CA-C-O 121.743 0.782 . . . . 0.0 112.345 176.273 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -67.35 -22.57 65.58 Favored 'General case' 0 N--CA 1.478 0.934 0 N-CA-C 116.191 1.923 . . . . 0.0 116.191 179.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -49.42 -34.58 19.44 Favored Glycine 0 CA--C 1.549 2.208 0 C-N-CA 124.688 1.137 . . . . 0.0 112.741 177.123 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 18.5 ttm180 -52.32 -50.87 61.39 Favored 'General case' 0 CA--C 1.549 0.906 0 C-N-CA 126.455 1.902 . . . . 0.0 114.977 -175.427 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 16.0 tt0 -133.5 40.58 3.13 Favored 'General case' 0 N--CA 1.479 0.977 0 N-CA-C 113.283 0.846 . . . . 0.0 113.283 -175.529 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 89.0 p 44.86 115.14 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.499 0 C-N-CA 125.303 1.441 . . . . 0.0 113.727 -172.445 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.56 HG13 HG22 ' A' ' 25' ' ' VAL . 8.0 tp -23.88 -56.82 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.483 1.177 0 N-CA-C 119.131 3.012 . . . . 0.0 119.131 -175.484 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 54.2 tttt -64.11 -55.52 21.35 Favored 'General case' 0 N--CA 1.48 1.045 0 N-CA-C 112.835 0.68 . . . . 0.0 112.835 -179.86 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -62.9 -38.66 91.81 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 124.936 1.294 . . . . 0.0 112.158 177.759 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 69.1 t80 -51.75 -58.42 6.45 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 125.617 1.567 . . . . 0.0 111.18 174.791 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.602 HD12 HG12 ' A' ' 15' ' ' VAL . 60.6 mt -70.47 -41.12 73.19 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 114.811 1.411 . . . . 0.0 114.811 -179.346 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.576 ' HA ' HG11 ' A' ' 19' ' ' VAL . 50.4 tptt -55.26 -49.96 70.72 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-N 114.004 -1.453 . . . . 0.0 113.174 178.076 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 52.8 tttp -74.55 -54.62 7.14 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-N 114.759 -1.109 . . . . 0.0 112.1 174.656 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . 0.409 ' O ' ' HB2' ' A' ' 62' ' ' LYS . 16.1 mt-10 -61.36 -41.78 97.63 Favored 'General case' 0 N--CA 1.472 0.625 0 N-CA-C 113.972 1.101 . . . . 0.0 113.972 -169.156 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.826 HG22 HG23 ' A' ' 67' ' ' VAL . 2.8 mm -78.09 -26.56 14.51 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.851 0 C-N-CA 120.13 -0.628 . . . . 0.0 112.192 -179.346 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 10.3 tppt? -61.94 -27.6 68.94 Favored 'General case' 0 CA--C 1.542 0.643 0 N-CA-C 114.332 1.234 . . . . 0.0 114.332 170.247 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 42.3 mmtm -89.18 -43.15 11.23 Favored 'General case' 0 N--CA 1.483 1.215 0 CA-C-N 113.647 -1.615 . . . . 0.0 111.387 178.475 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.457 ' HD3' HG21 ' A' ' 67' ' ' VAL . 2.7 tttm -68.88 -51.02 44.66 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 125.965 1.706 . . . . 0.0 114.89 -176.274 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 100.46 112.79 3.49 Favored Glycine 0 CA--C 1.534 1.273 0 N-CA-C 110.547 -1.021 . . . . 0.0 110.547 -172.654 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.44 ' HB3' HD12 ' A' ' 16' ' ' LEU . 10.5 mptt -41.99 -43.84 3.29 Favored 'General case' 0 N--CA 1.479 1.015 0 N-CA-C 118.139 2.644 . . . . 0.0 118.139 -172.643 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . 0.435 ' O ' ' HB ' ' A' ' 68' ' ' ILE . 0.0 OUTLIER -61.3 -42.78 99.24 Favored 'General case' 0 N--CA 1.477 0.905 0 N-CA-C 114.995 1.48 . . . . 0.0 114.995 177.552 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -68.78 -22.33 64.29 Favored 'General case' 0 N--CA 1.479 1.022 0 CA-C-N 114.878 -1.055 . . . . 0.0 113.171 173.742 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.826 HG23 HG22 ' A' ' 59' ' ' ILE . 61.8 t -75.53 -32.71 25.5 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.919 0 C-N-CA 123.725 0.81 . . . . 0.0 111.34 176.72 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.435 ' HB ' ' O ' ' A' ' 65' ' ' ARG . 18.6 mm -51.78 -47.47 39.51 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.153 0 C-N-CA 123.639 0.776 . . . . 0.0 109.814 165.714 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -68.22 -48.83 64.11 Favored 'General case' 0 N--CA 1.472 0.641 0 O-C-N 124.225 0.953 . . . . 0.0 113.406 178.038 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' TRP . . . . . 0.4 ' HE3' HG11 ' A' ' 67' ' ' VAL . 34.1 t90 . . . . . 0 N--CA 1.476 0.859 0 C-N-CA 125.587 1.555 . . . . 0.0 112.407 178.482 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.449 ' HB3' HG23 ' A' ' 7' ' ' ILE . 53.9 mtp . . . . . 0 N--CA 1.478 0.946 0 N-CA-C 112.367 0.506 . . . . 0.0 112.367 . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -55.47 -50.82 68.87 Favored 'General case' 0 N--CA 1.472 0.643 0 O-C-N 124.67 1.231 . . . . 0.0 112.711 177.291 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 52.7 tttp -72.91 -58.81 3.06 Favored 'General case' 0 CA--C 1.543 0.686 0 CA-C-N 114.257 -1.338 . . . . 0.0 113.573 -178.78 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -66.16 -43.74 86.09 Favored 'General case' 0 N--CA 1.471 0.601 0 N-CA-C 116.474 2.027 . . . . 0.0 116.474 -168.901 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . 0.562 ' HB2' HD13 ' A' ' 7' ' ' ILE . 38.4 m-85 -101.41 -18.06 16.19 Favored 'General case' 0 N--CA 1.476 0.857 0 N-CA-C 115.953 1.835 . . . . 0.0 115.953 -170.509 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 81.41 63.06 1.89 Allowed Glycine 0 N--CA 1.484 1.855 0 O-C-N 124.532 1.145 . . . . 0.0 110.714 -169.464 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.562 HD13 ' HB2' ' A' ' 5' ' ' PHE . 0.4 OUTLIER -122.55 145.93 46.23 Favored Pre-proline 0 N--CA 1.471 0.613 0 C-N-CA 125.587 1.555 . . . . 0.0 108.998 179.775 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_endo -86.44 152.1 9.12 Favored 'Trans proline' 0 CA--C 1.537 0.645 0 N-CA-C 108.173 -1.51 . . . . 0.0 108.173 161.13 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -47.69 -33.94 7.54 Favored 'General case' 0 N--CA 1.47 0.55 0 N-CA-C 115.663 1.727 . . . . 0.0 115.663 175.486 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -37.69 -57.37 0.98 Allowed 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 126.964 2.106 . . . . 0.0 113.931 173.374 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.868 HG11 HG21 ' A' ' 31' ' ' ILE . 23.9 m -83.97 -33.16 9.01 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.214 0 N-CA-C 113.728 1.01 . . . . 0.0 113.728 -175.259 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -64.09 -32.39 73.93 Favored 'General case' 0 CA--C 1.545 0.787 0 N-CA-C 112.303 0.483 . . . . 0.0 112.303 173.38 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -59.36 -44.62 96.45 Favored Glycine 0 CA--C 1.538 1.473 0 CA-C-O 122.497 1.054 . . . . 0.0 113.071 171.277 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 0.651 HG21 HG13 ' A' ' 28' ' ' ILE . 0.3 OUTLIER -63.17 -35.7 81.17 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 125.276 1.43 . . . . 0.0 113.586 176.542 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.459 HG21 HD22 ' A' ' 32' ' ' LEU . 5.1 t -58.15 -41.53 80.97 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 C-N-CA 124.205 1.002 . . . . 0.0 111.992 170.747 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 24.6 mt -61.32 -38.93 88.64 Favored 'General case' 0 N--CA 1.472 0.638 0 N-CA-C 113.222 0.823 . . . . 0.0 113.222 178.681 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -52.81 -48.06 67.18 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 124.798 1.239 . . . . 0.0 112.526 173.038 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.413 HG22 ' HA ' ' A' ' 25' ' ' VAL . 1.1 t -54.4 -54.0 25.55 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.984 0 CA-C-N 115.057 -0.974 . . . . 0.0 111.501 174.735 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.782 HG11 ' HA ' ' A' ' 56' ' ' LYS . 6.8 t -59.87 -47.58 90.98 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.014 0 O-C-N 123.803 0.689 . . . . 0.0 110.458 -177.505 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . 0.594 ' HG3' ' HE2' ' A' ' 64' ' ' LYS . 17.4 mt-10 -60.34 -36.74 78.69 Favored 'General case' 0 CA--C 1.542 0.666 0 N-CA-C 115.992 1.849 . . . . 0.0 115.992 -178.49 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -106.8 -9.97 16.22 Favored 'General case' 0 N--CA 1.477 0.876 0 N-CA-C 116.303 1.964 . . . . 0.0 116.303 -175.409 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 64.42 42.01 97.8 Favored Glycine 0 CA--C 1.549 2.196 0 N-CA-C 110.298 -1.121 . . . . 0.0 110.298 -168.12 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -92.53 175.24 37.23 Favored Glycine 0 CA--C 1.534 1.275 0 C-N-CA 124.27 0.938 . . . . 0.0 113.872 -167.436 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' TRP . . . . . 0.598 ' HB3' HG21 ' A' ' 26' ' ' THR . 81.5 m95 -67.29 104.83 1.58 Allowed 'General case' 0 N--CA 1.468 0.464 0 CA-C-O 122.55 1.167 . . . . 0.0 113.3 179.763 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.546 HG22 HG13 ' A' ' 51' ' ' ILE . 2.2 p -60.74 -22.08 25.36 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.971 0 CA-C-N 113.665 -1.607 . . . . 0.0 113.693 170.795 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.598 HG21 ' HB3' ' A' ' 24' ' ' TRP . 4.4 t -56.57 -46.38 80.8 Favored 'General case' 0 N--CA 1.485 1.316 0 N-CA-C 113.811 1.041 . . . . 0.0 113.811 -179.982 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' THR . . . . . 0.405 ' O ' HG12 ' A' ' 31' ' ' ILE . 0.0 OUTLIER -64.09 -41.01 97.45 Favored 'General case' 0 N--CA 1.479 1.016 0 O-C-N 123.972 0.795 . . . . 0.0 112.006 176.91 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.651 HG13 HG21 ' A' ' 14' ' ' THR . 2.0 mp -68.59 -44.37 82.8 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 C-N-CA 125.255 1.422 . . . . 0.0 111.904 -179.114 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.686 HG12 HD13 ' A' ' 43' ' ' LEU . 38.2 t -51.95 -48.88 39.74 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.349 0 C-N-CA 124.386 1.074 . . . . 0.0 111.069 174.52 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 42.3 m -52.34 -41.78 63.31 Favored 'General case' 0 N--CA 1.483 1.198 0 N-CA-C 114.555 1.317 . . . . 0.0 114.555 176.59 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.868 HG21 HG11 ' A' ' 11' ' ' VAL . 36.9 mm -75.35 -40.81 42.99 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.981 0 C-N-CA 124.407 1.083 . . . . 0.0 109.719 -177.766 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.657 HD23 ' HB ' ' A' ' 11' ' ' VAL . 3.9 mm? -55.96 -53.14 60.43 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 124.493 1.117 . . . . 0.0 112.294 171.565 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 1.2 p -66.4 -29.62 69.82 Favored 'General case' 0 N--CA 1.481 1.103 0 N-CA-C 115.974 1.842 . . . . 0.0 115.974 178.865 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -57.29 -27.94 62.59 Favored 'General case' 0 N--CA 1.477 0.882 0 O-C-N 124.303 1.002 . . . . 0.0 113.188 171.862 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 83.7 t -68.73 -32.85 56.64 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.297 0 C-N-CA 124.019 0.928 . . . . 0.0 111.628 172.898 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 108.45 -116.02 4.6 Favored Glycine 0 N--CA 1.47 0.928 0 C-N-CA 124.462 1.029 . . . . 0.0 111.825 -178.162 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 23.5 p -49.16 -47.78 45.48 Favored 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 115.754 1.761 . . . . 0.0 115.754 -175.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -60.65 -41.14 98.8 Favored Glycine 0 N--CA 1.474 1.193 0 C-N-CA 125.562 1.553 . . . . 0.0 114.251 -177.513 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.446 ' HA3' ' HB3' ' A' ' 32' ' ' LEU . . . -54.86 -52.35 46.89 Favored Glycine 0 N--CA 1.477 1.38 0 N-CA-C 111.032 -0.827 . . . . 0.0 111.032 173.328 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 94.8 mt -65.02 -49.14 71.35 Favored 'General case' 0 N--CA 1.48 1.028 0 N-CA-C 114.291 1.219 . . . . 0.0 114.291 -179.22 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 27.8 p -59.2 -38.83 80.85 Favored 'General case' 0 N--CA 1.48 1.065 0 N-CA-C 114.167 1.173 . . . . 0.0 114.167 175.873 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 13.8 tp -62.32 -50.61 70.93 Favored 'General case' 0 N--CA 1.48 1.047 0 CA-C-O 120.853 0.358 . . . . 0.0 111.11 170.275 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.686 HD13 HG12 ' A' ' 29' ' ' VAL . 0.7 OUTLIER -61.43 -30.89 70.85 Favored 'General case' 0 N--CA 1.473 0.706 0 N-CA-C 114.835 1.421 . . . . 0.0 114.835 -179.284 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -70.36 -43.79 69.45 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 123.568 0.747 . . . . 0.0 112.562 173.239 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -64.77 -31.43 72.65 Favored 'General case' 0 N--CA 1.475 0.798 0 N-CA-C 112.977 0.732 . . . . 0.0 112.977 174.074 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -60.22 -21.24 61.56 Favored 'General case' 0 N--CA 1.476 0.842 0 N-CA-C 115.817 1.784 . . . . 0.0 115.817 177.124 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -49.63 -33.63 18.94 Favored Glycine 0 CA--C 1.542 1.781 0 C-N-CA 126.198 1.856 . . . . 0.0 114.423 179.631 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 66.3 ttp85 -49.61 -60.2 3.08 Favored 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 125.602 1.561 . . . . 0.0 112.339 179.84 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 12.5 tt0 -129.15 32.08 4.77 Favored 'General case' 0 N--CA 1.48 1.069 0 CA-C-N 114.61 -1.177 . . . . 0.0 113.586 -172.571 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 8.0 t 49.75 123.55 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.295 0 C-N-CA 124.642 1.177 . . . . 0.0 113.692 -173.458 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.546 HG13 HG22 ' A' ' 25' ' ' VAL . 8.7 tp -29.01 -49.8 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.482 1.136 0 N-CA-C 117.947 2.573 . . . . 0.0 117.947 -174.713 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 33.8 ttmt -57.97 -68.67 0.22 Allowed 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 123.849 0.86 . . . . 0.0 111.93 177.383 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -62.61 -33.96 76.05 Favored 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 124.743 1.217 . . . . 0.0 113.397 179.588 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 88.5 t80 -49.5 -63.48 1.09 Allowed 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 125.11 1.364 . . . . 0.0 111.786 175.15 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.424 HD12 HG11 ' A' ' 15' ' ' VAL . 59.9 mt -65.09 -39.87 93.78 Favored 'General case' 0 N--CA 1.475 0.802 0 N-CA-C 114.469 1.285 . . . . 0.0 114.469 -178.299 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.782 ' HA ' HG11 ' A' ' 19' ' ' VAL . 97.8 mttt -58.66 -41.15 85.44 Favored 'General case' 0 N--CA 1.475 0.803 0 N-CA-C 114.34 1.237 . . . . 0.0 114.34 179.44 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 22.1 tttt -80.64 -49.66 10.96 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-N 114.628 -1.169 . . . . 0.0 111.983 173.753 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . 0.425 ' O ' ' HB2' ' A' ' 62' ' ' LYS . 31.2 tt0 -58.62 -49.29 78.05 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-N 115.672 -0.694 . . . . 0.0 112.421 -173.454 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.63 HD11 HG22 ' A' ' 67' ' ' VAL . 2.7 mm -75.53 -25.35 17.64 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.937 0 C-N-CA 120.658 -0.417 . . . . 0.0 111.91 -177.261 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.548 ' HB2' ' O ' ' A' ' 56' ' ' LYS . 2.5 tttt -62.85 -32.95 74.28 Favored 'General case' 0 N--CA 1.472 0.641 0 N-CA-C 114.599 1.333 . . . . 0.0 114.599 169.485 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 3.0 mptp? -81.36 -43.31 19.22 Favored 'General case' 0 N--CA 1.482 1.137 0 CA-C-N 114.132 -1.395 . . . . 0.0 112.373 173.271 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.425 ' HB2' ' O ' ' A' ' 58' ' ' GLU . 17.4 tptt -71.59 -52.52 17.66 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 126.636 1.974 . . . . 0.0 114.038 -171.72 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 97.6 114.63 3.28 Favored Glycine 0 N--CA 1.475 1.246 0 CA-C-O 122.602 1.112 . . . . 0.0 110.895 -170.216 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.594 ' HE2' ' HG3' ' A' ' 20' ' ' GLU . 11.8 mptt -32.25 -52.11 0.27 Allowed 'General case' 0 N--CA 1.474 0.747 0 N-CA-C 119.251 3.056 . . . . 0.0 119.251 177.024 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . 1.025 HH21 HG13 ' A' ' 68' ' ' ILE . 0.0 OUTLIER -59.74 -45.31 92.59 Favored 'General case' 0 N--CA 1.476 0.827 0 N-CA-C 114.318 1.229 . . . . 0.0 114.318 -179.354 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -63.36 -29.85 71.08 Favored 'General case' 0 N--CA 1.474 0.751 0 CA-C-N 114.026 -1.443 . . . . 0.0 113.871 172.413 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.63 HG22 HD11 ' A' ' 59' ' ' ILE . 95.4 t -71.13 -33.12 50.06 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 N-CA-C 112.527 0.566 . . . . 0.0 112.527 178.175 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 1.025 HG13 HH21 ' A' ' 65' ' ' ARG . 27.0 mm -51.57 -47.49 37.05 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.333 0 O-C-N 123.902 0.751 . . . . 0.0 109.669 167.347 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -69.19 -51.48 37.59 Favored 'General case' 0 N--CA 1.483 1.21 0 CA-C-N 114.898 -1.046 . . . . 0.0 113.326 178.881 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 29.3 t90 . . . . . 0 N--CA 1.479 0.99 0 C-N-CA 124.657 1.183 . . . . 0.0 113.096 179.703 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.783 ' HE2' HD13 ' A' ' 32' ' ' LEU . 2.4 mmm . . . . . 0 CA--C 1.537 0.449 0 N-CA-C 111.442 0.164 . . . . 0.0 111.442 . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -62.14 -58.78 6.5 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-N 113.65 -1.614 . . . . 0.0 112.261 177.871 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 15.5 ttpp -65.49 -54.05 33.73 Favored 'General case' 0 N--CA 1.476 0.832 0 CA-C-N 113.486 -1.688 . . . . 0.0 113.391 -173.478 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 12.1 tt0 -71.88 -37.47 70.16 Favored 'General case' 0 N--CA 1.477 0.911 0 N-CA-C 114.319 1.229 . . . . 0.0 114.319 -171.165 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . 0.446 ' HD1' ' HB2' ' A' ' 41' ' ' SER . 71.9 m-85 -102.84 -10.66 18.89 Favored 'General case' 0 N--CA 1.475 0.783 0 N-CA-C 117.473 2.397 . . . . 0.0 117.473 -172.944 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 74.36 50.9 9.13 Favored Glycine 0 CA--C 1.539 1.581 0 CA-C-O 122.459 1.033 . . . . 0.0 111.461 -174.604 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -113.86 146.84 36.43 Favored Pre-proline 0 N--CA 1.476 0.873 0 CA-C-N 112.998 -1.601 . . . . 0.0 109.767 179.405 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 97.4 Cg_endo -88.58 152.64 6.34 Favored 'Trans proline' 0 C--O 1.236 0.378 0 N-CA-C 109.733 -0.91 . . . . 0.0 109.733 165.498 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -48.77 -29.31 4.39 Favored 'General case' 0 N--CA 1.474 0.75 0 N-CA-C 115.119 1.525 . . . . 0.0 115.119 171.342 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -38.97 -47.75 1.5 Allowed 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 126.392 1.877 . . . . 0.0 114.498 170.092 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.732 HG11 HG21 ' A' ' 31' ' ' ILE . 33.0 m -99.04 -39.06 7.51 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.0 0 N-CA-C 113.791 1.034 . . . . 0.0 113.791 -176.892 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -62.8 -38.02 89.02 Favored 'General case' 0 CA--C 1.547 0.865 0 N-CA-C 112.814 0.672 . . . . 0.0 112.814 176.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -58.5 -47.45 89.85 Favored Glycine 0 N--CA 1.486 1.995 0 O-C-N 124.535 1.147 . . . . 0.0 112.394 173.551 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 16.4 m -59.06 -39.57 82.48 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 124.625 1.17 . . . . 0.0 113.918 173.967 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.475 ' O ' HG22 ' A' ' 19' ' ' VAL . 40.6 t -57.04 -44.73 83.38 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.116 0 C-N-CA 123.682 0.793 . . . . 0.0 111.239 172.824 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.65 HD13 HG12 ' A' ' 68' ' ' ILE . 37.0 mt -60.97 -45.96 92.67 Favored 'General case' 0 N--CA 1.481 1.116 0 N-CA-C 112.831 0.678 . . . . 0.0 112.831 178.782 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 24.6 t-20 -50.14 -50.22 49.53 Favored 'General case' 0 N--CA 1.48 1.051 0 O-C-N 124.612 1.195 . . . . 0.0 111.067 174.475 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 56.5 t -57.65 -50.41 77.46 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 CA-C-N 113.056 -1.884 . . . . 0.0 111.841 178.624 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.59 HG12 ' HB ' ' A' ' 59' ' ' ILE . 24.3 t -59.31 -45.68 93.03 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.291 0 O-C-N 123.681 0.613 . . . . 0.0 110.943 -179.937 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . 0.559 ' HG3' ' HE2' ' A' ' 64' ' ' LYS . 14.3 mt-10 -57.69 -44.39 85.78 Favored 'General case' 0 N--CA 1.477 0.875 0 C-N-CA 125.153 1.381 . . . . 0.0 114.232 179.921 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -77.36 -17.46 58.22 Favored 'General case' 0 CA--C 1.541 0.609 0 N-CA-C 113.97 1.1 . . . . 0.0 113.97 178.35 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 71.61 51.45 16.06 Favored Glycine 0 N--CA 1.477 1.382 0 O-C-N 124.138 0.898 . . . . 0.0 111.86 -170.277 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -109.75 167.31 12.75 Favored Glycine 0 N--CA 1.48 1.597 0 CA-C-O 122.844 1.247 . . . . 0.0 112.634 -177.415 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' TRP . . . . . 0.693 ' HB3' HG21 ' A' ' 26' ' ' THR . 77.1 m95 -78.19 105.95 9.77 Favored 'General case' 0 N--CA 1.479 0.997 0 CA-C-N 113.252 -1.474 . . . . 0.0 111.818 -178.524 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.799 HG23 ' HB2' ' A' ' 55' ' ' LEU . 0.4 OUTLIER -62.58 -16.5 16.89 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.948 0 CA-C-N 113.897 -1.501 . . . . 0.0 112.825 171.021 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.693 HG21 ' HB3' ' A' ' 24' ' ' TRP . 15.3 t -67.74 -27.71 67.02 Favored 'General case' 0 N--CA 1.48 1.045 0 N-CA-C 114.513 1.301 . . . . 0.0 114.513 -178.993 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' THR . . . . . 0.596 ' HB ' HD11 ' A' ' 28' ' ' ILE . 0.7 OUTLIER -71.11 -48.86 49.85 Favored 'General case' 0 N--CA 1.48 1.054 0 CA-C-O 121.445 0.64 . . . . 0.0 110.813 170.111 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.596 HD11 ' HB ' ' A' ' 27' ' ' THR . 3.4 mp -65.84 -25.36 36.08 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 C-N-CA 125.956 1.702 . . . . 0.0 112.86 -179.474 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.522 HG23 HD23 ' A' ' 43' ' ' LEU . 7.9 t -36.48 -44.21 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.409 0 C-N-CA 124.101 0.96 . . . . 0.0 112.013 162.255 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 85.2 p -59.01 -39.05 80.7 Favored 'General case' 0 N--CA 1.486 1.359 0 N-CA-C 113.831 1.048 . . . . 0.0 113.831 178.688 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.732 HG21 HG11 ' A' ' 11' ' ' VAL . 39.6 mm -76.65 -35.66 25.85 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.814 0 C-N-CA 124.51 1.124 . . . . 0.0 110.178 -177.557 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.783 HD13 ' HE2' ' A' ' 1' ' ' MET . 3.8 mm? -59.71 -54.38 47.08 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 125.161 1.384 . . . . 0.0 112.973 170.884 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -68.83 -24.2 64.35 Favored 'General case' 0 N--CA 1.476 0.833 0 N-CA-C 114.765 1.394 . . . . 0.0 114.765 177.066 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -53.54 -28.17 30.0 Favored 'General case' 0 N--CA 1.482 1.131 0 N-CA-C 113.4 0.889 . . . . 0.0 113.4 167.092 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.42 ' HB ' ' O ' ' A' ' 32' ' ' LEU . 70.0 t -69.92 -32.46 51.72 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.111 0 C-N-CA 125.087 1.355 . . . . 0.0 112.354 169.807 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 109.16 -114.64 4.06 Favored Glycine 0 N--CA 1.477 1.39 0 C-N-CA 125.435 1.493 . . . . 0.0 111.201 179.747 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 12.4 p -56.54 -39.92 74.22 Favored 'General case' 0 N--CA 1.481 1.076 0 CA-C-N 112.628 -1.786 . . . . 0.0 115.265 -178.784 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -56.52 -50.84 60.26 Favored Glycine 0 CA--C 1.538 1.528 0 O-C-N 124.739 1.274 . . . . 0.0 113.155 -179.335 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.432 ' O ' ' HG ' ' A' ' 43' ' ' LEU . . . -54.63 -46.9 72.95 Favored Glycine 0 CA--C 1.539 1.588 0 N-CA-C 111.433 -0.667 . . . . 0.0 111.433 173.998 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 79.4 mt -60.4 -49.7 76.52 Favored 'General case' 0 N--CA 1.479 1.022 0 N-CA-C 114.594 1.331 . . . . 0.0 114.594 179.594 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' SER . . . . . 0.446 ' HB2' ' HD1' ' A' ' 5' ' ' PHE . 2.1 p -57.34 -37.33 72.38 Favored 'General case' 0 N--CA 1.479 1.021 0 N-CA-C 114.344 1.239 . . . . 0.0 114.344 177.337 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.766 HD11 ' SD ' ' A' ' 1' ' ' MET . 18.8 tp -62.94 -49.2 75.7 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 123.692 0.797 . . . . 0.0 110.436 171.396 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.522 HD23 HG23 ' A' ' 29' ' ' VAL . 49.5 mt -58.38 -33.74 69.95 Favored 'General case' 0 N--CA 1.476 0.855 0 N-CA-C 114.7 1.37 . . . . 0.0 114.7 178.087 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -65.1 -43.95 90.37 Favored 'General case' 0 N--CA 1.476 0.838 0 N-CA-C 112.324 0.491 . . . . 0.0 112.324 172.581 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -63.18 -43.17 98.98 Favored 'General case' 0 N--CA 1.484 1.251 0 C-N-CA 122.849 0.46 . . . . 0.0 111.729 173.276 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -57.34 -26.49 61.06 Favored 'General case' 0 N--CA 1.472 0.665 0 N-CA-C 115.645 1.72 . . . . 0.0 115.645 -176.597 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -45.86 -42.43 11.31 Favored Glycine 0 CA--C 1.546 2.029 0 C-N-CA 125.764 1.65 . . . . 0.0 114.052 178.589 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . 0.501 ' CZ ' ' HH ' ' A' ' 54' ' ' TYR . 29.0 ttm180 -48.54 -53.25 18.94 Favored 'General case' 0 N--CA 1.476 0.844 0 CA-C-N 112.558 -1.821 . . . . 0.0 113.673 -175.723 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 17.2 tt0 -126.84 36.72 4.41 Favored 'General case' 0 N--CA 1.474 0.77 0 N-CA-C 113.258 0.836 . . . . 0.0 113.258 178.024 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 18.4 t 48.33 120.96 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.421 0 C-N-CA 126.17 1.788 . . . . 0.0 113.821 -178.031 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 7.8 tp -31.31 -51.42 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 N-CA-C 116.595 2.072 . . . . 0.0 116.595 -176.319 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 70.3 mttt -48.68 -67.03 0.3 Allowed 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 125.477 1.511 . . . . 0.0 112.927 176.113 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -74.47 -30.86 62.03 Favored 'General case' 0 N--CA 1.466 0.352 0 N-CA-C 114.735 1.384 . . . . 0.0 114.735 -179.198 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . 0.541 ' HD2' ' HG ' ' A' ' 55' ' ' LEU . 72.9 t80 -49.0 -63.82 0.99 Allowed 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 124.933 1.293 . . . . 0.0 112.291 -178.133 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.799 ' HB2' HG23 ' A' ' 25' ' ' VAL . 42.4 mt -73.29 -34.44 65.76 Favored 'General case' 0 N--CA 1.477 0.885 0 N-CA-C 114.884 1.438 . . . . 0.0 114.884 -174.595 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.56 ' HA ' HG11 ' A' ' 19' ' ' VAL . 57.8 mtpt -58.59 -46.17 87.53 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 114.438 -1.256 . . . . 0.0 112.67 177.052 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 61.6 tttm -77.44 -50.77 11.99 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 114.903 -1.044 . . . . 0.0 111.873 174.409 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 58.8 tt0 -59.1 -44.99 92.0 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-O 118.225 -0.893 . . . . 0.0 111.515 -170.404 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.762 HG22 HG23 ' A' ' 67' ' ' VAL . 4.0 mm -79.32 -20.08 12.61 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.789 0 C-N-CA 119.841 -0.744 . . . . 0.0 112.712 -175.262 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.462 ' HD2' ' HZ2' ' A' ' 64' ' ' LYS . 23.1 tptt -65.57 -37.28 86.22 Favored 'General case' 0 CA--C 1.549 0.909 0 CA-C-O 122.449 1.119 . . . . 0.0 113.454 170.545 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 21.6 ttpp -84.53 -37.78 20.82 Favored 'General case' 0 CA--C 1.554 1.101 0 CA-C-N 112.355 -2.202 . . . . 0.0 111.415 -178.601 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 6.9 tttt -77.21 -43.62 33.0 Favored 'General case' 0 CA--C 1.541 0.626 0 N-CA-C 116.603 2.075 . . . . 0.0 116.603 -177.432 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 91.35 111.5 1.7 Allowed Glycine 0 N--CA 1.478 1.445 0 CA-C-O 122.584 1.102 . . . . 0.0 111.332 -177.48 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.623 ' HB3' HD12 ' A' ' 16' ' ' LEU . 10.4 mptt -43.87 -41.21 4.99 Favored 'General case' 0 N--CA 1.487 1.377 0 N-CA-C 117.863 2.542 . . . . 0.0 117.863 -171.778 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . 0.477 ' O ' ' HB ' ' A' ' 68' ' ' ILE . 0.0 OUTLIER -56.16 -49.41 74.06 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 124.583 1.153 . . . . 0.0 113.386 178.402 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -67.65 -23.98 65.39 Favored 'General case' 0 N--CA 1.477 0.904 0 N-CA-C 114.61 1.337 . . . . 0.0 114.61 174.961 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.762 HG23 HG22 ' A' ' 59' ' ' ILE . 45.6 t -75.16 -32.23 26.05 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.083 0 CA-C-N 114.86 -1.064 . . . . 0.0 110.822 176.325 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.65 HG12 HD13 ' A' ' 16' ' ' LEU . 8.0 mm -51.7 -46.71 38.88 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.951 0 C-N-CA 123.355 0.662 . . . . 0.0 110.075 168.491 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -68.87 -48.91 62.24 Favored 'General case' 0 N--CA 1.482 1.143 0 O-C-N 124.542 1.152 . . . . 0.0 113.345 176.585 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' TRP . . . . . 0.411 ' HE3' HG11 ' A' ' 67' ' ' VAL . 34.6 t90 . . . . . 0 N--CA 1.477 0.88 0 C-N-CA 124.799 1.24 . . . . 0.0 113.6 -178.846 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.434 ' HE1' HG22 ' A' ' 7' ' ' ILE . 22.5 mtp . . . . . 0 N--CA 1.48 1.036 0 N-CA-C 112.553 0.575 . . . . 0.0 112.553 . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -60.56 -51.31 69.98 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-N 115.213 -0.903 . . . . 0.0 113.259 177.629 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 57.8 tttp -70.32 -51.44 30.15 Favored 'General case' 0 CA--C 1.551 0.987 0 CA-C-N 113.568 -1.651 . . . . 0.0 112.978 -173.42 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -77.22 -38.57 51.05 Favored 'General case' 0 N--CA 1.482 1.166 0 N-CA-C 116.577 2.065 . . . . 0.0 116.577 -170.361 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . 0.685 ' HD1' ' HB2' ' A' ' 41' ' ' SER . 53.3 m-85 -99.7 -30.99 11.78 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-N 112.914 -1.948 . . . . 0.0 115.356 -168.395 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 93.88 50.73 2.24 Favored Glycine 0 CA--C 1.541 1.682 0 O-C-N 125.277 1.611 . . . . 0.0 110.964 -171.174 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.434 HG22 ' HE1' ' A' ' 1' ' ' MET . 0.6 OUTLIER -117.83 147.76 41.82 Favored Pre-proline 0 N--CA 1.475 0.823 0 CA-C-N 113.4 -1.4 . . . . 0.0 109.287 -178.528 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_endo -89.42 155.04 5.42 Favored 'Trans proline' 0 C--N 1.332 -0.327 0 N-CA-C 108.861 -1.246 . . . . 0.0 108.861 161.307 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -50.18 -26.04 4.19 Favored 'General case' 0 CA--C 1.54 0.58 0 N-CA-C 115.208 1.558 . . . . 0.0 115.208 173.516 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -47.32 -59.38 3.23 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 125.237 1.415 . . . . 0.0 112.678 172.626 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.889 HG11 HG21 ' A' ' 31' ' ' ILE . 33.5 m -81.9 -27.6 9.61 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.988 0 N-CA-C 114.181 1.178 . . . . 0.0 114.181 -175.278 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -67.94 -33.84 75.44 Favored 'General case' 0 N--CA 1.478 0.932 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.651 172.863 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -61.24 -42.54 99.81 Favored Glycine 0 CA--C 1.537 1.451 0 C-N-CA 124.073 0.844 . . . . 0.0 112.833 173.263 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 0.429 HG21 HG13 ' A' ' 28' ' ' ILE . 0.8 OUTLIER -58.85 -41.63 87.41 Favored 'General case' 0 N--CA 1.478 0.966 0 N-CA-C 114.166 1.173 . . . . 0.0 114.166 173.792 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.543 HG12 HD11 ' A' ' 55' ' ' LEU . 22.2 t -53.87 -43.18 56.16 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.265 0 C-N-CA 123.514 0.725 . . . . 0.0 112.915 170.67 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 25.0 mt -60.74 -40.87 94.05 Favored 'General case' 0 N--CA 1.476 0.857 0 N-CA-C 113.278 0.844 . . . . 0.0 113.278 178.102 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -52.43 -45.5 66.0 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 124.405 1.082 . . . . 0.0 111.977 174.698 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -60.44 -51.65 70.57 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.682 0 CA-C-N 114.283 -1.326 . . . . 0.0 112.339 175.52 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.648 HG11 ' HA ' ' A' ' 56' ' ' LYS . 17.9 t -58.85 -45.0 91.82 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.388 0 O-C-N 124.265 0.978 . . . . 0.0 111.002 -178.876 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 21.0 mt-10 -66.88 -39.52 87.53 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 125.97 1.708 . . . . 0.0 115.418 -177.705 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -101.93 -24.19 14.04 Favored 'General case' 0 N--CA 1.474 0.753 0 N-CA-C 115.82 1.785 . . . . 0.0 115.82 -172.01 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . 0.617 ' HA3' ' HE2' ' A' ' 56' ' ' LYS . . . 77.7 44.21 13.1 Favored Glycine 0 N--CA 1.484 1.897 0 N-CA-C 110.742 -0.943 . . . . 0.0 110.742 -166.75 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -85.67 169.29 42.7 Favored Glycine 0 N--CA 1.474 1.208 0 C-N-CA 124.294 0.95 . . . . 0.0 112.995 -175.451 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 66.6 m95 -67.43 99.8 0.78 Allowed 'General case' 0 C--O 1.243 0.751 0 CA-C-O 123.257 1.503 . . . . 0.0 111.728 176.75 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.75 HG23 ' HA ' ' A' ' 52' ' ' LYS . 16.0 t -56.32 -24.46 18.38 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.939 0 CA-C-N 113.521 -1.672 . . . . 0.0 112.481 174.091 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 11.7 p -58.55 -45.68 88.42 Favored 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 123.735 0.814 . . . . 0.0 112.71 176.528 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -61.65 -45.22 94.96 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 124.095 0.958 . . . . 0.0 111.211 176.023 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.429 HG13 HG21 ' A' ' 14' ' ' THR . 1.7 mp -56.96 -48.43 81.62 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.915 0 CA-C-N 114.701 -1.136 . . . . 0.0 112.951 175.225 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.419 HG11 HD13 ' A' ' 43' ' ' LEU . 54.4 t -52.38 -41.83 36.34 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.059 0 C-N-CA 123.85 0.86 . . . . 0.0 111.937 176.948 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 73.2 m -55.96 -47.2 78.05 Favored 'General case' 0 N--CA 1.486 1.327 0 N-CA-C 113.625 0.972 . . . . 0.0 113.625 174.349 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.889 HG21 HG11 ' A' ' 11' ' ' VAL . 36.5 mm -69.47 -38.17 76.44 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.964 0 CA-C-N 115.149 -0.932 . . . . 0.0 109.349 -175.906 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.527 HD23 ' HB ' ' A' ' 11' ' ' VAL . 4.3 mm? -61.81 -52.66 63.29 Favored 'General case' 0 N--CA 1.48 1.026 0 CA-C-N 113.813 -1.54 . . . . 0.0 113.496 175.508 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 8.3 p -68.01 -31.72 71.6 Favored 'General case' 0 N--CA 1.476 0.834 0 N-CA-C 114.76 1.393 . . . . 0.0 114.76 177.36 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -52.46 -29.62 25.65 Favored 'General case' 0 N--CA 1.479 0.981 0 N-CA-C 113.714 1.005 . . . . 0.0 113.714 172.117 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 85.6 t -69.11 -33.42 58.48 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 C-N-CA 124.179 0.992 . . . . 0.0 112.453 171.789 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 117.04 -118.08 4.03 Favored Glycine 0 N--CA 1.473 1.152 0 C-N-CA 124.396 0.998 . . . . 0.0 111.235 179.898 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 5.2 p -62.12 -38.97 90.96 Favored 'General case' 0 N--CA 1.473 0.711 0 N-CA-C 115.831 1.789 . . . . 0.0 115.831 -173.577 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -52.64 -47.58 57.62 Favored Glycine 0 CA--C 1.542 1.761 0 O-C-N 124.83 1.331 . . . . 0.0 113.729 176.187 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.438 ' O ' ' HG ' ' A' ' 43' ' ' LEU . . . -56.73 -51.25 58.01 Favored Glycine 0 N--CA 1.478 1.49 0 N-CA-C 110.875 -0.89 . . . . 0.0 110.875 177.727 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 18.9 mt -59.07 -48.94 79.77 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 124.594 1.157 . . . . 0.0 114.097 177.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' SER . . . . . 0.685 ' HB2' ' HD1' ' A' ' 5' ' ' PHE . 0.0 OUTLIER -58.63 -41.46 86.03 Favored 'General case' 0 N--CA 1.479 1.014 0 N-CA-C 113.824 1.046 . . . . 0.0 113.824 174.927 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 15.3 tp -60.25 -44.44 95.26 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 122.477 0.311 . . . . 0.0 110.87 174.07 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.438 ' HG ' ' O ' ' A' ' 39' ' ' GLY . 79.6 mt -62.01 -36.25 80.97 Favored 'General case' 0 N--CA 1.477 0.891 0 N-CA-C 115.017 1.488 . . . . 0.0 115.017 178.103 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -63.12 -50.02 72.12 Favored 'General case' 0 N--CA 1.472 0.635 0 O-C-N 123.962 0.789 . . . . 0.0 112.076 172.2 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -62.67 -33.57 75.34 Favored 'General case' 0 N--CA 1.486 1.347 0 N-CA-C 112.571 0.582 . . . . 0.0 112.571 177.558 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -65.29 -19.72 66.09 Favored 'General case' 0 N--CA 1.474 0.732 0 N-CA-C 115.702 1.741 . . . . 0.0 115.702 178.289 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -52.61 -38.29 51.95 Favored Glycine 0 N--CA 1.477 1.412 0 O-C-N 124.665 1.228 . . . . 0.0 112.696 178.006 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 65.1 ttp85 -54.12 -47.03 72.29 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 125.541 1.536 . . . . 0.0 113.805 -174.744 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 15.8 tt0 -132.25 36.11 3.64 Favored 'General case' 0 N--CA 1.477 0.899 0 N-CA-C 114.903 1.446 . . . . 0.0 114.903 -174.722 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 78.2 p 49.37 116.99 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.823 0 C-N-CA 124.06 0.944 . . . . 0.0 113.073 -174.798 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.526 HG13 HG12 ' A' ' 25' ' ' VAL 0.256 8.2 tp -31.5 -49.54 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 N-CA-C 117.974 2.583 . . . . 0.0 117.974 -173.58 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 0.75 ' HA ' HG23 ' A' ' 25' ' ' VAL . 0.3 OUTLIER -64.98 -66.57 0.53 Allowed 'General case' 0 N--CA 1.489 1.518 0 CA-C-N 118.214 0.461 . . . . 0.0 111.885 178.132 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -50.74 -40.02 53.53 Favored 'General case' 0 C--O 1.236 0.349 0 O-C-N 124.868 1.355 . . . . 0.0 112.522 178.804 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 91.6 t80 -48.84 -62.82 1.32 Allowed 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 126.108 1.763 . . . . 0.0 111.23 174.212 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.543 HD11 HG12 ' A' ' 15' ' ' VAL . 92.4 mt -64.98 -39.62 93.74 Favored 'General case' 0 N--CA 1.478 0.956 0 N-CA-C 115.354 1.613 . . . . 0.0 115.354 -178.792 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.648 ' HA ' HG11 ' A' ' 19' ' ' VAL . 29.1 mttt -58.78 -48.07 82.55 Favored 'General case' 0 C--N 1.319 -0.717 0 N-CA-C 115.444 1.646 . . . . 0.0 115.444 176.7 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 71.4 tttt -74.48 -50.71 17.18 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-N 115.039 -0.982 . . . . 0.0 112.039 173.547 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . 0.484 ' O ' ' HB2' ' A' ' 62' ' ' LYS . 31.3 tt0 -63.28 -47.37 82.63 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-O 118.433 -0.794 . . . . 0.0 111.549 -168.542 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.71 HG22 HG22 ' A' ' 67' ' ' VAL . 3.2 mm -77.66 -19.62 13.96 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.928 0 N-CA-C 112.117 0.414 . . . . 0.0 112.117 -176.334 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 2.7 ttmp? -68.62 -41.61 79.24 Favored 'General case' 0 CA--C 1.547 0.835 0 CA-C-N 115.511 -0.768 . . . . 0.0 112.643 170.069 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 25.4 ttpp -72.6 -41.91 65.1 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 125.651 1.58 . . . . 0.0 112.91 175.223 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.484 ' HB2' ' O ' ' A' ' 58' ' ' GLU . 0.0 OUTLIER -70.68 -53.45 15.69 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 126.674 1.99 . . . . 0.0 113.855 -177.034 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 99.37 106.24 2.69 Favored Glycine 0 N--CA 1.477 1.405 0 N-CA-C 110.399 -1.08 . . . . 0.0 110.399 -174.246 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.765 ' HD2' ' H ' ' A' ' 64' ' ' LYS . 10.8 mptt -30.87 -50.21 0.14 Allowed 'General case' 0 N--CA 1.485 1.319 0 N-CA-C 118.769 2.878 . . . . 0.0 118.769 -175.738 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . 0.467 ' O ' ' HB ' ' A' ' 68' ' ' ILE . 0.0 OUTLIER -59.22 -42.1 90.2 Favored 'General case' 0 N--CA 1.474 0.73 0 N-CA-C 114.517 1.303 . . . . 0.0 114.517 178.759 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -69.56 -26.62 64.57 Favored 'General case' 0 N--CA 1.478 0.927 0 CA-C-N 114.55 -1.205 . . . . 0.0 113.65 174.729 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.71 HG22 HG22 ' A' ' 59' ' ' ILE . 72.6 t -69.63 -34.38 61.09 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.048 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.448 175.711 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.467 ' HB ' ' O ' ' A' ' 65' ' ' ARG . 19.8 mm -52.58 -41.57 37.52 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.941 0 O-C-N 124.223 0.952 . . . . 0.0 110.934 170.045 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -70.21 -53.84 15.37 Favored 'General case' 0 N--CA 1.48 1.042 0 N-CA-C 113.247 0.832 . . . . 0.0 113.247 174.535 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 46.7 t90 . . . . . 0 CA--C 1.545 0.76 0 C-N-CA 126.321 1.848 . . . . 0.0 114.325 -176.497 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.703 ' HE3' HG22 ' A' ' 15' ' ' VAL . 70.0 mtp . . . . . 0 N--CA 1.475 0.803 0 N-CA-C 112.98 0.733 . . . . 0.0 112.98 . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . 0.447 ' HA ' ' O ' ' A' ' 7' ' ' ILE . . . -61.52 -56.28 21.78 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-N 114.546 -1.206 . . . . 0.0 112.112 172.685 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 95.1 mttt -64.06 -62.86 1.36 Allowed 'General case' 0 CA--C 1.541 0.621 0 CA-C-N 114.015 -1.448 . . . . 0.0 114.453 -177.555 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 3.9 mp0 -75.21 -40.54 59.1 Favored 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 115.016 1.488 . . . . 0.0 115.016 -170.065 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . 0.481 ' HD2' ' HA ' ' A' ' 1' ' ' MET . 41.3 m-85 -101.85 -11.68 18.85 Favored 'General case' 0 N--CA 1.476 0.851 0 N-CA-C 116.557 2.058 . . . . 0.0 116.557 -174.005 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 67.39 37.37 90.33 Favored Glycine 0 CA--C 1.538 1.528 0 CA-C-O 121.855 0.697 . . . . 0.0 111.359 -173.731 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.664 HG22 HG22 ' A' ' 11' ' ' VAL . 0.7 OUTLIER -110.06 115.31 55.06 Favored Pre-proline 0 N--CA 1.474 0.73 0 C-N-CA 124.547 1.139 . . . . 0.0 109.086 179.016 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 96.3 Cg_endo -65.2 154.92 71.22 Favored 'Trans proline' 0 CA--C 1.536 0.602 0 C-N-CA 120.614 0.876 . . . . 0.0 111.019 -177.165 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -46.49 -30.11 2.05 Favored 'General case' 0 N--CA 1.472 0.662 0 N-CA-C 115.833 1.79 . . . . 0.0 115.833 174.478 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -40.4 -60.76 1.03 Allowed 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 126.337 1.855 . . . . 0.0 112.875 171.116 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.975 HG13 HG21 ' A' ' 31' ' ' ILE . 34.6 m -86.86 -31.11 5.99 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.915 0 CA-C-N 114.58 -1.191 . . . . 0.0 113.679 -174.793 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -59.63 -33.81 71.98 Favored 'General case' 0 CA--C 1.547 0.843 0 N-CA-C 113.24 0.829 . . . . 0.0 113.24 171.611 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -63.68 -44.18 96.77 Favored Glycine 0 N--CA 1.481 1.69 0 C-N-CA 124.044 0.831 . . . . 0.0 112.229 174.641 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 0.918 HG21 HG13 ' A' ' 28' ' ' ILE . 1.7 m -61.33 -36.87 81.34 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 125.368 1.467 . . . . 0.0 113.674 174.175 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.703 HG22 ' HE3' ' A' ' 1' ' ' MET . 6.1 t -58.16 -45.36 88.7 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.359 0 N-CA-C 113.044 0.757 . . . . 0.0 113.044 170.187 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.405 HD12 ' HB3' ' A' ' 64' ' ' LYS . 39.0 mt -57.07 -38.56 73.47 Favored 'General case' 0 N--CA 1.482 1.173 0 CA-C-N 115.352 -0.84 . . . . 0.0 112.868 177.102 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -53.01 -46.17 68.25 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-N 113.355 -1.748 . . . . 0.0 113.384 176.268 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.42 HG22 ' HA ' ' A' ' 25' ' ' VAL . 1.7 t -55.52 -49.47 73.25 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.124 0 C-N-CA 124.696 1.198 . . . . 0.0 113.042 172.26 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.765 HG11 ' HA ' ' A' ' 56' ' ' LYS . 11.6 t -63.45 -45.44 97.9 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.227 0 C-N-CA 123.635 0.774 . . . . 0.0 111.483 -174.961 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . 0.432 ' HG3' ' HE2' ' A' ' 64' ' ' LYS . 19.0 mt-10 -65.14 -40.98 95.17 Favored 'General case' 0 CA--C 1.541 0.6 0 N-CA-C 115.843 1.794 . . . . 0.0 115.843 -179.6 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -101.12 -20.9 15.13 Favored 'General case' 0 N--CA 1.479 1.007 0 N-CA-C 116.287 1.958 . . . . 0.0 116.287 -174.716 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 71.57 39.63 60.5 Favored Glycine 0 N--CA 1.481 1.634 0 N-CA-C 110.894 -0.882 . . . . 0.0 110.894 -164.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -82.17 164.52 44.2 Favored Glycine 0 N--CA 1.478 1.444 0 C-N-CA 124.388 0.994 . . . . 0.0 113.006 -174.123 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' TRP . . . . . 0.525 ' HB3' HG21 ' A' ' 26' ' ' THR . 2.3 m-90 -62.33 103.9 0.44 Allowed 'General case' 0 N--CA 1.475 0.787 0 CA-C-O 123.166 1.46 . . . . 0.0 112.107 179.603 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.42 ' HA ' HG22 ' A' ' 18' ' ' VAL . 3.0 p -55.57 -24.56 16.36 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.718 0 CA-C-N 112.89 -1.959 . . . . 0.0 112.851 172.87 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.525 HG21 ' HB3' ' A' ' 24' ' ' TRP . 9.8 t -62.49 -45.92 90.82 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-O 118.002 -0.999 . . . . 0.0 113.441 177.951 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -60.09 -42.06 93.85 Favored 'General case' 0 N--CA 1.484 1.26 0 O-C-N 124.416 1.072 . . . . 0.0 110.454 175.642 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.918 HG13 HG21 ' A' ' 14' ' ' THR . 1.9 mp -65.62 -47.53 85.92 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.649 0 C-N-CA 124.634 1.174 . . . . 0.0 112.583 -179.534 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 72.7 t -50.37 -42.7 21.29 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 O-C-N 123.755 0.66 . . . . 0.0 111.232 174.426 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 5.5 m -55.55 -40.95 72.57 Favored 'General case' 0 N--CA 1.481 1.106 0 N-CA-C 113.919 1.081 . . . . 0.0 113.919 175.948 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.975 HG21 HG13 ' A' ' 11' ' ' VAL . 34.9 mm -71.45 -38.86 70.07 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.957 0 C-N-CA 124.14 0.976 . . . . 0.0 109.932 179.802 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.513 HD23 ' HB ' ' A' ' 11' ' ' VAL . 3.4 mm? -61.15 -40.42 93.77 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 124.716 1.207 . . . . 0.0 112.184 171.491 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' THR . . . . . 0.686 HG22 ' HA3' ' A' ' 38' ' ' GLY . 10.0 m -67.63 -36.88 81.61 Favored 'General case' 0 N--CA 1.476 0.84 0 N-CA-C 114.05 1.13 . . . . 0.0 114.05 175.813 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -53.64 -31.55 47.89 Favored 'General case' 0 N--CA 1.488 1.437 0 C-N-CA 124.325 1.05 . . . . 0.0 113.797 175.2 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 42.9 t -58.78 -36.81 62.66 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.94 0 C-N-CA 125.802 1.641 . . . . 0.0 113.402 174.167 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . 0.423 ' C ' ' H ' ' A' ' 38' ' ' GLY . . . 118.06 160.6 11.65 Favored Glycine 0 CA--C 1.535 1.286 0 N-CA-C 108.982 -1.647 . . . . 0.0 108.982 -168.971 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' SER . . . . . 0.59 ' OG ' ' HB2' ' A' ' 40' ' ' LEU . 8.3 t 73.39 -37.77 0.39 Allowed 'General case' 0 N--CA 1.493 1.708 0 C-N-CA 126.376 1.87 . . . . 0.0 112.928 -175.914 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.686 ' HA3' HG22 ' A' ' 33' ' ' THR . . . 116.97 14.43 7.23 Favored Glycine 0 CA--C 1.54 1.608 0 C-N-CA 125.978 1.751 . . . . 0.0 112.459 -174.337 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.433 ' HA2' ' HB3' ' A' ' 32' ' ' LEU . . . 57.14 27.68 57.73 Favored Glycine 0 N--CA 1.484 1.837 0 N-CA-C 111.805 -0.518 . . . . 0.0 111.805 -159.765 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.59 ' HB2' ' OG ' ' A' ' 37' ' ' SER . 5.3 mt -56.97 -37.38 71.53 Favored 'General case' 0 N--CA 1.481 1.1 0 N-CA-C 115.954 1.835 . . . . 0.0 115.954 -167.869 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 12.3 p -59.15 -48.33 82.02 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 124.139 0.976 . . . . 0.0 112.661 176.335 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.435 HD21 ' HE2' ' A' ' 1' ' ' MET . 15.0 tp -62.75 -49.39 75.21 Favored 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 122.983 0.513 . . . . 0.0 110.572 173.062 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 77.8 mt -60.47 -31.22 70.25 Favored 'General case' 0 N--CA 1.475 0.81 0 N-CA-C 113.972 1.101 . . . . 0.0 113.972 -177.462 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -69.36 -46.14 67.7 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 123.463 0.705 . . . . 0.0 111.826 173.94 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -60.74 -30.85 70.24 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 123.833 0.853 . . . . 0.0 112.563 177.317 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.499 ' HB3' ' HA ' ' A' ' 51' ' ' ILE . . . -67.38 -27.82 67.42 Favored 'General case' 0 N--CA 1.471 0.608 0 N-CA-C 115.931 1.826 . . . . 0.0 115.931 178.276 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -45.76 -45.54 13.23 Favored Glycine 0 CA--C 1.544 1.851 0 C-N-CA 126.105 1.812 . . . . 0.0 114.295 -170.811 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 24.6 tpt180 -45.79 -48.43 15.56 Favored 'General case' 0 CA--C 1.544 0.736 0 CA-C-N 111.948 -2.126 . . . . 0.0 114.328 -179.221 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 18.9 tt0 -123.74 25.89 7.91 Favored 'General case' 0 N--CA 1.481 1.107 0 N-CA-C 114.499 1.296 . . . . 0.0 114.499 -176.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 33.2 t 50.21 133.18 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.486 0 C-N-CA 125.626 1.57 . . . . 0.0 111.83 -167.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.499 ' HA ' ' HB3' ' A' ' 46' ' ' ALA . 7.4 tp -43.13 -45.4 1.36 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.027 0 N-CA-C 115.536 1.68 . . . . 0.0 115.536 -175.599 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 5.6 tmtm? -53.84 -71.2 0.08 Allowed 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 125.061 1.344 . . . . 0.0 111.941 177.733 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -65.47 -29.18 69.81 Favored 'General case' 0 N--CA 1.471 0.576 0 N-CA-C 115.135 1.531 . . . . 0.0 115.135 179.385 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . 0.46 ' O ' ' HB2' ' A' ' 58' ' ' GLU . 86.9 t80 -51.1 -64.64 0.75 Allowed 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 125.417 1.487 . . . . 0.0 111.579 176.565 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.464 HD12 HG12 ' A' ' 15' ' ' VAL . 75.4 mt -60.77 -37.86 83.3 Favored 'General case' 0 N--CA 1.478 0.95 0 N-CA-C 114.617 1.34 . . . . 0.0 114.617 -176.18 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.765 ' HA ' HG11 ' A' ' 19' ' ' VAL . 94.0 mttt -61.3 -45.23 95.31 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 113.201 -1.818 . . . . 0.0 114.055 -179.335 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 81.4 tttt -77.25 -47.06 21.12 Favored 'General case' 0 CA--C 1.543 0.71 0 CA-C-N 115.275 -0.875 . . . . 0.0 112.703 171.463 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . 0.461 ' O ' ' HB2' ' A' ' 62' ' ' LYS . 4.1 mm-40 -57.22 -51.05 70.91 Favored 'General case' 0 C--O 1.219 -0.522 0 N-CA-C 113.743 1.016 . . . . 0.0 113.743 -175.105 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.716 HG22 HG22 ' A' ' 67' ' ' VAL . 2.6 mm -80.01 -21.1 11.91 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.484 0 N-CA-C 112.206 0.447 . . . . 0.0 112.206 -177.603 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.522 ' HB2' ' O ' ' A' ' 56' ' ' LYS . 6.9 tppt? -60.65 -42.79 97.71 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-O 123.783 1.754 . . . . 0.0 112.296 171.599 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . 0.277 19.5 tttm -81.32 -45.03 16.8 Favored 'General case' 0 CA--C 1.55 0.951 0 CA-C-N 111.132 -2.758 . . . . 0.0 111.74 -179.797 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.461 ' HB2' ' O ' ' A' ' 58' ' ' GLU . 15.5 tptt -58.51 -50.66 72.95 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 126.036 1.734 . . . . 0.0 113.605 -179.135 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 86.66 108.31 0.82 Allowed Glycine 0 N--CA 1.478 1.47 0 CA-C-N 113.582 -1.644 . . . . 0.0 109.911 -169.079 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.685 ' HD2' ' H ' ' A' ' 64' ' ' LYS . 10.0 mptt -28.48 -48.38 0.06 Allowed 'General case' 0 N--CA 1.481 1.083 0 N-CA-C 119.776 3.25 . . . . 0.0 119.776 -176.625 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . 0.4 ' O ' ' HB ' ' A' ' 68' ' ' ILE . 1.2 ttp85 -54.5 -44.03 72.35 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 125.625 1.57 . . . . 0.0 113.321 178.804 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -69.25 -23.25 63.84 Favored 'General case' 0 N--CA 1.474 0.761 0 N-CA-C 114.702 1.371 . . . . 0.0 114.702 176.116 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.716 HG22 HG22 ' A' ' 59' ' ' ILE . 63.9 t -75.67 -35.88 32.48 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.31 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.893 178.752 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.4 ' HB ' ' O ' ' A' ' 65' ' ' ARG . 17.3 mm -50.39 -42.56 21.2 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 C-N-CA 124.124 0.969 . . . . 0.0 111.107 169.304 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -74.9 -52.8 10.35 Favored 'General case' 0 N--CA 1.484 1.238 0 N-CA-C 113.718 1.007 . . . . 0.0 113.718 174.789 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 33.3 t90 . . . . . 0 N--CA 1.488 1.47 0 C-N-CA 125.704 1.602 . . . . 0.0 114.118 -178.301 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.711 ' HE1' HG23 ' A' ' 7' ' ' ILE . 68.1 mtp . . . . . 0 N--CA 1.478 0.969 0 N-CA-C 112.137 0.421 . . . . 0.0 112.137 . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . 0.569 ' HA ' ' O ' ' A' ' 7' ' ' ILE . . . -58.26 -52.78 64.14 Favored 'General case' 0 N--CA 1.475 0.825 0 CA-C-N 114.819 -1.082 . . . . 0.0 112.129 173.902 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.99 -65.11 0.84 Allowed 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 112.518 -2.128 . . . . 0.0 115.997 -174.962 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . 0.42 ' HB2' ' O ' ' A' ' 70' ' ' TRP . 1.8 mp0 -73.79 -26.34 60.58 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-N 112.877 -1.965 . . . . 0.0 113.496 -170.718 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . 0.421 ' HD1' ' HB2' ' A' ' 41' ' ' SER . 31.6 m-85 -118.02 -6.92 10.92 Favored 'General case' 0 N--CA 1.478 0.937 0 N-CA-C 118.025 2.602 . . . . 0.0 118.025 -174.167 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 63.13 37.22 94.56 Favored Glycine 0 CA--C 1.543 1.806 0 O-C-N 124.007 0.817 . . . . 0.0 112.551 -175.866 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.711 HG23 ' HE1' ' A' ' 1' ' ' MET . 0.5 OUTLIER -114.0 121.51 36.63 Favored Pre-proline 0 N--CA 1.475 0.778 0 CA-C-N 114.448 -0.876 . . . . 0.0 108.708 -179.833 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 96.6 Cg_endo -67.28 160.87 45.59 Favored 'Trans proline' 0 CA--C 1.532 0.411 0 C-N-CA 120.971 1.114 . . . . 0.0 111.334 -177.558 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -53.62 -27.62 28.05 Favored 'General case' 0 CA--C 1.545 0.772 0 N-CA-C 114.713 1.375 . . . . 0.0 114.713 173.048 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -45.43 -43.9 11.7 Favored 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 126.191 1.796 . . . . 0.0 114.357 174.216 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.528 ' HB ' HD23 ' A' ' 32' ' ' LEU . 34.5 m -102.65 -33.59 3.36 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.893 0 N-CA-C 114.306 1.225 . . . . 0.0 114.306 -176.947 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -61.45 -34.17 74.97 Favored 'General case' 0 N--CA 1.475 0.776 0 CA-C-N 114.8 -1.091 . . . . 0.0 112.181 173.686 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -59.71 -49.97 72.82 Favored Glycine 0 N--CA 1.478 1.434 0 C-N-CA 124.799 1.19 . . . . 0.0 112.775 173.57 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 0.43 HG23 HG13 ' A' ' 31' ' ' ILE . 9.1 m -62.13 -36.39 81.65 Favored 'General case' 0 N--CA 1.479 1.001 0 N-CA-C 114.612 1.338 . . . . 0.0 114.612 175.596 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.66 HG22 ' HE3' ' A' ' 1' ' ' MET . 72.0 t -56.94 -40.11 69.96 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.133 0 C-N-CA 123.213 0.605 . . . . 0.0 111.481 173.109 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.628 HD12 ' HB3' ' A' ' 64' ' ' LYS . 27.6 mt -61.36 -43.57 98.65 Favored 'General case' 0 N--CA 1.479 1.023 0 N-CA-C 113.418 0.896 . . . . 0.0 113.418 178.636 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 56.6 t-20 -54.77 -49.77 70.08 Favored 'General case' 0 CA--C 1.548 0.901 0 O-C-N 124.614 1.197 . . . . 0.0 111.055 173.443 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 96.8 t -54.9 -52.35 44.0 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.954 0 CA-C-N 114.6 -1.182 . . . . 0.0 111.204 175.823 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.656 HG12 ' HB ' ' A' ' 59' ' ' ILE . 81.7 t -53.88 -56.14 10.61 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.307 0 O-C-N 124.05 0.844 . . . . 0.0 111.124 179.788 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 14.5 tt0 -57.13 -37.69 72.38 Favored 'General case' 0 N--CA 1.476 0.829 0 O-C-N 124.972 1.42 . . . . 0.0 113.191 -176.825 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -88.12 -16.64 32.91 Favored 'General case' 0 N--CA 1.473 0.699 0 N-CA-C 116.294 1.961 . . . . 0.0 116.294 179.15 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 70.58 33.65 67.36 Favored Glycine 0 N--CA 1.487 2.099 0 C-N-CA 124.5 1.048 . . . . 0.0 112.143 -170.012 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -77.32 -177.12 45.69 Favored Glycine 0 CA--C 1.539 1.583 0 CA-C-O 124.155 1.975 . . . . 0.0 115.542 -170.954 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' TRP . . . . . 0.419 ' HB3' ' OG1' ' A' ' 26' ' ' THR . 74.0 m95 -63.7 122.65 16.9 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 110.717 -2.741 . . . . 0.0 116.73 -176.296 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 11.9 p -42.76 -37.75 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.379 0 CA-C-N 112.492 -2.14 . . . . 0.0 113.802 164.561 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.419 ' OG1' ' HB3' ' A' ' 24' ' ' TRP . 8.4 p -60.1 -44.26 94.97 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 123.782 0.833 . . . . 0.0 111.483 176.927 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -60.72 -29.54 69.42 Favored 'General case' 0 N--CA 1.485 1.317 0 N-CA-C 112.835 0.68 . . . . 0.0 112.835 176.321 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.496 ' O ' HD21 ' A' ' 32' ' ' LEU . 30.4 mt -72.75 -68.28 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.028 0 N-CA-C 109.36 -0.607 . . . . 0.0 109.36 167.239 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 85.7 t -54.39 -48.49 68.57 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.054 0 CA-C-O 118.159 -0.924 . . . . 0.0 112.896 -170.45 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 67.2 m -64.83 -26.15 68.21 Favored 'General case' 0 N--CA 1.477 0.897 0 N-CA-C 115.172 1.545 . . . . 0.0 115.172 179.349 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.492 HG21 HG11 ' A' ' 11' ' ' VAL . 35.7 mm -85.23 -42.41 16.3 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.921 0 C-N-CA 123.047 0.539 . . . . 0.0 110.166 174.659 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.528 HD23 ' HB ' ' A' ' 11' ' ' VAL . 3.5 mm? -62.18 -30.12 70.84 Favored 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 125.107 1.363 . . . . 0.0 114.328 176.015 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' THR . . . . . 0.756 ' HA ' ' HA3' ' A' ' 38' ' ' GLY . 2.8 p -68.54 -30.84 69.72 Favored 'General case' 0 N--CA 1.488 1.448 0 N-CA-C 116.424 2.009 . . . . 0.0 116.424 170.472 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -58.63 -25.46 62.71 Favored 'General case' 0 N--CA 1.475 0.82 0 O-C-N 124.654 1.221 . . . . 0.0 112.868 177.16 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.419 HG21 HG13 ' A' ' 11' ' ' VAL . 98.4 t -69.17 -31.7 51.04 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.077 0 C-N-CA 126.592 1.957 . . . . 0.0 112.597 175.408 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 109.8 -51.14 0.72 Allowed Glycine 0 CA--C 1.542 1.738 0 N-CA-C 111.178 -0.769 . . . . 0.0 111.178 -175.24 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 16.3 p -61.66 -4.28 1.37 Allowed 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 114.574 1.324 . . . . 0.0 114.574 174.615 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.756 ' HA3' ' HA ' ' A' ' 33' ' ' THR . . . 63.94 16.11 59.09 Favored Glycine 0 N--CA 1.487 2.097 0 C-N-CA 124.073 0.844 . . . . 0.0 114.62 173.886 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.511 ' HA2' ' HB3' ' A' ' 32' ' ' LEU . . . 51.8 27.33 20.03 Favored Glycine 0 CA--C 1.541 1.686 0 C-N-CA 125.408 1.48 . . . . 0.0 113.48 -163.423 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 20.8 mt -55.79 -43.16 76.54 Favored 'General case' 0 N--CA 1.477 0.908 0 N-CA-C 115.15 1.537 . . . . 0.0 115.15 -173.442 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' SER . . . . . 0.421 ' HB2' ' HD1' ' A' ' 5' ' ' PHE . 8.8 p -60.0 -46.39 89.61 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 123.861 0.864 . . . . 0.0 113.063 173.937 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 12.0 tp -60.91 -51.3 69.88 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 124.002 0.921 . . . . 0.0 110.366 172.096 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 52.1 mt -57.8 -33.06 68.17 Favored 'General case' 0 N--CA 1.476 0.84 0 N-CA-C 114.345 1.239 . . . . 0.0 114.345 -179.692 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -65.39 -48.43 72.9 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-N 115.765 -0.652 . . . . 0.0 112.529 172.697 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -64.7 -36.63 84.9 Favored 'General case' 0 N--CA 1.482 1.155 0 CA-C-O 121.892 0.853 . . . . 0.0 111.829 177.595 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.535 ' HB3' ' HA ' ' A' ' 51' ' ' ILE . . . -65.16 -15.74 62.75 Favored 'General case' 0 N--CA 1.476 0.843 0 N-CA-C 116.107 1.891 . . . . 0.0 116.107 179.071 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -51.77 -42.81 53.51 Favored Glycine 0 CA--C 1.544 1.87 0 C-N-CA 124.725 1.155 . . . . 0.0 112.988 177.914 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 44.9 ttp180 -49.58 -49.89 44.68 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 125.123 1.369 . . . . 0.0 113.817 -174.158 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.411 ' HB3' ' HD1' ' A' ' 54' ' ' TYR . 29.1 tt0 -129.64 36.06 4.13 Favored 'General case' 0 CA--C 1.547 0.849 0 N-CA-C 113.605 0.965 . . . . 0.0 113.605 -174.518 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 96.0 p 50.31 123.68 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.372 0 C-N-CA 126.527 1.931 . . . . 0.0 113.877 -175.524 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.535 ' HA ' ' HB3' ' A' ' 46' ' ' ALA 0.274 3.9 tp -35.23 -63.99 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.545 0.779 0 N-CA-C 117.547 2.425 . . . . 0.0 117.547 -170.134 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 16.0 ttpp -52.52 -58.49 6.6 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 123.387 0.675 . . . . 0.0 112.791 177.359 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -64.05 -38.37 90.83 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 124.518 1.127 . . . . 0.0 113.485 -178.147 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . 0.411 ' HD1' ' HB3' ' A' ' 49' ' ' GLU . 72.8 t80 -51.9 -65.6 0.53 Allowed 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 126.056 1.742 . . . . 0.0 109.625 175.441 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 48.1 mt -64.36 -37.27 86.93 Favored 'General case' 0 N--CA 1.474 0.765 0 N-CA-C 114.33 1.233 . . . . 0.0 114.33 -177.8 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.579 ' HA ' HG11 ' A' ' 19' ' ' VAL . 9.0 tmtm? -57.58 -48.86 78.21 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 114.594 -1.185 . . . . 0.0 112.598 178.602 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 41.2 tttm -77.88 -49.83 13.44 Favored 'General case' 0 N--CA 1.476 0.854 0 CA-C-N 115.18 -0.918 . . . . 0.0 112.601 175.171 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . 0.442 ' O ' ' HB2' ' A' ' 62' ' ' LYS . 39.5 tt0 -58.25 -49.2 77.93 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-O 118.523 -0.751 . . . . 0.0 110.53 -173.164 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.764 HG22 HG22 ' A' ' 67' ' ' VAL . 2.8 mm -75.89 -25.53 17.22 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.893 0 CA-C-O 119.18 -0.438 . . . . 0.0 111.902 -176.503 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.567 ' HB2' ' O ' ' A' ' 56' ' ' LYS . 0.9 OUTLIER -61.38 -34.03 74.65 Favored 'General case' 0 CA--C 1.546 0.796 0 O-C-N 124.56 1.162 . . . . 0.0 113.812 171.867 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -86.26 -43.34 13.02 Favored 'General case' 0 N--CA 1.481 1.098 0 CA-C-N 113.094 -1.866 . . . . 0.0 112.228 179.02 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.442 ' HB2' ' O ' ' A' ' 58' ' ' GLU . 22.8 tttm -67.06 -51.06 59.17 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 127.507 2.323 . . . . 0.0 112.34 -173.742 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 102.42 108.38 3.2 Favored Glycine 0 N--CA 1.476 1.325 0 N-CA-C 109.621 -1.392 . . . . 0.0 109.621 -173.048 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.628 ' HB3' HD12 ' A' ' 16' ' ' LEU . 10.9 mptt -40.04 -43.57 1.6 Allowed 'General case' 0 N--CA 1.487 1.375 0 N-CA-C 117.558 2.429 . . . . 0.0 117.558 -175.171 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . 0.445 ' O ' ' HB ' ' A' ' 68' ' ' ILE . 11.2 mmp_? -57.4 -43.39 83.66 Favored 'General case' 0 N--CA 1.478 0.931 0 N-CA-C 116.003 1.853 . . . . 0.0 116.003 178.749 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -67.65 -27.7 67.09 Favored 'General case' 0 N--CA 1.482 1.157 0 CA-C-N 114.15 -1.386 . . . . 0.0 113.209 173.104 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.764 HG22 HG22 ' A' ' 59' ' ' ILE . 78.8 t -70.92 -33.18 51.06 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.048 0 C-N-CA 123.337 0.655 . . . . 0.0 111.972 177.794 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.445 ' HB ' ' O ' ' A' ' 65' ' ' ARG . 14.1 mm -51.07 -44.38 28.23 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.022 0 C-N-CA 123.805 0.842 . . . . 0.0 110.894 166.831 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -71.96 -48.61 43.93 Favored 'General case' 0 N--CA 1.478 0.957 0 O-C-N 124.263 0.977 . . . . 0.0 112.697 176.727 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' TRP . . . . . 0.42 ' O ' ' HB2' ' A' ' 4' ' ' GLU . 40.6 t90 . . . . . 0 N--CA 1.48 1.041 0 C-N-CA 126.045 1.738 . . . . 0.0 113.519 -178.469 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.579 ' HE2' HG22 ' A' ' 15' ' ' VAL . 67.2 mtp . . . . . 0 N--CA 1.479 1.013 0 N-CA-C 112.615 0.598 . . . . 0.0 112.615 . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . 0.542 ' HA ' ' O ' ' A' ' 7' ' ' ILE . . . -53.67 -52.53 59.68 Favored 'General case' 0 CA--C 1.542 0.653 0 O-C-N 124.658 1.224 . . . . 0.0 112.691 172.407 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 39.7 ttmt -73.76 -55.32 6.37 Favored 'General case' 0 N--CA 1.472 0.675 0 CA-C-N 112.617 -2.083 . . . . 0.0 114.765 -175.637 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -74.86 -35.83 62.33 Favored 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 114.804 1.409 . . . . 0.0 114.804 -170.154 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . 0.532 ' HB2' HD11 ' A' ' 7' ' ' ILE . 61.1 m-85 -113.89 -23.23 9.73 Favored 'General case' 0 N--CA 1.48 1.045 0 N-CA-C 116.92 2.192 . . . . 0.0 116.92 -170.999 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 87.23 59.12 1.79 Allowed Glycine 0 N--CA 1.488 2.121 0 O-C-N 125.151 1.532 . . . . 0.0 111.878 -176.472 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.542 ' O ' ' HA ' ' A' ' 2' ' ' ALA . 1.0 OUTLIER -119.07 139.74 27.81 Favored Pre-proline 0 N--CA 1.48 1.031 0 C-N-CA 125.061 1.344 . . . . 0.0 110.412 178.85 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_endo -83.2 151.86 13.93 Favored 'Trans proline' 0 N--CA 1.455 -0.757 0 N-CA-C 108.714 -1.302 . . . . 0.0 108.714 162.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -42.76 -38.28 2.05 Favored 'General case' 0 N--CA 1.471 0.597 0 N-CA-C 116.403 2.001 . . . . 0.0 116.403 -179.629 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -30.62 -59.26 0.2 Allowed 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 127.081 2.153 . . . . 0.0 113.99 168.594 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.897 HG13 HG21 ' A' ' 31' ' ' ILE . 17.2 m -87.98 -31.01 5.61 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.668 0 N-CA-C 114.627 1.344 . . . . 0.0 114.627 -170.903 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -67.3 -29.27 68.81 Favored 'General case' 0 CA--C 1.549 0.927 0 CA-C-N 116.302 -0.408 . . . . 0.0 112.092 169.757 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . 0.523 ' HA3' HD11 ' A' ' 16' ' ' LEU . . . -67.56 -41.81 89.42 Favored Glycine 0 CA--C 1.545 1.908 0 C-N-CA 125.368 1.461 . . . . 0.0 112.936 171.209 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 0.527 HG21 HG13 ' A' ' 28' ' ' ILE . 8.6 m -65.84 -35.87 81.87 Favored 'General case' 0 N--CA 1.475 0.778 0 N-CA-C 113.046 0.758 . . . . 0.0 113.046 173.503 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.659 HG21 HD23 ' A' ' 32' ' ' LEU . 2.3 t -49.24 -38.48 11.75 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.066 0 C-N-CA 124.47 1.108 . . . . 0.0 113.599 166.126 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.641 HD21 ' HG3' ' A' ' 64' ' ' LYS . 84.6 mt -61.0 -38.12 84.91 Favored 'General case' 0 N--CA 1.475 0.822 0 N-CA-C 113.602 0.964 . . . . 0.0 113.602 178.648 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 35.2 t-20 -52.23 -42.72 63.83 Favored 'General case' 0 CA--C 1.547 0.838 0 O-C-N 124.0 0.813 . . . . 0.0 111.421 172.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -60.43 -56.3 18.61 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.816 0 CA-C-N 115.046 -0.979 . . . . 0.0 113.045 173.14 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.765 HG11 ' HA ' ' A' ' 56' ' ' LYS . 5.5 t -58.96 -49.69 82.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 124.026 0.829 . . . . 0.0 112.698 -177.53 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . 0.444 ' OE1' ' HB3' ' A' ' 16' ' ' LEU . 24.5 mt-10 -72.35 -42.4 65.38 Favored 'General case' 0 N--CA 1.473 0.696 0 N-CA-C 116.57 2.063 . . . . 0.0 116.57 -175.236 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -103.92 -25.87 12.88 Favored 'General case' 0 N--CA 1.481 1.125 0 N-CA-C 115.231 1.567 . . . . 0.0 115.231 -173.022 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 77.4 41.23 21.36 Favored Glycine 0 CA--C 1.541 1.699 0 N-CA-C 110.467 -1.053 . . . . 0.0 110.467 -165.71 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -76.44 173.86 54.01 Favored Glycine 0 CA--C 1.535 1.316 0 C-N-CA 124.914 1.245 . . . . 0.0 112.689 -173.439 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' TRP . . . . . 0.406 ' HB3' HG21 ' A' ' 26' ' ' THR . 3.6 m-90 -69.16 101.79 1.53 Allowed 'General case' 0 N--CA 1.473 0.72 0 CA-C-O 123.341 1.544 . . . . 0.0 110.93 -178.92 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.401 HG22 HG22 ' A' ' 51' ' ' ILE . 9.8 p -48.51 -29.44 2.53 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.821 0 CA-C-N 112.658 -2.064 . . . . 0.0 114.86 172.736 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.406 HG21 ' HB3' ' A' ' 24' ' ' TRP . 11.1 t -60.04 -46.62 88.93 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 123.73 0.812 . . . . 0.0 112.929 179.745 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' THR . . . . . 0.535 ' O ' HG12 ' A' ' 31' ' ' ILE . 2.0 m -60.09 -48.13 82.98 Favored 'General case' 0 N--CA 1.481 1.08 0 CA-C-N 114.144 -1.389 . . . . 0.0 109.992 175.913 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.527 HG13 HG21 ' A' ' 14' ' ' THR . 1.8 mp -58.32 -53.03 51.81 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.023 0 C-N-CA 123.912 0.885 . . . . 0.0 110.771 179.301 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 65.5 t -53.98 -47.81 64.62 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.744 0 CA-C-O 118.118 -0.944 . . . . 0.0 111.474 177.551 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 20.9 m -61.04 -36.91 80.83 Favored 'General case' 0 N--CA 1.481 1.119 0 N-CA-C 114.446 1.276 . . . . 0.0 114.446 178.672 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.897 HG21 HG13 ' A' ' 11' ' ' VAL . 42.2 mm -72.98 -42.44 59.77 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.93 0 C-N-CA 124.246 1.018 . . . . 0.0 109.463 178.88 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.659 HD23 HG21 ' A' ' 15' ' ' VAL . 4.2 mm? -57.83 -53.06 62.48 Favored 'General case' 0 N--CA 1.484 1.259 0 C-N-CA 125.097 1.359 . . . . 0.0 112.897 173.796 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -65.57 -28.11 68.91 Favored 'General case' 0 N--CA 1.481 1.104 0 N-CA-C 115.406 1.632 . . . . 0.0 115.406 178.329 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -52.37 -32.0 36.48 Favored 'General case' 0 N--CA 1.486 1.358 0 N-CA-C 113.907 1.077 . . . . 0.0 113.907 171.949 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 50.7 t -70.26 -28.04 34.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 C-N-CA 126.169 1.788 . . . . 0.0 112.41 173.816 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 105.58 -106.37 2.62 Favored Glycine 0 CA--C 1.532 1.125 0 C-N-CA 124.851 1.215 . . . . 0.0 110.678 179.344 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 8.9 p -60.64 -39.65 89.1 Favored 'General case' 0 N--CA 1.472 0.654 0 CA-C-N 113.431 -1.384 . . . . 0.0 114.116 -177.93 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -51.42 -45.08 53.49 Favored Glycine 0 CA--C 1.542 1.744 0 O-C-N 124.354 1.033 . . . . 0.0 113.8 177.232 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.5 ' HA3' ' HB3' ' A' ' 32' ' ' LEU . . . -59.53 -58.48 14.13 Favored Glycine 0 N--CA 1.482 1.765 0 N-CA-C 111.435 -0.666 . . . . 0.0 111.435 173.836 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 72.0 mt -57.54 -45.6 84.88 Favored 'General case' 0 N--CA 1.476 0.861 0 N-CA-C 115.937 1.828 . . . . 0.0 115.937 -176.297 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 79.5 p -62.54 -42.36 99.47 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-N 115.384 -0.825 . . . . 0.0 112.938 176.148 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 11.9 tp -63.59 -43.42 96.98 Favored 'General case' 0 N--CA 1.474 0.762 0 N-CA-C 110.026 -0.361 . . . . 0.0 110.026 175.731 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 94.7 mt -62.95 -35.97 81.91 Favored 'General case' 0 N--CA 1.475 0.784 0 N-CA-C 114.414 1.265 . . . . 0.0 114.414 -179.808 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -69.68 -40.69 76.24 Favored 'General case' 0 N--CA 1.473 0.691 0 O-C-N 123.83 0.706 . . . . 0.0 112.782 174.176 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -68.57 -36.17 78.39 Favored 'General case' 0 N--CA 1.475 0.817 0 CA-C-O 121.286 0.565 . . . . 0.0 112.128 177.508 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -53.95 -21.76 8.71 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 126.58 1.952 . . . . 0.0 115.587 173.197 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -50.01 -32.89 20.42 Favored Glycine 0 N--CA 1.478 1.49 0 C-N-CA 125.144 1.354 . . . . 0.0 114.007 178.936 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 68.0 ttp85 -55.36 -55.32 32.9 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 124.918 1.287 . . . . 0.0 113.33 178.573 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 8.2 tt0 -133.29 34.79 3.5 Favored 'General case' 0 CA--C 1.548 0.869 0 N-CA-C 114.803 1.408 . . . . 0.0 114.803 -173.931 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 32.8 t 44.31 127.09 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.041 0 N-CA-C 114.147 1.165 . . . . 0.0 114.147 -172.646 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.401 HG22 HG22 ' A' ' 25' ' ' VAL 0.266 8.8 tp -30.47 -57.28 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 N-CA-C 119.036 2.976 . . . . 0.0 119.036 -169.812 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 81.9 tttt -60.99 -56.0 26.25 Favored 'General case' 0 N--CA 1.478 0.927 0 N-CA-C 112.065 0.394 . . . . 0.0 112.065 -179.477 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -61.16 -38.44 86.44 Favored 'General case' 0 N--CA 1.486 1.363 0 C-N-CA 123.94 0.896 . . . . 0.0 113.203 177.603 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 89.9 t80 -52.41 -60.24 3.47 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 125.618 1.567 . . . . 0.0 112.253 175.479 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.406 HD12 HG12 ' A' ' 15' ' ' VAL . 64.5 mt -65.9 -38.88 89.89 Favored 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 114.053 1.131 . . . . 0.0 114.053 -179.929 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.765 ' HA ' HG11 ' A' ' 19' ' ' VAL . 30.9 mttm -53.81 -54.04 43.92 Favored 'General case' 0 N--CA 1.48 1.039 0 CA-C-N 114.029 -1.441 . . . . 0.0 113.377 178.482 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 55.2 tttp -68.93 -47.23 66.23 Favored 'General case' 0 CA--C 1.541 0.621 0 CA-C-N 115.294 -0.866 . . . . 0.0 112.537 176.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . 0.467 ' O ' ' HB2' ' A' ' 62' ' ' LYS . 66.8 mt-10 -56.61 -51.66 67.8 Favored 'General case' 0 N--CA 1.477 0.898 0 N-CA-C 112.26 0.467 . . . . 0.0 112.26 -175.351 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.48 ' HA ' ' HB2' ' A' ' 62' ' ' LYS . 6.3 mm -81.02 -20.61 11.21 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.258 0 N-CA-C 112.99 0.737 . . . . 0.0 112.99 -176.218 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.424 ' HD3' ' HA ' ' A' ' 60' ' ' LYS . 10.2 tppt? -62.44 -34.02 75.95 Favored 'General case' 0 CA--C 1.542 0.657 0 CA-C-O 121.985 0.898 . . . . 0.0 112.865 170.234 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 93.0 mttt -84.95 -44.67 12.91 Favored 'General case' 0 CA--C 1.546 0.806 0 CA-C-N 112.814 -1.994 . . . . 0.0 113.556 175.507 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.48 ' HB2' ' HA ' ' A' ' 59' ' ' ILE . 0.2 OUTLIER -65.06 -45.04 86.98 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-N 113.529 -1.669 . . . . 0.0 115.329 -172.929 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 85.91 111.72 0.79 Allowed Glycine 0 N--CA 1.47 0.949 0 N-CA-C 108.356 -1.898 . . . . 0.0 108.356 -172.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.813 ' HD2' ' H ' ' A' ' 64' ' ' LYS . 9.9 mptt -23.41 -46.53 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.437 0 N-CA-C 119.516 3.154 . . . . 0.0 119.516 -174.829 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . 0.284 8.9 ttt180 -48.92 -44.22 40.14 Favored 'General case' 0 N--CA 1.471 0.618 0 N-CA-C 115.365 1.617 . . . . 0.0 115.365 173.052 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -58.74 -31.25 68.15 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 116.243 -1.837 . . . . 0.0 113.124 174.575 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.534 HG13 ' O ' ' A' ' 64' ' ' LYS . 0.5 OUTLIER -64.06 -41.84 93.76 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.259 0 CA-C-N 119.393 0.997 . . . . 0.0 111.573 178.766 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 35.8 mm -57.82 -39.06 69.16 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.887 0 CA-C-N 113.251 -1.795 . . . . 0.0 110.471 177.141 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -80.24 -49.18 11.96 Favored 'General case' 0 N--CA 1.475 0.805 0 N-CA-C 114.288 1.218 . . . . 0.0 114.288 175.05 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 24.3 t90 . . . . . 0 N--CA 1.484 1.265 0 C-N-CA 127.055 2.142 . . . . 0.0 112.708 -179.363 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.747 ' HE2' HG22 ' A' ' 15' ' ' VAL . 52.3 mtp . . . . . 0 N--CA 1.479 0.979 0 N-CA-C 113.417 0.895 . . . . 0.0 113.417 . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -61.31 -49.27 77.68 Favored 'General case' 0 N--CA 1.474 0.757 0 CA-C-N 115.018 -0.992 . . . . 0.0 112.287 173.974 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 57.4 tttm -75.82 -60.46 2.31 Favored 'General case' 0 N--CA 1.478 0.948 0 CA-C-N 114.046 -1.434 . . . . 0.0 114.085 -176.428 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . 0.403 ' HB2' ' O ' ' A' ' 70' ' ' TRP . 2.1 mp0 -75.96 -29.07 58.16 Favored 'General case' 0 N--CA 1.474 0.744 0 N-CA-C 115.656 1.724 . . . . 0.0 115.656 -169.751 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . 0.417 ' HD1' ' HB2' ' A' ' 41' ' ' SER . 43.4 m-85 -115.11 -18.21 11.23 Favored 'General case' 0 N--CA 1.48 1.051 0 N-CA-C 117.496 2.406 . . . . 0.0 117.496 -173.243 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 72.82 40.67 51.94 Favored Glycine 0 CA--C 1.542 1.756 0 O-C-N 124.543 1.152 . . . . 0.0 112.11 -171.126 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.79 HG22 HG22 ' A' ' 11' ' ' VAL . 0.6 OUTLIER -121.91 106.23 36.89 Favored Pre-proline 0 N--CA 1.474 0.73 0 C-N-CA 124.566 1.146 . . . . 0.0 110.288 179.425 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_endo -63.93 168.23 12.5 Favored 'Trans proline' 0 CA--C 1.54 0.791 0 C-N-CA 122.567 2.178 . . . . 0.0 112.582 -172.825 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -51.34 -33.32 28.91 Favored 'General case' 0 N--CA 1.477 0.914 0 CA-C-N 113.617 -1.629 . . . . 0.0 114.212 172.493 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -49.87 -34.45 20.13 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 125.9 1.68 . . . . 0.0 114.567 176.099 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 1.066 HG13 HG21 ' A' ' 31' ' ' ILE . 30.4 m -112.0 -29.4 2.37 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.407 0 N-CA-C 114.145 1.165 . . . . 0.0 114.145 179.819 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . 0.406 ' O ' ' HG ' ' A' ' 16' ' ' LEU . . . -66.77 -37.35 84.41 Favored 'General case' 0 N--CA 1.475 0.794 0 N-CA-C 113.393 0.886 . . . . 0.0 113.393 174.791 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -61.09 -37.9 94.68 Favored Glycine 0 CA--C 1.544 1.871 0 C-N-CA 123.92 0.771 . . . . 0.0 112.287 170.62 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -70.32 -32.91 70.87 Favored 'General case' 0 N--CA 1.487 1.407 0 C-N-CA 125.051 1.34 . . . . 0.0 113.363 179.44 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.747 HG22 ' HE2' ' A' ' 1' ' ' MET . 10.4 t -61.2 -36.11 70.47 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.255 0 C-N-CA 123.895 0.878 . . . . 0.0 111.982 169.469 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.58 HD12 ' HB3' ' A' ' 64' ' ' LYS . 48.3 mt -66.09 -37.73 86.5 Favored 'General case' 0 N--CA 1.471 0.61 0 N-CA-C 113.242 0.83 . . . . 0.0 113.242 177.423 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 11.0 t30 -55.12 -44.59 75.13 Favored 'General case' 0 N--CA 1.478 0.934 0 CA-C-N 115.341 -0.845 . . . . 0.0 111.339 172.798 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.514 ' HB ' ' O ' ' A' ' 15' ' ' VAL . 12.8 t -50.64 -52.56 15.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 C-N-CA 124.642 1.177 . . . . 0.0 112.182 171.67 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.721 HG11 ' HA ' ' A' ' 56' ' ' LYS . 11.4 t -61.91 -52.66 57.88 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.191 0 C-N-CA 124.568 1.147 . . . . 0.0 111.479 -178.452 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 10.1 mt-10 -54.82 -44.04 73.51 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 125.692 1.597 . . . . 0.0 115.057 -178.401 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -93.17 -17.1 24.13 Favored 'General case' 0 CA--C 1.546 0.822 0 N-CA-C 115.701 1.741 . . . . 0.0 115.701 -175.376 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 68.39 40.96 86.69 Favored Glycine 0 CA--C 1.544 1.889 0 N-CA-C 110.438 -1.065 . . . . 0.0 110.438 -165.489 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -100.46 164.11 18.95 Favored Glycine 0 CA--C 1.537 1.428 0 C-N-CA 124.827 1.203 . . . . 0.0 114.145 -167.259 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' TRP . . . . . 0.495 ' HD1' ' HZ2' ' A' ' 52' ' ' LYS . 5.8 m-90 -67.69 104.53 1.66 Allowed 'General case' 0 C--O 1.24 0.583 0 CA-C-O 122.577 1.179 . . . . 0.0 113.831 -175.341 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.456 HG13 HG13 ' A' ' 51' ' ' ILE . 5.5 p -55.59 -25.13 17.43 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.825 0 CA-C-N 113.369 -1.741 . . . . 0.0 113.847 169.191 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 1.7 t -60.51 -40.33 91.04 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 114.305 1.224 . . . . 0.0 114.305 179.727 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 1.9 m -68.54 -39.1 81.26 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 122.928 0.491 . . . . 0.0 110.653 175.811 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 2.8 mp -72.23 -31.07 37.9 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.077 0 C-N-CA 124.854 1.262 . . . . 0.0 112.576 177.9 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.442 HG21 ' O ' ' A' ' 25' ' ' VAL . 55.6 t -55.54 -36.42 41.74 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.826 0 C-N-CA 123.104 0.562 . . . . 0.0 112.201 171.737 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 29.8 p -60.98 -26.15 67.37 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 114.813 1.412 . . . . 0.0 114.813 173.788 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 1.066 HG21 HG13 ' A' ' 11' ' ' VAL . 34.7 mm -85.01 -37.84 12.69 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.914 0 C-N-CA 123.901 0.88 . . . . 0.0 109.85 176.493 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.613 HD23 ' HB ' ' A' ' 11' ' ' VAL . 4.3 mm? -60.54 -34.49 74.21 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 124.835 1.254 . . . . 0.0 112.255 172.636 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' THR . . . . . 0.509 ' HA ' ' HA3' ' A' ' 38' ' ' GLY . 9.1 p -75.2 -36.24 61.43 Favored 'General case' 0 N--CA 1.474 0.775 0 N-CA-C 115.413 1.634 . . . . 0.0 115.413 174.057 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -52.88 -25.24 11.04 Favored 'General case' 0 N--CA 1.482 1.155 0 O-C-N 124.64 1.212 . . . . 0.0 114.183 172.236 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.408 HG22 HG23 ' A' ' 11' ' ' VAL . 93.0 t -60.82 -31.38 49.36 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.133 0 C-N-CA 126.32 1.848 . . . . 0.0 113.238 171.225 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . 0.42 ' C ' ' H ' ' A' ' 38' ' ' GLY . . . 112.58 -53.68 0.58 Allowed Glycine 0 CA--C 1.541 1.688 0 N-CA-C 112.093 -0.403 . . . . 0.0 112.093 -179.209 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 9.8 p -66.58 15.59 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.564 0 C-N-CA 125.572 1.549 . . . . 0.0 114.968 174.555 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.509 ' HA3' ' HA ' ' A' ' 33' ' ' THR . . . 54.28 15.9 6.05 Favored Glycine 0 N--CA 1.486 2.025 0 C-N-CA 126.266 1.888 . . . . 0.0 116.548 174.835 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.508 ' HA2' ' HB3' ' A' ' 32' ' ' LEU . . . 53.5 16.35 5.07 Favored Glycine 0 N--CA 1.487 2.069 0 C-N-CA 124.323 0.964 . . . . 0.0 113.461 -163.118 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 9.7 mt -54.6 -46.83 73.88 Favored 'General case' 0 N--CA 1.481 1.106 0 N-CA-C 116.563 2.06 . . . . 0.0 116.563 -168.501 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' SER . . . . . 0.417 ' HB2' ' HD1' ' A' ' 5' ' ' PHE . 11.6 p -60.11 -44.83 94.56 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 114.823 -1.08 . . . . 0.0 113.397 177.636 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.531 HD21 ' HE1' ' A' ' 1' ' ' MET . 10.8 tp -63.09 -50.31 71.04 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 123.887 0.875 . . . . 0.0 110.287 171.923 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 82.9 mt -60.77 -28.64 68.88 Favored 'General case' 0 N--CA 1.477 0.887 0 N-CA-C 114.875 1.435 . . . . 0.0 114.875 -177.23 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -67.3 -47.64 69.99 Favored 'General case' 0 N--CA 1.474 0.736 0 O-C-N 123.805 0.691 . . . . 0.0 112.798 170.785 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -62.46 -33.61 75.18 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 123.375 0.67 . . . . 0.0 112.44 179.247 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.424 ' HB3' ' HA ' ' A' ' 51' ' ' ILE . . . -57.18 -23.75 49.75 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 126.885 2.074 . . . . 0.0 115.546 174.655 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -52.11 -35.03 40.64 Favored Glycine 0 CA--C 1.538 1.486 0 C-N-CA 125.068 1.318 . . . . 0.0 113.91 -177.904 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 40.0 ttp180 -51.57 -53.51 37.33 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 125.0 1.32 . . . . 0.0 112.958 -176.233 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 20.6 tt0 -128.76 36.8 4.18 Favored 'General case' 0 N--CA 1.478 0.963 0 CA-C-N 115.166 -0.924 . . . . 0.0 113.153 -176.247 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 8.0 t 43.36 128.4 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 125.68 1.592 . . . . 0.0 114.474 -172.07 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.456 HG13 HG13 ' A' ' 25' ' ' VAL . 8.0 tp -32.25 -52.47 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.258 0 N-CA-C 118.156 2.65 . . . . 0.0 118.156 -171.161 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 0.495 ' HZ2' ' HD1' ' A' ' 24' ' ' TRP . 2.3 ttmt -60.37 -67.46 0.39 Allowed 'General case' 0 N--CA 1.472 0.631 0 N-CA-C 114.461 1.282 . . . . 0.0 114.461 178.441 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -56.62 -34.64 67.46 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 124.276 1.03 . . . . 0.0 113.667 177.817 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 66.7 t80 -50.86 -62.27 1.71 Allowed 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 124.875 1.27 . . . . 0.0 110.589 174.541 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.624 HD12 HG11 ' A' ' 15' ' ' VAL . 60.7 mt -65.26 -37.91 88.66 Favored 'General case' 0 N--CA 1.475 0.783 0 N-CA-C 115.001 1.482 . . . . 0.0 115.001 -176.123 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.721 ' HA ' HG11 ' A' ' 19' ' ' VAL . 93.9 mttt -61.94 -37.15 83.62 Favored 'General case' 0 N--CA 1.473 0.7 0 CA-C-N 113.445 -1.707 . . . . 0.0 114.732 178.523 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.469 ' HE3' ' HE3' ' A' ' 61' ' ' LYS . 80.2 tttt -85.64 -52.55 5.73 Favored 'General case' 0 CA--C 1.535 0.395 0 O-C-N 124.514 1.134 . . . . 0.0 111.241 173.03 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . 0.416 ' O ' ' HB2' ' A' ' 62' ' ' LYS . 29.0 tt0 -55.19 -51.08 67.67 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-O 118.687 -0.673 . . . . 0.0 111.771 -173.014 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.725 HG22 HG23 ' A' ' 67' ' ' VAL . 3.7 mm -75.96 -27.1 17.99 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.281 0 N-CA-C 112.769 0.655 . . . . 0.0 112.769 -173.64 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.458 ' HB2' ' O ' ' A' ' 56' ' ' LYS . 14.9 tttp -60.28 -36.32 77.56 Favored 'General case' 0 CA--C 1.544 0.749 0 CA-C-O 122.643 1.211 . . . . 0.0 113.496 174.02 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . 0.469 ' HE3' ' HE3' ' A' ' 57' ' ' LYS . 9.7 mttm -85.01 -33.17 22.6 Favored 'General case' 0 N--CA 1.474 0.757 0 CA-C-N 112.023 -2.353 . . . . 0.0 112.236 -179.412 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.416 ' HB2' ' O ' ' A' ' 58' ' ' GLU . 66.8 tttt -85.33 -60.13 2.12 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-N 112.744 -2.026 . . . . 0.0 111.561 -168.484 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . 0.46 ' O ' HG22 ' A' ' 67' ' ' VAL . . . 113.11 126.03 4.45 Favored Glycine 0 CA--C 1.532 1.122 0 N-CA-C 110.08 -1.208 . . . . 0.0 110.08 -172.297 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.58 ' HB3' HD12 ' A' ' 16' ' ' LEU . 0.0 OUTLIER -59.4 -42.04 90.81 Favored 'General case' 0 N--CA 1.482 1.135 0 N-CA-C 115.59 1.7 . . . . 0.0 115.59 -173.128 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -58.13 -47.3 83.73 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 125.251 1.42 . . . . 0.0 113.648 179.353 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -62.94 -32.05 73.28 Favored 'General case' 0 N--CA 1.475 0.777 0 CA-C-N 114.534 -1.212 . . . . 0.0 113.769 173.002 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.725 HG23 HG22 ' A' ' 59' ' ' ILE . 48.5 t -68.8 -35.97 72.07 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.989 0 C-N-CA 122.872 0.469 . . . . 0.0 111.179 179.497 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 18.0 mt -53.42 -48.5 57.08 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.01 0 C-N-CA 124.267 1.027 . . . . 0.0 109.722 169.385 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -67.08 -47.49 71.1 Favored 'General case' 0 N--CA 1.477 0.907 0 CA-C-N 115.581 -0.736 . . . . 0.0 112.901 178.808 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' TRP . . . . . 0.403 ' O ' ' HB2' ' A' ' 4' ' ' GLU . 43.0 t90 . . . . . 0 N--CA 1.477 0.891 0 C-N-CA 125.78 1.632 . . . . 0.0 112.22 -179.512 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.5 ' HB3' HG23 ' A' ' 7' ' ' ILE . 76.6 mtp . . . . . 0 C--O 1.238 0.487 0 N-CA-C 113.039 0.755 . . . . 0.0 113.039 . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . 0.439 ' HA ' ' O ' ' A' ' 7' ' ' ILE . . . -55.78 -54.13 48.14 Favored 'General case' 0 N--CA 1.475 0.814 0 CA-C-N 114.988 -1.005 . . . . 0.0 111.649 172.882 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 51.1 tttp -72.86 -61.02 1.96 Allowed 'General case' 0 N--CA 1.481 1.08 0 CA-C-N 113.952 -1.476 . . . . 0.0 113.982 -174.246 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -71.0 -37.25 72.66 Favored 'General case' 0 N--CA 1.475 0.815 0 N-CA-C 115.48 1.659 . . . . 0.0 115.48 -171.388 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . 0.413 ' HD2' ' HA ' ' A' ' 1' ' ' MET . 52.1 m-85 -107.95 -15.92 14.42 Favored 'General case' 0 N--CA 1.477 0.885 0 N-CA-C 116.532 2.049 . . . . 0.0 116.532 -172.063 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 79.65 54.25 4.02 Favored Glycine 0 CA--C 1.541 1.701 0 CA-C-O 122.311 0.95 . . . . 0.0 112.508 -176.023 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.5 HG23 ' HB3' ' A' ' 1' ' ' MET . 0.5 OUTLIER -112.73 147.99 38.34 Favored Pre-proline 0 N--CA 1.482 1.128 0 CA-C-N 113.526 -1.337 . . . . 0.0 111.645 -178.839 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 91.0 Cg_endo -86.06 153.39 9.69 Favored 'Trans proline' 0 CA--C 1.538 0.723 0 C-N-CA 121.685 1.59 . . . . 0.0 109.365 163.309 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -49.7 -33.67 16.55 Favored 'General case' 0 N--CA 1.47 0.574 0 N-CA-C 114.966 1.469 . . . . 0.0 114.966 176.346 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -39.08 -43.73 1.06 Allowed 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 127.792 2.437 . . . . 0.0 115.174 171.626 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.969 HG11 HG21 ' A' ' 31' ' ' ILE . 20.0 m -102.31 -29.09 3.04 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.914 0 N-CA-C 114.269 1.211 . . . . 0.0 114.269 -173.626 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -67.48 -30.65 70.41 Favored 'General case' 0 N--CA 1.489 1.483 0 CA-C-N 115.727 -0.67 . . . . 0.0 112.197 171.526 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . 0.446 ' O ' ' HB2' ' A' ' 16' ' ' LEU . . . -63.57 -43.05 98.6 Favored Glycine 0 CA--C 1.553 2.44 0 C-N-CA 124.278 0.942 . . . . 0.0 112.625 168.814 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 0.793 HG21 HG13 ' A' ' 28' ' ' ILE . 3.9 m -62.78 -37.49 86.87 Favored 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 113.371 0.878 . . . . 0.0 113.371 176.792 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.468 HG22 ' HE3' ' A' ' 1' ' ' MET . 2.4 t -50.52 -37.73 15.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 C-N-CA 124.155 0.982 . . . . 0.0 113.337 168.254 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.714 HD21 ' HG3' ' A' ' 64' ' ' LYS . 84.8 mt -61.98 -37.28 84.22 Favored 'General case' 0 N--CA 1.479 0.996 0 N-CA-C 113.989 1.107 . . . . 0.0 113.989 177.446 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 14.6 t-20 -53.99 -47.06 71.82 Favored 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 123.223 0.609 . . . . 0.0 110.864 173.417 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 3.1 t -52.01 -56.26 6.87 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.256 0 CA-C-N 114.996 -1.002 . . . . 0.0 112.67 170.556 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.745 HG11 ' HA ' ' A' ' 56' ' ' LYS . 3.8 t -60.11 -51.17 76.04 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 O-C-N 124.549 1.156 . . . . 0.0 111.523 -176.307 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -66.49 -44.37 82.83 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 126.166 1.786 . . . . 0.0 115.705 -175.636 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -101.59 -12.41 18.49 Favored 'General case' 0 CA--C 1.548 0.891 0 N-CA-C 115.413 1.635 . . . . 0.0 115.413 -170.492 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . 0.423 ' HA3' ' HE2' ' A' ' 56' ' ' LYS . . . 66.69 41.53 93.79 Favored Glycine 0 N--CA 1.482 1.762 0 N-CA-C 110.137 -1.185 . . . . 0.0 110.137 -161.734 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -74.53 158.92 51.98 Favored Glycine 0 N--CA 1.471 0.984 0 C-N-CA 125.151 1.358 . . . . 0.0 114.266 -169.3 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' TRP . . . . . 0.433 ' HB3' HG21 ' A' ' 26' ' ' THR . 88.7 m95 -61.68 102.99 0.29 Allowed 'General case' 0 N--CA 1.473 0.724 0 CA-C-N 113.277 -1.462 . . . . 0.0 111.785 175.538 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.56 HG22 HG13 ' A' ' 51' ' ' ILE . 2.7 p -54.49 -24.19 12.25 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.625 0 CA-C-N 114.279 -1.328 . . . . 0.0 114.58 175.331 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.433 HG21 ' HB3' ' A' ' 24' ' ' TRP . 3.6 t -60.29 -44.24 95.55 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 124.261 1.024 . . . . 0.0 113.632 -179.915 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' THR . . . . . 0.566 ' O ' HG12 ' A' ' 31' ' ' ILE . 0.8 OUTLIER -65.68 -46.34 79.43 Favored 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 123.799 0.84 . . . . 0.0 110.212 176.49 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.793 HG13 HG21 ' A' ' 14' ' ' THR . 2.0 mp -58.98 -51.49 71.87 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.979 0 C-N-CA 124.438 1.095 . . . . 0.0 111.622 177.375 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 50.6 t -53.11 -48.73 53.07 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.826 0 CA-C-O 117.037 -1.459 . . . . 0.0 111.556 176.59 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . 0.284 1.5 p -61.99 -29.85 70.54 Favored 'General case' 0 N--CA 1.479 1.016 0 N-CA-C 115.438 1.644 . . . . 0.0 115.438 179.712 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.969 HG21 HG11 ' A' ' 11' ' ' VAL . 21.2 mm -76.65 -43.26 34.51 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.006 0 C-N-CA 124.174 0.99 . . . . 0.0 110.115 176.38 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.629 HD23 ' HB ' ' A' ' 11' ' ' VAL . 4.2 mm? -55.52 -56.02 25.06 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 124.951 1.3 . . . . 0.0 112.427 172.796 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 3.1 p -64.0 -30.88 71.92 Favored 'General case' 0 N--CA 1.475 0.814 0 N-CA-C 114.825 1.417 . . . . 0.0 114.825 177.599 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -53.31 -25.41 14.74 Favored 'General case' 0 N--CA 1.482 1.134 0 N-CA-C 114.649 1.351 . . . . 0.0 114.649 172.355 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 61.7 t -74.13 -29.08 24.36 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.356 0 C-N-CA 124.547 1.139 . . . . 0.0 111.574 172.669 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 108.78 -116.97 4.83 Favored Glycine 0 N--CA 1.47 0.963 0 C-N-CA 125.0 1.286 . . . . 0.0 111.022 -176.421 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 33.8 p -54.72 -40.22 69.02 Favored 'General case' 0 N--CA 1.485 1.314 0 CA-C-N 113.487 -1.357 . . . . 0.0 114.494 -178.643 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -51.72 -46.2 54.32 Favored Glycine 0 CA--C 1.54 1.616 0 C-N-CA 124.851 1.215 . . . . 0.0 113.608 179.324 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.468 ' HA3' ' HB3' ' A' ' 32' ' ' LEU . . . -57.11 -54.96 32.94 Favored Glycine 0 N--CA 1.479 1.507 0 CA-C-N 115.034 -0.583 . . . . 0.0 111.76 174.129 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 78.4 mt -60.25 -41.65 93.65 Favored 'General case' 0 N--CA 1.482 1.142 0 N-CA-C 115.434 1.642 . . . . 0.0 115.434 -177.754 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 42.7 p -63.69 -43.28 97.1 Favored 'General case' 0 N--CA 1.476 0.863 0 N-CA-C 113.294 0.85 . . . . 0.0 113.294 174.922 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.443 HD11 ' HE2' ' A' ' 1' ' ' MET . 12.4 tp -61.7 -46.8 88.13 Favored 'General case' 0 N--CA 1.474 0.741 0 CA-C-O 121.22 0.534 . . . . 0.0 110.435 174.002 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 94.8 mt -59.96 -39.15 84.64 Favored 'General case' 0 N--CA 1.482 1.153 0 CA-C-N 114.457 -1.247 . . . . 0.0 114.328 179.983 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -61.93 -44.94 95.73 Favored 'General case' 0 N--CA 1.477 0.911 0 N-CA-C 112.362 0.504 . . . . 0.0 112.362 173.289 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -65.96 -33.29 75.47 Favored 'General case' 0 N--CA 1.479 0.992 0 N-CA-C 113.564 0.95 . . . . 0.0 113.564 177.339 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -75.65 -21.56 57.57 Favored 'General case' 0 CA--C 1.543 0.698 0 N-CA-C 116.888 2.181 . . . . 0.0 116.888 179.766 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -50.99 -39.8 41.57 Favored Glycine 0 N--CA 1.474 1.185 0 O-C-N 124.308 1.005 . . . . 0.0 113.914 -173.031 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . 0.461 ' HA ' ' HD2' ' A' ' 48' ' ' ARG . 0.3 OUTLIER -59.51 -49.74 76.61 Favored 'General case' 0 CA--C 1.542 0.643 0 CA-C-N 111.239 -2.48 . . . . 0.0 115.876 -176.479 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 5.4 tt0 -114.5 28.86 8.43 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-N 115.29 -0.868 . . . . 0.0 112.982 -175.242 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 94.2 p 48.33 121.45 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 125.9 1.68 . . . . 0.0 113.373 -172.796 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.56 HG13 HG22 ' A' ' 25' ' ' VAL . 7.6 tp -41.47 -46.14 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.42 0 N-CA-C 117.298 2.332 . . . . 0.0 117.298 -173.64 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 34.6 tttm -60.36 -62.6 1.75 Allowed 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 124.582 1.153 . . . . 0.0 112.266 177.035 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -59.66 -38.7 82.17 Favored 'General case' 0 N--CA 1.48 1.044 0 N-CA-C 113.96 1.096 . . . . 0.0 113.96 177.598 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 84.3 t80 -49.84 -62.11 1.75 Allowed 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 125.432 1.493 . . . . 0.0 111.071 177.343 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.418 HD21 HG12 ' A' ' 15' ' ' VAL . 45.0 mt -61.87 -38.98 90.28 Favored 'General case' 0 N--CA 1.484 1.234 0 N-CA-C 114.477 1.288 . . . . 0.0 114.477 -176.829 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.745 ' HA ' HG11 ' A' ' 19' ' ' VAL . 92.3 mttt -55.19 -54.64 40.73 Favored 'General case' 0 N--CA 1.472 0.638 0 O-C-N 124.83 1.331 . . . . 0.0 112.483 177.705 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.571 ' HG2' ' HD2' ' A' ' 61' ' ' LYS . 78.0 tttt -71.76 -45.75 60.66 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-N 114.622 -1.172 . . . . 0.0 112.575 178.452 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 7.7 mm-40 -52.55 -55.36 22.73 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 122.824 0.45 . . . . 0.0 111.087 -177.617 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 5.9 mm -80.1 -23.51 11.68 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 CA-C-N 114.652 -1.158 . . . . 0.0 112.957 -172.635 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.452 ' HB2' ' O ' ' A' ' 56' ' ' LYS . 16.7 tttp -59.08 -38.0 78.43 Favored 'General case' 0 CA--C 1.544 0.73 0 N-CA-C 114.195 1.183 . . . . 0.0 114.195 170.362 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . 0.571 ' HD2' ' HG2' ' A' ' 57' ' ' LYS . 23.4 mtpt -86.2 -43.59 12.87 Favored 'General case' 0 N--CA 1.479 0.994 0 CA-C-N 113.681 -1.599 . . . . 0.0 111.174 -179.518 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 17.3 tttt -72.14 -40.34 68.13 Favored 'General case' 0 N--CA 1.473 0.709 0 CA-C-N 112.664 -2.062 . . . . 0.0 115.048 -173.391 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 85.49 130.22 2.34 Favored Glycine 0 CA--C 1.538 1.5 0 N-CA-C 109.743 -1.343 . . . . 0.0 109.743 -171.817 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.721 ' HD2' ' H ' ' A' ' 64' ' ' LYS . 11.9 mptt -40.7 -45.16 2.33 Favored 'General case' 0 N--CA 1.486 1.348 0 N-CA-C 116.501 2.038 . . . . 0.0 116.501 -179.496 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -53.64 -43.89 69.14 Favored 'General case' 0 N--CA 1.468 0.441 0 N-CA-C 112.174 0.435 . . . . 0.0 112.174 179.391 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -64.55 -29.73 70.76 Favored 'General case' 0 N--CA 1.48 1.044 0 CA-C-N 113.632 -1.622 . . . . 0.0 114.566 174.787 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.658 HG13 ' O ' ' A' ' 64' ' ' LYS . 1.4 p -64.57 -43.07 96.76 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.342 0 CA-C-N 119.629 1.104 . . . . 0.0 111.759 175.137 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 45.1 mm -55.86 -42.64 71.51 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.276 0 CA-C-N 114.082 -1.417 . . . . 0.0 110.023 176.148 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -72.63 -51.43 19.6 Favored 'General case' 0 N--CA 1.48 1.056 0 N-CA-C 113.951 1.093 . . . . 0.0 113.951 175.573 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 25.9 t90 . . . . . 0 N--CA 1.478 0.952 0 C-N-CA 126.752 2.021 . . . . 0.0 112.176 -178.305 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.604 ' HE2' HG22 ' A' ' 15' ' ' VAL . 53.1 mtp . . . . . 0 N--CA 1.469 0.479 0 N-CA-C 112.592 0.59 . . . . 0.0 112.592 . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . 0.499 ' HA ' ' O ' ' A' ' 7' ' ' ILE . . . -56.51 -57.05 14.01 Favored 'General case' 0 N--CA 1.473 0.695 0 CA-C-N 114.823 -1.081 . . . . 0.0 112.12 175.873 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 18.6 ttpp -67.37 -49.2 64.94 Favored 'General case' 0 CA--C 1.547 0.841 0 CA-C-N 112.985 -1.916 . . . . 0.0 113.385 -172.014 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 10.2 tt0 -81.17 -48.08 12.58 Favored 'General case' 0 N--CA 1.477 0.903 0 N-CA-C 114.203 1.186 . . . . 0.0 114.203 -170.088 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . 0.614 ' HB2' HD13 ' A' ' 7' ' ' ILE . 48.0 m-85 -95.86 -17.06 21.41 Favored 'General case' 0 N--CA 1.474 0.733 0 N-CA-C 117.402 2.371 . . . . 0.0 117.402 -170.717 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 83.97 54.9 2.92 Favored Glycine 0 CA--C 1.539 1.564 0 CA-C-O 122.575 1.097 . . . . 0.0 111.052 -174.671 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.614 HD13 ' HB2' ' A' ' 5' ' ' PHE . 1.0 OUTLIER -117.65 142.65 30.91 Favored Pre-proline 0 N--CA 1.475 0.811 0 CA-C-N 113.665 -1.268 . . . . 0.0 110.777 -178.092 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 90.9 Cg_endo -87.82 158.98 7.53 Favored 'Trans proline' 0 CA--C 1.541 0.845 0 C-N-CA 121.26 1.307 . . . . 0.0 109.164 164.844 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -49.09 -32.33 9.55 Favored 'General case' 0 N--CA 1.48 1.07 0 N-CA-C 114.297 1.221 . . . . 0.0 114.297 171.829 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -43.8 -37.1 2.58 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 127.047 2.139 . . . . 0.0 115.615 174.618 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.922 HG11 HG21 ' A' ' 31' ' ' ILE . 26.9 m -109.22 -31.6 2.37 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.074 0 N-CA-C 114.13 1.159 . . . . 0.0 114.13 -179.537 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -69.39 -32.1 70.91 Favored 'General case' 0 N--CA 1.483 1.198 0 N-CA-C 113.354 0.872 . . . . 0.0 113.354 178.301 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -65.81 -36.67 92.52 Favored Glycine 0 N--CA 1.484 1.855 0 CA-C-O 122.717 1.176 . . . . 0.0 112.232 173.953 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 0.473 HG21 HG13 ' A' ' 28' ' ' ILE . 0.2 OUTLIER -68.44 -36.19 78.68 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 126.557 1.943 . . . . 0.0 113.356 176.877 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.604 HG22 ' HE2' ' A' ' 1' ' ' MET . 17.4 t -56.11 -39.82 60.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 C-N-CA 124.093 0.957 . . . . 0.0 112.065 168.167 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 39.6 mt -65.59 -41.18 93.11 Favored 'General case' 0 N--CA 1.476 0.829 0 N-CA-C 113.398 0.888 . . . . 0.0 113.398 179.599 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 25.5 t-20 -50.34 -47.54 55.85 Favored 'General case' 0 N--CA 1.475 0.783 0 O-C-N 124.317 1.011 . . . . 0.0 111.593 171.469 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 2.4 t -50.79 -48.69 27.87 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.993 0 C-N-CA 123.991 0.916 . . . . 0.0 112.106 177.183 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.791 HG11 ' HA ' ' A' ' 56' ' ' LYS . 9.7 t -64.84 -55.56 20.31 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.116 0 O-C-N 124.139 0.9 . . . . 0.0 109.806 -179.13 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 37.7 mt-10 -58.75 -49.71 76.62 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 125.897 1.679 . . . . 0.0 114.585 -177.586 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -77.66 -17.99 57.15 Favored 'General case' 0 N--CA 1.473 0.724 0 N-CA-C 114.904 1.446 . . . . 0.0 114.904 -176.282 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . 0.532 ' HA3' ' HE3' ' A' ' 56' ' ' LYS . . . 67.0 44.78 87.78 Favored Glycine 0 N--CA 1.486 1.969 0 N-CA-C 109.588 -1.405 . . . . 0.0 109.588 -162.309 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -96.79 157.65 21.24 Favored Glycine 0 N--CA 1.474 1.22 0 CA-C-N 113.661 -1.27 . . . . 0.0 114.777 -161.701 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 85.4 m95 -68.47 100.56 1.11 Allowed 'General case' 0 N--CA 1.473 0.691 0 CA-C-N 113.004 -1.598 . . . . 0.0 110.581 -178.562 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.512 HG22 HG13 ' A' ' 51' ' ' ILE . 0.6 OUTLIER -53.48 -26.15 12.3 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.799 0 CA-C-N 113.828 -1.533 . . . . 0.0 113.609 172.39 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 4.7 t -59.44 -43.92 93.03 Favored 'General case' 0 N--CA 1.481 1.076 0 CA-C-O 118.715 -0.659 . . . . 0.0 112.71 -176.364 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' THR . . . . . 0.443 ' HB ' HD13 ' A' ' 28' ' ' ILE . 2.7 m -57.82 -42.46 84.33 Favored 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 124.144 0.978 . . . . 0.0 111.855 174.218 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.473 HG13 HG21 ' A' ' 14' ' ' THR . 2.0 mp -73.73 -42.54 54.55 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.058 0 C-N-CA 125.98 1.712 . . . . 0.0 112.59 -178.124 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.577 HG11 HD13 ' A' ' 43' ' ' LEU . 40.1 t -49.64 -46.35 21.1 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.322 0 C-N-CA 124.815 1.246 . . . . 0.0 110.719 178.625 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -55.46 -35.86 65.95 Favored 'General case' 0 N--CA 1.486 1.364 0 C-N-CA 124.749 1.219 . . . . 0.0 113.906 176.366 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.922 HG21 HG11 ' A' ' 11' ' ' VAL . 22.3 mm -78.96 -39.36 21.65 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.071 0 C-N-CA 124.171 0.988 . . . . 0.0 109.083 -176.477 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.685 ' HB3' ' HA3' ' A' ' 39' ' ' GLY . 4.3 mm? -57.04 -49.38 75.98 Favored 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 124.553 1.141 . . . . 0.0 111.804 171.506 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 1.4 p -67.71 -27.38 66.77 Favored 'General case' 0 N--CA 1.474 0.734 0 N-CA-C 115.371 1.619 . . . . 0.0 115.371 178.018 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -55.71 -29.45 59.46 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 113.098 0.777 . . . . 0.0 113.098 169.95 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 23.0 t -71.61 -21.44 21.34 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.187 0 C-N-CA 125.166 1.386 . . . . 0.0 111.065 174.486 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 95.49 -102.13 2.79 Favored Glycine 0 N--CA 1.477 1.374 0 N-CA-C 109.416 -1.474 . . . . 0.0 109.416 -177.201 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 12.9 p -64.11 -44.48 92.11 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-N 113.115 -1.542 . . . . 0.0 114.973 -175.325 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -46.63 -49.26 16.53 Favored Glycine 0 N--CA 1.478 1.441 0 C-N-CA 124.496 1.046 . . . . 0.0 114.52 179.577 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.685 ' HA3' ' HB3' ' A' ' 32' ' ' LEU . . . -55.58 -53.55 40.65 Favored Glycine 0 N--CA 1.472 1.05 0 C-N-CA 124.291 0.948 . . . . 0.0 113.542 177.023 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 14.6 mt -62.53 -44.71 95.69 Favored 'General case' 0 N--CA 1.477 0.892 0 CA-C-N 113.149 -1.525 . . . . 0.0 113.96 -178.46 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 6.9 m -55.9 -47.12 77.99 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 123.745 0.818 . . . . 0.0 112.174 173.65 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.441 HD11 ' HE1' ' A' ' 1' ' ' MET . 12.3 tp -63.23 -45.22 92.63 Favored 'General case' 0 N--CA 1.48 1.035 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.763 177.691 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.577 HD13 HG11 ' A' ' 29' ' ' VAL . 46.8 mt -64.15 -21.46 66.56 Favored 'General case' 0 N--CA 1.477 0.909 0 N-CA-C 115.732 1.753 . . . . 0.0 115.732 -178.987 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -78.35 -42.4 30.62 Favored 'General case' 0 CA--C 1.545 0.767 0 CA-C-N 115.493 -0.776 . . . . 0.0 112.954 171.33 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -61.77 -29.48 70.16 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 123.752 0.821 . . . . 0.0 112.245 172.874 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -59.03 -23.87 62.34 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 125.581 1.552 . . . . 0.0 115.011 177.709 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -52.76 -34.42 44.39 Favored Glycine 0 CA--C 1.543 1.83 0 C-N-CA 125.474 1.512 . . . . 0.0 113.763 -176.147 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 65.5 ttp85 -55.04 -52.64 62.55 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 124.662 1.185 . . . . 0.0 112.937 -178.974 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.414 ' HB3' ' HA ' ' A' ' 54' ' ' TYR . 12.5 tt0 -137.37 38.13 2.49 Favored 'General case' 0 N--CA 1.477 0.906 0 N-CA-C 115.404 1.631 . . . . 0.0 115.404 -175.621 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 21.0 t 42.15 121.26 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.293 0 C-N-CA 125.325 1.45 . . . . 0.0 114.846 -174.08 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.512 HG13 HG22 ' A' ' 25' ' ' VAL 0.278 9.8 tp -27.42 -57.75 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.481 1.096 0 N-CA-C 118.654 2.835 . . . . 0.0 118.654 -169.231 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 39.4 tttm -57.75 -61.11 2.76 Favored 'General case' 0 N--CA 1.486 1.344 0 C-N-CA 123.703 0.801 . . . . 0.0 111.771 178.56 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -63.47 -39.17 93.75 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 124.843 1.257 . . . . 0.0 112.836 178.236 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . 0.414 ' HA ' ' HB3' ' A' ' 49' ' ' GLU . 79.3 t80 -48.22 -59.35 3.48 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 125.203 1.401 . . . . 0.0 111.932 176.684 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 64.0 mt -65.74 -39.61 91.3 Favored 'General case' 0 N--CA 1.478 0.973 0 CA-C-N 114.597 -1.183 . . . . 0.0 114.123 -179.883 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.791 ' HA ' HG11 ' A' ' 19' ' ' VAL . 43.7 mttp -57.9 -42.76 85.37 Favored 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 114.955 1.465 . . . . 0.0 114.955 179.869 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 55.7 tttp -78.9 -52.55 8.14 Favored 'General case' 0 N--CA 1.478 0.941 0 CA-C-N 115.256 -0.884 . . . . 0.0 111.54 170.984 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . 0.466 ' O ' ' HB2' ' A' ' 62' ' ' LYS . 28.0 tt0 -56.57 -49.94 73.39 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-O 118.558 -0.734 . . . . 0.0 111.975 -171.051 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.721 HG22 HG22 ' A' ' 67' ' ' VAL . 2.8 mm -75.86 -27.91 18.79 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 O-C-N 121.306 -0.872 . . . . 0.0 112.683 -175.959 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.469 ' HB2' ' O ' ' A' ' 56' ' ' LYS . 11.9 mttt -62.51 -34.12 76.24 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 116.935 2.198 . . . . 0.0 116.935 171.008 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 62.3 pttt -92.96 -25.36 18.05 Favored 'General case' 0 CA--C 1.546 0.825 0 CA-C-N 113.879 -1.51 . . . . 0.0 112.515 176.358 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.466 ' HB2' ' O ' ' A' ' 58' ' ' GLU . 29.1 tttm -80.27 -46.14 16.71 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 125.967 1.707 . . . . 0.0 113.594 -176.573 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 93.89 105.6 1.83 Allowed Glycine 0 N--CA 1.477 1.405 0 N-CA-C 110.589 -1.004 . . . . 0.0 110.589 -177.818 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.584 ' HD2' ' H ' ' A' ' 64' ' ' LYS . 5.6 mptt -32.01 -45.57 0.1 Allowed 'General case' 0 N--CA 1.489 1.479 0 C-N-CA 127.587 2.355 . . . . 0.0 116.266 -178.131 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . 0.403 ' CA ' ' HE ' ' A' ' 65' ' ' ARG 0.3 0.0 OUTLIER -46.94 -56.11 6.94 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 127.568 2.347 . . . . 0.0 114.105 175.781 . . . . . . . . 4 4 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -71.12 -23.24 62.05 Favored 'General case' 0 N--CA 1.478 0.957 0 CA-C-N 113.994 -1.457 . . . . 0.0 114.298 175.072 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.721 HG22 HG22 ' A' ' 59' ' ' ILE . 61.1 t -70.82 -39.11 75.08 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.174 0 C-N-CA 123.423 0.689 . . . . 0.0 110.838 177.91 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.412 HD12 ' HA ' ' A' ' 68' ' ' ILE . 19.0 mm -51.15 -44.24 28.94 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.87 0 C-N-CA 123.902 0.881 . . . . 0.0 111.089 169.682 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -68.91 -51.4 40.46 Favored 'General case' 0 N--CA 1.481 1.097 0 N-CA-C 113.559 0.948 . . . . 0.0 113.559 174.574 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 31.1 t90 . . . . . 0 N--CA 1.479 1.0 0 C-N-CA 125.419 1.487 . . . . 0.0 112.621 -179.302 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 62.9 mtp . . . . . 0 N--CA 1.477 0.879 0 N-CA-C 113.321 0.86 . . . . 0.0 113.321 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -60.19 -48.92 79.71 Favored 'General case' 0 N--CA 1.477 0.89 0 O-C-N 124.104 0.877 . . . . 0.0 112.959 177.269 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 42.2 tttm -72.5 -58.36 3.44 Favored 'General case' 0 N--CA 1.479 0.998 0 CA-C-N 114.404 -1.271 . . . . 0.0 113.624 -174.59 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . 0.459 ' HB2' ' O ' ' A' ' 70' ' ' TRP . 0.8 OUTLIER -70.29 -36.24 74.24 Favored 'General case' 0 CA--C 1.538 0.485 0 N-CA-C 114.327 1.232 . . . . 0.0 114.327 -171.658 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . 0.549 ' HB2' HD11 ' A' ' 7' ' ' ILE . 29.8 m-85 -108.86 -10.09 15.12 Favored 'General case' 0 N--CA 1.47 0.55 0 N-CA-C 117.014 2.227 . . . . 0.0 117.014 -170.36 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 68.08 56.65 10.08 Favored Glycine 0 CA--C 1.541 1.678 0 O-C-N 123.965 0.791 . . . . 0.0 111.351 -174.634 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.549 HD11 ' HB2' ' A' ' 5' ' ' PHE . 0.4 OUTLIER -111.95 140.37 23.34 Favored Pre-proline 0 N--CA 1.476 0.874 0 CA-C-N 113.466 -1.367 . . . . 0.0 110.149 -179.841 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -85.27 160.78 11.31 Favored 'Trans proline' 0 C--O 1.243 0.752 0 C-N-CA 121.161 1.241 . . . . 0.0 110.057 166.551 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -52.21 -32.76 38.0 Favored 'General case' 0 N--CA 1.484 1.225 0 N-CA-C 115.262 1.579 . . . . 0.0 115.262 175.807 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -41.0 -38.26 0.95 Allowed 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 126.688 1.995 . . . . 0.0 115.815 172.412 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.711 ' HB ' HD23 ' A' ' 32' ' ' LEU . 33.6 m -105.4 -41.24 6.24 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.95 0 N-CA-C 114.754 1.391 . . . . 0.0 114.754 -176.67 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . 0.461 ' HB3' HG23 ' A' ' 7' ' ' ILE . . . -67.29 -39.85 86.03 Favored 'General case' 0 N--CA 1.479 1.023 0 N-CA-C 112.992 0.738 . . . . 0.0 112.992 178.541 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -58.52 -41.9 95.69 Favored Glycine 0 CA--C 1.547 2.048 0 C-N-CA 123.923 0.773 . . . . 0.0 111.877 175.532 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 10.4 m -66.52 -39.88 88.88 Favored 'General case' 0 N--CA 1.484 1.232 0 CA-C-N 113.644 -1.278 . . . . 0.0 114.158 176.986 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 71.4 t -52.77 -43.36 44.86 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.017 0 N-CA-C 112.042 0.386 . . . . 0.0 112.042 169.445 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.591 HD13 HG12 ' A' ' 68' ' ' ILE . 38.3 mt -60.63 -43.84 97.07 Favored 'General case' 0 N--CA 1.481 1.095 0 N-CA-C 113.161 0.8 . . . . 0.0 113.161 179.75 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 20.4 t-20 -52.95 -50.78 63.35 Favored 'General case' 0 N--CA 1.48 1.05 0 O-C-N 124.934 1.396 . . . . 0.0 110.731 173.909 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.547 HG12 HD12 ' A' ' 28' ' ' ILE . 70.6 t -63.05 -41.62 93.54 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.088 0 CA-C-N 114.306 -1.315 . . . . 0.0 113.746 178.24 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.647 HG11 ' HA ' ' A' ' 56' ' ' LYS . 37.0 t -61.25 -45.75 97.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 123.845 0.716 . . . . 0.0 110.427 175.689 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . 0.422 ' HG3' ' HE2' ' A' ' 64' ' ' LYS . 31.3 mt-10 -60.67 -39.54 88.77 Favored 'General case' 0 CA--C 1.551 0.981 0 C-N-CA 124.914 1.286 . . . . 0.0 113.744 177.605 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -87.06 -15.98 36.97 Favored 'General case' 0 CA--C 1.543 0.68 0 N-CA-C 117.398 2.37 . . . . 0.0 117.398 -178.551 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 63.6 37.14 94.3 Favored Glycine 0 N--CA 1.484 1.851 0 C-N-CA 124.216 0.912 . . . . 0.0 112.219 -172.021 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -90.01 -166.23 41.29 Favored Glycine 0 N--CA 1.482 1.712 0 CA-C-O 122.808 1.227 . . . . 0.0 113.365 -172.694 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' TRP . . . . . 0.647 ' HB3' HG21 ' A' ' 26' ' ' THR . 5.4 m-90 -82.74 111.44 18.68 Favored 'General case' 0 N--CA 1.478 0.957 0 CA-C-O 122.328 1.061 . . . . 0.0 111.032 -179.891 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.423 ' HB ' ' HG2' ' A' ' 52' ' ' LYS . 39.6 t -65.02 -20.18 27.07 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.209 0 CA-C-N 114.669 -1.15 . . . . 0.0 112.307 168.278 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.647 HG21 ' HB3' ' A' ' 24' ' ' TRP . 10.9 t -64.26 -32.96 74.75 Favored 'General case' 0 N--CA 1.482 1.129 0 N-CA-C 113.96 1.096 . . . . 0.0 113.96 179.587 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -66.74 -33.68 76.16 Favored 'General case' 0 N--CA 1.485 1.313 0 N-CA-C 113.672 0.99 . . . . 0.0 113.672 173.875 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.547 HD12 HG12 ' A' ' 18' ' ' VAL . 0.0 OUTLIER -87.4 -38.0 11.57 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.165 0 CA-C-O 118.737 -0.649 . . . . 0.0 111.363 -178.798 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 14.0 t -44.82 -44.23 2.63 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.213 0 C-N-CA 124.225 1.01 . . . . 0.0 111.981 175.288 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 6.4 p -63.28 -31.76 72.99 Favored 'General case' 0 N--CA 1.484 1.229 0 N-CA-C 114.706 1.373 . . . . 0.0 114.706 175.92 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.684 HG21 HG11 ' A' ' 11' ' ' VAL . 15.3 mm -82.44 -37.94 14.83 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.152 0 C-N-CA 123.661 0.784 . . . . 0.0 109.732 179.006 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.711 HD23 ' HB ' ' A' ' 11' ' ' VAL . 3.7 mm? -53.72 -52.97 58.39 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 125.341 1.456 . . . . 0.0 111.283 170.356 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 17.2 p -70.18 -30.87 68.1 Favored 'General case' 0 N--CA 1.475 0.825 0 N-CA-C 114.277 1.214 . . . . 0.0 114.277 179.159 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -53.64 -33.47 55.27 Favored 'General case' 0 N--CA 1.483 1.184 0 N-CA-C 113.554 0.946 . . . . 0.0 113.554 170.022 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.489 ' HB ' ' O ' ' A' ' 32' ' ' LEU . 74.7 t -61.77 -26.98 41.29 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.426 0 C-N-CA 124.675 1.19 . . . . 0.0 112.899 170.934 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 103.3 -105.45 2.69 Favored Glycine 0 N--CA 1.472 1.073 0 N-CA-C 110.337 -1.105 . . . . 0.0 110.337 -178.923 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 30.2 p -61.28 -44.1 97.79 Favored 'General case' 0 N--CA 1.479 1.021 0 N-CA-C 114.08 1.141 . . . . 0.0 114.08 -176.521 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -52.16 -50.74 44.7 Favored Glycine 0 N--CA 1.474 1.181 0 C-N-CA 125.733 1.635 . . . . 0.0 113.96 -175.761 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.5 ' HA3' ' HB3' ' A' ' 32' ' ' LEU . . . -54.38 -55.27 27.61 Favored Glycine 0 N--CA 1.479 1.527 0 CA-C-N 114.336 -0.932 . . . . 0.0 111.753 175.2 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 52.5 mt -60.21 -47.38 86.23 Favored 'General case' 0 N--CA 1.478 0.949 0 N-CA-C 115.126 1.528 . . . . 0.0 115.126 -176.529 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 75.5 p -61.76 -41.29 97.5 Favored 'General case' 0 CA--C 1.544 0.715 0 N-CA-C 113.139 0.792 . . . . 0.0 113.139 176.665 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 9.8 tp -63.88 -47.37 80.91 Favored 'General case' 0 N--CA 1.482 1.135 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.405 173.87 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.476 ' HG ' ' O ' ' A' ' 39' ' ' GLY . 75.8 mt -60.6 -30.48 69.85 Favored 'General case' 0 N--CA 1.474 0.768 0 N-CA-C 114.783 1.401 . . . . 0.0 114.783 -178.916 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -70.3 -44.68 67.83 Favored 'General case' 0 N--CA 1.477 0.917 0 O-C-N 123.842 0.714 . . . . 0.0 112.724 172.897 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -68.64 -37.14 79.45 Favored 'General case' 0 N--CA 1.479 0.994 0 CA-C-O 121.607 0.717 . . . . 0.0 112.305 177.242 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.475 ' HB3' ' HA ' ' A' ' 51' ' ' ILE . . . -60.74 -25.24 66.33 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 126.45 1.9 . . . . 0.0 115.371 176.364 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -48.77 -36.83 20.05 Favored Glycine 0 CA--C 1.545 1.934 0 O-C-N 124.657 1.223 . . . . 0.0 113.564 176.642 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . 0.587 ' CZ ' ' HH ' ' A' ' 54' ' ' TYR . 25.0 ttm180 -43.64 -52.57 6.31 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 128.256 2.622 . . . . 0.0 113.228 -177.698 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 11.2 tt0 -128.55 36.12 4.29 Favored 'General case' 0 CA--C 1.545 0.761 0 N-CA-C 112.957 0.725 . . . . 0.0 112.957 -178.599 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 60.3 p 51.5 123.62 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.664 0 C-N-CA 125.065 1.346 . . . . 0.0 112.17 -169.101 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.475 ' HA ' ' HB3' ' A' ' 46' ' ' ALA . 5.8 tp -33.57 -50.51 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.164 0 N-CA-C 117.082 2.253 . . . . 0.0 117.082 -176.952 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 0.423 ' HG2' ' HB ' ' A' ' 25' ' ' VAL . 7.1 mttt -59.76 -62.86 1.56 Allowed 'General case' 0 N--CA 1.471 0.623 0 N-CA-C 114.388 1.255 . . . . 0.0 114.388 178.123 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -63.28 -34.1 76.94 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 113.24 -1.8 . . . . 0.0 112.662 -179.388 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . 0.587 ' HH ' ' CZ ' ' A' ' 48' ' ' ARG . 72.4 t80 -51.52 -63.61 1.08 Allowed 'General case' 0 C--O 1.224 -0.277 0 C-N-CA 125.955 1.702 . . . . 0.0 110.654 176.969 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 43.5 mt -65.96 -39.62 90.59 Favored 'General case' 0 N--CA 1.477 0.925 0 N-CA-C 115.265 1.58 . . . . 0.0 115.265 -175.859 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.647 ' HA ' HG11 ' A' ' 19' ' ' VAL . 1.8 mptm? -58.94 -44.38 91.41 Favored 'General case' 0 N--CA 1.472 0.644 0 N-CA-C 114.859 1.429 . . . . 0.0 114.859 177.767 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 15.6 tttm -79.39 -52.68 7.76 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-N 114.467 -1.242 . . . . 0.0 112.542 173.284 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . 0.547 ' O ' ' HB2' ' A' ' 62' ' ' LYS . 0.8 OUTLIER -59.22 -45.17 91.82 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-O 116.488 -1.72 . . . . 0.0 113.039 -171.62 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.667 HG22 HG22 ' A' ' 67' ' ' VAL . 3.2 mm -76.37 -26.64 17.05 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.04 0 C-N-CA 119.994 -0.682 . . . . 0.0 111.697 -179.637 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.524 ' HB2' ' O ' ' A' ' 56' ' ' LYS . 0.7 OUTLIER -59.22 -34.51 72.27 Favored 'General case' 0 CA--C 1.543 0.7 0 CA-C-O 122.162 0.982 . . . . 0.0 113.566 173.144 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 5.0 mttm -87.97 -44.97 10.62 Favored 'General case' 0 N--CA 1.479 0.985 0 CA-C-N 112.536 -2.12 . . . . 0.0 110.853 179.363 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.547 ' HB2' ' O ' ' A' ' 58' ' ' GLU . 19.9 tttt -68.51 -41.23 80.27 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 127.348 2.259 . . . . 0.0 114.41 -171.554 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 93.24 110.57 2.02 Favored Glycine 0 CA--C 1.534 1.231 0 N-CA-C 110.358 -1.097 . . . . 0.0 110.358 -177.719 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.728 ' HD2' ' H ' ' A' ' 64' ' ' LYS . 10.0 mptt -39.3 -47.61 1.73 Allowed 'General case' 0 N--CA 1.481 1.093 0 N-CA-C 117.395 2.369 . . . . 0.0 117.395 -176.189 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . 0.463 ' O ' ' HB ' ' A' ' 68' ' ' ILE . 4.6 ttp180 -58.51 -50.22 74.55 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 124.18 0.992 . . . . 0.0 113.436 179.448 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -61.96 -28.03 69.26 Favored 'General case' 0 N--CA 1.476 0.843 0 N-CA-C 114.118 1.155 . . . . 0.0 114.118 173.669 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.667 HG22 HG22 ' A' ' 59' ' ' ILE . 90.3 t -70.62 -33.15 51.98 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 N-CA-C 112.333 0.494 . . . . 0.0 112.333 176.509 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.591 HG12 HD13 ' A' ' 16' ' ' LEU . 4.1 mm -49.5 -47.28 20.38 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.332 0 C-N-CA 123.28 0.632 . . . . 0.0 109.718 167.719 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -66.95 -51.81 50.59 Favored 'General case' 0 N--CA 1.485 1.286 0 CA-C-N 114.811 -1.086 . . . . 0.0 112.751 177.807 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' TRP . . . . . 0.459 ' O ' ' HB2' ' A' ' 4' ' ' GLU . 39.6 t90 . . . . . 0 N--CA 1.484 1.263 0 C-N-CA 125.055 1.342 . . . . 0.0 113.121 -179.201 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.789 ' HE1' HG23 ' A' ' 7' ' ' ILE . 72.4 mtp . . . . . 0 N--CA 1.476 0.832 0 N-CA-C 112.814 0.672 . . . . 0.0 112.814 . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . 0.63 ' HA ' ' O ' ' A' ' 7' ' ' ILE . . . -60.91 -54.84 40.15 Favored 'General case' 0 N--CA 1.471 0.601 0 N-CA-C 113.584 0.957 . . . . 0.0 113.584 173.961 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 9.7 tptp -74.08 -57.05 4.22 Favored 'General case' 0 CA--C 1.543 0.711 0 CA-C-N 113.559 -1.655 . . . . 0.0 114.456 -174.597 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 11.3 tt0 -77.88 -43.74 29.27 Favored 'General case' 0 N--CA 1.477 0.88 0 N-CA-C 113.631 0.974 . . . . 0.0 113.631 -171.967 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 41.7 m-85 -95.35 -8.08 36.75 Favored 'General case' 0 CA--C 1.542 0.652 0 N-CA-C 117.396 2.369 . . . . 0.0 117.396 -173.749 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 63.48 38.53 96.48 Favored Glycine 0 N--CA 1.478 1.47 0 O-C-N 124.38 1.05 . . . . 0.0 112.848 -177.773 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.789 HG23 ' HE1' ' A' ' 1' ' ' MET . 0.8 OUTLIER -114.06 128.6 25.62 Favored Pre-proline 0 N--CA 1.479 1.005 0 C-N-CA 124.51 1.124 . . . . 0.0 108.474 -179.808 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -66.89 156.37 66.46 Favored 'Trans proline' 0 CA--C 1.54 0.785 0 CA-C-N 120.169 1.096 . . . . 0.0 110.943 179.721 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -51.8 -30.0 21.4 Favored 'General case' 0 N--CA 1.483 1.177 0 N-CA-C 115.077 1.51 . . . . 0.0 115.077 173.988 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -44.64 -46.98 10.44 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 126.332 1.853 . . . . 0.0 114.007 175.159 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.98 HG11 HG21 ' A' ' 31' ' ' ILE . 34.9 m -96.14 -32.43 4.31 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.345 0 N-CA-C 114.016 1.117 . . . . 0.0 114.016 -177.824 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . 0.411 ' O ' ' HG ' ' A' ' 16' ' ' LEU . . . -59.99 -34.61 73.55 Favored 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 112.483 0.549 . . . . 0.0 112.483 173.43 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -58.69 -46.73 92.95 Favored Glycine 0 CA--C 1.546 1.978 0 C-N-CA 124.823 1.201 . . . . 0.0 113.048 169.463 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -62.32 -39.98 94.82 Favored 'General case' 0 N--CA 1.487 1.391 0 C-N-CA 124.46 1.104 . . . . 0.0 113.633 176.822 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.655 HG22 ' HE3' ' A' ' 1' ' ' MET . 30.9 t -51.76 -39.37 24.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 C-N-CA 124.286 1.034 . . . . 0.0 112.768 169.338 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.582 HD21 ' HG3' ' A' ' 64' ' ' LYS . 56.3 mt -62.75 -38.35 90.23 Favored 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 113.773 1.027 . . . . 0.0 113.773 177.408 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 18.2 t-20 -51.84 -47.48 64.36 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 123.792 0.837 . . . . 0.0 111.762 173.338 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.44 HG22 ' HA ' ' A' ' 25' ' ' VAL . 2.1 t -52.33 -51.49 32.03 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.118 0 CA-C-N 115.366 -0.833 . . . . 0.0 113.039 173.507 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.579 HG11 ' HA ' ' A' ' 56' ' ' LYS . 4.1 t -63.28 -46.41 95.73 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.065 0 O-C-N 124.299 0.999 . . . . 0.0 110.982 -179.116 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 33.0 mt-10 -62.21 -45.72 92.08 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 125.075 1.35 . . . . 0.0 114.279 -178.09 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -94.9 -22.01 18.28 Favored 'General case' 0 N--CA 1.48 1.056 0 N-CA-C 116.34 1.978 . . . . 0.0 116.34 -172.035 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 73.89 45.54 26.73 Favored Glycine 0 N--CA 1.481 1.663 0 N-CA-C 109.042 -1.623 . . . . 0.0 109.042 -163.352 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -94.71 164.13 25.13 Favored Glycine 0 N--CA 1.477 1.401 0 C-N-CA 124.898 1.237 . . . . 0.0 113.829 -169.438 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 2.8 m-90 -66.86 102.12 0.92 Allowed 'General case' 0 N--CA 1.475 0.818 0 CA-C-O 122.568 1.175 . . . . 0.0 112.045 -178.542 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.633 HG22 HG13 ' A' ' 51' ' ' ILE . 5.5 p -53.45 -25.59 11.1 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.996 0 CA-C-N 112.979 -1.918 . . . . 0.0 115.225 170.881 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 10.6 t -62.42 -36.42 82.33 Favored 'General case' 0 N--CA 1.478 0.951 0 N-CA-C 113.434 0.902 . . . . 0.0 113.434 179.756 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 1.3 m -67.11 -42.7 84.07 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 124.082 0.953 . . . . 0.0 110.65 173.226 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.462 ' O ' HD21 ' A' ' 32' ' ' LEU . 1.6 mp -63.34 -44.7 99.16 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.759 0 C-N-CA 124.227 1.011 . . . . 0.0 112.633 178.272 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 77.2 t -52.38 -44.17 42.58 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.152 0 C-N-CA 123.816 0.846 . . . . 0.0 111.049 174.842 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 20.3 p -60.83 -33.59 73.27 Favored 'General case' 0 N--CA 1.482 1.15 0 N-CA-C 114.999 1.481 . . . . 0.0 114.999 175.944 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.98 HG21 HG11 ' A' ' 11' ' ' VAL . 27.7 mm -75.18 -40.73 44.1 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.692 0 C-N-CA 124.226 1.01 . . . . 0.0 109.319 178.891 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.619 ' HB3' ' HA2' ' A' ' 39' ' ' GLY . 3.6 mm? -59.68 -32.89 70.91 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 124.743 1.217 . . . . 0.0 111.391 169.236 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' THR . . . . . 0.552 HG22 ' HA3' ' A' ' 38' ' ' GLY . 2.9 m -73.38 -35.88 65.98 Favored 'General case' 0 N--CA 1.475 0.801 0 N-CA-C 113.984 1.105 . . . . 0.0 113.984 174.532 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -53.8 -30.38 44.64 Favored 'General case' 0 N--CA 1.487 1.383 0 N-CA-C 113.374 0.879 . . . . 0.0 113.374 175.94 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 55.5 t -65.14 -36.32 77.49 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.093 0 C-N-CA 126.823 2.049 . . . . 0.0 113.213 173.567 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 114.39 155.68 11.33 Favored Glycine 0 CA--C 1.535 1.339 0 N-CA-C 110.218 -1.153 . . . . 0.0 110.218 -166.224 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 56.9 p 77.27 -40.38 0.34 Allowed 'General case' 0 N--CA 1.49 1.541 0 C-N-CA 127.95 2.5 . . . . 0.0 113.158 -177.527 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.552 ' HA3' HG22 ' A' ' 33' ' ' THR . . . 118.46 6.17 12.05 Favored Glycine 0 CA--C 1.537 1.432 0 CA-C-N 114.208 -1.36 . . . . 0.0 113.05 -169.197 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.619 ' HA2' ' HB3' ' A' ' 32' ' ' LEU . . . 60.03 36.52 90.63 Favored Glycine 0 CA--C 1.55 2.28 0 N-CA-C 110.784 -0.926 . . . . 0.0 110.784 -155.892 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 10.8 mt -55.81 -37.34 68.52 Favored 'General case' 0 N--CA 1.483 1.216 0 N-CA-C 116.363 1.986 . . . . 0.0 116.363 -169.657 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 16.6 p -56.87 -43.64 81.44 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 124.376 1.07 . . . . 0.0 113.652 176.506 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 14.9 tp -66.68 -45.8 77.7 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 123.12 0.568 . . . . 0.0 110.845 175.316 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 88.4 mt -60.65 -30.77 70.09 Favored 'General case' 0 N--CA 1.477 0.89 0 CA-C-N 114.293 -1.321 . . . . 0.0 114.19 179.116 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -66.79 -48.18 69.82 Favored 'General case' 0 N--CA 1.474 0.726 0 N-CA-C 112.943 0.72 . . . . 0.0 112.943 173.546 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -64.36 -29.21 70.29 Favored 'General case' 0 N--CA 1.485 1.316 0 N-CA-C 113.029 0.752 . . . . 0.0 113.029 176.815 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -77.99 -9.53 59.15 Favored 'General case' 0 CA--C 1.543 0.683 0 N-CA-C 117.259 2.318 . . . . 0.0 117.259 -177.236 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -56.6 -57.06 21.41 Favored Glycine 0 CA--C 1.542 1.75 0 C-N-CA 124.321 0.962 . . . . 0.0 113.216 -166.881 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.71 -44.93 90.5 Favored 'General case' 0 CA--C 1.541 0.601 0 N-CA-C 115.681 1.734 . . . . 0.0 115.681 -177.321 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.493 ' OE1' ' HA ' ' A' ' 54' ' ' TYR . 13.0 tt0 -103.1 25.49 9.37 Favored 'General case' 0 N--CA 1.478 0.947 0 N-CA-C 114.749 1.389 . . . . 0.0 114.749 -175.058 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 91.8 p 46.63 118.85 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 125.756 1.622 . . . . 0.0 112.919 -174.594 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.633 HG13 HG22 ' A' ' 25' ' ' VAL . 8.0 tp -35.86 -52.18 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.263 0 N-CA-C 116.883 2.179 . . . . 0.0 116.883 -174.134 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 23.6 tptp -55.51 -67.98 0.24 Allowed 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 124.703 1.201 . . . . 0.0 112.863 174.518 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -57.73 -36.31 71.86 Favored 'General case' 0 N--CA 1.482 1.16 0 N-CA-C 113.993 1.108 . . . . 0.0 113.993 179.586 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . 0.493 ' HA ' ' OE1' ' A' ' 49' ' ' GLU . 94.3 t80 -50.0 -64.6 0.76 Allowed 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 125.533 1.533 . . . . 0.0 111.738 173.641 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.555 HD11 HG12 ' A' ' 15' ' ' VAL . 46.2 mt -63.16 -41.2 99.21 Favored 'General case' 0 N--CA 1.472 0.675 0 N-CA-C 114.023 1.12 . . . . 0.0 114.023 -178.357 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.579 ' HA ' HG11 ' A' ' 19' ' ' VAL . 54.1 tptt -53.57 -54.15 41.56 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-N 113.751 -1.568 . . . . 0.0 112.303 179.076 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 58.9 tttp -68.79 -54.42 15.96 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 115.127 -0.942 . . . . 0.0 111.943 173.895 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 8.9 tt0 -59.25 -48.23 82.4 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-N 115.655 -0.702 . . . . 0.0 111.845 -167.34 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.742 HG22 HG23 ' A' ' 67' ' ' VAL . 3.1 mm -75.99 -23.95 16.35 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.124 0 O-C-N 123.288 0.367 . . . . 0.0 111.359 -176.051 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.422 ' HB2' ' O ' ' A' ' 56' ' ' LYS . 24.3 mttt -65.92 -21.6 66.45 Favored 'General case' 0 C--O 1.222 -0.362 0 N-CA-C 117.3 2.333 . . . . 0.0 117.3 169.095 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 60.4 mtpt -91.26 -50.24 5.93 Favored 'General case' 0 N--CA 1.481 1.091 0 CA-C-N 112.831 -1.986 . . . . 0.0 110.614 172.481 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 36.9 tttp -65.19 -50.29 66.49 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 126.957 2.103 . . . . 0.0 114.909 -171.957 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 95.77 121.61 3.84 Favored Glycine 0 CA--C 1.533 1.181 0 CA-C-O 122.384 0.991 . . . . 0.0 110.888 -171.86 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.582 ' HG3' HD21 ' A' ' 16' ' ' LEU . 12.3 mptt -45.08 -39.38 5.8 Favored 'General case' 0 N--CA 1.48 1.054 0 N-CA-C 117.396 2.369 . . . . 0.0 117.396 -175.777 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . 0.415 ' O ' ' HB ' ' A' ' 68' ' ' ILE . 0.0 OUTLIER -59.66 -46.97 87.42 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 124.545 1.138 . . . . 0.0 112.805 178.208 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -63.26 -28.27 69.91 Favored 'General case' 0 N--CA 1.479 1.023 0 N-CA-C 114.54 1.311 . . . . 0.0 114.54 174.723 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.742 HG23 HG22 ' A' ' 59' ' ' ILE . 26.2 t -70.75 -36.9 66.82 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.868 0 C-N-CA 123.594 0.758 . . . . 0.0 111.282 178.536 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.415 ' HB ' ' O ' ' A' ' 65' ' ' ARG . 21.6 mm -52.95 -46.75 53.55 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.95 0 C-N-CA 123.926 0.89 . . . . 0.0 110.384 170.781 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -70.37 -50.88 34.3 Favored 'General case' 0 N--CA 1.479 1.009 0 CA-C-N 114.783 -1.099 . . . . 0.0 113.172 177.072 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 31.6 t90 . . . . . 0 N--CA 1.484 1.248 0 C-N-CA 125.611 1.564 . . . . 0.0 112.77 -179.494 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.533 ' HE2' HG22 ' A' ' 15' ' ' VAL . 74.2 mtp . . . . . 0 N--CA 1.471 0.577 0 N-CA-C 112.215 0.45 . . . . 0.0 112.215 . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . 0.428 ' HA ' ' O ' ' A' ' 7' ' ' ILE . . . -54.96 -58.38 7.85 Favored 'General case' 0 N--CA 1.472 0.664 0 O-C-N 124.734 1.271 . . . . 0.0 113.255 173.395 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 22.1 tptm -71.81 -50.75 26.91 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 113.684 -1.598 . . . . 0.0 113.104 -173.763 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 8.3 tt0 -78.1 -42.76 31.03 Favored 'General case' 0 N--CA 1.479 0.99 0 N-CA-C 114.674 1.361 . . . . 0.0 114.674 -170.254 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . 0.463 ' HD1' ' HB2' ' A' ' 41' ' ' SER . 58.3 m-85 -105.76 -15.15 15.03 Favored 'General case' 0 N--CA 1.474 0.738 0 N-CA-C 116.987 2.218 . . . . 0.0 116.987 -172.101 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 85.75 61.21 1.71 Allowed Glycine 0 N--CA 1.482 1.73 0 O-C-N 124.352 1.033 . . . . 0.0 112.331 -176.922 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.572 HG22 ' HB3' ' A' ' 12' ' ' ALA . 1.0 OUTLIER -111.48 137.14 21.04 Favored Pre-proline 0 N--CA 1.475 0.789 0 CA-C-N 114.365 -0.918 . . . . 0.0 109.771 173.47 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo -82.04 38.45 0.75 Allowed 'Trans proline' 0 CA--C 1.537 0.673 0 C-N-CA 122.861 2.374 . . . . 0.0 113.2 175.522 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . 53.85 -34.04 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.518 0 C-N-CA 129.69 3.196 . . . . 0.0 117.243 -169.959 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -37.23 -63.53 0.43 Allowed 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 128.735 2.814 . . . . 0.0 113.564 174.023 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.522 HG11 HG21 ' A' ' 31' ' ' ILE . 26.9 m -74.77 -21.43 16.99 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.862 0 N-CA-C 113.896 1.073 . . . . 0.0 113.896 -176.248 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . 0.572 ' HB3' HG22 ' A' ' 7' ' ' ILE . . . -67.6 -32.88 73.91 Favored 'General case' 0 N--CA 1.475 0.785 0 N-CA-C 112.356 0.502 . . . . 0.0 112.356 169.991 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -59.37 -38.04 92.84 Favored Glycine 0 CA--C 1.541 1.706 0 C-N-CA 123.836 0.731 . . . . 0.0 113.44 172.284 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 0.487 HG21 HG13 ' A' ' 28' ' ' ILE . 0.2 OUTLIER -69.79 -27.67 65.1 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 126.189 1.796 . . . . 0.0 115.124 176.329 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.533 HG22 ' HE2' ' A' ' 1' ' ' MET . 2.8 t -67.01 -44.07 88.62 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.169 0 C-N-CA 124.884 1.273 . . . . 0.0 110.691 171.501 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.462 ' HG ' ' O ' ' A' ' 12' ' ' ALA . 60.2 mt -63.44 -42.83 98.67 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 114.408 -1.269 . . . . 0.0 112.348 179.076 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . 0.41 ' HB2' ' O ' ' A' ' 14' ' ' THR 0.444 0.6 OUTLIER -48.33 -52.86 19.63 Favored 'General case' 0 C--N 1.31 -1.123 0 CA-C-N 114.484 -1.235 . . . . 0.0 114.161 169.281 . . . . . . . . 4 4 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.45 ' HB ' ' O ' ' A' ' 15' ' ' VAL . 2.9 t -46.17 -54.2 2.09 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.416 0 O-C-N 125.629 1.831 . . . . 0.0 110.342 173.434 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.796 HG11 ' HA ' ' A' ' 56' ' ' LYS . 4.1 t -62.33 -49.99 81.73 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.08 0 CA-C-N 115.011 -0.995 . . . . 0.0 111.16 -174.453 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 25.8 mt-10 -66.28 -38.59 88.14 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 126.128 1.771 . . . . 0.0 115.012 -171.959 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -99.63 -11.45 20.93 Favored 'General case' 0 N--CA 1.473 0.688 0 N-CA-C 114.473 1.286 . . . . 0.0 114.473 -175.044 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 68.03 39.83 88.81 Favored Glycine 0 CA--C 1.545 1.912 0 N-CA-C 111.423 -0.671 . . . . 0.0 111.423 -166.903 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -91.69 159.45 25.85 Favored Glycine 0 CA--C 1.541 1.689 0 CA-C-O 122.948 1.304 . . . . 0.0 113.776 -173.251 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 83.8 m95 -63.81 108.03 1.35 Allowed 'General case' 0 N--CA 1.47 0.558 0 CA-C-N 112.863 -1.668 . . . . 0.0 113.564 -179.512 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.596 HG22 HG13 ' A' ' 51' ' ' ILE . 5.5 p -58.46 -26.86 31.87 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 CA-C-N 111.741 -2.481 . . . . 0.0 113.864 168.653 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 10.1 t -65.09 -36.51 84.53 Favored 'General case' 0 N--CA 1.482 1.125 0 N-CA-C 113.431 0.901 . . . . 0.0 113.431 -173.867 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -70.45 -43.7 69.33 Favored 'General case' 0 N--CA 1.47 0.544 0 N-CA-C 112.367 0.506 . . . . 0.0 112.367 172.029 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.487 HG13 HG21 ' A' ' 14' ' ' THR . 1.6 mp -61.27 -44.0 97.59 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.564 0 C-N-CA 124.92 1.288 . . . . 0.0 112.539 -179.214 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.526 HG12 HD12 ' A' ' 43' ' ' LEU . 23.7 t -46.04 -47.54 5.76 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.703 0 C-N-CA 124.632 1.173 . . . . 0.0 111.594 171.572 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 22.7 p -60.52 -33.98 73.43 Favored 'General case' 0 N--CA 1.482 1.128 0 N-CA-C 114.606 1.335 . . . . 0.0 114.606 177.808 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.522 HG21 HG11 ' A' ' 11' ' ' VAL . 21.7 mm -77.28 -35.66 22.87 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 C-N-CA 124.142 0.977 . . . . 0.0 109.235 -178.951 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.61 ' HB3' ' HA3' ' A' ' 39' ' ' GLY . 4.0 mm? -60.66 -52.38 65.36 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 124.198 0.999 . . . . 0.0 111.587 173.5 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 1.7 p -60.84 -30.05 69.87 Favored 'General case' 0 N--CA 1.482 1.169 0 N-CA-C 115.37 1.619 . . . . 0.0 115.37 177.156 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -53.62 -33.51 55.28 Favored 'General case' 0 N--CA 1.479 1.009 0 N-CA-C 114.81 1.411 . . . . 0.0 114.81 175.251 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 68.8 t -68.69 -21.88 26.31 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.265 0 C-N-CA 125.916 1.686 . . . . 0.0 111.912 175.889 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 97.35 -96.74 1.88 Allowed Glycine 0 N--CA 1.477 1.377 0 N-CA-C 108.301 -1.919 . . . . 0.0 108.301 179.47 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 6.2 p -58.52 -48.57 80.4 Favored 'General case' 0 N--CA 1.487 1.413 0 CA-C-N 112.707 -1.746 . . . . 0.0 114.885 -174.255 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -54.69 -41.3 74.17 Favored Glycine 0 N--CA 1.479 1.544 0 O-C-N 125.941 2.025 . . . . 0.0 115.325 -175.442 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.61 ' HA3' ' HB3' ' A' ' 32' ' ' LEU . . . -62.6 -55.26 28.21 Favored Glycine 0 N--CA 1.473 1.143 0 N-CA-C 111.467 -0.653 . . . . 0.0 111.467 172.621 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 58.8 mt -57.89 -48.94 78.39 Favored 'General case' 0 N--CA 1.474 0.742 0 N-CA-C 115.452 1.649 . . . . 0.0 115.452 -175.971 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' SER . . . . . 0.463 ' HB2' ' HD1' ' A' ' 5' ' ' PHE . 13.1 p -61.91 -37.88 86.3 Favored 'General case' 0 CA--C 1.544 0.732 0 N-CA-C 114.828 1.418 . . . . 0.0 114.828 177.66 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 10.0 tp -69.74 -42.12 74.34 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 124.251 1.02 . . . . 0.0 111.005 175.183 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.526 HD12 HG12 ' A' ' 29' ' ' VAL . 51.2 mt -63.26 -25.79 68.48 Favored 'General case' 0 N--CA 1.469 0.506 0 N-CA-C 114.968 1.47 . . . . 0.0 114.968 178.516 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -72.09 -49.52 35.61 Favored 'General case' 0 N--CA 1.481 1.106 0 CA-C-N 115.909 -0.587 . . . . 0.0 112.286 171.273 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -60.9 -35.75 77.46 Favored 'General case' 0 N--CA 1.49 1.529 0 C-N-CA 124.847 1.259 . . . . 0.0 112.933 -179.229 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -52.4 -25.7 10.6 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 126.844 2.058 . . . . 0.0 114.347 174.293 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -45.7 -37.97 7.27 Favored Glycine 0 CA--C 1.539 1.561 0 C-N-CA 126.514 2.007 . . . . 0.0 114.101 178.868 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 4.5 tmm_? -62.96 -39.35 94.39 Favored 'General case' 0 CA--C 1.544 0.738 0 N-CA-C 114.802 1.408 . . . . 0.0 114.802 -173.079 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 11.5 tt0 -141.15 38.7 1.76 Allowed 'General case' 0 N--CA 1.479 0.981 0 N-CA-C 116.365 1.987 . . . . 0.0 116.365 -178.51 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 59.5 p 53.47 119.34 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.874 0 C-N-CA 125.184 1.394 . . . . 0.0 112.643 -177.131 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.596 HG13 HG22 ' A' ' 25' ' ' VAL 0.276 8.6 tp -36.7 -46.55 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 N-CA-C 117.89 2.552 . . . . 0.0 117.89 -171.945 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 24.7 tptt -55.86 -68.93 0.16 Allowed 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 126.107 1.763 . . . . 0.0 112.895 174.767 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -62.96 -32.3 73.59 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 124.904 1.282 . . . . 0.0 113.865 177.317 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 91.2 t80 -53.81 -62.91 1.35 Allowed 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 125.894 1.677 . . . . 0.0 110.88 -178.948 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 65.8 mt -65.09 -35.39 81.0 Favored 'General case' 0 N--CA 1.469 0.483 0 N-CA-C 114.134 1.161 . . . . 0.0 114.134 179.928 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.796 ' HA ' HG11 ' A' ' 19' ' ' VAL . 58.7 mttp -61.36 -47.96 83.46 Favored 'General case' 0 N--CA 1.477 0.904 0 CA-C-N 113.982 -1.463 . . . . 0.0 114.445 178.476 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 85.7 tttt -76.78 -50.64 13.02 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-N 114.764 -1.107 . . . . 0.0 111.695 175.406 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . 0.434 ' O ' ' HB2' ' A' ' 62' ' ' LYS . 28.8 tt0 -59.08 -49.21 78.75 Favored 'General case' 0 N--CA 1.471 0.596 0 N-CA-C 111.922 0.341 . . . . 0.0 111.922 -173.152 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.734 HD13 HG22 ' A' ' 67' ' ' VAL . 2.7 mm -72.09 -25.03 23.08 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.038 0 CA-C-O 118.428 -0.796 . . . . 0.0 112.391 -178.669 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 63.9 tttm -62.77 -33.17 74.62 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 114.682 1.364 . . . . 0.0 114.682 172.045 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 55.1 mtmt -80.91 -48.58 12.14 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-N 114.055 -1.429 . . . . 0.0 110.729 173.941 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.434 ' HB2' ' O ' ' A' ' 58' ' ' GLU . 5.9 tttm -64.51 -50.6 66.74 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 126.131 1.772 . . . . 0.0 115.77 -172.053 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 91.66 108.58 1.59 Allowed Glycine 0 N--CA 1.482 1.749 0 CA-C-N 114.932 -1.031 . . . . 0.0 110.747 -175.941 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.687 ' HD2' ' H ' ' A' ' 64' ' ' LYS . 8.6 mptt -31.95 -43.83 0.08 Allowed 'General case' 0 N--CA 1.482 1.153 0 N-CA-C 119.277 3.066 . . . . 0.0 119.277 -173.713 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.44 -47.94 82.34 Favored 'General case' 0 N--CA 1.475 0.78 0 N-CA-C 113.396 0.888 . . . . 0.0 113.396 178.865 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -60.77 -28.12 68.49 Favored 'General case' 0 N--CA 1.473 0.723 0 CA-C-N 115.015 -0.993 . . . . 0.0 113.402 172.937 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.734 HG22 HD13 ' A' ' 59' ' ' ILE . 96.2 t -72.95 -36.09 50.56 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.662 0 N-CA-C 112.877 0.695 . . . . 0.0 112.877 179.276 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 33.5 mm -53.21 -46.77 56.63 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.996 0 O-C-N 123.637 0.586 . . . . 0.0 109.952 168.721 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -68.6 -43.15 77.05 Favored 'General case' 0 N--CA 1.476 0.844 0 N-CA-C 113.598 0.962 . . . . 0.0 113.598 178.57 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 29.3 t90 . . . . . 0 N--CA 1.477 0.886 0 CA-C-N 114.816 -1.084 . . . . 0.0 113.069 178.337 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.605 ' HE3' HG22 ' A' ' 15' ' ' VAL . 39.7 mtp . . . . . 0 N--CA 1.477 0.918 0 N-CA-C 111.8 0.296 . . . . 0.0 111.8 . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . 0.419 ' HA ' ' O ' ' A' ' 7' ' ' ILE . . . -53.64 -55.19 28.04 Favored 'General case' 0 N--CA 1.475 0.789 0 CA-C-N 113.714 -1.585 . . . . 0.0 113.415 177.625 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -74.24 -44.11 54.32 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 113.639 -1.619 . . . . 0.0 114.156 -174.758 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 13.6 tt0 -78.52 -43.19 27.45 Favored 'General case' 0 N--CA 1.472 0.652 0 N-CA-C 114.241 1.2 . . . . 0.0 114.241 -170.898 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . 0.602 ' HB2' HD11 ' A' ' 7' ' ' ILE . 46.3 m-85 -105.34 -23.99 12.76 Favored 'General case' 0 N--CA 1.484 1.233 0 N-CA-C 116.258 1.947 . . . . 0.0 116.258 -170.16 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 95.72 58.38 1.12 Allowed Glycine 0 CA--C 1.534 1.276 0 C-N-CA 124.225 0.917 . . . . 0.0 111.77 -175.083 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.602 HD11 ' HB2' ' A' ' 5' ' ' PHE . 1.3 mt -125.77 151.11 70.46 Favored Pre-proline 0 N--CA 1.478 0.944 0 C-N-CA 124.764 1.225 . . . . 0.0 111.069 -173.57 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo -97.27 162.63 0.97 Allowed 'Trans proline' 0 C--O 1.24 0.597 0 C-N-CA 121.162 1.241 . . . . 0.0 109.703 161.596 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -53.44 -29.38 35.11 Favored 'General case' 0 CA--C 1.538 0.481 0 N-CA-C 114.719 1.377 . . . . 0.0 114.719 177.176 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -43.61 -59.87 2.0 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 126.196 1.799 . . . . 0.0 112.953 173.146 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.776 ' HB ' HD23 ' A' ' 32' ' ' LEU . 29.6 m -84.42 -29.89 7.13 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.195 0 N-CA-C 114.321 1.23 . . . . 0.0 114.321 -175.231 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -67.26 -29.79 69.5 Favored 'General case' 0 N--CA 1.48 1.064 0 N-CA-C 112.759 0.651 . . . . 0.0 112.759 172.943 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -66.66 -40.01 93.89 Favored Glycine 0 CA--C 1.536 1.374 0 C-N-CA 124.317 0.96 . . . . 0.0 112.401 170.616 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 0.75 HG21 HD13 ' A' ' 28' ' ' ILE . 1.0 OUTLIER -67.7 -34.13 76.29 Favored 'General case' 0 N--CA 1.487 1.404 0 C-N-CA 124.183 0.993 . . . . 0.0 112.937 177.232 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.605 HG22 ' HE3' ' A' ' 1' ' ' MET . 10.8 t -54.15 -40.58 47.3 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 C-N-CA 124.707 1.203 . . . . 0.0 112.879 165.772 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.47 HD21 ' HG3' ' A' ' 64' ' ' LYS . 83.2 mt -61.27 -37.13 82.03 Favored 'General case' 0 N--CA 1.472 0.645 0 N-CA-C 114.261 1.208 . . . . 0.0 114.261 176.494 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 48.2 t-20 -53.62 -47.9 69.8 Favored 'General case' 0 N--CA 1.481 1.076 0 CA-C-N 115.179 -0.919 . . . . 0.0 111.355 173.353 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.567 HG21 HG13 ' A' ' 28' ' ' ILE . 22.6 t -48.11 -51.61 9.0 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.213 0 CA-C-N 115.28 -0.873 . . . . 0.0 112.021 174.596 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.827 HG11 ' HA ' ' A' ' 56' ' ' LYS . 5.1 t -64.3 -48.16 86.62 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.144 0 C-N-CA 124.155 0.982 . . . . 0.0 111.327 -176.774 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -74.13 -43.11 58.72 Favored 'General case' 0 N--CA 1.469 0.519 0 N-CA-C 116.767 2.136 . . . . 0.0 116.767 -176.127 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -103.17 -22.45 13.74 Favored 'General case' 0 N--CA 1.481 1.107 0 N-CA-C 115.814 1.783 . . . . 0.0 115.814 -169.796 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 68.87 39.61 85.34 Favored Glycine 0 N--CA 1.477 1.413 0 N-CA-C 110.639 -0.984 . . . . 0.0 110.639 -165.928 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -86.55 142.82 18.91 Favored Glycine 0 N--CA 1.48 1.57 0 N-CA-C 108.815 -1.714 . . . . 0.0 108.815 -177.513 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 9.2 m-90 -49.6 103.15 0.04 OUTLIER 'General case' 0 N--CA 1.477 0.883 0 CA-C-N 113.624 -1.288 . . . . 0.0 112.71 -172.498 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 3.2 p -56.44 -23.41 16.68 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.758 0 CA-C-N 114.028 -1.442 . . . . 0.0 114.414 176.368 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 5.0 t -62.43 -44.42 96.47 Favored 'General case' 0 N--CA 1.484 1.225 0 CA-C-N 115.648 -0.705 . . . . 0.0 112.558 178.389 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 1.6 m -60.86 -45.76 93.25 Favored 'General case' 0 N--CA 1.485 1.287 0 C-N-CA 123.871 0.868 . . . . 0.0 110.937 172.998 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.75 HD13 HG21 ' A' ' 14' ' ' THR . 8.4 mm -62.37 -46.58 96.09 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.152 0 C-N-CA 124.394 1.078 . . . . 0.0 111.867 -179.09 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 48.7 t -50.31 -45.77 25.02 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.386 0 C-N-CA 124.757 1.223 . . . . 0.0 111.129 176.964 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 64.8 m -63.81 -27.31 69.09 Favored 'General case' 0 N--CA 1.481 1.095 0 N-CA-C 115.867 1.802 . . . . 0.0 115.867 177.825 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.77 HG21 HG11 ' A' ' 11' ' ' VAL . 34.9 mm -82.21 -39.81 16.67 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.032 0 C-N-CA 123.857 0.863 . . . . 0.0 109.07 178.967 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.776 HD23 ' HB ' ' A' ' 11' ' ' VAL . 3.4 mm? -56.64 -50.58 71.61 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 125.142 1.377 . . . . 0.0 112.204 172.171 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 1.4 p -70.89 -29.69 65.83 Favored 'General case' 0 N--CA 1.481 1.079 0 N-CA-C 114.683 1.364 . . . . 0.0 114.683 177.837 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -52.4 -25.63 10.43 Favored 'General case' 0 N--CA 1.477 0.918 0 N-CA-C 114.006 1.113 . . . . 0.0 114.006 170.456 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 58.5 t -70.9 -26.25 27.42 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.322 0 C-N-CA 124.327 1.051 . . . . 0.0 112.051 173.753 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 114.35 -118.78 4.5 Favored Glycine 0 CA--C 1.527 0.794 0 C-N-CA 125.21 1.386 . . . . 0.0 110.201 -176.813 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 17.8 p -61.44 -37.38 83.35 Favored 'General case' 0 N--CA 1.478 0.943 0 CA-C-N 112.979 -1.61 . . . . 0.0 114.259 -179.596 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -46.65 -54.75 8.69 Favored Glycine 0 N--CA 1.482 1.745 0 C-N-CA 124.789 1.185 . . . . 0.0 114.586 -175.729 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.529 ' O ' ' HG ' ' A' ' 43' ' ' LEU . . . -55.3 -49.23 64.82 Favored Glycine 0 N--CA 1.48 1.58 0 O-C-N 125.172 1.16 . . . . 0.0 113.018 176.922 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 22.3 mt -61.45 -48.27 81.91 Favored 'General case' 0 N--CA 1.479 0.981 0 CA-C-N 113.589 -1.306 . . . . 0.0 113.5 -178.845 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 17.0 m -57.92 -41.25 82.3 Favored 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 123.658 0.783 . . . . 0.0 112.758 176.188 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.494 HD11 ' HE2' ' A' ' 1' ' ' MET . 13.7 tp -60.5 -45.76 92.6 Favored 'General case' 0 N--CA 1.478 0.961 0 CA-C-N 115.554 -0.748 . . . . 0.0 111.393 173.969 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.529 ' HG ' ' O ' ' A' ' 39' ' ' GLY . 69.2 mt -61.85 -32.84 73.21 Favored 'General case' 0 N--CA 1.473 0.697 0 N-CA-C 113.66 0.985 . . . . 0.0 113.66 -179.269 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -63.9 -48.99 74.43 Favored 'General case' 0 N--CA 1.476 0.851 0 O-C-N 123.985 0.803 . . . . 0.0 112.102 171.802 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -62.52 -33.34 74.7 Favored 'General case' 0 N--CA 1.485 1.284 0 CA-C-O 122.239 1.019 . . . . 0.0 112.753 178.12 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -61.77 -14.33 31.64 Favored 'General case' 0 N--CA 1.478 0.933 0 N-CA-C 116.11 1.893 . . . . 0.0 116.11 176.559 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -48.54 -37.22 19.24 Favored Glycine 0 CA--C 1.542 1.771 0 O-C-N 124.718 1.261 . . . . 0.0 113.511 177.833 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 40.2 ttp180 -50.71 -50.76 54.46 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 125.671 1.588 . . . . 0.0 113.647 -173.602 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -145.52 37.98 1.12 Allowed 'General case' 0 N--CA 1.476 0.841 0 N-CA-C 114.064 1.135 . . . . 0.0 114.064 -175.013 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 27.6 t 52.96 133.37 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.504 0 C-N-CA 125.175 1.39 . . . . 0.0 112.855 -175.71 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.419 ' O ' ' HB3' ' A' ' 54' ' ' TYR 0.259 9.9 tp -37.79 -54.04 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.822 0 N-CA-C 117.89 2.552 . . . . 0.0 117.89 -168.186 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 38.4 tttt -61.98 -57.23 12.48 Favored 'General case' 0 CA--C 1.543 0.694 0 N-CA-C 114.096 1.147 . . . . 0.0 114.096 178.232 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -66.17 -30.0 70.39 Favored 'General case' 0 N--CA 1.479 1.011 0 O-C-N 123.925 0.765 . . . . 0.0 112.936 179.766 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . 0.419 ' HB3' ' O ' ' A' ' 51' ' ' ILE . 64.4 t80 -53.98 -61.42 2.31 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 124.893 1.277 . . . . 0.0 110.716 170.592 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.435 HD12 HG12 ' A' ' 15' ' ' VAL . 51.2 mt -65.01 -35.81 82.4 Favored 'General case' 0 N--CA 1.482 1.165 0 N-CA-C 113.622 0.971 . . . . 0.0 113.622 -174.662 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.827 ' HA ' HG11 ' A' ' 19' ' ' VAL . 55.6 mttm -54.41 -56.58 17.26 Favored 'General case' 0 N--CA 1.473 0.693 0 O-C-N 125.34 1.65 . . . . 0.0 112.065 173.024 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 57.1 tttm -68.43 -45.47 72.47 Favored 'General case' 0 CA--C 1.542 0.635 0 CA-C-N 115.411 -0.813 . . . . 0.0 112.113 176.799 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . 0.451 ' O ' ' HB2' ' A' ' 62' ' ' LYS . 4.1 tp10 -56.81 -52.37 65.31 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-N 114.969 -1.014 . . . . 0.0 112.962 -175.969 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.551 HG22 HG22 ' A' ' 67' ' ' VAL . 1.2 mm -74.8 -26.7 19.75 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.261 0 CA-C-N 116.04 -0.527 . . . . 0.0 112.1 -177.713 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.472 ' HB2' ' O ' ' A' ' 56' ' ' LYS . 3.8 tppt? -62.06 -42.2 98.94 Favored 'General case' 0 CA--C 1.539 0.543 0 O-C-N 124.383 1.052 . . . . 0.0 112.525 176.596 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 61.2 pttt -86.39 -26.99 24.49 Favored 'General case' 0 CA--C 1.547 0.86 0 CA-C-N 113.447 -1.706 . . . . 0.0 113.193 177.935 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.451 ' HB2' ' O ' ' A' ' 58' ' ' GLU . 35.7 tptt -76.16 -58.37 3.32 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 125.714 1.606 . . . . 0.0 114.542 -178.008 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 103.32 110.72 3.48 Favored Glycine 0 CA--C 1.543 1.803 0 CA-C-N 114.628 -1.169 . . . . 0.0 112.189 -174.304 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.486 ' HD2' ' H ' ' A' ' 64' ' ' LYS . 11.2 mptt -34.75 -52.27 0.52 Allowed 'General case' 0 N--CA 1.481 1.077 0 N-CA-C 119.784 3.253 . . . . 0.0 119.784 -172.641 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -61.55 -45.59 93.52 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 123.779 0.831 . . . . 0.0 112.993 -179.778 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -65.48 -25.82 67.65 Favored 'General case' 0 N--CA 1.478 0.97 0 CA-C-N 113.924 -1.489 . . . . 0.0 112.949 174.12 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.551 HG22 HG22 ' A' ' 59' ' ' ILE . 71.7 t -63.77 -43.86 98.09 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.314 0 C-N-CA 123.319 0.648 . . . . 0.0 110.411 174.864 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -51.78 -44.48 36.52 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.966 0 C-N-CA 123.339 0.656 . . . . 0.0 111.671 173.562 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -70.43 -47.64 59.79 Favored 'General case' 0 N--CA 1.481 1.077 0 N-CA-C 113.222 0.823 . . . . 0.0 113.222 177.629 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 30.7 t90 . . . . . 0 N--CA 1.481 1.083 0 C-N-CA 126.382 1.873 . . . . 0.0 112.433 -178.69 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.664 ' HB3' HG21 ' A' ' 7' ' ' ILE . 68.4 mtp . . . . . 0 N--CA 1.474 0.757 0 N-CA-C 113.471 0.915 . . . . 0.0 113.471 . . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -64.37 -38.83 92.42 Favored 'General case' 0 N--CA 1.475 0.813 0 N-CA-C 114.111 1.152 . . . . 0.0 114.111 176.562 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 35.6 ttmt -91.25 -68.54 0.79 Allowed 'General case' 0 N--CA 1.471 0.605 0 N-CA-C 114.125 1.157 . . . . 0.0 114.125 -176.89 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 8.5 tt0 -61.66 -31.14 71.23 Favored 'General case' 0 CA--C 1.55 0.974 0 C-N-CA 125.188 1.395 . . . . 0.0 113.796 -173.623 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . 0.548 ' HD1' ' HB2' ' A' ' 41' ' ' SER . 45.1 m-85 -109.77 -11.93 14.67 Favored 'General case' 0 N--CA 1.474 0.74 0 N-CA-C 116.948 2.203 . . . . 0.0 116.948 -179.94 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 64.44 31.62 81.47 Favored Glycine 0 CA--C 1.538 1.511 0 C-N-CA 124.176 0.893 . . . . 0.0 113.856 -174.228 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.664 HG21 ' HB3' ' A' ' 1' ' ' MET . 0.7 OUTLIER -104.21 118.01 57.97 Favored Pre-proline 0 N--CA 1.478 0.939 0 C-N-CA 123.418 0.687 . . . . 0.0 110.863 -177.524 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -64.27 161.61 33.52 Favored 'Trans proline' 0 CA--C 1.537 0.653 0 C-N-CA 122.506 2.137 . . . . 0.0 112.277 -171.807 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -55.75 -29.1 59.02 Favored 'General case' 0 N--CA 1.476 0.83 0 CA-C-N 113.278 -1.783 . . . . 0.0 114.137 173.141 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -49.03 -33.55 11.52 Favored 'General case' 0 N--CA 1.48 1.033 0 N-CA-C 114.853 1.427 . . . . 0.0 114.853 172.941 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.745 HG11 HG21 ' A' ' 31' ' ' ILE . 30.2 m -112.15 -35.45 2.43 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.016 0 N-CA-C 113.789 1.033 . . . . 0.0 113.789 179.895 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -64.57 -40.21 95.14 Favored 'General case' 0 N--CA 1.476 0.852 0 N-CA-C 113.651 0.982 . . . . 0.0 113.651 174.802 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -61.72 -40.67 99.09 Favored Glycine 0 CA--C 1.548 2.104 0 C-N-CA 124.172 0.891 . . . . 0.0 112.276 174.542 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 0.494 HG21 HD13 ' A' ' 28' ' ' ILE . 4.3 m -66.81 -40.99 88.25 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 125.139 1.376 . . . . 0.0 113.46 177.324 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.618 HG22 ' HE3' ' A' ' 1' ' ' MET . 54.4 t -52.54 -46.96 49.05 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.207 0 C-N-CA 123.126 0.57 . . . . 0.0 111.249 169.056 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.665 HD13 HG12 ' A' ' 68' ' ' ILE . 23.8 mt -57.28 -48.19 79.54 Favored 'General case' 0 N--CA 1.482 1.174 0 O-C-N 123.839 0.712 . . . . 0.0 112.904 179.205 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 11.8 t-20 -54.44 -44.68 72.67 Favored 'General case' 0 CA--C 1.542 0.665 0 CA-C-N 114.857 -1.065 . . . . 0.0 111.338 179.168 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.933 HG22 HD12 ' A' ' 28' ' ' ILE . 2.8 t -68.68 -40.96 82.35 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.762 0 CA-C-N 113.475 -1.693 . . . . 0.0 114.087 179.336 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.633 HG11 ' HA ' ' A' ' 56' ' ' LYS . 40.5 t -59.01 -52.48 60.16 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.357 0 O-C-N 124.392 1.058 . . . . 0.0 109.265 175.73 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . 0.543 ' HG3' ' HE2' ' A' ' 64' ' ' LYS . 36.0 mt-10 -55.01 -53.54 54.46 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 125.232 1.413 . . . . 0.0 113.35 178.099 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -77.24 -11.66 59.85 Favored 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 115.683 1.735 . . . . 0.0 115.683 -175.379 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 67.66 47.93 59.01 Favored Glycine 0 N--CA 1.478 1.472 0 C-N-CA 124.523 1.059 . . . . 0.0 111.424 -172.44 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -94.13 -160.1 34.44 Favored Glycine 0 N--CA 1.475 1.248 0 CA-C-O 123.163 1.424 . . . . 0.0 113.293 -173.958 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' TRP . . . . . 0.422 ' HB3' HG21 ' A' ' 26' ' ' THR . 9.1 m-90 -102.89 105.69 16.1 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-O 122.651 1.215 . . . . 0.0 113.305 179.16 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.473 HG21 ' HE3' ' A' ' 56' ' ' LYS . 77.4 t -55.67 -27.23 21.36 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.045 0 CA-C-N 114.057 -1.429 . . . . 0.0 112.899 168.338 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.422 HG21 ' HB3' ' A' ' 24' ' ' TRP . 3.1 t -60.28 -38.32 83.19 Favored 'General case' 0 N--CA 1.485 1.286 0 N-CA-C 113.349 0.87 . . . . 0.0 113.349 179.143 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 2.7 m -64.07 -41.03 97.49 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 125.09 1.356 . . . . 0.0 110.684 175.013 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.933 HD12 HG22 ' A' ' 18' ' ' VAL . 1.6 mm -73.65 -39.85 53.87 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.277 0 CA-C-N 115.508 -0.769 . . . . 0.0 111.411 -178.79 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 25.6 t -46.09 -44.77 5.5 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 C-N-CA 124.113 0.965 . . . . 0.0 111.639 175.589 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 20.0 m -57.1 -41.31 78.68 Favored 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 124.966 1.307 . . . . 0.0 114.472 174.287 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.745 HG21 HG11 ' A' ' 11' ' ' VAL . 16.4 mm -75.09 -37.62 40.79 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.272 0 C-N-CA 124.483 1.113 . . . . 0.0 110.196 -178.957 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.536 ' HB3' ' HA2' ' A' ' 39' ' ' GLY . 4.2 mm? -55.37 -41.17 72.23 Favored 'General case' 0 N--CA 1.49 1.573 0 C-N-CA 124.342 1.057 . . . . 0.0 110.926 168.805 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' THR . . . . . 0.564 HG22 ' HA3' ' A' ' 38' ' ' GLY . 25.5 m -68.53 -38.83 81.2 Favored 'General case' 0 N--CA 1.485 1.317 0 N-CA-C 114.232 1.197 . . . . 0.0 114.232 174.961 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -55.68 -30.12 60.53 Favored 'General case' 0 N--CA 1.481 1.115 0 O-C-N 124.7 1.25 . . . . 0.0 113.242 175.131 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.457 ' HB ' ' O ' ' A' ' 32' ' ' LEU . 54.5 t -57.32 -33.15 42.94 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.034 0 C-N-CA 125.838 1.655 . . . . 0.0 113.423 172.916 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . 0.486 ' C ' ' H ' ' A' ' 38' ' ' GLY . . . 111.78 169.5 18.48 Favored Glycine 0 CA--C 1.537 1.407 0 N-CA-C 107.633 -2.187 . . . . 0.0 107.633 -167.788 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' SER . . . . . 0.546 ' OG ' ' HB2' ' A' ' 40' ' ' LEU . 9.6 t 70.37 -39.47 0.44 Allowed 'General case' 0 N--CA 1.493 1.7 0 C-N-CA 126.039 1.735 . . . . 0.0 113.185 -173.763 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.564 ' HA3' HG22 ' A' ' 33' ' ' THR . . . 113.31 9.99 16.38 Favored Glycine 0 CA--C 1.537 1.455 0 C-N-CA 126.236 1.874 . . . . 0.0 112.133 -169.251 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.536 ' HA2' ' HB3' ' A' ' 32' ' ' LEU . . . 59.05 23.7 57.5 Favored Glycine 0 CA--C 1.546 1.977 0 C-N-CA 123.696 0.665 . . . . 0.0 111.899 -159.512 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.546 ' HB2' ' OG ' ' A' ' 37' ' ' SER . 9.4 mt -51.91 -40.03 60.07 Favored 'General case' 0 N--CA 1.485 1.303 0 N-CA-C 116.631 2.086 . . . . 0.0 116.631 -168.52 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' SER . . . . . 0.548 ' HB2' ' HD1' ' A' ' 5' ' ' PHE . 7.9 p -59.8 -49.04 79.26 Favored 'General case' 0 CA--C 1.546 0.792 0 N-CA-C 113.448 0.907 . . . . 0.0 113.448 178.792 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.496 HD21 ' HE2' ' A' ' 1' ' ' MET . 15.8 tp -61.16 -47.36 86.56 Favored 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 122.968 0.507 . . . . 0.0 110.43 172.684 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 43.9 mt -66.19 -26.64 67.5 Favored 'General case' 0 N--CA 1.476 0.863 0 CA-C-N 114.605 -1.179 . . . . 0.0 114.062 -175.215 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -69.75 -45.16 68.71 Favored 'General case' 0 N--CA 1.475 0.823 0 CA-C-N 115.694 -0.685 . . . . 0.0 111.82 171.57 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -63.54 -35.81 81.7 Favored 'General case' 0 N--CA 1.479 0.976 0 CA-C-O 121.005 0.431 . . . . 0.0 111.875 173.845 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -66.13 -28.59 68.91 Favored 'General case' 0 N--CA 1.474 0.774 0 N-CA-C 116.193 1.923 . . . . 0.0 116.193 179.654 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -53.14 -35.05 48.37 Favored Glycine 0 N--CA 1.482 1.717 0 C-N-CA 124.818 1.199 . . . . 0.0 113.39 -178.433 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 42.2 ttp180 -57.24 -41.92 80.48 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 126.233 1.813 . . . . 0.0 113.929 -176.177 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -138.57 57.43 1.69 Allowed 'General case' 0 N--CA 1.476 0.839 0 CA-C-O 121.887 0.851 . . . . 0.0 110.149 178.197 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 9.0 t 30.33 114.32 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.225 0 N-CA-C 116.84 2.163 . . . . 0.0 116.84 -178.868 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 7.0 tp -26.99 -54.04 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.349 0 N-CA-C 118.023 2.601 . . . . 0.0 118.023 -177.273 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 0.49 ' NZ ' ' HZ3' ' A' ' 56' ' ' LYS . 24.1 tptp -57.65 -58.15 9.57 Favored 'General case' 0 N--CA 1.481 1.108 0 C-N-CA 124.494 1.118 . . . . 0.0 111.913 -177.762 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -72.01 -35.21 69.37 Favored 'General case' 0 N--CA 1.484 1.237 0 O-C-N 124.579 1.174 . . . . 0.0 113.831 177.847 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 67.8 t80 -45.78 -60.96 1.93 Allowed 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 125.445 1.498 . . . . 0.0 112.117 -179.695 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 59.4 mt -65.86 -36.14 82.61 Favored 'General case' 0 N--CA 1.475 0.811 0 N-CA-C 114.782 1.401 . . . . 0.0 114.782 -175.24 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.633 ' HA ' HG11 ' A' ' 19' ' ' VAL . 35.5 mmtp -57.67 -56.2 25.02 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-N 114.211 -1.359 . . . . 0.0 112.311 177.386 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.445 ' HE3' ' HE3' ' A' ' 61' ' ' LYS . 64.0 tttp -69.51 -51.15 38.4 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-N 115.054 -0.975 . . . . 0.0 111.968 175.673 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . 0.553 ' O ' ' HB2' ' A' ' 62' ' ' LYS . 3.6 mm-40 -54.93 -50.75 68.08 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-O 118.281 -0.866 . . . . 0.0 112.682 -173.377 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.615 HG22 HG22 ' A' ' 67' ' ' VAL . 2.7 mm -79.14 -25.68 12.94 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.077 0 CA-C-O 118.618 -0.706 . . . . 0.0 112.007 -175.824 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.613 ' HA ' ' HZ3' ' A' ' 64' ' ' LYS . 8.7 tppt? -62.1 -32.42 72.98 Favored 'General case' 0 N--CA 1.473 0.698 0 N-CA-C 114.416 1.265 . . . . 0.0 114.416 171.894 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . 0.445 ' HE3' ' HE3' ' A' ' 57' ' ' LYS . 48.4 mttm -88.56 -45.7 9.68 Favored 'General case' 0 N--CA 1.476 0.838 0 CA-C-N 113.351 -1.75 . . . . 0.0 112.42 176.127 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.553 ' HB2' ' O ' ' A' ' 58' ' ' GLU . 2.9 tttm -64.41 -45.55 87.07 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 126.448 1.899 . . . . 0.0 112.96 -172.512 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 95.45 113.66 2.75 Favored Glycine 0 N--CA 1.479 1.546 0 O-C-N 124.958 1.411 . . . . 0.0 109.65 -175.546 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.64 ' HD2' ' H ' ' A' ' 64' ' ' LYS . 10.7 mptt -44.66 -43.7 8.5 Favored 'General case' 0 N--CA 1.484 1.234 0 N-CA-C 116.801 2.148 . . . . 0.0 116.801 -172.636 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . 0.464 ' O ' ' HB ' ' A' ' 68' ' ' ILE . 0.0 OUTLIER -56.16 -48.53 76.11 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 125.381 1.472 . . . . 0.0 114.576 178.054 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -64.71 -28.05 69.33 Favored 'General case' 0 N--CA 1.473 0.718 0 N-CA-C 114.463 1.282 . . . . 0.0 114.463 172.526 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.615 HG22 HG22 ' A' ' 59' ' ' ILE . 95.3 t -72.96 -32.82 41.25 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.944 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.321 179.098 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.665 HG12 HD13 ' A' ' 16' ' ' LEU . 4.3 mm -50.05 -49.57 21.55 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.332 0 C-N-CA 123.494 0.718 . . . . 0.0 110.098 167.132 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -64.59 -50.0 68.92 Favored 'General case' 0 N--CA 1.481 1.076 0 CA-C-N 114.917 -1.038 . . . . 0.0 112.912 178.636 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 23.2 t90 . . . . . 0 CA--C 1.544 0.728 0 C-N-CA 126.489 1.915 . . . . 0.0 112.987 179.394 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.743 ' HE3' HG22 ' A' ' 15' ' ' VAL . 74.1 mtp . . . . . 0 N--CA 1.482 1.156 0 N-CA-C 113.327 0.862 . . . . 0.0 113.327 . . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -65.18 -56.12 14.68 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-N 114.915 -1.039 . . . . 0.0 112.67 175.474 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 14.4 ttmm -71.09 -52.96 16.4 Favored 'General case' 0 CA--C 1.549 0.935 0 CA-C-N 114.361 -1.291 . . . . 0.0 114.118 -172.967 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . 0.435 ' HB2' ' O ' ' A' ' 70' ' ' TRP . 1.8 mp0 -79.77 -38.45 33.15 Favored 'General case' 0 N--CA 1.476 0.829 0 N-CA-C 115.052 1.501 . . . . 0.0 115.052 -174.559 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . 0.517 ' HD2' ' HA ' ' A' ' 1' ' ' MET . 73.9 m-85 -106.28 -9.72 16.71 Favored 'General case' 0 N--CA 1.484 1.253 0 N-CA-C 117.041 2.237 . . . . 0.0 117.041 -172.236 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 66.73 36.92 91.94 Favored Glycine 0 CA--C 1.54 1.632 0 CA-C-O 121.971 0.762 . . . . 0.0 112.917 -176.055 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.671 HG22 HG22 ' A' ' 11' ' ' VAL . 0.6 OUTLIER -116.12 112.87 41.81 Favored Pre-proline 0 N--CA 1.472 0.657 0 C-N-CA 124.327 1.051 . . . . 0.0 109.413 179.106 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_endo -63.86 164.05 23.02 Favored 'Trans proline' 0 N--CA 1.48 0.68 0 C-N-CA 121.184 1.256 . . . . 0.0 111.597 -174.471 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -55.76 -28.42 55.85 Favored 'General case' 0 N--CA 1.479 0.989 0 N-CA-C 114.674 1.361 . . . . 0.0 114.674 176.75 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -45.51 -43.98 12.21 Favored 'General case' 0 CA--C 1.549 0.917 0 C-N-CA 125.985 1.714 . . . . 0.0 113.753 174.628 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.962 HG13 HG21 ' A' ' 31' ' ' ILE . 33.6 m -100.24 -28.92 3.28 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.054 0 N-CA-C 114.766 1.395 . . . . 0.0 114.766 179.248 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -67.6 -34.97 78.07 Favored 'General case' 0 N--CA 1.477 0.895 0 N-CA-C 113.791 1.034 . . . . 0.0 113.791 176.76 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -61.47 -41.34 99.53 Favored Glycine 0 N--CA 1.478 1.44 0 CA-C-O 122.467 1.037 . . . . 0.0 112.304 172.357 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 3.1 m -64.1 -34.05 77.15 Favored 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 126.046 1.738 . . . . 0.0 112.893 175.524 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.743 HG22 ' HE3' ' A' ' 1' ' ' MET . 20.5 t -63.5 -36.64 77.06 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.065 0 C-N-CA 123.667 0.787 . . . . 0.0 112.083 172.039 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.635 HD12 ' HB3' ' A' ' 64' ' ' LYS . 31.6 mt -65.43 -40.36 93.21 Favored 'General case' 0 N--CA 1.485 1.305 0 N-CA-C 112.913 0.708 . . . . 0.0 112.913 174.234 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 4.6 m120 -57.62 -43.99 85.18 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 124.976 1.31 . . . . 0.0 112.448 174.384 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 4.1 t -48.11 -57.64 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.35 0 C-N-CA 123.835 0.854 . . . . 0.0 111.373 168.391 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.566 HG11 ' HA ' ' A' ' 56' ' ' LYS . 4.8 t -60.66 -44.78 97.76 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 123.935 0.772 . . . . 0.0 111.913 -176.16 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 27.6 mt-10 -63.93 -43.74 94.97 Favored 'General case' 0 N--CA 1.472 0.634 0 N-CA-C 115.301 1.593 . . . . 0.0 115.301 179.506 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -97.04 -11.51 24.39 Favored 'General case' 0 N--CA 1.478 0.934 0 N-CA-C 116.221 1.934 . . . . 0.0 116.221 -170.917 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . 0.494 ' HA3' ' HZ2' ' A' ' 56' ' ' LYS . . . 73.49 25.28 72.98 Favored Glycine 0 CA--C 1.544 1.866 0 O-C-N 123.521 0.513 . . . . 0.0 112.736 -169.002 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -78.76 149.94 33.8 Favored Glycine 0 N--CA 1.476 1.362 0 CA-C-O 122.419 1.01 . . . . 0.0 113.689 -171.054 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' TRP . . . . . 0.521 ' HB3' HG21 ' A' ' 26' ' ' THR . 2.9 m-90 -62.1 98.08 0.1 Allowed 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 125.31 1.444 . . . . 0.0 112.327 178.402 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 5.0 p -51.87 -27.84 9.19 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.868 0 CA-C-N 113.734 -1.575 . . . . 0.0 113.985 173.187 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.521 HG21 ' HB3' ' A' ' 24' ' ' TRP . 13.9 t -59.52 -40.72 88.05 Favored 'General case' 0 CA--C 1.546 0.827 0 C-N-CA 124.735 1.214 . . . . 0.0 112.937 -178.055 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -67.66 -47.07 70.57 Favored 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 124.101 0.96 . . . . 0.0 110.604 174.964 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 2.3 mp -60.21 -35.4 61.72 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.036 0 C-N-CA 125.259 1.424 . . . . 0.0 112.99 177.179 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.41 ' O ' ' HB2' ' A' ' 32' ' ' LEU . 15.9 t -48.97 -40.62 12.78 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.365 0 C-N-CA 124.403 1.081 . . . . 0.0 112.38 173.845 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 59.7 p -61.03 -30.3 70.22 Favored 'General case' 0 N--CA 1.477 0.888 0 N-CA-C 114.02 1.118 . . . . 0.0 114.02 176.255 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.962 HG21 HG13 ' A' ' 11' ' ' VAL . 42.6 mm -77.33 -36.47 23.96 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.989 0 C-N-CA 124.07 0.948 . . . . 0.0 109.191 179.965 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.56 ' HB3' ' HA2' ' A' ' 39' ' ' GLY . 3.9 mm? -60.13 -36.42 77.45 Favored 'General case' 0 N--CA 1.49 1.554 0 C-N-CA 123.741 0.817 . . . . 0.0 111.315 169.414 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' THR . . . . . 0.744 HG22 ' HA3' ' A' ' 38' ' ' GLY . 2.5 m -72.55 -34.31 67.42 Favored 'General case' 0 N--CA 1.483 1.176 0 N-CA-C 114.698 1.37 . . . . 0.0 114.698 175.403 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -54.49 -29.02 48.77 Favored 'General case' 0 N--CA 1.482 1.16 0 O-C-N 124.245 0.965 . . . . 0.0 113.459 174.317 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.403 ' HB ' ' O ' ' A' ' 32' ' ' LEU . 70.5 t -56.65 -34.06 41.53 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.255 0 C-N-CA 126.313 1.845 . . . . 0.0 113.03 172.031 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 116.82 -51.24 0.74 Allowed Glycine 0 N--CA 1.482 1.757 0 O-C-N 123.221 0.326 . . . . 0.0 112.941 -178.392 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 62.8 p -62.04 5.74 0.09 Allowed 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 116.148 1.907 . . . . 0.0 116.148 173.883 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.744 ' HA3' HG22 ' A' ' 33' ' ' THR . . . 66.22 0.98 8.47 Favored Glycine 0 N--CA 1.483 1.806 0 C-N-CA 124.473 1.035 . . . . 0.0 115.511 -179.803 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.56 ' HA2' ' HB3' ' A' ' 32' ' ' LEU . . . 60.88 18.31 53.32 Favored Glycine 0 CA--C 1.543 1.815 0 C-N-CA 124.897 1.237 . . . . 0.0 113.404 -159.892 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 14.3 mt -53.23 -41.74 65.7 Favored 'General case' 0 N--CA 1.48 1.059 0 N-CA-C 116.459 2.022 . . . . 0.0 116.459 -171.127 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' SER . . . . . 0.478 ' HB2' ' HD1' ' A' ' 5' ' ' PHE . 11.5 p -59.47 -51.62 69.1 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 125.327 1.451 . . . . 0.0 113.86 175.26 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 14.5 tp -60.74 -43.48 97.87 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 123.676 0.79 . . . . 0.0 110.31 174.157 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 82.7 mt -65.68 -27.37 68.3 Favored 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 114.618 1.34 . . . . 0.0 114.618 -178.23 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -70.33 -48.26 57.32 Favored 'General case' 0 N--CA 1.478 0.953 0 CA-C-N 115.43 -0.805 . . . . 0.0 112.323 169.91 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -59.19 -37.16 76.74 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 123.446 0.699 . . . . 0.0 112.697 176.292 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -57.87 -28.95 64.62 Favored 'General case' 0 C--N 1.321 -0.63 0 C-N-CA 126.546 1.938 . . . . 0.0 115.642 177.76 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -47.81 -41.78 20.67 Favored Glycine 0 CA--C 1.536 1.371 0 C-N-CA 125.438 1.494 . . . . 0.0 114.608 -174.514 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 41.0 ttp-105 -53.81 -47.02 71.27 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 126.0 1.72 . . . . 0.0 113.81 -174.797 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 5.0 tt0 -127.14 31.01 5.32 Favored 'General case' 0 CA--C 1.547 0.854 0 N-CA-C 113.787 1.032 . . . . 0.0 113.787 -177.553 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 24.5 t 45.85 126.8 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 125.353 1.461 . . . . 0.0 113.809 -171.545 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 9.8 tp -37.44 -42.25 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 N-CA-C 117.239 2.311 . . . . 0.0 117.239 -173.437 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 8.4 mmtt -57.41 -72.05 0.09 Allowed 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 124.31 1.044 . . . . 0.0 112.05 174.393 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -62.49 -34.8 77.57 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 125.196 1.398 . . . . 0.0 113.853 -177.842 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 87.6 t80 -48.62 -59.45 3.51 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 125.497 1.519 . . . . 0.0 111.646 175.715 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.516 HD12 HG11 ' A' ' 15' ' ' VAL . 75.0 mt -67.86 -41.67 82.54 Favored 'General case' 0 N--CA 1.482 1.149 0 N-CA-C 114.448 1.277 . . . . 0.0 114.448 -177.873 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.566 ' HA ' HG11 ' A' ' 19' ' ' VAL . 33.2 mmtp -55.98 -42.16 75.92 Favored 'General case' 0 N--CA 1.479 0.993 0 CA-C-N 113.253 -1.794 . . . . 0.0 114.507 178.963 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 59.3 tttm -80.35 -54.97 5.23 Favored 'General case' 0 N--CA 1.473 0.715 0 O-C-N 124.843 1.34 . . . . 0.0 112.327 172.559 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 72.9 tt0 -58.68 -46.02 88.16 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-O 117.766 -1.111 . . . . 0.0 112.489 -168.694 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.684 HG22 HG23 ' A' ' 67' ' ' VAL . 3.7 mm -79.36 -20.02 12.59 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.895 0 C-N-CA 119.911 -0.716 . . . . 0.0 112.081 -173.814 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 22.9 tttp -72.55 -24.91 61.19 Favored 'General case' 0 CA--C 1.547 0.851 0 O-C-N 124.713 1.258 . . . . 0.0 114.147 172.638 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 45.3 mmtm -97.25 -38.8 9.54 Favored 'General case' 0 N--CA 1.477 0.886 0 CA-C-N 113.549 -1.66 . . . . 0.0 111.58 178.455 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.438 ' HD3' HG21 ' A' ' 67' ' ' VAL . 31.6 tttp -71.54 -52.65 17.1 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 126.282 1.833 . . . . 0.0 114.514 -177.938 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 102.17 114.62 3.88 Favored Glycine 0 N--CA 1.483 1.79 0 O-C-N 124.361 1.038 . . . . 0.0 111.022 -173.289 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.643 ' HD2' ' H ' ' A' ' 64' ' ' LYS . 9.0 mptt -41.44 -44.37 2.86 Favored 'General case' 0 N--CA 1.486 1.354 0 N-CA-C 117.548 2.425 . . . . 0.0 117.548 -176.043 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . 0.373 0.0 OUTLIER -53.08 -51.76 60.78 Favored 'General case' 0 C--N 1.315 -0.912 0 C-N-CA 127.801 2.44 . . . . 0.0 114.124 177.216 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -65.71 -27.62 68.47 Favored 'General case' 0 N--CA 1.475 0.788 0 N-CA-C 114.111 1.152 . . . . 0.0 114.111 173.436 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.684 HG23 HG22 ' A' ' 59' ' ' ILE . 21.7 t -71.08 -36.16 61.88 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.966 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.502 179.876 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.402 HG12 HD13 ' A' ' 16' ' ' LEU . 14.2 mm -49.01 -44.61 15.99 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.847 0 C-N-CA 124.243 1.017 . . . . 0.0 110.939 167.696 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -70.77 -51.76 25.01 Favored 'General case' 0 N--CA 1.477 0.877 0 CA-C-N 115.004 -0.998 . . . . 0.0 112.331 179.088 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' TRP . . . . . 0.435 ' O ' ' HB2' ' A' ' 4' ' ' GLU . 36.2 t90 . . . . . 0 CA--C 1.553 1.073 0 C-N-CA 125.303 1.441 . . . . 0.0 113.352 -177.277 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.456 ' HE3' HG22 ' A' ' 15' ' ' VAL . 34.3 mtp . . . . . 0 CA--C 1.533 0.294 0 CA-C-O 119.718 -0.182 . . . . 0.0 110.738 . . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . 0.413 ' HA ' ' O ' ' A' ' 7' ' ' ILE . . . -60.29 -50.39 73.84 Favored 'General case' 0 N--CA 1.478 0.966 0 CA-C-N 114.374 -1.285 . . . . 0.0 112.863 178.844 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.44 ' HA ' ' HD2' ' A' ' 3' ' ' LYS . 10.5 tptm -71.73 -58.92 3.05 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 113.543 -1.662 . . . . 0.0 114.55 -175.716 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -67.95 -43.58 78.77 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 116.263 1.949 . . . . 0.0 116.263 -170.209 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . 0.495 ' HB2' HD13 ' A' ' 7' ' ' ILE . 33.7 m-85 -102.0 -26.09 13.52 Favored 'General case' 0 N--CA 1.481 1.113 0 N-CA-C 116.665 2.098 . . . . 0.0 116.665 -170.408 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 92.47 58.64 1.34 Allowed Glycine 0 N--CA 1.477 1.384 0 O-C-N 124.931 1.394 . . . . 0.0 110.537 -174.975 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.495 HD13 ' HB2' ' A' ' 5' ' ' PHE . 0.7 OUTLIER -120.47 140.48 30.38 Favored Pre-proline 0 N--CA 1.476 0.831 0 CA-C-N 114.365 -0.918 . . . . 0.0 110.309 -179.12 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 68.3 Cg_endo -89.47 152.71 5.36 Favored 'Trans proline' 0 CA--C 1.534 0.495 0 C-N-CA 121.27 1.313 . . . . 0.0 109.069 166.828 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -44.65 -34.37 2.17 Favored 'General case' 0 N--CA 1.47 0.532 0 N-CA-C 116.108 1.892 . . . . 0.0 116.108 177.03 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -36.2 -43.29 0.35 Allowed 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 125.984 1.714 . . . . 0.0 115.108 168.687 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.925 HG13 HG21 ' A' ' 31' ' ' ILE . 10.4 m -103.66 -37.28 4.49 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.1 0 N-CA-C 115.192 1.553 . . . . 0.0 115.192 -177.442 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . 0.483 ' O ' ' HG ' ' A' ' 16' ' ' LEU . . . -64.76 -36.28 83.8 Favored 'General case' 0 N--CA 1.482 1.15 0 N-CA-C 113.145 0.795 . . . . 0.0 113.145 177.758 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -64.12 -40.87 98.49 Favored Glycine 0 N--CA 1.479 1.567 0 C-N-CA 125.777 1.656 . . . . 0.0 112.35 176.13 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 2.1 m -63.98 -41.86 97.39 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 124.54 1.136 . . . . 0.0 112.404 174.308 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.652 HG11 HD11 ' A' ' 55' ' ' LEU . 32.1 t -53.75 -40.91 45.34 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.934 0 CA-C-O 121.174 0.512 . . . . 0.0 112.2 170.188 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.593 HD13 HG12 ' A' ' 68' ' ' ILE . 45.7 mt -64.99 -49.88 68.53 Favored 'General case' 0 N--CA 1.477 0.898 0 CA-C-N 115.699 -0.682 . . . . 0.0 112.725 178.825 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 1.7 t30 -42.8 -45.2 4.75 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-O 123.167 1.461 . . . . 0.0 113.839 172.657 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.739 HG11 ' O ' ' A' ' 23' ' ' GLY . 5.3 t -63.27 -50.99 76.72 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.746 0 CA-C-N 109.976 -3.284 . . . . 0.0 112.29 178.793 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.726 HG11 ' HA ' ' A' ' 56' ' ' LYS . 36.0 t -59.91 -46.39 93.98 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.889 0 O-C-N 124.77 1.294 . . . . 0.0 110.691 179.419 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -63.58 -39.82 95.37 Favored 'General case' 0 N--CA 1.466 0.369 0 N-CA-C 114.342 1.238 . . . . 0.0 114.342 -177.51 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -96.39 2.53 52.74 Favored 'General case' 0 N--CA 1.478 0.963 0 N-CA-C 115.616 1.71 . . . . 0.0 115.616 -177.593 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 56.97 47.08 89.95 Favored Glycine 0 CA--C 1.541 1.702 0 C-N-CA 123.644 0.64 . . . . 0.0 111.572 -174.39 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.739 ' O ' HG11 ' A' ' 18' ' ' VAL . . . -102.97 154.49 18.22 Favored Glycine 0 N--CA 1.476 1.313 0 CA-C-O 123.944 1.858 . . . . 0.0 112.594 -174.576 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 4.5 m-90 -73.43 101.11 3.4 Favored 'General case' 0 N--CA 1.473 0.689 0 CA-C-N 112.961 -1.619 . . . . 0.0 112.807 -175.69 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.706 ' HB ' HG12 ' A' ' 18' ' ' VAL . 7.6 p -62.37 -20.46 24.66 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 N-CA-C 114.171 1.174 . . . . 0.0 114.171 173.3 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 6.4 t -61.02 -28.62 69.18 Favored 'General case' 0 N--CA 1.481 1.09 0 N-CA-C 112.952 0.723 . . . . 0.0 112.952 178.942 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -74.91 -43.61 53.3 Favored 'General case' 0 N--CA 1.474 0.73 0 CA-C-O 119.625 -0.226 . . . . 0.0 111.118 174.669 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 3.2 mp -64.12 -30.93 51.4 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.053 0 C-N-CA 127.67 2.388 . . . . 0.0 112.853 178.15 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.577 HG11 HD12 ' A' ' 43' ' ' LEU . 31.2 t -44.96 -37.47 1.63 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.14 0 C-N-CA 124.616 1.166 . . . . 0.0 112.702 172.542 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 91.5 p -60.4 -35.39 75.65 Favored 'General case' 0 N--CA 1.476 0.873 0 N-CA-C 113.217 0.821 . . . . 0.0 113.217 176.415 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.925 HG21 HG13 ' A' ' 11' ' ' VAL . 33.8 mm -77.87 -34.08 19.28 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.775 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.304 -179.781 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.599 HD23 ' HB ' ' A' ' 11' ' ' VAL . 4.1 mm? -60.92 -50.03 75.08 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 124.127 0.971 . . . . 0.0 112.159 172.105 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -69.84 -26.14 64.08 Favored 'General case' 0 N--CA 1.482 1.132 0 N-CA-C 114.925 1.454 . . . . 0.0 114.925 -179.87 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -51.56 -38.38 54.09 Favored 'General case' 0 CA--C 1.545 0.758 0 O-C-N 124.139 0.899 . . . . 0.0 112.508 169.736 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 22.8 t -63.89 -32.4 56.95 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.081 0 C-N-CA 125.346 1.458 . . . . 0.0 111.607 174.852 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 105.56 -106.19 2.59 Favored Glycine 0 N--CA 1.476 1.34 0 N-CA-C 110.0 -1.24 . . . . 0.0 110.0 178.36 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 2.8 p -58.4 -45.86 87.55 Favored 'General case' 0 N--CA 1.474 0.761 0 CA-C-N 113.871 -1.165 . . . . 0.0 112.826 -174.615 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -49.98 -54.05 20.13 Favored Glycine 0 N--CA 1.476 1.357 0 O-C-N 125.547 1.779 . . . . 0.0 113.449 179.2 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.471 ' HA3' ' HB3' ' A' ' 32' ' ' LEU . . . -56.1 -51.84 53.13 Favored Glycine 0 CA--C 1.535 1.302 0 O-C-N 125.262 1.213 . . . . 0.0 110.788 177.836 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 66.4 mt -60.32 -52.41 65.38 Favored 'General case' 0 N--CA 1.47 0.565 0 N-CA-C 116.388 1.996 . . . . 0.0 116.388 -179.675 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 23.4 p -62.78 -35.15 78.91 Favored 'General case' 0 N--CA 1.479 0.997 0 CA-C-O 118.092 -0.956 . . . . 0.0 113.16 177.939 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 13.4 tp -61.05 -50.62 72.59 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 123.007 0.523 . . . . 0.0 111.12 170.56 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.577 HD12 HG11 ' A' ' 29' ' ' VAL . 59.1 mt -61.92 -34.45 76.08 Favored 'General case' 0 N--CA 1.479 0.985 0 O-C-N 124.222 0.951 . . . . 0.0 113.439 -179.532 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -63.24 -46.03 88.8 Favored 'General case' 0 N--CA 1.473 0.692 0 N-CA-C 112.995 0.739 . . . . 0.0 112.995 172.895 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -65.07 -35.72 82.06 Favored 'General case' 0 N--CA 1.487 1.388 0 CA-C-N 115.268 -0.878 . . . . 0.0 112.483 175.437 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -60.81 -28.31 68.69 Favored 'General case' 0 N--CA 1.475 0.779 0 N-CA-C 115.122 1.527 . . . . 0.0 115.122 179.837 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -44.85 -35.53 4.45 Favored Glycine 0 N--CA 1.48 1.601 0 C-N-CA 126.679 2.085 . . . . 0.0 114.193 -175.789 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . 0.492 ' HE ' ' HE1' ' A' ' 54' ' ' TYR . 63.3 ttp85 -51.61 -54.99 21.85 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-N 112.875 -1.663 . . . . 0.0 112.732 -176.692 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 25.4 tt0 -127.71 36.73 4.31 Favored 'General case' 0 N--CA 1.473 0.71 0 N-CA-C 114.154 1.168 . . . . 0.0 114.154 -173.14 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 75.8 p 50.4 121.69 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 125.221 1.408 . . . . 0.0 111.974 -171.387 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.473 ' O ' ' HB3' ' A' ' 54' ' ' TYR 0.276 6.3 tp -31.35 -53.86 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.483 1.223 0 N-CA-C 117.16 2.282 . . . . 0.0 117.16 -173.438 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 0.621 ' HG3' HG11 ' A' ' 25' ' ' VAL . 0.1 OUTLIER -59.11 -66.97 0.42 Allowed 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 115.561 1.689 . . . . 0.0 115.561 175.402 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -54.99 -34.17 63.15 Favored 'General case' 0 N--CA 1.475 0.788 0 O-C-N 124.776 1.298 . . . . 0.0 113.252 177.601 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . 0.492 ' HE1' ' HE ' ' A' ' 48' ' ' ARG . 87.5 t80 -54.36 -63.34 1.18 Allowed 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 126.141 1.776 . . . . 0.0 110.541 174.981 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.652 HD11 HG11 ' A' ' 15' ' ' VAL . 96.4 mt -66.98 -42.2 85.48 Favored 'General case' 0 N--CA 1.476 0.843 0 N-CA-C 115.379 1.622 . . . . 0.0 115.379 -177.453 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.726 ' HA ' HG11 ' A' ' 19' ' ' VAL . 96.4 mttt -56.52 -43.21 79.58 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 113.109 -1.859 . . . . 0.0 114.092 178.522 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.408 ' O ' ' HG3' ' A' ' 61' ' ' LYS . 15.6 tttt -82.64 -50.07 9.15 Favored 'General case' 0 C--N 1.318 -0.776 0 O-C-N 124.158 0.911 . . . . 0.0 112.997 174.306 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . 0.461 ' O ' ' HB2' ' A' ' 62' ' ' LYS . 31.1 tt0 -57.72 -47.49 82.26 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 118.2 -0.905 . . . . 0.0 112.397 -175.95 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.627 HG22 HG22 ' A' ' 67' ' ' VAL . 1.8 mm -75.84 -23.32 16.29 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.26 0 N-CA-C 112.266 0.469 . . . . 0.0 112.266 -175.49 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.457 ' HA ' ' HZ2' ' A' ' 64' ' ' LYS . 32.2 tptt -64.01 -38.55 91.5 Favored 'General case' 0 CA--C 1.544 0.717 0 O-C-N 124.695 1.247 . . . . 0.0 112.284 170.354 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . 0.408 ' HG3' ' O ' ' A' ' 57' ' ' LYS . 26.5 mtpt -77.3 -45.44 26.25 Favored 'General case' 0 N--CA 1.481 1.108 0 CA-C-N 112.925 -1.943 . . . . 0.0 113.05 177.139 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.461 ' HB2' ' O ' ' A' ' 58' ' ' GLU . 10.4 tttm -70.25 -47.32 61.84 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 126.699 1.999 . . . . 0.0 113.352 -172.468 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 96.05 99.58 1.85 Allowed Glycine 0 N--CA 1.467 0.708 0 CA-C-N 114.46 -1.245 . . . . 0.0 110.658 179.067 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.698 ' HD2' ' H ' ' A' ' 64' ' ' LYS . 10.8 mptt -22.42 -47.6 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.838 0 N-CA-C 119.673 3.212 . . . . 0.0 119.673 -175.673 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . 0.412 ' O ' ' HB ' ' A' ' 68' ' ' ILE . 0.1 OUTLIER -56.02 -49.5 73.5 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 124.687 1.195 . . . . 0.0 113.08 177.386 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -62.23 -26.12 68.2 Favored 'General case' 0 N--CA 1.471 0.61 0 N-CA-C 114.536 1.31 . . . . 0.0 114.536 174.514 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.627 HG22 HG22 ' A' ' 59' ' ' ILE . 99.1 t -72.97 -34.68 46.74 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.638 0 C-N-CA 123.094 0.558 . . . . 0.0 111.094 177.001 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.593 HG12 HD13 ' A' ' 16' ' ' LEU . 5.2 mm -51.06 -45.85 30.34 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.117 0 O-C-N 123.904 0.752 . . . . 0.0 110.468 169.689 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -64.83 -52.58 55.92 Favored 'General case' 0 CA--C 1.549 0.937 0 CA-C-N 114.368 -1.287 . . . . 0.0 113.033 175.906 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 35.3 t90 . . . . . 0 N--CA 1.484 1.228 0 C-N-CA 125.582 1.553 . . . . 0.0 115.007 -178.983 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.461 ' HE1' HD11 ' A' ' 32' ' ' LEU . 33.3 mtp . . . . . 0 N--CA 1.48 1.06 0 N-CA-C 111.988 0.366 . . . . 0.0 111.988 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 2' ' ' ALA . . . . . 0.451 ' HA ' ' O ' ' A' ' 7' ' ' ILE . . . -55.19 -50.75 68.57 Favored 'General case' 0 CA--C 1.543 0.68 0 O-C-N 124.475 1.109 . . . . 0.0 112.511 178.343 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 54.7 tttp -73.25 -59.95 2.47 Favored 'General case' 0 CA--C 1.543 0.7 0 CA-C-N 112.695 -2.048 . . . . 0.0 114.097 -176.717 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 14.0 tt0 -67.93 -42.54 80.85 Favored 'General case' 0 N--CA 1.481 1.075 0 N-CA-C 115.009 1.485 . . . . 0.0 115.009 -168.831 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 5' ' ' PHE . . . . . 0.409 ' HB2' HD12 ' A' ' 7' ' ' ILE . 70.4 m-85 -100.32 -18.71 16.67 Favored 'General case' 0 N--CA 1.468 0.467 0 N-CA-C 116.824 2.157 . . . . 0.0 116.824 -173.913 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 83.28 57.82 2.42 Favored Glycine 0 CA--C 1.544 1.892 0 O-C-N 124.688 1.242 . . . . 0.0 111.519 -173.652 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.451 ' O ' ' HA ' ' A' ' 2' ' ' ALA . 0.4 OUTLIER -115.67 150.17 44.31 Favored Pre-proline 0 N--CA 1.481 1.106 0 CA-C-N 113.384 -1.408 . . . . 0.0 110.638 177.888 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_endo -88.37 151.99 6.6 Favored 'Trans proline' 0 CA--C 1.53 0.312 0 N-CA-C 109.513 -0.995 . . . . 0.0 109.513 159.587 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -51.19 -26.97 7.73 Favored 'General case' 0 N--CA 1.476 0.86 0 N-CA-C 115.217 1.562 . . . . 0.0 115.217 176.156 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -41.94 -56.16 2.86 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 126.298 1.839 . . . . 0.0 112.312 169.948 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.797 HG12 HG22 ' A' ' 31' ' ' ILE . 21.3 m -88.91 -29.45 5.23 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.004 0 N-CA-C 114.371 1.249 . . . . 0.0 114.371 -173.7 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -64.92 -32.16 73.75 Favored 'General case' 0 N--CA 1.477 0.877 0 N-CA-C 112.964 0.727 . . . . 0.0 112.964 173.564 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -65.96 -40.37 95.29 Favored Glycine 0 CA--C 1.542 1.736 0 O-C-N 124.161 0.913 . . . . 0.0 112.809 173.581 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.639 HG22 HG13 ' A' ' 28' ' ' ILE . 1.0 OUTLIER -60.75 -40.6 93.07 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 123.969 0.908 . . . . 0.0 112.554 173.378 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.822 HG13 HD13 ' A' ' 55' ' ' LEU . 18.3 t -54.73 -43.34 66.05 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.086 0 C-N-CA 124.22 1.008 . . . . 0.0 112.86 168.776 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 81.5 mt -60.28 -38.72 84.46 Favored 'General case' 0 N--CA 1.481 1.096 0 N-CA-C 114.03 1.122 . . . . 0.0 114.03 177.115 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 24.7 t-20 -51.94 -48.64 64.17 Favored 'General case' 0 N--CA 1.481 1.077 0 O-C-N 124.512 1.132 . . . . 0.0 111.869 173.089 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -49.39 -49.39 18.08 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.182 0 CA-C-N 114.428 -1.26 . . . . 0.0 112.559 174.638 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.74 HG13 ' HA ' ' A' ' 56' ' ' LYS . 3.4 t -66.2 -51.27 61.16 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.975 0 O-C-N 125.071 1.482 . . . . 0.0 110.446 -177.069 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 25.3 mt-10 -60.45 -38.86 85.54 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 125.231 1.412 . . . . 0.0 114.215 -175.792 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -103.7 -16.21 15.53 Favored 'General case' 0 N--CA 1.472 0.645 0 N-CA-C 116.948 2.203 . . . . 0.0 116.948 -174.159 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 69.16 46.72 56.94 Favored Glycine 0 CA--C 1.545 1.926 0 N-CA-C 111.991 -0.443 . . . . 0.0 111.991 -169.885 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -102.71 167.82 17.82 Favored Glycine 0 CA--C 1.542 1.74 0 CA-C-N 114.036 -1.082 . . . . 0.0 114.384 -167.425 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' TRP . . . . . 0.461 ' HB3' HG22 ' A' ' 26' ' ' THR . 75.8 m95 -62.71 106.51 0.8 Allowed 'General case' 0 N--CA 1.476 0.84 0 CA-C-N 113.054 -1.573 . . . . 0.0 112.2 -178.849 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.49 HG21 HG22 ' A' ' 51' ' ' ILE . 2.6 p -57.46 -23.68 20.15 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.835 0 CA-C-N 113.624 -1.626 . . . . 0.0 113.723 168.698 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.461 HG22 ' HB3' ' A' ' 24' ' ' TRP . 1.7 t -55.4 -43.84 75.59 Favored 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 113.329 0.863 . . . . 0.0 113.329 -179.96 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 27' ' ' THR . . . . . 0.439 ' O ' HG12 ' A' ' 31' ' ' ILE . 0.0 OUTLIER -65.46 -45.06 85.24 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 123.883 0.873 . . . . 0.0 112.242 174.868 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.639 HG13 HG22 ' A' ' 14' ' ' THR . 1.6 mp -59.78 -44.89 94.92 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.89 0 CA-C-N 114.598 -1.183 . . . . 0.0 111.796 177.398 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.487 HG13 HD11 ' A' ' 43' ' ' LEU . 53.2 t -53.77 -43.79 57.18 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.999 0 C-N-CA 124.126 0.97 . . . . 0.0 112.434 178.544 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 1.1 m -59.62 -43.08 93.93 Favored 'General case' 0 N--CA 1.485 1.317 0 N-CA-C 112.693 0.627 . . . . 0.0 112.693 176.078 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.797 HG22 HG12 ' A' ' 11' ' ' VAL . 35.5 mm -68.71 -38.8 79.4 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.138 0 CA-C-N 115.319 -0.855 . . . . 0.0 109.572 -176.544 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.679 HD22 ' HB ' ' A' ' 11' ' ' VAL . 3.7 mm? -63.89 -51.78 62.95 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 125.906 1.683 . . . . 0.0 112.624 176.35 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 27.7 p -70.19 -28.94 65.7 Favored 'General case' 0 N--CA 1.472 0.67 0 N-CA-C 114.28 1.215 . . . . 0.0 114.28 -179.733 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -52.57 -27.58 17.39 Favored 'General case' 0 N--CA 1.482 1.133 0 N-CA-C 113.951 1.093 . . . . 0.0 113.951 170.881 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 46.6 t . . . . . 0 N--CA 1.482 1.15 0 C-N-CA 125.433 1.493 . . . . 0.0 111.785 170.592 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 39' ' ' GLY . . . . . 0.458 ' O ' ' HG ' ' A' ' 43' ' ' LEU . . . . . . . . 0 CA--C 1.538 1.495 0 N-CA-C 112.271 -0.332 . . . . 0.0 112.271 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 12.2 mt -62.84 -44.16 96.89 Favored 'General case' 0 N--CA 1.478 0.93 0 CA-C-N 113.641 -1.28 . . . . 0.0 114.035 -178.065 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 28.6 p -61.53 -39.82 92.42 Favored 'General case' 0 N--CA 1.481 1.076 0 N-CA-C 113.234 0.827 . . . . 0.0 113.234 175.977 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 12.4 tp -62.21 -47.76 83.02 Favored 'General case' 0 N--CA 1.484 1.245 0 C-N-CA 122.863 0.465 . . . . 0.0 110.531 171.999 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.487 HD11 HG13 ' A' ' 29' ' ' VAL . 63.7 mt -60.5 -32.62 71.62 Favored 'General case' 0 N--CA 1.481 1.113 0 N-CA-C 114.86 1.43 . . . . 0.0 114.86 -179.606 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -66.53 -31.23 71.81 Favored 'General case' 0 N--CA 1.482 1.156 0 N-CA-C 113.732 1.012 . . . . 0.0 113.732 174.51 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -53.5 -48.52 68.88 Favored 'General case' 0 N--CA 1.477 0.875 0 N-CA-C 115.155 1.539 . . . . 0.0 115.155 -170.648 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -144.48 50.16 1.3 Allowed 'General case' 0 N--CA 1.482 1.129 0 CA-C-O 122.482 1.134 . . . . 0.0 113.503 174.271 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -51.37 -50.39 41.24 Favored Glycine 0 N--CA 1.487 2.076 0 CA-C-N 113.473 -1.694 . . . . 0.0 113.349 -176.969 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 79.4 ttt180 -58.83 -48.95 79.52 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 126.125 1.77 . . . . 0.0 113.974 -179.855 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 5.6 tm-20 -80.03 18.92 0.76 Allowed 'General case' 0 N--CA 1.476 0.838 0 N-CA-C 114.001 1.111 . . . . 0.0 114.001 -179.06 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 52.2 p 53.14 124.95 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 127.213 2.205 . . . . 0.0 111.911 -168.786 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.49 HG22 HG21 ' A' ' 25' ' ' VAL . 29.5 mm -52.44 -31.18 15.07 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.055 0 CA-C-N 115.081 -0.963 . . . . 0.0 112.816 170.419 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 71.1 tttt -57.14 -64.96 0.71 Allowed 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 124.36 1.064 . . . . 0.0 111.436 177.347 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -62.73 -35.17 78.89 Favored 'General case' 0 N--CA 1.472 0.659 0 N-CA-C 113.4 0.889 . . . . 0.0 113.4 178.694 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 15.7 t80 -51.17 -67.68 0.23 Allowed 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 124.984 1.314 . . . . 0.0 111.758 173.651 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.822 HD13 HG13 ' A' ' 15' ' ' VAL . 39.6 mt -61.97 -38.18 87.58 Favored 'General case' 0 N--CA 1.479 1.003 0 N-CA-C 113.084 0.772 . . . . 0.0 113.084 -177.115 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 56' ' ' LYS . . . . . 0.74 ' HA ' HG13 ' A' ' 19' ' ' VAL . 96.2 mttt -54.88 -52.3 63.27 Favored 'General case' 0 C--O 1.219 -0.502 0 CA-C-N 114.353 -1.294 . . . . 0.0 113.609 177.433 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 2.3 ttpm? -74.99 -45.22 43.52 Favored 'General case' 0 N--CA 1.476 0.828 0 CA-C-N 114.945 -1.025 . . . . 0.0 112.392 176.026 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' GLU . . . . . 0.431 ' O ' ' HB2' ' A' ' 62' ' ' LYS . 44.4 tt0 -58.67 -49.93 75.72 Favored 'General case' 0 N--CA 1.471 0.596 0 O-C-N 123.384 0.428 . . . . 0.0 111.199 -174.918 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.697 HG23 HG21 ' A' ' 67' ' ' VAL . 3.2 mm -76.33 -27.4 17.55 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.162 0 CA-C-O 118.934 -0.555 . . . . 0.0 112.258 -177.924 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 60' ' ' LYS . . . . . 0.473 ' HB2' ' O ' ' A' ' 56' ' ' LYS . 19.9 ttmm -59.5 -27.83 66.5 Favored 'General case' 0 N--CA 1.469 0.508 0 N-CA-C 114.422 1.267 . . . . 0.0 114.422 172.005 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 75.0 mttt -93.92 -41.87 9.37 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-N 113.283 -1.781 . . . . 0.0 113.432 176.76 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' LYS . . . . . 0.431 ' HB2' ' O ' ' A' ' 58' ' ' GLU . 30.6 tttt -67.05 -60.94 2.2 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 126.511 1.924 . . . . 0.0 113.828 -175.301 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 104.09 110.21 3.46 Favored Glycine 0 CA--C 1.54 1.631 0 CA-C-N 114.795 -1.093 . . . . 0.0 112.448 -169.572 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.533 ' HD2' ' H ' ' A' ' 64' ' ' LYS . 0.0 OUTLIER -36.79 -43.36 0.43 Allowed 'General case' 0 N--CA 1.477 0.918 0 N-CA-C 119.577 3.177 . . . . 0.0 119.577 -175.668 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 65' ' ' ARG . . . . . 0.415 ' O ' ' HB ' ' A' ' 68' ' ' ILE . 1.8 ttp180 -56.56 -47.12 80.16 Favored 'General case' 0 N--CA 1.477 0.883 0 N-CA-C 114.146 1.165 . . . . 0.0 114.146 179.356 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -64.58 -26.13 68.27 Favored 'General case' 0 N--CA 1.475 0.798 0 CA-C-N 114.509 -1.223 . . . . 0.0 113.62 175.157 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.697 HG21 HG23 ' A' ' 59' ' ' ILE . 30.4 t -72.12 -36.9 58.15 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.042 0 C-N-CA 123.671 0.788 . . . . 0.0 110.707 179.95 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.415 ' HB ' ' O ' ' A' ' 65' ' ' ARG . 19.9 mm -51.76 -46.79 39.65 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.171 0 C-N-CA 124.12 0.968 . . . . 0.0 110.748 167.934 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -69.99 -49.46 51.3 Favored 'General case' 0 N--CA 1.477 0.913 0 N-CA-C 113.802 1.038 . . . . 0.0 113.802 177.019 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' TRP . . . . . 0.426 ' CE3' ' HG3' ' A' ' 1' ' ' MET . 32.2 t90 . . . . . 0 N--CA 1.48 1.031 0 C-N-CA 126.412 1.885 . . . . 0.0 112.98 -178.049 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.655 ' HE1' HG21 ' A' ' 15' ' ' VAL . 56.8 mtp . . . . . 0 CA--C 1.542 0.651 0 N-CA-C 112.238 0.459 . . . . 0.0 112.238 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 2' ' ' ALA . . . . . 0.407 ' HA ' ' O ' ' A' ' 7' ' ' ILE . . . -57.46 -52.37 65.66 Favored 'General case' 0 N--CA 1.488 1.471 0 CA-C-N 114.806 -1.088 . . . . 0.0 112.96 176.772 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 3' ' ' LYS . . . . . 0.413 ' HB2' ' O ' ' A' ' 69' ' ' ALA . 10.7 tptp -66.04 -58.35 5.68 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 127.491 2.316 . . . . 0.0 112.461 -177.425 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 4' ' ' GLU . . . . . 0.446 ' HB2' ' O ' ' A' ' 70' ' ' TRP . 0.7 OUTLIER -74.41 -47.54 33.22 Favored 'General case' 0 N--CA 1.477 0.883 0 N-CA-C 115.972 1.841 . . . . 0.0 115.972 -171.796 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 5' ' ' PHE . . . . . 0.636 ' HB2' HD12 ' A' ' 7' ' ' ILE . 47.8 m-85 -100.14 -11.2 20.67 Favored 'General case' 0 N--CA 1.473 0.683 0 N-CA-C 115.747 1.758 . . . . 0.0 115.747 -169.021 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 75.79 61.01 3.0 Favored Glycine 0 N--CA 1.478 1.443 0 O-C-N 124.614 1.197 . . . . 0.0 111.245 -173.413 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.636 HD12 ' HB2' ' A' ' 5' ' ' PHE . 1.0 OUTLIER -117.76 145.53 36.73 Favored Pre-proline 0 N--CA 1.478 0.951 0 C-N-CA 125.287 1.435 . . . . 0.0 111.941 179.696 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_endo -89.78 154.17 5.06 Favored 'Trans proline' 0 CA--C 1.535 0.548 0 N-CA-C 109.176 -1.125 . . . . 0.0 109.176 158.383 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -48.77 -29.78 4.92 Favored 'General case' 0 CA--C 1.544 0.73 0 N-CA-C 115.23 1.567 . . . . 0.0 115.23 176.774 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -39.67 -44.91 1.59 Allowed 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 126.388 1.875 . . . . 0.0 114.503 172.069 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.855 HG12 HG22 ' A' ' 31' ' ' ILE . 22.6 m -101.05 -29.51 3.17 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.93 0 N-CA-C 114.959 1.466 . . . . 0.0 114.959 -176.219 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 0.419 ' O ' ' HG ' ' A' ' 16' ' ' LEU . . . -68.48 -31.21 70.32 Favored 'General case' 0 CA--C 1.546 0.817 0 N-CA-C 112.547 0.573 . . . . 0.0 112.547 175.631 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -61.06 -42.87 99.94 Favored Glycine 0 CA--C 1.543 1.84 0 CA-C-O 122.186 0.881 . . . . 0.0 112.393 170.485 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.776 HG22 HG13 ' A' ' 28' ' ' ILE . 1.4 m -62.62 -36.89 84.22 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 124.928 1.291 . . . . 0.0 113.562 176.02 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.655 HG21 ' HE1' ' A' ' 1' ' ' MET . 2.4 t -58.05 -41.05 79.53 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 C-N-CA 124.03 0.932 . . . . 0.0 112.443 170.691 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.452 HD22 ' HG3' ' A' ' 64' ' ' LYS . 53.2 mt -60.04 -37.31 79.43 Favored 'General case' 0 N--CA 1.476 0.837 0 N-CA-C 112.73 0.641 . . . . 0.0 112.73 177.497 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 27.5 t-20 -56.96 -44.57 82.72 Favored 'General case' 0 N--CA 1.474 0.756 0 CA-C-N 115.765 -0.652 . . . . 0.0 112.527 175.864 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 3.7 t -48.49 -48.79 14.15 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.155 0 C-N-CA 123.086 0.555 . . . . 0.0 111.699 172.131 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.791 HG13 ' HA ' ' A' ' 56' ' ' LYS . 5.8 t -67.5 -50.46 61.5 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.389 0 CA-C-N 113.997 -1.456 . . . . 0.0 110.789 -176.351 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 29.2 mt-10 -65.81 -42.02 91.15 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 126.478 1.911 . . . . 0.0 115.606 -177.728 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -99.62 -22.91 15.23 Favored 'General case' 0 N--CA 1.477 0.919 0 N-CA-C 116.219 1.933 . . . . 0.0 116.219 -173.0 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' GLY . . . . . 0.53 ' HA2' ' NZ ' ' A' ' 56' ' ' LYS . . . 77.39 34.02 41.89 Favored Glycine 0 N--CA 1.481 1.68 0 N-CA-C 112.02 -0.432 . . . . 0.0 112.02 -171.248 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -99.85 172.53 24.8 Favored Glycine 0 N--CA 1.47 0.949 0 CA-C-N 113.263 -1.468 . . . . 0.0 114.102 -165.458 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 89.4 m95 -57.67 100.6 0.06 Allowed 'General case' 0 N--CA 1.476 0.866 0 CA-C-N 111.764 -2.218 . . . . 0.0 114.148 -176.967 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.593 HG21 HG13 ' A' ' 51' ' ' ILE . 4.3 p -56.72 -25.53 21.79 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 CA-C-N 112.553 -2.112 . . . . 0.0 113.779 169.244 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 11.5 p -61.34 -46.36 90.58 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 124.176 0.99 . . . . 0.0 112.277 -178.547 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' THR . . . . . 0.427 ' O ' HG12 ' A' ' 31' ' ' ILE . 0.2 OUTLIER -60.8 -44.88 96.27 Favored 'General case' 0 N--CA 1.478 0.945 0 CA-C-N 114.01 -1.45 . . . . 0.0 110.994 175.039 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.776 HG13 HG22 ' A' ' 14' ' ' THR . 1.7 mp -62.63 -47.67 91.84 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.084 0 C-N-CA 124.073 0.949 . . . . 0.0 111.749 179.023 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.487 HG13 HD11 ' A' ' 43' ' ' LEU . 39.8 t -52.41 -43.5 41.34 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.067 0 C-N-CA 124.379 1.072 . . . . 0.0 111.325 179.064 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 90.4 p -65.79 -32.09 73.43 Favored 'General case' 0 N--CA 1.478 0.965 0 N-CA-C 115.391 1.626 . . . . 0.0 115.391 176.324 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.855 HG22 HG12 ' A' ' 11' ' ' VAL . 40.5 mm -70.9 -40.47 76.5 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.33 0 C-N-CA 123.7 0.8 . . . . 0.0 109.583 177.235 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.666 ' HB3' ' HA2' ' A' ' 39' ' ' GLY . 3.8 mm? -61.59 -52.07 65.94 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 125.365 1.466 . . . . 0.0 112.745 174.606 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 7.5 p -65.76 -27.1 68.05 Favored 'General case' 0 N--CA 1.484 1.243 0 N-CA-C 114.159 1.17 . . . . 0.0 114.159 179.317 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -53.0 -29.36 28.79 Favored 'General case' 0 N--CA 1.483 1.225 0 N-CA-C 113.892 1.071 . . . . 0.0 113.892 166.969 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 54.5 t . . . . . 0 N--CA 1.491 1.619 0 C-N-CA 124.238 1.015 . . . . 0.0 112.411 172.192 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 39' ' ' GLY . . . . . 0.666 ' HA2' ' HB3' ' A' ' 32' ' ' LEU . . . . . . . . 0 N--CA 1.475 1.25 0 N-CA-C 111.413 -0.675 . . . . 0.0 111.413 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 44.7 mt -58.86 -48.46 81.28 Favored 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 115.26 1.578 . . . . 0.0 115.26 -176.222 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' SER . . . . . 0.426 ' HB2' ' HD1' ' A' ' 5' ' ' PHE . 29.6 p -60.69 -39.49 88.66 Favored 'General case' 0 N--CA 1.475 0.791 0 N-CA-C 114.488 1.292 . . . . 0.0 114.488 175.669 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 13.8 tp -63.79 -48.46 76.79 Favored 'General case' 0 N--CA 1.483 1.2 0 C-N-CA 122.505 0.322 . . . . 0.0 110.888 173.839 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.487 HD11 HG13 ' A' ' 29' ' ' VAL . 80.5 mt -61.98 -27.57 68.94 Favored 'General case' 0 N--CA 1.482 1.131 0 N-CA-C 114.843 1.423 . . . . 0.0 114.843 -176.344 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -70.81 -45.4 64.7 Favored 'General case' 0 CA--C 1.549 0.905 0 N-CA-C 112.839 0.681 . . . . 0.0 112.839 173.933 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -65.12 -40.47 94.53 Favored 'General case' 0 N--CA 1.477 0.917 0 CA-C-O 122.715 1.245 . . . . 0.0 111.999 179.902 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.446 ' HB1' ' HA ' ' A' ' 51' ' ' ILE . . . -59.18 -26.76 65.07 Favored 'General case' 0 CA--C 1.537 0.447 0 N-CA-C 116.438 2.014 . . . . 0.0 116.438 179.131 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -47.78 -40.62 18.81 Favored Glycine 0 N--CA 1.482 1.73 0 C-N-CA 125.598 1.57 . . . . 0.0 113.641 -177.942 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 35.4 ttp-105 -53.62 -47.78 69.91 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 125.184 1.394 . . . . 0.0 113.931 -173.937 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 11.8 tt0 -126.0 37.32 4.36 Favored 'General case' 0 N--CA 1.478 0.968 0 N-CA-C 114.285 1.217 . . . . 0.0 114.285 -177.962 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 72.0 p 50.77 127.49 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.502 0 C-N-CA 125.603 1.561 . . . . 0.0 112.792 -172.057 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.593 HG13 HG21 ' A' ' 25' ' ' VAL . 6.3 tp -39.04 -51.65 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 N-CA-C 117.728 2.492 . . . . 0.0 117.728 -172.791 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 56.3 tttt -65.95 -57.17 8.44 Favored 'General case' 0 N--CA 1.469 0.516 0 N-CA-C 113.618 0.97 . . . . 0.0 113.618 179.877 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -60.59 -38.17 83.75 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 124.591 1.156 . . . . 0.0 112.763 178.497 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' TYR . . . . . 0.401 ' HB3' ' O ' ' A' ' 51' ' ' ILE . 90.4 t80 -47.66 -63.51 1.04 Allowed 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 125.961 1.704 . . . . 0.0 109.861 170.233 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 79.1 mt -64.24 -41.98 96.74 Favored 'General case' 0 N--CA 1.473 0.721 0 N-CA-C 113.894 1.072 . . . . 0.0 113.894 -176.575 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' LYS . . . . . 0.791 ' HA ' HG13 ' A' ' 19' ' ' VAL . 29.2 mtpp -55.97 -44.73 78.79 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 114.653 -1.158 . . . . 0.0 113.447 177.466 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 57' ' ' LYS . . . . . 0.42 ' O ' ' HG2' ' A' ' 61' ' ' LYS . 66.7 tttt -77.3 -50.13 13.51 Favored 'General case' 0 N--CA 1.475 0.787 0 CA-C-N 115.292 -0.867 . . . . 0.0 112.051 172.947 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 58' ' ' GLU . . . . . 0.501 ' O ' ' HB2' ' A' ' 62' ' ' LYS . 4.2 tp10 -54.51 -51.38 65.29 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 123.979 0.912 . . . . 0.0 111.831 -173.51 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.683 HG23 HG21 ' A' ' 67' ' ' VAL . 1.3 mm -75.87 -26.32 17.69 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.05 0 CA-C-N 115.623 -0.717 . . . . 0.0 111.846 -175.255 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 6.7 mtpp -60.07 -39.05 84.72 Favored 'General case' 0 CA--C 1.538 0.487 0 N-CA-C 115.336 1.606 . . . . 0.0 115.336 170.285 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' LYS . . . . . 0.42 ' HG2' ' O ' ' A' ' 57' ' ' LYS . 70.4 mmtt -79.32 -46.24 18.09 Favored 'General case' 0 N--CA 1.476 0.834 0 O-C-N 126.188 2.18 . . . . 0.0 110.93 176.977 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 62' ' ' LYS . . . . . 0.501 ' HB2' ' O ' ' A' ' 58' ' ' GLU . 5.7 tptp -66.53 -52.22 48.17 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 126.728 2.011 . . . . 0.0 114.822 -175.561 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 96.6 117.87 3.47 Favored Glycine 0 N--CA 1.483 1.828 0 CA-C-N 114.593 -1.185 . . . . 0.0 110.332 -173.94 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.687 ' HD2' ' H ' ' A' ' 64' ' ' LYS . 9.8 mptt -36.18 -46.78 0.53 Allowed 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 117.782 2.512 . . . . 0.0 117.782 -177.422 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.22 -51.63 69.14 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 125.538 1.535 . . . . 0.0 114.958 176.89 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -64.83 -27.3 68.78 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-N 114.423 -1.262 . . . . 0.0 112.907 174.771 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.683 HG21 HG23 ' A' ' 59' ' ' ILE . 98.7 t -67.13 -41.78 87.43 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.251 0 C-N-CA 123.191 0.597 . . . . 0.0 110.942 175.19 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 35.1 mm -51.15 -42.66 25.87 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.856 0 O-C-N 124.18 0.925 . . . . 0.0 110.764 172.061 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.413 ' O ' ' HB2' ' A' ' 3' ' ' LYS . . . -71.38 -52.62 17.62 Favored 'General case' 0 N--CA 1.473 0.725 0 O-C-N 124.683 1.239 . . . . 0.0 112.585 176.117 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 70' ' ' TRP . . . . . 0.446 ' O ' ' HB2' ' A' ' 4' ' ' GLU . 30.9 t90 . . . . . 0 N--CA 1.485 1.277 0 C-N-CA 127.034 2.134 . . . . 0.0 112.646 -178.449 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.507 ' HE1' HG21 ' A' ' 15' ' ' VAL . 72.3 mtp . . . . . 0 N--CA 1.472 0.63 0 N-CA-C 112.184 0.439 . . . . 0.0 112.184 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -56.79 -49.6 74.83 Favored 'General case' 0 CA--C 1.547 0.828 0 CA-C-N 115.541 -0.754 . . . . 0.0 112.602 177.499 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 50.2 tttm -76.32 -51.65 11.54 Favored 'General case' 0 N--CA 1.475 0.799 0 CA-C-N 113.407 -1.724 . . . . 0.0 113.303 -173.195 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 4' ' ' GLU . . . . . 0.429 ' HB2' ' O ' ' A' ' 70' ' ' TRP . 1.8 mp0 -79.03 -33.33 44.91 Favored 'General case' 0 N--CA 1.47 0.536 0 N-CA-C 115.94 1.83 . . . . 0.0 115.94 -173.411 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 5' ' ' PHE . . . . . 0.41 ' HB2' HD12 ' A' ' 7' ' ' ILE . 26.7 m-85 -113.41 -14.13 12.79 Favored 'General case' 0 N--CA 1.474 0.774 0 N-CA-C 117.621 2.452 . . . . 0.0 117.621 -171.556 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 82.33 58.84 2.36 Favored Glycine 0 CA--C 1.538 1.506 0 C-N-CA 124.133 0.873 . . . . 0.0 111.159 -179.155 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.515 HG21 ' HB2' ' A' ' 12' ' ' ALA . 0.8 OUTLIER -120.39 146.71 43.51 Favored Pre-proline 0 N--CA 1.479 1.009 0 CA-C-N 112.747 -1.726 . . . . 0.0 113.307 -176.102 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -91.51 161.12 3.59 Favored 'Trans proline' 0 CA--C 1.537 0.662 0 C-N-CA 121.123 1.215 . . . . 0.0 110.745 160.535 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -52.75 -32.08 41.44 Favored 'General case' 0 CA--C 1.544 0.716 0 N-CA-C 114.07 1.137 . . . . 0.0 114.07 174.312 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -40.84 -39.46 1.13 Allowed 'General case' 0 N--CA 1.485 1.323 0 C-N-CA 126.784 2.033 . . . . 0.0 114.976 172.879 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.942 HG12 HG22 ' A' ' 31' ' ' ILE . 17.3 m -110.95 -31.63 2.25 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.354 0 N-CA-C 114.939 1.459 . . . . 0.0 114.939 -177.162 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 0.515 ' HB2' HG21 ' A' ' 7' ' ' ILE . . . -65.94 -36.91 84.65 Favored 'General case' 0 N--CA 1.476 0.864 0 N-CA-C 112.61 0.596 . . . . 0.0 112.61 174.016 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 13' ' ' GLY . . . . . 0.516 ' O ' ' HB2' ' A' ' 16' ' ' LEU . . . -58.18 -41.95 95.02 Favored Glycine 0 CA--C 1.54 1.603 0 C-N-CA 124.033 0.825 . . . . 0.0 112.563 171.813 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.775 HG22 HG13 ' A' ' 28' ' ' ILE . 0.2 OUTLIER -62.14 -34.05 75.65 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 125.546 1.538 . . . . 0.0 114.045 176.719 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.507 HG21 ' HE1' ' A' ' 1' ' ' MET . 5.2 t -58.15 -46.93 88.34 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.29 0 C-N-CA 123.846 0.858 . . . . 0.0 112.798 171.045 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.516 ' HB2' ' O ' ' A' ' 13' ' ' GLY . 9.5 mp -52.5 -38.61 59.94 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 124.912 1.285 . . . . 0.0 113.384 173.026 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 15.3 t-20 -57.4 -49.13 77.18 Favored 'General case' 0 N--CA 1.485 1.279 0 O-C-N 123.873 0.733 . . . . 0.0 110.815 177.768 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 2.4 t -50.19 -50.89 19.21 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.767 0 O-C-N 124.366 1.041 . . . . 0.0 112.77 173.31 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.564 HG13 ' HA ' ' A' ' 56' ' ' LYS . 9.0 t -65.34 -48.97 81.22 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.235 0 CA-C-N 114.647 -1.16 . . . . 0.0 112.411 -175.075 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -71.39 -46.72 59.59 Favored 'General case' 0 CA--C 1.548 0.872 0 N-CA-C 114.692 1.367 . . . . 0.0 114.692 -177.425 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -96.04 -9.18 31.59 Favored 'General case' 0 N--CA 1.475 0.807 0 N-CA-C 115.733 1.753 . . . . 0.0 115.733 -170.352 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 65.19 33.13 86.1 Favored Glycine 0 CA--C 1.542 1.773 0 C-N-CA 124.327 0.965 . . . . 0.0 112.494 -171.523 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -78.31 167.66 53.39 Favored Glycine 0 N--CA 1.476 1.357 0 C-N-CA 125.372 1.463 . . . . 0.0 115.698 -175.044 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' TRP . . . . . 0.409 ' HB3' HG22 ' A' ' 26' ' ' THR . 2.5 m-90 -68.2 106.39 2.42 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-N 113.454 -1.373 . . . . 0.0 111.999 -178.666 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 2.8 p -57.58 -24.84 23.14 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.781 0 CA-C-N 114.122 -1.399 . . . . 0.0 114.07 173.65 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.409 HG22 ' HB3' ' A' ' 24' ' ' TRP . 10.0 t -60.0 -44.54 94.48 Favored 'General case' 0 N--CA 1.483 1.214 0 C-N-CA 124.053 0.941 . . . . 0.0 113.239 -179.823 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 27' ' ' THR . . . . . 0.452 ' O ' HG12 ' A' ' 31' ' ' ILE . 0.0 OUTLIER -65.28 -42.76 92.81 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 124.254 1.021 . . . . 0.0 111.787 175.657 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.775 HG13 HG22 ' A' ' 14' ' ' THR . 1.8 mp -62.3 -46.1 97.22 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 C-N-CA 124.427 1.091 . . . . 0.0 111.037 178.235 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.485 HG13 HD11 ' A' ' 43' ' ' LEU . 39.6 t -56.11 -45.27 80.62 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.837 0 C-N-CA 124.344 1.058 . . . . 0.0 111.978 174.009 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 36.9 m -58.34 -37.03 74.32 Favored 'General case' 0 N--CA 1.486 1.344 0 N-CA-C 113.855 1.057 . . . . 0.0 113.855 175.256 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.942 HG22 HG12 ' A' ' 11' ' ' VAL . 43.5 mm -75.9 -39.34 37.56 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.41 0 C-N-CA 123.926 0.891 . . . . 0.0 110.434 179.737 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.676 HD22 ' HB ' ' A' ' 11' ' ' VAL . 3.7 mm? -60.57 -50.94 71.51 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 125.564 1.546 . . . . 0.0 112.251 174.003 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 18.0 p -67.25 -30.55 70.47 Favored 'General case' 0 N--CA 1.484 1.229 0 N-CA-C 114.609 1.337 . . . . 0.0 114.609 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -49.1 -40.6 32.66 Favored 'General case' 0 N--CA 1.485 1.291 0 N-CA-C 113.52 0.933 . . . . 0.0 113.52 170.37 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 57.7 t . . . . . 0 N--CA 1.487 1.382 0 C-N-CA 125.139 1.376 . . . . 0.0 112.934 173.008 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 39' ' ' GLY . . . . . 0.543 ' HA2' ' HB3' ' A' ' 32' ' ' LEU . . . . . . . . 0 CA--C 1.535 1.307 0 N-CA-C 111.57 -0.612 . . . . 0.0 111.57 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 30.3 mt -59.34 -45.71 90.62 Favored 'General case' 0 N--CA 1.48 1.03 0 N-CA-C 114.983 1.475 . . . . 0.0 114.983 -177.789 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 51.9 p -66.2 -37.58 85.93 Favored 'General case' 0 N--CA 1.48 1.033 0 N-CA-C 113.926 1.084 . . . . 0.0 113.926 176.132 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 12.7 tp -65.98 -44.16 85.71 Favored 'General case' 0 N--CA 1.482 1.149 0 CA-C-O 120.963 0.411 . . . . 0.0 110.217 173.033 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.485 HD11 HG13 ' A' ' 29' ' ' VAL . 82.6 mt -64.9 -22.74 67.05 Favored 'General case' 0 N--CA 1.476 0.874 0 N-CA-C 115.031 1.493 . . . . 0.0 115.031 178.997 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -72.98 -47.85 41.69 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-N 115.706 -0.679 . . . . 0.0 112.16 170.15 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -60.22 -35.56 75.71 Favored 'General case' 0 N--CA 1.487 1.391 0 C-N-CA 124.221 1.009 . . . . 0.0 111.739 177.08 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -52.74 -26.87 15.43 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 127.209 2.204 . . . . 0.0 115.821 174.855 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -46.46 -43.22 14.62 Favored Glycine 0 N--CA 1.483 1.769 0 C-N-CA 125.676 1.608 . . . . 0.0 114.249 -175.5 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 66.6 ttp85 -47.48 -55.8 8.33 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 126.01 1.724 . . . . 0.0 113.486 -176.597 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 10.5 tt0 -136.38 38.54 2.69 Favored 'General case' 0 N--CA 1.483 1.198 0 N-CA-C 113.656 0.984 . . . . 0.0 113.656 -174.216 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 23.2 t 45.86 125.77 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 125.313 1.445 . . . . 0.0 114.096 -173.849 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 10.5 tp -31.3 -49.74 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.481 1.083 0 N-CA-C 118.355 2.724 . . . . 0.0 118.355 -174.32 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 52.2 tptt -55.77 -70.05 0.12 Allowed 'General case' 0 N--CA 1.483 1.215 0 C-N-CA 124.575 1.15 . . . . 0.0 111.848 176.525 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -61.3 -38.44 86.83 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 124.377 1.071 . . . . 0.0 113.525 179.709 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 85.9 t80 -46.8 -60.43 2.42 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 124.84 1.256 . . . . 0.0 111.587 173.359 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 67.4 mt -67.05 -43.81 81.76 Favored 'General case' 0 N--CA 1.478 0.952 0 N-CA-C 113.992 1.108 . . . . 0.0 113.992 -177.085 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' LYS . . . . . 0.564 ' HA ' HG13 ' A' ' 19' ' ' VAL . 6.5 mmmt -52.24 -43.37 64.29 Favored 'General case' 0 N--CA 1.478 0.947 0 CA-C-N 113.995 -1.457 . . . . 0.0 114.438 177.911 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 33.4 tttm -80.53 -55.25 4.99 Favored 'General case' 0 N--CA 1.476 0.847 0 CA-C-N 114.583 -1.189 . . . . 0.0 111.67 172.235 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' GLU . . . . . 0.555 ' O ' ' HB2' ' A' ' 62' ' ' LYS . 34.3 tt0 -54.06 -51.43 64.09 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-O 117.038 -1.458 . . . . 0.0 110.895 -170.478 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.765 HG23 HG21 ' A' ' 67' ' ' VAL . 3.4 mm -78.92 -23.51 12.86 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.349 0 CA-C-O 118.719 -0.658 . . . . 0.0 112.335 -174.707 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 1.2 tppm? -61.52 -37.64 84.47 Favored 'General case' 0 N--CA 1.466 0.368 0 N-CA-C 113.997 1.11 . . . . 0.0 113.997 172.436 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 45.1 mttt -90.93 -37.86 13.25 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-N 112.465 -2.152 . . . . 0.0 113.419 -178.453 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' LYS . . . . . 0.555 ' HB2' ' O ' ' A' ' 58' ' ' GLU . 24.1 tttm -67.51 -45.44 75.78 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 126.562 1.945 . . . . 0.0 113.574 -176.994 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 98.32 102.97 2.29 Favored Glycine 0 CA--C 1.534 1.229 0 CA-C-O 122.11 0.839 . . . . 0.0 111.409 -177.155 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.509 ' HD2' ' H ' ' A' ' 64' ' ' LYS . 2.2 mptp? -31.58 -47.6 0.12 Allowed 'General case' 0 N--CA 1.477 0.909 0 N-CA-C 119.136 3.013 . . . . 0.0 119.136 -178.076 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 4.8 ttp-105 -62.27 -47.81 82.68 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 124.76 1.224 . . . . 0.0 113.628 179.56 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -60.98 -26.95 67.94 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-N 114.642 -1.163 . . . . 0.0 113.952 172.489 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.765 HG21 HG23 ' A' ' 59' ' ' ILE . 63.9 t -68.6 -40.38 81.76 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.291 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.635 176.442 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 45.5 mm -53.52 -45.83 59.09 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.08 0 C-N-CA 123.485 0.714 . . . . 0.0 109.895 172.145 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -64.8 -52.58 56.05 Favored 'General case' 0 N--CA 1.482 1.134 0 N-CA-C 112.79 0.663 . . . . 0.0 112.79 176.111 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' TRP . . . . . 0.429 ' O ' ' HB2' ' A' ' 4' ' ' GLU . 33.9 t90 . . . . . 0 N--CA 1.479 1.018 0 C-N-CA 126.051 1.74 . . . . 0.0 112.336 178.36 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.59 ' HE1' HG21 ' A' ' 15' ' ' VAL . 46.1 mtp . . . . . 0 N--CA 1.471 0.577 0 N-CA-C 112.457 0.54 . . . . 0.0 112.457 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 2' ' ' ALA . . . . . 0.475 ' HA ' ' O ' ' A' ' 7' ' ' ILE . . . -52.22 -51.83 55.92 Favored 'General case' 0 N--CA 1.47 0.538 0 O-C-N 124.568 1.167 . . . . 0.0 112.73 176.708 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 14.7 tttt -79.93 -51.75 8.72 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 112.717 -2.038 . . . . 0.0 114.578 -173.555 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 10.6 mt-10 -73.04 -35.15 66.69 Favored 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 115.382 1.623 . . . . 0.0 115.382 -173.772 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 50.6 m-85 -109.04 -13.85 14.64 Favored 'General case' 0 N--CA 1.478 0.933 0 N-CA-C 117.356 2.354 . . . . 0.0 117.356 -173.997 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 82.75 60.49 2.07 Favored Glycine 0 CA--C 1.542 1.765 0 O-C-N 124.342 1.027 . . . . 0.0 110.65 -177.83 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.475 ' O ' ' HA ' ' A' ' 2' ' ' ALA . 0.8 OUTLIER -125.23 143.38 44.2 Favored Pre-proline 0 N--CA 1.481 1.12 0 CA-C-N 113.63 -1.285 . . . . 0.0 112.457 -175.924 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_endo -87.92 159.54 7.4 Favored 'Trans proline' 0 CA--C 1.538 0.675 0 C-N-CA 120.94 1.094 . . . . 0.0 109.376 163.797 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -50.58 -33.2 21.1 Favored 'General case' 0 N--CA 1.476 0.874 0 N-CA-C 114.253 1.205 . . . . 0.0 114.253 174.895 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -37.03 -41.85 0.38 Allowed 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 127.45 2.3 . . . . 0.0 115.917 169.725 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.9 HG12 HG22 ' A' ' 31' ' ' ILE . 19.0 m -111.37 -28.53 2.57 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 N-CA-C 115.395 1.628 . . . . 0.0 115.395 -176.749 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 0.463 ' O ' ' HG ' ' A' ' 16' ' ' LEU . . . -66.28 -33.61 76.14 Favored 'General case' 0 N--CA 1.477 0.891 0 N-CA-C 112.71 0.633 . . . . 0.0 112.71 171.433 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -59.62 -37.41 92.22 Favored Glycine 0 CA--C 1.539 1.59 0 C-N-CA 124.448 1.023 . . . . 0.0 112.674 171.349 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.65 HG22 HG13 ' A' ' 28' ' ' ILE . 0.2 OUTLIER -71.98 -37.15 69.93 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 125.188 1.395 . . . . 0.0 112.598 177.908 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.649 HG23 HD21 ' A' ' 32' ' ' LEU . 20.9 t -55.93 -41.65 68.23 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.237 0 C-N-CA 123.423 0.689 . . . . 0.0 111.88 166.366 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.463 ' HG ' ' O ' ' A' ' 12' ' ' ALA . 77.6 mt -61.25 -37.1 81.91 Favored 'General case' 0 N--CA 1.486 1.347 0 N-CA-C 114.518 1.303 . . . . 0.0 114.518 177.929 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 12.0 t-20 -52.35 -49.2 64.8 Favored 'General case' 0 CA--C 1.545 0.767 0 CA-C-N 114.395 -1.275 . . . . 0.0 112.065 173.424 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.449 ' HB ' ' O ' ' A' ' 15' ' ' VAL . 5.0 t -52.08 -50.57 34.8 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 CA-C-N 113.295 -1.775 . . . . 0.0 111.502 175.848 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.625 HG13 ' HA ' ' A' ' 56' ' ' LYS . 13.0 t -66.86 -48.62 79.21 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.255 0 O-C-N 123.991 0.807 . . . . 0.0 111.043 -176.124 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -63.73 -44.01 94.81 Favored 'General case' 0 CA--C 1.542 0.656 0 N-CA-C 114.446 1.276 . . . . 0.0 114.446 -176.638 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -103.06 -19.94 14.37 Favored 'General case' 0 N--CA 1.479 1.005 0 N-CA-C 115.559 1.689 . . . . 0.0 115.559 -171.194 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 71.17 39.69 62.33 Favored Glycine 0 N--CA 1.481 1.66 0 N-CA-C 109.905 -1.278 . . . . 0.0 109.905 -166.767 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -83.82 162.8 39.58 Favored Glycine 0 CA--C 1.527 0.806 0 N-CA-C 109.168 -1.573 . . . . 0.0 109.168 -178.96 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' TRP . . . . . 0.437 ' O ' HD13 ' A' ' 28' ' ' ILE . 31.5 m95 -64.76 104.6 0.85 Allowed 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 112.365 -1.918 . . . . 0.0 112.48 -175.132 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.578 HG21 HG13 ' A' ' 51' ' ' ILE . 3.1 p -57.35 -24.91 22.51 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.927 0 CA-C-N 113.147 -1.842 . . . . 0.0 113.39 171.395 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 3.1 p -61.34 -47.21 86.95 Favored 'General case' 0 N--CA 1.484 1.246 0 N-CA-C 113.786 1.032 . . . . 0.0 113.786 -179.516 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -62.4 -40.83 97.79 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 123.24 0.616 . . . . 0.0 111.357 173.862 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.65 HG13 HG22 ' A' ' 14' ' ' THR . 1.8 mp -60.02 -48.69 86.88 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 C-N-CA 124.878 1.271 . . . . 0.0 112.253 177.504 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.521 HG23 ' O ' ' A' ' 25' ' ' VAL . 53.5 t -49.59 -45.68 20.34 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 C-N-CA 124.406 1.082 . . . . 0.0 112.264 178.356 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -62.27 -41.72 98.71 Favored 'General case' 0 N--CA 1.485 1.314 0 N-CA-C 112.917 0.71 . . . . 0.0 112.917 178.38 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.9 HG22 HG12 ' A' ' 11' ' ' VAL . 36.7 mm -70.9 -38.86 74.19 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.145 0 C-N-CA 123.436 0.695 . . . . 0.0 109.805 -179.057 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.763 HD22 ' HB ' ' A' ' 11' ' ' VAL . 3.2 mm? -58.05 -53.44 58.18 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 125.475 1.51 . . . . 0.0 112.039 173.78 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 11.0 m -71.86 -21.19 61.7 Favored 'General case' 0 N--CA 1.477 0.916 0 N-CA-C 113.496 0.924 . . . . 0.0 113.496 179.473 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -58.89 -28.83 66.53 Favored 'General case' 0 N--CA 1.484 1.26 0 C-N-CA 123.967 0.907 . . . . 0.0 113.402 172.425 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 74.8 t . . . . . 0 N--CA 1.484 1.256 0 C-N-CA 124.045 0.938 . . . . 0.0 111.495 170.916 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 39' ' ' GLY . . . . . 0.431 ' O ' ' HG ' ' A' ' 43' ' ' LEU . . . . . . . . 0 N--CA 1.478 1.493 0 N-CA-C 114.901 0.72 . . . . 0.0 114.901 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 43.9 mt -67.05 -44.93 78.89 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 124.242 1.017 . . . . 0.0 113.42 -177.143 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -55.44 -39.79 70.74 Favored 'General case' 0 N--CA 1.481 1.082 0 O-C-N 124.079 0.862 . . . . 0.0 112.838 171.903 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 16.8 tp -64.09 -48.17 77.2 Favored 'General case' 0 N--CA 1.477 0.884 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.042 175.859 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.431 ' HG ' ' O ' ' A' ' 39' ' ' GLY . 44.1 mt -61.05 -30.94 70.62 Favored 'General case' 0 N--CA 1.479 0.999 0 N-CA-C 114.603 1.334 . . . . 0.0 114.603 179.078 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -66.62 -50.39 63.15 Favored 'General case' 0 N--CA 1.478 0.96 0 CA-C-N 115.882 -0.599 . . . . 0.0 112.211 171.402 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -61.16 -34.73 75.49 Favored 'General case' 0 N--CA 1.485 1.301 0 CA-C-O 121.743 0.782 . . . . 0.0 112.345 176.273 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -67.35 -22.57 65.58 Favored 'General case' 0 N--CA 1.478 0.934 0 N-CA-C 116.191 1.923 . . . . 0.0 116.191 179.993 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -49.42 -34.58 19.44 Favored Glycine 0 CA--C 1.549 2.208 0 C-N-CA 124.688 1.137 . . . . 0.0 112.741 177.123 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 18.5 ttm180 -52.32 -50.87 61.39 Favored 'General case' 0 CA--C 1.549 0.906 0 C-N-CA 126.455 1.902 . . . . 0.0 114.977 -175.427 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 16.0 tt0 -133.5 40.58 3.13 Favored 'General case' 0 N--CA 1.479 0.977 0 N-CA-C 113.283 0.846 . . . . 0.0 113.283 -175.529 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 89.0 p 44.86 115.14 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.499 0 C-N-CA 125.303 1.441 . . . . 0.0 113.727 -172.445 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.578 HG13 HG21 ' A' ' 25' ' ' VAL . 8.0 tp -23.88 -56.82 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.483 1.177 0 N-CA-C 119.131 3.012 . . . . 0.0 119.131 -175.484 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 54.2 tttt -64.11 -55.52 21.35 Favored 'General case' 0 N--CA 1.48 1.045 0 N-CA-C 112.835 0.68 . . . . 0.0 112.835 -179.86 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -62.9 -38.66 91.81 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 124.936 1.294 . . . . 0.0 112.158 177.759 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 69.1 t80 -51.75 -58.42 6.45 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 125.617 1.567 . . . . 0.0 111.18 174.791 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.601 HD13 HG13 ' A' ' 15' ' ' VAL . 60.6 mt -70.47 -41.12 73.19 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 114.811 1.411 . . . . 0.0 114.811 -179.346 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 56' ' ' LYS . . . . . 0.625 ' HA ' HG13 ' A' ' 19' ' ' VAL . 50.4 tptt -55.26 -49.96 70.72 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-N 114.004 -1.453 . . . . 0.0 113.174 178.076 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 52.8 tttp -74.55 -54.62 7.14 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-N 114.759 -1.109 . . . . 0.0 112.1 174.656 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' GLU . . . . . 0.409 ' O ' ' HB2' ' A' ' 62' ' ' LYS . 16.1 mt-10 -61.36 -41.78 97.63 Favored 'General case' 0 N--CA 1.472 0.625 0 N-CA-C 113.972 1.101 . . . . 0.0 113.972 -169.156 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.814 HG23 HG21 ' A' ' 67' ' ' VAL . 2.8 mm -78.09 -26.56 14.51 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.851 0 C-N-CA 120.13 -0.628 . . . . 0.0 112.192 -179.346 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 10.3 tppt? -61.94 -27.6 68.94 Favored 'General case' 0 CA--C 1.542 0.643 0 N-CA-C 114.332 1.234 . . . . 0.0 114.332 170.247 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 42.3 mmtm -89.18 -43.15 11.23 Favored 'General case' 0 N--CA 1.483 1.215 0 CA-C-N 113.647 -1.615 . . . . 0.0 111.387 178.475 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' LYS . . . . . 0.458 ' HD3' HG22 ' A' ' 67' ' ' VAL . 2.7 tttm -68.88 -51.02 44.66 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 125.965 1.706 . . . . 0.0 114.89 -176.274 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 100.46 112.79 3.49 Favored Glycine 0 CA--C 1.534 1.273 0 N-CA-C 110.547 -1.021 . . . . 0.0 110.547 -172.654 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.436 ' HB3' HD13 ' A' ' 16' ' ' LEU . 10.5 mptt -41.99 -43.84 3.29 Favored 'General case' 0 N--CA 1.479 1.015 0 N-CA-C 118.139 2.644 . . . . 0.0 118.139 -172.643 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 65' ' ' ARG . . . . . 0.437 ' O ' ' HB ' ' A' ' 68' ' ' ILE . 0.0 OUTLIER -61.3 -42.78 99.24 Favored 'General case' 0 N--CA 1.477 0.905 0 N-CA-C 114.995 1.48 . . . . 0.0 114.995 177.552 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -68.78 -22.33 64.29 Favored 'General case' 0 N--CA 1.479 1.022 0 CA-C-N 114.878 -1.055 . . . . 0.0 113.171 173.742 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.814 HG21 HG23 ' A' ' 59' ' ' ILE . 61.8 t -75.53 -32.71 25.5 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.919 0 C-N-CA 123.725 0.81 . . . . 0.0 111.34 176.72 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.437 ' HB ' ' O ' ' A' ' 65' ' ' ARG . 18.6 mm -51.78 -47.47 39.51 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.153 0 C-N-CA 123.639 0.776 . . . . 0.0 109.814 165.714 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -68.22 -48.83 64.11 Favored 'General case' 0 N--CA 1.472 0.641 0 O-C-N 124.225 0.953 . . . . 0.0 113.406 178.038 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 34.1 t90 . . . . . 0 N--CA 1.476 0.859 0 C-N-CA 125.587 1.555 . . . . 0.0 112.407 178.482 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.449 ' HB3' HG21 ' A' ' 7' ' ' ILE . 53.9 mtp . . . . . 0 N--CA 1.478 0.946 0 N-CA-C 112.367 0.506 . . . . 0.0 112.367 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -55.47 -50.82 68.87 Favored 'General case' 0 N--CA 1.472 0.643 0 O-C-N 124.67 1.231 . . . . 0.0 112.711 177.291 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 52.7 tttp -72.91 -58.81 3.06 Favored 'General case' 0 CA--C 1.543 0.686 0 CA-C-N 114.257 -1.338 . . . . 0.0 113.573 -178.78 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -66.16 -43.74 86.09 Favored 'General case' 0 N--CA 1.471 0.601 0 N-CA-C 116.474 2.027 . . . . 0.0 116.474 -168.901 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 5' ' ' PHE . . . . . 0.561 ' HB2' HD12 ' A' ' 7' ' ' ILE . 38.4 m-85 -101.41 -18.06 16.19 Favored 'General case' 0 N--CA 1.476 0.857 0 N-CA-C 115.953 1.835 . . . . 0.0 115.953 -170.509 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 81.41 63.06 1.89 Allowed Glycine 0 N--CA 1.484 1.855 0 O-C-N 124.532 1.145 . . . . 0.0 110.714 -169.464 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.561 HD12 ' HB2' ' A' ' 5' ' ' PHE . 0.4 OUTLIER -122.55 145.93 46.23 Favored Pre-proline 0 N--CA 1.471 0.613 0 C-N-CA 125.587 1.555 . . . . 0.0 108.998 179.775 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_endo -86.44 152.1 9.12 Favored 'Trans proline' 0 CA--C 1.537 0.645 0 N-CA-C 108.173 -1.51 . . . . 0.0 108.173 161.13 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -47.69 -33.94 7.54 Favored 'General case' 0 N--CA 1.47 0.55 0 N-CA-C 115.663 1.727 . . . . 0.0 115.663 175.486 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -37.69 -57.37 0.98 Allowed 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 126.964 2.106 . . . . 0.0 113.931 173.374 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.873 HG12 HG22 ' A' ' 31' ' ' ILE . 23.9 m -83.97 -33.16 9.01 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.214 0 N-CA-C 113.728 1.01 . . . . 0.0 113.728 -175.259 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -64.09 -32.39 73.93 Favored 'General case' 0 CA--C 1.545 0.787 0 N-CA-C 112.303 0.483 . . . . 0.0 112.303 173.38 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -59.36 -44.62 96.45 Favored Glycine 0 CA--C 1.538 1.473 0 CA-C-O 122.497 1.054 . . . . 0.0 113.071 171.277 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.7 HG22 HG13 ' A' ' 28' ' ' ILE . 0.3 OUTLIER -63.17 -35.7 81.17 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 125.276 1.43 . . . . 0.0 113.586 176.542 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.469 HG23 HD21 ' A' ' 32' ' ' LEU . 5.1 t -58.15 -41.53 80.97 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 C-N-CA 124.205 1.002 . . . . 0.0 111.992 170.747 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 24.6 mt -61.32 -38.93 88.64 Favored 'General case' 0 N--CA 1.472 0.638 0 N-CA-C 113.222 0.823 . . . . 0.0 113.222 178.681 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -52.81 -48.06 67.18 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 124.798 1.239 . . . . 0.0 112.526 173.038 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 1.1 t -54.4 -54.0 25.55 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.984 0 CA-C-N 115.057 -0.974 . . . . 0.0 111.501 174.735 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.795 HG13 ' HA ' ' A' ' 56' ' ' LYS . 6.8 t -59.87 -47.58 90.98 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.014 0 O-C-N 123.803 0.689 . . . . 0.0 110.458 -177.505 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 20' ' ' GLU . . . . . 0.595 ' HG3' ' HE2' ' A' ' 64' ' ' LYS . 17.4 mt-10 -60.34 -36.74 78.69 Favored 'General case' 0 CA--C 1.542 0.666 0 N-CA-C 115.992 1.849 . . . . 0.0 115.992 -178.49 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -106.8 -9.97 16.22 Favored 'General case' 0 N--CA 1.477 0.876 0 N-CA-C 116.303 1.964 . . . . 0.0 116.303 -175.409 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 64.42 42.01 97.8 Favored Glycine 0 CA--C 1.549 2.196 0 N-CA-C 110.298 -1.121 . . . . 0.0 110.298 -168.12 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -92.53 175.24 37.23 Favored Glycine 0 CA--C 1.534 1.275 0 C-N-CA 124.27 0.938 . . . . 0.0 113.872 -167.436 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' TRP . . . . . 0.546 ' HB3' HG22 ' A' ' 26' ' ' THR . 81.5 m95 -67.29 104.83 1.58 Allowed 'General case' 0 N--CA 1.468 0.464 0 CA-C-O 122.55 1.167 . . . . 0.0 113.3 179.763 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.565 HG21 HG13 ' A' ' 51' ' ' ILE . 2.2 p -60.74 -22.08 25.36 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.971 0 CA-C-N 113.665 -1.607 . . . . 0.0 113.693 170.795 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.546 HG22 ' HB3' ' A' ' 24' ' ' TRP . 4.4 t -56.57 -46.38 80.8 Favored 'General case' 0 N--CA 1.485 1.316 0 N-CA-C 113.811 1.041 . . . . 0.0 113.811 -179.982 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 27' ' ' THR . . . . . 0.405 ' O ' HG12 ' A' ' 31' ' ' ILE . 0.0 OUTLIER -64.09 -41.01 97.45 Favored 'General case' 0 N--CA 1.479 1.016 0 O-C-N 123.972 0.795 . . . . 0.0 112.006 176.91 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.7 HG13 HG22 ' A' ' 14' ' ' THR . 2.0 mp -68.59 -44.37 82.8 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 C-N-CA 125.255 1.422 . . . . 0.0 111.904 -179.114 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.691 HG13 HD11 ' A' ' 43' ' ' LEU . 38.2 t -51.95 -48.88 39.74 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.349 0 C-N-CA 124.386 1.074 . . . . 0.0 111.069 174.52 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 42.3 m -52.34 -41.78 63.31 Favored 'General case' 0 N--CA 1.483 1.198 0 N-CA-C 114.555 1.317 . . . . 0.0 114.555 176.59 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.873 HG22 HG12 ' A' ' 11' ' ' VAL . 36.9 mm -75.35 -40.81 42.99 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.981 0 C-N-CA 124.407 1.083 . . . . 0.0 109.719 -177.766 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.651 HD22 ' HB ' ' A' ' 11' ' ' VAL . 3.9 mm? -55.96 -53.14 60.43 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 124.493 1.117 . . . . 0.0 112.294 171.565 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 1.2 p -66.4 -29.62 69.82 Favored 'General case' 0 N--CA 1.481 1.103 0 N-CA-C 115.974 1.842 . . . . 0.0 115.974 178.865 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -57.29 -27.94 62.59 Favored 'General case' 0 N--CA 1.477 0.882 0 O-C-N 124.303 1.002 . . . . 0.0 113.188 171.862 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 83.7 t . . . . . 0 N--CA 1.485 1.297 0 C-N-CA 124.019 0.928 . . . . 0.0 111.628 172.898 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 39' ' ' GLY . . . . . 0.447 ' HA2' ' HB3' ' A' ' 32' ' ' LEU . . . . . . . . 0 N--CA 1.477 1.38 0 N-CA-C 111.032 -0.827 . . . . 0.0 111.032 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 94.8 mt -65.02 -49.14 71.35 Favored 'General case' 0 N--CA 1.48 1.028 0 N-CA-C 114.291 1.219 . . . . 0.0 114.291 -179.22 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 27.8 p -59.2 -38.83 80.85 Favored 'General case' 0 N--CA 1.48 1.065 0 N-CA-C 114.167 1.173 . . . . 0.0 114.167 175.873 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 13.8 tp -62.32 -50.61 70.93 Favored 'General case' 0 N--CA 1.48 1.047 0 CA-C-O 120.853 0.358 . . . . 0.0 111.11 170.275 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.691 HD11 HG13 ' A' ' 29' ' ' VAL . 0.7 OUTLIER -61.43 -30.89 70.85 Favored 'General case' 0 N--CA 1.473 0.706 0 N-CA-C 114.835 1.421 . . . . 0.0 114.835 -179.284 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -70.36 -43.79 69.45 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 123.568 0.747 . . . . 0.0 112.562 173.239 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -64.77 -31.43 72.65 Favored 'General case' 0 N--CA 1.475 0.798 0 N-CA-C 112.977 0.732 . . . . 0.0 112.977 174.074 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -60.22 -21.24 61.56 Favored 'General case' 0 N--CA 1.476 0.842 0 N-CA-C 115.817 1.784 . . . . 0.0 115.817 177.124 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -49.63 -33.63 18.94 Favored Glycine 0 CA--C 1.542 1.781 0 C-N-CA 126.198 1.856 . . . . 0.0 114.423 179.631 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 66.3 ttp85 -49.61 -60.2 3.08 Favored 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 125.602 1.561 . . . . 0.0 112.339 179.84 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 12.5 tt0 -129.15 32.08 4.77 Favored 'General case' 0 N--CA 1.48 1.069 0 CA-C-N 114.61 -1.177 . . . . 0.0 113.586 -172.571 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 8.0 t 49.75 123.55 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.295 0 C-N-CA 124.642 1.177 . . . . 0.0 113.692 -173.458 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.565 HG13 HG21 ' A' ' 25' ' ' VAL . 8.7 tp -29.01 -49.8 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.482 1.136 0 N-CA-C 117.947 2.573 . . . . 0.0 117.947 -174.713 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 33.8 ttmt -57.97 -68.67 0.22 Allowed 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 123.849 0.86 . . . . 0.0 111.93 177.383 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -62.61 -33.96 76.05 Favored 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 124.743 1.217 . . . . 0.0 113.397 179.588 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 88.5 t80 -49.5 -63.48 1.09 Allowed 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 125.11 1.364 . . . . 0.0 111.786 175.15 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.423 HD13 HG13 ' A' ' 15' ' ' VAL . 59.9 mt -65.09 -39.87 93.78 Favored 'General case' 0 N--CA 1.475 0.802 0 N-CA-C 114.469 1.285 . . . . 0.0 114.469 -178.299 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 56' ' ' LYS . . . . . 0.795 ' HA ' HG13 ' A' ' 19' ' ' VAL . 97.8 mttt -58.66 -41.15 85.44 Favored 'General case' 0 N--CA 1.475 0.803 0 N-CA-C 114.34 1.237 . . . . 0.0 114.34 179.44 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 22.1 tttt -80.64 -49.66 10.96 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-N 114.628 -1.169 . . . . 0.0 111.983 173.753 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' GLU . . . . . 0.425 ' O ' ' HB2' ' A' ' 62' ' ' LYS . 31.2 tt0 -58.62 -49.29 78.05 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-N 115.672 -0.694 . . . . 0.0 112.421 -173.454 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.633 HD12 HG21 ' A' ' 67' ' ' VAL . 2.7 mm -75.53 -25.35 17.64 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.937 0 C-N-CA 120.658 -0.417 . . . . 0.0 111.91 -177.261 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 60' ' ' LYS . . . . . 0.548 ' HB2' ' O ' ' A' ' 56' ' ' LYS . 2.5 tttt -62.85 -32.95 74.28 Favored 'General case' 0 N--CA 1.472 0.641 0 N-CA-C 114.599 1.333 . . . . 0.0 114.599 169.485 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 3.0 mptp? -81.36 -43.31 19.22 Favored 'General case' 0 N--CA 1.482 1.137 0 CA-C-N 114.132 -1.395 . . . . 0.0 112.373 173.271 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' LYS . . . . . 0.425 ' HB2' ' O ' ' A' ' 58' ' ' GLU . 17.4 tptt -71.59 -52.52 17.66 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 126.636 1.974 . . . . 0.0 114.038 -171.72 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 97.6 114.63 3.28 Favored Glycine 0 N--CA 1.475 1.246 0 CA-C-O 122.602 1.112 . . . . 0.0 110.895 -170.216 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.595 ' HE2' ' HG3' ' A' ' 20' ' ' GLU . 11.8 mptt -32.25 -52.11 0.27 Allowed 'General case' 0 N--CA 1.474 0.747 0 N-CA-C 119.251 3.056 . . . . 0.0 119.251 177.024 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 65' ' ' ARG . . . . . 1.045 HH21 HG13 ' A' ' 68' ' ' ILE . 0.0 OUTLIER -59.74 -45.31 92.59 Favored 'General case' 0 N--CA 1.476 0.827 0 N-CA-C 114.318 1.229 . . . . 0.0 114.318 -179.354 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -63.36 -29.85 71.08 Favored 'General case' 0 N--CA 1.474 0.751 0 CA-C-N 114.026 -1.443 . . . . 0.0 113.871 172.413 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.633 HG21 HD12 ' A' ' 59' ' ' ILE . 95.4 t -71.13 -33.12 50.06 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 N-CA-C 112.527 0.566 . . . . 0.0 112.527 178.175 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 1.045 HG13 HH21 ' A' ' 65' ' ' ARG . 27.0 mm -51.57 -47.49 37.05 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.333 0 O-C-N 123.902 0.751 . . . . 0.0 109.669 167.347 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -69.19 -51.48 37.59 Favored 'General case' 0 N--CA 1.483 1.21 0 CA-C-N 114.898 -1.046 . . . . 0.0 113.326 178.881 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 29.3 t90 . . . . . 0 N--CA 1.479 0.99 0 C-N-CA 124.657 1.183 . . . . 0.0 113.096 179.703 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.768 ' SD ' HD13 ' A' ' 42' ' ' LEU . 2.4 mmm . . . . . 0 CA--C 1.537 0.449 0 N-CA-C 111.442 0.164 . . . . 0.0 111.442 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -62.14 -58.78 6.5 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-N 113.65 -1.614 . . . . 0.0 112.261 177.871 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 15.5 ttpp -65.49 -54.05 33.73 Favored 'General case' 0 N--CA 1.476 0.832 0 CA-C-N 113.486 -1.688 . . . . 0.0 113.391 -173.478 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 12.1 tt0 -71.88 -37.47 70.16 Favored 'General case' 0 N--CA 1.477 0.911 0 N-CA-C 114.319 1.229 . . . . 0.0 114.319 -171.165 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 5' ' ' PHE . . . . . 0.436 ' HD1' ' HB2' ' A' ' 41' ' ' SER . 71.9 m-85 -102.84 -10.66 18.89 Favored 'General case' 0 N--CA 1.475 0.783 0 N-CA-C 117.473 2.397 . . . . 0.0 117.473 -172.944 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 74.36 50.9 9.13 Favored Glycine 0 CA--C 1.539 1.581 0 CA-C-O 122.459 1.033 . . . . 0.0 111.461 -174.604 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -113.86 146.84 36.43 Favored Pre-proline 0 N--CA 1.476 0.873 0 CA-C-N 112.998 -1.601 . . . . 0.0 109.767 179.405 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 97.4 Cg_endo -88.58 152.64 6.34 Favored 'Trans proline' 0 C--O 1.236 0.378 0 N-CA-C 109.733 -0.91 . . . . 0.0 109.733 165.498 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -48.77 -29.31 4.39 Favored 'General case' 0 N--CA 1.474 0.75 0 N-CA-C 115.119 1.525 . . . . 0.0 115.119 171.342 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -38.97 -47.75 1.5 Allowed 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 126.392 1.877 . . . . 0.0 114.498 170.092 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.729 HG12 HG22 ' A' ' 31' ' ' ILE . 33.0 m -99.04 -39.06 7.51 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.0 0 N-CA-C 113.791 1.034 . . . . 0.0 113.791 -176.892 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 0.402 ' O ' ' HG ' ' A' ' 16' ' ' LEU . . . -62.8 -38.02 89.02 Favored 'General case' 0 CA--C 1.547 0.865 0 N-CA-C 112.814 0.672 . . . . 0.0 112.814 176.982 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -58.5 -47.45 89.85 Favored Glycine 0 N--CA 1.486 1.995 0 O-C-N 124.535 1.147 . . . . 0.0 112.394 173.551 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 16.4 m -59.06 -39.57 82.48 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 124.625 1.17 . . . . 0.0 113.918 173.967 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.472 ' O ' HG23 ' A' ' 19' ' ' VAL . 40.6 t -57.04 -44.73 83.38 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.116 0 C-N-CA 123.682 0.793 . . . . 0.0 111.239 172.824 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.66 HD11 HG12 ' A' ' 68' ' ' ILE . 37.0 mt -60.97 -45.96 92.67 Favored 'General case' 0 N--CA 1.481 1.116 0 N-CA-C 112.831 0.678 . . . . 0.0 112.831 178.782 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 24.6 t-20 -50.14 -50.22 49.53 Favored 'General case' 0 N--CA 1.48 1.051 0 O-C-N 124.612 1.195 . . . . 0.0 111.067 174.475 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 56.5 t -57.65 -50.41 77.46 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 CA-C-N 113.056 -1.884 . . . . 0.0 111.841 178.624 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.611 HG11 ' HB ' ' A' ' 59' ' ' ILE . 24.3 t -59.31 -45.68 93.03 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.291 0 O-C-N 123.681 0.613 . . . . 0.0 110.943 -179.937 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 20' ' ' GLU . . . . . 0.558 ' HG3' ' HE2' ' A' ' 64' ' ' LYS . 14.3 mt-10 -57.69 -44.39 85.78 Favored 'General case' 0 N--CA 1.477 0.875 0 C-N-CA 125.153 1.381 . . . . 0.0 114.232 179.921 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -77.36 -17.46 58.22 Favored 'General case' 0 CA--C 1.541 0.609 0 N-CA-C 113.97 1.1 . . . . 0.0 113.97 178.35 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 71.61 51.45 16.06 Favored Glycine 0 N--CA 1.477 1.382 0 O-C-N 124.138 0.898 . . . . 0.0 111.86 -170.277 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -109.75 167.31 12.75 Favored Glycine 0 N--CA 1.48 1.597 0 CA-C-O 122.844 1.247 . . . . 0.0 112.634 -177.415 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' TRP . . . . . 0.669 ' HB3' HG22 ' A' ' 26' ' ' THR . 77.1 m95 -78.19 105.95 9.77 Favored 'General case' 0 N--CA 1.479 0.997 0 CA-C-N 113.252 -1.474 . . . . 0.0 111.818 -178.524 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.797 HG21 ' HB2' ' A' ' 55' ' ' LEU . 0.4 OUTLIER -62.58 -16.5 16.89 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.948 0 CA-C-N 113.897 -1.501 . . . . 0.0 112.825 171.021 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.669 HG22 ' HB3' ' A' ' 24' ' ' TRP . 15.3 t -67.74 -27.71 67.02 Favored 'General case' 0 N--CA 1.48 1.045 0 N-CA-C 114.513 1.301 . . . . 0.0 114.513 -178.993 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 27' ' ' THR . . . . . 0.606 ' HB ' HD12 ' A' ' 28' ' ' ILE . 0.7 OUTLIER -71.11 -48.86 49.85 Favored 'General case' 0 N--CA 1.48 1.054 0 CA-C-O 121.445 0.64 . . . . 0.0 110.813 170.111 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.606 HD12 ' HB ' ' A' ' 27' ' ' THR . 3.4 mp -65.84 -25.36 36.08 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 C-N-CA 125.956 1.702 . . . . 0.0 112.86 -179.474 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.502 HG22 HD21 ' A' ' 43' ' ' LEU . 7.9 t -36.48 -44.21 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.409 0 C-N-CA 124.101 0.96 . . . . 0.0 112.013 162.255 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 85.2 p -59.01 -39.05 80.7 Favored 'General case' 0 N--CA 1.486 1.359 0 N-CA-C 113.831 1.048 . . . . 0.0 113.831 178.688 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.729 HG22 HG12 ' A' ' 11' ' ' VAL . 39.6 mm -76.65 -35.66 25.85 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.814 0 C-N-CA 124.51 1.124 . . . . 0.0 110.178 -177.557 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.701 HD22 ' HB ' ' A' ' 11' ' ' VAL . 3.8 mm? -59.71 -54.38 47.08 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 125.161 1.384 . . . . 0.0 112.973 170.884 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -68.83 -24.2 64.35 Favored 'General case' 0 N--CA 1.476 0.833 0 N-CA-C 114.765 1.394 . . . . 0.0 114.765 177.066 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -53.54 -28.17 30.0 Favored 'General case' 0 N--CA 1.482 1.131 0 N-CA-C 113.4 0.889 . . . . 0.0 113.4 167.092 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.404 ' HB ' ' O ' ' A' ' 32' ' ' LEU . 70.0 t . . . . . 0 N--CA 1.481 1.111 0 C-N-CA 125.087 1.355 . . . . 0.0 112.354 169.807 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' GLY . . . . . 0.441 ' O ' ' HG ' ' A' ' 43' ' ' LEU . . . . . . . . 0 CA--C 1.539 1.588 0 N-CA-C 111.433 -0.667 . . . . 0.0 111.433 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 79.4 mt -60.4 -49.7 76.52 Favored 'General case' 0 N--CA 1.479 1.022 0 N-CA-C 114.594 1.331 . . . . 0.0 114.594 179.594 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' SER . . . . . 0.436 ' HB2' ' HD1' ' A' ' 5' ' ' PHE . 2.1 p -57.34 -37.33 72.38 Favored 'General case' 0 N--CA 1.479 1.021 0 N-CA-C 114.344 1.239 . . . . 0.0 114.344 177.337 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.768 HD13 ' SD ' ' A' ' 1' ' ' MET . 18.8 tp -62.94 -49.2 75.7 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 123.692 0.797 . . . . 0.0 110.436 171.396 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.502 HD21 HG22 ' A' ' 29' ' ' VAL . 49.5 mt -58.38 -33.74 69.95 Favored 'General case' 0 N--CA 1.476 0.855 0 N-CA-C 114.7 1.37 . . . . 0.0 114.7 178.087 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -65.1 -43.95 90.37 Favored 'General case' 0 N--CA 1.476 0.838 0 N-CA-C 112.324 0.491 . . . . 0.0 112.324 172.581 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -63.18 -43.17 98.98 Favored 'General case' 0 N--CA 1.484 1.251 0 C-N-CA 122.849 0.46 . . . . 0.0 111.729 173.276 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -57.34 -26.49 61.06 Favored 'General case' 0 N--CA 1.472 0.665 0 N-CA-C 115.645 1.72 . . . . 0.0 115.645 -176.597 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -45.86 -42.43 11.31 Favored Glycine 0 CA--C 1.546 2.029 0 C-N-CA 125.764 1.65 . . . . 0.0 114.052 178.589 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 29.0 ttm180 -48.54 -53.25 18.94 Favored 'General case' 0 N--CA 1.476 0.844 0 CA-C-N 112.558 -1.821 . . . . 0.0 113.673 -175.723 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 17.2 tt0 -126.84 36.72 4.41 Favored 'General case' 0 N--CA 1.474 0.77 0 N-CA-C 113.258 0.836 . . . . 0.0 113.258 178.024 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 18.4 t 48.33 120.96 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.421 0 C-N-CA 126.17 1.788 . . . . 0.0 113.821 -178.031 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 7.8 tp -31.31 -51.42 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 N-CA-C 116.595 2.072 . . . . 0.0 116.595 -176.319 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 70.3 mttt -48.68 -67.03 0.3 Allowed 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 125.477 1.511 . . . . 0.0 112.927 176.113 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -74.47 -30.86 62.03 Favored 'General case' 0 N--CA 1.466 0.352 0 N-CA-C 114.735 1.384 . . . . 0.0 114.735 -179.198 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' TYR . . . . . 0.504 ' HD2' ' HG ' ' A' ' 55' ' ' LEU . 72.9 t80 -49.0 -63.82 0.99 Allowed 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 124.933 1.293 . . . . 0.0 112.291 -178.133 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.797 ' HB2' HG21 ' A' ' 25' ' ' VAL . 42.4 mt -73.29 -34.44 65.76 Favored 'General case' 0 N--CA 1.477 0.885 0 N-CA-C 114.884 1.438 . . . . 0.0 114.884 -174.595 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 56' ' ' LYS . . . . . 0.578 ' HA ' HG13 ' A' ' 19' ' ' VAL . 57.8 mtpt -58.59 -46.17 87.53 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 114.438 -1.256 . . . . 0.0 112.67 177.052 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 61.6 tttm -77.44 -50.77 11.99 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 114.903 -1.044 . . . . 0.0 111.873 174.409 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 58.8 tt0 -59.1 -44.99 92.0 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-O 118.225 -0.893 . . . . 0.0 111.515 -170.404 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.748 HG23 HG21 ' A' ' 67' ' ' VAL . 4.0 mm -79.32 -20.08 12.61 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.789 0 C-N-CA 119.841 -0.744 . . . . 0.0 112.712 -175.262 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 23.1 tptt -65.57 -37.28 86.22 Favored 'General case' 0 CA--C 1.549 0.909 0 CA-C-O 122.449 1.119 . . . . 0.0 113.454 170.545 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 21.6 ttpp -84.53 -37.78 20.82 Favored 'General case' 0 CA--C 1.554 1.101 0 CA-C-N 112.355 -2.202 . . . . 0.0 111.415 -178.601 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 6.9 tttt -77.21 -43.62 33.0 Favored 'General case' 0 CA--C 1.541 0.626 0 N-CA-C 116.603 2.075 . . . . 0.0 116.603 -177.432 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 91.35 111.5 1.7 Allowed Glycine 0 N--CA 1.478 1.445 0 CA-C-O 122.584 1.102 . . . . 0.0 111.332 -177.48 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.635 ' HD2' ' H ' ' A' ' 64' ' ' LYS . 10.4 mptt -43.87 -41.21 4.99 Favored 'General case' 0 N--CA 1.487 1.377 0 N-CA-C 117.863 2.542 . . . . 0.0 117.863 -171.778 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 65' ' ' ARG . . . . . 0.485 ' O ' ' HB ' ' A' ' 68' ' ' ILE . 0.0 OUTLIER -56.16 -49.41 74.06 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 124.583 1.153 . . . . 0.0 113.386 178.402 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -67.65 -23.98 65.39 Favored 'General case' 0 N--CA 1.477 0.904 0 N-CA-C 114.61 1.337 . . . . 0.0 114.61 174.961 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.748 HG21 HG23 ' A' ' 59' ' ' ILE . 45.6 t -75.16 -32.23 26.05 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.083 0 CA-C-N 114.86 -1.064 . . . . 0.0 110.822 176.325 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.66 HG12 HD11 ' A' ' 16' ' ' LEU . 8.0 mm -51.7 -46.71 38.88 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.951 0 C-N-CA 123.355 0.662 . . . . 0.0 110.075 168.491 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -68.87 -48.91 62.24 Favored 'General case' 0 N--CA 1.482 1.143 0 O-C-N 124.542 1.152 . . . . 0.0 113.345 176.585 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 34.6 t90 . . . . . 0 N--CA 1.477 0.88 0 C-N-CA 124.799 1.24 . . . . 0.0 113.6 -178.846 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.536 ' HE3' HD13 ' A' ' 7' ' ' ILE . 22.5 mtp . . . . . 0 N--CA 1.48 1.036 0 N-CA-C 112.553 0.575 . . . . 0.0 112.553 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -60.56 -51.31 69.98 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-N 115.213 -0.903 . . . . 0.0 113.259 177.629 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 57.8 tttp -70.32 -51.44 30.15 Favored 'General case' 0 CA--C 1.551 0.987 0 CA-C-N 113.568 -1.651 . . . . 0.0 112.978 -173.42 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -77.22 -38.57 51.05 Favored 'General case' 0 N--CA 1.482 1.166 0 N-CA-C 116.577 2.065 . . . . 0.0 116.577 -170.361 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 5' ' ' PHE . . . . . 0.676 ' HD1' ' HB2' ' A' ' 41' ' ' SER . 53.3 m-85 -99.7 -30.99 11.78 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-N 112.914 -1.948 . . . . 0.0 115.356 -168.395 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 93.88 50.73 2.24 Favored Glycine 0 CA--C 1.541 1.682 0 O-C-N 125.277 1.611 . . . . 0.0 110.964 -171.174 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.536 HD13 ' HE3' ' A' ' 1' ' ' MET . 0.6 OUTLIER -117.83 147.76 41.82 Favored Pre-proline 0 N--CA 1.475 0.823 0 CA-C-N 113.4 -1.4 . . . . 0.0 109.287 -178.528 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_endo -89.42 155.04 5.42 Favored 'Trans proline' 0 C--N 1.332 -0.327 0 N-CA-C 108.861 -1.246 . . . . 0.0 108.861 161.307 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -50.18 -26.04 4.19 Favored 'General case' 0 CA--C 1.54 0.58 0 N-CA-C 115.208 1.558 . . . . 0.0 115.208 173.516 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -47.32 -59.38 3.23 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 125.237 1.415 . . . . 0.0 112.678 172.626 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.89 HG12 HG22 ' A' ' 31' ' ' ILE . 33.5 m -81.9 -27.6 9.61 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.988 0 N-CA-C 114.181 1.178 . . . . 0.0 114.181 -175.278 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -67.94 -33.84 75.44 Favored 'General case' 0 N--CA 1.478 0.932 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.651 172.863 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -61.24 -42.54 99.81 Favored Glycine 0 CA--C 1.537 1.451 0 C-N-CA 124.073 0.844 . . . . 0.0 112.833 173.263 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.476 HG22 HG13 ' A' ' 28' ' ' ILE . 0.8 OUTLIER -58.85 -41.63 87.41 Favored 'General case' 0 N--CA 1.478 0.966 0 N-CA-C 114.166 1.173 . . . . 0.0 114.166 173.792 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.539 HG13 HD13 ' A' ' 55' ' ' LEU . 22.2 t -53.87 -43.18 56.16 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.265 0 C-N-CA 123.514 0.725 . . . . 0.0 112.915 170.67 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 25.0 mt -60.74 -40.87 94.05 Favored 'General case' 0 N--CA 1.476 0.857 0 N-CA-C 113.278 0.844 . . . . 0.0 113.278 178.102 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 7.8 t30 -52.43 -45.5 66.0 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 124.405 1.082 . . . . 0.0 111.977 174.698 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -60.44 -51.65 70.57 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.682 0 CA-C-N 114.283 -1.326 . . . . 0.0 112.339 175.52 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.673 HG13 ' HA ' ' A' ' 56' ' ' LYS . 17.9 t -58.85 -45.0 91.82 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.388 0 O-C-N 124.265 0.978 . . . . 0.0 111.002 -178.876 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 21.0 mt-10 -66.88 -39.52 87.53 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 125.97 1.708 . . . . 0.0 115.418 -177.705 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -101.93 -24.19 14.04 Favored 'General case' 0 N--CA 1.474 0.753 0 N-CA-C 115.82 1.785 . . . . 0.0 115.82 -172.01 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' GLY . . . . . 0.618 ' HA2' ' HE2' ' A' ' 56' ' ' LYS . . . 77.7 44.21 13.1 Favored Glycine 0 N--CA 1.484 1.897 0 N-CA-C 110.742 -0.943 . . . . 0.0 110.742 -166.75 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -85.67 169.29 42.7 Favored Glycine 0 N--CA 1.474 1.208 0 C-N-CA 124.294 0.95 . . . . 0.0 112.995 -175.451 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 66.6 m95 -67.43 99.8 0.78 Allowed 'General case' 0 C--O 1.243 0.751 0 CA-C-O 123.257 1.503 . . . . 0.0 111.728 176.75 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.753 HG21 ' HA ' ' A' ' 52' ' ' LYS . 16.0 t -56.32 -24.46 18.38 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.939 0 CA-C-N 113.521 -1.672 . . . . 0.0 112.481 174.091 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 11.7 p -58.55 -45.68 88.42 Favored 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 123.735 0.814 . . . . 0.0 112.71 176.528 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -61.65 -45.22 94.96 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 124.095 0.958 . . . . 0.0 111.211 176.023 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.476 HG13 HG22 ' A' ' 14' ' ' THR . 1.7 mp -56.96 -48.43 81.62 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.915 0 CA-C-N 114.701 -1.136 . . . . 0.0 112.951 175.225 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.427 HG13 HD11 ' A' ' 43' ' ' LEU . 54.4 t -52.38 -41.83 36.34 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.059 0 C-N-CA 123.85 0.86 . . . . 0.0 111.937 176.948 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 73.2 m -55.96 -47.2 78.05 Favored 'General case' 0 N--CA 1.486 1.327 0 N-CA-C 113.625 0.972 . . . . 0.0 113.625 174.349 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.89 HG22 HG12 ' A' ' 11' ' ' VAL . 36.5 mm -69.47 -38.17 76.44 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.964 0 CA-C-N 115.149 -0.932 . . . . 0.0 109.349 -175.906 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.53 HD22 ' HB ' ' A' ' 11' ' ' VAL . 4.3 mm? -61.81 -52.66 63.29 Favored 'General case' 0 N--CA 1.48 1.026 0 CA-C-N 113.813 -1.54 . . . . 0.0 113.496 175.508 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 8.3 p -68.01 -31.72 71.6 Favored 'General case' 0 N--CA 1.476 0.834 0 N-CA-C 114.76 1.393 . . . . 0.0 114.76 177.36 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -52.46 -29.62 25.65 Favored 'General case' 0 N--CA 1.479 0.981 0 N-CA-C 113.714 1.005 . . . . 0.0 113.714 172.117 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 85.6 t . . . . . 0 N--CA 1.492 1.652 0 C-N-CA 124.179 0.992 . . . . 0.0 112.453 171.789 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 39' ' ' GLY . . . . . 0.433 ' O ' ' HG ' ' A' ' 43' ' ' LEU . . . . . . . . 0 N--CA 1.478 1.49 0 N-CA-C 110.875 -0.89 . . . . 0.0 110.875 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 18.9 mt -59.07 -48.94 79.77 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 124.594 1.157 . . . . 0.0 114.097 177.999 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' SER . . . . . 0.676 ' HB2' ' HD1' ' A' ' 5' ' ' PHE . 0.0 OUTLIER -58.63 -41.46 86.03 Favored 'General case' 0 N--CA 1.479 1.014 0 N-CA-C 113.824 1.046 . . . . 0.0 113.824 174.927 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 15.3 tp -60.25 -44.44 95.26 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 122.477 0.311 . . . . 0.0 110.87 174.07 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.433 ' HG ' ' O ' ' A' ' 39' ' ' GLY . 79.6 mt -62.01 -36.25 80.97 Favored 'General case' 0 N--CA 1.477 0.891 0 N-CA-C 115.017 1.488 . . . . 0.0 115.017 178.103 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -63.12 -50.02 72.12 Favored 'General case' 0 N--CA 1.472 0.635 0 O-C-N 123.962 0.789 . . . . 0.0 112.076 172.2 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -62.67 -33.57 75.34 Favored 'General case' 0 N--CA 1.486 1.347 0 N-CA-C 112.571 0.582 . . . . 0.0 112.571 177.558 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -65.29 -19.72 66.09 Favored 'General case' 0 N--CA 1.474 0.732 0 N-CA-C 115.702 1.741 . . . . 0.0 115.702 178.289 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -52.61 -38.29 51.95 Favored Glycine 0 N--CA 1.477 1.412 0 O-C-N 124.665 1.228 . . . . 0.0 112.696 178.006 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 65.1 ttp85 -54.12 -47.03 72.29 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 125.541 1.536 . . . . 0.0 113.805 -174.744 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 15.8 tt0 -132.25 36.11 3.64 Favored 'General case' 0 N--CA 1.477 0.899 0 N-CA-C 114.903 1.446 . . . . 0.0 114.903 -174.722 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 78.2 p 49.37 116.99 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.823 0 C-N-CA 124.06 0.944 . . . . 0.0 113.073 -174.798 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.544 HG13 HG11 ' A' ' 25' ' ' VAL 0.256 8.2 tp -31.5 -49.54 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 N-CA-C 117.974 2.583 . . . . 0.0 117.974 -173.58 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 0.753 ' HA ' HG21 ' A' ' 25' ' ' VAL . 0.3 OUTLIER -64.98 -66.57 0.53 Allowed 'General case' 0 N--CA 1.489 1.518 0 CA-C-N 118.214 0.461 . . . . 0.0 111.885 178.132 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -50.74 -40.02 53.53 Favored 'General case' 0 C--O 1.236 0.349 0 O-C-N 124.868 1.355 . . . . 0.0 112.522 178.804 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 91.6 t80 -48.84 -62.82 1.32 Allowed 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 126.108 1.763 . . . . 0.0 111.23 174.212 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.539 HD13 HG13 ' A' ' 15' ' ' VAL . 92.4 mt -64.98 -39.62 93.74 Favored 'General case' 0 N--CA 1.478 0.956 0 N-CA-C 115.354 1.613 . . . . 0.0 115.354 -178.792 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 56' ' ' LYS . . . . . 0.673 ' HA ' HG13 ' A' ' 19' ' ' VAL . 29.1 mttt -58.78 -48.07 82.55 Favored 'General case' 0 C--N 1.319 -0.717 0 N-CA-C 115.444 1.646 . . . . 0.0 115.444 176.7 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 71.4 tttt -74.48 -50.71 17.18 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-N 115.039 -0.982 . . . . 0.0 112.039 173.547 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' GLU . . . . . 0.484 ' O ' ' HB2' ' A' ' 62' ' ' LYS . 31.3 tt0 -63.28 -47.37 82.63 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-O 118.433 -0.794 . . . . 0.0 111.549 -168.542 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.693 HG23 HG21 ' A' ' 67' ' ' VAL . 3.2 mm -77.66 -19.62 13.96 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.928 0 N-CA-C 112.117 0.414 . . . . 0.0 112.117 -176.334 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 2.7 ttmp? -68.62 -41.61 79.24 Favored 'General case' 0 CA--C 1.547 0.835 0 CA-C-N 115.511 -0.768 . . . . 0.0 112.643 170.069 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 25.4 ttpp -72.6 -41.91 65.1 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 125.651 1.58 . . . . 0.0 112.91 175.223 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' LYS . . . . . 0.484 ' HB2' ' O ' ' A' ' 58' ' ' GLU . 0.0 OUTLIER -70.68 -53.45 15.69 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 126.674 1.99 . . . . 0.0 113.855 -177.034 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 99.37 106.24 2.69 Favored Glycine 0 N--CA 1.477 1.405 0 N-CA-C 110.399 -1.08 . . . . 0.0 110.399 -174.246 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.786 ' HD2' ' H ' ' A' ' 64' ' ' LYS . 10.8 mptt -30.87 -50.21 0.14 Allowed 'General case' 0 N--CA 1.485 1.319 0 N-CA-C 118.769 2.878 . . . . 0.0 118.769 -175.738 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 65' ' ' ARG . . . . . 0.467 ' O ' ' HB ' ' A' ' 68' ' ' ILE . 0.0 OUTLIER -59.22 -42.1 90.2 Favored 'General case' 0 N--CA 1.474 0.73 0 N-CA-C 114.517 1.303 . . . . 0.0 114.517 178.759 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -69.56 -26.62 64.57 Favored 'General case' 0 N--CA 1.478 0.927 0 CA-C-N 114.55 -1.205 . . . . 0.0 113.65 174.729 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.693 HG21 HG23 ' A' ' 59' ' ' ILE . 72.6 t -69.63 -34.38 61.09 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.048 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.448 175.711 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.467 ' HB ' ' O ' ' A' ' 65' ' ' ARG . 19.8 mm -52.58 -41.57 37.52 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.941 0 O-C-N 124.223 0.952 . . . . 0.0 110.934 170.045 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -70.21 -53.84 15.37 Favored 'General case' 0 N--CA 1.48 1.042 0 N-CA-C 113.247 0.832 . . . . 0.0 113.247 174.535 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 46.7 t90 . . . . . 0 CA--C 1.545 0.76 0 C-N-CA 126.321 1.848 . . . . 0.0 114.325 -176.497 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.752 ' HE1' HG21 ' A' ' 15' ' ' VAL . 70.0 mtp . . . . . 0 N--CA 1.475 0.803 0 N-CA-C 112.98 0.733 . . . . 0.0 112.98 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 2' ' ' ALA . . . . . 0.418 ' HA ' ' O ' ' A' ' 7' ' ' ILE . . . -61.52 -56.28 21.78 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-N 114.546 -1.206 . . . . 0.0 112.112 172.685 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 95.1 mttt -64.06 -62.86 1.36 Allowed 'General case' 0 CA--C 1.541 0.621 0 CA-C-N 114.015 -1.448 . . . . 0.0 114.453 -177.555 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 3.9 mp0 -75.21 -40.54 59.1 Favored 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 115.016 1.488 . . . . 0.0 115.016 -170.065 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 5' ' ' PHE . . . . . 0.486 ' HD2' ' HA ' ' A' ' 1' ' ' MET . 41.3 m-85 -101.85 -11.68 18.85 Favored 'General case' 0 N--CA 1.476 0.851 0 N-CA-C 116.557 2.058 . . . . 0.0 116.557 -174.005 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 67.39 37.37 90.33 Favored Glycine 0 CA--C 1.538 1.528 0 CA-C-O 121.855 0.697 . . . . 0.0 111.359 -173.731 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.663 HG23 HG23 ' A' ' 11' ' ' VAL . 0.7 OUTLIER -110.06 115.31 55.06 Favored Pre-proline 0 N--CA 1.474 0.73 0 C-N-CA 124.547 1.139 . . . . 0.0 109.086 179.016 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 96.3 Cg_endo -65.2 154.92 71.22 Favored 'Trans proline' 0 CA--C 1.536 0.602 0 C-N-CA 120.614 0.876 . . . . 0.0 111.019 -177.165 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -46.49 -30.11 2.05 Favored 'General case' 0 N--CA 1.472 0.662 0 N-CA-C 115.833 1.79 . . . . 0.0 115.833 174.478 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -40.4 -60.76 1.03 Allowed 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 126.337 1.855 . . . . 0.0 112.875 171.116 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.98 HG12 HG22 ' A' ' 31' ' ' ILE . 34.6 m -86.86 -31.11 5.99 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.915 0 CA-C-N 114.58 -1.191 . . . . 0.0 113.679 -174.793 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -59.63 -33.81 71.98 Favored 'General case' 0 CA--C 1.547 0.843 0 N-CA-C 113.24 0.829 . . . . 0.0 113.24 171.611 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -63.68 -44.18 96.77 Favored Glycine 0 N--CA 1.481 1.69 0 C-N-CA 124.044 0.831 . . . . 0.0 112.229 174.641 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.915 HG22 HG13 ' A' ' 28' ' ' ILE . 1.7 m -61.33 -36.87 81.34 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 125.368 1.467 . . . . 0.0 113.674 174.175 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.752 HG21 ' HE1' ' A' ' 1' ' ' MET . 6.1 t -58.16 -45.36 88.7 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.359 0 N-CA-C 113.044 0.757 . . . . 0.0 113.044 170.187 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.404 HD13 ' HB3' ' A' ' 64' ' ' LYS . 39.0 mt -57.07 -38.56 73.47 Favored 'General case' 0 N--CA 1.482 1.173 0 CA-C-N 115.352 -0.84 . . . . 0.0 112.868 177.102 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 5.3 t-20 -53.01 -46.17 68.25 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-N 113.355 -1.748 . . . . 0.0 113.384 176.268 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 1.7 t -55.52 -49.47 73.25 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.124 0 C-N-CA 124.696 1.198 . . . . 0.0 113.042 172.26 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.792 HG13 ' HA ' ' A' ' 56' ' ' LYS . 11.6 t -63.45 -45.44 97.9 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.227 0 C-N-CA 123.635 0.774 . . . . 0.0 111.483 -174.961 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 20' ' ' GLU . . . . . 0.432 ' HG3' ' HE2' ' A' ' 64' ' ' LYS . 19.0 mt-10 -65.14 -40.98 95.17 Favored 'General case' 0 CA--C 1.541 0.6 0 N-CA-C 115.843 1.794 . . . . 0.0 115.843 -179.6 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -101.12 -20.9 15.13 Favored 'General case' 0 N--CA 1.479 1.007 0 N-CA-C 116.287 1.958 . . . . 0.0 116.287 -174.716 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 71.57 39.63 60.5 Favored Glycine 0 N--CA 1.481 1.634 0 N-CA-C 110.894 -0.882 . . . . 0.0 110.894 -164.954 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -82.17 164.52 44.2 Favored Glycine 0 N--CA 1.478 1.444 0 C-N-CA 124.388 0.994 . . . . 0.0 113.006 -174.123 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' TRP . . . . . 0.499 ' HB3' HG22 ' A' ' 26' ' ' THR . 2.3 m-90 -62.33 103.9 0.44 Allowed 'General case' 0 N--CA 1.475 0.787 0 CA-C-O 123.166 1.46 . . . . 0.0 112.107 179.603 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 3.0 p -55.57 -24.56 16.36 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.718 0 CA-C-N 112.89 -1.959 . . . . 0.0 112.851 172.87 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.499 HG22 ' HB3' ' A' ' 24' ' ' TRP . 9.8 t -62.49 -45.92 90.82 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-O 118.002 -0.999 . . . . 0.0 113.441 177.951 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -60.09 -42.06 93.85 Favored 'General case' 0 N--CA 1.484 1.26 0 O-C-N 124.416 1.072 . . . . 0.0 110.454 175.642 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.915 HG13 HG22 ' A' ' 14' ' ' THR . 1.9 mp -65.62 -47.53 85.92 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.649 0 C-N-CA 124.634 1.174 . . . . 0.0 112.583 -179.534 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 72.7 t -50.37 -42.7 21.29 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 O-C-N 123.755 0.66 . . . . 0.0 111.232 174.426 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 5.5 m -55.55 -40.95 72.57 Favored 'General case' 0 N--CA 1.481 1.106 0 N-CA-C 113.919 1.081 . . . . 0.0 113.919 175.948 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.98 HG22 HG12 ' A' ' 11' ' ' VAL . 34.9 mm -71.45 -38.86 70.07 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.957 0 C-N-CA 124.14 0.976 . . . . 0.0 109.932 179.802 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.495 HD22 ' HB ' ' A' ' 11' ' ' VAL . 3.4 mm? -61.15 -40.42 93.77 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 124.716 1.207 . . . . 0.0 112.184 171.491 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 10.0 m -67.63 -36.88 81.61 Favored 'General case' 0 N--CA 1.476 0.84 0 N-CA-C 114.05 1.13 . . . . 0.0 114.05 175.813 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -53.64 -31.55 47.89 Favored 'General case' 0 N--CA 1.488 1.437 0 C-N-CA 124.325 1.05 . . . . 0.0 113.797 175.2 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 42.9 t . . . . . 0 N--CA 1.478 0.94 0 C-N-CA 125.802 1.641 . . . . 0.0 113.402 174.167 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 39' ' ' GLY . . . . . 0.433 ' HA3' ' HB3' ' A' ' 32' ' ' LEU . . . . . . . . 0 N--CA 1.484 1.837 0 N-CA-C 111.805 -0.518 . . . . 0.0 111.805 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 5.3 mt -56.97 -37.38 71.53 Favored 'General case' 0 N--CA 1.481 1.1 0 N-CA-C 115.954 1.835 . . . . 0.0 115.954 -167.869 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 12.3 p -59.15 -48.33 82.02 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 124.139 0.976 . . . . 0.0 112.661 176.335 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 15.0 tp -62.75 -49.39 75.21 Favored 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 122.983 0.513 . . . . 0.0 110.572 173.062 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 77.8 mt -60.47 -31.22 70.25 Favored 'General case' 0 N--CA 1.475 0.81 0 N-CA-C 113.972 1.101 . . . . 0.0 113.972 -177.462 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -69.36 -46.14 67.7 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 123.463 0.705 . . . . 0.0 111.826 173.94 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -60.74 -30.85 70.24 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 123.833 0.853 . . . . 0.0 112.563 177.317 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.426 ' HB1' ' HA ' ' A' ' 51' ' ' ILE . . . -67.38 -27.82 67.42 Favored 'General case' 0 N--CA 1.471 0.608 0 N-CA-C 115.931 1.826 . . . . 0.0 115.931 178.276 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -45.76 -45.54 13.23 Favored Glycine 0 CA--C 1.544 1.851 0 C-N-CA 126.105 1.812 . . . . 0.0 114.295 -170.811 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 24.6 tpt180 -45.79 -48.43 15.56 Favored 'General case' 0 CA--C 1.544 0.736 0 CA-C-N 111.948 -2.126 . . . . 0.0 114.328 -179.221 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 18.9 tt0 -123.74 25.89 7.91 Favored 'General case' 0 N--CA 1.481 1.107 0 N-CA-C 114.499 1.296 . . . . 0.0 114.499 -176.997 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 33.2 t 50.21 133.18 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.486 0 C-N-CA 125.626 1.57 . . . . 0.0 111.83 -167.971 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.426 ' HA ' ' HB1' ' A' ' 46' ' ' ALA . 7.4 tp -43.13 -45.4 1.36 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.027 0 N-CA-C 115.536 1.68 . . . . 0.0 115.536 -175.599 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 5.6 tmtm? -53.84 -71.2 0.08 Allowed 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 125.061 1.344 . . . . 0.0 111.941 177.733 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -65.47 -29.18 69.81 Favored 'General case' 0 N--CA 1.471 0.576 0 N-CA-C 115.135 1.531 . . . . 0.0 115.135 179.385 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' TYR . . . . . 0.459 ' O ' ' HB2' ' A' ' 58' ' ' GLU . 86.9 t80 -51.1 -64.64 0.75 Allowed 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 125.417 1.487 . . . . 0.0 111.579 176.565 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.461 HD13 HG13 ' A' ' 15' ' ' VAL . 75.4 mt -60.77 -37.86 83.3 Favored 'General case' 0 N--CA 1.478 0.95 0 N-CA-C 114.617 1.34 . . . . 0.0 114.617 -176.18 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 56' ' ' LYS . . . . . 0.792 ' HA ' HG13 ' A' ' 19' ' ' VAL . 94.0 mttt -61.3 -45.23 95.31 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 113.201 -1.818 . . . . 0.0 114.055 -179.335 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 81.4 tttt -77.25 -47.06 21.12 Favored 'General case' 0 CA--C 1.543 0.71 0 CA-C-N 115.275 -0.875 . . . . 0.0 112.703 171.463 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' GLU . . . . . 0.461 ' O ' ' HB2' ' A' ' 62' ' ' LYS . 4.1 mm-40 -57.22 -51.05 70.91 Favored 'General case' 0 C--O 1.219 -0.522 0 N-CA-C 113.743 1.016 . . . . 0.0 113.743 -175.105 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.697 HG23 HG21 ' A' ' 67' ' ' VAL . 2.6 mm -80.01 -21.1 11.91 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.484 0 N-CA-C 112.206 0.447 . . . . 0.0 112.206 -177.603 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 60' ' ' LYS . . . . . 0.522 ' HB2' ' O ' ' A' ' 56' ' ' LYS . 6.9 tppt? -60.65 -42.79 97.71 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-O 123.783 1.754 . . . . 0.0 112.296 171.599 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . 0.277 19.5 tttm -81.32 -45.03 16.8 Favored 'General case' 0 CA--C 1.55 0.951 0 CA-C-N 111.132 -2.758 . . . . 0.0 111.74 -179.797 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 62' ' ' LYS . . . . . 0.461 ' HB2' ' O ' ' A' ' 58' ' ' GLU . 15.5 tptt -58.51 -50.66 72.95 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 126.036 1.734 . . . . 0.0 113.605 -179.135 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 86.66 108.31 0.82 Allowed Glycine 0 N--CA 1.478 1.47 0 CA-C-N 113.582 -1.644 . . . . 0.0 109.911 -169.079 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.71 ' HD2' ' H ' ' A' ' 64' ' ' LYS . 10.0 mptt -28.48 -48.38 0.06 Allowed 'General case' 0 N--CA 1.481 1.083 0 N-CA-C 119.776 3.25 . . . . 0.0 119.776 -176.625 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 65' ' ' ARG . . . . . 0.406 ' O ' ' HB ' ' A' ' 68' ' ' ILE . 1.2 ttp85 -54.5 -44.03 72.35 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 125.625 1.57 . . . . 0.0 113.321 178.804 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -69.25 -23.25 63.84 Favored 'General case' 0 N--CA 1.474 0.761 0 N-CA-C 114.702 1.371 . . . . 0.0 114.702 176.116 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.697 HG21 HG23 ' A' ' 59' ' ' ILE . 63.9 t -75.67 -35.88 32.48 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.31 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.893 178.752 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.406 ' HB ' ' O ' ' A' ' 65' ' ' ARG . 17.3 mm -50.39 -42.56 21.2 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 C-N-CA 124.124 0.969 . . . . 0.0 111.107 169.304 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -74.9 -52.8 10.35 Favored 'General case' 0 N--CA 1.484 1.238 0 N-CA-C 113.718 1.007 . . . . 0.0 113.718 174.789 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 33.3 t90 . . . . . 0 N--CA 1.488 1.47 0 C-N-CA 125.704 1.602 . . . . 0.0 114.118 -178.301 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.548 ' HB3' HG22 ' A' ' 7' ' ' ILE . 68.1 mtp . . . . . 0 N--CA 1.478 0.969 0 N-CA-C 112.137 0.421 . . . . 0.0 112.137 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 2' ' ' ALA . . . . . 0.54 ' HA ' ' O ' ' A' ' 7' ' ' ILE . . . -58.26 -52.78 64.14 Favored 'General case' 0 N--CA 1.475 0.825 0 CA-C-N 114.819 -1.082 . . . . 0.0 112.129 173.902 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.99 -65.11 0.84 Allowed 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 112.518 -2.128 . . . . 0.0 115.997 -174.962 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 4' ' ' GLU . . . . . 0.421 ' HB2' ' O ' ' A' ' 70' ' ' TRP . 1.8 mp0 -73.79 -26.34 60.58 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-N 112.877 -1.965 . . . . 0.0 113.496 -170.718 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 5' ' ' PHE . . . . . 0.413 ' HD1' ' HB2' ' A' ' 41' ' ' SER . 31.6 m-85 -118.02 -6.92 10.92 Favored 'General case' 0 N--CA 1.478 0.937 0 N-CA-C 118.025 2.602 . . . . 0.0 118.025 -174.167 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 63.13 37.22 94.56 Favored Glycine 0 CA--C 1.543 1.806 0 O-C-N 124.007 0.817 . . . . 0.0 112.551 -175.866 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.548 HG22 ' HB3' ' A' ' 1' ' ' MET . 0.5 OUTLIER -114.0 121.51 36.63 Favored Pre-proline 0 N--CA 1.475 0.778 0 CA-C-N 114.448 -0.876 . . . . 0.0 108.708 -179.833 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 96.6 Cg_endo -67.28 160.87 45.59 Favored 'Trans proline' 0 CA--C 1.532 0.411 0 C-N-CA 120.971 1.114 . . . . 0.0 111.334 -177.558 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -53.62 -27.62 28.05 Favored 'General case' 0 CA--C 1.545 0.772 0 N-CA-C 114.713 1.375 . . . . 0.0 114.713 173.048 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -45.43 -43.9 11.7 Favored 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 126.191 1.796 . . . . 0.0 114.357 174.216 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.531 HG23 HG23 ' A' ' 7' ' ' ILE . 34.5 m -102.65 -33.59 3.36 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.893 0 N-CA-C 114.306 1.225 . . . . 0.0 114.306 -176.947 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 0.412 ' O ' ' HG ' ' A' ' 16' ' ' LEU . . . -61.45 -34.17 74.97 Favored 'General case' 0 N--CA 1.475 0.776 0 CA-C-N 114.8 -1.091 . . . . 0.0 112.181 173.686 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -59.71 -49.97 72.82 Favored Glycine 0 N--CA 1.478 1.434 0 C-N-CA 124.799 1.19 . . . . 0.0 112.775 173.57 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 9.1 m -62.13 -36.39 81.65 Favored 'General case' 0 N--CA 1.479 1.001 0 N-CA-C 114.612 1.338 . . . . 0.0 114.612 175.596 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.438 ' O ' HG23 ' A' ' 19' ' ' VAL . 72.0 t -56.94 -40.11 69.96 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.133 0 C-N-CA 123.213 0.605 . . . . 0.0 111.481 173.109 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.622 HD13 ' HB3' ' A' ' 64' ' ' LYS . 27.6 mt -61.36 -43.57 98.65 Favored 'General case' 0 N--CA 1.479 1.023 0 N-CA-C 113.418 0.896 . . . . 0.0 113.418 178.636 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 56.6 t-20 -54.77 -49.77 70.08 Favored 'General case' 0 CA--C 1.548 0.901 0 O-C-N 124.614 1.197 . . . . 0.0 111.055 173.443 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 96.8 t -54.9 -52.35 44.0 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.954 0 CA-C-N 114.6 -1.182 . . . . 0.0 111.204 175.823 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.643 HG11 ' HB ' ' A' ' 59' ' ' ILE . 81.7 t -53.88 -56.14 10.61 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.307 0 O-C-N 124.05 0.844 . . . . 0.0 111.124 179.788 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 14.5 tt0 -57.13 -37.69 72.38 Favored 'General case' 0 N--CA 1.476 0.829 0 O-C-N 124.972 1.42 . . . . 0.0 113.191 -176.825 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -88.12 -16.64 32.91 Favored 'General case' 0 N--CA 1.473 0.699 0 N-CA-C 116.294 1.961 . . . . 0.0 116.294 179.15 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 70.58 33.65 67.36 Favored Glycine 0 N--CA 1.487 2.099 0 C-N-CA 124.5 1.048 . . . . 0.0 112.143 -170.012 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -77.32 -177.12 45.69 Favored Glycine 0 CA--C 1.539 1.583 0 CA-C-O 124.155 1.975 . . . . 0.0 115.542 -170.954 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' TRP . . . . . 0.419 ' HB3' ' OG1' ' A' ' 26' ' ' THR . 74.0 m95 -63.7 122.65 16.9 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 110.717 -2.741 . . . . 0.0 116.73 -176.296 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 11.9 p -42.76 -37.75 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.379 0 CA-C-N 112.492 -2.14 . . . . 0.0 113.802 164.561 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.419 ' OG1' ' HB3' ' A' ' 24' ' ' TRP . 8.4 p -60.1 -44.26 94.97 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 123.782 0.833 . . . . 0.0 111.483 176.927 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -60.72 -29.54 69.42 Favored 'General case' 0 N--CA 1.485 1.317 0 N-CA-C 112.835 0.68 . . . . 0.0 112.835 176.321 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.488 ' O ' HD23 ' A' ' 32' ' ' LEU . 30.4 mt -72.75 -68.28 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.028 0 N-CA-C 109.36 -0.607 . . . . 0.0 109.36 167.239 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 85.7 t -54.39 -48.49 68.57 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.054 0 CA-C-O 118.159 -0.924 . . . . 0.0 112.896 -170.45 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 67.2 m -64.83 -26.15 68.21 Favored 'General case' 0 N--CA 1.477 0.897 0 N-CA-C 115.172 1.545 . . . . 0.0 115.172 179.349 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.49 HG22 HG12 ' A' ' 11' ' ' VAL . 35.7 mm -85.23 -42.41 16.3 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.921 0 C-N-CA 123.047 0.539 . . . . 0.0 110.166 174.659 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.527 HD22 ' HB ' ' A' ' 11' ' ' VAL . 3.5 mm? -62.18 -30.12 70.84 Favored 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 125.107 1.363 . . . . 0.0 114.328 176.015 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 2.8 p -68.54 -30.84 69.72 Favored 'General case' 0 N--CA 1.488 1.448 0 N-CA-C 116.424 2.009 . . . . 0.0 116.424 170.472 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -58.63 -25.46 62.71 Favored 'General case' 0 N--CA 1.475 0.82 0 O-C-N 124.654 1.221 . . . . 0.0 112.868 177.16 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.43 HG23 HG11 ' A' ' 11' ' ' VAL . 98.4 t . . . . . 0 N--CA 1.481 1.077 0 C-N-CA 126.592 1.957 . . . . 0.0 112.597 175.408 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' GLY . . . . . 0.511 ' HA3' ' HB3' ' A' ' 32' ' ' LEU . . . . . . . . 0 CA--C 1.541 1.686 0 CA-C-O 119.109 -0.828 . . . . 0.0 113.48 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 20.8 mt -55.79 -43.16 76.54 Favored 'General case' 0 N--CA 1.477 0.908 0 N-CA-C 115.15 1.537 . . . . 0.0 115.15 -173.442 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' SER . . . . . 0.413 ' HB2' ' HD1' ' A' ' 5' ' ' PHE . 8.8 p -60.0 -46.39 89.61 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 123.861 0.864 . . . . 0.0 113.063 173.937 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 12.0 tp -60.91 -51.3 69.88 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 124.002 0.921 . . . . 0.0 110.366 172.096 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.406 ' HG ' ' O ' ' A' ' 39' ' ' GLY . 52.1 mt -57.8 -33.06 68.17 Favored 'General case' 0 N--CA 1.476 0.84 0 N-CA-C 114.345 1.239 . . . . 0.0 114.345 -179.692 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -65.39 -48.43 72.9 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-N 115.765 -0.652 . . . . 0.0 112.529 172.697 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -64.7 -36.63 84.9 Favored 'General case' 0 N--CA 1.482 1.155 0 CA-C-O 121.892 0.853 . . . . 0.0 111.829 177.595 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.466 ' HB1' ' HA ' ' A' ' 51' ' ' ILE . . . -65.16 -15.74 62.75 Favored 'General case' 0 N--CA 1.476 0.843 0 N-CA-C 116.107 1.891 . . . . 0.0 116.107 179.071 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -51.77 -42.81 53.51 Favored Glycine 0 CA--C 1.544 1.87 0 C-N-CA 124.725 1.155 . . . . 0.0 112.988 177.914 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 44.9 ttp180 -49.58 -49.89 44.68 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 125.123 1.369 . . . . 0.0 113.817 -174.158 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.404 ' HB3' ' HD1' ' A' ' 54' ' ' TYR . 29.1 tt0 -129.64 36.06 4.13 Favored 'General case' 0 CA--C 1.547 0.849 0 N-CA-C 113.605 0.965 . . . . 0.0 113.605 -174.518 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 96.0 p 50.31 123.68 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.372 0 C-N-CA 126.527 1.931 . . . . 0.0 113.877 -175.524 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.466 ' HA ' ' HB1' ' A' ' 46' ' ' ALA 0.274 3.9 tp -35.23 -63.99 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.545 0.779 0 N-CA-C 117.547 2.425 . . . . 0.0 117.547 -170.134 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 16.0 ttpp -52.52 -58.49 6.6 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 123.387 0.675 . . . . 0.0 112.791 177.359 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -64.05 -38.37 90.83 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 124.518 1.127 . . . . 0.0 113.485 -178.147 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' TYR . . . . . 0.404 ' HD1' ' HB3' ' A' ' 49' ' ' GLU . 72.8 t80 -51.9 -65.6 0.53 Allowed 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 126.056 1.742 . . . . 0.0 109.625 175.441 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 48.1 mt -64.36 -37.27 86.93 Favored 'General case' 0 N--CA 1.474 0.765 0 N-CA-C 114.33 1.233 . . . . 0.0 114.33 -177.8 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' LYS . . . . . 0.612 ' HA ' HG13 ' A' ' 19' ' ' VAL . 9.0 tmtm? -57.58 -48.86 78.21 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 114.594 -1.185 . . . . 0.0 112.598 178.602 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 41.2 tttm -77.88 -49.83 13.44 Favored 'General case' 0 N--CA 1.476 0.854 0 CA-C-N 115.18 -0.918 . . . . 0.0 112.601 175.171 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' GLU . . . . . 0.442 ' O ' ' HB2' ' A' ' 62' ' ' LYS . 39.5 tt0 -58.25 -49.2 77.93 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-O 118.523 -0.751 . . . . 0.0 110.53 -173.164 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.741 HG23 HG21 ' A' ' 67' ' ' VAL . 2.8 mm -75.89 -25.53 17.22 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.893 0 CA-C-O 119.18 -0.438 . . . . 0.0 111.902 -176.503 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 60' ' ' LYS . . . . . 0.567 ' HB2' ' O ' ' A' ' 56' ' ' LYS . 0.9 OUTLIER -61.38 -34.03 74.65 Favored 'General case' 0 CA--C 1.546 0.796 0 O-C-N 124.56 1.162 . . . . 0.0 113.812 171.867 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -86.26 -43.34 13.02 Favored 'General case' 0 N--CA 1.481 1.098 0 CA-C-N 113.094 -1.866 . . . . 0.0 112.228 179.02 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' LYS . . . . . 0.442 ' HB2' ' O ' ' A' ' 58' ' ' GLU . 22.8 tttm -67.06 -51.06 59.17 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 127.507 2.323 . . . . 0.0 112.34 -173.742 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 102.42 108.38 3.2 Favored Glycine 0 N--CA 1.476 1.325 0 N-CA-C 109.621 -1.392 . . . . 0.0 109.621 -173.048 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.622 ' HB3' HD13 ' A' ' 16' ' ' LEU . 10.9 mptt -40.04 -43.57 1.6 Allowed 'General case' 0 N--CA 1.487 1.375 0 N-CA-C 117.558 2.429 . . . . 0.0 117.558 -175.171 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 65' ' ' ARG . . . . . 0.446 ' O ' ' HB ' ' A' ' 68' ' ' ILE . 11.2 mmp_? -57.4 -43.39 83.66 Favored 'General case' 0 N--CA 1.478 0.931 0 N-CA-C 116.003 1.853 . . . . 0.0 116.003 178.749 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -67.65 -27.7 67.09 Favored 'General case' 0 N--CA 1.482 1.157 0 CA-C-N 114.15 -1.386 . . . . 0.0 113.209 173.104 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.741 HG21 HG23 ' A' ' 59' ' ' ILE . 78.8 t -70.92 -33.18 51.06 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.048 0 C-N-CA 123.337 0.655 . . . . 0.0 111.972 177.794 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.446 ' HB ' ' O ' ' A' ' 65' ' ' ARG . 14.1 mm -51.07 -44.38 28.23 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.022 0 C-N-CA 123.805 0.842 . . . . 0.0 110.894 166.831 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -71.96 -48.61 43.93 Favored 'General case' 0 N--CA 1.478 0.957 0 O-C-N 124.263 0.977 . . . . 0.0 112.697 176.727 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' TRP . . . . . 0.421 ' O ' ' HB2' ' A' ' 4' ' ' GLU . 40.6 t90 . . . . . 0 N--CA 1.48 1.041 0 C-N-CA 126.045 1.738 . . . . 0.0 113.519 -178.469 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.605 ' HE3' HD13 ' A' ' 7' ' ' ILE . 67.2 mtp . . . . . 0 N--CA 1.479 1.013 0 N-CA-C 112.615 0.598 . . . . 0.0 112.615 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 2' ' ' ALA . . . . . 0.531 ' HA ' ' O ' ' A' ' 7' ' ' ILE . . . -53.67 -52.53 59.68 Favored 'General case' 0 CA--C 1.542 0.653 0 O-C-N 124.658 1.224 . . . . 0.0 112.691 172.407 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 39.7 ttmt -73.76 -55.32 6.37 Favored 'General case' 0 N--CA 1.472 0.675 0 CA-C-N 112.617 -2.083 . . . . 0.0 114.765 -175.637 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -74.86 -35.83 62.33 Favored 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 114.804 1.409 . . . . 0.0 114.804 -170.154 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 5' ' ' PHE . . . . . 0.533 ' HB2' HD12 ' A' ' 7' ' ' ILE . 61.1 m-85 -113.89 -23.23 9.73 Favored 'General case' 0 N--CA 1.48 1.045 0 N-CA-C 116.92 2.192 . . . . 0.0 116.92 -170.999 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 87.23 59.12 1.79 Allowed Glycine 0 N--CA 1.488 2.121 0 O-C-N 125.151 1.532 . . . . 0.0 111.878 -176.472 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.605 HD13 ' HE3' ' A' ' 1' ' ' MET . 1.0 OUTLIER -119.07 139.74 27.81 Favored Pre-proline 0 N--CA 1.48 1.031 0 C-N-CA 125.061 1.344 . . . . 0.0 110.412 178.85 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_endo -83.2 151.86 13.93 Favored 'Trans proline' 0 N--CA 1.455 -0.757 0 N-CA-C 108.714 -1.302 . . . . 0.0 108.714 162.978 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -42.76 -38.28 2.05 Favored 'General case' 0 N--CA 1.471 0.597 0 N-CA-C 116.403 2.001 . . . . 0.0 116.403 -179.629 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -30.62 -59.26 0.2 Allowed 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 127.081 2.153 . . . . 0.0 113.99 168.594 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.894 HG12 HG22 ' A' ' 31' ' ' ILE . 17.2 m -87.98 -31.01 5.61 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.668 0 N-CA-C 114.627 1.344 . . . . 0.0 114.627 -170.903 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -67.3 -29.27 68.81 Favored 'General case' 0 CA--C 1.549 0.927 0 CA-C-N 116.302 -0.408 . . . . 0.0 112.092 169.757 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' GLY . . . . . 0.523 ' HA2' HD12 ' A' ' 16' ' ' LEU . . . -67.56 -41.81 89.42 Favored Glycine 0 CA--C 1.545 1.908 0 C-N-CA 125.368 1.461 . . . . 0.0 112.936 171.209 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.529 HG22 HG13 ' A' ' 28' ' ' ILE . 8.6 m -65.84 -35.87 81.87 Favored 'General case' 0 N--CA 1.475 0.778 0 N-CA-C 113.046 0.758 . . . . 0.0 113.046 173.503 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.673 HG23 HD21 ' A' ' 32' ' ' LEU . 2.3 t -49.24 -38.48 11.75 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.066 0 C-N-CA 124.47 1.108 . . . . 0.0 113.599 166.126 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.643 HD22 ' HG3' ' A' ' 64' ' ' LYS . 84.6 mt -61.0 -38.12 84.91 Favored 'General case' 0 N--CA 1.475 0.822 0 N-CA-C 113.602 0.964 . . . . 0.0 113.602 178.648 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 35.2 t-20 -52.23 -42.72 63.83 Favored 'General case' 0 CA--C 1.547 0.838 0 O-C-N 124.0 0.813 . . . . 0.0 111.421 172.983 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.409 HG23 HD13 ' A' ' 28' ' ' ILE . 1.0 OUTLIER -60.43 -56.3 18.61 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.816 0 CA-C-N 115.046 -0.979 . . . . 0.0 113.045 173.14 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.779 HG13 ' HA ' ' A' ' 56' ' ' LYS . 5.5 t -58.96 -49.69 82.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 124.026 0.829 . . . . 0.0 112.698 -177.53 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 20' ' ' GLU . . . . . 0.443 ' OE1' ' HB3' ' A' ' 16' ' ' LEU . 24.5 mt-10 -72.35 -42.4 65.38 Favored 'General case' 0 N--CA 1.473 0.696 0 N-CA-C 116.57 2.063 . . . . 0.0 116.57 -175.236 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -103.92 -25.87 12.88 Favored 'General case' 0 N--CA 1.481 1.125 0 N-CA-C 115.231 1.567 . . . . 0.0 115.231 -173.022 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 77.4 41.23 21.36 Favored Glycine 0 CA--C 1.541 1.699 0 N-CA-C 110.467 -1.053 . . . . 0.0 110.467 -165.71 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -76.44 173.86 54.01 Favored Glycine 0 CA--C 1.535 1.316 0 C-N-CA 124.914 1.245 . . . . 0.0 112.689 -173.439 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 3.6 m-90 -69.16 101.79 1.53 Allowed 'General case' 0 N--CA 1.473 0.72 0 CA-C-O 123.341 1.544 . . . . 0.0 110.93 -178.92 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 9.8 p -48.51 -29.44 2.53 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.821 0 CA-C-N 112.658 -2.064 . . . . 0.0 114.86 172.736 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 11.1 t -60.04 -46.62 88.93 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 123.73 0.812 . . . . 0.0 112.929 179.745 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' THR . . . . . 0.536 ' O ' HG12 ' A' ' 31' ' ' ILE . 2.0 m -60.09 -48.13 82.98 Favored 'General case' 0 N--CA 1.481 1.08 0 CA-C-N 114.144 -1.389 . . . . 0.0 109.992 175.913 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.529 HG13 HG22 ' A' ' 14' ' ' THR . 1.8 mp -58.32 -53.03 51.81 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.023 0 C-N-CA 123.912 0.885 . . . . 0.0 110.771 179.301 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 65.5 t -53.98 -47.81 64.62 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.744 0 CA-C-O 118.118 -0.944 . . . . 0.0 111.474 177.551 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 20.9 m -61.04 -36.91 80.83 Favored 'General case' 0 N--CA 1.481 1.119 0 N-CA-C 114.446 1.276 . . . . 0.0 114.446 178.672 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.894 HG22 HG12 ' A' ' 11' ' ' VAL . 42.2 mm -72.98 -42.44 59.77 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.93 0 C-N-CA 124.246 1.018 . . . . 0.0 109.463 178.88 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.673 HD21 HG23 ' A' ' 15' ' ' VAL . 4.2 mm? -57.83 -53.06 62.48 Favored 'General case' 0 N--CA 1.484 1.259 0 C-N-CA 125.097 1.359 . . . . 0.0 112.897 173.796 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -65.57 -28.11 68.91 Favored 'General case' 0 N--CA 1.481 1.104 0 N-CA-C 115.406 1.632 . . . . 0.0 115.406 178.329 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -52.37 -32.0 36.48 Favored 'General case' 0 N--CA 1.486 1.358 0 N-CA-C 113.907 1.077 . . . . 0.0 113.907 171.949 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 50.7 t . . . . . 0 N--CA 1.49 1.561 0 C-N-CA 126.169 1.788 . . . . 0.0 112.41 173.816 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 39' ' ' GLY . . . . . 0.5 ' HA2' ' HB3' ' A' ' 32' ' ' LEU . . . . . . . . 0 N--CA 1.482 1.765 0 N-CA-C 111.435 -0.666 . . . . 0.0 111.435 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 72.0 mt -57.54 -45.6 84.88 Favored 'General case' 0 N--CA 1.476 0.861 0 N-CA-C 115.937 1.828 . . . . 0.0 115.937 -176.297 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 79.5 p -62.54 -42.36 99.47 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-N 115.384 -0.825 . . . . 0.0 112.938 176.148 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 11.9 tp -63.59 -43.42 96.98 Favored 'General case' 0 N--CA 1.474 0.762 0 N-CA-C 110.026 -0.361 . . . . 0.0 110.026 175.731 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 94.7 mt -62.95 -35.97 81.91 Favored 'General case' 0 N--CA 1.475 0.784 0 N-CA-C 114.414 1.265 . . . . 0.0 114.414 -179.808 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -69.68 -40.69 76.24 Favored 'General case' 0 N--CA 1.473 0.691 0 O-C-N 123.83 0.706 . . . . 0.0 112.782 174.176 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -68.57 -36.17 78.39 Favored 'General case' 0 N--CA 1.475 0.817 0 CA-C-O 121.286 0.565 . . . . 0.0 112.128 177.508 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -53.95 -21.76 8.71 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 126.58 1.952 . . . . 0.0 115.587 173.197 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -50.01 -32.89 20.42 Favored Glycine 0 N--CA 1.478 1.49 0 C-N-CA 125.144 1.354 . . . . 0.0 114.007 178.936 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 68.0 ttp85 -55.36 -55.32 32.9 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 124.918 1.287 . . . . 0.0 113.33 178.573 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 8.2 tt0 -133.29 34.79 3.5 Favored 'General case' 0 CA--C 1.548 0.869 0 N-CA-C 114.803 1.408 . . . . 0.0 114.803 -173.931 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 32.8 t 44.31 127.09 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.041 0 N-CA-C 114.147 1.165 . . . . 0.0 114.147 -172.646 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . 0.266 8.8 tp -30.47 -57.28 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 N-CA-C 119.036 2.976 . . . . 0.0 119.036 -169.812 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 81.9 tttt -60.99 -56.0 26.25 Favored 'General case' 0 N--CA 1.478 0.927 0 N-CA-C 112.065 0.394 . . . . 0.0 112.065 -179.477 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -61.16 -38.44 86.44 Favored 'General case' 0 N--CA 1.486 1.363 0 C-N-CA 123.94 0.896 . . . . 0.0 113.203 177.603 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 89.9 t80 -52.41 -60.24 3.47 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 125.618 1.567 . . . . 0.0 112.253 175.479 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 64.5 mt -65.9 -38.88 89.89 Favored 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 114.053 1.131 . . . . 0.0 114.053 -179.929 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' LYS . . . . . 0.779 ' HA ' HG13 ' A' ' 19' ' ' VAL . 30.9 mttm -53.81 -54.04 43.92 Favored 'General case' 0 N--CA 1.48 1.039 0 CA-C-N 114.029 -1.441 . . . . 0.0 113.377 178.482 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 55.2 tttp -68.93 -47.23 66.23 Favored 'General case' 0 CA--C 1.541 0.621 0 CA-C-N 115.294 -0.866 . . . . 0.0 112.537 176.981 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' GLU . . . . . 0.467 ' O ' ' HB2' ' A' ' 62' ' ' LYS . 66.8 mt-10 -56.61 -51.66 67.8 Favored 'General case' 0 N--CA 1.477 0.898 0 N-CA-C 112.26 0.467 . . . . 0.0 112.26 -175.351 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.468 ' HA ' ' HB2' ' A' ' 62' ' ' LYS . 6.3 mm -81.02 -20.61 11.21 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.258 0 N-CA-C 112.99 0.737 . . . . 0.0 112.99 -176.218 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 60' ' ' LYS . . . . . 0.413 ' HB2' ' O ' ' A' ' 56' ' ' LYS . 10.2 tppt? -62.44 -34.02 75.95 Favored 'General case' 0 CA--C 1.542 0.657 0 CA-C-O 121.985 0.898 . . . . 0.0 112.865 170.234 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 93.0 mttt -84.95 -44.67 12.91 Favored 'General case' 0 CA--C 1.546 0.806 0 CA-C-N 112.814 -1.994 . . . . 0.0 113.556 175.507 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' LYS . . . . . 0.468 ' HB2' ' HA ' ' A' ' 59' ' ' ILE . 0.2 OUTLIER -65.06 -45.04 86.98 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-N 113.529 -1.669 . . . . 0.0 115.329 -172.929 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 85.91 111.72 0.79 Allowed Glycine 0 N--CA 1.47 0.949 0 N-CA-C 108.356 -1.898 . . . . 0.0 108.356 -172.964 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.866 ' HD2' ' H ' ' A' ' 64' ' ' LYS . 9.9 mptt -23.41 -46.53 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.437 0 N-CA-C 119.516 3.154 . . . . 0.0 119.516 -174.829 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . 0.284 8.9 ttt180 -48.92 -44.22 40.14 Favored 'General case' 0 N--CA 1.471 0.618 0 N-CA-C 115.365 1.617 . . . . 0.0 115.365 173.052 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -58.74 -31.25 68.15 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 116.243 -1.837 . . . . 0.0 113.124 174.575 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.523 HG12 ' O ' ' A' ' 64' ' ' LYS . 0.5 OUTLIER -64.06 -41.84 93.76 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.259 0 CA-C-N 119.393 0.997 . . . . 0.0 111.573 178.766 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 35.8 mm -57.82 -39.06 69.16 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.887 0 CA-C-N 113.251 -1.795 . . . . 0.0 110.471 177.141 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -80.24 -49.18 11.96 Favored 'General case' 0 N--CA 1.475 0.805 0 N-CA-C 114.288 1.218 . . . . 0.0 114.288 175.05 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 24.3 t90 . . . . . 0 N--CA 1.484 1.265 0 C-N-CA 127.055 2.142 . . . . 0.0 112.708 -179.363 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.761 ' HE1' HG21 ' A' ' 15' ' ' VAL . 52.3 mtp . . . . . 0 N--CA 1.479 0.979 0 N-CA-C 113.417 0.895 . . . . 0.0 113.417 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -61.31 -49.27 77.68 Favored 'General case' 0 N--CA 1.474 0.757 0 CA-C-N 115.018 -0.992 . . . . 0.0 112.287 173.974 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 57.4 tttm -75.82 -60.46 2.31 Favored 'General case' 0 N--CA 1.478 0.948 0 CA-C-N 114.046 -1.434 . . . . 0.0 114.085 -176.428 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 4' ' ' GLU . . . . . 0.402 ' HB2' ' O ' ' A' ' 70' ' ' TRP . 2.1 mp0 -75.96 -29.07 58.16 Favored 'General case' 0 N--CA 1.474 0.744 0 N-CA-C 115.656 1.724 . . . . 0.0 115.656 -169.751 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 5' ' ' PHE . . . . . 0.409 ' HD1' ' HB2' ' A' ' 41' ' ' SER . 43.4 m-85 -115.11 -18.21 11.23 Favored 'General case' 0 N--CA 1.48 1.051 0 N-CA-C 117.496 2.406 . . . . 0.0 117.496 -173.243 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 72.82 40.67 51.94 Favored Glycine 0 CA--C 1.542 1.756 0 O-C-N 124.543 1.152 . . . . 0.0 112.11 -171.126 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.789 HG23 HG23 ' A' ' 11' ' ' VAL . 0.6 OUTLIER -121.91 106.23 36.89 Favored Pre-proline 0 N--CA 1.474 0.73 0 C-N-CA 124.566 1.146 . . . . 0.0 110.288 179.425 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_endo -63.93 168.23 12.5 Favored 'Trans proline' 0 CA--C 1.54 0.791 0 C-N-CA 122.567 2.178 . . . . 0.0 112.582 -172.825 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -51.34 -33.32 28.91 Favored 'General case' 0 N--CA 1.477 0.914 0 CA-C-N 113.617 -1.629 . . . . 0.0 114.212 172.493 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -49.87 -34.45 20.13 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 125.9 1.68 . . . . 0.0 114.567 176.099 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 1.084 HG12 HG22 ' A' ' 31' ' ' ILE . 30.4 m -112.0 -29.4 2.37 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.407 0 N-CA-C 114.145 1.165 . . . . 0.0 114.145 179.819 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -66.77 -37.35 84.41 Favored 'General case' 0 N--CA 1.475 0.794 0 N-CA-C 113.393 0.886 . . . . 0.0 113.393 174.791 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -61.09 -37.9 94.68 Favored Glycine 0 CA--C 1.544 1.871 0 C-N-CA 123.92 0.771 . . . . 0.0 112.287 170.62 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -70.32 -32.91 70.87 Favored 'General case' 0 N--CA 1.487 1.407 0 C-N-CA 125.051 1.34 . . . . 0.0 113.363 179.44 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.761 HG21 ' HE1' ' A' ' 1' ' ' MET . 10.4 t -61.2 -36.11 70.47 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.255 0 C-N-CA 123.895 0.878 . . . . 0.0 111.982 169.469 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.57 HD13 ' HB3' ' A' ' 64' ' ' LYS . 48.3 mt -66.09 -37.73 86.5 Favored 'General case' 0 N--CA 1.471 0.61 0 N-CA-C 113.242 0.83 . . . . 0.0 113.242 177.423 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 11.0 t30 -55.12 -44.59 75.13 Favored 'General case' 0 N--CA 1.478 0.934 0 CA-C-N 115.341 -0.845 . . . . 0.0 111.339 172.798 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.526 ' HB ' ' O ' ' A' ' 15' ' ' VAL . 12.8 t -50.64 -52.56 15.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 C-N-CA 124.642 1.177 . . . . 0.0 112.182 171.67 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.758 HG13 ' HA ' ' A' ' 56' ' ' LYS . 11.4 t -61.91 -52.66 57.88 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.191 0 C-N-CA 124.568 1.147 . . . . 0.0 111.479 -178.452 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 10.1 mt-10 -54.82 -44.04 73.51 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 125.692 1.597 . . . . 0.0 115.057 -178.401 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -93.17 -17.1 24.13 Favored 'General case' 0 CA--C 1.546 0.822 0 N-CA-C 115.701 1.741 . . . . 0.0 115.701 -175.376 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 68.39 40.96 86.69 Favored Glycine 0 CA--C 1.544 1.889 0 N-CA-C 110.438 -1.065 . . . . 0.0 110.438 -165.489 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -100.46 164.11 18.95 Favored Glycine 0 CA--C 1.537 1.428 0 C-N-CA 124.827 1.203 . . . . 0.0 114.145 -167.259 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 5.8 m-90 -67.69 104.53 1.66 Allowed 'General case' 0 C--O 1.24 0.583 0 CA-C-O 122.577 1.179 . . . . 0.0 113.831 -175.341 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.46 HG11 HG13 ' A' ' 51' ' ' ILE . 5.5 p -55.59 -25.13 17.43 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.825 0 CA-C-N 113.369 -1.741 . . . . 0.0 113.847 169.191 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 1.7 t -60.51 -40.33 91.04 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 114.305 1.224 . . . . 0.0 114.305 179.727 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 1.9 m -68.54 -39.1 81.26 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 122.928 0.491 . . . . 0.0 110.653 175.811 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 2.8 mp -72.23 -31.07 37.9 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.077 0 C-N-CA 124.854 1.262 . . . . 0.0 112.576 177.9 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.447 HG23 ' O ' ' A' ' 25' ' ' VAL . 55.6 t -55.54 -36.42 41.74 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.826 0 C-N-CA 123.104 0.562 . . . . 0.0 112.201 171.737 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 29.8 p -60.98 -26.15 67.37 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 114.813 1.412 . . . . 0.0 114.813 173.788 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 1.084 HG22 HG12 ' A' ' 11' ' ' VAL . 34.7 mm -85.01 -37.84 12.69 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.914 0 C-N-CA 123.901 0.88 . . . . 0.0 109.85 176.493 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.59 HD22 ' HB ' ' A' ' 11' ' ' VAL . 4.3 mm? -60.54 -34.49 74.21 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 124.835 1.254 . . . . 0.0 112.255 172.636 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 9.1 p -75.2 -36.24 61.43 Favored 'General case' 0 N--CA 1.474 0.775 0 N-CA-C 115.413 1.634 . . . . 0.0 115.413 174.057 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -52.88 -25.24 11.04 Favored 'General case' 0 N--CA 1.482 1.155 0 O-C-N 124.64 1.212 . . . . 0.0 114.183 172.236 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 93.0 t . . . . . 0 N--CA 1.482 1.133 0 C-N-CA 126.32 1.848 . . . . 0.0 113.238 171.225 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 39' ' ' GLY . . . . . 0.508 ' HA3' ' HB3' ' A' ' 32' ' ' LEU . . . . . . . . 0 N--CA 1.487 2.069 0 CA-C-O 119.6 -0.555 . . . . 0.0 113.461 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 9.7 mt -54.6 -46.83 73.88 Favored 'General case' 0 N--CA 1.481 1.106 0 N-CA-C 116.563 2.06 . . . . 0.0 116.563 -168.501 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' SER . . . . . 0.409 ' HB2' ' HD1' ' A' ' 5' ' ' PHE . 11.6 p -60.11 -44.83 94.56 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 114.823 -1.08 . . . . 0.0 113.397 177.636 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 10.8 tp -63.09 -50.31 71.04 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 123.887 0.875 . . . . 0.0 110.287 171.923 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 82.9 mt -60.77 -28.64 68.88 Favored 'General case' 0 N--CA 1.477 0.887 0 N-CA-C 114.875 1.435 . . . . 0.0 114.875 -177.23 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -67.3 -47.64 69.99 Favored 'General case' 0 N--CA 1.474 0.736 0 O-C-N 123.805 0.691 . . . . 0.0 112.798 170.785 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -62.46 -33.61 75.18 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 123.375 0.67 . . . . 0.0 112.44 179.247 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -57.18 -23.75 49.75 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 126.885 2.074 . . . . 0.0 115.546 174.655 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -52.11 -35.03 40.64 Favored Glycine 0 CA--C 1.538 1.486 0 C-N-CA 125.068 1.318 . . . . 0.0 113.91 -177.904 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 40.0 ttp180 -51.57 -53.51 37.33 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 125.0 1.32 . . . . 0.0 112.958 -176.233 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 20.6 tt0 -128.76 36.8 4.18 Favored 'General case' 0 N--CA 1.478 0.963 0 CA-C-N 115.166 -0.924 . . . . 0.0 113.153 -176.247 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 8.0 t 43.36 128.4 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 125.68 1.592 . . . . 0.0 114.474 -172.07 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.46 HG13 HG11 ' A' ' 25' ' ' VAL . 8.0 tp -32.25 -52.47 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.258 0 N-CA-C 118.156 2.65 . . . . 0.0 118.156 -171.161 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 2.3 ttmt -60.37 -67.46 0.39 Allowed 'General case' 0 N--CA 1.472 0.631 0 N-CA-C 114.461 1.282 . . . . 0.0 114.461 178.441 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -56.62 -34.64 67.46 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 124.276 1.03 . . . . 0.0 113.667 177.817 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 66.7 t80 -50.86 -62.27 1.71 Allowed 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 124.875 1.27 . . . . 0.0 110.589 174.541 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.62 HD13 HG13 ' A' ' 15' ' ' VAL . 60.7 mt -65.26 -37.91 88.66 Favored 'General case' 0 N--CA 1.475 0.783 0 N-CA-C 115.001 1.482 . . . . 0.0 115.001 -176.123 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 56' ' ' LYS . . . . . 0.758 ' HA ' HG13 ' A' ' 19' ' ' VAL . 93.9 mttt -61.94 -37.15 83.62 Favored 'General case' 0 N--CA 1.473 0.7 0 CA-C-N 113.445 -1.707 . . . . 0.0 114.732 178.523 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 57' ' ' LYS . . . . . 0.469 ' HE3' ' HE3' ' A' ' 61' ' ' LYS . 80.2 tttt -85.64 -52.55 5.73 Favored 'General case' 0 CA--C 1.535 0.395 0 O-C-N 124.514 1.134 . . . . 0.0 111.241 173.03 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 58' ' ' GLU . . . . . 0.415 ' O ' ' HB2' ' A' ' 62' ' ' LYS . 29.0 tt0 -55.19 -51.08 67.67 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-O 118.687 -0.673 . . . . 0.0 111.771 -173.014 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.71 HG23 HG21 ' A' ' 67' ' ' VAL . 3.7 mm -75.96 -27.1 17.99 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.281 0 N-CA-C 112.769 0.655 . . . . 0.0 112.769 -173.64 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 60' ' ' LYS . . . . . 0.457 ' HB2' ' O ' ' A' ' 56' ' ' LYS . 14.9 tttp -60.28 -36.32 77.56 Favored 'General case' 0 CA--C 1.544 0.749 0 CA-C-O 122.643 1.211 . . . . 0.0 113.496 174.02 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 61' ' ' LYS . . . . . 0.469 ' HE3' ' HE3' ' A' ' 57' ' ' LYS . 9.7 mttm -85.01 -33.17 22.6 Favored 'General case' 0 N--CA 1.474 0.757 0 CA-C-N 112.023 -2.353 . . . . 0.0 112.236 -179.412 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 62' ' ' LYS . . . . . 0.415 ' HB2' ' O ' ' A' ' 58' ' ' GLU . 66.8 tttt -85.33 -60.13 2.12 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-N 112.744 -2.026 . . . . 0.0 111.561 -168.484 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 63' ' ' GLY . . . . . 0.46 ' O ' HG23 ' A' ' 67' ' ' VAL . . . 113.11 126.03 4.45 Favored Glycine 0 CA--C 1.532 1.122 0 N-CA-C 110.08 -1.208 . . . . 0.0 110.08 -172.297 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.57 ' HB3' HD13 ' A' ' 16' ' ' LEU . 0.0 OUTLIER -59.4 -42.04 90.81 Favored 'General case' 0 N--CA 1.482 1.135 0 N-CA-C 115.59 1.7 . . . . 0.0 115.59 -173.128 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -58.13 -47.3 83.73 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 125.251 1.42 . . . . 0.0 113.648 179.353 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -62.94 -32.05 73.28 Favored 'General case' 0 N--CA 1.475 0.777 0 CA-C-N 114.534 -1.212 . . . . 0.0 113.769 173.002 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.71 HG21 HG23 ' A' ' 59' ' ' ILE . 48.5 t -68.8 -35.97 72.07 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.989 0 C-N-CA 122.872 0.469 . . . . 0.0 111.179 179.497 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 18.0 mt -53.42 -48.5 57.08 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.01 0 C-N-CA 124.267 1.027 . . . . 0.0 109.722 169.385 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -67.08 -47.49 71.1 Favored 'General case' 0 N--CA 1.477 0.907 0 CA-C-N 115.581 -0.736 . . . . 0.0 112.901 178.808 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 70' ' ' TRP . . . . . 0.402 ' O ' ' HB2' ' A' ' 4' ' ' GLU . 43.0 t90 . . . . . 0 N--CA 1.477 0.891 0 C-N-CA 125.78 1.632 . . . . 0.0 112.22 -179.512 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.497 ' HB3' HG21 ' A' ' 7' ' ' ILE . 76.6 mtp . . . . . 0 C--O 1.238 0.487 0 N-CA-C 113.039 0.755 . . . . 0.0 113.039 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 2' ' ' ALA . . . . . 0.436 ' HA ' ' O ' ' A' ' 7' ' ' ILE . . . -55.78 -54.13 48.14 Favored 'General case' 0 N--CA 1.475 0.814 0 CA-C-N 114.988 -1.005 . . . . 0.0 111.649 172.882 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 51.1 tttp -72.86 -61.02 1.96 Allowed 'General case' 0 N--CA 1.481 1.08 0 CA-C-N 113.952 -1.476 . . . . 0.0 113.982 -174.246 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -71.0 -37.25 72.66 Favored 'General case' 0 N--CA 1.475 0.815 0 N-CA-C 115.48 1.659 . . . . 0.0 115.48 -171.388 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 5' ' ' PHE . . . . . 0.422 ' HD2' ' HA ' ' A' ' 1' ' ' MET . 52.1 m-85 -107.95 -15.92 14.42 Favored 'General case' 0 N--CA 1.477 0.885 0 N-CA-C 116.532 2.049 . . . . 0.0 116.532 -172.063 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 79.65 54.25 4.02 Favored Glycine 0 CA--C 1.541 1.701 0 CA-C-O 122.311 0.95 . . . . 0.0 112.508 -176.023 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.497 HG21 ' HB3' ' A' ' 1' ' ' MET . 0.5 OUTLIER -112.73 147.99 38.34 Favored Pre-proline 0 N--CA 1.482 1.128 0 CA-C-N 113.526 -1.337 . . . . 0.0 111.645 -178.839 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 91.0 Cg_endo -86.06 153.39 9.69 Favored 'Trans proline' 0 CA--C 1.538 0.723 0 C-N-CA 121.685 1.59 . . . . 0.0 109.365 163.309 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -49.7 -33.67 16.55 Favored 'General case' 0 N--CA 1.47 0.574 0 N-CA-C 114.966 1.469 . . . . 0.0 114.966 176.346 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -39.08 -43.73 1.06 Allowed 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 127.792 2.437 . . . . 0.0 115.174 171.626 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.981 HG12 HG22 ' A' ' 31' ' ' ILE . 20.0 m -102.31 -29.09 3.04 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.914 0 N-CA-C 114.269 1.211 . . . . 0.0 114.269 -173.626 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -67.48 -30.65 70.41 Favored 'General case' 0 N--CA 1.489 1.483 0 CA-C-N 115.727 -0.67 . . . . 0.0 112.197 171.526 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' GLY . . . . . 0.446 ' O ' ' HB2' ' A' ' 16' ' ' LEU . . . -63.57 -43.05 98.6 Favored Glycine 0 CA--C 1.553 2.44 0 C-N-CA 124.278 0.942 . . . . 0.0 112.625 168.814 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.806 HG22 HG13 ' A' ' 28' ' ' ILE . 3.9 m -62.78 -37.49 86.87 Favored 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 113.371 0.878 . . . . 0.0 113.371 176.792 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.463 HG21 ' HE1' ' A' ' 1' ' ' MET . 2.4 t -50.52 -37.73 15.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 C-N-CA 124.155 0.982 . . . . 0.0 113.337 168.254 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.716 HD22 ' HG3' ' A' ' 64' ' ' LYS . 84.8 mt -61.98 -37.28 84.22 Favored 'General case' 0 N--CA 1.479 0.996 0 N-CA-C 113.989 1.107 . . . . 0.0 113.989 177.446 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 14.6 t-20 -53.99 -47.06 71.82 Favored 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 123.223 0.609 . . . . 0.0 110.864 173.417 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 3.1 t -52.01 -56.26 6.87 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.256 0 CA-C-N 114.996 -1.002 . . . . 0.0 112.67 170.556 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.754 HG13 ' HA ' ' A' ' 56' ' ' LYS . 3.8 t -60.11 -51.17 76.04 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 O-C-N 124.549 1.156 . . . . 0.0 111.523 -176.307 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -66.49 -44.37 82.83 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 126.166 1.786 . . . . 0.0 115.705 -175.636 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -101.59 -12.41 18.49 Favored 'General case' 0 CA--C 1.548 0.891 0 N-CA-C 115.413 1.635 . . . . 0.0 115.413 -170.492 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' GLY . . . . . 0.424 ' HA2' ' HE2' ' A' ' 56' ' ' LYS . . . 66.69 41.53 93.79 Favored Glycine 0 N--CA 1.482 1.762 0 N-CA-C 110.137 -1.185 . . . . 0.0 110.137 -161.734 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -74.53 158.92 51.98 Favored Glycine 0 N--CA 1.471 0.984 0 C-N-CA 125.151 1.358 . . . . 0.0 114.266 -169.3 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 88.7 m95 -61.68 102.99 0.29 Allowed 'General case' 0 N--CA 1.473 0.724 0 CA-C-N 113.277 -1.462 . . . . 0.0 111.785 175.538 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.564 HG21 HG13 ' A' ' 51' ' ' ILE . 2.7 p -54.49 -24.19 12.25 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.625 0 CA-C-N 114.279 -1.328 . . . . 0.0 114.58 175.331 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 3.6 t -60.29 -44.24 95.55 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 124.261 1.024 . . . . 0.0 113.632 -179.915 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' THR . . . . . 0.566 ' O ' HG12 ' A' ' 31' ' ' ILE . 0.8 OUTLIER -65.68 -46.34 79.43 Favored 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 123.799 0.84 . . . . 0.0 110.212 176.49 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.806 HG13 HG22 ' A' ' 14' ' ' THR . 2.0 mp -58.98 -51.49 71.87 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.979 0 C-N-CA 124.438 1.095 . . . . 0.0 111.622 177.375 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 50.6 t -53.11 -48.73 53.07 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.826 0 CA-C-O 117.037 -1.459 . . . . 0.0 111.556 176.59 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . 0.284 1.5 p -61.99 -29.85 70.54 Favored 'General case' 0 N--CA 1.479 1.016 0 N-CA-C 115.438 1.644 . . . . 0.0 115.438 179.712 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.981 HG22 HG12 ' A' ' 11' ' ' VAL . 21.2 mm -76.65 -43.26 34.51 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.006 0 C-N-CA 124.174 0.99 . . . . 0.0 110.115 176.38 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.63 HD22 ' HB ' ' A' ' 11' ' ' VAL . 4.2 mm? -55.52 -56.02 25.06 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 124.951 1.3 . . . . 0.0 112.427 172.796 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 3.1 p -64.0 -30.88 71.92 Favored 'General case' 0 N--CA 1.475 0.814 0 N-CA-C 114.825 1.417 . . . . 0.0 114.825 177.599 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -53.31 -25.41 14.74 Favored 'General case' 0 N--CA 1.482 1.134 0 N-CA-C 114.649 1.351 . . . . 0.0 114.649 172.355 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 61.7 t . . . . . 0 N--CA 1.486 1.356 0 C-N-CA 124.547 1.139 . . . . 0.0 111.574 172.669 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 39' ' ' GLY . . . . . 0.468 ' HA2' ' HB3' ' A' ' 32' ' ' LEU . . . . . . . . 0 N--CA 1.479 1.507 0 N-CA-C 111.76 -0.536 . . . . 0.0 111.76 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 78.4 mt -60.25 -41.65 93.65 Favored 'General case' 0 N--CA 1.482 1.142 0 N-CA-C 115.434 1.642 . . . . 0.0 115.434 -177.754 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 42.7 p -63.69 -43.28 97.1 Favored 'General case' 0 N--CA 1.476 0.863 0 N-CA-C 113.294 0.85 . . . . 0.0 113.294 174.922 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 12.4 tp -61.7 -46.8 88.13 Favored 'General case' 0 N--CA 1.474 0.741 0 CA-C-O 121.22 0.534 . . . . 0.0 110.435 174.002 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 94.8 mt -59.96 -39.15 84.64 Favored 'General case' 0 N--CA 1.482 1.153 0 CA-C-N 114.457 -1.247 . . . . 0.0 114.328 179.983 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -61.93 -44.94 95.73 Favored 'General case' 0 N--CA 1.477 0.911 0 N-CA-C 112.362 0.504 . . . . 0.0 112.362 173.289 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -65.96 -33.29 75.47 Favored 'General case' 0 N--CA 1.479 0.992 0 N-CA-C 113.564 0.95 . . . . 0.0 113.564 177.339 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -75.65 -21.56 57.57 Favored 'General case' 0 CA--C 1.543 0.698 0 N-CA-C 116.888 2.181 . . . . 0.0 116.888 179.766 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -50.99 -39.8 41.57 Favored Glycine 0 N--CA 1.474 1.185 0 O-C-N 124.308 1.005 . . . . 0.0 113.914 -173.031 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' ARG . . . . . 0.515 ' HA ' ' HD2' ' A' ' 48' ' ' ARG . 0.3 OUTLIER -59.51 -49.74 76.61 Favored 'General case' 0 CA--C 1.542 0.643 0 CA-C-N 111.239 -2.48 . . . . 0.0 115.876 -176.479 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 5.4 tt0 -114.5 28.86 8.43 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-N 115.29 -0.868 . . . . 0.0 112.982 -175.242 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 94.2 p 48.33 121.45 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 125.9 1.68 . . . . 0.0 113.373 -172.796 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.564 HG13 HG21 ' A' ' 25' ' ' VAL . 7.6 tp -41.47 -46.14 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.42 0 N-CA-C 117.298 2.332 . . . . 0.0 117.298 -173.64 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 34.6 tttm -60.36 -62.6 1.75 Allowed 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 124.582 1.153 . . . . 0.0 112.266 177.035 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -59.66 -38.7 82.17 Favored 'General case' 0 N--CA 1.48 1.044 0 N-CA-C 113.96 1.096 . . . . 0.0 113.96 177.598 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 84.3 t80 -49.84 -62.11 1.75 Allowed 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 125.432 1.493 . . . . 0.0 111.071 177.343 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.41 HD22 HG13 ' A' ' 15' ' ' VAL . 45.0 mt -61.87 -38.98 90.28 Favored 'General case' 0 N--CA 1.484 1.234 0 N-CA-C 114.477 1.288 . . . . 0.0 114.477 -176.829 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 56' ' ' LYS . . . . . 0.754 ' HA ' HG13 ' A' ' 19' ' ' VAL . 92.3 mttt -55.19 -54.64 40.73 Favored 'General case' 0 N--CA 1.472 0.638 0 O-C-N 124.83 1.331 . . . . 0.0 112.483 177.705 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 57' ' ' LYS . . . . . 0.572 ' HG2' ' HD2' ' A' ' 61' ' ' LYS . 78.0 tttt -71.76 -45.75 60.66 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-N 114.622 -1.172 . . . . 0.0 112.575 178.452 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 7.7 mm-40 -52.55 -55.36 22.73 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 122.824 0.45 . . . . 0.0 111.087 -177.617 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 5.9 mm -80.1 -23.51 11.68 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 CA-C-N 114.652 -1.158 . . . . 0.0 112.957 -172.635 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 60' ' ' LYS . . . . . 0.452 ' HB2' ' O ' ' A' ' 56' ' ' LYS . 16.7 tttp -59.08 -38.0 78.43 Favored 'General case' 0 CA--C 1.544 0.73 0 N-CA-C 114.195 1.183 . . . . 0.0 114.195 170.362 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 61' ' ' LYS . . . . . 0.572 ' HD2' ' HG2' ' A' ' 57' ' ' LYS . 23.4 mtpt -86.2 -43.59 12.87 Favored 'General case' 0 N--CA 1.479 0.994 0 CA-C-N 113.681 -1.599 . . . . 0.0 111.174 -179.518 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 17.3 tttt -72.14 -40.34 68.13 Favored 'General case' 0 N--CA 1.473 0.709 0 CA-C-N 112.664 -2.062 . . . . 0.0 115.048 -173.391 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 85.49 130.22 2.34 Favored Glycine 0 CA--C 1.538 1.5 0 N-CA-C 109.743 -1.343 . . . . 0.0 109.743 -171.817 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.733 ' HD2' ' H ' ' A' ' 64' ' ' LYS . 11.9 mptt -40.7 -45.16 2.33 Favored 'General case' 0 N--CA 1.486 1.348 0 N-CA-C 116.501 2.038 . . . . 0.0 116.501 -179.496 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -53.64 -43.89 69.14 Favored 'General case' 0 N--CA 1.468 0.441 0 N-CA-C 112.174 0.435 . . . . 0.0 112.174 179.391 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -64.55 -29.73 70.76 Favored 'General case' 0 N--CA 1.48 1.044 0 CA-C-N 113.632 -1.622 . . . . 0.0 114.566 174.787 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.661 HG12 ' O ' ' A' ' 64' ' ' LYS . 1.4 p -64.57 -43.07 96.76 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.342 0 CA-C-N 119.629 1.104 . . . . 0.0 111.759 175.137 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 45.1 mm -55.86 -42.64 71.51 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.276 0 CA-C-N 114.082 -1.417 . . . . 0.0 110.023 176.148 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -72.63 -51.43 19.6 Favored 'General case' 0 N--CA 1.48 1.056 0 N-CA-C 113.951 1.093 . . . . 0.0 113.951 175.573 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 25.9 t90 . . . . . 0 N--CA 1.478 0.952 0 C-N-CA 126.752 2.021 . . . . 0.0 112.176 -178.305 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.61 ' HE3' HD13 ' A' ' 7' ' ' ILE . 53.1 mtp . . . . . 0 N--CA 1.469 0.479 0 N-CA-C 112.592 0.59 . . . . 0.0 112.592 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 2' ' ' ALA . . . . . 0.503 ' HA ' ' O ' ' A' ' 7' ' ' ILE . . . -56.51 -57.05 14.01 Favored 'General case' 0 N--CA 1.473 0.695 0 CA-C-N 114.823 -1.081 . . . . 0.0 112.12 175.873 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 18.6 ttpp -67.37 -49.2 64.94 Favored 'General case' 0 CA--C 1.547 0.841 0 CA-C-N 112.985 -1.916 . . . . 0.0 113.385 -172.014 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 10.2 tt0 -81.17 -48.08 12.58 Favored 'General case' 0 N--CA 1.477 0.903 0 N-CA-C 114.203 1.186 . . . . 0.0 114.203 -170.088 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 5' ' ' PHE . . . . . 0.615 ' HB2' HD12 ' A' ' 7' ' ' ILE . 48.0 m-85 -95.86 -17.06 21.41 Favored 'General case' 0 N--CA 1.474 0.733 0 N-CA-C 117.402 2.371 . . . . 0.0 117.402 -170.717 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 83.97 54.9 2.92 Favored Glycine 0 CA--C 1.539 1.564 0 CA-C-O 122.575 1.097 . . . . 0.0 111.052 -174.671 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.615 HD12 ' HB2' ' A' ' 5' ' ' PHE . 1.0 OUTLIER -117.65 142.65 30.91 Favored Pre-proline 0 N--CA 1.475 0.811 0 CA-C-N 113.665 -1.268 . . . . 0.0 110.777 -178.092 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 90.9 Cg_endo -87.82 158.98 7.53 Favored 'Trans proline' 0 CA--C 1.541 0.845 0 C-N-CA 121.26 1.307 . . . . 0.0 109.164 164.844 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -49.09 -32.33 9.55 Favored 'General case' 0 N--CA 1.48 1.07 0 N-CA-C 114.297 1.221 . . . . 0.0 114.297 171.829 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -43.8 -37.1 2.58 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 127.047 2.139 . . . . 0.0 115.615 174.618 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.934 HG12 HG22 ' A' ' 31' ' ' ILE . 26.9 m -109.22 -31.6 2.37 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.074 0 N-CA-C 114.13 1.159 . . . . 0.0 114.13 -179.537 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -69.39 -32.1 70.91 Favored 'General case' 0 N--CA 1.483 1.198 0 N-CA-C 113.354 0.872 . . . . 0.0 113.354 178.301 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -65.81 -36.67 92.52 Favored Glycine 0 N--CA 1.484 1.855 0 CA-C-O 122.717 1.176 . . . . 0.0 112.232 173.953 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.53 HG22 HG13 ' A' ' 28' ' ' ILE . 0.2 OUTLIER -68.44 -36.19 78.68 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 126.557 1.943 . . . . 0.0 113.356 176.877 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.558 HG21 ' HE1' ' A' ' 1' ' ' MET . 17.4 t -56.11 -39.82 60.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 C-N-CA 124.093 0.957 . . . . 0.0 112.065 168.167 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 39.6 mt -65.59 -41.18 93.11 Favored 'General case' 0 N--CA 1.476 0.829 0 N-CA-C 113.398 0.888 . . . . 0.0 113.398 179.599 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 25.5 t-20 -50.34 -47.54 55.85 Favored 'General case' 0 N--CA 1.475 0.783 0 O-C-N 124.317 1.011 . . . . 0.0 111.593 171.469 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.412 ' HB ' ' O ' ' A' ' 15' ' ' VAL . 2.4 t -50.79 -48.69 27.87 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.993 0 C-N-CA 123.991 0.916 . . . . 0.0 112.106 177.183 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.812 HG13 ' HA ' ' A' ' 56' ' ' LYS . 9.7 t -64.84 -55.56 20.31 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.116 0 O-C-N 124.139 0.9 . . . . 0.0 109.806 -179.13 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 37.7 mt-10 -58.75 -49.71 76.62 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 125.897 1.679 . . . . 0.0 114.585 -177.586 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -77.66 -17.99 57.15 Favored 'General case' 0 N--CA 1.473 0.724 0 N-CA-C 114.904 1.446 . . . . 0.0 114.904 -176.282 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' GLY . . . . . 0.532 ' HA2' ' HE3' ' A' ' 56' ' ' LYS . . . 67.0 44.78 87.78 Favored Glycine 0 N--CA 1.486 1.969 0 N-CA-C 109.588 -1.405 . . . . 0.0 109.588 -162.309 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -96.79 157.65 21.24 Favored Glycine 0 N--CA 1.474 1.22 0 CA-C-N 113.661 -1.27 . . . . 0.0 114.777 -161.701 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 85.4 m95 -68.47 100.56 1.11 Allowed 'General case' 0 N--CA 1.473 0.691 0 CA-C-N 113.004 -1.598 . . . . 0.0 110.581 -178.562 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.526 HG21 HG13 ' A' ' 51' ' ' ILE . 0.6 OUTLIER -53.48 -26.15 12.3 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.799 0 CA-C-N 113.828 -1.533 . . . . 0.0 113.609 172.39 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 4.7 t -59.44 -43.92 93.03 Favored 'General case' 0 N--CA 1.481 1.076 0 CA-C-O 118.715 -0.659 . . . . 0.0 112.71 -176.364 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' THR . . . . . 0.452 ' HB ' HD12 ' A' ' 28' ' ' ILE . 2.7 m -57.82 -42.46 84.33 Favored 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 124.144 0.978 . . . . 0.0 111.855 174.218 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.53 HG13 HG22 ' A' ' 14' ' ' THR . 2.0 mp -73.73 -42.54 54.55 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.058 0 C-N-CA 125.98 1.712 . . . . 0.0 112.59 -178.124 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.582 HG13 HD11 ' A' ' 43' ' ' LEU . 40.1 t -49.64 -46.35 21.1 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.322 0 C-N-CA 124.815 1.246 . . . . 0.0 110.719 178.625 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -55.46 -35.86 65.95 Favored 'General case' 0 N--CA 1.486 1.364 0 C-N-CA 124.749 1.219 . . . . 0.0 113.906 176.366 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.934 HG22 HG12 ' A' ' 11' ' ' VAL . 22.3 mm -78.96 -39.36 21.65 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.071 0 C-N-CA 124.171 0.988 . . . . 0.0 109.083 -176.477 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.684 ' HB3' ' HA2' ' A' ' 39' ' ' GLY . 4.3 mm? -57.04 -49.38 75.98 Favored 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 124.553 1.141 . . . . 0.0 111.804 171.506 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 1.4 p -67.71 -27.38 66.77 Favored 'General case' 0 N--CA 1.474 0.734 0 N-CA-C 115.371 1.619 . . . . 0.0 115.371 178.018 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -55.71 -29.45 59.46 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 113.098 0.777 . . . . 0.0 113.098 169.95 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 23.0 t . . . . . 0 N--CA 1.483 1.187 0 C-N-CA 125.166 1.386 . . . . 0.0 111.065 174.486 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 39' ' ' GLY . . . . . 0.684 ' HA2' ' HB3' ' A' ' 32' ' ' LEU . . . . . . . . 0 N--CA 1.472 1.05 0 CA-C-O 121.287 0.382 . . . . 0.0 113.542 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 14.6 mt -62.53 -44.71 95.69 Favored 'General case' 0 N--CA 1.477 0.892 0 CA-C-N 113.149 -1.525 . . . . 0.0 113.96 -178.46 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 6.9 m -55.9 -47.12 77.99 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 123.745 0.818 . . . . 0.0 112.174 173.65 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 12.3 tp -63.23 -45.22 92.63 Favored 'General case' 0 N--CA 1.48 1.035 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.763 177.691 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.582 HD11 HG13 ' A' ' 29' ' ' VAL . 46.8 mt -64.15 -21.46 66.56 Favored 'General case' 0 N--CA 1.477 0.909 0 N-CA-C 115.732 1.753 . . . . 0.0 115.732 -178.987 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -78.35 -42.4 30.62 Favored 'General case' 0 CA--C 1.545 0.767 0 CA-C-N 115.493 -0.776 . . . . 0.0 112.954 171.33 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -61.77 -29.48 70.16 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 123.752 0.821 . . . . 0.0 112.245 172.874 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -59.03 -23.87 62.34 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 125.581 1.552 . . . . 0.0 115.011 177.709 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -52.76 -34.42 44.39 Favored Glycine 0 CA--C 1.543 1.83 0 C-N-CA 125.474 1.512 . . . . 0.0 113.763 -176.147 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 65.5 ttp85 -55.04 -52.64 62.55 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 124.662 1.185 . . . . 0.0 112.937 -178.974 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.409 ' HB3' ' HA ' ' A' ' 54' ' ' TYR . 12.5 tt0 -137.37 38.13 2.49 Favored 'General case' 0 N--CA 1.477 0.906 0 N-CA-C 115.404 1.631 . . . . 0.0 115.404 -175.621 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 21.0 t 42.15 121.26 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.293 0 C-N-CA 125.325 1.45 . . . . 0.0 114.846 -174.08 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.526 HG13 HG21 ' A' ' 25' ' ' VAL 0.278 9.8 tp -27.42 -57.75 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.481 1.096 0 N-CA-C 118.654 2.835 . . . . 0.0 118.654 -169.231 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 39.4 tttm -57.75 -61.11 2.76 Favored 'General case' 0 N--CA 1.486 1.344 0 C-N-CA 123.703 0.801 . . . . 0.0 111.771 178.56 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -63.47 -39.17 93.75 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 124.843 1.257 . . . . 0.0 112.836 178.236 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 54' ' ' TYR . . . . . 0.409 ' HA ' ' HB3' ' A' ' 49' ' ' GLU . 79.3 t80 -48.22 -59.35 3.48 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 125.203 1.401 . . . . 0.0 111.932 176.684 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 64.0 mt -65.74 -39.61 91.3 Favored 'General case' 0 N--CA 1.478 0.973 0 CA-C-N 114.597 -1.183 . . . . 0.0 114.123 -179.883 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 56' ' ' LYS . . . . . 0.812 ' HA ' HG13 ' A' ' 19' ' ' VAL . 43.7 mttp -57.9 -42.76 85.37 Favored 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 114.955 1.465 . . . . 0.0 114.955 179.869 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 55.7 tttp -78.9 -52.55 8.14 Favored 'General case' 0 N--CA 1.478 0.941 0 CA-C-N 115.256 -0.884 . . . . 0.0 111.54 170.984 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 58' ' ' GLU . . . . . 0.466 ' O ' ' HB2' ' A' ' 62' ' ' LYS . 28.0 tt0 -56.57 -49.94 73.39 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-O 118.558 -0.734 . . . . 0.0 111.975 -171.051 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.71 HG23 HG21 ' A' ' 67' ' ' VAL . 2.8 mm -75.86 -27.91 18.79 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 O-C-N 121.306 -0.872 . . . . 0.0 112.683 -175.959 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 60' ' ' LYS . . . . . 0.469 ' HB2' ' O ' ' A' ' 56' ' ' LYS . 11.9 mttt -62.51 -34.12 76.24 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 116.935 2.198 . . . . 0.0 116.935 171.008 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 62.3 pttt -92.96 -25.36 18.05 Favored 'General case' 0 CA--C 1.546 0.825 0 CA-C-N 113.879 -1.51 . . . . 0.0 112.515 176.358 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 62' ' ' LYS . . . . . 0.466 ' HB2' ' O ' ' A' ' 58' ' ' GLU . 29.1 tttm -80.27 -46.14 16.71 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 125.967 1.707 . . . . 0.0 113.594 -176.573 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 93.89 105.6 1.83 Allowed Glycine 0 N--CA 1.477 1.405 0 N-CA-C 110.589 -1.004 . . . . 0.0 110.589 -177.818 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.608 ' HD2' ' H ' ' A' ' 64' ' ' LYS . 5.6 mptt -32.01 -45.57 0.1 Allowed 'General case' 0 N--CA 1.489 1.479 0 C-N-CA 127.587 2.355 . . . . 0.0 116.266 -178.131 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . 0.3 0.0 OUTLIER -46.94 -56.11 6.94 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 127.568 2.347 . . . . 0.0 114.105 175.781 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -71.12 -23.24 62.05 Favored 'General case' 0 N--CA 1.478 0.957 0 CA-C-N 113.994 -1.457 . . . . 0.0 114.298 175.072 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.71 HG21 HG23 ' A' ' 59' ' ' ILE . 61.1 t -70.82 -39.11 75.08 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.174 0 C-N-CA 123.423 0.689 . . . . 0.0 110.838 177.91 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 19.0 mm -51.15 -44.24 28.94 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.87 0 C-N-CA 123.902 0.881 . . . . 0.0 111.089 169.682 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -68.91 -51.4 40.46 Favored 'General case' 0 N--CA 1.481 1.097 0 N-CA-C 113.559 0.948 . . . . 0.0 113.559 174.574 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 31.1 t90 . . . . . 0 N--CA 1.479 1.0 0 C-N-CA 125.419 1.487 . . . . 0.0 112.621 -179.302 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.403 ' HE3' HD13 ' A' ' 7' ' ' ILE . 62.9 mtp . . . . . 0 N--CA 1.477 0.879 0 N-CA-C 113.321 0.86 . . . . 0.0 113.321 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -60.19 -48.92 79.71 Favored 'General case' 0 N--CA 1.477 0.89 0 O-C-N 124.104 0.877 . . . . 0.0 112.959 177.269 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 42.2 tttm -72.5 -58.36 3.44 Favored 'General case' 0 N--CA 1.479 0.998 0 CA-C-N 114.404 -1.271 . . . . 0.0 113.624 -174.59 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 4' ' ' GLU . . . . . 0.46 ' HB2' ' O ' ' A' ' 70' ' ' TRP . 0.8 OUTLIER -70.29 -36.24 74.24 Favored 'General case' 0 CA--C 1.538 0.485 0 N-CA-C 114.327 1.232 . . . . 0.0 114.327 -171.658 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 5' ' ' PHE . . . . . 0.55 ' HB2' HD12 ' A' ' 7' ' ' ILE . 29.8 m-85 -108.86 -10.09 15.12 Favored 'General case' 0 N--CA 1.47 0.55 0 N-CA-C 117.014 2.227 . . . . 0.0 117.014 -170.36 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 68.08 56.65 10.08 Favored Glycine 0 CA--C 1.541 1.678 0 O-C-N 123.965 0.791 . . . . 0.0 111.351 -174.634 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.55 HD12 ' HB2' ' A' ' 5' ' ' PHE . 0.4 OUTLIER -111.95 140.37 23.34 Favored Pre-proline 0 N--CA 1.476 0.874 0 CA-C-N 113.466 -1.367 . . . . 0.0 110.149 -179.841 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -85.27 160.78 11.31 Favored 'Trans proline' 0 C--O 1.243 0.752 0 C-N-CA 121.161 1.241 . . . . 0.0 110.057 166.551 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -52.21 -32.76 38.0 Favored 'General case' 0 N--CA 1.484 1.225 0 N-CA-C 115.262 1.579 . . . . 0.0 115.262 175.807 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -41.0 -38.26 0.95 Allowed 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 126.688 1.995 . . . . 0.0 115.815 172.412 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.701 ' HB ' HD22 ' A' ' 32' ' ' LEU . 33.6 m -105.4 -41.24 6.24 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.95 0 N-CA-C 114.754 1.391 . . . . 0.0 114.754 -176.67 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 0.432 ' HB2' HG21 ' A' ' 7' ' ' ILE . . . -67.29 -39.85 86.03 Favored 'General case' 0 N--CA 1.479 1.023 0 N-CA-C 112.992 0.738 . . . . 0.0 112.992 178.541 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -58.52 -41.9 95.69 Favored Glycine 0 CA--C 1.547 2.048 0 C-N-CA 123.923 0.773 . . . . 0.0 111.877 175.532 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 10.4 m -66.52 -39.88 88.88 Favored 'General case' 0 N--CA 1.484 1.232 0 CA-C-N 113.644 -1.278 . . . . 0.0 114.158 176.986 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 71.4 t -52.77 -43.36 44.86 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.017 0 N-CA-C 112.042 0.386 . . . . 0.0 112.042 169.445 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.595 HD11 HG12 ' A' ' 68' ' ' ILE . 38.3 mt -60.63 -43.84 97.07 Favored 'General case' 0 N--CA 1.481 1.095 0 N-CA-C 113.161 0.8 . . . . 0.0 113.161 179.75 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 20.4 t-20 -52.95 -50.78 63.35 Favored 'General case' 0 N--CA 1.48 1.05 0 O-C-N 124.934 1.396 . . . . 0.0 110.731 173.909 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.56 HG11 HD11 ' A' ' 28' ' ' ILE . 70.6 t -63.05 -41.62 93.54 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.088 0 CA-C-N 114.306 -1.315 . . . . 0.0 113.746 178.24 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.685 HG13 ' HA ' ' A' ' 56' ' ' LYS . 37.0 t -61.25 -45.75 97.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 123.845 0.716 . . . . 0.0 110.427 175.689 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 20' ' ' GLU . . . . . 0.42 ' HG3' ' HE2' ' A' ' 64' ' ' LYS . 31.3 mt-10 -60.67 -39.54 88.77 Favored 'General case' 0 CA--C 1.551 0.981 0 C-N-CA 124.914 1.286 . . . . 0.0 113.744 177.605 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -87.06 -15.98 36.97 Favored 'General case' 0 CA--C 1.543 0.68 0 N-CA-C 117.398 2.37 . . . . 0.0 117.398 -178.551 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 63.6 37.14 94.3 Favored Glycine 0 N--CA 1.484 1.851 0 C-N-CA 124.216 0.912 . . . . 0.0 112.219 -172.021 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -90.01 -166.23 41.29 Favored Glycine 0 N--CA 1.482 1.712 0 CA-C-O 122.808 1.227 . . . . 0.0 113.365 -172.694 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' TRP . . . . . 0.602 ' HB3' HG22 ' A' ' 26' ' ' THR . 5.4 m-90 -82.74 111.44 18.68 Favored 'General case' 0 N--CA 1.478 0.957 0 CA-C-O 122.328 1.061 . . . . 0.0 111.032 -179.891 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.41 ' HB ' ' HG2' ' A' ' 52' ' ' LYS . 39.6 t -65.02 -20.18 27.07 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.209 0 CA-C-N 114.669 -1.15 . . . . 0.0 112.307 168.278 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.602 HG22 ' HB3' ' A' ' 24' ' ' TRP . 10.9 t -64.26 -32.96 74.75 Favored 'General case' 0 N--CA 1.482 1.129 0 N-CA-C 113.96 1.096 . . . . 0.0 113.96 179.587 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -66.74 -33.68 76.16 Favored 'General case' 0 N--CA 1.485 1.313 0 N-CA-C 113.672 0.99 . . . . 0.0 113.672 173.875 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.56 HD11 HG11 ' A' ' 18' ' ' VAL . 0.0 OUTLIER -87.4 -38.0 11.57 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.165 0 CA-C-O 118.737 -0.649 . . . . 0.0 111.363 -178.798 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 14.0 t -44.82 -44.23 2.63 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.213 0 C-N-CA 124.225 1.01 . . . . 0.0 111.981 175.288 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 6.4 p -63.28 -31.76 72.99 Favored 'General case' 0 N--CA 1.484 1.229 0 N-CA-C 114.706 1.373 . . . . 0.0 114.706 175.92 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.699 HG22 HG12 ' A' ' 11' ' ' VAL . 15.3 mm -82.44 -37.94 14.83 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.152 0 C-N-CA 123.661 0.784 . . . . 0.0 109.732 179.006 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.701 HD22 ' HB ' ' A' ' 11' ' ' VAL . 3.7 mm? -53.72 -52.97 58.39 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 125.341 1.456 . . . . 0.0 111.283 170.356 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 17.2 p -70.18 -30.87 68.1 Favored 'General case' 0 N--CA 1.475 0.825 0 N-CA-C 114.277 1.214 . . . . 0.0 114.277 179.159 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -53.64 -33.47 55.27 Favored 'General case' 0 N--CA 1.483 1.184 0 N-CA-C 113.554 0.946 . . . . 0.0 113.554 170.022 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.476 ' HB ' ' O ' ' A' ' 32' ' ' LEU . 74.7 t . . . . . 0 N--CA 1.488 1.426 0 C-N-CA 124.675 1.19 . . . . 0.0 112.899 170.934 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' GLY . . . . . 0.499 ' HA2' ' HB3' ' A' ' 32' ' ' LEU . . . . . . . . 0 N--CA 1.479 1.527 0 N-CA-C 111.753 -0.539 . . . . 0.0 111.753 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 52.5 mt -60.21 -47.38 86.23 Favored 'General case' 0 N--CA 1.478 0.949 0 N-CA-C 115.126 1.528 . . . . 0.0 115.126 -176.529 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 75.5 p -61.76 -41.29 97.5 Favored 'General case' 0 CA--C 1.544 0.715 0 N-CA-C 113.139 0.792 . . . . 0.0 113.139 176.665 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 9.8 tp -63.88 -47.37 80.91 Favored 'General case' 0 N--CA 1.482 1.135 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.405 173.87 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.477 ' HG ' ' O ' ' A' ' 39' ' ' GLY . 75.8 mt -60.6 -30.48 69.85 Favored 'General case' 0 N--CA 1.474 0.768 0 N-CA-C 114.783 1.401 . . . . 0.0 114.783 -178.916 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -70.3 -44.68 67.83 Favored 'General case' 0 N--CA 1.477 0.917 0 O-C-N 123.842 0.714 . . . . 0.0 112.724 172.897 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -68.64 -37.14 79.45 Favored 'General case' 0 N--CA 1.479 0.994 0 CA-C-O 121.607 0.717 . . . . 0.0 112.305 177.242 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.423 ' HB1' ' HA ' ' A' ' 51' ' ' ILE . . . -60.74 -25.24 66.33 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 126.45 1.9 . . . . 0.0 115.371 176.364 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -48.77 -36.83 20.05 Favored Glycine 0 CA--C 1.545 1.934 0 O-C-N 124.657 1.223 . . . . 0.0 113.564 176.642 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 25.0 ttm180 -43.64 -52.57 6.31 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 128.256 2.622 . . . . 0.0 113.228 -177.698 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 11.2 tt0 -128.55 36.12 4.29 Favored 'General case' 0 CA--C 1.545 0.761 0 N-CA-C 112.957 0.725 . . . . 0.0 112.957 -178.599 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 60.3 p 51.5 123.62 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.664 0 C-N-CA 125.065 1.346 . . . . 0.0 112.17 -169.101 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.423 ' HA ' ' HB1' ' A' ' 46' ' ' ALA . 5.8 tp -33.57 -50.51 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.164 0 N-CA-C 117.082 2.253 . . . . 0.0 117.082 -176.952 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 0.41 ' HG2' ' HB ' ' A' ' 25' ' ' VAL . 7.1 mttt -59.76 -62.86 1.56 Allowed 'General case' 0 N--CA 1.471 0.623 0 N-CA-C 114.388 1.255 . . . . 0.0 114.388 178.123 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -63.28 -34.1 76.94 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 113.24 -1.8 . . . . 0.0 112.662 -179.388 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 72.4 t80 -51.52 -63.61 1.08 Allowed 'General case' 0 C--O 1.224 -0.277 0 C-N-CA 125.955 1.702 . . . . 0.0 110.654 176.969 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 43.5 mt -65.96 -39.62 90.59 Favored 'General case' 0 N--CA 1.477 0.925 0 N-CA-C 115.265 1.58 . . . . 0.0 115.265 -175.859 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 56' ' ' LYS . . . . . 0.685 ' HA ' HG13 ' A' ' 19' ' ' VAL . 1.8 mptm? -58.94 -44.38 91.41 Favored 'General case' 0 N--CA 1.472 0.644 0 N-CA-C 114.859 1.429 . . . . 0.0 114.859 177.767 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 15.6 tttm -79.39 -52.68 7.76 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-N 114.467 -1.242 . . . . 0.0 112.542 173.284 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 58' ' ' GLU . . . . . 0.546 ' O ' ' HB2' ' A' ' 62' ' ' LYS . 0.8 OUTLIER -59.22 -45.17 91.82 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-O 116.488 -1.72 . . . . 0.0 113.039 -171.62 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.653 HG23 HG21 ' A' ' 67' ' ' VAL . 3.2 mm -76.37 -26.64 17.05 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.04 0 C-N-CA 119.994 -0.682 . . . . 0.0 111.697 -179.637 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 60' ' ' LYS . . . . . 0.523 ' HB2' ' O ' ' A' ' 56' ' ' LYS . 0.7 OUTLIER -59.22 -34.51 72.27 Favored 'General case' 0 CA--C 1.543 0.7 0 CA-C-O 122.162 0.982 . . . . 0.0 113.566 173.144 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 5.0 mttm -87.97 -44.97 10.62 Favored 'General case' 0 N--CA 1.479 0.985 0 CA-C-N 112.536 -2.12 . . . . 0.0 110.853 179.363 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 62' ' ' LYS . . . . . 0.546 ' HB2' ' O ' ' A' ' 58' ' ' GLU . 19.9 tttt -68.51 -41.23 80.27 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 127.348 2.259 . . . . 0.0 114.41 -171.554 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 93.24 110.57 2.02 Favored Glycine 0 CA--C 1.534 1.231 0 N-CA-C 110.358 -1.097 . . . . 0.0 110.358 -177.719 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.714 ' HD2' ' H ' ' A' ' 64' ' ' LYS . 10.0 mptt -39.3 -47.61 1.73 Allowed 'General case' 0 N--CA 1.481 1.093 0 N-CA-C 117.395 2.369 . . . . 0.0 117.395 -176.189 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 65' ' ' ARG . . . . . 0.485 ' O ' ' HB ' ' A' ' 68' ' ' ILE . 4.6 ttp180 -58.51 -50.22 74.55 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 124.18 0.992 . . . . 0.0 113.436 179.448 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -61.96 -28.03 69.26 Favored 'General case' 0 N--CA 1.476 0.843 0 N-CA-C 114.118 1.155 . . . . 0.0 114.118 173.669 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.653 HG21 HG23 ' A' ' 59' ' ' ILE . 90.3 t -70.62 -33.15 51.98 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 N-CA-C 112.333 0.494 . . . . 0.0 112.333 176.509 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.595 HG12 HD11 ' A' ' 16' ' ' LEU . 4.1 mm -49.5 -47.28 20.38 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.332 0 C-N-CA 123.28 0.632 . . . . 0.0 109.718 167.719 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -66.95 -51.81 50.59 Favored 'General case' 0 N--CA 1.485 1.286 0 CA-C-N 114.811 -1.086 . . . . 0.0 112.751 177.807 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 70' ' ' TRP . . . . . 0.46 ' O ' ' HB2' ' A' ' 4' ' ' GLU . 39.6 t90 . . . . . 0 N--CA 1.484 1.263 0 C-N-CA 125.055 1.342 . . . . 0.0 113.121 -179.201 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.552 ' HE1' HG21 ' A' ' 15' ' ' VAL . 72.4 mtp . . . . . 0 N--CA 1.476 0.832 0 N-CA-C 112.814 0.672 . . . . 0.0 112.814 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 2' ' ' ALA . . . . . 0.611 ' HA ' ' O ' ' A' ' 7' ' ' ILE . . . -60.91 -54.84 40.15 Favored 'General case' 0 N--CA 1.471 0.601 0 N-CA-C 113.584 0.957 . . . . 0.0 113.584 173.961 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 9.7 tptp -74.08 -57.05 4.22 Favored 'General case' 0 CA--C 1.543 0.711 0 CA-C-N 113.559 -1.655 . . . . 0.0 114.456 -174.597 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 11.3 tt0 -77.88 -43.74 29.27 Favored 'General case' 0 N--CA 1.477 0.88 0 N-CA-C 113.631 0.974 . . . . 0.0 113.631 -171.967 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 41.7 m-85 -95.35 -8.08 36.75 Favored 'General case' 0 CA--C 1.542 0.652 0 N-CA-C 117.396 2.369 . . . . 0.0 117.396 -173.749 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 63.48 38.53 96.48 Favored Glycine 0 N--CA 1.478 1.47 0 O-C-N 124.38 1.05 . . . . 0.0 112.848 -177.773 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.611 ' O ' ' HA ' ' A' ' 2' ' ' ALA . 0.8 OUTLIER -114.06 128.6 25.62 Favored Pre-proline 0 N--CA 1.479 1.005 0 C-N-CA 124.51 1.124 . . . . 0.0 108.474 -179.808 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -66.89 156.37 66.46 Favored 'Trans proline' 0 CA--C 1.54 0.785 0 CA-C-N 120.169 1.096 . . . . 0.0 110.943 179.721 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -51.8 -30.0 21.4 Favored 'General case' 0 N--CA 1.483 1.177 0 N-CA-C 115.077 1.51 . . . . 0.0 115.077 173.988 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -44.64 -46.98 10.44 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 126.332 1.853 . . . . 0.0 114.007 175.159 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.973 HG12 HG22 ' A' ' 31' ' ' ILE . 34.9 m -96.14 -32.43 4.31 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.345 0 N-CA-C 114.016 1.117 . . . . 0.0 114.016 -177.824 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 0.41 ' O ' ' HG ' ' A' ' 16' ' ' LEU . . . -59.99 -34.61 73.55 Favored 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 112.483 0.549 . . . . 0.0 112.483 173.43 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -58.69 -46.73 92.95 Favored Glycine 0 CA--C 1.546 1.978 0 C-N-CA 124.823 1.201 . . . . 0.0 113.048 169.463 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -62.32 -39.98 94.82 Favored 'General case' 0 N--CA 1.487 1.391 0 C-N-CA 124.46 1.104 . . . . 0.0 113.633 176.822 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.558 HG13 HD13 ' A' ' 55' ' ' LEU . 30.9 t -51.76 -39.37 24.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 C-N-CA 124.286 1.034 . . . . 0.0 112.768 169.338 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.581 HD22 ' HG3' ' A' ' 64' ' ' LYS . 56.3 mt -62.75 -38.35 90.23 Favored 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 113.773 1.027 . . . . 0.0 113.773 177.408 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 18.2 t-20 -51.84 -47.48 64.36 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 123.792 0.837 . . . . 0.0 111.762 173.338 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.407 HG21 ' HA ' ' A' ' 25' ' ' VAL . 2.1 t -52.33 -51.49 32.03 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.118 0 CA-C-N 115.366 -0.833 . . . . 0.0 113.039 173.507 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.603 HG13 ' HA ' ' A' ' 56' ' ' LYS . 4.1 t -63.28 -46.41 95.73 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.065 0 O-C-N 124.299 0.999 . . . . 0.0 110.982 -179.116 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 33.0 mt-10 -62.21 -45.72 92.08 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 125.075 1.35 . . . . 0.0 114.279 -178.09 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -94.9 -22.01 18.28 Favored 'General case' 0 N--CA 1.48 1.056 0 N-CA-C 116.34 1.978 . . . . 0.0 116.34 -172.035 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 73.89 45.54 26.73 Favored Glycine 0 N--CA 1.481 1.663 0 N-CA-C 109.042 -1.623 . . . . 0.0 109.042 -163.352 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -94.71 164.13 25.13 Favored Glycine 0 N--CA 1.477 1.401 0 C-N-CA 124.898 1.237 . . . . 0.0 113.829 -169.438 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 2.8 m-90 -66.86 102.12 0.92 Allowed 'General case' 0 N--CA 1.475 0.818 0 CA-C-O 122.568 1.175 . . . . 0.0 112.045 -178.542 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.637 HG21 HG13 ' A' ' 51' ' ' ILE . 5.5 p -53.45 -25.59 11.1 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.996 0 CA-C-N 112.979 -1.918 . . . . 0.0 115.225 170.881 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 10.6 t -62.42 -36.42 82.33 Favored 'General case' 0 N--CA 1.478 0.951 0 N-CA-C 113.434 0.902 . . . . 0.0 113.434 179.756 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 1.3 m -67.11 -42.7 84.07 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 124.082 0.953 . . . . 0.0 110.65 173.226 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.448 ' O ' HD23 ' A' ' 32' ' ' LEU . 1.6 mp -63.34 -44.7 99.16 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.759 0 C-N-CA 124.227 1.011 . . . . 0.0 112.633 178.272 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 77.2 t -52.38 -44.17 42.58 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.152 0 C-N-CA 123.816 0.846 . . . . 0.0 111.049 174.842 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 20.3 p -60.83 -33.59 73.27 Favored 'General case' 0 N--CA 1.482 1.15 0 N-CA-C 114.999 1.481 . . . . 0.0 114.999 175.944 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.973 HG22 HG12 ' A' ' 11' ' ' VAL . 27.7 mm -75.18 -40.73 44.1 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.692 0 C-N-CA 124.226 1.01 . . . . 0.0 109.319 178.891 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.619 ' HB3' ' HA3' ' A' ' 39' ' ' GLY . 3.6 mm? -59.68 -32.89 70.91 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 124.743 1.217 . . . . 0.0 111.391 169.236 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 2.9 m -73.38 -35.88 65.98 Favored 'General case' 0 N--CA 1.475 0.801 0 N-CA-C 113.984 1.105 . . . . 0.0 113.984 174.532 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -53.8 -30.38 44.64 Favored 'General case' 0 N--CA 1.487 1.383 0 N-CA-C 113.374 0.879 . . . . 0.0 113.374 175.94 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 55.5 t . . . . . 0 N--CA 1.481 1.093 0 C-N-CA 126.823 2.049 . . . . 0.0 113.213 173.567 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 39' ' ' GLY . . . . . 0.619 ' HA3' ' HB3' ' A' ' 32' ' ' LEU . . . . . . . . 0 CA--C 1.55 2.28 0 N-CA-C 110.784 -0.926 . . . . 0.0 110.784 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 10.8 mt -55.81 -37.34 68.52 Favored 'General case' 0 N--CA 1.483 1.216 0 N-CA-C 116.363 1.986 . . . . 0.0 116.363 -169.657 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 16.6 p -56.87 -43.64 81.44 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 124.376 1.07 . . . . 0.0 113.652 176.506 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.41 HD22 ' HE1' ' A' ' 1' ' ' MET . 14.9 tp -66.68 -45.8 77.7 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 123.12 0.568 . . . . 0.0 110.845 175.316 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 88.4 mt -60.65 -30.77 70.09 Favored 'General case' 0 N--CA 1.477 0.89 0 CA-C-N 114.293 -1.321 . . . . 0.0 114.19 179.116 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -66.79 -48.18 69.82 Favored 'General case' 0 N--CA 1.474 0.726 0 N-CA-C 112.943 0.72 . . . . 0.0 112.943 173.546 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -64.36 -29.21 70.29 Favored 'General case' 0 N--CA 1.485 1.316 0 N-CA-C 113.029 0.752 . . . . 0.0 113.029 176.815 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -77.99 -9.53 59.15 Favored 'General case' 0 CA--C 1.543 0.683 0 N-CA-C 117.259 2.318 . . . . 0.0 117.259 -177.236 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -56.6 -57.06 21.41 Favored Glycine 0 CA--C 1.542 1.75 0 C-N-CA 124.321 0.962 . . . . 0.0 113.216 -166.881 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.71 -44.93 90.5 Favored 'General case' 0 CA--C 1.541 0.601 0 N-CA-C 115.681 1.734 . . . . 0.0 115.681 -177.321 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.502 ' OE1' ' HA ' ' A' ' 54' ' ' TYR . 13.0 tt0 -103.1 25.49 9.37 Favored 'General case' 0 N--CA 1.478 0.947 0 N-CA-C 114.749 1.389 . . . . 0.0 114.749 -175.058 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 91.8 p 46.63 118.85 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 125.756 1.622 . . . . 0.0 112.919 -174.594 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.637 HG13 HG21 ' A' ' 25' ' ' VAL . 8.0 tp -35.86 -52.18 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.263 0 N-CA-C 116.883 2.179 . . . . 0.0 116.883 -174.134 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 23.6 tptp -55.51 -67.98 0.24 Allowed 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 124.703 1.201 . . . . 0.0 112.863 174.518 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -57.73 -36.31 71.86 Favored 'General case' 0 N--CA 1.482 1.16 0 N-CA-C 113.993 1.108 . . . . 0.0 113.993 179.586 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 54' ' ' TYR . . . . . 0.502 ' HA ' ' OE1' ' A' ' 49' ' ' GLU . 94.3 t80 -50.0 -64.6 0.76 Allowed 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 125.533 1.533 . . . . 0.0 111.738 173.641 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.558 HD13 HG13 ' A' ' 15' ' ' VAL . 46.2 mt -63.16 -41.2 99.21 Favored 'General case' 0 N--CA 1.472 0.675 0 N-CA-C 114.023 1.12 . . . . 0.0 114.023 -178.357 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 56' ' ' LYS . . . . . 0.603 ' HA ' HG13 ' A' ' 19' ' ' VAL . 54.1 tptt -53.57 -54.15 41.56 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-N 113.751 -1.568 . . . . 0.0 112.303 179.076 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 58.9 tttp -68.79 -54.42 15.96 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 115.127 -0.942 . . . . 0.0 111.943 173.895 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 8.9 tt0 -59.25 -48.23 82.4 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-N 115.655 -0.702 . . . . 0.0 111.845 -167.34 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.716 HG23 HG21 ' A' ' 67' ' ' VAL . 3.1 mm -75.99 -23.95 16.35 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.124 0 O-C-N 123.288 0.367 . . . . 0.0 111.359 -176.051 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 60' ' ' LYS . . . . . 0.421 ' HB2' ' O ' ' A' ' 56' ' ' LYS . 24.3 mttt -65.92 -21.6 66.45 Favored 'General case' 0 C--O 1.222 -0.362 0 N-CA-C 117.3 2.333 . . . . 0.0 117.3 169.095 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 60.4 mtpt -91.26 -50.24 5.93 Favored 'General case' 0 N--CA 1.481 1.091 0 CA-C-N 112.831 -1.986 . . . . 0.0 110.614 172.481 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 36.9 tttp -65.19 -50.29 66.49 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 126.957 2.103 . . . . 0.0 114.909 -171.957 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 95.77 121.61 3.84 Favored Glycine 0 CA--C 1.533 1.181 0 CA-C-O 122.384 0.991 . . . . 0.0 110.888 -171.86 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.581 ' HG3' HD22 ' A' ' 16' ' ' LEU . 12.3 mptt -45.08 -39.38 5.8 Favored 'General case' 0 N--CA 1.48 1.054 0 N-CA-C 117.396 2.369 . . . . 0.0 117.396 -175.777 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 65' ' ' ARG . . . . . 0.418 ' O ' ' HB ' ' A' ' 68' ' ' ILE . 0.0 OUTLIER -59.66 -46.97 87.42 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 124.545 1.138 . . . . 0.0 112.805 178.208 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -63.26 -28.27 69.91 Favored 'General case' 0 N--CA 1.479 1.023 0 N-CA-C 114.54 1.311 . . . . 0.0 114.54 174.723 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.716 HG21 HG23 ' A' ' 59' ' ' ILE . 26.2 t -70.75 -36.9 66.82 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.868 0 C-N-CA 123.594 0.758 . . . . 0.0 111.282 178.536 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.418 ' HB ' ' O ' ' A' ' 65' ' ' ARG . 21.6 mm -52.95 -46.75 53.55 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.95 0 C-N-CA 123.926 0.89 . . . . 0.0 110.384 170.781 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -70.37 -50.88 34.3 Favored 'General case' 0 N--CA 1.479 1.009 0 CA-C-N 114.783 -1.099 . . . . 0.0 113.172 177.072 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 31.6 t90 . . . . . 0 N--CA 1.484 1.248 0 C-N-CA 125.611 1.564 . . . . 0.0 112.77 -179.494 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.45 ' HE1' HG21 ' A' ' 15' ' ' VAL . 74.2 mtp . . . . . 0 N--CA 1.471 0.577 0 N-CA-C 112.215 0.45 . . . . 0.0 112.215 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 2' ' ' ALA . . . . . 0.425 ' HA ' ' O ' ' A' ' 7' ' ' ILE . . . -54.96 -58.38 7.85 Favored 'General case' 0 N--CA 1.472 0.664 0 O-C-N 124.734 1.271 . . . . 0.0 113.255 173.395 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 22.1 tptm -71.81 -50.75 26.91 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 113.684 -1.598 . . . . 0.0 113.104 -173.763 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 8.3 tt0 -78.1 -42.76 31.03 Favored 'General case' 0 N--CA 1.479 0.99 0 N-CA-C 114.674 1.361 . . . . 0.0 114.674 -170.254 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 5' ' ' PHE . . . . . 0.457 ' HD1' ' HB2' ' A' ' 41' ' ' SER . 58.3 m-85 -105.76 -15.15 15.03 Favored 'General case' 0 N--CA 1.474 0.738 0 N-CA-C 116.987 2.218 . . . . 0.0 116.987 -172.101 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 85.75 61.21 1.71 Allowed Glycine 0 N--CA 1.482 1.73 0 O-C-N 124.352 1.033 . . . . 0.0 112.331 -176.922 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.538 HG21 ' HB2' ' A' ' 12' ' ' ALA . 1.0 OUTLIER -111.48 137.14 21.04 Favored Pre-proline 0 N--CA 1.475 0.789 0 CA-C-N 114.365 -0.918 . . . . 0.0 109.771 173.47 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.416 ' C ' ' H ' ' A' ' 10' ' ' ALA . 47.5 Cg_endo -82.04 38.45 0.75 Allowed 'Trans proline' 0 CA--C 1.537 0.673 0 C-N-CA 122.861 2.374 . . . . 0.0 113.2 175.522 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . 53.85 -34.04 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.518 0 C-N-CA 129.69 3.196 . . . . 0.0 117.243 -169.959 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.416 ' H ' ' C ' ' A' ' 8' ' ' PRO . . . -37.23 -63.53 0.43 Allowed 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 128.735 2.814 . . . . 0.0 113.564 174.023 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.537 HG12 HG22 ' A' ' 31' ' ' ILE . 26.9 m -74.77 -21.43 16.99 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.862 0 N-CA-C 113.896 1.073 . . . . 0.0 113.896 -176.248 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 0.538 ' HB2' HG21 ' A' ' 7' ' ' ILE . . . -67.6 -32.88 73.91 Favored 'General case' 0 N--CA 1.475 0.785 0 N-CA-C 112.356 0.502 . . . . 0.0 112.356 169.991 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -59.37 -38.04 92.84 Favored Glycine 0 CA--C 1.541 1.706 0 C-N-CA 123.836 0.731 . . . . 0.0 113.44 172.284 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.541 HG22 HG13 ' A' ' 28' ' ' ILE . 0.2 OUTLIER -69.79 -27.67 65.1 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 126.189 1.796 . . . . 0.0 115.124 176.329 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.484 ' O ' ' HB ' ' A' ' 18' ' ' VAL . 2.8 t -67.01 -44.07 88.62 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.169 0 C-N-CA 124.884 1.273 . . . . 0.0 110.691 171.501 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.451 HD13 ' HB3' ' A' ' 64' ' ' LYS . 60.2 mt -63.44 -42.83 98.67 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 114.408 -1.269 . . . . 0.0 112.348 179.076 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 17' ' ' ASN . . . . . 0.41 ' HB2' ' O ' ' A' ' 14' ' ' THR 0.444 0.6 OUTLIER -48.33 -52.86 19.63 Favored 'General case' 0 C--N 1.31 -1.123 0 CA-C-N 114.484 -1.235 . . . . 0.0 114.161 169.281 . . . . . . . . 4 4 . 1 . 016 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.484 ' HB ' ' O ' ' A' ' 15' ' ' VAL . 2.9 t -46.17 -54.2 2.09 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.416 0 O-C-N 125.629 1.831 . . . . 0.0 110.342 173.434 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.823 HG13 ' HA ' ' A' ' 56' ' ' LYS . 4.1 t -62.33 -49.99 81.73 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.08 0 CA-C-N 115.011 -0.995 . . . . 0.0 111.16 -174.453 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 25.8 mt-10 -66.28 -38.59 88.14 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 126.128 1.771 . . . . 0.0 115.012 -171.959 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -99.63 -11.45 20.93 Favored 'General case' 0 N--CA 1.473 0.688 0 N-CA-C 114.473 1.286 . . . . 0.0 114.473 -175.044 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 68.03 39.83 88.81 Favored Glycine 0 CA--C 1.545 1.912 0 N-CA-C 111.423 -0.671 . . . . 0.0 111.423 -166.903 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -91.69 159.45 25.85 Favored Glycine 0 CA--C 1.541 1.689 0 CA-C-O 122.948 1.304 . . . . 0.0 113.776 -173.251 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 83.8 m95 -63.81 108.03 1.35 Allowed 'General case' 0 N--CA 1.47 0.558 0 CA-C-N 112.863 -1.668 . . . . 0.0 113.564 -179.512 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.614 HG21 HG13 ' A' ' 51' ' ' ILE . 5.5 p -58.46 -26.86 31.87 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 CA-C-N 111.741 -2.481 . . . . 0.0 113.864 168.653 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 10.1 t -65.09 -36.51 84.53 Favored 'General case' 0 N--CA 1.482 1.125 0 N-CA-C 113.431 0.901 . . . . 0.0 113.431 -173.867 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -70.45 -43.7 69.33 Favored 'General case' 0 N--CA 1.47 0.544 0 N-CA-C 112.367 0.506 . . . . 0.0 112.367 172.029 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.541 HG13 HG22 ' A' ' 14' ' ' THR . 1.6 mp -61.27 -44.0 97.59 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.564 0 C-N-CA 124.92 1.288 . . . . 0.0 112.539 -179.214 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.527 HG13 HD11 ' A' ' 43' ' ' LEU . 23.7 t -46.04 -47.54 5.76 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.703 0 C-N-CA 124.632 1.173 . . . . 0.0 111.594 171.572 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 22.7 p -60.52 -33.98 73.43 Favored 'General case' 0 N--CA 1.482 1.128 0 N-CA-C 114.606 1.335 . . . . 0.0 114.606 177.808 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.537 HG22 HG12 ' A' ' 11' ' ' VAL . 21.7 mm -77.28 -35.66 22.87 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 C-N-CA 124.142 0.977 . . . . 0.0 109.235 -178.951 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.611 ' HB3' ' HA2' ' A' ' 39' ' ' GLY . 4.0 mm? -60.66 -52.38 65.36 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 124.198 0.999 . . . . 0.0 111.587 173.5 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 1.7 p -60.84 -30.05 69.87 Favored 'General case' 0 N--CA 1.482 1.169 0 N-CA-C 115.37 1.619 . . . . 0.0 115.37 177.156 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -53.62 -33.51 55.28 Favored 'General case' 0 N--CA 1.479 1.009 0 N-CA-C 114.81 1.411 . . . . 0.0 114.81 175.251 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 68.8 t . . . . . 0 N--CA 1.484 1.265 0 C-N-CA 125.916 1.686 . . . . 0.0 111.912 175.889 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 39' ' ' GLY . . . . . 0.611 ' HA2' ' HB3' ' A' ' 32' ' ' LEU . . . . . . . . 0 N--CA 1.473 1.143 0 N-CA-C 111.467 -0.653 . . . . 0.0 111.467 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 58.8 mt -57.89 -48.94 78.39 Favored 'General case' 0 N--CA 1.474 0.742 0 N-CA-C 115.452 1.649 . . . . 0.0 115.452 -175.971 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 41' ' ' SER . . . . . 0.457 ' HB2' ' HD1' ' A' ' 5' ' ' PHE . 13.1 p -61.91 -37.88 86.3 Favored 'General case' 0 CA--C 1.544 0.732 0 N-CA-C 114.828 1.418 . . . . 0.0 114.828 177.66 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 10.0 tp -69.74 -42.12 74.34 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 124.251 1.02 . . . . 0.0 111.005 175.183 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.527 HD11 HG13 ' A' ' 29' ' ' VAL . 51.2 mt -63.26 -25.79 68.48 Favored 'General case' 0 N--CA 1.469 0.506 0 N-CA-C 114.968 1.47 . . . . 0.0 114.968 178.516 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -72.09 -49.52 35.61 Favored 'General case' 0 N--CA 1.481 1.106 0 CA-C-N 115.909 -0.587 . . . . 0.0 112.286 171.273 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -60.9 -35.75 77.46 Favored 'General case' 0 N--CA 1.49 1.529 0 C-N-CA 124.847 1.259 . . . . 0.0 112.933 -179.229 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -52.4 -25.7 10.6 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 126.844 2.058 . . . . 0.0 114.347 174.293 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -45.7 -37.97 7.27 Favored Glycine 0 CA--C 1.539 1.561 0 C-N-CA 126.514 2.007 . . . . 0.0 114.101 178.868 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 4.5 tmm_? -62.96 -39.35 94.39 Favored 'General case' 0 CA--C 1.544 0.738 0 N-CA-C 114.802 1.408 . . . . 0.0 114.802 -173.079 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 11.5 tt0 -141.15 38.7 1.76 Allowed 'General case' 0 N--CA 1.479 0.981 0 N-CA-C 116.365 1.987 . . . . 0.0 116.365 -178.51 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 59.5 p 53.47 119.34 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.874 0 C-N-CA 125.184 1.394 . . . . 0.0 112.643 -177.131 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.614 HG13 HG21 ' A' ' 25' ' ' VAL 0.276 8.6 tp -36.7 -46.55 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 N-CA-C 117.89 2.552 . . . . 0.0 117.89 -171.945 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 24.7 tptt -55.86 -68.93 0.16 Allowed 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 126.107 1.763 . . . . 0.0 112.895 174.767 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -62.96 -32.3 73.59 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 124.904 1.282 . . . . 0.0 113.865 177.317 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 91.2 t80 -53.81 -62.91 1.35 Allowed 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 125.894 1.677 . . . . 0.0 110.88 -178.948 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 65.8 mt -65.09 -35.39 81.0 Favored 'General case' 0 N--CA 1.469 0.483 0 N-CA-C 114.134 1.161 . . . . 0.0 114.134 179.928 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 56' ' ' LYS . . . . . 0.823 ' HA ' HG13 ' A' ' 19' ' ' VAL . 58.7 mttp -61.36 -47.96 83.46 Favored 'General case' 0 N--CA 1.477 0.904 0 CA-C-N 113.982 -1.463 . . . . 0.0 114.445 178.476 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 85.7 tttt -76.78 -50.64 13.02 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-N 114.764 -1.107 . . . . 0.0 111.695 175.406 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 58' ' ' GLU . . . . . 0.434 ' O ' ' HB2' ' A' ' 62' ' ' LYS . 28.8 tt0 -59.08 -49.21 78.75 Favored 'General case' 0 N--CA 1.471 0.596 0 N-CA-C 111.922 0.341 . . . . 0.0 111.922 -173.152 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.739 HD12 HG21 ' A' ' 67' ' ' VAL . 2.7 mm -72.09 -25.03 23.08 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.038 0 CA-C-O 118.428 -0.796 . . . . 0.0 112.391 -178.669 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 63.9 tttm -62.77 -33.17 74.62 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 114.682 1.364 . . . . 0.0 114.682 172.045 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 55.1 mtmt -80.91 -48.58 12.14 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-N 114.055 -1.429 . . . . 0.0 110.729 173.941 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 62' ' ' LYS . . . . . 0.434 ' HB2' ' O ' ' A' ' 58' ' ' GLU . 5.9 tttm -64.51 -50.6 66.74 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 126.131 1.772 . . . . 0.0 115.77 -172.053 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 91.66 108.58 1.59 Allowed Glycine 0 N--CA 1.482 1.749 0 CA-C-N 114.932 -1.031 . . . . 0.0 110.747 -175.941 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.707 ' HD2' ' H ' ' A' ' 64' ' ' LYS . 8.6 mptt -31.95 -43.83 0.08 Allowed 'General case' 0 N--CA 1.482 1.153 0 N-CA-C 119.277 3.066 . . . . 0.0 119.277 -173.713 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.44 -47.94 82.34 Favored 'General case' 0 N--CA 1.475 0.78 0 N-CA-C 113.396 0.888 . . . . 0.0 113.396 178.865 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -60.77 -28.12 68.49 Favored 'General case' 0 N--CA 1.473 0.723 0 CA-C-N 115.015 -0.993 . . . . 0.0 113.402 172.937 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.739 HG21 HD12 ' A' ' 59' ' ' ILE . 96.2 t -72.95 -36.09 50.56 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.662 0 N-CA-C 112.877 0.695 . . . . 0.0 112.877 179.276 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 33.5 mm -53.21 -46.77 56.63 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.996 0 O-C-N 123.637 0.586 . . . . 0.0 109.952 168.721 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -68.6 -43.15 77.05 Favored 'General case' 0 N--CA 1.476 0.844 0 N-CA-C 113.598 0.962 . . . . 0.0 113.598 178.57 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 29.3 t90 . . . . . 0 N--CA 1.477 0.886 0 CA-C-N 114.816 -1.084 . . . . 0.0 113.069 178.337 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.624 ' HE3' HD13 ' A' ' 7' ' ' ILE . 39.7 mtp . . . . . 0 N--CA 1.477 0.918 0 N-CA-C 111.8 0.296 . . . . 0.0 111.8 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 2' ' ' ALA . . . . . 0.423 ' HA ' ' O ' ' A' ' 7' ' ' ILE . . . -53.64 -55.19 28.04 Favored 'General case' 0 N--CA 1.475 0.789 0 CA-C-N 113.714 -1.585 . . . . 0.0 113.415 177.625 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -74.24 -44.11 54.32 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 113.639 -1.619 . . . . 0.0 114.156 -174.758 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 13.6 tt0 -78.52 -43.19 27.45 Favored 'General case' 0 N--CA 1.472 0.652 0 N-CA-C 114.241 1.2 . . . . 0.0 114.241 -170.898 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 5' ' ' PHE . . . . . 0.6 ' HB2' HD12 ' A' ' 7' ' ' ILE . 46.3 m-85 -105.34 -23.99 12.76 Favored 'General case' 0 N--CA 1.484 1.233 0 N-CA-C 116.258 1.947 . . . . 0.0 116.258 -170.16 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 95.72 58.38 1.12 Allowed Glycine 0 CA--C 1.534 1.276 0 C-N-CA 124.225 0.917 . . . . 0.0 111.77 -175.083 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.624 HD13 ' HE3' ' A' ' 1' ' ' MET . 1.3 mt -125.77 151.11 70.46 Favored Pre-proline 0 N--CA 1.478 0.944 0 C-N-CA 124.764 1.225 . . . . 0.0 111.069 -173.57 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo -97.27 162.63 0.97 Allowed 'Trans proline' 0 C--O 1.24 0.597 0 C-N-CA 121.162 1.241 . . . . 0.0 109.703 161.596 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -53.44 -29.38 35.11 Favored 'General case' 0 CA--C 1.538 0.481 0 N-CA-C 114.719 1.377 . . . . 0.0 114.719 177.176 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -43.61 -59.87 2.0 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 126.196 1.799 . . . . 0.0 112.953 173.146 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.779 HG12 HG22 ' A' ' 31' ' ' ILE . 29.6 m -84.42 -29.89 7.13 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.195 0 N-CA-C 114.321 1.23 . . . . 0.0 114.321 -175.231 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -67.26 -29.79 69.5 Favored 'General case' 0 N--CA 1.48 1.064 0 N-CA-C 112.759 0.651 . . . . 0.0 112.759 172.943 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -66.66 -40.01 93.89 Favored Glycine 0 CA--C 1.536 1.374 0 C-N-CA 124.317 0.96 . . . . 0.0 112.401 170.616 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.756 HG22 HD12 ' A' ' 28' ' ' ILE . 1.0 OUTLIER -67.7 -34.13 76.29 Favored 'General case' 0 N--CA 1.487 1.404 0 C-N-CA 124.183 0.993 . . . . 0.0 112.937 177.232 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.569 HG21 ' HE1' ' A' ' 1' ' ' MET . 10.8 t -54.15 -40.58 47.3 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 C-N-CA 124.707 1.203 . . . . 0.0 112.879 165.772 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.478 HD22 ' HG3' ' A' ' 64' ' ' LYS . 83.2 mt -61.27 -37.13 82.03 Favored 'General case' 0 N--CA 1.472 0.645 0 N-CA-C 114.261 1.208 . . . . 0.0 114.261 176.494 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 48.2 t-20 -53.62 -47.9 69.8 Favored 'General case' 0 N--CA 1.481 1.076 0 CA-C-N 115.179 -0.919 . . . . 0.0 111.355 173.353 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.574 HG23 HG13 ' A' ' 28' ' ' ILE . 22.6 t -48.11 -51.61 9.0 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.213 0 CA-C-N 115.28 -0.873 . . . . 0.0 112.021 174.596 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.829 HG13 ' HA ' ' A' ' 56' ' ' LYS . 5.1 t -64.3 -48.16 86.62 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.144 0 C-N-CA 124.155 0.982 . . . . 0.0 111.327 -176.774 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -74.13 -43.11 58.72 Favored 'General case' 0 N--CA 1.469 0.519 0 N-CA-C 116.767 2.136 . . . . 0.0 116.767 -176.127 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -103.17 -22.45 13.74 Favored 'General case' 0 N--CA 1.481 1.107 0 N-CA-C 115.814 1.783 . . . . 0.0 115.814 -169.796 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 68.87 39.61 85.34 Favored Glycine 0 N--CA 1.477 1.413 0 N-CA-C 110.639 -0.984 . . . . 0.0 110.639 -165.928 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -86.55 142.82 18.91 Favored Glycine 0 N--CA 1.48 1.57 0 N-CA-C 108.815 -1.714 . . . . 0.0 108.815 -177.513 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 9.2 m-90 -49.6 103.15 0.04 OUTLIER 'General case' 0 N--CA 1.477 0.883 0 CA-C-N 113.624 -1.288 . . . . 0.0 112.71 -172.498 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.402 ' O ' HG23 ' A' ' 29' ' ' VAL . 3.2 p -56.44 -23.41 16.68 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.758 0 CA-C-N 114.028 -1.442 . . . . 0.0 114.414 176.368 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 5.0 t -62.43 -44.42 96.47 Favored 'General case' 0 N--CA 1.484 1.225 0 CA-C-N 115.648 -0.705 . . . . 0.0 112.558 178.389 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 1.6 m -60.86 -45.76 93.25 Favored 'General case' 0 N--CA 1.485 1.287 0 C-N-CA 123.871 0.868 . . . . 0.0 110.937 172.998 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.756 HD12 HG22 ' A' ' 14' ' ' THR . 8.4 mm -62.37 -46.58 96.09 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.152 0 C-N-CA 124.394 1.078 . . . . 0.0 111.867 -179.09 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.402 HG23 ' O ' ' A' ' 25' ' ' VAL . 48.7 t -50.31 -45.77 25.02 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.386 0 C-N-CA 124.757 1.223 . . . . 0.0 111.129 176.964 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 64.8 m -63.81 -27.31 69.09 Favored 'General case' 0 N--CA 1.481 1.095 0 N-CA-C 115.867 1.802 . . . . 0.0 115.867 177.825 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.779 HG22 HG12 ' A' ' 11' ' ' VAL . 34.9 mm -82.21 -39.81 16.67 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.032 0 C-N-CA 123.857 0.863 . . . . 0.0 109.07 178.967 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.773 HD22 ' HB ' ' A' ' 11' ' ' VAL . 3.4 mm? -56.64 -50.58 71.61 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 125.142 1.377 . . . . 0.0 112.204 172.171 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 1.4 p -70.89 -29.69 65.83 Favored 'General case' 0 N--CA 1.481 1.079 0 N-CA-C 114.683 1.364 . . . . 0.0 114.683 177.837 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -52.4 -25.63 10.43 Favored 'General case' 0 N--CA 1.477 0.918 0 N-CA-C 114.006 1.113 . . . . 0.0 114.006 170.456 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 58.5 t . . . . . 0 N--CA 1.485 1.322 0 C-N-CA 124.327 1.051 . . . . 0.0 112.051 173.753 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 39' ' ' GLY . . . . . 0.526 ' O ' ' HG ' ' A' ' 43' ' ' LEU . . . . . . . . 0 N--CA 1.48 1.58 0 CA-C-O 120.34 -0.144 . . . . 0.0 113.018 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 22.3 mt -61.45 -48.27 81.91 Favored 'General case' 0 N--CA 1.479 0.981 0 CA-C-N 113.589 -1.306 . . . . 0.0 113.5 -178.845 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 17.0 m -57.92 -41.25 82.3 Favored 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 123.658 0.783 . . . . 0.0 112.758 176.188 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 13.7 tp -60.5 -45.76 92.6 Favored 'General case' 0 N--CA 1.478 0.961 0 CA-C-N 115.554 -0.748 . . . . 0.0 111.393 173.969 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.526 ' HG ' ' O ' ' A' ' 39' ' ' GLY . 69.2 mt -61.85 -32.84 73.21 Favored 'General case' 0 N--CA 1.473 0.697 0 N-CA-C 113.66 0.985 . . . . 0.0 113.66 -179.269 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -63.9 -48.99 74.43 Favored 'General case' 0 N--CA 1.476 0.851 0 O-C-N 123.985 0.803 . . . . 0.0 112.102 171.802 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -62.52 -33.34 74.7 Favored 'General case' 0 N--CA 1.485 1.284 0 CA-C-O 122.239 1.019 . . . . 0.0 112.753 178.12 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -61.77 -14.33 31.64 Favored 'General case' 0 N--CA 1.478 0.933 0 N-CA-C 116.11 1.893 . . . . 0.0 116.11 176.559 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -48.54 -37.22 19.24 Favored Glycine 0 CA--C 1.542 1.771 0 O-C-N 124.718 1.261 . . . . 0.0 113.511 177.833 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 40.2 ttp180 -50.71 -50.76 54.46 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 125.671 1.588 . . . . 0.0 113.647 -173.602 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -145.52 37.98 1.12 Allowed 'General case' 0 N--CA 1.476 0.841 0 N-CA-C 114.064 1.135 . . . . 0.0 114.064 -175.013 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 27.6 t 52.96 133.37 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.504 0 C-N-CA 125.175 1.39 . . . . 0.0 112.855 -175.71 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.419 ' O ' ' HB3' ' A' ' 54' ' ' TYR 0.259 9.9 tp -37.79 -54.04 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.822 0 N-CA-C 117.89 2.552 . . . . 0.0 117.89 -168.186 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 38.4 tttt -61.98 -57.23 12.48 Favored 'General case' 0 CA--C 1.543 0.694 0 N-CA-C 114.096 1.147 . . . . 0.0 114.096 178.232 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -66.17 -30.0 70.39 Favored 'General case' 0 N--CA 1.479 1.011 0 O-C-N 123.925 0.765 . . . . 0.0 112.936 179.766 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 54' ' ' TYR . . . . . 0.419 ' HB3' ' O ' ' A' ' 51' ' ' ILE . 64.4 t80 -53.98 -61.42 2.31 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 124.893 1.277 . . . . 0.0 110.716 170.592 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.431 HD13 HG13 ' A' ' 15' ' ' VAL . 51.2 mt -65.01 -35.81 82.4 Favored 'General case' 0 N--CA 1.482 1.165 0 N-CA-C 113.622 0.971 . . . . 0.0 113.622 -174.662 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 56' ' ' LYS . . . . . 0.829 ' HA ' HG13 ' A' ' 19' ' ' VAL . 55.6 mttm -54.41 -56.58 17.26 Favored 'General case' 0 N--CA 1.473 0.693 0 O-C-N 125.34 1.65 . . . . 0.0 112.065 173.024 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 57.1 tttm -68.43 -45.47 72.47 Favored 'General case' 0 CA--C 1.542 0.635 0 CA-C-N 115.411 -0.813 . . . . 0.0 112.113 176.799 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 58' ' ' GLU . . . . . 0.451 ' O ' ' HB2' ' A' ' 62' ' ' LYS . 4.1 tp10 -56.81 -52.37 65.31 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-N 114.969 -1.014 . . . . 0.0 112.962 -175.969 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.532 HG23 HG21 ' A' ' 67' ' ' VAL . 1.2 mm -74.8 -26.7 19.75 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.261 0 CA-C-N 116.04 -0.527 . . . . 0.0 112.1 -177.713 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 60' ' ' LYS . . . . . 0.472 ' HB2' ' O ' ' A' ' 56' ' ' LYS . 3.8 tppt? -62.06 -42.2 98.94 Favored 'General case' 0 CA--C 1.539 0.543 0 O-C-N 124.383 1.052 . . . . 0.0 112.525 176.596 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 61.2 pttt -86.39 -26.99 24.49 Favored 'General case' 0 CA--C 1.547 0.86 0 CA-C-N 113.447 -1.706 . . . . 0.0 113.193 177.935 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 62' ' ' LYS . . . . . 0.451 ' HB2' ' O ' ' A' ' 58' ' ' GLU . 35.7 tptt -76.16 -58.37 3.32 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 125.714 1.606 . . . . 0.0 114.542 -178.008 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 103.32 110.72 3.48 Favored Glycine 0 CA--C 1.543 1.803 0 CA-C-N 114.628 -1.169 . . . . 0.0 112.189 -174.304 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.517 ' HD2' ' H ' ' A' ' 64' ' ' LYS . 11.2 mptt -34.75 -52.27 0.52 Allowed 'General case' 0 N--CA 1.481 1.077 0 N-CA-C 119.784 3.253 . . . . 0.0 119.784 -172.641 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -61.55 -45.59 93.52 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 123.779 0.831 . . . . 0.0 112.993 -179.778 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -65.48 -25.82 67.65 Favored 'General case' 0 N--CA 1.478 0.97 0 CA-C-N 113.924 -1.489 . . . . 0.0 112.949 174.12 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.532 HG21 HG23 ' A' ' 59' ' ' ILE . 71.7 t -63.77 -43.86 98.09 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.314 0 C-N-CA 123.319 0.648 . . . . 0.0 110.411 174.864 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -51.78 -44.48 36.52 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.966 0 C-N-CA 123.339 0.656 . . . . 0.0 111.671 173.562 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -70.43 -47.64 59.79 Favored 'General case' 0 N--CA 1.481 1.077 0 N-CA-C 113.222 0.823 . . . . 0.0 113.222 177.629 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 30.7 t90 . . . . . 0 N--CA 1.481 1.083 0 C-N-CA 126.382 1.873 . . . . 0.0 112.433 -178.69 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.668 ' HB3' HG22 ' A' ' 7' ' ' ILE . 68.4 mtp . . . . . 0 N--CA 1.474 0.757 0 N-CA-C 113.471 0.915 . . . . 0.0 113.471 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -64.37 -38.83 92.42 Favored 'General case' 0 N--CA 1.475 0.813 0 N-CA-C 114.111 1.152 . . . . 0.0 114.111 176.562 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 35.6 ttmt -91.25 -68.54 0.79 Allowed 'General case' 0 N--CA 1.471 0.605 0 N-CA-C 114.125 1.157 . . . . 0.0 114.125 -176.89 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 8.5 tt0 -61.66 -31.14 71.23 Favored 'General case' 0 CA--C 1.55 0.974 0 C-N-CA 125.188 1.395 . . . . 0.0 113.796 -173.623 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 5' ' ' PHE . . . . . 0.541 ' HD1' ' HB2' ' A' ' 41' ' ' SER . 45.1 m-85 -109.77 -11.93 14.67 Favored 'General case' 0 N--CA 1.474 0.74 0 N-CA-C 116.948 2.203 . . . . 0.0 116.948 -179.94 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 64.44 31.62 81.47 Favored Glycine 0 CA--C 1.538 1.511 0 C-N-CA 124.176 0.893 . . . . 0.0 113.856 -174.228 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.668 HG22 ' HB3' ' A' ' 1' ' ' MET . 0.7 OUTLIER -104.21 118.01 57.97 Favored Pre-proline 0 N--CA 1.478 0.939 0 C-N-CA 123.418 0.687 . . . . 0.0 110.863 -177.524 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -64.27 161.61 33.52 Favored 'Trans proline' 0 CA--C 1.537 0.653 0 C-N-CA 122.506 2.137 . . . . 0.0 112.277 -171.807 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -55.75 -29.1 59.02 Favored 'General case' 0 N--CA 1.476 0.83 0 CA-C-N 113.278 -1.783 . . . . 0.0 114.137 173.141 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -49.03 -33.55 11.52 Favored 'General case' 0 N--CA 1.48 1.033 0 N-CA-C 114.853 1.427 . . . . 0.0 114.853 172.941 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.763 HG12 HG22 ' A' ' 31' ' ' ILE . 30.2 m -112.15 -35.45 2.43 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.016 0 N-CA-C 113.789 1.033 . . . . 0.0 113.789 179.895 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 0.413 ' O ' ' HG ' ' A' ' 16' ' ' LEU . . . -64.57 -40.21 95.14 Favored 'General case' 0 N--CA 1.476 0.852 0 N-CA-C 113.651 0.982 . . . . 0.0 113.651 174.802 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -61.72 -40.67 99.09 Favored Glycine 0 CA--C 1.548 2.104 0 C-N-CA 124.172 0.891 . . . . 0.0 112.276 174.542 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.528 HG22 HD12 ' A' ' 28' ' ' ILE . 4.3 m -66.81 -40.99 88.25 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 125.139 1.376 . . . . 0.0 113.46 177.324 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.479 HG21 ' HE1' ' A' ' 1' ' ' MET . 54.4 t -52.54 -46.96 49.05 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.207 0 C-N-CA 123.126 0.57 . . . . 0.0 111.249 169.056 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.666 HD11 HG12 ' A' ' 68' ' ' ILE . 23.8 mt -57.28 -48.19 79.54 Favored 'General case' 0 N--CA 1.482 1.174 0 O-C-N 123.839 0.712 . . . . 0.0 112.904 179.205 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 11.8 t-20 -54.44 -44.68 72.67 Favored 'General case' 0 CA--C 1.542 0.665 0 CA-C-N 114.857 -1.065 . . . . 0.0 111.338 179.168 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.932 HG21 HD11 ' A' ' 28' ' ' ILE . 2.8 t -68.68 -40.96 82.35 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.762 0 CA-C-N 113.475 -1.693 . . . . 0.0 114.087 179.336 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.656 HG13 ' HA ' ' A' ' 56' ' ' LYS . 40.5 t -59.01 -52.48 60.16 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.357 0 O-C-N 124.392 1.058 . . . . 0.0 109.265 175.73 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 20' ' ' GLU . . . . . 0.542 ' HG3' ' HE2' ' A' ' 64' ' ' LYS . 36.0 mt-10 -55.01 -53.54 54.46 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 125.232 1.413 . . . . 0.0 113.35 178.099 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -77.24 -11.66 59.85 Favored 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 115.683 1.735 . . . . 0.0 115.683 -175.379 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 67.66 47.93 59.01 Favored Glycine 0 N--CA 1.478 1.472 0 C-N-CA 124.523 1.059 . . . . 0.0 111.424 -172.44 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -94.13 -160.1 34.44 Favored Glycine 0 N--CA 1.475 1.248 0 CA-C-O 123.163 1.424 . . . . 0.0 113.293 -173.958 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 9.1 m-90 -102.89 105.69 16.1 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-O 122.651 1.215 . . . . 0.0 113.305 179.16 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.48 HG23 ' HE3' ' A' ' 56' ' ' LYS . 77.4 t -55.67 -27.23 21.36 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.045 0 CA-C-N 114.057 -1.429 . . . . 0.0 112.899 168.338 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 3.1 t -60.28 -38.32 83.19 Favored 'General case' 0 N--CA 1.485 1.286 0 N-CA-C 113.349 0.87 . . . . 0.0 113.349 179.143 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 2.7 m -64.07 -41.03 97.49 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 125.09 1.356 . . . . 0.0 110.684 175.013 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.932 HD11 HG21 ' A' ' 18' ' ' VAL . 1.6 mm -73.65 -39.85 53.87 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.277 0 CA-C-N 115.508 -0.769 . . . . 0.0 111.411 -178.79 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 25.6 t -46.09 -44.77 5.5 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 C-N-CA 124.113 0.965 . . . . 0.0 111.639 175.589 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 20.0 m -57.1 -41.31 78.68 Favored 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 124.966 1.307 . . . . 0.0 114.472 174.287 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.763 HG22 HG12 ' A' ' 11' ' ' VAL . 16.4 mm -75.09 -37.62 40.79 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.272 0 C-N-CA 124.483 1.113 . . . . 0.0 110.196 -178.957 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.535 ' HB3' ' HA3' ' A' ' 39' ' ' GLY . 4.2 mm? -55.37 -41.17 72.23 Favored 'General case' 0 N--CA 1.49 1.573 0 C-N-CA 124.342 1.057 . . . . 0.0 110.926 168.805 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 25.5 m -68.53 -38.83 81.2 Favored 'General case' 0 N--CA 1.485 1.317 0 N-CA-C 114.232 1.197 . . . . 0.0 114.232 174.961 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -55.68 -30.12 60.53 Favored 'General case' 0 N--CA 1.481 1.115 0 O-C-N 124.7 1.25 . . . . 0.0 113.242 175.131 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.427 ' HB ' ' O ' ' A' ' 32' ' ' LEU . 54.5 t . . . . . 0 N--CA 1.48 1.034 0 C-N-CA 125.838 1.655 . . . . 0.0 113.423 172.916 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 39' ' ' GLY . . . . . 0.535 ' HA3' ' HB3' ' A' ' 32' ' ' LEU . . . . . . . . 0 CA--C 1.546 1.977 0 N-CA-C 111.899 -0.481 . . . . 0.0 111.899 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 9.4 mt -51.91 -40.03 60.07 Favored 'General case' 0 N--CA 1.485 1.303 0 N-CA-C 116.631 2.086 . . . . 0.0 116.631 -168.52 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 41' ' ' SER . . . . . 0.541 ' HB2' ' HD1' ' A' ' 5' ' ' PHE . 7.9 p -59.8 -49.04 79.26 Favored 'General case' 0 CA--C 1.546 0.792 0 N-CA-C 113.448 0.907 . . . . 0.0 113.448 178.792 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 15.8 tp -61.16 -47.36 86.56 Favored 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 122.968 0.507 . . . . 0.0 110.43 172.684 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 43.9 mt -66.19 -26.64 67.5 Favored 'General case' 0 N--CA 1.476 0.863 0 CA-C-N 114.605 -1.179 . . . . 0.0 114.062 -175.215 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -69.75 -45.16 68.71 Favored 'General case' 0 N--CA 1.475 0.823 0 CA-C-N 115.694 -0.685 . . . . 0.0 111.82 171.57 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -63.54 -35.81 81.7 Favored 'General case' 0 N--CA 1.479 0.976 0 CA-C-O 121.005 0.431 . . . . 0.0 111.875 173.845 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -66.13 -28.59 68.91 Favored 'General case' 0 N--CA 1.474 0.774 0 N-CA-C 116.193 1.923 . . . . 0.0 116.193 179.654 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -53.14 -35.05 48.37 Favored Glycine 0 N--CA 1.482 1.717 0 C-N-CA 124.818 1.199 . . . . 0.0 113.39 -178.433 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 42.2 ttp180 -57.24 -41.92 80.48 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 126.233 1.813 . . . . 0.0 113.929 -176.177 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -138.57 57.43 1.69 Allowed 'General case' 0 N--CA 1.476 0.839 0 CA-C-O 121.887 0.851 . . . . 0.0 110.149 178.197 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 9.0 t 30.33 114.32 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.225 0 N-CA-C 116.84 2.163 . . . . 0.0 116.84 -178.868 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 7.0 tp -26.99 -54.04 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.349 0 N-CA-C 118.023 2.601 . . . . 0.0 118.023 -177.273 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 0.449 ' HD2' ' HB ' ' A' ' 25' ' ' VAL . 24.1 tptp -57.65 -58.15 9.57 Favored 'General case' 0 N--CA 1.481 1.108 0 C-N-CA 124.494 1.118 . . . . 0.0 111.913 -177.762 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -72.01 -35.21 69.37 Favored 'General case' 0 N--CA 1.484 1.237 0 O-C-N 124.579 1.174 . . . . 0.0 113.831 177.847 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 67.8 t80 -45.78 -60.96 1.93 Allowed 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 125.445 1.498 . . . . 0.0 112.117 -179.695 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 59.4 mt -65.86 -36.14 82.61 Favored 'General case' 0 N--CA 1.475 0.811 0 N-CA-C 114.782 1.401 . . . . 0.0 114.782 -175.24 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 56' ' ' LYS . . . . . 0.656 ' HA ' HG13 ' A' ' 19' ' ' VAL . 35.5 mmtp -57.67 -56.2 25.02 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-N 114.211 -1.359 . . . . 0.0 112.311 177.386 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 57' ' ' LYS . . . . . 0.445 ' HE3' ' HE3' ' A' ' 61' ' ' LYS . 64.0 tttp -69.51 -51.15 38.4 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-N 115.054 -0.975 . . . . 0.0 111.968 175.673 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 58' ' ' GLU . . . . . 0.553 ' O ' ' HB2' ' A' ' 62' ' ' LYS . 3.6 mm-40 -54.93 -50.75 68.08 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-O 118.281 -0.866 . . . . 0.0 112.682 -173.377 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.606 HG23 HG21 ' A' ' 67' ' ' VAL . 2.7 mm -79.14 -25.68 12.94 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.077 0 CA-C-O 118.618 -0.706 . . . . 0.0 112.007 -175.824 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 60' ' ' LYS . . . . . 0.414 ' HB2' ' O ' ' A' ' 56' ' ' LYS . 8.7 tppt? -62.1 -32.42 72.98 Favored 'General case' 0 N--CA 1.473 0.698 0 N-CA-C 114.416 1.265 . . . . 0.0 114.416 171.894 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 61' ' ' LYS . . . . . 0.445 ' HE3' ' HE3' ' A' ' 57' ' ' LYS . 48.4 mttm -88.56 -45.7 9.68 Favored 'General case' 0 N--CA 1.476 0.838 0 CA-C-N 113.351 -1.75 . . . . 0.0 112.42 176.127 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 62' ' ' LYS . . . . . 0.553 ' HB2' ' O ' ' A' ' 58' ' ' GLU . 2.9 tttm -64.41 -45.55 87.07 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 126.448 1.899 . . . . 0.0 112.96 -172.512 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 95.45 113.66 2.75 Favored Glycine 0 N--CA 1.479 1.546 0 O-C-N 124.958 1.411 . . . . 0.0 109.65 -175.546 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.622 ' HD2' ' H ' ' A' ' 64' ' ' LYS . 10.7 mptt -44.66 -43.7 8.5 Favored 'General case' 0 N--CA 1.484 1.234 0 N-CA-C 116.801 2.148 . . . . 0.0 116.801 -172.636 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 65' ' ' ARG . . . . . 0.489 ' O ' ' HB ' ' A' ' 68' ' ' ILE . 0.0 OUTLIER -56.16 -48.53 76.11 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 125.381 1.472 . . . . 0.0 114.576 178.054 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -64.71 -28.05 69.33 Favored 'General case' 0 N--CA 1.473 0.718 0 N-CA-C 114.463 1.282 . . . . 0.0 114.463 172.526 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.606 HG21 HG23 ' A' ' 59' ' ' ILE . 95.3 t -72.96 -32.82 41.25 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.944 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.321 179.098 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.666 HG12 HD11 ' A' ' 16' ' ' LEU . 4.3 mm -50.05 -49.57 21.55 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.332 0 C-N-CA 123.494 0.718 . . . . 0.0 110.098 167.132 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -64.59 -50.0 68.92 Favored 'General case' 0 N--CA 1.481 1.076 0 CA-C-N 114.917 -1.038 . . . . 0.0 112.912 178.636 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 23.2 t90 . . . . . 0 CA--C 1.544 0.728 0 C-N-CA 126.489 1.915 . . . . 0.0 112.987 179.394 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.73 ' HE1' HG21 ' A' ' 15' ' ' VAL . 74.1 mtp . . . . . 0 N--CA 1.482 1.156 0 N-CA-C 113.327 0.862 . . . . 0.0 113.327 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -65.18 -56.12 14.68 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-N 114.915 -1.039 . . . . 0.0 112.67 175.474 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 14.4 ttmm -71.09 -52.96 16.4 Favored 'General case' 0 CA--C 1.549 0.935 0 CA-C-N 114.361 -1.291 . . . . 0.0 114.118 -172.967 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 4' ' ' GLU . . . . . 0.434 ' HB2' ' O ' ' A' ' 70' ' ' TRP . 1.8 mp0 -79.77 -38.45 33.15 Favored 'General case' 0 N--CA 1.476 0.829 0 N-CA-C 115.052 1.501 . . . . 0.0 115.052 -174.559 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 5' ' ' PHE . . . . . 0.509 ' HD2' ' HA ' ' A' ' 1' ' ' MET . 73.9 m-85 -106.28 -9.72 16.71 Favored 'General case' 0 N--CA 1.484 1.253 0 N-CA-C 117.041 2.237 . . . . 0.0 117.041 -172.236 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 66.73 36.92 91.94 Favored Glycine 0 CA--C 1.54 1.632 0 CA-C-O 121.971 0.762 . . . . 0.0 112.917 -176.055 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.669 HG23 HG23 ' A' ' 11' ' ' VAL . 0.6 OUTLIER -116.12 112.87 41.81 Favored Pre-proline 0 N--CA 1.472 0.657 0 C-N-CA 124.327 1.051 . . . . 0.0 109.413 179.106 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_endo -63.86 164.05 23.02 Favored 'Trans proline' 0 N--CA 1.48 0.68 0 C-N-CA 121.184 1.256 . . . . 0.0 111.597 -174.471 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -55.76 -28.42 55.85 Favored 'General case' 0 N--CA 1.479 0.989 0 N-CA-C 114.674 1.361 . . . . 0.0 114.674 176.75 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -45.51 -43.98 12.21 Favored 'General case' 0 CA--C 1.549 0.917 0 C-N-CA 125.985 1.714 . . . . 0.0 113.753 174.628 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.952 HG12 HG22 ' A' ' 31' ' ' ILE . 33.6 m -100.24 -28.92 3.28 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.054 0 N-CA-C 114.766 1.395 . . . . 0.0 114.766 179.248 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -67.6 -34.97 78.07 Favored 'General case' 0 N--CA 1.477 0.895 0 N-CA-C 113.791 1.034 . . . . 0.0 113.791 176.76 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -61.47 -41.34 99.53 Favored Glycine 0 N--CA 1.478 1.44 0 CA-C-O 122.467 1.037 . . . . 0.0 112.304 172.357 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 3.1 m -64.1 -34.05 77.15 Favored 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 126.046 1.738 . . . . 0.0 112.893 175.524 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.73 HG21 ' HE1' ' A' ' 1' ' ' MET . 20.5 t -63.5 -36.64 77.06 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.065 0 C-N-CA 123.667 0.787 . . . . 0.0 112.083 172.039 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.631 HD13 ' HB3' ' A' ' 64' ' ' LYS . 31.6 mt -65.43 -40.36 93.21 Favored 'General case' 0 N--CA 1.485 1.305 0 N-CA-C 112.913 0.708 . . . . 0.0 112.913 174.234 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 74.1 m-20 -57.62 -43.99 85.18 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 124.976 1.31 . . . . 0.0 112.448 174.384 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.412 ' HB ' ' O ' ' A' ' 15' ' ' VAL . 4.1 t -48.11 -57.64 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.35 0 C-N-CA 123.835 0.854 . . . . 0.0 111.373 168.391 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.595 HG13 ' HA ' ' A' ' 56' ' ' LYS . 4.8 t -60.66 -44.78 97.76 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 123.935 0.772 . . . . 0.0 111.913 -176.16 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 27.6 mt-10 -63.93 -43.74 94.97 Favored 'General case' 0 N--CA 1.472 0.634 0 N-CA-C 115.301 1.593 . . . . 0.0 115.301 179.506 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -97.04 -11.51 24.39 Favored 'General case' 0 N--CA 1.478 0.934 0 N-CA-C 116.221 1.934 . . . . 0.0 116.221 -170.917 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 73.49 25.28 72.98 Favored Glycine 0 CA--C 1.544 1.866 0 O-C-N 123.521 0.513 . . . . 0.0 112.736 -169.002 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -78.76 149.94 33.8 Favored Glycine 0 N--CA 1.476 1.362 0 CA-C-O 122.419 1.01 . . . . 0.0 113.689 -171.054 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 24' ' ' TRP . . . . . 0.492 ' HB3' HG22 ' A' ' 26' ' ' THR . 2.9 m-90 -62.1 98.08 0.1 Allowed 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 125.31 1.444 . . . . 0.0 112.327 178.402 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 5.0 p -51.87 -27.84 9.19 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.868 0 CA-C-N 113.734 -1.575 . . . . 0.0 113.985 173.187 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.492 HG22 ' HB3' ' A' ' 24' ' ' TRP . 13.9 t -59.52 -40.72 88.05 Favored 'General case' 0 CA--C 1.546 0.827 0 C-N-CA 124.735 1.214 . . . . 0.0 112.937 -178.055 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -67.66 -47.07 70.57 Favored 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 124.101 0.96 . . . . 0.0 110.604 174.964 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 2.3 mp -60.21 -35.4 61.72 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.036 0 C-N-CA 125.259 1.424 . . . . 0.0 112.99 177.179 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.411 ' O ' ' HB2' ' A' ' 32' ' ' LEU . 15.9 t -48.97 -40.62 12.78 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.365 0 C-N-CA 124.403 1.081 . . . . 0.0 112.38 173.845 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 59.7 p -61.03 -30.3 70.22 Favored 'General case' 0 N--CA 1.477 0.888 0 N-CA-C 114.02 1.118 . . . . 0.0 114.02 176.255 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.952 HG22 HG12 ' A' ' 11' ' ' VAL . 42.6 mm -77.33 -36.47 23.96 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.989 0 C-N-CA 124.07 0.948 . . . . 0.0 109.191 179.965 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.561 ' HB3' ' HA3' ' A' ' 39' ' ' GLY . 3.9 mm? -60.13 -36.42 77.45 Favored 'General case' 0 N--CA 1.49 1.554 0 C-N-CA 123.741 0.817 . . . . 0.0 111.315 169.414 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 2.5 m -72.55 -34.31 67.42 Favored 'General case' 0 N--CA 1.483 1.176 0 N-CA-C 114.698 1.37 . . . . 0.0 114.698 175.403 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -54.49 -29.02 48.77 Favored 'General case' 0 N--CA 1.482 1.16 0 O-C-N 124.245 0.965 . . . . 0.0 113.459 174.317 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 70.5 t . . . . . 0 N--CA 1.484 1.255 0 C-N-CA 126.313 1.845 . . . . 0.0 113.03 172.031 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 39' ' ' GLY . . . . . 0.561 ' HA3' ' HB3' ' A' ' 32' ' ' LEU . . . . . . . . 0 CA--C 1.543 1.815 0 N-CA-C 113.404 0.121 . . . . 0.0 113.404 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 14.3 mt -53.23 -41.74 65.7 Favored 'General case' 0 N--CA 1.48 1.059 0 N-CA-C 116.459 2.022 . . . . 0.0 116.459 -171.127 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 41' ' ' SER . . . . . 0.469 ' HB2' ' HD1' ' A' ' 5' ' ' PHE . 11.5 p -59.47 -51.62 69.1 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 125.327 1.451 . . . . 0.0 113.86 175.26 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 14.5 tp -60.74 -43.48 97.87 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 123.676 0.79 . . . . 0.0 110.31 174.157 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 82.7 mt -65.68 -27.37 68.3 Favored 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 114.618 1.34 . . . . 0.0 114.618 -178.23 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -70.33 -48.26 57.32 Favored 'General case' 0 N--CA 1.478 0.953 0 CA-C-N 115.43 -0.805 . . . . 0.0 112.323 169.91 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -59.19 -37.16 76.74 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 123.446 0.699 . . . . 0.0 112.697 176.292 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -57.87 -28.95 64.62 Favored 'General case' 0 C--N 1.321 -0.63 0 C-N-CA 126.546 1.938 . . . . 0.0 115.642 177.76 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -47.81 -41.78 20.67 Favored Glycine 0 CA--C 1.536 1.371 0 C-N-CA 125.438 1.494 . . . . 0.0 114.608 -174.514 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 41.0 ttp-105 -53.81 -47.02 71.27 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 126.0 1.72 . . . . 0.0 113.81 -174.797 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 5.0 tt0 -127.14 31.01 5.32 Favored 'General case' 0 CA--C 1.547 0.854 0 N-CA-C 113.787 1.032 . . . . 0.0 113.787 -177.553 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 24.5 t 45.85 126.8 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 125.353 1.461 . . . . 0.0 113.809 -171.545 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 9.8 tp -37.44 -42.25 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 N-CA-C 117.239 2.311 . . . . 0.0 117.239 -173.437 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 8.4 mmtt -57.41 -72.05 0.09 Allowed 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 124.31 1.044 . . . . 0.0 112.05 174.393 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -62.49 -34.8 77.57 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 125.196 1.398 . . . . 0.0 113.853 -177.842 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 87.6 t80 -48.62 -59.45 3.51 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 125.497 1.519 . . . . 0.0 111.646 175.715 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.513 HD13 HG13 ' A' ' 15' ' ' VAL . 75.0 mt -67.86 -41.67 82.54 Favored 'General case' 0 N--CA 1.482 1.149 0 N-CA-C 114.448 1.277 . . . . 0.0 114.448 -177.873 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 56' ' ' LYS . . . . . 0.595 ' HA ' HG13 ' A' ' 19' ' ' VAL . 33.2 mmtp -55.98 -42.16 75.92 Favored 'General case' 0 N--CA 1.479 0.993 0 CA-C-N 113.253 -1.794 . . . . 0.0 114.507 178.963 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 59.3 tttm -80.35 -54.97 5.23 Favored 'General case' 0 N--CA 1.473 0.715 0 O-C-N 124.843 1.34 . . . . 0.0 112.327 172.559 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 72.9 tt0 -58.68 -46.02 88.16 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-O 117.766 -1.111 . . . . 0.0 112.489 -168.694 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.676 HG23 HG21 ' A' ' 67' ' ' VAL . 3.7 mm -79.36 -20.02 12.59 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.895 0 C-N-CA 119.911 -0.716 . . . . 0.0 112.081 -173.814 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 22.9 tttp -72.55 -24.91 61.19 Favored 'General case' 0 CA--C 1.547 0.851 0 O-C-N 124.713 1.258 . . . . 0.0 114.147 172.638 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 45.3 mmtm -97.25 -38.8 9.54 Favored 'General case' 0 N--CA 1.477 0.886 0 CA-C-N 113.549 -1.66 . . . . 0.0 111.58 178.455 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 62' ' ' LYS . . . . . 0.439 ' HD3' HG22 ' A' ' 67' ' ' VAL . 31.6 tttp -71.54 -52.65 17.1 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 126.282 1.833 . . . . 0.0 114.514 -177.938 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 102.17 114.62 3.88 Favored Glycine 0 N--CA 1.483 1.79 0 O-C-N 124.361 1.038 . . . . 0.0 111.022 -173.289 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.659 ' HD2' ' H ' ' A' ' 64' ' ' LYS . 9.0 mptt -41.44 -44.37 2.86 Favored 'General case' 0 N--CA 1.486 1.354 0 N-CA-C 117.548 2.425 . . . . 0.0 117.548 -176.043 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . 0.373 0.0 OUTLIER -53.08 -51.76 60.78 Favored 'General case' 0 C--N 1.315 -0.912 0 C-N-CA 127.801 2.44 . . . . 0.0 114.124 177.216 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -65.71 -27.62 68.47 Favored 'General case' 0 N--CA 1.475 0.788 0 N-CA-C 114.111 1.152 . . . . 0.0 114.111 173.436 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.676 HG21 HG23 ' A' ' 59' ' ' ILE . 21.7 t -71.08 -36.16 61.88 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.966 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.502 179.876 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.402 HG12 HD11 ' A' ' 16' ' ' LEU . 14.2 mm -49.01 -44.61 15.99 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.847 0 C-N-CA 124.243 1.017 . . . . 0.0 110.939 167.696 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -70.77 -51.76 25.01 Favored 'General case' 0 N--CA 1.477 0.877 0 CA-C-N 115.004 -0.998 . . . . 0.0 112.331 179.088 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 70' ' ' TRP . . . . . 0.434 ' O ' ' HB2' ' A' ' 4' ' ' GLU . 36.2 t90 . . . . . 0 CA--C 1.553 1.073 0 C-N-CA 125.303 1.441 . . . . 0.0 113.352 -177.277 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.418 ' HE1' HG21 ' A' ' 15' ' ' VAL . 34.3 mtp . . . . . 0 CA--C 1.533 0.294 0 CA-C-O 119.718 -0.182 . . . . 0.0 110.738 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 2' ' ' ALA . . . . . 0.412 ' HA ' ' O ' ' A' ' 7' ' ' ILE . . . -60.29 -50.39 73.84 Favored 'General case' 0 N--CA 1.478 0.966 0 CA-C-N 114.374 -1.285 . . . . 0.0 112.863 178.844 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 10.5 tptm -71.73 -58.92 3.05 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 113.543 -1.662 . . . . 0.0 114.55 -175.716 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -67.95 -43.58 78.77 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 116.263 1.949 . . . . 0.0 116.263 -170.209 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 5' ' ' PHE . . . . . 0.496 ' HB2' HD12 ' A' ' 7' ' ' ILE . 33.7 m-85 -102.0 -26.09 13.52 Favored 'General case' 0 N--CA 1.481 1.113 0 N-CA-C 116.665 2.098 . . . . 0.0 116.665 -170.408 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 92.47 58.64 1.34 Allowed Glycine 0 N--CA 1.477 1.384 0 O-C-N 124.931 1.394 . . . . 0.0 110.537 -174.975 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.496 HD12 ' HB2' ' A' ' 5' ' ' PHE . 0.7 OUTLIER -120.47 140.48 30.38 Favored Pre-proline 0 N--CA 1.476 0.831 0 CA-C-N 114.365 -0.918 . . . . 0.0 110.309 -179.12 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 68.3 Cg_endo -89.47 152.71 5.36 Favored 'Trans proline' 0 CA--C 1.534 0.495 0 C-N-CA 121.27 1.313 . . . . 0.0 109.069 166.828 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -44.65 -34.37 2.17 Favored 'General case' 0 N--CA 1.47 0.532 0 N-CA-C 116.108 1.892 . . . . 0.0 116.108 177.03 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -36.2 -43.29 0.35 Allowed 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 125.984 1.714 . . . . 0.0 115.108 168.687 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.921 HG12 HG22 ' A' ' 31' ' ' ILE . 10.4 m -103.66 -37.28 4.49 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.1 0 N-CA-C 115.192 1.553 . . . . 0.0 115.192 -177.442 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 0.489 ' O ' ' HG ' ' A' ' 16' ' ' LEU . . . -64.76 -36.28 83.8 Favored 'General case' 0 N--CA 1.482 1.15 0 N-CA-C 113.145 0.795 . . . . 0.0 113.145 177.758 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -64.12 -40.87 98.49 Favored Glycine 0 N--CA 1.479 1.567 0 C-N-CA 125.777 1.656 . . . . 0.0 112.35 176.13 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 2.1 m -63.98 -41.86 97.39 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 124.54 1.136 . . . . 0.0 112.404 174.308 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.663 HG13 HD13 ' A' ' 55' ' ' LEU . 32.1 t -53.75 -40.91 45.34 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.934 0 CA-C-O 121.174 0.512 . . . . 0.0 112.2 170.188 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.597 HD11 HG12 ' A' ' 68' ' ' ILE . 45.7 mt -64.99 -49.88 68.53 Favored 'General case' 0 N--CA 1.477 0.898 0 CA-C-N 115.699 -0.682 . . . . 0.0 112.725 178.825 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 1.7 t30 -42.8 -45.2 4.75 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-O 123.167 1.461 . . . . 0.0 113.839 172.657 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.739 HG13 ' O ' ' A' ' 23' ' ' GLY . 5.3 t -63.27 -50.99 76.72 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.746 0 CA-C-N 109.976 -3.284 . . . . 0.0 112.29 178.793 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.746 HG13 ' HA ' ' A' ' 56' ' ' LYS . 36.0 t -59.91 -46.39 93.98 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.889 0 O-C-N 124.77 1.294 . . . . 0.0 110.691 179.419 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -63.58 -39.82 95.37 Favored 'General case' 0 N--CA 1.466 0.369 0 N-CA-C 114.342 1.238 . . . . 0.0 114.342 -177.51 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -96.39 2.53 52.74 Favored 'General case' 0 N--CA 1.478 0.963 0 N-CA-C 115.616 1.71 . . . . 0.0 115.616 -177.593 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 56.97 47.08 89.95 Favored Glycine 0 CA--C 1.541 1.702 0 C-N-CA 123.644 0.64 . . . . 0.0 111.572 -174.39 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.739 ' O ' HG13 ' A' ' 18' ' ' VAL . . . -102.97 154.49 18.22 Favored Glycine 0 N--CA 1.476 1.313 0 CA-C-O 123.944 1.858 . . . . 0.0 112.594 -174.576 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 4.5 m-90 -73.43 101.11 3.4 Favored 'General case' 0 N--CA 1.473 0.689 0 CA-C-N 112.961 -1.619 . . . . 0.0 112.807 -175.69 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.682 ' HB ' HG11 ' A' ' 18' ' ' VAL . 7.6 p -62.37 -20.46 24.66 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 N-CA-C 114.171 1.174 . . . . 0.0 114.171 173.3 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 6.4 t -61.02 -28.62 69.18 Favored 'General case' 0 N--CA 1.481 1.09 0 N-CA-C 112.952 0.723 . . . . 0.0 112.952 178.942 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -74.91 -43.61 53.3 Favored 'General case' 0 N--CA 1.474 0.73 0 CA-C-O 119.625 -0.226 . . . . 0.0 111.118 174.669 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 3.2 mp -64.12 -30.93 51.4 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.053 0 C-N-CA 127.67 2.388 . . . . 0.0 112.853 178.15 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.578 HG13 HD11 ' A' ' 43' ' ' LEU . 31.2 t -44.96 -37.47 1.63 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.14 0 C-N-CA 124.616 1.166 . . . . 0.0 112.702 172.542 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 91.5 p -60.4 -35.39 75.65 Favored 'General case' 0 N--CA 1.476 0.873 0 N-CA-C 113.217 0.821 . . . . 0.0 113.217 176.415 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.921 HG22 HG12 ' A' ' 11' ' ' VAL . 33.8 mm -77.87 -34.08 19.28 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.775 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.304 -179.781 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.591 HD22 ' HB ' ' A' ' 11' ' ' VAL . 4.1 mm? -60.92 -50.03 75.08 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 124.127 0.971 . . . . 0.0 112.159 172.105 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -69.84 -26.14 64.08 Favored 'General case' 0 N--CA 1.482 1.132 0 N-CA-C 114.925 1.454 . . . . 0.0 114.925 -179.87 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -51.56 -38.38 54.09 Favored 'General case' 0 CA--C 1.545 0.758 0 O-C-N 124.139 0.899 . . . . 0.0 112.508 169.736 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 22.8 t . . . . . 0 N--CA 1.481 1.081 0 C-N-CA 125.346 1.458 . . . . 0.0 111.607 174.852 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 39' ' ' GLY . . . . . 0.471 ' HA2' ' HB3' ' A' ' 32' ' ' LEU . . . . . . . . 0 CA--C 1.535 1.302 0 N-CA-C 110.788 -0.925 . . . . 0.0 110.788 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 66.4 mt -60.32 -52.41 65.38 Favored 'General case' 0 N--CA 1.47 0.565 0 N-CA-C 116.388 1.996 . . . . 0.0 116.388 -179.675 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 23.4 p -62.78 -35.15 78.91 Favored 'General case' 0 N--CA 1.479 0.997 0 CA-C-O 118.092 -0.956 . . . . 0.0 113.16 177.939 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 13.4 tp -61.05 -50.62 72.59 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 123.007 0.523 . . . . 0.0 111.12 170.56 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.578 HD11 HG13 ' A' ' 29' ' ' VAL . 59.1 mt -61.92 -34.45 76.08 Favored 'General case' 0 N--CA 1.479 0.985 0 O-C-N 124.222 0.951 . . . . 0.0 113.439 -179.532 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -63.24 -46.03 88.8 Favored 'General case' 0 N--CA 1.473 0.692 0 N-CA-C 112.995 0.739 . . . . 0.0 112.995 172.895 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -65.07 -35.72 82.06 Favored 'General case' 0 N--CA 1.487 1.388 0 CA-C-N 115.268 -0.878 . . . . 0.0 112.483 175.437 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -60.81 -28.31 68.69 Favored 'General case' 0 N--CA 1.475 0.779 0 N-CA-C 115.122 1.527 . . . . 0.0 115.122 179.837 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -44.85 -35.53 4.45 Favored Glycine 0 N--CA 1.48 1.601 0 C-N-CA 126.679 2.085 . . . . 0.0 114.193 -175.789 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 48' ' ' ARG . . . . . 0.517 ' HE ' ' HE1' ' A' ' 54' ' ' TYR . 63.3 ttp85 -51.61 -54.99 21.85 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-N 112.875 -1.663 . . . . 0.0 112.732 -176.692 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 25.4 tt0 -127.71 36.73 4.31 Favored 'General case' 0 N--CA 1.473 0.71 0 N-CA-C 114.154 1.168 . . . . 0.0 114.154 -173.14 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 75.8 p 50.4 121.69 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 125.221 1.408 . . . . 0.0 111.974 -171.387 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.473 ' O ' ' HB3' ' A' ' 54' ' ' TYR 0.276 6.3 tp -31.35 -53.86 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.483 1.223 0 N-CA-C 117.16 2.282 . . . . 0.0 117.16 -173.438 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 0.622 ' HG3' HG12 ' A' ' 25' ' ' VAL . 0.1 OUTLIER -59.11 -66.97 0.42 Allowed 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 115.561 1.689 . . . . 0.0 115.561 175.402 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -54.99 -34.17 63.15 Favored 'General case' 0 N--CA 1.475 0.788 0 O-C-N 124.776 1.298 . . . . 0.0 113.252 177.601 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 54' ' ' TYR . . . . . 0.517 ' HE1' ' HE ' ' A' ' 48' ' ' ARG . 87.5 t80 -54.36 -63.34 1.18 Allowed 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 126.141 1.776 . . . . 0.0 110.541 174.981 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.663 HD13 HG13 ' A' ' 15' ' ' VAL . 96.4 mt -66.98 -42.2 85.48 Favored 'General case' 0 N--CA 1.476 0.843 0 N-CA-C 115.379 1.622 . . . . 0.0 115.379 -177.453 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 56' ' ' LYS . . . . . 0.746 ' HA ' HG13 ' A' ' 19' ' ' VAL . 96.4 mttt -56.52 -43.21 79.58 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 113.109 -1.859 . . . . 0.0 114.092 178.522 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 57' ' ' LYS . . . . . 0.409 ' O ' ' HG3' ' A' ' 61' ' ' LYS . 15.6 tttt -82.64 -50.07 9.15 Favored 'General case' 0 C--N 1.318 -0.776 0 O-C-N 124.158 0.911 . . . . 0.0 112.997 174.306 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 58' ' ' GLU . . . . . 0.461 ' O ' ' HB2' ' A' ' 62' ' ' LYS . 31.1 tt0 -57.72 -47.49 82.26 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 118.2 -0.905 . . . . 0.0 112.397 -175.95 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.606 HG23 HG21 ' A' ' 67' ' ' VAL . 1.8 mm -75.84 -23.32 16.29 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.26 0 N-CA-C 112.266 0.469 . . . . 0.0 112.266 -175.49 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 60' ' ' LYS . . . . . 0.441 ' HB2' ' O ' ' A' ' 56' ' ' LYS . 32.2 tptt -64.01 -38.55 91.5 Favored 'General case' 0 CA--C 1.544 0.717 0 O-C-N 124.695 1.247 . . . . 0.0 112.284 170.354 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 61' ' ' LYS . . . . . 0.409 ' HG3' ' O ' ' A' ' 57' ' ' LYS . 26.5 mtpt -77.3 -45.44 26.25 Favored 'General case' 0 N--CA 1.481 1.108 0 CA-C-N 112.925 -1.943 . . . . 0.0 113.05 177.139 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 62' ' ' LYS . . . . . 0.461 ' HB2' ' O ' ' A' ' 58' ' ' GLU . 10.4 tttm -70.25 -47.32 61.84 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 126.699 1.999 . . . . 0.0 113.352 -172.468 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 96.05 99.58 1.85 Allowed Glycine 0 N--CA 1.467 0.708 0 CA-C-N 114.46 -1.245 . . . . 0.0 110.658 179.067 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.748 ' HD2' ' H ' ' A' ' 64' ' ' LYS . 10.8 mptt -22.42 -47.6 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.838 0 N-CA-C 119.673 3.212 . . . . 0.0 119.673 -175.673 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 65' ' ' ARG . . . . . 0.43 ' O ' ' HB ' ' A' ' 68' ' ' ILE . 0.1 OUTLIER -56.02 -49.5 73.5 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 124.687 1.195 . . . . 0.0 113.08 177.386 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -62.23 -26.12 68.2 Favored 'General case' 0 N--CA 1.471 0.61 0 N-CA-C 114.536 1.31 . . . . 0.0 114.536 174.514 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.606 HG21 HG23 ' A' ' 59' ' ' ILE . 99.1 t -72.97 -34.68 46.74 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.638 0 C-N-CA 123.094 0.558 . . . . 0.0 111.094 177.001 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.597 HG12 HD11 ' A' ' 16' ' ' LEU . 5.2 mm -51.06 -45.85 30.34 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.117 0 O-C-N 123.904 0.752 . . . . 0.0 110.468 169.689 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -64.83 -52.58 55.92 Favored 'General case' 0 CA--C 1.549 0.937 0 CA-C-N 114.368 -1.287 . . . . 0.0 113.033 175.906 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 35.3 t90 . . . . . 0 N--CA 1.484 1.228 0 C-N-CA 125.582 1.553 . . . . 0.0 115.007 -178.983 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.461 ' HE1' HD11 ' A' ' 32' ' ' LEU . 33.3 mtp . . . . . 0 N--CA 1.48 1.06 0 N-CA-C 111.988 0.366 . . . . 0.0 111.988 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 2' ' ' ALA . . . . . 0.451 ' HA ' ' O ' ' A' ' 7' ' ' ILE . . . -55.19 -50.75 68.57 Favored 'General case' 0 CA--C 1.543 0.68 0 O-C-N 124.475 1.109 . . . . 0.0 112.511 178.343 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 54.7 tttp -73.25 -59.95 2.47 Favored 'General case' 0 CA--C 1.543 0.7 0 CA-C-N 112.695 -2.048 . . . . 0.0 114.097 -176.717 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 14.0 tt0 -67.93 -42.54 80.85 Favored 'General case' 0 N--CA 1.481 1.075 0 N-CA-C 115.009 1.485 . . . . 0.0 115.009 -168.831 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' PHE . . . . . 0.409 ' HB2' HD12 ' A' ' 7' ' ' ILE . 70.4 m-85 -100.32 -18.71 16.67 Favored 'General case' 0 N--CA 1.468 0.467 0 N-CA-C 116.824 2.157 . . . . 0.0 116.824 -173.913 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 83.28 57.82 2.42 Favored Glycine 0 CA--C 1.544 1.892 0 O-C-N 124.688 1.242 . . . . 0.0 111.519 -173.652 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.451 ' O ' ' HA ' ' A' ' 2' ' ' ALA . 0.4 OUTLIER -115.67 150.17 44.31 Favored Pre-proline 0 N--CA 1.481 1.106 0 CA-C-N 113.384 -1.408 . . . . 0.0 110.638 177.888 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_endo -88.37 151.99 6.6 Favored 'Trans proline' 0 CA--C 1.53 0.312 0 N-CA-C 109.513 -0.995 . . . . 0.0 109.513 159.587 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -51.19 -26.97 7.73 Favored 'General case' 0 N--CA 1.476 0.86 0 N-CA-C 115.217 1.562 . . . . 0.0 115.217 176.156 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -41.94 -56.16 2.86 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 126.298 1.839 . . . . 0.0 112.312 169.948 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.797 HG12 HG22 ' A' ' 31' ' ' ILE . 21.3 m -88.91 -29.45 5.23 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.004 0 N-CA-C 114.371 1.249 . . . . 0.0 114.371 -173.7 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -64.92 -32.16 73.75 Favored 'General case' 0 N--CA 1.477 0.877 0 N-CA-C 112.964 0.727 . . . . 0.0 112.964 173.564 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -65.96 -40.37 95.29 Favored Glycine 0 CA--C 1.542 1.736 0 O-C-N 124.161 0.913 . . . . 0.0 112.809 173.581 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.639 HG22 HG13 ' A' ' 28' ' ' ILE . 1.0 OUTLIER -60.75 -40.6 93.07 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 123.969 0.908 . . . . 0.0 112.554 173.378 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.822 HG13 HD13 ' A' ' 55' ' ' LEU . 18.3 t -54.73 -43.34 66.05 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.086 0 C-N-CA 124.22 1.008 . . . . 0.0 112.86 168.776 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 81.5 mt -60.28 -38.72 84.46 Favored 'General case' 0 N--CA 1.481 1.096 0 N-CA-C 114.03 1.122 . . . . 0.0 114.03 177.115 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 24.7 t-20 -51.94 -48.64 64.17 Favored 'General case' 0 N--CA 1.481 1.077 0 O-C-N 124.512 1.132 . . . . 0.0 111.869 173.089 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -49.39 -49.39 18.08 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.182 0 CA-C-N 114.428 -1.26 . . . . 0.0 112.559 174.638 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.74 HG13 ' HA ' ' A' ' 56' ' ' LYS . 3.4 t -66.2 -51.27 61.16 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.975 0 O-C-N 125.071 1.482 . . . . 0.0 110.446 -177.069 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 25.3 mt-10 -60.45 -38.86 85.54 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 125.231 1.412 . . . . 0.0 114.215 -175.792 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -103.7 -16.21 15.53 Favored 'General case' 0 N--CA 1.472 0.645 0 N-CA-C 116.948 2.203 . . . . 0.0 116.948 -174.159 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 69.16 46.72 56.94 Favored Glycine 0 CA--C 1.545 1.926 0 N-CA-C 111.991 -0.443 . . . . 0.0 111.991 -169.885 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -102.71 167.82 17.82 Favored Glycine 0 CA--C 1.542 1.74 0 CA-C-N 114.036 -1.082 . . . . 0.0 114.384 -167.425 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' TRP . . . . . 0.461 ' HB3' HG22 ' A' ' 26' ' ' THR . 75.8 m95 -62.71 106.51 0.8 Allowed 'General case' 0 N--CA 1.476 0.84 0 CA-C-N 113.054 -1.573 . . . . 0.0 112.2 -178.849 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.49 HG21 HG22 ' A' ' 51' ' ' ILE . 2.6 p -57.46 -23.68 20.15 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.835 0 CA-C-N 113.624 -1.626 . . . . 0.0 113.723 168.698 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.461 HG22 ' HB3' ' A' ' 24' ' ' TRP . 1.7 t -55.4 -43.84 75.59 Favored 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 113.329 0.863 . . . . 0.0 113.329 -179.96 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.439 ' O ' HG12 ' A' ' 31' ' ' ILE . 0.0 OUTLIER -65.46 -45.06 85.24 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 123.883 0.873 . . . . 0.0 112.242 174.868 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.639 HG13 HG22 ' A' ' 14' ' ' THR . 1.6 mp -59.78 -44.89 94.92 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.89 0 CA-C-N 114.598 -1.183 . . . . 0.0 111.796 177.398 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.487 HG13 HD11 ' A' ' 43' ' ' LEU . 53.2 t -53.77 -43.79 57.18 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.999 0 C-N-CA 124.126 0.97 . . . . 0.0 112.434 178.544 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 1.1 m -59.62 -43.08 93.93 Favored 'General case' 0 N--CA 1.485 1.317 0 N-CA-C 112.693 0.627 . . . . 0.0 112.693 176.078 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.797 HG22 HG12 ' A' ' 11' ' ' VAL . 35.5 mm -68.71 -38.8 79.4 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.138 0 CA-C-N 115.319 -0.855 . . . . 0.0 109.572 -176.544 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.679 HD22 ' HB ' ' A' ' 11' ' ' VAL . 3.7 mm? -63.89 -51.78 62.95 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 125.906 1.683 . . . . 0.0 112.624 176.35 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 27.7 p -70.19 -28.94 65.7 Favored 'General case' 0 N--CA 1.472 0.67 0 N-CA-C 114.28 1.215 . . . . 0.0 114.28 -179.733 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -52.57 -27.58 17.39 Favored 'General case' 0 N--CA 1.482 1.133 0 N-CA-C 113.951 1.093 . . . . 0.0 113.951 170.881 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 46.6 t -68.36 -38.73 79.84 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.15 0 C-N-CA 125.433 1.493 . . . . 0.0 111.785 170.592 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 118.68 -123.53 5.72 Favored Glycine 0 N--CA 1.478 1.454 0 C-N-CA 124.77 1.176 . . . . 0.0 110.421 -175.472 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 13.3 p -59.26 -38.64 80.59 Favored 'General case' 0 N--CA 1.478 0.964 0 CA-C-N 112.739 -1.731 . . . . 0.0 115.181 -174.381 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -50.07 -43.13 40.82 Favored Glycine 0 N--CA 1.484 1.886 0 O-C-N 124.525 1.141 . . . . 0.0 114.209 177.308 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.458 ' O ' ' HG ' ' A' ' 43' ' ' LEU . . . -62.73 -49.78 69.97 Favored Glycine 0 CA--C 1.538 1.495 0 C-N-CA 123.393 0.52 . . . . 0.0 112.271 176.842 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 12.2 mt -62.84 -44.16 96.89 Favored 'General case' 0 N--CA 1.478 0.93 0 CA-C-N 113.641 -1.28 . . . . 0.0 114.035 -178.065 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 28.6 p -61.53 -39.82 92.42 Favored 'General case' 0 N--CA 1.481 1.076 0 N-CA-C 113.234 0.827 . . . . 0.0 113.234 175.977 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 12.4 tp -62.21 -47.76 83.02 Favored 'General case' 0 N--CA 1.484 1.245 0 C-N-CA 122.863 0.465 . . . . 0.0 110.531 171.999 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.487 HD11 HG13 ' A' ' 29' ' ' VAL . 63.7 mt -60.5 -32.62 71.62 Favored 'General case' 0 N--CA 1.481 1.113 0 N-CA-C 114.86 1.43 . . . . 0.0 114.86 -179.606 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -66.53 -31.23 71.81 Favored 'General case' 0 N--CA 1.482 1.156 0 N-CA-C 113.732 1.012 . . . . 0.0 113.732 174.51 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -53.5 -48.52 68.88 Favored 'General case' 0 N--CA 1.477 0.875 0 N-CA-C 115.155 1.539 . . . . 0.0 115.155 -170.648 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -144.48 50.16 1.3 Allowed 'General case' 0 N--CA 1.482 1.129 0 CA-C-O 122.482 1.134 . . . . 0.0 113.503 174.271 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -51.37 -50.39 41.24 Favored Glycine 0 N--CA 1.487 2.076 0 CA-C-N 113.473 -1.694 . . . . 0.0 113.349 -176.969 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 79.4 ttt180 -58.83 -48.95 79.52 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 126.125 1.77 . . . . 0.0 113.974 -179.855 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 5.6 tm-20 -80.03 18.92 0.76 Allowed 'General case' 0 N--CA 1.476 0.838 0 N-CA-C 114.001 1.111 . . . . 0.0 114.001 -179.06 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 52.2 p 53.14 124.95 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 127.213 2.205 . . . . 0.0 111.911 -168.786 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.49 HG22 HG21 ' A' ' 25' ' ' VAL . 29.5 mm -52.44 -31.18 15.07 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.055 0 CA-C-N 115.081 -0.963 . . . . 0.0 112.816 170.419 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 71.1 tttt -57.14 -64.96 0.71 Allowed 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 124.36 1.064 . . . . 0.0 111.436 177.347 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -62.73 -35.17 78.89 Favored 'General case' 0 N--CA 1.472 0.659 0 N-CA-C 113.4 0.889 . . . . 0.0 113.4 178.694 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 15.7 t80 -51.17 -67.68 0.23 Allowed 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 124.984 1.314 . . . . 0.0 111.758 173.651 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.822 HD13 HG13 ' A' ' 15' ' ' VAL . 39.6 mt -61.97 -38.18 87.58 Favored 'General case' 0 N--CA 1.479 1.003 0 N-CA-C 113.084 0.772 . . . . 0.0 113.084 -177.115 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.74 ' HA ' HG13 ' A' ' 19' ' ' VAL . 96.2 mttt -54.88 -52.3 63.27 Favored 'General case' 0 C--O 1.219 -0.502 0 CA-C-N 114.353 -1.294 . . . . 0.0 113.609 177.433 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 2.3 ttpm? -74.99 -45.22 43.52 Favored 'General case' 0 N--CA 1.476 0.828 0 CA-C-N 114.945 -1.025 . . . . 0.0 112.392 176.026 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' GLU . . . . . 0.431 ' O ' ' HB2' ' A' ' 62' ' ' LYS . 44.4 tt0 -58.67 -49.93 75.72 Favored 'General case' 0 N--CA 1.471 0.596 0 O-C-N 123.384 0.428 . . . . 0.0 111.199 -174.918 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.697 HG23 HG21 ' A' ' 67' ' ' VAL . 3.2 mm -76.33 -27.4 17.55 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.162 0 CA-C-O 118.934 -0.555 . . . . 0.0 112.258 -177.924 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.473 ' HB2' ' O ' ' A' ' 56' ' ' LYS . 19.9 ttmm -59.5 -27.83 66.5 Favored 'General case' 0 N--CA 1.469 0.508 0 N-CA-C 114.422 1.267 . . . . 0.0 114.422 172.005 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 75.0 mttt -93.92 -41.87 9.37 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-N 113.283 -1.781 . . . . 0.0 113.432 176.76 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.431 ' HB2' ' O ' ' A' ' 58' ' ' GLU . 30.6 tttt -67.05 -60.94 2.2 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 126.511 1.924 . . . . 0.0 113.828 -175.301 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 104.09 110.21 3.46 Favored Glycine 0 CA--C 1.54 1.631 0 CA-C-N 114.795 -1.093 . . . . 0.0 112.448 -169.572 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.533 ' HD2' ' H ' ' A' ' 64' ' ' LYS . 0.0 OUTLIER -36.79 -43.36 0.43 Allowed 'General case' 0 N--CA 1.477 0.918 0 N-CA-C 119.577 3.177 . . . . 0.0 119.577 -175.668 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.415 ' O ' ' HB ' ' A' ' 68' ' ' ILE . 1.8 ttp180 -56.56 -47.12 80.16 Favored 'General case' 0 N--CA 1.477 0.883 0 N-CA-C 114.146 1.165 . . . . 0.0 114.146 179.356 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -64.58 -26.13 68.27 Favored 'General case' 0 N--CA 1.475 0.798 0 CA-C-N 114.509 -1.223 . . . . 0.0 113.62 175.157 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.697 HG21 HG23 ' A' ' 59' ' ' ILE . 30.4 t -72.12 -36.9 58.15 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.042 0 C-N-CA 123.671 0.788 . . . . 0.0 110.707 179.95 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.415 ' HB ' ' O ' ' A' ' 65' ' ' ARG . 19.9 mm -51.76 -46.79 39.65 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.171 0 C-N-CA 124.12 0.968 . . . . 0.0 110.748 167.934 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -69.99 -49.46 51.3 Favored 'General case' 0 N--CA 1.477 0.913 0 N-CA-C 113.802 1.038 . . . . 0.0 113.802 177.019 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' TRP . . . . . 0.426 ' CE3' ' HG3' ' A' ' 1' ' ' MET . 32.2 t90 . . . . . 0 N--CA 1.48 1.031 0 C-N-CA 126.412 1.885 . . . . 0.0 112.98 -178.049 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.655 ' HE1' HG21 ' A' ' 15' ' ' VAL . 56.8 mtp . . . . . 0 CA--C 1.542 0.651 0 N-CA-C 112.238 0.459 . . . . 0.0 112.238 . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 2' ' ' ALA . . . . . 0.407 ' HA ' ' O ' ' A' ' 7' ' ' ILE . . . -57.46 -52.37 65.66 Favored 'General case' 0 N--CA 1.488 1.471 0 CA-C-N 114.806 -1.088 . . . . 0.0 112.96 176.772 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.413 ' HB2' ' O ' ' A' ' 69' ' ' ALA . 10.7 tptp -66.04 -58.35 5.68 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 127.491 2.316 . . . . 0.0 112.461 -177.425 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 4' ' ' GLU . . . . . 0.446 ' HB2' ' O ' ' A' ' 70' ' ' TRP . 0.7 OUTLIER -74.41 -47.54 33.22 Favored 'General case' 0 N--CA 1.477 0.883 0 N-CA-C 115.972 1.841 . . . . 0.0 115.972 -171.796 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 5' ' ' PHE . . . . . 0.636 ' HB2' HD12 ' A' ' 7' ' ' ILE . 47.8 m-85 -100.14 -11.2 20.67 Favored 'General case' 0 N--CA 1.473 0.683 0 N-CA-C 115.747 1.758 . . . . 0.0 115.747 -169.021 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 75.79 61.01 3.0 Favored Glycine 0 N--CA 1.478 1.443 0 O-C-N 124.614 1.197 . . . . 0.0 111.245 -173.413 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.636 HD12 ' HB2' ' A' ' 5' ' ' PHE . 1.0 OUTLIER -117.76 145.53 36.73 Favored Pre-proline 0 N--CA 1.478 0.951 0 C-N-CA 125.287 1.435 . . . . 0.0 111.941 179.696 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_endo -89.78 154.17 5.06 Favored 'Trans proline' 0 CA--C 1.535 0.548 0 N-CA-C 109.176 -1.125 . . . . 0.0 109.176 158.383 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -48.77 -29.78 4.92 Favored 'General case' 0 CA--C 1.544 0.73 0 N-CA-C 115.23 1.567 . . . . 0.0 115.23 176.774 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -39.67 -44.91 1.59 Allowed 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 126.388 1.875 . . . . 0.0 114.503 172.069 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.855 HG12 HG22 ' A' ' 31' ' ' ILE . 22.6 m -101.05 -29.51 3.17 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.93 0 N-CA-C 114.959 1.466 . . . . 0.0 114.959 -176.219 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.419 ' O ' ' HG ' ' A' ' 16' ' ' LEU . . . -68.48 -31.21 70.32 Favored 'General case' 0 CA--C 1.546 0.817 0 N-CA-C 112.547 0.573 . . . . 0.0 112.547 175.631 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -61.06 -42.87 99.94 Favored Glycine 0 CA--C 1.543 1.84 0 CA-C-O 122.186 0.881 . . . . 0.0 112.393 170.485 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.776 HG22 HG13 ' A' ' 28' ' ' ILE . 1.4 m -62.62 -36.89 84.22 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 124.928 1.291 . . . . 0.0 113.562 176.02 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.655 HG21 ' HE1' ' A' ' 1' ' ' MET . 2.4 t -58.05 -41.05 79.53 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 C-N-CA 124.03 0.932 . . . . 0.0 112.443 170.691 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.452 HD22 ' HG3' ' A' ' 64' ' ' LYS . 53.2 mt -60.04 -37.31 79.43 Favored 'General case' 0 N--CA 1.476 0.837 0 N-CA-C 112.73 0.641 . . . . 0.0 112.73 177.497 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 27.5 t-20 -56.96 -44.57 82.72 Favored 'General case' 0 N--CA 1.474 0.756 0 CA-C-N 115.765 -0.652 . . . . 0.0 112.527 175.864 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 3.7 t -48.49 -48.79 14.15 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.155 0 C-N-CA 123.086 0.555 . . . . 0.0 111.699 172.131 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.791 HG13 ' HA ' ' A' ' 56' ' ' LYS . 5.8 t -67.5 -50.46 61.5 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.389 0 CA-C-N 113.997 -1.456 . . . . 0.0 110.789 -176.351 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 29.2 mt-10 -65.81 -42.02 91.15 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 126.478 1.911 . . . . 0.0 115.606 -177.728 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -99.62 -22.91 15.23 Favored 'General case' 0 N--CA 1.477 0.919 0 N-CA-C 116.219 1.933 . . . . 0.0 116.219 -173.0 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.53 ' HA2' ' NZ ' ' A' ' 56' ' ' LYS . . . 77.39 34.02 41.89 Favored Glycine 0 N--CA 1.481 1.68 0 N-CA-C 112.02 -0.432 . . . . 0.0 112.02 -171.248 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -99.85 172.53 24.8 Favored Glycine 0 N--CA 1.47 0.949 0 CA-C-N 113.263 -1.468 . . . . 0.0 114.102 -165.458 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 89.4 m95 -57.67 100.6 0.06 Allowed 'General case' 0 N--CA 1.476 0.866 0 CA-C-N 111.764 -2.218 . . . . 0.0 114.148 -176.967 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.593 HG21 HG13 ' A' ' 51' ' ' ILE . 4.3 p -56.72 -25.53 21.79 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 CA-C-N 112.553 -2.112 . . . . 0.0 113.779 169.244 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 11.5 p -61.34 -46.36 90.58 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 124.176 0.99 . . . . 0.0 112.277 -178.547 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.427 ' O ' HG12 ' A' ' 31' ' ' ILE . 0.2 OUTLIER -60.8 -44.88 96.27 Favored 'General case' 0 N--CA 1.478 0.945 0 CA-C-N 114.01 -1.45 . . . . 0.0 110.994 175.039 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.776 HG13 HG22 ' A' ' 14' ' ' THR . 1.7 mp -62.63 -47.67 91.84 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.084 0 C-N-CA 124.073 0.949 . . . . 0.0 111.749 179.023 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.487 HG13 HD11 ' A' ' 43' ' ' LEU . 39.8 t -52.41 -43.5 41.34 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.067 0 C-N-CA 124.379 1.072 . . . . 0.0 111.325 179.064 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 90.4 p -65.79 -32.09 73.43 Favored 'General case' 0 N--CA 1.478 0.965 0 N-CA-C 115.391 1.626 . . . . 0.0 115.391 176.324 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.855 HG22 HG12 ' A' ' 11' ' ' VAL . 40.5 mm -70.9 -40.47 76.5 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.33 0 C-N-CA 123.7 0.8 . . . . 0.0 109.583 177.235 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.666 ' HB3' ' HA2' ' A' ' 39' ' ' GLY . 3.8 mm? -61.59 -52.07 65.94 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 125.365 1.466 . . . . 0.0 112.745 174.606 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 7.5 p -65.76 -27.1 68.05 Favored 'General case' 0 N--CA 1.484 1.243 0 N-CA-C 114.159 1.17 . . . . 0.0 114.159 179.317 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -53.0 -29.36 28.79 Favored 'General case' 0 N--CA 1.483 1.225 0 N-CA-C 113.892 1.071 . . . . 0.0 113.892 166.969 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 54.5 t -75.34 -27.16 19.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 C-N-CA 124.238 1.015 . . . . 0.0 112.411 172.192 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 97.88 -100.4 2.37 Favored Glycine 0 N--CA 1.481 1.658 0 C-N-CA 124.727 1.156 . . . . 0.0 111.015 -176.797 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 2.7 p -55.41 -47.34 76.07 Favored 'General case' 0 N--CA 1.483 1.21 0 CA-C-N 113.628 -1.286 . . . . 0.0 113.569 -177.014 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.406 ' HA3' HG13 ' A' ' 7' ' ' ILE . . . -54.28 -40.97 69.7 Favored Glycine 0 CA--C 1.539 1.592 0 C-N-CA 124.875 1.226 . . . . 0.0 115.106 -178.58 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.666 ' HA2' ' HB3' ' A' ' 32' ' ' LEU . . . -60.18 -58.56 13.44 Favored Glycine 0 N--CA 1.475 1.25 0 O-C-N 124.604 0.826 . . . . 0.0 111.413 173.595 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 44.7 mt -58.86 -48.46 81.28 Favored 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 115.26 1.578 . . . . 0.0 115.26 -176.222 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' SER . . . . . 0.426 ' HB2' ' HD1' ' A' ' 5' ' ' PHE . 29.6 p -60.69 -39.49 88.66 Favored 'General case' 0 N--CA 1.475 0.791 0 N-CA-C 114.488 1.292 . . . . 0.0 114.488 175.669 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 13.8 tp -63.79 -48.46 76.79 Favored 'General case' 0 N--CA 1.483 1.2 0 C-N-CA 122.505 0.322 . . . . 0.0 110.888 173.839 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.487 HD11 HG13 ' A' ' 29' ' ' VAL . 80.5 mt -61.98 -27.57 68.94 Favored 'General case' 0 N--CA 1.482 1.131 0 N-CA-C 114.843 1.423 . . . . 0.0 114.843 -176.344 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -70.81 -45.4 64.7 Favored 'General case' 0 CA--C 1.549 0.905 0 N-CA-C 112.839 0.681 . . . . 0.0 112.839 173.933 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -65.12 -40.47 94.53 Favored 'General case' 0 N--CA 1.477 0.917 0 CA-C-O 122.715 1.245 . . . . 0.0 111.999 179.902 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.446 ' HB1' ' HA ' ' A' ' 51' ' ' ILE . . . -59.18 -26.76 65.07 Favored 'General case' 0 CA--C 1.537 0.447 0 N-CA-C 116.438 2.014 . . . . 0.0 116.438 179.131 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -47.78 -40.62 18.81 Favored Glycine 0 N--CA 1.482 1.73 0 C-N-CA 125.598 1.57 . . . . 0.0 113.641 -177.942 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 35.4 ttp-105 -53.62 -47.78 69.91 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 125.184 1.394 . . . . 0.0 113.931 -173.937 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 11.8 tt0 -126.0 37.32 4.36 Favored 'General case' 0 N--CA 1.478 0.968 0 N-CA-C 114.285 1.217 . . . . 0.0 114.285 -177.962 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 72.0 p 50.77 127.49 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.502 0 C-N-CA 125.603 1.561 . . . . 0.0 112.792 -172.057 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.593 HG13 HG21 ' A' ' 25' ' ' VAL . 6.3 tp -39.04 -51.65 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 N-CA-C 117.728 2.492 . . . . 0.0 117.728 -172.791 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 56.3 tttt -65.95 -57.17 8.44 Favored 'General case' 0 N--CA 1.469 0.516 0 N-CA-C 113.618 0.97 . . . . 0.0 113.618 179.877 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -60.59 -38.17 83.75 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 124.591 1.156 . . . . 0.0 112.763 178.497 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' TYR . . . . . 0.401 ' HB3' ' O ' ' A' ' 51' ' ' ILE . 90.4 t80 -47.66 -63.51 1.04 Allowed 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 125.961 1.704 . . . . 0.0 109.861 170.233 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 79.1 mt -64.24 -41.98 96.74 Favored 'General case' 0 N--CA 1.473 0.721 0 N-CA-C 113.894 1.072 . . . . 0.0 113.894 -176.575 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.791 ' HA ' HG13 ' A' ' 19' ' ' VAL . 29.2 mtpp -55.97 -44.73 78.79 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 114.653 -1.158 . . . . 0.0 113.447 177.466 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.42 ' O ' ' HG2' ' A' ' 61' ' ' LYS . 66.7 tttt -77.3 -50.13 13.51 Favored 'General case' 0 N--CA 1.475 0.787 0 CA-C-N 115.292 -0.867 . . . . 0.0 112.051 172.947 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 58' ' ' GLU . . . . . 0.501 ' O ' ' HB2' ' A' ' 62' ' ' LYS . 4.2 tp10 -54.51 -51.38 65.29 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 123.979 0.912 . . . . 0.0 111.831 -173.51 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.683 HG23 HG21 ' A' ' 67' ' ' VAL . 1.3 mm -75.87 -26.32 17.69 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.05 0 CA-C-N 115.623 -0.717 . . . . 0.0 111.846 -175.255 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 6.7 mtpp -60.07 -39.05 84.72 Favored 'General case' 0 CA--C 1.538 0.487 0 N-CA-C 115.336 1.606 . . . . 0.0 115.336 170.285 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.42 ' HG2' ' O ' ' A' ' 57' ' ' LYS . 70.4 mmtt -79.32 -46.24 18.09 Favored 'General case' 0 N--CA 1.476 0.834 0 O-C-N 126.188 2.18 . . . . 0.0 110.93 176.977 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.501 ' HB2' ' O ' ' A' ' 58' ' ' GLU . 5.7 tptp -66.53 -52.22 48.17 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 126.728 2.011 . . . . 0.0 114.822 -175.561 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 96.6 117.87 3.47 Favored Glycine 0 N--CA 1.483 1.828 0 CA-C-N 114.593 -1.185 . . . . 0.0 110.332 -173.94 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.687 ' HD2' ' H ' ' A' ' 64' ' ' LYS . 9.8 mptt -36.18 -46.78 0.53 Allowed 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 117.782 2.512 . . . . 0.0 117.782 -177.422 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.22 -51.63 69.14 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 125.538 1.535 . . . . 0.0 114.958 176.89 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -64.83 -27.3 68.78 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-N 114.423 -1.262 . . . . 0.0 112.907 174.771 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.683 HG21 HG23 ' A' ' 59' ' ' ILE . 98.7 t -67.13 -41.78 87.43 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.251 0 C-N-CA 123.191 0.597 . . . . 0.0 110.942 175.19 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 35.1 mm -51.15 -42.66 25.87 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.856 0 O-C-N 124.18 0.925 . . . . 0.0 110.764 172.061 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.413 ' O ' ' HB2' ' A' ' 3' ' ' LYS . . . -71.38 -52.62 17.62 Favored 'General case' 0 N--CA 1.473 0.725 0 O-C-N 124.683 1.239 . . . . 0.0 112.585 176.117 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 70' ' ' TRP . . . . . 0.446 ' O ' ' HB2' ' A' ' 4' ' ' GLU . 30.9 t90 . . . . . 0 N--CA 1.485 1.277 0 C-N-CA 127.034 2.134 . . . . 0.0 112.646 -178.449 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.507 ' HE1' HG21 ' A' ' 15' ' ' VAL . 72.3 mtp . . . . . 0 N--CA 1.472 0.63 0 N-CA-C 112.184 0.439 . . . . 0.0 112.184 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -56.79 -49.6 74.83 Favored 'General case' 0 CA--C 1.547 0.828 0 CA-C-N 115.541 -0.754 . . . . 0.0 112.602 177.499 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 50.2 tttm -76.32 -51.65 11.54 Favored 'General case' 0 N--CA 1.475 0.799 0 CA-C-N 113.407 -1.724 . . . . 0.0 113.303 -173.195 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' GLU . . . . . 0.429 ' HB2' ' O ' ' A' ' 70' ' ' TRP . 1.8 mp0 -79.03 -33.33 44.91 Favored 'General case' 0 N--CA 1.47 0.536 0 N-CA-C 115.94 1.83 . . . . 0.0 115.94 -173.411 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 5' ' ' PHE . . . . . 0.41 ' HB2' HD12 ' A' ' 7' ' ' ILE . 26.7 m-85 -113.41 -14.13 12.79 Favored 'General case' 0 N--CA 1.474 0.774 0 N-CA-C 117.621 2.452 . . . . 0.0 117.621 -171.556 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 82.33 58.84 2.36 Favored Glycine 0 CA--C 1.538 1.506 0 C-N-CA 124.133 0.873 . . . . 0.0 111.159 -179.155 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.515 HG21 ' HB2' ' A' ' 12' ' ' ALA . 0.8 OUTLIER -120.39 146.71 43.51 Favored Pre-proline 0 N--CA 1.479 1.009 0 CA-C-N 112.747 -1.726 . . . . 0.0 113.307 -176.102 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -91.51 161.12 3.59 Favored 'Trans proline' 0 CA--C 1.537 0.662 0 C-N-CA 121.123 1.215 . . . . 0.0 110.745 160.535 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -52.75 -32.08 41.44 Favored 'General case' 0 CA--C 1.544 0.716 0 N-CA-C 114.07 1.137 . . . . 0.0 114.07 174.312 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -40.84 -39.46 1.13 Allowed 'General case' 0 N--CA 1.485 1.323 0 C-N-CA 126.784 2.033 . . . . 0.0 114.976 172.879 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.942 HG12 HG22 ' A' ' 31' ' ' ILE . 17.3 m -110.95 -31.63 2.25 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.354 0 N-CA-C 114.939 1.459 . . . . 0.0 114.939 -177.162 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.515 ' HB2' HG21 ' A' ' 7' ' ' ILE . . . -65.94 -36.91 84.65 Favored 'General case' 0 N--CA 1.476 0.864 0 N-CA-C 112.61 0.596 . . . . 0.0 112.61 174.016 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' GLY . . . . . 0.516 ' O ' ' HB2' ' A' ' 16' ' ' LEU . . . -58.18 -41.95 95.02 Favored Glycine 0 CA--C 1.54 1.603 0 C-N-CA 124.033 0.825 . . . . 0.0 112.563 171.813 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.775 HG22 HG13 ' A' ' 28' ' ' ILE . 0.2 OUTLIER -62.14 -34.05 75.65 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 125.546 1.538 . . . . 0.0 114.045 176.719 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.507 HG21 ' HE1' ' A' ' 1' ' ' MET . 5.2 t -58.15 -46.93 88.34 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.29 0 C-N-CA 123.846 0.858 . . . . 0.0 112.798 171.045 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.516 ' HB2' ' O ' ' A' ' 13' ' ' GLY . 9.5 mp -52.5 -38.61 59.94 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 124.912 1.285 . . . . 0.0 113.384 173.026 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 15.3 t-20 -57.4 -49.13 77.18 Favored 'General case' 0 N--CA 1.485 1.279 0 O-C-N 123.873 0.733 . . . . 0.0 110.815 177.768 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 2.4 t -50.19 -50.89 19.21 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.767 0 O-C-N 124.366 1.041 . . . . 0.0 112.77 173.31 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.564 HG13 ' HA ' ' A' ' 56' ' ' LYS . 9.0 t -65.34 -48.97 81.22 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.235 0 CA-C-N 114.647 -1.16 . . . . 0.0 112.411 -175.075 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -71.39 -46.72 59.59 Favored 'General case' 0 CA--C 1.548 0.872 0 N-CA-C 114.692 1.367 . . . . 0.0 114.692 -177.425 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -96.04 -9.18 31.59 Favored 'General case' 0 N--CA 1.475 0.807 0 N-CA-C 115.733 1.753 . . . . 0.0 115.733 -170.352 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 65.19 33.13 86.1 Favored Glycine 0 CA--C 1.542 1.773 0 C-N-CA 124.327 0.965 . . . . 0.0 112.494 -171.523 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -78.31 167.66 53.39 Favored Glycine 0 N--CA 1.476 1.357 0 C-N-CA 125.372 1.463 . . . . 0.0 115.698 -175.044 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' TRP . . . . . 0.409 ' HB3' HG22 ' A' ' 26' ' ' THR . 2.5 m-90 -68.2 106.39 2.42 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-N 113.454 -1.373 . . . . 0.0 111.999 -178.666 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 2.8 p -57.58 -24.84 23.14 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.781 0 CA-C-N 114.122 -1.399 . . . . 0.0 114.07 173.65 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.409 HG22 ' HB3' ' A' ' 24' ' ' TRP . 10.0 t -60.0 -44.54 94.48 Favored 'General case' 0 N--CA 1.483 1.214 0 C-N-CA 124.053 0.941 . . . . 0.0 113.239 -179.823 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.452 ' O ' HG12 ' A' ' 31' ' ' ILE . 0.0 OUTLIER -65.28 -42.76 92.81 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 124.254 1.021 . . . . 0.0 111.787 175.657 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.775 HG13 HG22 ' A' ' 14' ' ' THR . 1.8 mp -62.3 -46.1 97.22 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 C-N-CA 124.427 1.091 . . . . 0.0 111.037 178.235 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.485 HG13 HD11 ' A' ' 43' ' ' LEU . 39.6 t -56.11 -45.27 80.62 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.837 0 C-N-CA 124.344 1.058 . . . . 0.0 111.978 174.009 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 36.9 m -58.34 -37.03 74.32 Favored 'General case' 0 N--CA 1.486 1.344 0 N-CA-C 113.855 1.057 . . . . 0.0 113.855 175.256 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.942 HG22 HG12 ' A' ' 11' ' ' VAL . 43.5 mm -75.9 -39.34 37.56 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.41 0 C-N-CA 123.926 0.891 . . . . 0.0 110.434 179.737 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.676 HD22 ' HB ' ' A' ' 11' ' ' VAL . 3.7 mm? -60.57 -50.94 71.51 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 125.564 1.546 . . . . 0.0 112.251 174.003 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 18.0 p -67.25 -30.55 70.47 Favored 'General case' 0 N--CA 1.484 1.229 0 N-CA-C 114.609 1.337 . . . . 0.0 114.609 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -49.1 -40.6 32.66 Favored 'General case' 0 N--CA 1.485 1.291 0 N-CA-C 113.52 0.933 . . . . 0.0 113.52 170.37 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 57.7 t -63.74 -20.32 26.18 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.382 0 C-N-CA 125.139 1.376 . . . . 0.0 112.934 173.008 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 91.38 -102.12 2.88 Favored Glycine 0 N--CA 1.473 1.141 0 C-N-CA 125.091 1.329 . . . . 0.0 110.416 -179.463 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 11.9 p -56.62 -45.3 81.58 Favored 'General case' 0 N--CA 1.479 0.992 0 CA-C-N 112.306 -1.947 . . . . 0.0 113.904 -175.774 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -51.02 -48.17 46.69 Favored Glycine 0 N--CA 1.477 1.401 0 C-N-CA 124.898 1.237 . . . . 0.0 114.76 179.345 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.543 ' HA2' ' HB3' ' A' ' 32' ' ' LEU . . . -60.04 -52.99 49.48 Favored Glycine 0 CA--C 1.535 1.307 0 N-CA-C 111.57 -0.612 . . . . 0.0 111.57 176.269 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 30.3 mt -59.34 -45.71 90.62 Favored 'General case' 0 N--CA 1.48 1.03 0 N-CA-C 114.983 1.475 . . . . 0.0 114.983 -177.789 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 51.9 p -66.2 -37.58 85.93 Favored 'General case' 0 N--CA 1.48 1.033 0 N-CA-C 113.926 1.084 . . . . 0.0 113.926 176.132 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 12.7 tp -65.98 -44.16 85.71 Favored 'General case' 0 N--CA 1.482 1.149 0 CA-C-O 120.963 0.411 . . . . 0.0 110.217 173.033 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.485 HD11 HG13 ' A' ' 29' ' ' VAL . 82.6 mt -64.9 -22.74 67.05 Favored 'General case' 0 N--CA 1.476 0.874 0 N-CA-C 115.031 1.493 . . . . 0.0 115.031 178.997 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -72.98 -47.85 41.69 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-N 115.706 -0.679 . . . . 0.0 112.16 170.15 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -60.22 -35.56 75.71 Favored 'General case' 0 N--CA 1.487 1.391 0 C-N-CA 124.221 1.009 . . . . 0.0 111.739 177.08 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -52.74 -26.87 15.43 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 127.209 2.204 . . . . 0.0 115.821 174.855 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -46.46 -43.22 14.62 Favored Glycine 0 N--CA 1.483 1.769 0 C-N-CA 125.676 1.608 . . . . 0.0 114.249 -175.5 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 66.6 ttp85 -47.48 -55.8 8.33 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 126.01 1.724 . . . . 0.0 113.486 -176.597 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 10.5 tt0 -136.38 38.54 2.69 Favored 'General case' 0 N--CA 1.483 1.198 0 N-CA-C 113.656 0.984 . . . . 0.0 113.656 -174.216 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 23.2 t 45.86 125.77 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 125.313 1.445 . . . . 0.0 114.096 -173.849 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 10.5 tp -31.3 -49.74 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.481 1.083 0 N-CA-C 118.355 2.724 . . . . 0.0 118.355 -174.32 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 52.2 tptt -55.77 -70.05 0.12 Allowed 'General case' 0 N--CA 1.483 1.215 0 C-N-CA 124.575 1.15 . . . . 0.0 111.848 176.525 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -61.3 -38.44 86.83 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 124.377 1.071 . . . . 0.0 113.525 179.709 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 85.9 t80 -46.8 -60.43 2.42 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 124.84 1.256 . . . . 0.0 111.587 173.359 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 67.4 mt -67.05 -43.81 81.76 Favored 'General case' 0 N--CA 1.478 0.952 0 N-CA-C 113.992 1.108 . . . . 0.0 113.992 -177.085 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.564 ' HA ' HG13 ' A' ' 19' ' ' VAL . 6.5 mmmt -52.24 -43.37 64.29 Favored 'General case' 0 N--CA 1.478 0.947 0 CA-C-N 113.995 -1.457 . . . . 0.0 114.438 177.911 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 33.4 tttm -80.53 -55.25 4.99 Favored 'General case' 0 N--CA 1.476 0.847 0 CA-C-N 114.583 -1.189 . . . . 0.0 111.67 172.235 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' GLU . . . . . 0.555 ' O ' ' HB2' ' A' ' 62' ' ' LYS . 34.3 tt0 -54.06 -51.43 64.09 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-O 117.038 -1.458 . . . . 0.0 110.895 -170.478 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.765 HG23 HG21 ' A' ' 67' ' ' VAL . 3.4 mm -78.92 -23.51 12.86 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.349 0 CA-C-O 118.719 -0.658 . . . . 0.0 112.335 -174.707 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 1.2 tppm? -61.52 -37.64 84.47 Favored 'General case' 0 N--CA 1.466 0.368 0 N-CA-C 113.997 1.11 . . . . 0.0 113.997 172.436 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 45.1 mttt -90.93 -37.86 13.25 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-N 112.465 -2.152 . . . . 0.0 113.419 -178.453 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.555 ' HB2' ' O ' ' A' ' 58' ' ' GLU . 24.1 tttm -67.51 -45.44 75.78 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 126.562 1.945 . . . . 0.0 113.574 -176.994 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 98.32 102.97 2.29 Favored Glycine 0 CA--C 1.534 1.229 0 CA-C-O 122.11 0.839 . . . . 0.0 111.409 -177.155 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.509 ' HD2' ' H ' ' A' ' 64' ' ' LYS . 2.2 mptp? -31.58 -47.6 0.12 Allowed 'General case' 0 N--CA 1.477 0.909 0 N-CA-C 119.136 3.013 . . . . 0.0 119.136 -178.076 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 4.8 ttp-105 -62.27 -47.81 82.68 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 124.76 1.224 . . . . 0.0 113.628 179.56 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -60.98 -26.95 67.94 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-N 114.642 -1.163 . . . . 0.0 113.952 172.489 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.765 HG21 HG23 ' A' ' 59' ' ' ILE . 63.9 t -68.6 -40.38 81.76 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.291 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.635 176.442 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 45.5 mm -53.52 -45.83 59.09 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.08 0 C-N-CA 123.485 0.714 . . . . 0.0 109.895 172.145 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -64.8 -52.58 56.05 Favored 'General case' 0 N--CA 1.482 1.134 0 N-CA-C 112.79 0.663 . . . . 0.0 112.79 176.111 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' TRP . . . . . 0.429 ' O ' ' HB2' ' A' ' 4' ' ' GLU . 33.9 t90 . . . . . 0 N--CA 1.479 1.018 0 C-N-CA 126.051 1.74 . . . . 0.0 112.336 178.36 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.59 ' HE1' HG21 ' A' ' 15' ' ' VAL . 46.1 mtp . . . . . 0 N--CA 1.471 0.577 0 N-CA-C 112.457 0.54 . . . . 0.0 112.457 . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 2' ' ' ALA . . . . . 0.475 ' HA ' ' O ' ' A' ' 7' ' ' ILE . . . -52.22 -51.83 55.92 Favored 'General case' 0 N--CA 1.47 0.538 0 O-C-N 124.568 1.167 . . . . 0.0 112.73 176.708 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 14.7 tttt -79.93 -51.75 8.72 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 112.717 -2.038 . . . . 0.0 114.578 -173.555 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 10.6 mt-10 -73.04 -35.15 66.69 Favored 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 115.382 1.623 . . . . 0.0 115.382 -173.772 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 50.6 m-85 -109.04 -13.85 14.64 Favored 'General case' 0 N--CA 1.478 0.933 0 N-CA-C 117.356 2.354 . . . . 0.0 117.356 -173.997 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 82.75 60.49 2.07 Favored Glycine 0 CA--C 1.542 1.765 0 O-C-N 124.342 1.027 . . . . 0.0 110.65 -177.83 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.475 ' O ' ' HA ' ' A' ' 2' ' ' ALA . 0.8 OUTLIER -125.23 143.38 44.2 Favored Pre-proline 0 N--CA 1.481 1.12 0 CA-C-N 113.63 -1.285 . . . . 0.0 112.457 -175.924 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_endo -87.92 159.54 7.4 Favored 'Trans proline' 0 CA--C 1.538 0.675 0 C-N-CA 120.94 1.094 . . . . 0.0 109.376 163.797 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -50.58 -33.2 21.1 Favored 'General case' 0 N--CA 1.476 0.874 0 N-CA-C 114.253 1.205 . . . . 0.0 114.253 174.895 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -37.03 -41.85 0.38 Allowed 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 127.45 2.3 . . . . 0.0 115.917 169.725 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.9 HG12 HG22 ' A' ' 31' ' ' ILE . 19.0 m -111.37 -28.53 2.57 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 N-CA-C 115.395 1.628 . . . . 0.0 115.395 -176.749 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.463 ' O ' ' HG ' ' A' ' 16' ' ' LEU . . . -66.28 -33.61 76.14 Favored 'General case' 0 N--CA 1.477 0.891 0 N-CA-C 112.71 0.633 . . . . 0.0 112.71 171.433 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -59.62 -37.41 92.22 Favored Glycine 0 CA--C 1.539 1.59 0 C-N-CA 124.448 1.023 . . . . 0.0 112.674 171.349 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.65 HG22 HG13 ' A' ' 28' ' ' ILE . 0.2 OUTLIER -71.98 -37.15 69.93 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 125.188 1.395 . . . . 0.0 112.598 177.908 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.649 HG23 HD21 ' A' ' 32' ' ' LEU . 20.9 t -55.93 -41.65 68.23 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.237 0 C-N-CA 123.423 0.689 . . . . 0.0 111.88 166.366 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.463 ' HG ' ' O ' ' A' ' 12' ' ' ALA . 77.6 mt -61.25 -37.1 81.91 Favored 'General case' 0 N--CA 1.486 1.347 0 N-CA-C 114.518 1.303 . . . . 0.0 114.518 177.929 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 12.0 t-20 -52.35 -49.2 64.8 Favored 'General case' 0 CA--C 1.545 0.767 0 CA-C-N 114.395 -1.275 . . . . 0.0 112.065 173.424 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.449 ' HB ' ' O ' ' A' ' 15' ' ' VAL . 5.0 t -52.08 -50.57 34.8 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 CA-C-N 113.295 -1.775 . . . . 0.0 111.502 175.848 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.625 HG13 ' HA ' ' A' ' 56' ' ' LYS . 13.0 t -66.86 -48.62 79.21 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.255 0 O-C-N 123.991 0.807 . . . . 0.0 111.043 -176.124 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -63.73 -44.01 94.81 Favored 'General case' 0 CA--C 1.542 0.656 0 N-CA-C 114.446 1.276 . . . . 0.0 114.446 -176.638 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -103.06 -19.94 14.37 Favored 'General case' 0 N--CA 1.479 1.005 0 N-CA-C 115.559 1.689 . . . . 0.0 115.559 -171.194 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 71.17 39.69 62.33 Favored Glycine 0 N--CA 1.481 1.66 0 N-CA-C 109.905 -1.278 . . . . 0.0 109.905 -166.767 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -83.82 162.8 39.58 Favored Glycine 0 CA--C 1.527 0.806 0 N-CA-C 109.168 -1.573 . . . . 0.0 109.168 -178.96 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' TRP . . . . . 0.437 ' O ' HD13 ' A' ' 28' ' ' ILE . 31.5 m95 -64.76 104.6 0.85 Allowed 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 112.365 -1.918 . . . . 0.0 112.48 -175.132 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.578 HG21 HG13 ' A' ' 51' ' ' ILE . 3.1 p -57.35 -24.91 22.51 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.927 0 CA-C-N 113.147 -1.842 . . . . 0.0 113.39 171.395 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 3.1 p -61.34 -47.21 86.95 Favored 'General case' 0 N--CA 1.484 1.246 0 N-CA-C 113.786 1.032 . . . . 0.0 113.786 -179.516 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -62.4 -40.83 97.79 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 123.24 0.616 . . . . 0.0 111.357 173.862 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.65 HG13 HG22 ' A' ' 14' ' ' THR . 1.8 mp -60.02 -48.69 86.88 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 C-N-CA 124.878 1.271 . . . . 0.0 112.253 177.504 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.521 HG23 ' O ' ' A' ' 25' ' ' VAL . 53.5 t -49.59 -45.68 20.34 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 C-N-CA 124.406 1.082 . . . . 0.0 112.264 178.356 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -62.27 -41.72 98.71 Favored 'General case' 0 N--CA 1.485 1.314 0 N-CA-C 112.917 0.71 . . . . 0.0 112.917 178.38 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.9 HG22 HG12 ' A' ' 11' ' ' VAL . 36.7 mm -70.9 -38.86 74.19 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.145 0 C-N-CA 123.436 0.695 . . . . 0.0 109.805 -179.057 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.763 HD22 ' HB ' ' A' ' 11' ' ' VAL . 3.2 mm? -58.05 -53.44 58.18 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 125.475 1.51 . . . . 0.0 112.039 173.78 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 11.0 m -71.86 -21.19 61.7 Favored 'General case' 0 N--CA 1.477 0.916 0 N-CA-C 113.496 0.924 . . . . 0.0 113.496 179.473 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -58.89 -28.83 66.53 Favored 'General case' 0 N--CA 1.484 1.26 0 C-N-CA 123.967 0.907 . . . . 0.0 113.402 172.425 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 74.8 t -59.16 -38.28 73.35 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.256 0 C-N-CA 124.045 0.938 . . . . 0.0 111.495 170.916 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 89.86 109.28 1.3 Allowed Glycine 0 CA--C 1.537 1.412 0 N-CA-C 110.313 -1.115 . . . . 0.0 110.313 -175.482 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 50.4 m 76.05 -38.55 0.34 Allowed 'General case' 0 N--CA 1.494 1.738 0 C-N-CA 127.649 2.379 . . . . 0.0 113.959 -176.557 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -51.76 -53.16 30.79 Favored Glycine 0 N--CA 1.485 1.953 0 C-N-CA 124.732 1.158 . . . . 0.0 113.262 -175.586 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.431 ' O ' ' HG ' ' A' ' 43' ' ' LEU . . . -58.19 -41.33 94.72 Favored Glycine 0 N--CA 1.478 1.493 0 CA-C-N 114.316 -0.942 . . . . 0.0 114.901 176.087 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 43.9 mt -67.05 -44.93 78.89 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 124.242 1.017 . . . . 0.0 113.42 -177.143 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -55.44 -39.79 70.74 Favored 'General case' 0 N--CA 1.481 1.082 0 O-C-N 124.079 0.862 . . . . 0.0 112.838 171.903 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 16.8 tp -64.09 -48.17 77.2 Favored 'General case' 0 N--CA 1.477 0.884 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.042 175.859 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.431 ' HG ' ' O ' ' A' ' 39' ' ' GLY . 44.1 mt -61.05 -30.94 70.62 Favored 'General case' 0 N--CA 1.479 0.999 0 N-CA-C 114.603 1.334 . . . . 0.0 114.603 179.078 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -66.62 -50.39 63.15 Favored 'General case' 0 N--CA 1.478 0.96 0 CA-C-N 115.882 -0.599 . . . . 0.0 112.211 171.402 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -61.16 -34.73 75.49 Favored 'General case' 0 N--CA 1.485 1.301 0 CA-C-O 121.743 0.782 . . . . 0.0 112.345 176.273 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -67.35 -22.57 65.58 Favored 'General case' 0 N--CA 1.478 0.934 0 N-CA-C 116.191 1.923 . . . . 0.0 116.191 179.993 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -49.42 -34.58 19.44 Favored Glycine 0 CA--C 1.549 2.208 0 C-N-CA 124.688 1.137 . . . . 0.0 112.741 177.123 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 18.5 ttm180 -52.32 -50.87 61.39 Favored 'General case' 0 CA--C 1.549 0.906 0 C-N-CA 126.455 1.902 . . . . 0.0 114.977 -175.427 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 16.0 tt0 -133.5 40.58 3.13 Favored 'General case' 0 N--CA 1.479 0.977 0 N-CA-C 113.283 0.846 . . . . 0.0 113.283 -175.529 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 89.0 p 44.86 115.14 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.499 0 C-N-CA 125.303 1.441 . . . . 0.0 113.727 -172.445 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.578 HG13 HG21 ' A' ' 25' ' ' VAL . 8.0 tp -23.88 -56.82 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.483 1.177 0 N-CA-C 119.131 3.012 . . . . 0.0 119.131 -175.484 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 54.2 tttt -64.11 -55.52 21.35 Favored 'General case' 0 N--CA 1.48 1.045 0 N-CA-C 112.835 0.68 . . . . 0.0 112.835 -179.86 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -62.9 -38.66 91.81 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 124.936 1.294 . . . . 0.0 112.158 177.759 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 69.1 t80 -51.75 -58.42 6.45 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 125.617 1.567 . . . . 0.0 111.18 174.791 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.601 HD13 HG13 ' A' ' 15' ' ' VAL . 60.6 mt -70.47 -41.12 73.19 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 114.811 1.411 . . . . 0.0 114.811 -179.346 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.625 ' HA ' HG13 ' A' ' 19' ' ' VAL . 50.4 tptt -55.26 -49.96 70.72 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-N 114.004 -1.453 . . . . 0.0 113.174 178.076 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 52.8 tttp -74.55 -54.62 7.14 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-N 114.759 -1.109 . . . . 0.0 112.1 174.656 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' GLU . . . . . 0.409 ' O ' ' HB2' ' A' ' 62' ' ' LYS . 16.1 mt-10 -61.36 -41.78 97.63 Favored 'General case' 0 N--CA 1.472 0.625 0 N-CA-C 113.972 1.101 . . . . 0.0 113.972 -169.156 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.814 HG23 HG21 ' A' ' 67' ' ' VAL . 2.8 mm -78.09 -26.56 14.51 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.851 0 C-N-CA 120.13 -0.628 . . . . 0.0 112.192 -179.346 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 10.3 tppt? -61.94 -27.6 68.94 Favored 'General case' 0 CA--C 1.542 0.643 0 N-CA-C 114.332 1.234 . . . . 0.0 114.332 170.247 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 42.3 mmtm -89.18 -43.15 11.23 Favored 'General case' 0 N--CA 1.483 1.215 0 CA-C-N 113.647 -1.615 . . . . 0.0 111.387 178.475 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.458 ' HD3' HG22 ' A' ' 67' ' ' VAL . 2.7 tttm -68.88 -51.02 44.66 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 125.965 1.706 . . . . 0.0 114.89 -176.274 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 100.46 112.79 3.49 Favored Glycine 0 CA--C 1.534 1.273 0 N-CA-C 110.547 -1.021 . . . . 0.0 110.547 -172.654 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.436 ' HB3' HD13 ' A' ' 16' ' ' LEU . 10.5 mptt -41.99 -43.84 3.29 Favored 'General case' 0 N--CA 1.479 1.015 0 N-CA-C 118.139 2.644 . . . . 0.0 118.139 -172.643 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.437 ' O ' ' HB ' ' A' ' 68' ' ' ILE . 0.0 OUTLIER -61.3 -42.78 99.24 Favored 'General case' 0 N--CA 1.477 0.905 0 N-CA-C 114.995 1.48 . . . . 0.0 114.995 177.552 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -68.78 -22.33 64.29 Favored 'General case' 0 N--CA 1.479 1.022 0 CA-C-N 114.878 -1.055 . . . . 0.0 113.171 173.742 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.814 HG21 HG23 ' A' ' 59' ' ' ILE . 61.8 t -75.53 -32.71 25.5 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.919 0 C-N-CA 123.725 0.81 . . . . 0.0 111.34 176.72 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.437 ' HB ' ' O ' ' A' ' 65' ' ' ARG . 18.6 mm -51.78 -47.47 39.51 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.153 0 C-N-CA 123.639 0.776 . . . . 0.0 109.814 165.714 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -68.22 -48.83 64.11 Favored 'General case' 0 N--CA 1.472 0.641 0 O-C-N 124.225 0.953 . . . . 0.0 113.406 178.038 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 34.1 t90 . . . . . 0 N--CA 1.476 0.859 0 C-N-CA 125.587 1.555 . . . . 0.0 112.407 178.482 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.449 ' HB3' HG21 ' A' ' 7' ' ' ILE . 53.9 mtp . . . . . 0 N--CA 1.478 0.946 0 N-CA-C 112.367 0.506 . . . . 0.0 112.367 . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -55.47 -50.82 68.87 Favored 'General case' 0 N--CA 1.472 0.643 0 O-C-N 124.67 1.231 . . . . 0.0 112.711 177.291 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 52.7 tttp -72.91 -58.81 3.06 Favored 'General case' 0 CA--C 1.543 0.686 0 CA-C-N 114.257 -1.338 . . . . 0.0 113.573 -178.78 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -66.16 -43.74 86.09 Favored 'General case' 0 N--CA 1.471 0.601 0 N-CA-C 116.474 2.027 . . . . 0.0 116.474 -168.901 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' PHE . . . . . 0.561 ' HB2' HD12 ' A' ' 7' ' ' ILE . 38.4 m-85 -101.41 -18.06 16.19 Favored 'General case' 0 N--CA 1.476 0.857 0 N-CA-C 115.953 1.835 . . . . 0.0 115.953 -170.509 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 81.41 63.06 1.89 Allowed Glycine 0 N--CA 1.484 1.855 0 O-C-N 124.532 1.145 . . . . 0.0 110.714 -169.464 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.561 HD12 ' HB2' ' A' ' 5' ' ' PHE . 0.4 OUTLIER -122.55 145.93 46.23 Favored Pre-proline 0 N--CA 1.471 0.613 0 C-N-CA 125.587 1.555 . . . . 0.0 108.998 179.775 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_endo -86.44 152.1 9.12 Favored 'Trans proline' 0 CA--C 1.537 0.645 0 N-CA-C 108.173 -1.51 . . . . 0.0 108.173 161.13 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -47.69 -33.94 7.54 Favored 'General case' 0 N--CA 1.47 0.55 0 N-CA-C 115.663 1.727 . . . . 0.0 115.663 175.486 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -37.69 -57.37 0.98 Allowed 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 126.964 2.106 . . . . 0.0 113.931 173.374 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.873 HG12 HG22 ' A' ' 31' ' ' ILE . 23.9 m -83.97 -33.16 9.01 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.214 0 N-CA-C 113.728 1.01 . . . . 0.0 113.728 -175.259 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -64.09 -32.39 73.93 Favored 'General case' 0 CA--C 1.545 0.787 0 N-CA-C 112.303 0.483 . . . . 0.0 112.303 173.38 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -59.36 -44.62 96.45 Favored Glycine 0 CA--C 1.538 1.473 0 CA-C-O 122.497 1.054 . . . . 0.0 113.071 171.277 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.7 HG22 HG13 ' A' ' 28' ' ' ILE . 0.3 OUTLIER -63.17 -35.7 81.17 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 125.276 1.43 . . . . 0.0 113.586 176.542 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.469 HG23 HD21 ' A' ' 32' ' ' LEU . 5.1 t -58.15 -41.53 80.97 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 C-N-CA 124.205 1.002 . . . . 0.0 111.992 170.747 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 24.6 mt -61.32 -38.93 88.64 Favored 'General case' 0 N--CA 1.472 0.638 0 N-CA-C 113.222 0.823 . . . . 0.0 113.222 178.681 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -52.81 -48.06 67.18 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 124.798 1.239 . . . . 0.0 112.526 173.038 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 1.1 t -54.4 -54.0 25.55 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.984 0 CA-C-N 115.057 -0.974 . . . . 0.0 111.501 174.735 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.795 HG13 ' HA ' ' A' ' 56' ' ' LYS . 6.8 t -59.87 -47.58 90.98 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.014 0 O-C-N 123.803 0.689 . . . . 0.0 110.458 -177.505 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' GLU . . . . . 0.595 ' HG3' ' HE2' ' A' ' 64' ' ' LYS . 17.4 mt-10 -60.34 -36.74 78.69 Favored 'General case' 0 CA--C 1.542 0.666 0 N-CA-C 115.992 1.849 . . . . 0.0 115.992 -178.49 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -106.8 -9.97 16.22 Favored 'General case' 0 N--CA 1.477 0.876 0 N-CA-C 116.303 1.964 . . . . 0.0 116.303 -175.409 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 64.42 42.01 97.8 Favored Glycine 0 CA--C 1.549 2.196 0 N-CA-C 110.298 -1.121 . . . . 0.0 110.298 -168.12 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -92.53 175.24 37.23 Favored Glycine 0 CA--C 1.534 1.275 0 C-N-CA 124.27 0.938 . . . . 0.0 113.872 -167.436 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' TRP . . . . . 0.546 ' HB3' HG22 ' A' ' 26' ' ' THR . 81.5 m95 -67.29 104.83 1.58 Allowed 'General case' 0 N--CA 1.468 0.464 0 CA-C-O 122.55 1.167 . . . . 0.0 113.3 179.763 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.565 HG21 HG13 ' A' ' 51' ' ' ILE . 2.2 p -60.74 -22.08 25.36 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.971 0 CA-C-N 113.665 -1.607 . . . . 0.0 113.693 170.795 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.546 HG22 ' HB3' ' A' ' 24' ' ' TRP . 4.4 t -56.57 -46.38 80.8 Favored 'General case' 0 N--CA 1.485 1.316 0 N-CA-C 113.811 1.041 . . . . 0.0 113.811 -179.982 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.405 ' O ' HG12 ' A' ' 31' ' ' ILE . 0.0 OUTLIER -64.09 -41.01 97.45 Favored 'General case' 0 N--CA 1.479 1.016 0 O-C-N 123.972 0.795 . . . . 0.0 112.006 176.91 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.7 HG13 HG22 ' A' ' 14' ' ' THR . 2.0 mp -68.59 -44.37 82.8 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 C-N-CA 125.255 1.422 . . . . 0.0 111.904 -179.114 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.691 HG13 HD11 ' A' ' 43' ' ' LEU . 38.2 t -51.95 -48.88 39.74 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.349 0 C-N-CA 124.386 1.074 . . . . 0.0 111.069 174.52 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 42.3 m -52.34 -41.78 63.31 Favored 'General case' 0 N--CA 1.483 1.198 0 N-CA-C 114.555 1.317 . . . . 0.0 114.555 176.59 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.873 HG22 HG12 ' A' ' 11' ' ' VAL . 36.9 mm -75.35 -40.81 42.99 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.981 0 C-N-CA 124.407 1.083 . . . . 0.0 109.719 -177.766 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.651 HD22 ' HB ' ' A' ' 11' ' ' VAL . 3.9 mm? -55.96 -53.14 60.43 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 124.493 1.117 . . . . 0.0 112.294 171.565 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 1.2 p -66.4 -29.62 69.82 Favored 'General case' 0 N--CA 1.481 1.103 0 N-CA-C 115.974 1.842 . . . . 0.0 115.974 178.865 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -57.29 -27.94 62.59 Favored 'General case' 0 N--CA 1.477 0.882 0 O-C-N 124.303 1.002 . . . . 0.0 113.188 171.862 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 83.7 t -68.73 -32.85 56.64 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.297 0 C-N-CA 124.019 0.928 . . . . 0.0 111.628 172.898 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 108.45 -116.02 4.6 Favored Glycine 0 N--CA 1.47 0.928 0 C-N-CA 124.462 1.029 . . . . 0.0 111.825 -178.162 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 23.5 p -49.16 -47.78 45.48 Favored 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 115.754 1.761 . . . . 0.0 115.754 -175.982 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -60.65 -41.14 98.8 Favored Glycine 0 N--CA 1.474 1.193 0 C-N-CA 125.562 1.553 . . . . 0.0 114.251 -177.513 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.447 ' HA2' ' HB3' ' A' ' 32' ' ' LEU . . . -54.86 -52.35 46.89 Favored Glycine 0 N--CA 1.477 1.38 0 N-CA-C 111.032 -0.827 . . . . 0.0 111.032 173.328 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 94.8 mt -65.02 -49.14 71.35 Favored 'General case' 0 N--CA 1.48 1.028 0 N-CA-C 114.291 1.219 . . . . 0.0 114.291 -179.22 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 27.8 p -59.2 -38.83 80.85 Favored 'General case' 0 N--CA 1.48 1.065 0 N-CA-C 114.167 1.173 . . . . 0.0 114.167 175.873 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 13.8 tp -62.32 -50.61 70.93 Favored 'General case' 0 N--CA 1.48 1.047 0 CA-C-O 120.853 0.358 . . . . 0.0 111.11 170.275 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.691 HD11 HG13 ' A' ' 29' ' ' VAL . 0.7 OUTLIER -61.43 -30.89 70.85 Favored 'General case' 0 N--CA 1.473 0.706 0 N-CA-C 114.835 1.421 . . . . 0.0 114.835 -179.284 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -70.36 -43.79 69.45 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 123.568 0.747 . . . . 0.0 112.562 173.239 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -64.77 -31.43 72.65 Favored 'General case' 0 N--CA 1.475 0.798 0 N-CA-C 112.977 0.732 . . . . 0.0 112.977 174.074 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -60.22 -21.24 61.56 Favored 'General case' 0 N--CA 1.476 0.842 0 N-CA-C 115.817 1.784 . . . . 0.0 115.817 177.124 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -49.63 -33.63 18.94 Favored Glycine 0 CA--C 1.542 1.781 0 C-N-CA 126.198 1.856 . . . . 0.0 114.423 179.631 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 66.3 ttp85 -49.61 -60.2 3.08 Favored 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 125.602 1.561 . . . . 0.0 112.339 179.84 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 12.5 tt0 -129.15 32.08 4.77 Favored 'General case' 0 N--CA 1.48 1.069 0 CA-C-N 114.61 -1.177 . . . . 0.0 113.586 -172.571 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 8.0 t 49.75 123.55 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.295 0 C-N-CA 124.642 1.177 . . . . 0.0 113.692 -173.458 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.565 HG13 HG21 ' A' ' 25' ' ' VAL . 8.7 tp -29.01 -49.8 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.482 1.136 0 N-CA-C 117.947 2.573 . . . . 0.0 117.947 -174.713 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 33.8 ttmt -57.97 -68.67 0.22 Allowed 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 123.849 0.86 . . . . 0.0 111.93 177.383 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -62.61 -33.96 76.05 Favored 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 124.743 1.217 . . . . 0.0 113.397 179.588 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 88.5 t80 -49.5 -63.48 1.09 Allowed 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 125.11 1.364 . . . . 0.0 111.786 175.15 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.423 HD13 HG13 ' A' ' 15' ' ' VAL . 59.9 mt -65.09 -39.87 93.78 Favored 'General case' 0 N--CA 1.475 0.802 0 N-CA-C 114.469 1.285 . . . . 0.0 114.469 -178.299 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.795 ' HA ' HG13 ' A' ' 19' ' ' VAL . 97.8 mttt -58.66 -41.15 85.44 Favored 'General case' 0 N--CA 1.475 0.803 0 N-CA-C 114.34 1.237 . . . . 0.0 114.34 179.44 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 22.1 tttt -80.64 -49.66 10.96 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-N 114.628 -1.169 . . . . 0.0 111.983 173.753 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' GLU . . . . . 0.425 ' O ' ' HB2' ' A' ' 62' ' ' LYS . 31.2 tt0 -58.62 -49.29 78.05 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-N 115.672 -0.694 . . . . 0.0 112.421 -173.454 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.633 HD12 HG21 ' A' ' 67' ' ' VAL . 2.7 mm -75.53 -25.35 17.64 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.937 0 C-N-CA 120.658 -0.417 . . . . 0.0 111.91 -177.261 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.548 ' HB2' ' O ' ' A' ' 56' ' ' LYS . 2.5 tttt -62.85 -32.95 74.28 Favored 'General case' 0 N--CA 1.472 0.641 0 N-CA-C 114.599 1.333 . . . . 0.0 114.599 169.485 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 3.0 mptp? -81.36 -43.31 19.22 Favored 'General case' 0 N--CA 1.482 1.137 0 CA-C-N 114.132 -1.395 . . . . 0.0 112.373 173.271 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.425 ' HB2' ' O ' ' A' ' 58' ' ' GLU . 17.4 tptt -71.59 -52.52 17.66 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 126.636 1.974 . . . . 0.0 114.038 -171.72 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 97.6 114.63 3.28 Favored Glycine 0 N--CA 1.475 1.246 0 CA-C-O 122.602 1.112 . . . . 0.0 110.895 -170.216 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.595 ' HE2' ' HG3' ' A' ' 20' ' ' GLU . 11.8 mptt -32.25 -52.11 0.27 Allowed 'General case' 0 N--CA 1.474 0.747 0 N-CA-C 119.251 3.056 . . . . 0.0 119.251 177.024 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 1.045 HH21 HG13 ' A' ' 68' ' ' ILE . 0.0 OUTLIER -59.74 -45.31 92.59 Favored 'General case' 0 N--CA 1.476 0.827 0 N-CA-C 114.318 1.229 . . . . 0.0 114.318 -179.354 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -63.36 -29.85 71.08 Favored 'General case' 0 N--CA 1.474 0.751 0 CA-C-N 114.026 -1.443 . . . . 0.0 113.871 172.413 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.633 HG21 HD12 ' A' ' 59' ' ' ILE . 95.4 t -71.13 -33.12 50.06 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 N-CA-C 112.527 0.566 . . . . 0.0 112.527 178.175 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 1.045 HG13 HH21 ' A' ' 65' ' ' ARG . 27.0 mm -51.57 -47.49 37.05 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.333 0 O-C-N 123.902 0.751 . . . . 0.0 109.669 167.347 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -69.19 -51.48 37.59 Favored 'General case' 0 N--CA 1.483 1.21 0 CA-C-N 114.898 -1.046 . . . . 0.0 113.326 178.881 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 29.3 t90 . . . . . 0 N--CA 1.479 0.99 0 C-N-CA 124.657 1.183 . . . . 0.0 113.096 179.703 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.768 ' SD ' HD13 ' A' ' 42' ' ' LEU . 2.4 mmm . . . . . 0 CA--C 1.537 0.449 0 N-CA-C 111.442 0.164 . . . . 0.0 111.442 . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -62.14 -58.78 6.5 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-N 113.65 -1.614 . . . . 0.0 112.261 177.871 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 15.5 ttpp -65.49 -54.05 33.73 Favored 'General case' 0 N--CA 1.476 0.832 0 CA-C-N 113.486 -1.688 . . . . 0.0 113.391 -173.478 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 12.1 tt0 -71.88 -37.47 70.16 Favored 'General case' 0 N--CA 1.477 0.911 0 N-CA-C 114.319 1.229 . . . . 0.0 114.319 -171.165 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' PHE . . . . . 0.436 ' HD1' ' HB2' ' A' ' 41' ' ' SER . 71.9 m-85 -102.84 -10.66 18.89 Favored 'General case' 0 N--CA 1.475 0.783 0 N-CA-C 117.473 2.397 . . . . 0.0 117.473 -172.944 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 74.36 50.9 9.13 Favored Glycine 0 CA--C 1.539 1.581 0 CA-C-O 122.459 1.033 . . . . 0.0 111.461 -174.604 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -113.86 146.84 36.43 Favored Pre-proline 0 N--CA 1.476 0.873 0 CA-C-N 112.998 -1.601 . . . . 0.0 109.767 179.405 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 97.4 Cg_endo -88.58 152.64 6.34 Favored 'Trans proline' 0 C--O 1.236 0.378 0 N-CA-C 109.733 -0.91 . . . . 0.0 109.733 165.498 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -48.77 -29.31 4.39 Favored 'General case' 0 N--CA 1.474 0.75 0 N-CA-C 115.119 1.525 . . . . 0.0 115.119 171.342 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -38.97 -47.75 1.5 Allowed 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 126.392 1.877 . . . . 0.0 114.498 170.092 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.729 HG12 HG22 ' A' ' 31' ' ' ILE . 33.0 m -99.04 -39.06 7.51 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.0 0 N-CA-C 113.791 1.034 . . . . 0.0 113.791 -176.892 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.402 ' O ' ' HG ' ' A' ' 16' ' ' LEU . . . -62.8 -38.02 89.02 Favored 'General case' 0 CA--C 1.547 0.865 0 N-CA-C 112.814 0.672 . . . . 0.0 112.814 176.982 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -58.5 -47.45 89.85 Favored Glycine 0 N--CA 1.486 1.995 0 O-C-N 124.535 1.147 . . . . 0.0 112.394 173.551 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 16.4 m -59.06 -39.57 82.48 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 124.625 1.17 . . . . 0.0 113.918 173.967 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.472 ' O ' HG23 ' A' ' 19' ' ' VAL . 40.6 t -57.04 -44.73 83.38 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.116 0 C-N-CA 123.682 0.793 . . . . 0.0 111.239 172.824 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.66 HD11 HG12 ' A' ' 68' ' ' ILE . 37.0 mt -60.97 -45.96 92.67 Favored 'General case' 0 N--CA 1.481 1.116 0 N-CA-C 112.831 0.678 . . . . 0.0 112.831 178.782 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 24.6 t-20 -50.14 -50.22 49.53 Favored 'General case' 0 N--CA 1.48 1.051 0 O-C-N 124.612 1.195 . . . . 0.0 111.067 174.475 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 56.5 t -57.65 -50.41 77.46 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 CA-C-N 113.056 -1.884 . . . . 0.0 111.841 178.624 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.611 HG11 ' HB ' ' A' ' 59' ' ' ILE . 24.3 t -59.31 -45.68 93.03 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.291 0 O-C-N 123.681 0.613 . . . . 0.0 110.943 -179.937 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' GLU . . . . . 0.558 ' HG3' ' HE2' ' A' ' 64' ' ' LYS . 14.3 mt-10 -57.69 -44.39 85.78 Favored 'General case' 0 N--CA 1.477 0.875 0 C-N-CA 125.153 1.381 . . . . 0.0 114.232 179.921 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -77.36 -17.46 58.22 Favored 'General case' 0 CA--C 1.541 0.609 0 N-CA-C 113.97 1.1 . . . . 0.0 113.97 178.35 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 71.61 51.45 16.06 Favored Glycine 0 N--CA 1.477 1.382 0 O-C-N 124.138 0.898 . . . . 0.0 111.86 -170.277 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -109.75 167.31 12.75 Favored Glycine 0 N--CA 1.48 1.597 0 CA-C-O 122.844 1.247 . . . . 0.0 112.634 -177.415 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' TRP . . . . . 0.669 ' HB3' HG22 ' A' ' 26' ' ' THR . 77.1 m95 -78.19 105.95 9.77 Favored 'General case' 0 N--CA 1.479 0.997 0 CA-C-N 113.252 -1.474 . . . . 0.0 111.818 -178.524 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.797 HG21 ' HB2' ' A' ' 55' ' ' LEU . 0.4 OUTLIER -62.58 -16.5 16.89 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.948 0 CA-C-N 113.897 -1.501 . . . . 0.0 112.825 171.021 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.669 HG22 ' HB3' ' A' ' 24' ' ' TRP . 15.3 t -67.74 -27.71 67.02 Favored 'General case' 0 N--CA 1.48 1.045 0 N-CA-C 114.513 1.301 . . . . 0.0 114.513 -178.993 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.606 ' HB ' HD12 ' A' ' 28' ' ' ILE . 0.7 OUTLIER -71.11 -48.86 49.85 Favored 'General case' 0 N--CA 1.48 1.054 0 CA-C-O 121.445 0.64 . . . . 0.0 110.813 170.111 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.606 HD12 ' HB ' ' A' ' 27' ' ' THR . 3.4 mp -65.84 -25.36 36.08 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 C-N-CA 125.956 1.702 . . . . 0.0 112.86 -179.474 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.502 HG22 HD21 ' A' ' 43' ' ' LEU . 7.9 t -36.48 -44.21 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.409 0 C-N-CA 124.101 0.96 . . . . 0.0 112.013 162.255 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 85.2 p -59.01 -39.05 80.7 Favored 'General case' 0 N--CA 1.486 1.359 0 N-CA-C 113.831 1.048 . . . . 0.0 113.831 178.688 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.729 HG22 HG12 ' A' ' 11' ' ' VAL . 39.6 mm -76.65 -35.66 25.85 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.814 0 C-N-CA 124.51 1.124 . . . . 0.0 110.178 -177.557 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.701 HD22 ' HB ' ' A' ' 11' ' ' VAL . 3.8 mm? -59.71 -54.38 47.08 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 125.161 1.384 . . . . 0.0 112.973 170.884 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -68.83 -24.2 64.35 Favored 'General case' 0 N--CA 1.476 0.833 0 N-CA-C 114.765 1.394 . . . . 0.0 114.765 177.066 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -53.54 -28.17 30.0 Favored 'General case' 0 N--CA 1.482 1.131 0 N-CA-C 113.4 0.889 . . . . 0.0 113.4 167.092 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.404 ' HB ' ' O ' ' A' ' 32' ' ' LEU . 70.0 t -69.92 -32.46 51.72 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.111 0 C-N-CA 125.087 1.355 . . . . 0.0 112.354 169.807 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 109.16 -114.64 4.06 Favored Glycine 0 N--CA 1.477 1.39 0 C-N-CA 125.435 1.493 . . . . 0.0 111.201 179.747 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 12.4 p -56.54 -39.92 74.22 Favored 'General case' 0 N--CA 1.481 1.076 0 CA-C-N 112.628 -1.786 . . . . 0.0 115.265 -178.784 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -56.52 -50.84 60.26 Favored Glycine 0 CA--C 1.538 1.528 0 O-C-N 124.739 1.274 . . . . 0.0 113.155 -179.335 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.441 ' O ' ' HG ' ' A' ' 43' ' ' LEU . . . -54.63 -46.9 72.95 Favored Glycine 0 CA--C 1.539 1.588 0 N-CA-C 111.433 -0.667 . . . . 0.0 111.433 173.998 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 79.4 mt -60.4 -49.7 76.52 Favored 'General case' 0 N--CA 1.479 1.022 0 N-CA-C 114.594 1.331 . . . . 0.0 114.594 179.594 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' SER . . . . . 0.436 ' HB2' ' HD1' ' A' ' 5' ' ' PHE . 2.1 p -57.34 -37.33 72.38 Favored 'General case' 0 N--CA 1.479 1.021 0 N-CA-C 114.344 1.239 . . . . 0.0 114.344 177.337 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.768 HD13 ' SD ' ' A' ' 1' ' ' MET . 18.8 tp -62.94 -49.2 75.7 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 123.692 0.797 . . . . 0.0 110.436 171.396 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.502 HD21 HG22 ' A' ' 29' ' ' VAL . 49.5 mt -58.38 -33.74 69.95 Favored 'General case' 0 N--CA 1.476 0.855 0 N-CA-C 114.7 1.37 . . . . 0.0 114.7 178.087 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -65.1 -43.95 90.37 Favored 'General case' 0 N--CA 1.476 0.838 0 N-CA-C 112.324 0.491 . . . . 0.0 112.324 172.581 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -63.18 -43.17 98.98 Favored 'General case' 0 N--CA 1.484 1.251 0 C-N-CA 122.849 0.46 . . . . 0.0 111.729 173.276 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -57.34 -26.49 61.06 Favored 'General case' 0 N--CA 1.472 0.665 0 N-CA-C 115.645 1.72 . . . . 0.0 115.645 -176.597 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -45.86 -42.43 11.31 Favored Glycine 0 CA--C 1.546 2.029 0 C-N-CA 125.764 1.65 . . . . 0.0 114.052 178.589 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 29.0 ttm180 -48.54 -53.25 18.94 Favored 'General case' 0 N--CA 1.476 0.844 0 CA-C-N 112.558 -1.821 . . . . 0.0 113.673 -175.723 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 17.2 tt0 -126.84 36.72 4.41 Favored 'General case' 0 N--CA 1.474 0.77 0 N-CA-C 113.258 0.836 . . . . 0.0 113.258 178.024 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 18.4 t 48.33 120.96 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.421 0 C-N-CA 126.17 1.788 . . . . 0.0 113.821 -178.031 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 7.8 tp -31.31 -51.42 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 N-CA-C 116.595 2.072 . . . . 0.0 116.595 -176.319 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 70.3 mttt -48.68 -67.03 0.3 Allowed 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 125.477 1.511 . . . . 0.0 112.927 176.113 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -74.47 -30.86 62.03 Favored 'General case' 0 N--CA 1.466 0.352 0 N-CA-C 114.735 1.384 . . . . 0.0 114.735 -179.198 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' TYR . . . . . 0.504 ' HD2' ' HG ' ' A' ' 55' ' ' LEU . 72.9 t80 -49.0 -63.82 0.99 Allowed 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 124.933 1.293 . . . . 0.0 112.291 -178.133 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.797 ' HB2' HG21 ' A' ' 25' ' ' VAL . 42.4 mt -73.29 -34.44 65.76 Favored 'General case' 0 N--CA 1.477 0.885 0 N-CA-C 114.884 1.438 . . . . 0.0 114.884 -174.595 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.578 ' HA ' HG13 ' A' ' 19' ' ' VAL . 57.8 mtpt -58.59 -46.17 87.53 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 114.438 -1.256 . . . . 0.0 112.67 177.052 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 61.6 tttm -77.44 -50.77 11.99 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 114.903 -1.044 . . . . 0.0 111.873 174.409 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 58.8 tt0 -59.1 -44.99 92.0 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-O 118.225 -0.893 . . . . 0.0 111.515 -170.404 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.748 HG23 HG21 ' A' ' 67' ' ' VAL . 4.0 mm -79.32 -20.08 12.61 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.789 0 C-N-CA 119.841 -0.744 . . . . 0.0 112.712 -175.262 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 23.1 tptt -65.57 -37.28 86.22 Favored 'General case' 0 CA--C 1.549 0.909 0 CA-C-O 122.449 1.119 . . . . 0.0 113.454 170.545 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 21.6 ttpp -84.53 -37.78 20.82 Favored 'General case' 0 CA--C 1.554 1.101 0 CA-C-N 112.355 -2.202 . . . . 0.0 111.415 -178.601 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 6.9 tttt -77.21 -43.62 33.0 Favored 'General case' 0 CA--C 1.541 0.626 0 N-CA-C 116.603 2.075 . . . . 0.0 116.603 -177.432 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 91.35 111.5 1.7 Allowed Glycine 0 N--CA 1.478 1.445 0 CA-C-O 122.584 1.102 . . . . 0.0 111.332 -177.48 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.635 ' HD2' ' H ' ' A' ' 64' ' ' LYS . 10.4 mptt -43.87 -41.21 4.99 Favored 'General case' 0 N--CA 1.487 1.377 0 N-CA-C 117.863 2.542 . . . . 0.0 117.863 -171.778 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.485 ' O ' ' HB ' ' A' ' 68' ' ' ILE . 0.0 OUTLIER -56.16 -49.41 74.06 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 124.583 1.153 . . . . 0.0 113.386 178.402 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -67.65 -23.98 65.39 Favored 'General case' 0 N--CA 1.477 0.904 0 N-CA-C 114.61 1.337 . . . . 0.0 114.61 174.961 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.748 HG21 HG23 ' A' ' 59' ' ' ILE . 45.6 t -75.16 -32.23 26.05 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.083 0 CA-C-N 114.86 -1.064 . . . . 0.0 110.822 176.325 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.66 HG12 HD11 ' A' ' 16' ' ' LEU . 8.0 mm -51.7 -46.71 38.88 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.951 0 C-N-CA 123.355 0.662 . . . . 0.0 110.075 168.491 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -68.87 -48.91 62.24 Favored 'General case' 0 N--CA 1.482 1.143 0 O-C-N 124.542 1.152 . . . . 0.0 113.345 176.585 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 34.6 t90 . . . . . 0 N--CA 1.477 0.88 0 C-N-CA 124.799 1.24 . . . . 0.0 113.6 -178.846 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.536 ' HE3' HD13 ' A' ' 7' ' ' ILE . 22.5 mtp . . . . . 0 N--CA 1.48 1.036 0 N-CA-C 112.553 0.575 . . . . 0.0 112.553 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -60.56 -51.31 69.98 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-N 115.213 -0.903 . . . . 0.0 113.259 177.629 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 57.8 tttp -70.32 -51.44 30.15 Favored 'General case' 0 CA--C 1.551 0.987 0 CA-C-N 113.568 -1.651 . . . . 0.0 112.978 -173.42 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -77.22 -38.57 51.05 Favored 'General case' 0 N--CA 1.482 1.166 0 N-CA-C 116.577 2.065 . . . . 0.0 116.577 -170.361 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 5' ' ' PHE . . . . . 0.676 ' HD1' ' HB2' ' A' ' 41' ' ' SER . 53.3 m-85 -99.7 -30.99 11.78 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-N 112.914 -1.948 . . . . 0.0 115.356 -168.395 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 93.88 50.73 2.24 Favored Glycine 0 CA--C 1.541 1.682 0 O-C-N 125.277 1.611 . . . . 0.0 110.964 -171.174 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.536 HD13 ' HE3' ' A' ' 1' ' ' MET . 0.6 OUTLIER -117.83 147.76 41.82 Favored Pre-proline 0 N--CA 1.475 0.823 0 CA-C-N 113.4 -1.4 . . . . 0.0 109.287 -178.528 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_endo -89.42 155.04 5.42 Favored 'Trans proline' 0 C--N 1.332 -0.327 0 N-CA-C 108.861 -1.246 . . . . 0.0 108.861 161.307 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -50.18 -26.04 4.19 Favored 'General case' 0 CA--C 1.54 0.58 0 N-CA-C 115.208 1.558 . . . . 0.0 115.208 173.516 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -47.32 -59.38 3.23 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 125.237 1.415 . . . . 0.0 112.678 172.626 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.89 HG12 HG22 ' A' ' 31' ' ' ILE . 33.5 m -81.9 -27.6 9.61 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.988 0 N-CA-C 114.181 1.178 . . . . 0.0 114.181 -175.278 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -67.94 -33.84 75.44 Favored 'General case' 0 N--CA 1.478 0.932 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.651 172.863 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -61.24 -42.54 99.81 Favored Glycine 0 CA--C 1.537 1.451 0 C-N-CA 124.073 0.844 . . . . 0.0 112.833 173.263 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.476 HG22 HG13 ' A' ' 28' ' ' ILE . 0.8 OUTLIER -58.85 -41.63 87.41 Favored 'General case' 0 N--CA 1.478 0.966 0 N-CA-C 114.166 1.173 . . . . 0.0 114.166 173.792 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.539 HG13 HD13 ' A' ' 55' ' ' LEU . 22.2 t -53.87 -43.18 56.16 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.265 0 C-N-CA 123.514 0.725 . . . . 0.0 112.915 170.67 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 25.0 mt -60.74 -40.87 94.05 Favored 'General case' 0 N--CA 1.476 0.857 0 N-CA-C 113.278 0.844 . . . . 0.0 113.278 178.102 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 7.8 t30 -52.43 -45.5 66.0 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 124.405 1.082 . . . . 0.0 111.977 174.698 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -60.44 -51.65 70.57 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.682 0 CA-C-N 114.283 -1.326 . . . . 0.0 112.339 175.52 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.673 HG13 ' HA ' ' A' ' 56' ' ' LYS . 17.9 t -58.85 -45.0 91.82 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.388 0 O-C-N 124.265 0.978 . . . . 0.0 111.002 -178.876 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 21.0 mt-10 -66.88 -39.52 87.53 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 125.97 1.708 . . . . 0.0 115.418 -177.705 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -101.93 -24.19 14.04 Favored 'General case' 0 N--CA 1.474 0.753 0 N-CA-C 115.82 1.785 . . . . 0.0 115.82 -172.01 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.618 ' HA2' ' HE2' ' A' ' 56' ' ' LYS . . . 77.7 44.21 13.1 Favored Glycine 0 N--CA 1.484 1.897 0 N-CA-C 110.742 -0.943 . . . . 0.0 110.742 -166.75 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -85.67 169.29 42.7 Favored Glycine 0 N--CA 1.474 1.208 0 C-N-CA 124.294 0.95 . . . . 0.0 112.995 -175.451 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 66.6 m95 -67.43 99.8 0.78 Allowed 'General case' 0 C--O 1.243 0.751 0 CA-C-O 123.257 1.503 . . . . 0.0 111.728 176.75 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.753 HG21 ' HA ' ' A' ' 52' ' ' LYS . 16.0 t -56.32 -24.46 18.38 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.939 0 CA-C-N 113.521 -1.672 . . . . 0.0 112.481 174.091 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 11.7 p -58.55 -45.68 88.42 Favored 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 123.735 0.814 . . . . 0.0 112.71 176.528 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -61.65 -45.22 94.96 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 124.095 0.958 . . . . 0.0 111.211 176.023 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.476 HG13 HG22 ' A' ' 14' ' ' THR . 1.7 mp -56.96 -48.43 81.62 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.915 0 CA-C-N 114.701 -1.136 . . . . 0.0 112.951 175.225 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.427 HG13 HD11 ' A' ' 43' ' ' LEU . 54.4 t -52.38 -41.83 36.34 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.059 0 C-N-CA 123.85 0.86 . . . . 0.0 111.937 176.948 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 73.2 m -55.96 -47.2 78.05 Favored 'General case' 0 N--CA 1.486 1.327 0 N-CA-C 113.625 0.972 . . . . 0.0 113.625 174.349 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.89 HG22 HG12 ' A' ' 11' ' ' VAL . 36.5 mm -69.47 -38.17 76.44 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.964 0 CA-C-N 115.149 -0.932 . . . . 0.0 109.349 -175.906 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.53 HD22 ' HB ' ' A' ' 11' ' ' VAL . 4.3 mm? -61.81 -52.66 63.29 Favored 'General case' 0 N--CA 1.48 1.026 0 CA-C-N 113.813 -1.54 . . . . 0.0 113.496 175.508 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 8.3 p -68.01 -31.72 71.6 Favored 'General case' 0 N--CA 1.476 0.834 0 N-CA-C 114.76 1.393 . . . . 0.0 114.76 177.36 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -52.46 -29.62 25.65 Favored 'General case' 0 N--CA 1.479 0.981 0 N-CA-C 113.714 1.005 . . . . 0.0 113.714 172.117 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 85.6 t -69.11 -33.42 58.48 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 C-N-CA 124.179 0.992 . . . . 0.0 112.453 171.789 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 117.04 -118.08 4.03 Favored Glycine 0 N--CA 1.473 1.152 0 C-N-CA 124.396 0.998 . . . . 0.0 111.235 179.898 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 5.2 p -62.12 -38.97 90.96 Favored 'General case' 0 N--CA 1.473 0.711 0 N-CA-C 115.831 1.789 . . . . 0.0 115.831 -173.577 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -52.64 -47.58 57.62 Favored Glycine 0 CA--C 1.542 1.761 0 O-C-N 124.83 1.331 . . . . 0.0 113.729 176.187 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.433 ' O ' ' HG ' ' A' ' 43' ' ' LEU . . . -56.73 -51.25 58.01 Favored Glycine 0 N--CA 1.478 1.49 0 N-CA-C 110.875 -0.89 . . . . 0.0 110.875 177.727 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 18.9 mt -59.07 -48.94 79.77 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 124.594 1.157 . . . . 0.0 114.097 177.999 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' SER . . . . . 0.676 ' HB2' ' HD1' ' A' ' 5' ' ' PHE . 0.0 OUTLIER -58.63 -41.46 86.03 Favored 'General case' 0 N--CA 1.479 1.014 0 N-CA-C 113.824 1.046 . . . . 0.0 113.824 174.927 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 15.3 tp -60.25 -44.44 95.26 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 122.477 0.311 . . . . 0.0 110.87 174.07 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.433 ' HG ' ' O ' ' A' ' 39' ' ' GLY . 79.6 mt -62.01 -36.25 80.97 Favored 'General case' 0 N--CA 1.477 0.891 0 N-CA-C 115.017 1.488 . . . . 0.0 115.017 178.103 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -63.12 -50.02 72.12 Favored 'General case' 0 N--CA 1.472 0.635 0 O-C-N 123.962 0.789 . . . . 0.0 112.076 172.2 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -62.67 -33.57 75.34 Favored 'General case' 0 N--CA 1.486 1.347 0 N-CA-C 112.571 0.582 . . . . 0.0 112.571 177.558 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -65.29 -19.72 66.09 Favored 'General case' 0 N--CA 1.474 0.732 0 N-CA-C 115.702 1.741 . . . . 0.0 115.702 178.289 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -52.61 -38.29 51.95 Favored Glycine 0 N--CA 1.477 1.412 0 O-C-N 124.665 1.228 . . . . 0.0 112.696 178.006 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 65.1 ttp85 -54.12 -47.03 72.29 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 125.541 1.536 . . . . 0.0 113.805 -174.744 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 15.8 tt0 -132.25 36.11 3.64 Favored 'General case' 0 N--CA 1.477 0.899 0 N-CA-C 114.903 1.446 . . . . 0.0 114.903 -174.722 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 78.2 p 49.37 116.99 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.823 0 C-N-CA 124.06 0.944 . . . . 0.0 113.073 -174.798 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.544 HG13 HG11 ' A' ' 25' ' ' VAL 0.256 8.2 tp -31.5 -49.54 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 N-CA-C 117.974 2.583 . . . . 0.0 117.974 -173.58 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.753 ' HA ' HG21 ' A' ' 25' ' ' VAL . 0.3 OUTLIER -64.98 -66.57 0.53 Allowed 'General case' 0 N--CA 1.489 1.518 0 CA-C-N 118.214 0.461 . . . . 0.0 111.885 178.132 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -50.74 -40.02 53.53 Favored 'General case' 0 C--O 1.236 0.349 0 O-C-N 124.868 1.355 . . . . 0.0 112.522 178.804 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 91.6 t80 -48.84 -62.82 1.32 Allowed 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 126.108 1.763 . . . . 0.0 111.23 174.212 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.539 HD13 HG13 ' A' ' 15' ' ' VAL . 92.4 mt -64.98 -39.62 93.74 Favored 'General case' 0 N--CA 1.478 0.956 0 N-CA-C 115.354 1.613 . . . . 0.0 115.354 -178.792 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.673 ' HA ' HG13 ' A' ' 19' ' ' VAL . 29.1 mttt -58.78 -48.07 82.55 Favored 'General case' 0 C--N 1.319 -0.717 0 N-CA-C 115.444 1.646 . . . . 0.0 115.444 176.7 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 71.4 tttt -74.48 -50.71 17.18 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-N 115.039 -0.982 . . . . 0.0 112.039 173.547 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' GLU . . . . . 0.484 ' O ' ' HB2' ' A' ' 62' ' ' LYS . 31.3 tt0 -63.28 -47.37 82.63 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-O 118.433 -0.794 . . . . 0.0 111.549 -168.542 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.693 HG23 HG21 ' A' ' 67' ' ' VAL . 3.2 mm -77.66 -19.62 13.96 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.928 0 N-CA-C 112.117 0.414 . . . . 0.0 112.117 -176.334 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 2.7 ttmp? -68.62 -41.61 79.24 Favored 'General case' 0 CA--C 1.547 0.835 0 CA-C-N 115.511 -0.768 . . . . 0.0 112.643 170.069 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 25.4 ttpp -72.6 -41.91 65.1 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 125.651 1.58 . . . . 0.0 112.91 175.223 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.484 ' HB2' ' O ' ' A' ' 58' ' ' GLU . 0.0 OUTLIER -70.68 -53.45 15.69 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 126.674 1.99 . . . . 0.0 113.855 -177.034 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 99.37 106.24 2.69 Favored Glycine 0 N--CA 1.477 1.405 0 N-CA-C 110.399 -1.08 . . . . 0.0 110.399 -174.246 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.786 ' HD2' ' H ' ' A' ' 64' ' ' LYS . 10.8 mptt -30.87 -50.21 0.14 Allowed 'General case' 0 N--CA 1.485 1.319 0 N-CA-C 118.769 2.878 . . . . 0.0 118.769 -175.738 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.467 ' O ' ' HB ' ' A' ' 68' ' ' ILE . 0.0 OUTLIER -59.22 -42.1 90.2 Favored 'General case' 0 N--CA 1.474 0.73 0 N-CA-C 114.517 1.303 . . . . 0.0 114.517 178.759 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -69.56 -26.62 64.57 Favored 'General case' 0 N--CA 1.478 0.927 0 CA-C-N 114.55 -1.205 . . . . 0.0 113.65 174.729 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.693 HG21 HG23 ' A' ' 59' ' ' ILE . 72.6 t -69.63 -34.38 61.09 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.048 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.448 175.711 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.467 ' HB ' ' O ' ' A' ' 65' ' ' ARG . 19.8 mm -52.58 -41.57 37.52 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.941 0 O-C-N 124.223 0.952 . . . . 0.0 110.934 170.045 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -70.21 -53.84 15.37 Favored 'General case' 0 N--CA 1.48 1.042 0 N-CA-C 113.247 0.832 . . . . 0.0 113.247 174.535 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 46.7 t90 . . . . . 0 CA--C 1.545 0.76 0 C-N-CA 126.321 1.848 . . . . 0.0 114.325 -176.497 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.752 ' HE1' HG21 ' A' ' 15' ' ' VAL . 70.0 mtp . . . . . 0 N--CA 1.475 0.803 0 N-CA-C 112.98 0.733 . . . . 0.0 112.98 . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 2' ' ' ALA . . . . . 0.418 ' HA ' ' O ' ' A' ' 7' ' ' ILE . . . -61.52 -56.28 21.78 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-N 114.546 -1.206 . . . . 0.0 112.112 172.685 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 95.1 mttt -64.06 -62.86 1.36 Allowed 'General case' 0 CA--C 1.541 0.621 0 CA-C-N 114.015 -1.448 . . . . 0.0 114.453 -177.555 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 3.9 mp0 -75.21 -40.54 59.1 Favored 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 115.016 1.488 . . . . 0.0 115.016 -170.065 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' PHE . . . . . 0.486 ' HD2' ' HA ' ' A' ' 1' ' ' MET . 41.3 m-85 -101.85 -11.68 18.85 Favored 'General case' 0 N--CA 1.476 0.851 0 N-CA-C 116.557 2.058 . . . . 0.0 116.557 -174.005 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 67.39 37.37 90.33 Favored Glycine 0 CA--C 1.538 1.528 0 CA-C-O 121.855 0.697 . . . . 0.0 111.359 -173.731 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.663 HG23 HG23 ' A' ' 11' ' ' VAL . 0.7 OUTLIER -110.06 115.31 55.06 Favored Pre-proline 0 N--CA 1.474 0.73 0 C-N-CA 124.547 1.139 . . . . 0.0 109.086 179.016 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 96.3 Cg_endo -65.2 154.92 71.22 Favored 'Trans proline' 0 CA--C 1.536 0.602 0 C-N-CA 120.614 0.876 . . . . 0.0 111.019 -177.165 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -46.49 -30.11 2.05 Favored 'General case' 0 N--CA 1.472 0.662 0 N-CA-C 115.833 1.79 . . . . 0.0 115.833 174.478 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -40.4 -60.76 1.03 Allowed 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 126.337 1.855 . . . . 0.0 112.875 171.116 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.98 HG12 HG22 ' A' ' 31' ' ' ILE . 34.6 m -86.86 -31.11 5.99 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.915 0 CA-C-N 114.58 -1.191 . . . . 0.0 113.679 -174.793 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -59.63 -33.81 71.98 Favored 'General case' 0 CA--C 1.547 0.843 0 N-CA-C 113.24 0.829 . . . . 0.0 113.24 171.611 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -63.68 -44.18 96.77 Favored Glycine 0 N--CA 1.481 1.69 0 C-N-CA 124.044 0.831 . . . . 0.0 112.229 174.641 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.915 HG22 HG13 ' A' ' 28' ' ' ILE . 1.7 m -61.33 -36.87 81.34 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 125.368 1.467 . . . . 0.0 113.674 174.175 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.752 HG21 ' HE1' ' A' ' 1' ' ' MET . 6.1 t -58.16 -45.36 88.7 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.359 0 N-CA-C 113.044 0.757 . . . . 0.0 113.044 170.187 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.404 HD13 ' HB3' ' A' ' 64' ' ' LYS . 39.0 mt -57.07 -38.56 73.47 Favored 'General case' 0 N--CA 1.482 1.173 0 CA-C-N 115.352 -0.84 . . . . 0.0 112.868 177.102 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 5.3 t-20 -53.01 -46.17 68.25 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-N 113.355 -1.748 . . . . 0.0 113.384 176.268 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 1.7 t -55.52 -49.47 73.25 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.124 0 C-N-CA 124.696 1.198 . . . . 0.0 113.042 172.26 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.792 HG13 ' HA ' ' A' ' 56' ' ' LYS . 11.6 t -63.45 -45.44 97.9 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.227 0 C-N-CA 123.635 0.774 . . . . 0.0 111.483 -174.961 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' GLU . . . . . 0.432 ' HG3' ' HE2' ' A' ' 64' ' ' LYS . 19.0 mt-10 -65.14 -40.98 95.17 Favored 'General case' 0 CA--C 1.541 0.6 0 N-CA-C 115.843 1.794 . . . . 0.0 115.843 -179.6 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -101.12 -20.9 15.13 Favored 'General case' 0 N--CA 1.479 1.007 0 N-CA-C 116.287 1.958 . . . . 0.0 116.287 -174.716 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 71.57 39.63 60.5 Favored Glycine 0 N--CA 1.481 1.634 0 N-CA-C 110.894 -0.882 . . . . 0.0 110.894 -164.954 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -82.17 164.52 44.2 Favored Glycine 0 N--CA 1.478 1.444 0 C-N-CA 124.388 0.994 . . . . 0.0 113.006 -174.123 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' TRP . . . . . 0.499 ' HB3' HG22 ' A' ' 26' ' ' THR . 2.3 m-90 -62.33 103.9 0.44 Allowed 'General case' 0 N--CA 1.475 0.787 0 CA-C-O 123.166 1.46 . . . . 0.0 112.107 179.603 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 3.0 p -55.57 -24.56 16.36 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.718 0 CA-C-N 112.89 -1.959 . . . . 0.0 112.851 172.87 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.499 HG22 ' HB3' ' A' ' 24' ' ' TRP . 9.8 t -62.49 -45.92 90.82 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-O 118.002 -0.999 . . . . 0.0 113.441 177.951 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -60.09 -42.06 93.85 Favored 'General case' 0 N--CA 1.484 1.26 0 O-C-N 124.416 1.072 . . . . 0.0 110.454 175.642 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.915 HG13 HG22 ' A' ' 14' ' ' THR . 1.9 mp -65.62 -47.53 85.92 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.649 0 C-N-CA 124.634 1.174 . . . . 0.0 112.583 -179.534 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 72.7 t -50.37 -42.7 21.29 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 O-C-N 123.755 0.66 . . . . 0.0 111.232 174.426 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 5.5 m -55.55 -40.95 72.57 Favored 'General case' 0 N--CA 1.481 1.106 0 N-CA-C 113.919 1.081 . . . . 0.0 113.919 175.948 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.98 HG22 HG12 ' A' ' 11' ' ' VAL . 34.9 mm -71.45 -38.86 70.07 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.957 0 C-N-CA 124.14 0.976 . . . . 0.0 109.932 179.802 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.495 HD22 ' HB ' ' A' ' 11' ' ' VAL . 3.4 mm? -61.15 -40.42 93.77 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 124.716 1.207 . . . . 0.0 112.184 171.491 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.734 HG23 ' HA2' ' A' ' 38' ' ' GLY . 10.0 m -67.63 -36.88 81.61 Favored 'General case' 0 N--CA 1.476 0.84 0 N-CA-C 114.05 1.13 . . . . 0.0 114.05 175.813 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -53.64 -31.55 47.89 Favored 'General case' 0 N--CA 1.488 1.437 0 C-N-CA 124.325 1.05 . . . . 0.0 113.797 175.2 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 42.9 t -58.78 -36.81 62.66 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.94 0 C-N-CA 125.802 1.641 . . . . 0.0 113.402 174.167 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 118.06 160.6 11.65 Favored Glycine 0 CA--C 1.535 1.286 0 N-CA-C 108.982 -1.647 . . . . 0.0 108.982 -168.971 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' SER . . . . . 0.59 ' OG ' ' HB2' ' A' ' 40' ' ' LEU . 8.3 t 73.39 -37.77 0.39 Allowed 'General case' 0 N--CA 1.493 1.708 0 C-N-CA 126.376 1.87 . . . . 0.0 112.928 -175.914 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.734 ' HA2' HG23 ' A' ' 33' ' ' THR . . . 116.97 14.43 7.23 Favored Glycine 0 CA--C 1.54 1.608 0 C-N-CA 125.978 1.751 . . . . 0.0 112.459 -174.337 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.433 ' HA3' ' HB3' ' A' ' 32' ' ' LEU . . . 57.14 27.68 57.73 Favored Glycine 0 N--CA 1.484 1.837 0 N-CA-C 111.805 -0.518 . . . . 0.0 111.805 -159.765 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.59 ' HB2' ' OG ' ' A' ' 37' ' ' SER . 5.3 mt -56.97 -37.38 71.53 Favored 'General case' 0 N--CA 1.481 1.1 0 N-CA-C 115.954 1.835 . . . . 0.0 115.954 -167.869 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 12.3 p -59.15 -48.33 82.02 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 124.139 0.976 . . . . 0.0 112.661 176.335 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 15.0 tp -62.75 -49.39 75.21 Favored 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 122.983 0.513 . . . . 0.0 110.572 173.062 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 77.8 mt -60.47 -31.22 70.25 Favored 'General case' 0 N--CA 1.475 0.81 0 N-CA-C 113.972 1.101 . . . . 0.0 113.972 -177.462 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -69.36 -46.14 67.7 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 123.463 0.705 . . . . 0.0 111.826 173.94 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -60.74 -30.85 70.24 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 123.833 0.853 . . . . 0.0 112.563 177.317 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.426 ' HB1' ' HA ' ' A' ' 51' ' ' ILE . . . -67.38 -27.82 67.42 Favored 'General case' 0 N--CA 1.471 0.608 0 N-CA-C 115.931 1.826 . . . . 0.0 115.931 178.276 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -45.76 -45.54 13.23 Favored Glycine 0 CA--C 1.544 1.851 0 C-N-CA 126.105 1.812 . . . . 0.0 114.295 -170.811 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 24.6 tpt180 -45.79 -48.43 15.56 Favored 'General case' 0 CA--C 1.544 0.736 0 CA-C-N 111.948 -2.126 . . . . 0.0 114.328 -179.221 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 18.9 tt0 -123.74 25.89 7.91 Favored 'General case' 0 N--CA 1.481 1.107 0 N-CA-C 114.499 1.296 . . . . 0.0 114.499 -176.997 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 33.2 t 50.21 133.18 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.486 0 C-N-CA 125.626 1.57 . . . . 0.0 111.83 -167.971 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.426 ' HA ' ' HB1' ' A' ' 46' ' ' ALA . 7.4 tp -43.13 -45.4 1.36 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.027 0 N-CA-C 115.536 1.68 . . . . 0.0 115.536 -175.599 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 5.6 tmtm? -53.84 -71.2 0.08 Allowed 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 125.061 1.344 . . . . 0.0 111.941 177.733 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -65.47 -29.18 69.81 Favored 'General case' 0 N--CA 1.471 0.576 0 N-CA-C 115.135 1.531 . . . . 0.0 115.135 179.385 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' TYR . . . . . 0.459 ' O ' ' HB2' ' A' ' 58' ' ' GLU . 86.9 t80 -51.1 -64.64 0.75 Allowed 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 125.417 1.487 . . . . 0.0 111.579 176.565 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.461 HD13 HG13 ' A' ' 15' ' ' VAL . 75.4 mt -60.77 -37.86 83.3 Favored 'General case' 0 N--CA 1.478 0.95 0 N-CA-C 114.617 1.34 . . . . 0.0 114.617 -176.18 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.792 ' HA ' HG13 ' A' ' 19' ' ' VAL . 94.0 mttt -61.3 -45.23 95.31 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 113.201 -1.818 . . . . 0.0 114.055 -179.335 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 81.4 tttt -77.25 -47.06 21.12 Favored 'General case' 0 CA--C 1.543 0.71 0 CA-C-N 115.275 -0.875 . . . . 0.0 112.703 171.463 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' GLU . . . . . 0.461 ' O ' ' HB2' ' A' ' 62' ' ' LYS . 4.1 mm-40 -57.22 -51.05 70.91 Favored 'General case' 0 C--O 1.219 -0.522 0 N-CA-C 113.743 1.016 . . . . 0.0 113.743 -175.105 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.697 HG23 HG21 ' A' ' 67' ' ' VAL . 2.6 mm -80.01 -21.1 11.91 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.484 0 N-CA-C 112.206 0.447 . . . . 0.0 112.206 -177.603 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.522 ' HB2' ' O ' ' A' ' 56' ' ' LYS . 6.9 tppt? -60.65 -42.79 97.71 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-O 123.783 1.754 . . . . 0.0 112.296 171.599 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . 0.277 19.5 tttm -81.32 -45.03 16.8 Favored 'General case' 0 CA--C 1.55 0.951 0 CA-C-N 111.132 -2.758 . . . . 0.0 111.74 -179.797 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.461 ' HB2' ' O ' ' A' ' 58' ' ' GLU . 15.5 tptt -58.51 -50.66 72.95 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 126.036 1.734 . . . . 0.0 113.605 -179.135 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 86.66 108.31 0.82 Allowed Glycine 0 N--CA 1.478 1.47 0 CA-C-N 113.582 -1.644 . . . . 0.0 109.911 -169.079 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.71 ' HD2' ' H ' ' A' ' 64' ' ' LYS . 10.0 mptt -28.48 -48.38 0.06 Allowed 'General case' 0 N--CA 1.481 1.083 0 N-CA-C 119.776 3.25 . . . . 0.0 119.776 -176.625 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.406 ' O ' ' HB ' ' A' ' 68' ' ' ILE . 1.2 ttp85 -54.5 -44.03 72.35 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 125.625 1.57 . . . . 0.0 113.321 178.804 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -69.25 -23.25 63.84 Favored 'General case' 0 N--CA 1.474 0.761 0 N-CA-C 114.702 1.371 . . . . 0.0 114.702 176.116 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.697 HG21 HG23 ' A' ' 59' ' ' ILE . 63.9 t -75.67 -35.88 32.48 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.31 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.893 178.752 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.406 ' HB ' ' O ' ' A' ' 65' ' ' ARG . 17.3 mm -50.39 -42.56 21.2 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 C-N-CA 124.124 0.969 . . . . 0.0 111.107 169.304 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -74.9 -52.8 10.35 Favored 'General case' 0 N--CA 1.484 1.238 0 N-CA-C 113.718 1.007 . . . . 0.0 113.718 174.789 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 33.3 t90 . . . . . 0 N--CA 1.488 1.47 0 C-N-CA 125.704 1.602 . . . . 0.0 114.118 -178.301 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.548 ' HB3' HG22 ' A' ' 7' ' ' ILE . 68.1 mtp . . . . . 0 N--CA 1.478 0.969 0 N-CA-C 112.137 0.421 . . . . 0.0 112.137 . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 2' ' ' ALA . . . . . 0.54 ' HA ' ' O ' ' A' ' 7' ' ' ILE . . . -58.26 -52.78 64.14 Favored 'General case' 0 N--CA 1.475 0.825 0 CA-C-N 114.819 -1.082 . . . . 0.0 112.129 173.902 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.99 -65.11 0.84 Allowed 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 112.518 -2.128 . . . . 0.0 115.997 -174.962 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 4' ' ' GLU . . . . . 0.421 ' HB2' ' O ' ' A' ' 70' ' ' TRP . 1.8 mp0 -73.79 -26.34 60.58 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-N 112.877 -1.965 . . . . 0.0 113.496 -170.718 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 5' ' ' PHE . . . . . 0.413 ' HD1' ' HB2' ' A' ' 41' ' ' SER . 31.6 m-85 -118.02 -6.92 10.92 Favored 'General case' 0 N--CA 1.478 0.937 0 N-CA-C 118.025 2.602 . . . . 0.0 118.025 -174.167 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 63.13 37.22 94.56 Favored Glycine 0 CA--C 1.543 1.806 0 O-C-N 124.007 0.817 . . . . 0.0 112.551 -175.866 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.548 HG22 ' HB3' ' A' ' 1' ' ' MET . 0.5 OUTLIER -114.0 121.51 36.63 Favored Pre-proline 0 N--CA 1.475 0.778 0 CA-C-N 114.448 -0.876 . . . . 0.0 108.708 -179.833 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 96.6 Cg_endo -67.28 160.87 45.59 Favored 'Trans proline' 0 CA--C 1.532 0.411 0 C-N-CA 120.971 1.114 . . . . 0.0 111.334 -177.558 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -53.62 -27.62 28.05 Favored 'General case' 0 CA--C 1.545 0.772 0 N-CA-C 114.713 1.375 . . . . 0.0 114.713 173.048 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -45.43 -43.9 11.7 Favored 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 126.191 1.796 . . . . 0.0 114.357 174.216 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.531 HG23 HG23 ' A' ' 7' ' ' ILE . 34.5 m -102.65 -33.59 3.36 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.893 0 N-CA-C 114.306 1.225 . . . . 0.0 114.306 -176.947 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.412 ' O ' ' HG ' ' A' ' 16' ' ' LEU . . . -61.45 -34.17 74.97 Favored 'General case' 0 N--CA 1.475 0.776 0 CA-C-N 114.8 -1.091 . . . . 0.0 112.181 173.686 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -59.71 -49.97 72.82 Favored Glycine 0 N--CA 1.478 1.434 0 C-N-CA 124.799 1.19 . . . . 0.0 112.775 173.57 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 9.1 m -62.13 -36.39 81.65 Favored 'General case' 0 N--CA 1.479 1.001 0 N-CA-C 114.612 1.338 . . . . 0.0 114.612 175.596 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.438 ' O ' HG23 ' A' ' 19' ' ' VAL . 72.0 t -56.94 -40.11 69.96 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.133 0 C-N-CA 123.213 0.605 . . . . 0.0 111.481 173.109 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.622 HD13 ' HB3' ' A' ' 64' ' ' LYS . 27.6 mt -61.36 -43.57 98.65 Favored 'General case' 0 N--CA 1.479 1.023 0 N-CA-C 113.418 0.896 . . . . 0.0 113.418 178.636 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 56.6 t-20 -54.77 -49.77 70.08 Favored 'General case' 0 CA--C 1.548 0.901 0 O-C-N 124.614 1.197 . . . . 0.0 111.055 173.443 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 96.8 t -54.9 -52.35 44.0 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.954 0 CA-C-N 114.6 -1.182 . . . . 0.0 111.204 175.823 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.643 HG11 ' HB ' ' A' ' 59' ' ' ILE . 81.7 t -53.88 -56.14 10.61 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.307 0 O-C-N 124.05 0.844 . . . . 0.0 111.124 179.788 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 14.5 tt0 -57.13 -37.69 72.38 Favored 'General case' 0 N--CA 1.476 0.829 0 O-C-N 124.972 1.42 . . . . 0.0 113.191 -176.825 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -88.12 -16.64 32.91 Favored 'General case' 0 N--CA 1.473 0.699 0 N-CA-C 116.294 1.961 . . . . 0.0 116.294 179.15 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 70.58 33.65 67.36 Favored Glycine 0 N--CA 1.487 2.099 0 C-N-CA 124.5 1.048 . . . . 0.0 112.143 -170.012 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -77.32 -177.12 45.69 Favored Glycine 0 CA--C 1.539 1.583 0 CA-C-O 124.155 1.975 . . . . 0.0 115.542 -170.954 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' TRP . . . . . 0.419 ' HB3' ' OG1' ' A' ' 26' ' ' THR . 74.0 m95 -63.7 122.65 16.9 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 110.717 -2.741 . . . . 0.0 116.73 -176.296 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 11.9 p -42.76 -37.75 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.379 0 CA-C-N 112.492 -2.14 . . . . 0.0 113.802 164.561 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.419 ' OG1' ' HB3' ' A' ' 24' ' ' TRP . 8.4 p -60.1 -44.26 94.97 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 123.782 0.833 . . . . 0.0 111.483 176.927 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -60.72 -29.54 69.42 Favored 'General case' 0 N--CA 1.485 1.317 0 N-CA-C 112.835 0.68 . . . . 0.0 112.835 176.321 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.488 ' O ' HD23 ' A' ' 32' ' ' LEU . 30.4 mt -72.75 -68.28 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.028 0 N-CA-C 109.36 -0.607 . . . . 0.0 109.36 167.239 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 85.7 t -54.39 -48.49 68.57 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.054 0 CA-C-O 118.159 -0.924 . . . . 0.0 112.896 -170.45 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 67.2 m -64.83 -26.15 68.21 Favored 'General case' 0 N--CA 1.477 0.897 0 N-CA-C 115.172 1.545 . . . . 0.0 115.172 179.349 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.49 HG22 HG12 ' A' ' 11' ' ' VAL . 35.7 mm -85.23 -42.41 16.3 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.921 0 C-N-CA 123.047 0.539 . . . . 0.0 110.166 174.659 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.527 HD22 ' HB ' ' A' ' 11' ' ' VAL . 3.5 mm? -62.18 -30.12 70.84 Favored 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 125.107 1.363 . . . . 0.0 114.328 176.015 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.727 ' HA ' ' HA2' ' A' ' 38' ' ' GLY . 2.8 p -68.54 -30.84 69.72 Favored 'General case' 0 N--CA 1.488 1.448 0 N-CA-C 116.424 2.009 . . . . 0.0 116.424 170.472 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -58.63 -25.46 62.71 Favored 'General case' 0 N--CA 1.475 0.82 0 O-C-N 124.654 1.221 . . . . 0.0 112.868 177.16 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.43 HG23 HG11 ' A' ' 11' ' ' VAL . 98.4 t -69.17 -31.7 51.04 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.077 0 C-N-CA 126.592 1.957 . . . . 0.0 112.597 175.408 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 109.8 -51.14 0.72 Allowed Glycine 0 CA--C 1.542 1.738 0 N-CA-C 111.178 -0.769 . . . . 0.0 111.178 -175.24 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 16.3 p -61.66 -4.28 1.37 Allowed 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 114.574 1.324 . . . . 0.0 114.574 174.615 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.727 ' HA2' ' HA ' ' A' ' 33' ' ' THR . . . 63.94 16.11 59.09 Favored Glycine 0 N--CA 1.487 2.097 0 C-N-CA 124.073 0.844 . . . . 0.0 114.62 173.886 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.511 ' HA3' ' HB3' ' A' ' 32' ' ' LEU . . . 51.8 27.33 20.03 Favored Glycine 0 CA--C 1.541 1.686 0 C-N-CA 125.408 1.48 . . . . 0.0 113.48 -163.423 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 20.8 mt -55.79 -43.16 76.54 Favored 'General case' 0 N--CA 1.477 0.908 0 N-CA-C 115.15 1.537 . . . . 0.0 115.15 -173.442 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' SER . . . . . 0.413 ' HB2' ' HD1' ' A' ' 5' ' ' PHE . 8.8 p -60.0 -46.39 89.61 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 123.861 0.864 . . . . 0.0 113.063 173.937 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 12.0 tp -60.91 -51.3 69.88 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 124.002 0.921 . . . . 0.0 110.366 172.096 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.406 ' HG ' ' O ' ' A' ' 39' ' ' GLY . 52.1 mt -57.8 -33.06 68.17 Favored 'General case' 0 N--CA 1.476 0.84 0 N-CA-C 114.345 1.239 . . . . 0.0 114.345 -179.692 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -65.39 -48.43 72.9 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-N 115.765 -0.652 . . . . 0.0 112.529 172.697 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -64.7 -36.63 84.9 Favored 'General case' 0 N--CA 1.482 1.155 0 CA-C-O 121.892 0.853 . . . . 0.0 111.829 177.595 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.466 ' HB1' ' HA ' ' A' ' 51' ' ' ILE . . . -65.16 -15.74 62.75 Favored 'General case' 0 N--CA 1.476 0.843 0 N-CA-C 116.107 1.891 . . . . 0.0 116.107 179.071 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -51.77 -42.81 53.51 Favored Glycine 0 CA--C 1.544 1.87 0 C-N-CA 124.725 1.155 . . . . 0.0 112.988 177.914 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 44.9 ttp180 -49.58 -49.89 44.68 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 125.123 1.369 . . . . 0.0 113.817 -174.158 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.404 ' HB3' ' HD1' ' A' ' 54' ' ' TYR . 29.1 tt0 -129.64 36.06 4.13 Favored 'General case' 0 CA--C 1.547 0.849 0 N-CA-C 113.605 0.965 . . . . 0.0 113.605 -174.518 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 96.0 p 50.31 123.68 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.372 0 C-N-CA 126.527 1.931 . . . . 0.0 113.877 -175.524 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.466 ' HA ' ' HB1' ' A' ' 46' ' ' ALA 0.274 3.9 tp -35.23 -63.99 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.545 0.779 0 N-CA-C 117.547 2.425 . . . . 0.0 117.547 -170.134 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 16.0 ttpp -52.52 -58.49 6.6 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 123.387 0.675 . . . . 0.0 112.791 177.359 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -64.05 -38.37 90.83 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 124.518 1.127 . . . . 0.0 113.485 -178.147 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' TYR . . . . . 0.404 ' HD1' ' HB3' ' A' ' 49' ' ' GLU . 72.8 t80 -51.9 -65.6 0.53 Allowed 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 126.056 1.742 . . . . 0.0 109.625 175.441 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 48.1 mt -64.36 -37.27 86.93 Favored 'General case' 0 N--CA 1.474 0.765 0 N-CA-C 114.33 1.233 . . . . 0.0 114.33 -177.8 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.612 ' HA ' HG13 ' A' ' 19' ' ' VAL . 9.0 tmtm? -57.58 -48.86 78.21 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 114.594 -1.185 . . . . 0.0 112.598 178.602 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 41.2 tttm -77.88 -49.83 13.44 Favored 'General case' 0 N--CA 1.476 0.854 0 CA-C-N 115.18 -0.918 . . . . 0.0 112.601 175.171 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' GLU . . . . . 0.442 ' O ' ' HB2' ' A' ' 62' ' ' LYS . 39.5 tt0 -58.25 -49.2 77.93 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-O 118.523 -0.751 . . . . 0.0 110.53 -173.164 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.741 HG23 HG21 ' A' ' 67' ' ' VAL . 2.8 mm -75.89 -25.53 17.22 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.893 0 CA-C-O 119.18 -0.438 . . . . 0.0 111.902 -176.503 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.567 ' HB2' ' O ' ' A' ' 56' ' ' LYS . 0.9 OUTLIER -61.38 -34.03 74.65 Favored 'General case' 0 CA--C 1.546 0.796 0 O-C-N 124.56 1.162 . . . . 0.0 113.812 171.867 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -86.26 -43.34 13.02 Favored 'General case' 0 N--CA 1.481 1.098 0 CA-C-N 113.094 -1.866 . . . . 0.0 112.228 179.02 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.442 ' HB2' ' O ' ' A' ' 58' ' ' GLU . 22.8 tttm -67.06 -51.06 59.17 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 127.507 2.323 . . . . 0.0 112.34 -173.742 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 102.42 108.38 3.2 Favored Glycine 0 N--CA 1.476 1.325 0 N-CA-C 109.621 -1.392 . . . . 0.0 109.621 -173.048 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.622 ' HB3' HD13 ' A' ' 16' ' ' LEU . 10.9 mptt -40.04 -43.57 1.6 Allowed 'General case' 0 N--CA 1.487 1.375 0 N-CA-C 117.558 2.429 . . . . 0.0 117.558 -175.171 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.446 ' O ' ' HB ' ' A' ' 68' ' ' ILE . 11.2 mmp_? -57.4 -43.39 83.66 Favored 'General case' 0 N--CA 1.478 0.931 0 N-CA-C 116.003 1.853 . . . . 0.0 116.003 178.749 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -67.65 -27.7 67.09 Favored 'General case' 0 N--CA 1.482 1.157 0 CA-C-N 114.15 -1.386 . . . . 0.0 113.209 173.104 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.741 HG21 HG23 ' A' ' 59' ' ' ILE . 78.8 t -70.92 -33.18 51.06 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.048 0 C-N-CA 123.337 0.655 . . . . 0.0 111.972 177.794 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.446 ' HB ' ' O ' ' A' ' 65' ' ' ARG . 14.1 mm -51.07 -44.38 28.23 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.022 0 C-N-CA 123.805 0.842 . . . . 0.0 110.894 166.831 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -71.96 -48.61 43.93 Favored 'General case' 0 N--CA 1.478 0.957 0 O-C-N 124.263 0.977 . . . . 0.0 112.697 176.727 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' TRP . . . . . 0.421 ' O ' ' HB2' ' A' ' 4' ' ' GLU . 40.6 t90 . . . . . 0 N--CA 1.48 1.041 0 C-N-CA 126.045 1.738 . . . . 0.0 113.519 -178.469 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.605 ' HE3' HD13 ' A' ' 7' ' ' ILE . 67.2 mtp . . . . . 0 N--CA 1.479 1.013 0 N-CA-C 112.615 0.598 . . . . 0.0 112.615 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 2' ' ' ALA . . . . . 0.531 ' HA ' ' O ' ' A' ' 7' ' ' ILE . . . -53.67 -52.53 59.68 Favored 'General case' 0 CA--C 1.542 0.653 0 O-C-N 124.658 1.224 . . . . 0.0 112.691 172.407 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 39.7 ttmt -73.76 -55.32 6.37 Favored 'General case' 0 N--CA 1.472 0.675 0 CA-C-N 112.617 -2.083 . . . . 0.0 114.765 -175.637 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -74.86 -35.83 62.33 Favored 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 114.804 1.409 . . . . 0.0 114.804 -170.154 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' PHE . . . . . 0.533 ' HB2' HD12 ' A' ' 7' ' ' ILE . 61.1 m-85 -113.89 -23.23 9.73 Favored 'General case' 0 N--CA 1.48 1.045 0 N-CA-C 116.92 2.192 . . . . 0.0 116.92 -170.999 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 87.23 59.12 1.79 Allowed Glycine 0 N--CA 1.488 2.121 0 O-C-N 125.151 1.532 . . . . 0.0 111.878 -176.472 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.605 HD13 ' HE3' ' A' ' 1' ' ' MET . 1.0 OUTLIER -119.07 139.74 27.81 Favored Pre-proline 0 N--CA 1.48 1.031 0 C-N-CA 125.061 1.344 . . . . 0.0 110.412 178.85 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_endo -83.2 151.86 13.93 Favored 'Trans proline' 0 N--CA 1.455 -0.757 0 N-CA-C 108.714 -1.302 . . . . 0.0 108.714 162.978 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -42.76 -38.28 2.05 Favored 'General case' 0 N--CA 1.471 0.597 0 N-CA-C 116.403 2.001 . . . . 0.0 116.403 -179.629 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -30.62 -59.26 0.2 Allowed 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 127.081 2.153 . . . . 0.0 113.99 168.594 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.894 HG12 HG22 ' A' ' 31' ' ' ILE . 17.2 m -87.98 -31.01 5.61 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.668 0 N-CA-C 114.627 1.344 . . . . 0.0 114.627 -170.903 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -67.3 -29.27 68.81 Favored 'General case' 0 CA--C 1.549 0.927 0 CA-C-N 116.302 -0.408 . . . . 0.0 112.092 169.757 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' GLY . . . . . 0.523 ' HA2' HD12 ' A' ' 16' ' ' LEU . . . -67.56 -41.81 89.42 Favored Glycine 0 CA--C 1.545 1.908 0 C-N-CA 125.368 1.461 . . . . 0.0 112.936 171.209 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.529 HG22 HG13 ' A' ' 28' ' ' ILE . 8.6 m -65.84 -35.87 81.87 Favored 'General case' 0 N--CA 1.475 0.778 0 N-CA-C 113.046 0.758 . . . . 0.0 113.046 173.503 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.673 HG23 HD21 ' A' ' 32' ' ' LEU . 2.3 t -49.24 -38.48 11.75 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.066 0 C-N-CA 124.47 1.108 . . . . 0.0 113.599 166.126 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.643 HD22 ' HG3' ' A' ' 64' ' ' LYS . 84.6 mt -61.0 -38.12 84.91 Favored 'General case' 0 N--CA 1.475 0.822 0 N-CA-C 113.602 0.964 . . . . 0.0 113.602 178.648 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 35.2 t-20 -52.23 -42.72 63.83 Favored 'General case' 0 CA--C 1.547 0.838 0 O-C-N 124.0 0.813 . . . . 0.0 111.421 172.983 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.409 HG23 HD13 ' A' ' 28' ' ' ILE . 1.0 OUTLIER -60.43 -56.3 18.61 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.816 0 CA-C-N 115.046 -0.979 . . . . 0.0 113.045 173.14 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.779 HG13 ' HA ' ' A' ' 56' ' ' LYS . 5.5 t -58.96 -49.69 82.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 124.026 0.829 . . . . 0.0 112.698 -177.53 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' GLU . . . . . 0.443 ' OE1' ' HB3' ' A' ' 16' ' ' LEU . 24.5 mt-10 -72.35 -42.4 65.38 Favored 'General case' 0 N--CA 1.473 0.696 0 N-CA-C 116.57 2.063 . . . . 0.0 116.57 -175.236 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -103.92 -25.87 12.88 Favored 'General case' 0 N--CA 1.481 1.125 0 N-CA-C 115.231 1.567 . . . . 0.0 115.231 -173.022 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 77.4 41.23 21.36 Favored Glycine 0 CA--C 1.541 1.699 0 N-CA-C 110.467 -1.053 . . . . 0.0 110.467 -165.71 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -76.44 173.86 54.01 Favored Glycine 0 CA--C 1.535 1.316 0 C-N-CA 124.914 1.245 . . . . 0.0 112.689 -173.439 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 3.6 m-90 -69.16 101.79 1.53 Allowed 'General case' 0 N--CA 1.473 0.72 0 CA-C-O 123.341 1.544 . . . . 0.0 110.93 -178.92 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 9.8 p -48.51 -29.44 2.53 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.821 0 CA-C-N 112.658 -2.064 . . . . 0.0 114.86 172.736 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 11.1 t -60.04 -46.62 88.93 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 123.73 0.812 . . . . 0.0 112.929 179.745 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.536 ' O ' HG12 ' A' ' 31' ' ' ILE . 2.0 m -60.09 -48.13 82.98 Favored 'General case' 0 N--CA 1.481 1.08 0 CA-C-N 114.144 -1.389 . . . . 0.0 109.992 175.913 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.529 HG13 HG22 ' A' ' 14' ' ' THR . 1.8 mp -58.32 -53.03 51.81 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.023 0 C-N-CA 123.912 0.885 . . . . 0.0 110.771 179.301 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 65.5 t -53.98 -47.81 64.62 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.744 0 CA-C-O 118.118 -0.944 . . . . 0.0 111.474 177.551 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 20.9 m -61.04 -36.91 80.83 Favored 'General case' 0 N--CA 1.481 1.119 0 N-CA-C 114.446 1.276 . . . . 0.0 114.446 178.672 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.894 HG22 HG12 ' A' ' 11' ' ' VAL . 42.2 mm -72.98 -42.44 59.77 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.93 0 C-N-CA 124.246 1.018 . . . . 0.0 109.463 178.88 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.673 HD21 HG23 ' A' ' 15' ' ' VAL . 4.2 mm? -57.83 -53.06 62.48 Favored 'General case' 0 N--CA 1.484 1.259 0 C-N-CA 125.097 1.359 . . . . 0.0 112.897 173.796 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -65.57 -28.11 68.91 Favored 'General case' 0 N--CA 1.481 1.104 0 N-CA-C 115.406 1.632 . . . . 0.0 115.406 178.329 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -52.37 -32.0 36.48 Favored 'General case' 0 N--CA 1.486 1.358 0 N-CA-C 113.907 1.077 . . . . 0.0 113.907 171.949 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 50.7 t -70.26 -28.04 34.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 C-N-CA 126.169 1.788 . . . . 0.0 112.41 173.816 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 105.58 -106.37 2.62 Favored Glycine 0 CA--C 1.532 1.125 0 C-N-CA 124.851 1.215 . . . . 0.0 110.678 179.344 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 8.9 p -60.64 -39.65 89.1 Favored 'General case' 0 N--CA 1.472 0.654 0 CA-C-N 113.431 -1.384 . . . . 0.0 114.116 -177.93 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -51.42 -45.08 53.49 Favored Glycine 0 CA--C 1.542 1.744 0 O-C-N 124.354 1.033 . . . . 0.0 113.8 177.232 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.5 ' HA2' ' HB3' ' A' ' 32' ' ' LEU . . . -59.53 -58.48 14.13 Favored Glycine 0 N--CA 1.482 1.765 0 N-CA-C 111.435 -0.666 . . . . 0.0 111.435 173.836 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 72.0 mt -57.54 -45.6 84.88 Favored 'General case' 0 N--CA 1.476 0.861 0 N-CA-C 115.937 1.828 . . . . 0.0 115.937 -176.297 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 79.5 p -62.54 -42.36 99.47 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-N 115.384 -0.825 . . . . 0.0 112.938 176.148 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 11.9 tp -63.59 -43.42 96.98 Favored 'General case' 0 N--CA 1.474 0.762 0 N-CA-C 110.026 -0.361 . . . . 0.0 110.026 175.731 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 94.7 mt -62.95 -35.97 81.91 Favored 'General case' 0 N--CA 1.475 0.784 0 N-CA-C 114.414 1.265 . . . . 0.0 114.414 -179.808 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -69.68 -40.69 76.24 Favored 'General case' 0 N--CA 1.473 0.691 0 O-C-N 123.83 0.706 . . . . 0.0 112.782 174.176 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -68.57 -36.17 78.39 Favored 'General case' 0 N--CA 1.475 0.817 0 CA-C-O 121.286 0.565 . . . . 0.0 112.128 177.508 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -53.95 -21.76 8.71 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 126.58 1.952 . . . . 0.0 115.587 173.197 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -50.01 -32.89 20.42 Favored Glycine 0 N--CA 1.478 1.49 0 C-N-CA 125.144 1.354 . . . . 0.0 114.007 178.936 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 68.0 ttp85 -55.36 -55.32 32.9 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 124.918 1.287 . . . . 0.0 113.33 178.573 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 8.2 tt0 -133.29 34.79 3.5 Favored 'General case' 0 CA--C 1.548 0.869 0 N-CA-C 114.803 1.408 . . . . 0.0 114.803 -173.931 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 32.8 t 44.31 127.09 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.041 0 N-CA-C 114.147 1.165 . . . . 0.0 114.147 -172.646 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . 0.266 8.8 tp -30.47 -57.28 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 N-CA-C 119.036 2.976 . . . . 0.0 119.036 -169.812 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 81.9 tttt -60.99 -56.0 26.25 Favored 'General case' 0 N--CA 1.478 0.927 0 N-CA-C 112.065 0.394 . . . . 0.0 112.065 -179.477 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -61.16 -38.44 86.44 Favored 'General case' 0 N--CA 1.486 1.363 0 C-N-CA 123.94 0.896 . . . . 0.0 113.203 177.603 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 89.9 t80 -52.41 -60.24 3.47 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 125.618 1.567 . . . . 0.0 112.253 175.479 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 64.5 mt -65.9 -38.88 89.89 Favored 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 114.053 1.131 . . . . 0.0 114.053 -179.929 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.779 ' HA ' HG13 ' A' ' 19' ' ' VAL . 30.9 mttm -53.81 -54.04 43.92 Favored 'General case' 0 N--CA 1.48 1.039 0 CA-C-N 114.029 -1.441 . . . . 0.0 113.377 178.482 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 55.2 tttp -68.93 -47.23 66.23 Favored 'General case' 0 CA--C 1.541 0.621 0 CA-C-N 115.294 -0.866 . . . . 0.0 112.537 176.981 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' GLU . . . . . 0.467 ' O ' ' HB2' ' A' ' 62' ' ' LYS . 66.8 mt-10 -56.61 -51.66 67.8 Favored 'General case' 0 N--CA 1.477 0.898 0 N-CA-C 112.26 0.467 . . . . 0.0 112.26 -175.351 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.468 ' HA ' ' HB2' ' A' ' 62' ' ' LYS . 6.3 mm -81.02 -20.61 11.21 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.258 0 N-CA-C 112.99 0.737 . . . . 0.0 112.99 -176.218 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.413 ' HB2' ' O ' ' A' ' 56' ' ' LYS . 10.2 tppt? -62.44 -34.02 75.95 Favored 'General case' 0 CA--C 1.542 0.657 0 CA-C-O 121.985 0.898 . . . . 0.0 112.865 170.234 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 93.0 mttt -84.95 -44.67 12.91 Favored 'General case' 0 CA--C 1.546 0.806 0 CA-C-N 112.814 -1.994 . . . . 0.0 113.556 175.507 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.468 ' HB2' ' HA ' ' A' ' 59' ' ' ILE . 0.2 OUTLIER -65.06 -45.04 86.98 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-N 113.529 -1.669 . . . . 0.0 115.329 -172.929 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 85.91 111.72 0.79 Allowed Glycine 0 N--CA 1.47 0.949 0 N-CA-C 108.356 -1.898 . . . . 0.0 108.356 -172.964 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.866 ' HD2' ' H ' ' A' ' 64' ' ' LYS . 9.9 mptt -23.41 -46.53 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.437 0 N-CA-C 119.516 3.154 . . . . 0.0 119.516 -174.829 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . 0.284 8.9 ttt180 -48.92 -44.22 40.14 Favored 'General case' 0 N--CA 1.471 0.618 0 N-CA-C 115.365 1.617 . . . . 0.0 115.365 173.052 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -58.74 -31.25 68.15 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 116.243 -1.837 . . . . 0.0 113.124 174.575 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.523 HG12 ' O ' ' A' ' 64' ' ' LYS . 0.5 OUTLIER -64.06 -41.84 93.76 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.259 0 CA-C-N 119.393 0.997 . . . . 0.0 111.573 178.766 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 35.8 mm -57.82 -39.06 69.16 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.887 0 CA-C-N 113.251 -1.795 . . . . 0.0 110.471 177.141 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -80.24 -49.18 11.96 Favored 'General case' 0 N--CA 1.475 0.805 0 N-CA-C 114.288 1.218 . . . . 0.0 114.288 175.05 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 24.3 t90 . . . . . 0 N--CA 1.484 1.265 0 C-N-CA 127.055 2.142 . . . . 0.0 112.708 -179.363 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.761 ' HE1' HG21 ' A' ' 15' ' ' VAL . 52.3 mtp . . . . . 0 N--CA 1.479 0.979 0 N-CA-C 113.417 0.895 . . . . 0.0 113.417 . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -61.31 -49.27 77.68 Favored 'General case' 0 N--CA 1.474 0.757 0 CA-C-N 115.018 -0.992 . . . . 0.0 112.287 173.974 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 57.4 tttm -75.82 -60.46 2.31 Favored 'General case' 0 N--CA 1.478 0.948 0 CA-C-N 114.046 -1.434 . . . . 0.0 114.085 -176.428 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' GLU . . . . . 0.402 ' HB2' ' O ' ' A' ' 70' ' ' TRP . 2.1 mp0 -75.96 -29.07 58.16 Favored 'General case' 0 N--CA 1.474 0.744 0 N-CA-C 115.656 1.724 . . . . 0.0 115.656 -169.751 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 5' ' ' PHE . . . . . 0.409 ' HD1' ' HB2' ' A' ' 41' ' ' SER . 43.4 m-85 -115.11 -18.21 11.23 Favored 'General case' 0 N--CA 1.48 1.051 0 N-CA-C 117.496 2.406 . . . . 0.0 117.496 -173.243 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 72.82 40.67 51.94 Favored Glycine 0 CA--C 1.542 1.756 0 O-C-N 124.543 1.152 . . . . 0.0 112.11 -171.126 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.789 HG23 HG23 ' A' ' 11' ' ' VAL . 0.6 OUTLIER -121.91 106.23 36.89 Favored Pre-proline 0 N--CA 1.474 0.73 0 C-N-CA 124.566 1.146 . . . . 0.0 110.288 179.425 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_endo -63.93 168.23 12.5 Favored 'Trans proline' 0 CA--C 1.54 0.791 0 C-N-CA 122.567 2.178 . . . . 0.0 112.582 -172.825 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -51.34 -33.32 28.91 Favored 'General case' 0 N--CA 1.477 0.914 0 CA-C-N 113.617 -1.629 . . . . 0.0 114.212 172.493 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -49.87 -34.45 20.13 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 125.9 1.68 . . . . 0.0 114.567 176.099 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 1.084 HG12 HG22 ' A' ' 31' ' ' ILE . 30.4 m -112.0 -29.4 2.37 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.407 0 N-CA-C 114.145 1.165 . . . . 0.0 114.145 179.819 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -66.77 -37.35 84.41 Favored 'General case' 0 N--CA 1.475 0.794 0 N-CA-C 113.393 0.886 . . . . 0.0 113.393 174.791 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -61.09 -37.9 94.68 Favored Glycine 0 CA--C 1.544 1.871 0 C-N-CA 123.92 0.771 . . . . 0.0 112.287 170.62 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -70.32 -32.91 70.87 Favored 'General case' 0 N--CA 1.487 1.407 0 C-N-CA 125.051 1.34 . . . . 0.0 113.363 179.44 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.761 HG21 ' HE1' ' A' ' 1' ' ' MET . 10.4 t -61.2 -36.11 70.47 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.255 0 C-N-CA 123.895 0.878 . . . . 0.0 111.982 169.469 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.57 HD13 ' HB3' ' A' ' 64' ' ' LYS . 48.3 mt -66.09 -37.73 86.5 Favored 'General case' 0 N--CA 1.471 0.61 0 N-CA-C 113.242 0.83 . . . . 0.0 113.242 177.423 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 11.0 t30 -55.12 -44.59 75.13 Favored 'General case' 0 N--CA 1.478 0.934 0 CA-C-N 115.341 -0.845 . . . . 0.0 111.339 172.798 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.526 ' HB ' ' O ' ' A' ' 15' ' ' VAL . 12.8 t -50.64 -52.56 15.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 C-N-CA 124.642 1.177 . . . . 0.0 112.182 171.67 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.758 HG13 ' HA ' ' A' ' 56' ' ' LYS . 11.4 t -61.91 -52.66 57.88 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.191 0 C-N-CA 124.568 1.147 . . . . 0.0 111.479 -178.452 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 10.1 mt-10 -54.82 -44.04 73.51 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 125.692 1.597 . . . . 0.0 115.057 -178.401 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -93.17 -17.1 24.13 Favored 'General case' 0 CA--C 1.546 0.822 0 N-CA-C 115.701 1.741 . . . . 0.0 115.701 -175.376 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 68.39 40.96 86.69 Favored Glycine 0 CA--C 1.544 1.889 0 N-CA-C 110.438 -1.065 . . . . 0.0 110.438 -165.489 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -100.46 164.11 18.95 Favored Glycine 0 CA--C 1.537 1.428 0 C-N-CA 124.827 1.203 . . . . 0.0 114.145 -167.259 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 5.8 m-90 -67.69 104.53 1.66 Allowed 'General case' 0 C--O 1.24 0.583 0 CA-C-O 122.577 1.179 . . . . 0.0 113.831 -175.341 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.46 HG11 HG13 ' A' ' 51' ' ' ILE . 5.5 p -55.59 -25.13 17.43 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.825 0 CA-C-N 113.369 -1.741 . . . . 0.0 113.847 169.191 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 1.7 t -60.51 -40.33 91.04 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 114.305 1.224 . . . . 0.0 114.305 179.727 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 1.9 m -68.54 -39.1 81.26 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 122.928 0.491 . . . . 0.0 110.653 175.811 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 2.8 mp -72.23 -31.07 37.9 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.077 0 C-N-CA 124.854 1.262 . . . . 0.0 112.576 177.9 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.447 HG23 ' O ' ' A' ' 25' ' ' VAL . 55.6 t -55.54 -36.42 41.74 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.826 0 C-N-CA 123.104 0.562 . . . . 0.0 112.201 171.737 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 29.8 p -60.98 -26.15 67.37 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 114.813 1.412 . . . . 0.0 114.813 173.788 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 1.084 HG22 HG12 ' A' ' 11' ' ' VAL . 34.7 mm -85.01 -37.84 12.69 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.914 0 C-N-CA 123.901 0.88 . . . . 0.0 109.85 176.493 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.59 HD22 ' HB ' ' A' ' 11' ' ' VAL . 4.3 mm? -60.54 -34.49 74.21 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 124.835 1.254 . . . . 0.0 112.255 172.636 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.48 ' HA ' ' HA2' ' A' ' 38' ' ' GLY . 9.1 p -75.2 -36.24 61.43 Favored 'General case' 0 N--CA 1.474 0.775 0 N-CA-C 115.413 1.634 . . . . 0.0 115.413 174.057 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -52.88 -25.24 11.04 Favored 'General case' 0 N--CA 1.482 1.155 0 O-C-N 124.64 1.212 . . . . 0.0 114.183 172.236 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 93.0 t -60.82 -31.38 49.36 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.133 0 C-N-CA 126.32 1.848 . . . . 0.0 113.238 171.225 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 112.58 -53.68 0.58 Allowed Glycine 0 CA--C 1.541 1.688 0 N-CA-C 112.093 -0.403 . . . . 0.0 112.093 -179.209 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 9.8 p -66.58 15.59 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.564 0 C-N-CA 125.572 1.549 . . . . 0.0 114.968 174.555 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.48 ' HA2' ' HA ' ' A' ' 33' ' ' THR . . . 54.28 15.9 6.05 Favored Glycine 0 N--CA 1.486 2.025 0 C-N-CA 126.266 1.888 . . . . 0.0 116.548 174.835 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.508 ' HA3' ' HB3' ' A' ' 32' ' ' LEU . . . 53.5 16.35 5.07 Favored Glycine 0 N--CA 1.487 2.069 0 C-N-CA 124.323 0.964 . . . . 0.0 113.461 -163.118 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 9.7 mt -54.6 -46.83 73.88 Favored 'General case' 0 N--CA 1.481 1.106 0 N-CA-C 116.563 2.06 . . . . 0.0 116.563 -168.501 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' SER . . . . . 0.409 ' HB2' ' HD1' ' A' ' 5' ' ' PHE . 11.6 p -60.11 -44.83 94.56 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 114.823 -1.08 . . . . 0.0 113.397 177.636 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 10.8 tp -63.09 -50.31 71.04 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 123.887 0.875 . . . . 0.0 110.287 171.923 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 82.9 mt -60.77 -28.64 68.88 Favored 'General case' 0 N--CA 1.477 0.887 0 N-CA-C 114.875 1.435 . . . . 0.0 114.875 -177.23 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -67.3 -47.64 69.99 Favored 'General case' 0 N--CA 1.474 0.736 0 O-C-N 123.805 0.691 . . . . 0.0 112.798 170.785 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -62.46 -33.61 75.18 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 123.375 0.67 . . . . 0.0 112.44 179.247 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -57.18 -23.75 49.75 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 126.885 2.074 . . . . 0.0 115.546 174.655 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -52.11 -35.03 40.64 Favored Glycine 0 CA--C 1.538 1.486 0 C-N-CA 125.068 1.318 . . . . 0.0 113.91 -177.904 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 40.0 ttp180 -51.57 -53.51 37.33 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 125.0 1.32 . . . . 0.0 112.958 -176.233 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 20.6 tt0 -128.76 36.8 4.18 Favored 'General case' 0 N--CA 1.478 0.963 0 CA-C-N 115.166 -0.924 . . . . 0.0 113.153 -176.247 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 8.0 t 43.36 128.4 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 125.68 1.592 . . . . 0.0 114.474 -172.07 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.46 HG13 HG11 ' A' ' 25' ' ' VAL . 8.0 tp -32.25 -52.47 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.258 0 N-CA-C 118.156 2.65 . . . . 0.0 118.156 -171.161 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 2.3 ttmt -60.37 -67.46 0.39 Allowed 'General case' 0 N--CA 1.472 0.631 0 N-CA-C 114.461 1.282 . . . . 0.0 114.461 178.441 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -56.62 -34.64 67.46 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 124.276 1.03 . . . . 0.0 113.667 177.817 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 66.7 t80 -50.86 -62.27 1.71 Allowed 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 124.875 1.27 . . . . 0.0 110.589 174.541 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.62 HD13 HG13 ' A' ' 15' ' ' VAL . 60.7 mt -65.26 -37.91 88.66 Favored 'General case' 0 N--CA 1.475 0.783 0 N-CA-C 115.001 1.482 . . . . 0.0 115.001 -176.123 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.758 ' HA ' HG13 ' A' ' 19' ' ' VAL . 93.9 mttt -61.94 -37.15 83.62 Favored 'General case' 0 N--CA 1.473 0.7 0 CA-C-N 113.445 -1.707 . . . . 0.0 114.732 178.523 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.469 ' HE3' ' HE3' ' A' ' 61' ' ' LYS . 80.2 tttt -85.64 -52.55 5.73 Favored 'General case' 0 CA--C 1.535 0.395 0 O-C-N 124.514 1.134 . . . . 0.0 111.241 173.03 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 58' ' ' GLU . . . . . 0.415 ' O ' ' HB2' ' A' ' 62' ' ' LYS . 29.0 tt0 -55.19 -51.08 67.67 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-O 118.687 -0.673 . . . . 0.0 111.771 -173.014 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.71 HG23 HG21 ' A' ' 67' ' ' VAL . 3.7 mm -75.96 -27.1 17.99 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.281 0 N-CA-C 112.769 0.655 . . . . 0.0 112.769 -173.64 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.457 ' HB2' ' O ' ' A' ' 56' ' ' LYS . 14.9 tttp -60.28 -36.32 77.56 Favored 'General case' 0 CA--C 1.544 0.749 0 CA-C-O 122.643 1.211 . . . . 0.0 113.496 174.02 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.469 ' HE3' ' HE3' ' A' ' 57' ' ' LYS . 9.7 mttm -85.01 -33.17 22.6 Favored 'General case' 0 N--CA 1.474 0.757 0 CA-C-N 112.023 -2.353 . . . . 0.0 112.236 -179.412 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.415 ' HB2' ' O ' ' A' ' 58' ' ' GLU . 66.8 tttt -85.33 -60.13 2.12 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-N 112.744 -2.026 . . . . 0.0 111.561 -168.484 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 63' ' ' GLY . . . . . 0.46 ' O ' HG23 ' A' ' 67' ' ' VAL . . . 113.11 126.03 4.45 Favored Glycine 0 CA--C 1.532 1.122 0 N-CA-C 110.08 -1.208 . . . . 0.0 110.08 -172.297 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.57 ' HB3' HD13 ' A' ' 16' ' ' LEU . 0.0 OUTLIER -59.4 -42.04 90.81 Favored 'General case' 0 N--CA 1.482 1.135 0 N-CA-C 115.59 1.7 . . . . 0.0 115.59 -173.128 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -58.13 -47.3 83.73 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 125.251 1.42 . . . . 0.0 113.648 179.353 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -62.94 -32.05 73.28 Favored 'General case' 0 N--CA 1.475 0.777 0 CA-C-N 114.534 -1.212 . . . . 0.0 113.769 173.002 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.71 HG21 HG23 ' A' ' 59' ' ' ILE . 48.5 t -68.8 -35.97 72.07 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.989 0 C-N-CA 122.872 0.469 . . . . 0.0 111.179 179.497 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 18.0 mt -53.42 -48.5 57.08 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.01 0 C-N-CA 124.267 1.027 . . . . 0.0 109.722 169.385 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -67.08 -47.49 71.1 Favored 'General case' 0 N--CA 1.477 0.907 0 CA-C-N 115.581 -0.736 . . . . 0.0 112.901 178.808 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' TRP . . . . . 0.402 ' O ' ' HB2' ' A' ' 4' ' ' GLU . 43.0 t90 . . . . . 0 N--CA 1.477 0.891 0 C-N-CA 125.78 1.632 . . . . 0.0 112.22 -179.512 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.497 ' HB3' HG21 ' A' ' 7' ' ' ILE . 76.6 mtp . . . . . 0 C--O 1.238 0.487 0 N-CA-C 113.039 0.755 . . . . 0.0 113.039 . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 2' ' ' ALA . . . . . 0.436 ' HA ' ' O ' ' A' ' 7' ' ' ILE . . . -55.78 -54.13 48.14 Favored 'General case' 0 N--CA 1.475 0.814 0 CA-C-N 114.988 -1.005 . . . . 0.0 111.649 172.882 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 51.1 tttp -72.86 -61.02 1.96 Allowed 'General case' 0 N--CA 1.481 1.08 0 CA-C-N 113.952 -1.476 . . . . 0.0 113.982 -174.246 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -71.0 -37.25 72.66 Favored 'General case' 0 N--CA 1.475 0.815 0 N-CA-C 115.48 1.659 . . . . 0.0 115.48 -171.388 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' PHE . . . . . 0.422 ' HD2' ' HA ' ' A' ' 1' ' ' MET . 52.1 m-85 -107.95 -15.92 14.42 Favored 'General case' 0 N--CA 1.477 0.885 0 N-CA-C 116.532 2.049 . . . . 0.0 116.532 -172.063 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 79.65 54.25 4.02 Favored Glycine 0 CA--C 1.541 1.701 0 CA-C-O 122.311 0.95 . . . . 0.0 112.508 -176.023 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.497 HG21 ' HB3' ' A' ' 1' ' ' MET . 0.5 OUTLIER -112.73 147.99 38.34 Favored Pre-proline 0 N--CA 1.482 1.128 0 CA-C-N 113.526 -1.337 . . . . 0.0 111.645 -178.839 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 91.0 Cg_endo -86.06 153.39 9.69 Favored 'Trans proline' 0 CA--C 1.538 0.723 0 C-N-CA 121.685 1.59 . . . . 0.0 109.365 163.309 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -49.7 -33.67 16.55 Favored 'General case' 0 N--CA 1.47 0.574 0 N-CA-C 114.966 1.469 . . . . 0.0 114.966 176.346 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -39.08 -43.73 1.06 Allowed 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 127.792 2.437 . . . . 0.0 115.174 171.626 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.981 HG12 HG22 ' A' ' 31' ' ' ILE . 20.0 m -102.31 -29.09 3.04 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.914 0 N-CA-C 114.269 1.211 . . . . 0.0 114.269 -173.626 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -67.48 -30.65 70.41 Favored 'General case' 0 N--CA 1.489 1.483 0 CA-C-N 115.727 -0.67 . . . . 0.0 112.197 171.526 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' GLY . . . . . 0.446 ' O ' ' HB2' ' A' ' 16' ' ' LEU . . . -63.57 -43.05 98.6 Favored Glycine 0 CA--C 1.553 2.44 0 C-N-CA 124.278 0.942 . . . . 0.0 112.625 168.814 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.806 HG22 HG13 ' A' ' 28' ' ' ILE . 3.9 m -62.78 -37.49 86.87 Favored 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 113.371 0.878 . . . . 0.0 113.371 176.792 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.463 HG21 ' HE1' ' A' ' 1' ' ' MET . 2.4 t -50.52 -37.73 15.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 C-N-CA 124.155 0.982 . . . . 0.0 113.337 168.254 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.716 HD22 ' HG3' ' A' ' 64' ' ' LYS . 84.8 mt -61.98 -37.28 84.22 Favored 'General case' 0 N--CA 1.479 0.996 0 N-CA-C 113.989 1.107 . . . . 0.0 113.989 177.446 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 14.6 t-20 -53.99 -47.06 71.82 Favored 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 123.223 0.609 . . . . 0.0 110.864 173.417 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 3.1 t -52.01 -56.26 6.87 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.256 0 CA-C-N 114.996 -1.002 . . . . 0.0 112.67 170.556 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.754 HG13 ' HA ' ' A' ' 56' ' ' LYS . 3.8 t -60.11 -51.17 76.04 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 O-C-N 124.549 1.156 . . . . 0.0 111.523 -176.307 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -66.49 -44.37 82.83 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 126.166 1.786 . . . . 0.0 115.705 -175.636 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -101.59 -12.41 18.49 Favored 'General case' 0 CA--C 1.548 0.891 0 N-CA-C 115.413 1.635 . . . . 0.0 115.413 -170.492 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.424 ' HA2' ' HE2' ' A' ' 56' ' ' LYS . . . 66.69 41.53 93.79 Favored Glycine 0 N--CA 1.482 1.762 0 N-CA-C 110.137 -1.185 . . . . 0.0 110.137 -161.734 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -74.53 158.92 51.98 Favored Glycine 0 N--CA 1.471 0.984 0 C-N-CA 125.151 1.358 . . . . 0.0 114.266 -169.3 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 88.7 m95 -61.68 102.99 0.29 Allowed 'General case' 0 N--CA 1.473 0.724 0 CA-C-N 113.277 -1.462 . . . . 0.0 111.785 175.538 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.564 HG21 HG13 ' A' ' 51' ' ' ILE . 2.7 p -54.49 -24.19 12.25 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.625 0 CA-C-N 114.279 -1.328 . . . . 0.0 114.58 175.331 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 3.6 t -60.29 -44.24 95.55 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 124.261 1.024 . . . . 0.0 113.632 -179.915 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.566 ' O ' HG12 ' A' ' 31' ' ' ILE . 0.8 OUTLIER -65.68 -46.34 79.43 Favored 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 123.799 0.84 . . . . 0.0 110.212 176.49 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.806 HG13 HG22 ' A' ' 14' ' ' THR . 2.0 mp -58.98 -51.49 71.87 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.979 0 C-N-CA 124.438 1.095 . . . . 0.0 111.622 177.375 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 50.6 t -53.11 -48.73 53.07 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.826 0 CA-C-O 117.037 -1.459 . . . . 0.0 111.556 176.59 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . 0.284 1.5 p -61.99 -29.85 70.54 Favored 'General case' 0 N--CA 1.479 1.016 0 N-CA-C 115.438 1.644 . . . . 0.0 115.438 179.712 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.981 HG22 HG12 ' A' ' 11' ' ' VAL . 21.2 mm -76.65 -43.26 34.51 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.006 0 C-N-CA 124.174 0.99 . . . . 0.0 110.115 176.38 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.63 HD22 ' HB ' ' A' ' 11' ' ' VAL . 4.2 mm? -55.52 -56.02 25.06 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 124.951 1.3 . . . . 0.0 112.427 172.796 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 3.1 p -64.0 -30.88 71.92 Favored 'General case' 0 N--CA 1.475 0.814 0 N-CA-C 114.825 1.417 . . . . 0.0 114.825 177.599 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -53.31 -25.41 14.74 Favored 'General case' 0 N--CA 1.482 1.134 0 N-CA-C 114.649 1.351 . . . . 0.0 114.649 172.355 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 61.7 t -74.13 -29.08 24.36 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.356 0 C-N-CA 124.547 1.139 . . . . 0.0 111.574 172.669 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 108.78 -116.97 4.83 Favored Glycine 0 N--CA 1.47 0.963 0 C-N-CA 125.0 1.286 . . . . 0.0 111.022 -176.421 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 33.8 p -54.72 -40.22 69.02 Favored 'General case' 0 N--CA 1.485 1.314 0 CA-C-N 113.487 -1.357 . . . . 0.0 114.494 -178.643 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -51.72 -46.2 54.32 Favored Glycine 0 CA--C 1.54 1.616 0 C-N-CA 124.851 1.215 . . . . 0.0 113.608 179.324 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.468 ' HA2' ' HB3' ' A' ' 32' ' ' LEU . . . -57.11 -54.96 32.94 Favored Glycine 0 N--CA 1.479 1.507 0 CA-C-N 115.034 -0.583 . . . . 0.0 111.76 174.129 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 78.4 mt -60.25 -41.65 93.65 Favored 'General case' 0 N--CA 1.482 1.142 0 N-CA-C 115.434 1.642 . . . . 0.0 115.434 -177.754 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 42.7 p -63.69 -43.28 97.1 Favored 'General case' 0 N--CA 1.476 0.863 0 N-CA-C 113.294 0.85 . . . . 0.0 113.294 174.922 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 12.4 tp -61.7 -46.8 88.13 Favored 'General case' 0 N--CA 1.474 0.741 0 CA-C-O 121.22 0.534 . . . . 0.0 110.435 174.002 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 94.8 mt -59.96 -39.15 84.64 Favored 'General case' 0 N--CA 1.482 1.153 0 CA-C-N 114.457 -1.247 . . . . 0.0 114.328 179.983 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -61.93 -44.94 95.73 Favored 'General case' 0 N--CA 1.477 0.911 0 N-CA-C 112.362 0.504 . . . . 0.0 112.362 173.289 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -65.96 -33.29 75.47 Favored 'General case' 0 N--CA 1.479 0.992 0 N-CA-C 113.564 0.95 . . . . 0.0 113.564 177.339 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -75.65 -21.56 57.57 Favored 'General case' 0 CA--C 1.543 0.698 0 N-CA-C 116.888 2.181 . . . . 0.0 116.888 179.766 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -50.99 -39.8 41.57 Favored Glycine 0 N--CA 1.474 1.185 0 O-C-N 124.308 1.005 . . . . 0.0 113.914 -173.031 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' ARG . . . . . 0.515 ' HA ' ' HD2' ' A' ' 48' ' ' ARG . 0.3 OUTLIER -59.51 -49.74 76.61 Favored 'General case' 0 CA--C 1.542 0.643 0 CA-C-N 111.239 -2.48 . . . . 0.0 115.876 -176.479 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 5.4 tt0 -114.5 28.86 8.43 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-N 115.29 -0.868 . . . . 0.0 112.982 -175.242 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 94.2 p 48.33 121.45 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 125.9 1.68 . . . . 0.0 113.373 -172.796 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.564 HG13 HG21 ' A' ' 25' ' ' VAL . 7.6 tp -41.47 -46.14 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.42 0 N-CA-C 117.298 2.332 . . . . 0.0 117.298 -173.64 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 34.6 tttm -60.36 -62.6 1.75 Allowed 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 124.582 1.153 . . . . 0.0 112.266 177.035 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -59.66 -38.7 82.17 Favored 'General case' 0 N--CA 1.48 1.044 0 N-CA-C 113.96 1.096 . . . . 0.0 113.96 177.598 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 84.3 t80 -49.84 -62.11 1.75 Allowed 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 125.432 1.493 . . . . 0.0 111.071 177.343 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.41 HD22 HG13 ' A' ' 15' ' ' VAL . 45.0 mt -61.87 -38.98 90.28 Favored 'General case' 0 N--CA 1.484 1.234 0 N-CA-C 114.477 1.288 . . . . 0.0 114.477 -176.829 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.754 ' HA ' HG13 ' A' ' 19' ' ' VAL . 92.3 mttt -55.19 -54.64 40.73 Favored 'General case' 0 N--CA 1.472 0.638 0 O-C-N 124.83 1.331 . . . . 0.0 112.483 177.705 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.572 ' HG2' ' HD2' ' A' ' 61' ' ' LYS . 78.0 tttt -71.76 -45.75 60.66 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-N 114.622 -1.172 . . . . 0.0 112.575 178.452 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 7.7 mm-40 -52.55 -55.36 22.73 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 122.824 0.45 . . . . 0.0 111.087 -177.617 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 5.9 mm -80.1 -23.51 11.68 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 CA-C-N 114.652 -1.158 . . . . 0.0 112.957 -172.635 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.452 ' HB2' ' O ' ' A' ' 56' ' ' LYS . 16.7 tttp -59.08 -38.0 78.43 Favored 'General case' 0 CA--C 1.544 0.73 0 N-CA-C 114.195 1.183 . . . . 0.0 114.195 170.362 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.572 ' HD2' ' HG2' ' A' ' 57' ' ' LYS . 23.4 mtpt -86.2 -43.59 12.87 Favored 'General case' 0 N--CA 1.479 0.994 0 CA-C-N 113.681 -1.599 . . . . 0.0 111.174 -179.518 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 17.3 tttt -72.14 -40.34 68.13 Favored 'General case' 0 N--CA 1.473 0.709 0 CA-C-N 112.664 -2.062 . . . . 0.0 115.048 -173.391 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 85.49 130.22 2.34 Favored Glycine 0 CA--C 1.538 1.5 0 N-CA-C 109.743 -1.343 . . . . 0.0 109.743 -171.817 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.733 ' HD2' ' H ' ' A' ' 64' ' ' LYS . 11.9 mptt -40.7 -45.16 2.33 Favored 'General case' 0 N--CA 1.486 1.348 0 N-CA-C 116.501 2.038 . . . . 0.0 116.501 -179.496 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -53.64 -43.89 69.14 Favored 'General case' 0 N--CA 1.468 0.441 0 N-CA-C 112.174 0.435 . . . . 0.0 112.174 179.391 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -64.55 -29.73 70.76 Favored 'General case' 0 N--CA 1.48 1.044 0 CA-C-N 113.632 -1.622 . . . . 0.0 114.566 174.787 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.661 HG12 ' O ' ' A' ' 64' ' ' LYS . 1.4 p -64.57 -43.07 96.76 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.342 0 CA-C-N 119.629 1.104 . . . . 0.0 111.759 175.137 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 45.1 mm -55.86 -42.64 71.51 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.276 0 CA-C-N 114.082 -1.417 . . . . 0.0 110.023 176.148 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -72.63 -51.43 19.6 Favored 'General case' 0 N--CA 1.48 1.056 0 N-CA-C 113.951 1.093 . . . . 0.0 113.951 175.573 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 25.9 t90 . . . . . 0 N--CA 1.478 0.952 0 C-N-CA 126.752 2.021 . . . . 0.0 112.176 -178.305 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.61 ' HE3' HD13 ' A' ' 7' ' ' ILE . 53.1 mtp . . . . . 0 N--CA 1.469 0.479 0 N-CA-C 112.592 0.59 . . . . 0.0 112.592 . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 2' ' ' ALA . . . . . 0.503 ' HA ' ' O ' ' A' ' 7' ' ' ILE . . . -56.51 -57.05 14.01 Favored 'General case' 0 N--CA 1.473 0.695 0 CA-C-N 114.823 -1.081 . . . . 0.0 112.12 175.873 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 18.6 ttpp -67.37 -49.2 64.94 Favored 'General case' 0 CA--C 1.547 0.841 0 CA-C-N 112.985 -1.916 . . . . 0.0 113.385 -172.014 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 10.2 tt0 -81.17 -48.08 12.58 Favored 'General case' 0 N--CA 1.477 0.903 0 N-CA-C 114.203 1.186 . . . . 0.0 114.203 -170.088 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' PHE . . . . . 0.615 ' HB2' HD12 ' A' ' 7' ' ' ILE . 48.0 m-85 -95.86 -17.06 21.41 Favored 'General case' 0 N--CA 1.474 0.733 0 N-CA-C 117.402 2.371 . . . . 0.0 117.402 -170.717 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 83.97 54.9 2.92 Favored Glycine 0 CA--C 1.539 1.564 0 CA-C-O 122.575 1.097 . . . . 0.0 111.052 -174.671 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.615 HD12 ' HB2' ' A' ' 5' ' ' PHE . 1.0 OUTLIER -117.65 142.65 30.91 Favored Pre-proline 0 N--CA 1.475 0.811 0 CA-C-N 113.665 -1.268 . . . . 0.0 110.777 -178.092 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 90.9 Cg_endo -87.82 158.98 7.53 Favored 'Trans proline' 0 CA--C 1.541 0.845 0 C-N-CA 121.26 1.307 . . . . 0.0 109.164 164.844 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -49.09 -32.33 9.55 Favored 'General case' 0 N--CA 1.48 1.07 0 N-CA-C 114.297 1.221 . . . . 0.0 114.297 171.829 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -43.8 -37.1 2.58 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 127.047 2.139 . . . . 0.0 115.615 174.618 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.934 HG12 HG22 ' A' ' 31' ' ' ILE . 26.9 m -109.22 -31.6 2.37 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.074 0 N-CA-C 114.13 1.159 . . . . 0.0 114.13 -179.537 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -69.39 -32.1 70.91 Favored 'General case' 0 N--CA 1.483 1.198 0 N-CA-C 113.354 0.872 . . . . 0.0 113.354 178.301 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -65.81 -36.67 92.52 Favored Glycine 0 N--CA 1.484 1.855 0 CA-C-O 122.717 1.176 . . . . 0.0 112.232 173.953 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.53 HG22 HG13 ' A' ' 28' ' ' ILE . 0.2 OUTLIER -68.44 -36.19 78.68 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 126.557 1.943 . . . . 0.0 113.356 176.877 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.558 HG21 ' HE1' ' A' ' 1' ' ' MET . 17.4 t -56.11 -39.82 60.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 C-N-CA 124.093 0.957 . . . . 0.0 112.065 168.167 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 39.6 mt -65.59 -41.18 93.11 Favored 'General case' 0 N--CA 1.476 0.829 0 N-CA-C 113.398 0.888 . . . . 0.0 113.398 179.599 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 25.5 t-20 -50.34 -47.54 55.85 Favored 'General case' 0 N--CA 1.475 0.783 0 O-C-N 124.317 1.011 . . . . 0.0 111.593 171.469 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.412 ' HB ' ' O ' ' A' ' 15' ' ' VAL . 2.4 t -50.79 -48.69 27.87 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.993 0 C-N-CA 123.991 0.916 . . . . 0.0 112.106 177.183 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.812 HG13 ' HA ' ' A' ' 56' ' ' LYS . 9.7 t -64.84 -55.56 20.31 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.116 0 O-C-N 124.139 0.9 . . . . 0.0 109.806 -179.13 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 37.7 mt-10 -58.75 -49.71 76.62 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 125.897 1.679 . . . . 0.0 114.585 -177.586 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -77.66 -17.99 57.15 Favored 'General case' 0 N--CA 1.473 0.724 0 N-CA-C 114.904 1.446 . . . . 0.0 114.904 -176.282 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.532 ' HA2' ' HE3' ' A' ' 56' ' ' LYS . . . 67.0 44.78 87.78 Favored Glycine 0 N--CA 1.486 1.969 0 N-CA-C 109.588 -1.405 . . . . 0.0 109.588 -162.309 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -96.79 157.65 21.24 Favored Glycine 0 N--CA 1.474 1.22 0 CA-C-N 113.661 -1.27 . . . . 0.0 114.777 -161.701 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 85.4 m95 -68.47 100.56 1.11 Allowed 'General case' 0 N--CA 1.473 0.691 0 CA-C-N 113.004 -1.598 . . . . 0.0 110.581 -178.562 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.526 HG21 HG13 ' A' ' 51' ' ' ILE . 0.6 OUTLIER -53.48 -26.15 12.3 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.799 0 CA-C-N 113.828 -1.533 . . . . 0.0 113.609 172.39 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 4.7 t -59.44 -43.92 93.03 Favored 'General case' 0 N--CA 1.481 1.076 0 CA-C-O 118.715 -0.659 . . . . 0.0 112.71 -176.364 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.452 ' HB ' HD12 ' A' ' 28' ' ' ILE . 2.7 m -57.82 -42.46 84.33 Favored 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 124.144 0.978 . . . . 0.0 111.855 174.218 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.53 HG13 HG22 ' A' ' 14' ' ' THR . 2.0 mp -73.73 -42.54 54.55 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.058 0 C-N-CA 125.98 1.712 . . . . 0.0 112.59 -178.124 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.582 HG13 HD11 ' A' ' 43' ' ' LEU . 40.1 t -49.64 -46.35 21.1 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.322 0 C-N-CA 124.815 1.246 . . . . 0.0 110.719 178.625 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -55.46 -35.86 65.95 Favored 'General case' 0 N--CA 1.486 1.364 0 C-N-CA 124.749 1.219 . . . . 0.0 113.906 176.366 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.934 HG22 HG12 ' A' ' 11' ' ' VAL . 22.3 mm -78.96 -39.36 21.65 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.071 0 C-N-CA 124.171 0.988 . . . . 0.0 109.083 -176.477 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.684 ' HB3' ' HA2' ' A' ' 39' ' ' GLY . 4.3 mm? -57.04 -49.38 75.98 Favored 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 124.553 1.141 . . . . 0.0 111.804 171.506 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 1.4 p -67.71 -27.38 66.77 Favored 'General case' 0 N--CA 1.474 0.734 0 N-CA-C 115.371 1.619 . . . . 0.0 115.371 178.018 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -55.71 -29.45 59.46 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 113.098 0.777 . . . . 0.0 113.098 169.95 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 23.0 t -71.61 -21.44 21.34 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.187 0 C-N-CA 125.166 1.386 . . . . 0.0 111.065 174.486 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 95.49 -102.13 2.79 Favored Glycine 0 N--CA 1.477 1.374 0 N-CA-C 109.416 -1.474 . . . . 0.0 109.416 -177.201 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 12.9 p -64.11 -44.48 92.11 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-N 113.115 -1.542 . . . . 0.0 114.973 -175.325 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -46.63 -49.26 16.53 Favored Glycine 0 N--CA 1.478 1.441 0 C-N-CA 124.496 1.046 . . . . 0.0 114.52 179.577 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.684 ' HA2' ' HB3' ' A' ' 32' ' ' LEU . . . -55.58 -53.55 40.65 Favored Glycine 0 N--CA 1.472 1.05 0 C-N-CA 124.291 0.948 . . . . 0.0 113.542 177.023 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 14.6 mt -62.53 -44.71 95.69 Favored 'General case' 0 N--CA 1.477 0.892 0 CA-C-N 113.149 -1.525 . . . . 0.0 113.96 -178.46 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 6.9 m -55.9 -47.12 77.99 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 123.745 0.818 . . . . 0.0 112.174 173.65 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 12.3 tp -63.23 -45.22 92.63 Favored 'General case' 0 N--CA 1.48 1.035 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.763 177.691 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.582 HD11 HG13 ' A' ' 29' ' ' VAL . 46.8 mt -64.15 -21.46 66.56 Favored 'General case' 0 N--CA 1.477 0.909 0 N-CA-C 115.732 1.753 . . . . 0.0 115.732 -178.987 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -78.35 -42.4 30.62 Favored 'General case' 0 CA--C 1.545 0.767 0 CA-C-N 115.493 -0.776 . . . . 0.0 112.954 171.33 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -61.77 -29.48 70.16 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 123.752 0.821 . . . . 0.0 112.245 172.874 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -59.03 -23.87 62.34 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 125.581 1.552 . . . . 0.0 115.011 177.709 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -52.76 -34.42 44.39 Favored Glycine 0 CA--C 1.543 1.83 0 C-N-CA 125.474 1.512 . . . . 0.0 113.763 -176.147 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 65.5 ttp85 -55.04 -52.64 62.55 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 124.662 1.185 . . . . 0.0 112.937 -178.974 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.409 ' HB3' ' HA ' ' A' ' 54' ' ' TYR . 12.5 tt0 -137.37 38.13 2.49 Favored 'General case' 0 N--CA 1.477 0.906 0 N-CA-C 115.404 1.631 . . . . 0.0 115.404 -175.621 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 21.0 t 42.15 121.26 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.293 0 C-N-CA 125.325 1.45 . . . . 0.0 114.846 -174.08 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.526 HG13 HG21 ' A' ' 25' ' ' VAL 0.278 9.8 tp -27.42 -57.75 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.481 1.096 0 N-CA-C 118.654 2.835 . . . . 0.0 118.654 -169.231 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 39.4 tttm -57.75 -61.11 2.76 Favored 'General case' 0 N--CA 1.486 1.344 0 C-N-CA 123.703 0.801 . . . . 0.0 111.771 178.56 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -63.47 -39.17 93.75 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 124.843 1.257 . . . . 0.0 112.836 178.236 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' TYR . . . . . 0.409 ' HA ' ' HB3' ' A' ' 49' ' ' GLU . 79.3 t80 -48.22 -59.35 3.48 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 125.203 1.401 . . . . 0.0 111.932 176.684 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 64.0 mt -65.74 -39.61 91.3 Favored 'General case' 0 N--CA 1.478 0.973 0 CA-C-N 114.597 -1.183 . . . . 0.0 114.123 -179.883 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.812 ' HA ' HG13 ' A' ' 19' ' ' VAL . 43.7 mttp -57.9 -42.76 85.37 Favored 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 114.955 1.465 . . . . 0.0 114.955 179.869 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 55.7 tttp -78.9 -52.55 8.14 Favored 'General case' 0 N--CA 1.478 0.941 0 CA-C-N 115.256 -0.884 . . . . 0.0 111.54 170.984 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' GLU . . . . . 0.466 ' O ' ' HB2' ' A' ' 62' ' ' LYS . 28.0 tt0 -56.57 -49.94 73.39 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-O 118.558 -0.734 . . . . 0.0 111.975 -171.051 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.71 HG23 HG21 ' A' ' 67' ' ' VAL . 2.8 mm -75.86 -27.91 18.79 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 O-C-N 121.306 -0.872 . . . . 0.0 112.683 -175.959 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.469 ' HB2' ' O ' ' A' ' 56' ' ' LYS . 11.9 mttt -62.51 -34.12 76.24 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 116.935 2.198 . . . . 0.0 116.935 171.008 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 62.3 pttt -92.96 -25.36 18.05 Favored 'General case' 0 CA--C 1.546 0.825 0 CA-C-N 113.879 -1.51 . . . . 0.0 112.515 176.358 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.466 ' HB2' ' O ' ' A' ' 58' ' ' GLU . 29.1 tttm -80.27 -46.14 16.71 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 125.967 1.707 . . . . 0.0 113.594 -176.573 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 93.89 105.6 1.83 Allowed Glycine 0 N--CA 1.477 1.405 0 N-CA-C 110.589 -1.004 . . . . 0.0 110.589 -177.818 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.608 ' HD2' ' H ' ' A' ' 64' ' ' LYS . 5.6 mptt -32.01 -45.57 0.1 Allowed 'General case' 0 N--CA 1.489 1.479 0 C-N-CA 127.587 2.355 . . . . 0.0 116.266 -178.131 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . 0.3 0.0 OUTLIER -46.94 -56.11 6.94 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 127.568 2.347 . . . . 0.0 114.105 175.781 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -71.12 -23.24 62.05 Favored 'General case' 0 N--CA 1.478 0.957 0 CA-C-N 113.994 -1.457 . . . . 0.0 114.298 175.072 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.71 HG21 HG23 ' A' ' 59' ' ' ILE . 61.1 t -70.82 -39.11 75.08 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.174 0 C-N-CA 123.423 0.689 . . . . 0.0 110.838 177.91 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 19.0 mm -51.15 -44.24 28.94 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.87 0 C-N-CA 123.902 0.881 . . . . 0.0 111.089 169.682 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -68.91 -51.4 40.46 Favored 'General case' 0 N--CA 1.481 1.097 0 N-CA-C 113.559 0.948 . . . . 0.0 113.559 174.574 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 31.1 t90 . . . . . 0 N--CA 1.479 1.0 0 C-N-CA 125.419 1.487 . . . . 0.0 112.621 -179.302 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.403 ' HE3' HD13 ' A' ' 7' ' ' ILE . 62.9 mtp . . . . . 0 N--CA 1.477 0.879 0 N-CA-C 113.321 0.86 . . . . 0.0 113.321 . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -60.19 -48.92 79.71 Favored 'General case' 0 N--CA 1.477 0.89 0 O-C-N 124.104 0.877 . . . . 0.0 112.959 177.269 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 42.2 tttm -72.5 -58.36 3.44 Favored 'General case' 0 N--CA 1.479 0.998 0 CA-C-N 114.404 -1.271 . . . . 0.0 113.624 -174.59 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' GLU . . . . . 0.46 ' HB2' ' O ' ' A' ' 70' ' ' TRP . 0.8 OUTLIER -70.29 -36.24 74.24 Favored 'General case' 0 CA--C 1.538 0.485 0 N-CA-C 114.327 1.232 . . . . 0.0 114.327 -171.658 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 5' ' ' PHE . . . . . 0.55 ' HB2' HD12 ' A' ' 7' ' ' ILE . 29.8 m-85 -108.86 -10.09 15.12 Favored 'General case' 0 N--CA 1.47 0.55 0 N-CA-C 117.014 2.227 . . . . 0.0 117.014 -170.36 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 68.08 56.65 10.08 Favored Glycine 0 CA--C 1.541 1.678 0 O-C-N 123.965 0.791 . . . . 0.0 111.351 -174.634 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.55 HD12 ' HB2' ' A' ' 5' ' ' PHE . 0.4 OUTLIER -111.95 140.37 23.34 Favored Pre-proline 0 N--CA 1.476 0.874 0 CA-C-N 113.466 -1.367 . . . . 0.0 110.149 -179.841 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -85.27 160.78 11.31 Favored 'Trans proline' 0 C--O 1.243 0.752 0 C-N-CA 121.161 1.241 . . . . 0.0 110.057 166.551 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -52.21 -32.76 38.0 Favored 'General case' 0 N--CA 1.484 1.225 0 N-CA-C 115.262 1.579 . . . . 0.0 115.262 175.807 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -41.0 -38.26 0.95 Allowed 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 126.688 1.995 . . . . 0.0 115.815 172.412 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.701 ' HB ' HD22 ' A' ' 32' ' ' LEU . 33.6 m -105.4 -41.24 6.24 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.95 0 N-CA-C 114.754 1.391 . . . . 0.0 114.754 -176.67 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.432 ' HB2' HG21 ' A' ' 7' ' ' ILE . . . -67.29 -39.85 86.03 Favored 'General case' 0 N--CA 1.479 1.023 0 N-CA-C 112.992 0.738 . . . . 0.0 112.992 178.541 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -58.52 -41.9 95.69 Favored Glycine 0 CA--C 1.547 2.048 0 C-N-CA 123.923 0.773 . . . . 0.0 111.877 175.532 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 10.4 m -66.52 -39.88 88.88 Favored 'General case' 0 N--CA 1.484 1.232 0 CA-C-N 113.644 -1.278 . . . . 0.0 114.158 176.986 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 71.4 t -52.77 -43.36 44.86 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.017 0 N-CA-C 112.042 0.386 . . . . 0.0 112.042 169.445 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.595 HD11 HG12 ' A' ' 68' ' ' ILE . 38.3 mt -60.63 -43.84 97.07 Favored 'General case' 0 N--CA 1.481 1.095 0 N-CA-C 113.161 0.8 . . . . 0.0 113.161 179.75 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 20.4 t-20 -52.95 -50.78 63.35 Favored 'General case' 0 N--CA 1.48 1.05 0 O-C-N 124.934 1.396 . . . . 0.0 110.731 173.909 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.56 HG11 HD11 ' A' ' 28' ' ' ILE . 70.6 t -63.05 -41.62 93.54 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.088 0 CA-C-N 114.306 -1.315 . . . . 0.0 113.746 178.24 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.685 HG13 ' HA ' ' A' ' 56' ' ' LYS . 37.0 t -61.25 -45.75 97.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 123.845 0.716 . . . . 0.0 110.427 175.689 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 20' ' ' GLU . . . . . 0.42 ' HG3' ' HE2' ' A' ' 64' ' ' LYS . 31.3 mt-10 -60.67 -39.54 88.77 Favored 'General case' 0 CA--C 1.551 0.981 0 C-N-CA 124.914 1.286 . . . . 0.0 113.744 177.605 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -87.06 -15.98 36.97 Favored 'General case' 0 CA--C 1.543 0.68 0 N-CA-C 117.398 2.37 . . . . 0.0 117.398 -178.551 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 63.6 37.14 94.3 Favored Glycine 0 N--CA 1.484 1.851 0 C-N-CA 124.216 0.912 . . . . 0.0 112.219 -172.021 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -90.01 -166.23 41.29 Favored Glycine 0 N--CA 1.482 1.712 0 CA-C-O 122.808 1.227 . . . . 0.0 113.365 -172.694 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' TRP . . . . . 0.602 ' HB3' HG22 ' A' ' 26' ' ' THR . 5.4 m-90 -82.74 111.44 18.68 Favored 'General case' 0 N--CA 1.478 0.957 0 CA-C-O 122.328 1.061 . . . . 0.0 111.032 -179.891 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.41 ' HB ' ' HG2' ' A' ' 52' ' ' LYS . 39.6 t -65.02 -20.18 27.07 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.209 0 CA-C-N 114.669 -1.15 . . . . 0.0 112.307 168.278 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.602 HG22 ' HB3' ' A' ' 24' ' ' TRP . 10.9 t -64.26 -32.96 74.75 Favored 'General case' 0 N--CA 1.482 1.129 0 N-CA-C 113.96 1.096 . . . . 0.0 113.96 179.587 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -66.74 -33.68 76.16 Favored 'General case' 0 N--CA 1.485 1.313 0 N-CA-C 113.672 0.99 . . . . 0.0 113.672 173.875 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.56 HD11 HG11 ' A' ' 18' ' ' VAL . 0.0 OUTLIER -87.4 -38.0 11.57 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.165 0 CA-C-O 118.737 -0.649 . . . . 0.0 111.363 -178.798 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 14.0 t -44.82 -44.23 2.63 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.213 0 C-N-CA 124.225 1.01 . . . . 0.0 111.981 175.288 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 6.4 p -63.28 -31.76 72.99 Favored 'General case' 0 N--CA 1.484 1.229 0 N-CA-C 114.706 1.373 . . . . 0.0 114.706 175.92 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.699 HG22 HG12 ' A' ' 11' ' ' VAL . 15.3 mm -82.44 -37.94 14.83 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.152 0 C-N-CA 123.661 0.784 . . . . 0.0 109.732 179.006 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.701 HD22 ' HB ' ' A' ' 11' ' ' VAL . 3.7 mm? -53.72 -52.97 58.39 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 125.341 1.456 . . . . 0.0 111.283 170.356 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 17.2 p -70.18 -30.87 68.1 Favored 'General case' 0 N--CA 1.475 0.825 0 N-CA-C 114.277 1.214 . . . . 0.0 114.277 179.159 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -53.64 -33.47 55.27 Favored 'General case' 0 N--CA 1.483 1.184 0 N-CA-C 113.554 0.946 . . . . 0.0 113.554 170.022 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.476 ' HB ' ' O ' ' A' ' 32' ' ' LEU . 74.7 t -61.77 -26.98 41.29 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.426 0 C-N-CA 124.675 1.19 . . . . 0.0 112.899 170.934 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 103.3 -105.45 2.69 Favored Glycine 0 N--CA 1.472 1.073 0 N-CA-C 110.337 -1.105 . . . . 0.0 110.337 -178.923 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 30.2 p -61.28 -44.1 97.79 Favored 'General case' 0 N--CA 1.479 1.021 0 N-CA-C 114.08 1.141 . . . . 0.0 114.08 -176.521 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -52.16 -50.74 44.7 Favored Glycine 0 N--CA 1.474 1.181 0 C-N-CA 125.733 1.635 . . . . 0.0 113.96 -175.761 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.499 ' HA2' ' HB3' ' A' ' 32' ' ' LEU . . . -54.38 -55.27 27.61 Favored Glycine 0 N--CA 1.479 1.527 0 CA-C-N 114.336 -0.932 . . . . 0.0 111.753 175.2 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 52.5 mt -60.21 -47.38 86.23 Favored 'General case' 0 N--CA 1.478 0.949 0 N-CA-C 115.126 1.528 . . . . 0.0 115.126 -176.529 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 75.5 p -61.76 -41.29 97.5 Favored 'General case' 0 CA--C 1.544 0.715 0 N-CA-C 113.139 0.792 . . . . 0.0 113.139 176.665 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 9.8 tp -63.88 -47.37 80.91 Favored 'General case' 0 N--CA 1.482 1.135 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.405 173.87 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.477 ' HG ' ' O ' ' A' ' 39' ' ' GLY . 75.8 mt -60.6 -30.48 69.85 Favored 'General case' 0 N--CA 1.474 0.768 0 N-CA-C 114.783 1.401 . . . . 0.0 114.783 -178.916 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -70.3 -44.68 67.83 Favored 'General case' 0 N--CA 1.477 0.917 0 O-C-N 123.842 0.714 . . . . 0.0 112.724 172.897 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -68.64 -37.14 79.45 Favored 'General case' 0 N--CA 1.479 0.994 0 CA-C-O 121.607 0.717 . . . . 0.0 112.305 177.242 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.423 ' HB1' ' HA ' ' A' ' 51' ' ' ILE . . . -60.74 -25.24 66.33 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 126.45 1.9 . . . . 0.0 115.371 176.364 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -48.77 -36.83 20.05 Favored Glycine 0 CA--C 1.545 1.934 0 O-C-N 124.657 1.223 . . . . 0.0 113.564 176.642 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 25.0 ttm180 -43.64 -52.57 6.31 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 128.256 2.622 . . . . 0.0 113.228 -177.698 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 11.2 tt0 -128.55 36.12 4.29 Favored 'General case' 0 CA--C 1.545 0.761 0 N-CA-C 112.957 0.725 . . . . 0.0 112.957 -178.599 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 60.3 p 51.5 123.62 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.664 0 C-N-CA 125.065 1.346 . . . . 0.0 112.17 -169.101 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.423 ' HA ' ' HB1' ' A' ' 46' ' ' ALA . 5.8 tp -33.57 -50.51 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.164 0 N-CA-C 117.082 2.253 . . . . 0.0 117.082 -176.952 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.41 ' HG2' ' HB ' ' A' ' 25' ' ' VAL . 7.1 mttt -59.76 -62.86 1.56 Allowed 'General case' 0 N--CA 1.471 0.623 0 N-CA-C 114.388 1.255 . . . . 0.0 114.388 178.123 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -63.28 -34.1 76.94 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 113.24 -1.8 . . . . 0.0 112.662 -179.388 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 72.4 t80 -51.52 -63.61 1.08 Allowed 'General case' 0 C--O 1.224 -0.277 0 C-N-CA 125.955 1.702 . . . . 0.0 110.654 176.969 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 43.5 mt -65.96 -39.62 90.59 Favored 'General case' 0 N--CA 1.477 0.925 0 N-CA-C 115.265 1.58 . . . . 0.0 115.265 -175.859 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.685 ' HA ' HG13 ' A' ' 19' ' ' VAL . 1.8 mptm? -58.94 -44.38 91.41 Favored 'General case' 0 N--CA 1.472 0.644 0 N-CA-C 114.859 1.429 . . . . 0.0 114.859 177.767 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 15.6 tttm -79.39 -52.68 7.76 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-N 114.467 -1.242 . . . . 0.0 112.542 173.284 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' GLU . . . . . 0.546 ' O ' ' HB2' ' A' ' 62' ' ' LYS . 0.8 OUTLIER -59.22 -45.17 91.82 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-O 116.488 -1.72 . . . . 0.0 113.039 -171.62 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.653 HG23 HG21 ' A' ' 67' ' ' VAL . 3.2 mm -76.37 -26.64 17.05 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.04 0 C-N-CA 119.994 -0.682 . . . . 0.0 111.697 -179.637 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.523 ' HB2' ' O ' ' A' ' 56' ' ' LYS . 0.7 OUTLIER -59.22 -34.51 72.27 Favored 'General case' 0 CA--C 1.543 0.7 0 CA-C-O 122.162 0.982 . . . . 0.0 113.566 173.144 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 5.0 mttm -87.97 -44.97 10.62 Favored 'General case' 0 N--CA 1.479 0.985 0 CA-C-N 112.536 -2.12 . . . . 0.0 110.853 179.363 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.546 ' HB2' ' O ' ' A' ' 58' ' ' GLU . 19.9 tttt -68.51 -41.23 80.27 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 127.348 2.259 . . . . 0.0 114.41 -171.554 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 93.24 110.57 2.02 Favored Glycine 0 CA--C 1.534 1.231 0 N-CA-C 110.358 -1.097 . . . . 0.0 110.358 -177.719 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.714 ' HD2' ' H ' ' A' ' 64' ' ' LYS . 10.0 mptt -39.3 -47.61 1.73 Allowed 'General case' 0 N--CA 1.481 1.093 0 N-CA-C 117.395 2.369 . . . . 0.0 117.395 -176.189 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.485 ' O ' ' HB ' ' A' ' 68' ' ' ILE . 4.6 ttp180 -58.51 -50.22 74.55 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 124.18 0.992 . . . . 0.0 113.436 179.448 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -61.96 -28.03 69.26 Favored 'General case' 0 N--CA 1.476 0.843 0 N-CA-C 114.118 1.155 . . . . 0.0 114.118 173.669 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.653 HG21 HG23 ' A' ' 59' ' ' ILE . 90.3 t -70.62 -33.15 51.98 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 N-CA-C 112.333 0.494 . . . . 0.0 112.333 176.509 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.595 HG12 HD11 ' A' ' 16' ' ' LEU . 4.1 mm -49.5 -47.28 20.38 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.332 0 C-N-CA 123.28 0.632 . . . . 0.0 109.718 167.719 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -66.95 -51.81 50.59 Favored 'General case' 0 N--CA 1.485 1.286 0 CA-C-N 114.811 -1.086 . . . . 0.0 112.751 177.807 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' TRP . . . . . 0.46 ' O ' ' HB2' ' A' ' 4' ' ' GLU . 39.6 t90 . . . . . 0 N--CA 1.484 1.263 0 C-N-CA 125.055 1.342 . . . . 0.0 113.121 -179.201 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.552 ' HE1' HG21 ' A' ' 15' ' ' VAL . 72.4 mtp . . . . . 0 N--CA 1.476 0.832 0 N-CA-C 112.814 0.672 . . . . 0.0 112.814 . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 2' ' ' ALA . . . . . 0.611 ' HA ' ' O ' ' A' ' 7' ' ' ILE . . . -60.91 -54.84 40.15 Favored 'General case' 0 N--CA 1.471 0.601 0 N-CA-C 113.584 0.957 . . . . 0.0 113.584 173.961 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 9.7 tptp -74.08 -57.05 4.22 Favored 'General case' 0 CA--C 1.543 0.711 0 CA-C-N 113.559 -1.655 . . . . 0.0 114.456 -174.597 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 11.3 tt0 -77.88 -43.74 29.27 Favored 'General case' 0 N--CA 1.477 0.88 0 N-CA-C 113.631 0.974 . . . . 0.0 113.631 -171.967 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 41.7 m-85 -95.35 -8.08 36.75 Favored 'General case' 0 CA--C 1.542 0.652 0 N-CA-C 117.396 2.369 . . . . 0.0 117.396 -173.749 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 63.48 38.53 96.48 Favored Glycine 0 N--CA 1.478 1.47 0 O-C-N 124.38 1.05 . . . . 0.0 112.848 -177.773 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.611 ' O ' ' HA ' ' A' ' 2' ' ' ALA . 0.8 OUTLIER -114.06 128.6 25.62 Favored Pre-proline 0 N--CA 1.479 1.005 0 C-N-CA 124.51 1.124 . . . . 0.0 108.474 -179.808 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -66.89 156.37 66.46 Favored 'Trans proline' 0 CA--C 1.54 0.785 0 CA-C-N 120.169 1.096 . . . . 0.0 110.943 179.721 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -51.8 -30.0 21.4 Favored 'General case' 0 N--CA 1.483 1.177 0 N-CA-C 115.077 1.51 . . . . 0.0 115.077 173.988 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -44.64 -46.98 10.44 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 126.332 1.853 . . . . 0.0 114.007 175.159 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.973 HG12 HG22 ' A' ' 31' ' ' ILE . 34.9 m -96.14 -32.43 4.31 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.345 0 N-CA-C 114.016 1.117 . . . . 0.0 114.016 -177.824 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.41 ' O ' ' HG ' ' A' ' 16' ' ' LEU . . . -59.99 -34.61 73.55 Favored 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 112.483 0.549 . . . . 0.0 112.483 173.43 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -58.69 -46.73 92.95 Favored Glycine 0 CA--C 1.546 1.978 0 C-N-CA 124.823 1.201 . . . . 0.0 113.048 169.463 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -62.32 -39.98 94.82 Favored 'General case' 0 N--CA 1.487 1.391 0 C-N-CA 124.46 1.104 . . . . 0.0 113.633 176.822 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.558 HG13 HD13 ' A' ' 55' ' ' LEU . 30.9 t -51.76 -39.37 24.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 C-N-CA 124.286 1.034 . . . . 0.0 112.768 169.338 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.581 HD22 ' HG3' ' A' ' 64' ' ' LYS . 56.3 mt -62.75 -38.35 90.23 Favored 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 113.773 1.027 . . . . 0.0 113.773 177.408 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 18.2 t-20 -51.84 -47.48 64.36 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 123.792 0.837 . . . . 0.0 111.762 173.338 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.407 HG21 ' HA ' ' A' ' 25' ' ' VAL . 2.1 t -52.33 -51.49 32.03 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.118 0 CA-C-N 115.366 -0.833 . . . . 0.0 113.039 173.507 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.603 HG13 ' HA ' ' A' ' 56' ' ' LYS . 4.1 t -63.28 -46.41 95.73 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.065 0 O-C-N 124.299 0.999 . . . . 0.0 110.982 -179.116 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 33.0 mt-10 -62.21 -45.72 92.08 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 125.075 1.35 . . . . 0.0 114.279 -178.09 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -94.9 -22.01 18.28 Favored 'General case' 0 N--CA 1.48 1.056 0 N-CA-C 116.34 1.978 . . . . 0.0 116.34 -172.035 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 73.89 45.54 26.73 Favored Glycine 0 N--CA 1.481 1.663 0 N-CA-C 109.042 -1.623 . . . . 0.0 109.042 -163.352 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -94.71 164.13 25.13 Favored Glycine 0 N--CA 1.477 1.401 0 C-N-CA 124.898 1.237 . . . . 0.0 113.829 -169.438 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 2.8 m-90 -66.86 102.12 0.92 Allowed 'General case' 0 N--CA 1.475 0.818 0 CA-C-O 122.568 1.175 . . . . 0.0 112.045 -178.542 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.637 HG21 HG13 ' A' ' 51' ' ' ILE . 5.5 p -53.45 -25.59 11.1 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.996 0 CA-C-N 112.979 -1.918 . . . . 0.0 115.225 170.881 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 10.6 t -62.42 -36.42 82.33 Favored 'General case' 0 N--CA 1.478 0.951 0 N-CA-C 113.434 0.902 . . . . 0.0 113.434 179.756 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 1.3 m -67.11 -42.7 84.07 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 124.082 0.953 . . . . 0.0 110.65 173.226 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.448 ' O ' HD23 ' A' ' 32' ' ' LEU . 1.6 mp -63.34 -44.7 99.16 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.759 0 C-N-CA 124.227 1.011 . . . . 0.0 112.633 178.272 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 77.2 t -52.38 -44.17 42.58 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.152 0 C-N-CA 123.816 0.846 . . . . 0.0 111.049 174.842 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 20.3 p -60.83 -33.59 73.27 Favored 'General case' 0 N--CA 1.482 1.15 0 N-CA-C 114.999 1.481 . . . . 0.0 114.999 175.944 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.973 HG22 HG12 ' A' ' 11' ' ' VAL . 27.7 mm -75.18 -40.73 44.1 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.692 0 C-N-CA 124.226 1.01 . . . . 0.0 109.319 178.891 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.619 ' HB3' ' HA3' ' A' ' 39' ' ' GLY . 3.6 mm? -59.68 -32.89 70.91 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 124.743 1.217 . . . . 0.0 111.391 169.236 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.545 HG23 ' HA2' ' A' ' 38' ' ' GLY . 2.9 m -73.38 -35.88 65.98 Favored 'General case' 0 N--CA 1.475 0.801 0 N-CA-C 113.984 1.105 . . . . 0.0 113.984 174.532 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -53.8 -30.38 44.64 Favored 'General case' 0 N--CA 1.487 1.383 0 N-CA-C 113.374 0.879 . . . . 0.0 113.374 175.94 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 55.5 t -65.14 -36.32 77.49 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.093 0 C-N-CA 126.823 2.049 . . . . 0.0 113.213 173.567 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 114.39 155.68 11.33 Favored Glycine 0 CA--C 1.535 1.339 0 N-CA-C 110.218 -1.153 . . . . 0.0 110.218 -166.224 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 56.9 p 77.27 -40.38 0.34 Allowed 'General case' 0 N--CA 1.49 1.541 0 C-N-CA 127.95 2.5 . . . . 0.0 113.158 -177.527 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.545 ' HA2' HG23 ' A' ' 33' ' ' THR . . . 118.46 6.17 12.05 Favored Glycine 0 CA--C 1.537 1.432 0 CA-C-N 114.208 -1.36 . . . . 0.0 113.05 -169.197 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.619 ' HA3' ' HB3' ' A' ' 32' ' ' LEU . . . 60.03 36.52 90.63 Favored Glycine 0 CA--C 1.55 2.28 0 N-CA-C 110.784 -0.926 . . . . 0.0 110.784 -155.892 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 10.8 mt -55.81 -37.34 68.52 Favored 'General case' 0 N--CA 1.483 1.216 0 N-CA-C 116.363 1.986 . . . . 0.0 116.363 -169.657 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 16.6 p -56.87 -43.64 81.44 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 124.376 1.07 . . . . 0.0 113.652 176.506 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.41 HD22 ' HE1' ' A' ' 1' ' ' MET . 14.9 tp -66.68 -45.8 77.7 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 123.12 0.568 . . . . 0.0 110.845 175.316 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 88.4 mt -60.65 -30.77 70.09 Favored 'General case' 0 N--CA 1.477 0.89 0 CA-C-N 114.293 -1.321 . . . . 0.0 114.19 179.116 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -66.79 -48.18 69.82 Favored 'General case' 0 N--CA 1.474 0.726 0 N-CA-C 112.943 0.72 . . . . 0.0 112.943 173.546 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -64.36 -29.21 70.29 Favored 'General case' 0 N--CA 1.485 1.316 0 N-CA-C 113.029 0.752 . . . . 0.0 113.029 176.815 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -77.99 -9.53 59.15 Favored 'General case' 0 CA--C 1.543 0.683 0 N-CA-C 117.259 2.318 . . . . 0.0 117.259 -177.236 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -56.6 -57.06 21.41 Favored Glycine 0 CA--C 1.542 1.75 0 C-N-CA 124.321 0.962 . . . . 0.0 113.216 -166.881 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.71 -44.93 90.5 Favored 'General case' 0 CA--C 1.541 0.601 0 N-CA-C 115.681 1.734 . . . . 0.0 115.681 -177.321 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.502 ' OE1' ' HA ' ' A' ' 54' ' ' TYR . 13.0 tt0 -103.1 25.49 9.37 Favored 'General case' 0 N--CA 1.478 0.947 0 N-CA-C 114.749 1.389 . . . . 0.0 114.749 -175.058 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 91.8 p 46.63 118.85 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 125.756 1.622 . . . . 0.0 112.919 -174.594 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.637 HG13 HG21 ' A' ' 25' ' ' VAL . 8.0 tp -35.86 -52.18 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.263 0 N-CA-C 116.883 2.179 . . . . 0.0 116.883 -174.134 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 23.6 tptp -55.51 -67.98 0.24 Allowed 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 124.703 1.201 . . . . 0.0 112.863 174.518 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -57.73 -36.31 71.86 Favored 'General case' 0 N--CA 1.482 1.16 0 N-CA-C 113.993 1.108 . . . . 0.0 113.993 179.586 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' TYR . . . . . 0.502 ' HA ' ' OE1' ' A' ' 49' ' ' GLU . 94.3 t80 -50.0 -64.6 0.76 Allowed 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 125.533 1.533 . . . . 0.0 111.738 173.641 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.558 HD13 HG13 ' A' ' 15' ' ' VAL . 46.2 mt -63.16 -41.2 99.21 Favored 'General case' 0 N--CA 1.472 0.675 0 N-CA-C 114.023 1.12 . . . . 0.0 114.023 -178.357 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.603 ' HA ' HG13 ' A' ' 19' ' ' VAL . 54.1 tptt -53.57 -54.15 41.56 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-N 113.751 -1.568 . . . . 0.0 112.303 179.076 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 58.9 tttp -68.79 -54.42 15.96 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 115.127 -0.942 . . . . 0.0 111.943 173.895 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 8.9 tt0 -59.25 -48.23 82.4 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-N 115.655 -0.702 . . . . 0.0 111.845 -167.34 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.716 HG23 HG21 ' A' ' 67' ' ' VAL . 3.1 mm -75.99 -23.95 16.35 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.124 0 O-C-N 123.288 0.367 . . . . 0.0 111.359 -176.051 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.421 ' HB2' ' O ' ' A' ' 56' ' ' LYS . 24.3 mttt -65.92 -21.6 66.45 Favored 'General case' 0 C--O 1.222 -0.362 0 N-CA-C 117.3 2.333 . . . . 0.0 117.3 169.095 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 60.4 mtpt -91.26 -50.24 5.93 Favored 'General case' 0 N--CA 1.481 1.091 0 CA-C-N 112.831 -1.986 . . . . 0.0 110.614 172.481 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 36.9 tttp -65.19 -50.29 66.49 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 126.957 2.103 . . . . 0.0 114.909 -171.957 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 95.77 121.61 3.84 Favored Glycine 0 CA--C 1.533 1.181 0 CA-C-O 122.384 0.991 . . . . 0.0 110.888 -171.86 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.581 ' HG3' HD22 ' A' ' 16' ' ' LEU . 12.3 mptt -45.08 -39.38 5.8 Favored 'General case' 0 N--CA 1.48 1.054 0 N-CA-C 117.396 2.369 . . . . 0.0 117.396 -175.777 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.418 ' O ' ' HB ' ' A' ' 68' ' ' ILE . 0.0 OUTLIER -59.66 -46.97 87.42 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 124.545 1.138 . . . . 0.0 112.805 178.208 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -63.26 -28.27 69.91 Favored 'General case' 0 N--CA 1.479 1.023 0 N-CA-C 114.54 1.311 . . . . 0.0 114.54 174.723 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.716 HG21 HG23 ' A' ' 59' ' ' ILE . 26.2 t -70.75 -36.9 66.82 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.868 0 C-N-CA 123.594 0.758 . . . . 0.0 111.282 178.536 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.418 ' HB ' ' O ' ' A' ' 65' ' ' ARG . 21.6 mm -52.95 -46.75 53.55 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.95 0 C-N-CA 123.926 0.89 . . . . 0.0 110.384 170.781 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -70.37 -50.88 34.3 Favored 'General case' 0 N--CA 1.479 1.009 0 CA-C-N 114.783 -1.099 . . . . 0.0 113.172 177.072 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 31.6 t90 . . . . . 0 N--CA 1.484 1.248 0 C-N-CA 125.611 1.564 . . . . 0.0 112.77 -179.494 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.45 ' HE1' HG21 ' A' ' 15' ' ' VAL . 74.2 mtp . . . . . 0 N--CA 1.471 0.577 0 N-CA-C 112.215 0.45 . . . . 0.0 112.215 . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 2' ' ' ALA . . . . . 0.425 ' HA ' ' O ' ' A' ' 7' ' ' ILE . . . -54.96 -58.38 7.85 Favored 'General case' 0 N--CA 1.472 0.664 0 O-C-N 124.734 1.271 . . . . 0.0 113.255 173.395 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 22.1 tptm -71.81 -50.75 26.91 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 113.684 -1.598 . . . . 0.0 113.104 -173.763 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 8.3 tt0 -78.1 -42.76 31.03 Favored 'General case' 0 N--CA 1.479 0.99 0 N-CA-C 114.674 1.361 . . . . 0.0 114.674 -170.254 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' PHE . . . . . 0.457 ' HD1' ' HB2' ' A' ' 41' ' ' SER . 58.3 m-85 -105.76 -15.15 15.03 Favored 'General case' 0 N--CA 1.474 0.738 0 N-CA-C 116.987 2.218 . . . . 0.0 116.987 -172.101 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 85.75 61.21 1.71 Allowed Glycine 0 N--CA 1.482 1.73 0 O-C-N 124.352 1.033 . . . . 0.0 112.331 -176.922 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.538 HG21 ' HB2' ' A' ' 12' ' ' ALA . 1.0 OUTLIER -111.48 137.14 21.04 Favored Pre-proline 0 N--CA 1.475 0.789 0 CA-C-N 114.365 -0.918 . . . . 0.0 109.771 173.47 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.416 ' C ' ' H ' ' A' ' 10' ' ' ALA . 47.5 Cg_endo -82.04 38.45 0.75 Allowed 'Trans proline' 0 CA--C 1.537 0.673 0 C-N-CA 122.861 2.374 . . . . 0.0 113.2 175.522 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . 53.85 -34.04 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.518 0 C-N-CA 129.69 3.196 . . . . 0.0 117.243 -169.959 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.416 ' H ' ' C ' ' A' ' 8' ' ' PRO . . . -37.23 -63.53 0.43 Allowed 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 128.735 2.814 . . . . 0.0 113.564 174.023 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.537 HG12 HG22 ' A' ' 31' ' ' ILE . 26.9 m -74.77 -21.43 16.99 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.862 0 N-CA-C 113.896 1.073 . . . . 0.0 113.896 -176.248 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.538 ' HB2' HG21 ' A' ' 7' ' ' ILE . . . -67.6 -32.88 73.91 Favored 'General case' 0 N--CA 1.475 0.785 0 N-CA-C 112.356 0.502 . . . . 0.0 112.356 169.991 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -59.37 -38.04 92.84 Favored Glycine 0 CA--C 1.541 1.706 0 C-N-CA 123.836 0.731 . . . . 0.0 113.44 172.284 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.541 HG22 HG13 ' A' ' 28' ' ' ILE . 0.2 OUTLIER -69.79 -27.67 65.1 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 126.189 1.796 . . . . 0.0 115.124 176.329 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.484 ' O ' ' HB ' ' A' ' 18' ' ' VAL . 2.8 t -67.01 -44.07 88.62 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.169 0 C-N-CA 124.884 1.273 . . . . 0.0 110.691 171.501 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.451 HD13 ' HB3' ' A' ' 64' ' ' LYS . 60.2 mt -63.44 -42.83 98.67 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 114.408 -1.269 . . . . 0.0 112.348 179.076 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 17' ' ' ASN . . . . . 0.41 ' HB2' ' O ' ' A' ' 14' ' ' THR 0.444 0.6 OUTLIER -48.33 -52.86 19.63 Favored 'General case' 0 C--N 1.31 -1.123 0 CA-C-N 114.484 -1.235 . . . . 0.0 114.161 169.281 . . . . . . . . 4 4 . 1 . 016 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.484 ' HB ' ' O ' ' A' ' 15' ' ' VAL . 2.9 t -46.17 -54.2 2.09 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.416 0 O-C-N 125.629 1.831 . . . . 0.0 110.342 173.434 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.823 HG13 ' HA ' ' A' ' 56' ' ' LYS . 4.1 t -62.33 -49.99 81.73 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.08 0 CA-C-N 115.011 -0.995 . . . . 0.0 111.16 -174.453 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 25.8 mt-10 -66.28 -38.59 88.14 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 126.128 1.771 . . . . 0.0 115.012 -171.959 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -99.63 -11.45 20.93 Favored 'General case' 0 N--CA 1.473 0.688 0 N-CA-C 114.473 1.286 . . . . 0.0 114.473 -175.044 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 68.03 39.83 88.81 Favored Glycine 0 CA--C 1.545 1.912 0 N-CA-C 111.423 -0.671 . . . . 0.0 111.423 -166.903 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -91.69 159.45 25.85 Favored Glycine 0 CA--C 1.541 1.689 0 CA-C-O 122.948 1.304 . . . . 0.0 113.776 -173.251 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 83.8 m95 -63.81 108.03 1.35 Allowed 'General case' 0 N--CA 1.47 0.558 0 CA-C-N 112.863 -1.668 . . . . 0.0 113.564 -179.512 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.614 HG21 HG13 ' A' ' 51' ' ' ILE . 5.5 p -58.46 -26.86 31.87 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 CA-C-N 111.741 -2.481 . . . . 0.0 113.864 168.653 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 10.1 t -65.09 -36.51 84.53 Favored 'General case' 0 N--CA 1.482 1.125 0 N-CA-C 113.431 0.901 . . . . 0.0 113.431 -173.867 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -70.45 -43.7 69.33 Favored 'General case' 0 N--CA 1.47 0.544 0 N-CA-C 112.367 0.506 . . . . 0.0 112.367 172.029 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.541 HG13 HG22 ' A' ' 14' ' ' THR . 1.6 mp -61.27 -44.0 97.59 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.564 0 C-N-CA 124.92 1.288 . . . . 0.0 112.539 -179.214 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.527 HG13 HD11 ' A' ' 43' ' ' LEU . 23.7 t -46.04 -47.54 5.76 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.703 0 C-N-CA 124.632 1.173 . . . . 0.0 111.594 171.572 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 22.7 p -60.52 -33.98 73.43 Favored 'General case' 0 N--CA 1.482 1.128 0 N-CA-C 114.606 1.335 . . . . 0.0 114.606 177.808 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.537 HG22 HG12 ' A' ' 11' ' ' VAL . 21.7 mm -77.28 -35.66 22.87 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 C-N-CA 124.142 0.977 . . . . 0.0 109.235 -178.951 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.611 ' HB3' ' HA2' ' A' ' 39' ' ' GLY . 4.0 mm? -60.66 -52.38 65.36 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 124.198 0.999 . . . . 0.0 111.587 173.5 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 1.7 p -60.84 -30.05 69.87 Favored 'General case' 0 N--CA 1.482 1.169 0 N-CA-C 115.37 1.619 . . . . 0.0 115.37 177.156 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -53.62 -33.51 55.28 Favored 'General case' 0 N--CA 1.479 1.009 0 N-CA-C 114.81 1.411 . . . . 0.0 114.81 175.251 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 68.8 t -68.69 -21.88 26.31 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.265 0 C-N-CA 125.916 1.686 . . . . 0.0 111.912 175.889 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 97.35 -96.74 1.88 Allowed Glycine 0 N--CA 1.477 1.377 0 N-CA-C 108.301 -1.919 . . . . 0.0 108.301 179.47 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 6.2 p -58.52 -48.57 80.4 Favored 'General case' 0 N--CA 1.487 1.413 0 CA-C-N 112.707 -1.746 . . . . 0.0 114.885 -174.255 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -54.69 -41.3 74.17 Favored Glycine 0 N--CA 1.479 1.544 0 O-C-N 125.941 2.025 . . . . 0.0 115.325 -175.442 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.611 ' HA2' ' HB3' ' A' ' 32' ' ' LEU . . . -62.6 -55.26 28.21 Favored Glycine 0 N--CA 1.473 1.143 0 N-CA-C 111.467 -0.653 . . . . 0.0 111.467 172.621 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 58.8 mt -57.89 -48.94 78.39 Favored 'General case' 0 N--CA 1.474 0.742 0 N-CA-C 115.452 1.649 . . . . 0.0 115.452 -175.971 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' SER . . . . . 0.457 ' HB2' ' HD1' ' A' ' 5' ' ' PHE . 13.1 p -61.91 -37.88 86.3 Favored 'General case' 0 CA--C 1.544 0.732 0 N-CA-C 114.828 1.418 . . . . 0.0 114.828 177.66 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 10.0 tp -69.74 -42.12 74.34 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 124.251 1.02 . . . . 0.0 111.005 175.183 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.527 HD11 HG13 ' A' ' 29' ' ' VAL . 51.2 mt -63.26 -25.79 68.48 Favored 'General case' 0 N--CA 1.469 0.506 0 N-CA-C 114.968 1.47 . . . . 0.0 114.968 178.516 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -72.09 -49.52 35.61 Favored 'General case' 0 N--CA 1.481 1.106 0 CA-C-N 115.909 -0.587 . . . . 0.0 112.286 171.273 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -60.9 -35.75 77.46 Favored 'General case' 0 N--CA 1.49 1.529 0 C-N-CA 124.847 1.259 . . . . 0.0 112.933 -179.229 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -52.4 -25.7 10.6 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 126.844 2.058 . . . . 0.0 114.347 174.293 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -45.7 -37.97 7.27 Favored Glycine 0 CA--C 1.539 1.561 0 C-N-CA 126.514 2.007 . . . . 0.0 114.101 178.868 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 4.5 tmm_? -62.96 -39.35 94.39 Favored 'General case' 0 CA--C 1.544 0.738 0 N-CA-C 114.802 1.408 . . . . 0.0 114.802 -173.079 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 11.5 tt0 -141.15 38.7 1.76 Allowed 'General case' 0 N--CA 1.479 0.981 0 N-CA-C 116.365 1.987 . . . . 0.0 116.365 -178.51 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 59.5 p 53.47 119.34 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.874 0 C-N-CA 125.184 1.394 . . . . 0.0 112.643 -177.131 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.614 HG13 HG21 ' A' ' 25' ' ' VAL 0.276 8.6 tp -36.7 -46.55 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 N-CA-C 117.89 2.552 . . . . 0.0 117.89 -171.945 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 24.7 tptt -55.86 -68.93 0.16 Allowed 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 126.107 1.763 . . . . 0.0 112.895 174.767 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -62.96 -32.3 73.59 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 124.904 1.282 . . . . 0.0 113.865 177.317 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 91.2 t80 -53.81 -62.91 1.35 Allowed 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 125.894 1.677 . . . . 0.0 110.88 -178.948 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 65.8 mt -65.09 -35.39 81.0 Favored 'General case' 0 N--CA 1.469 0.483 0 N-CA-C 114.134 1.161 . . . . 0.0 114.134 179.928 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.823 ' HA ' HG13 ' A' ' 19' ' ' VAL . 58.7 mttp -61.36 -47.96 83.46 Favored 'General case' 0 N--CA 1.477 0.904 0 CA-C-N 113.982 -1.463 . . . . 0.0 114.445 178.476 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 85.7 tttt -76.78 -50.64 13.02 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-N 114.764 -1.107 . . . . 0.0 111.695 175.406 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' GLU . . . . . 0.434 ' O ' ' HB2' ' A' ' 62' ' ' LYS . 28.8 tt0 -59.08 -49.21 78.75 Favored 'General case' 0 N--CA 1.471 0.596 0 N-CA-C 111.922 0.341 . . . . 0.0 111.922 -173.152 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.739 HD12 HG21 ' A' ' 67' ' ' VAL . 2.7 mm -72.09 -25.03 23.08 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.038 0 CA-C-O 118.428 -0.796 . . . . 0.0 112.391 -178.669 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 63.9 tttm -62.77 -33.17 74.62 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 114.682 1.364 . . . . 0.0 114.682 172.045 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 55.1 mtmt -80.91 -48.58 12.14 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-N 114.055 -1.429 . . . . 0.0 110.729 173.941 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.434 ' HB2' ' O ' ' A' ' 58' ' ' GLU . 5.9 tttm -64.51 -50.6 66.74 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 126.131 1.772 . . . . 0.0 115.77 -172.053 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 91.66 108.58 1.59 Allowed Glycine 0 N--CA 1.482 1.749 0 CA-C-N 114.932 -1.031 . . . . 0.0 110.747 -175.941 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.707 ' HD2' ' H ' ' A' ' 64' ' ' LYS . 8.6 mptt -31.95 -43.83 0.08 Allowed 'General case' 0 N--CA 1.482 1.153 0 N-CA-C 119.277 3.066 . . . . 0.0 119.277 -173.713 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.44 -47.94 82.34 Favored 'General case' 0 N--CA 1.475 0.78 0 N-CA-C 113.396 0.888 . . . . 0.0 113.396 178.865 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -60.77 -28.12 68.49 Favored 'General case' 0 N--CA 1.473 0.723 0 CA-C-N 115.015 -0.993 . . . . 0.0 113.402 172.937 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.739 HG21 HD12 ' A' ' 59' ' ' ILE . 96.2 t -72.95 -36.09 50.56 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.662 0 N-CA-C 112.877 0.695 . . . . 0.0 112.877 179.276 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 33.5 mm -53.21 -46.77 56.63 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.996 0 O-C-N 123.637 0.586 . . . . 0.0 109.952 168.721 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -68.6 -43.15 77.05 Favored 'General case' 0 N--CA 1.476 0.844 0 N-CA-C 113.598 0.962 . . . . 0.0 113.598 178.57 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 29.3 t90 . . . . . 0 N--CA 1.477 0.886 0 CA-C-N 114.816 -1.084 . . . . 0.0 113.069 178.337 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.624 ' HE3' HD13 ' A' ' 7' ' ' ILE . 39.7 mtp . . . . . 0 N--CA 1.477 0.918 0 N-CA-C 111.8 0.296 . . . . 0.0 111.8 . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 2' ' ' ALA . . . . . 0.423 ' HA ' ' O ' ' A' ' 7' ' ' ILE . . . -53.64 -55.19 28.04 Favored 'General case' 0 N--CA 1.475 0.789 0 CA-C-N 113.714 -1.585 . . . . 0.0 113.415 177.625 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -74.24 -44.11 54.32 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 113.639 -1.619 . . . . 0.0 114.156 -174.758 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 13.6 tt0 -78.52 -43.19 27.45 Favored 'General case' 0 N--CA 1.472 0.652 0 N-CA-C 114.241 1.2 . . . . 0.0 114.241 -170.898 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' PHE . . . . . 0.6 ' HB2' HD12 ' A' ' 7' ' ' ILE . 46.3 m-85 -105.34 -23.99 12.76 Favored 'General case' 0 N--CA 1.484 1.233 0 N-CA-C 116.258 1.947 . . . . 0.0 116.258 -170.16 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 95.72 58.38 1.12 Allowed Glycine 0 CA--C 1.534 1.276 0 C-N-CA 124.225 0.917 . . . . 0.0 111.77 -175.083 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.624 HD13 ' HE3' ' A' ' 1' ' ' MET . 1.3 mt -125.77 151.11 70.46 Favored Pre-proline 0 N--CA 1.478 0.944 0 C-N-CA 124.764 1.225 . . . . 0.0 111.069 -173.57 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo -97.27 162.63 0.97 Allowed 'Trans proline' 0 C--O 1.24 0.597 0 C-N-CA 121.162 1.241 . . . . 0.0 109.703 161.596 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -53.44 -29.38 35.11 Favored 'General case' 0 CA--C 1.538 0.481 0 N-CA-C 114.719 1.377 . . . . 0.0 114.719 177.176 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -43.61 -59.87 2.0 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 126.196 1.799 . . . . 0.0 112.953 173.146 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.779 HG12 HG22 ' A' ' 31' ' ' ILE . 29.6 m -84.42 -29.89 7.13 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.195 0 N-CA-C 114.321 1.23 . . . . 0.0 114.321 -175.231 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -67.26 -29.79 69.5 Favored 'General case' 0 N--CA 1.48 1.064 0 N-CA-C 112.759 0.651 . . . . 0.0 112.759 172.943 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -66.66 -40.01 93.89 Favored Glycine 0 CA--C 1.536 1.374 0 C-N-CA 124.317 0.96 . . . . 0.0 112.401 170.616 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.756 HG22 HD12 ' A' ' 28' ' ' ILE . 1.0 OUTLIER -67.7 -34.13 76.29 Favored 'General case' 0 N--CA 1.487 1.404 0 C-N-CA 124.183 0.993 . . . . 0.0 112.937 177.232 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.569 HG21 ' HE1' ' A' ' 1' ' ' MET . 10.8 t -54.15 -40.58 47.3 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 C-N-CA 124.707 1.203 . . . . 0.0 112.879 165.772 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.478 HD22 ' HG3' ' A' ' 64' ' ' LYS . 83.2 mt -61.27 -37.13 82.03 Favored 'General case' 0 N--CA 1.472 0.645 0 N-CA-C 114.261 1.208 . . . . 0.0 114.261 176.494 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 48.2 t-20 -53.62 -47.9 69.8 Favored 'General case' 0 N--CA 1.481 1.076 0 CA-C-N 115.179 -0.919 . . . . 0.0 111.355 173.353 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.574 HG23 HG13 ' A' ' 28' ' ' ILE . 22.6 t -48.11 -51.61 9.0 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.213 0 CA-C-N 115.28 -0.873 . . . . 0.0 112.021 174.596 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.829 HG13 ' HA ' ' A' ' 56' ' ' LYS . 5.1 t -64.3 -48.16 86.62 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.144 0 C-N-CA 124.155 0.982 . . . . 0.0 111.327 -176.774 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -74.13 -43.11 58.72 Favored 'General case' 0 N--CA 1.469 0.519 0 N-CA-C 116.767 2.136 . . . . 0.0 116.767 -176.127 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -103.17 -22.45 13.74 Favored 'General case' 0 N--CA 1.481 1.107 0 N-CA-C 115.814 1.783 . . . . 0.0 115.814 -169.796 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 68.87 39.61 85.34 Favored Glycine 0 N--CA 1.477 1.413 0 N-CA-C 110.639 -0.984 . . . . 0.0 110.639 -165.928 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -86.55 142.82 18.91 Favored Glycine 0 N--CA 1.48 1.57 0 N-CA-C 108.815 -1.714 . . . . 0.0 108.815 -177.513 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 9.2 m-90 -49.6 103.15 0.04 OUTLIER 'General case' 0 N--CA 1.477 0.883 0 CA-C-N 113.624 -1.288 . . . . 0.0 112.71 -172.498 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.402 ' O ' HG23 ' A' ' 29' ' ' VAL . 3.2 p -56.44 -23.41 16.68 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.758 0 CA-C-N 114.028 -1.442 . . . . 0.0 114.414 176.368 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 5.0 t -62.43 -44.42 96.47 Favored 'General case' 0 N--CA 1.484 1.225 0 CA-C-N 115.648 -0.705 . . . . 0.0 112.558 178.389 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 1.6 m -60.86 -45.76 93.25 Favored 'General case' 0 N--CA 1.485 1.287 0 C-N-CA 123.871 0.868 . . . . 0.0 110.937 172.998 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.756 HD12 HG22 ' A' ' 14' ' ' THR . 8.4 mm -62.37 -46.58 96.09 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.152 0 C-N-CA 124.394 1.078 . . . . 0.0 111.867 -179.09 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.402 HG23 ' O ' ' A' ' 25' ' ' VAL . 48.7 t -50.31 -45.77 25.02 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.386 0 C-N-CA 124.757 1.223 . . . . 0.0 111.129 176.964 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 64.8 m -63.81 -27.31 69.09 Favored 'General case' 0 N--CA 1.481 1.095 0 N-CA-C 115.867 1.802 . . . . 0.0 115.867 177.825 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.779 HG22 HG12 ' A' ' 11' ' ' VAL . 34.9 mm -82.21 -39.81 16.67 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.032 0 C-N-CA 123.857 0.863 . . . . 0.0 109.07 178.967 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.773 HD22 ' HB ' ' A' ' 11' ' ' VAL . 3.4 mm? -56.64 -50.58 71.61 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 125.142 1.377 . . . . 0.0 112.204 172.171 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 1.4 p -70.89 -29.69 65.83 Favored 'General case' 0 N--CA 1.481 1.079 0 N-CA-C 114.683 1.364 . . . . 0.0 114.683 177.837 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -52.4 -25.63 10.43 Favored 'General case' 0 N--CA 1.477 0.918 0 N-CA-C 114.006 1.113 . . . . 0.0 114.006 170.456 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 58.5 t -70.9 -26.25 27.42 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.322 0 C-N-CA 124.327 1.051 . . . . 0.0 112.051 173.753 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 114.35 -118.78 4.5 Favored Glycine 0 CA--C 1.527 0.794 0 C-N-CA 125.21 1.386 . . . . 0.0 110.201 -176.813 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 17.8 p -61.44 -37.38 83.35 Favored 'General case' 0 N--CA 1.478 0.943 0 CA-C-N 112.979 -1.61 . . . . 0.0 114.259 -179.596 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -46.65 -54.75 8.69 Favored Glycine 0 N--CA 1.482 1.745 0 C-N-CA 124.789 1.185 . . . . 0.0 114.586 -175.729 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.526 ' O ' ' HG ' ' A' ' 43' ' ' LEU . . . -55.3 -49.23 64.82 Favored Glycine 0 N--CA 1.48 1.58 0 O-C-N 125.172 1.16 . . . . 0.0 113.018 176.922 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 22.3 mt -61.45 -48.27 81.91 Favored 'General case' 0 N--CA 1.479 0.981 0 CA-C-N 113.589 -1.306 . . . . 0.0 113.5 -178.845 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 17.0 m -57.92 -41.25 82.3 Favored 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 123.658 0.783 . . . . 0.0 112.758 176.188 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 13.7 tp -60.5 -45.76 92.6 Favored 'General case' 0 N--CA 1.478 0.961 0 CA-C-N 115.554 -0.748 . . . . 0.0 111.393 173.969 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.526 ' HG ' ' O ' ' A' ' 39' ' ' GLY . 69.2 mt -61.85 -32.84 73.21 Favored 'General case' 0 N--CA 1.473 0.697 0 N-CA-C 113.66 0.985 . . . . 0.0 113.66 -179.269 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -63.9 -48.99 74.43 Favored 'General case' 0 N--CA 1.476 0.851 0 O-C-N 123.985 0.803 . . . . 0.0 112.102 171.802 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -62.52 -33.34 74.7 Favored 'General case' 0 N--CA 1.485 1.284 0 CA-C-O 122.239 1.019 . . . . 0.0 112.753 178.12 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -61.77 -14.33 31.64 Favored 'General case' 0 N--CA 1.478 0.933 0 N-CA-C 116.11 1.893 . . . . 0.0 116.11 176.559 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -48.54 -37.22 19.24 Favored Glycine 0 CA--C 1.542 1.771 0 O-C-N 124.718 1.261 . . . . 0.0 113.511 177.833 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 40.2 ttp180 -50.71 -50.76 54.46 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 125.671 1.588 . . . . 0.0 113.647 -173.602 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -145.52 37.98 1.12 Allowed 'General case' 0 N--CA 1.476 0.841 0 N-CA-C 114.064 1.135 . . . . 0.0 114.064 -175.013 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 27.6 t 52.96 133.37 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.504 0 C-N-CA 125.175 1.39 . . . . 0.0 112.855 -175.71 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.419 ' O ' ' HB3' ' A' ' 54' ' ' TYR 0.259 9.9 tp -37.79 -54.04 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.822 0 N-CA-C 117.89 2.552 . . . . 0.0 117.89 -168.186 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 38.4 tttt -61.98 -57.23 12.48 Favored 'General case' 0 CA--C 1.543 0.694 0 N-CA-C 114.096 1.147 . . . . 0.0 114.096 178.232 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -66.17 -30.0 70.39 Favored 'General case' 0 N--CA 1.479 1.011 0 O-C-N 123.925 0.765 . . . . 0.0 112.936 179.766 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' TYR . . . . . 0.419 ' HB3' ' O ' ' A' ' 51' ' ' ILE . 64.4 t80 -53.98 -61.42 2.31 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 124.893 1.277 . . . . 0.0 110.716 170.592 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.431 HD13 HG13 ' A' ' 15' ' ' VAL . 51.2 mt -65.01 -35.81 82.4 Favored 'General case' 0 N--CA 1.482 1.165 0 N-CA-C 113.622 0.971 . . . . 0.0 113.622 -174.662 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.829 ' HA ' HG13 ' A' ' 19' ' ' VAL . 55.6 mttm -54.41 -56.58 17.26 Favored 'General case' 0 N--CA 1.473 0.693 0 O-C-N 125.34 1.65 . . . . 0.0 112.065 173.024 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 57.1 tttm -68.43 -45.47 72.47 Favored 'General case' 0 CA--C 1.542 0.635 0 CA-C-N 115.411 -0.813 . . . . 0.0 112.113 176.799 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' GLU . . . . . 0.451 ' O ' ' HB2' ' A' ' 62' ' ' LYS . 4.1 tp10 -56.81 -52.37 65.31 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-N 114.969 -1.014 . . . . 0.0 112.962 -175.969 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.532 HG23 HG21 ' A' ' 67' ' ' VAL . 1.2 mm -74.8 -26.7 19.75 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.261 0 CA-C-N 116.04 -0.527 . . . . 0.0 112.1 -177.713 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.472 ' HB2' ' O ' ' A' ' 56' ' ' LYS . 3.8 tppt? -62.06 -42.2 98.94 Favored 'General case' 0 CA--C 1.539 0.543 0 O-C-N 124.383 1.052 . . . . 0.0 112.525 176.596 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 61.2 pttt -86.39 -26.99 24.49 Favored 'General case' 0 CA--C 1.547 0.86 0 CA-C-N 113.447 -1.706 . . . . 0.0 113.193 177.935 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.451 ' HB2' ' O ' ' A' ' 58' ' ' GLU . 35.7 tptt -76.16 -58.37 3.32 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 125.714 1.606 . . . . 0.0 114.542 -178.008 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 103.32 110.72 3.48 Favored Glycine 0 CA--C 1.543 1.803 0 CA-C-N 114.628 -1.169 . . . . 0.0 112.189 -174.304 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.517 ' HD2' ' H ' ' A' ' 64' ' ' LYS . 11.2 mptt -34.75 -52.27 0.52 Allowed 'General case' 0 N--CA 1.481 1.077 0 N-CA-C 119.784 3.253 . . . . 0.0 119.784 -172.641 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -61.55 -45.59 93.52 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 123.779 0.831 . . . . 0.0 112.993 -179.778 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -65.48 -25.82 67.65 Favored 'General case' 0 N--CA 1.478 0.97 0 CA-C-N 113.924 -1.489 . . . . 0.0 112.949 174.12 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.532 HG21 HG23 ' A' ' 59' ' ' ILE . 71.7 t -63.77 -43.86 98.09 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.314 0 C-N-CA 123.319 0.648 . . . . 0.0 110.411 174.864 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -51.78 -44.48 36.52 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.966 0 C-N-CA 123.339 0.656 . . . . 0.0 111.671 173.562 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -70.43 -47.64 59.79 Favored 'General case' 0 N--CA 1.481 1.077 0 N-CA-C 113.222 0.823 . . . . 0.0 113.222 177.629 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 30.7 t90 . . . . . 0 N--CA 1.481 1.083 0 C-N-CA 126.382 1.873 . . . . 0.0 112.433 -178.69 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.668 ' HB3' HG22 ' A' ' 7' ' ' ILE . 68.4 mtp . . . . . 0 N--CA 1.474 0.757 0 N-CA-C 113.471 0.915 . . . . 0.0 113.471 . . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -64.37 -38.83 92.42 Favored 'General case' 0 N--CA 1.475 0.813 0 N-CA-C 114.111 1.152 . . . . 0.0 114.111 176.562 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 35.6 ttmt -91.25 -68.54 0.79 Allowed 'General case' 0 N--CA 1.471 0.605 0 N-CA-C 114.125 1.157 . . . . 0.0 114.125 -176.89 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 8.5 tt0 -61.66 -31.14 71.23 Favored 'General case' 0 CA--C 1.55 0.974 0 C-N-CA 125.188 1.395 . . . . 0.0 113.796 -173.623 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' PHE . . . . . 0.541 ' HD1' ' HB2' ' A' ' 41' ' ' SER . 45.1 m-85 -109.77 -11.93 14.67 Favored 'General case' 0 N--CA 1.474 0.74 0 N-CA-C 116.948 2.203 . . . . 0.0 116.948 -179.94 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 64.44 31.62 81.47 Favored Glycine 0 CA--C 1.538 1.511 0 C-N-CA 124.176 0.893 . . . . 0.0 113.856 -174.228 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.668 HG22 ' HB3' ' A' ' 1' ' ' MET . 0.7 OUTLIER -104.21 118.01 57.97 Favored Pre-proline 0 N--CA 1.478 0.939 0 C-N-CA 123.418 0.687 . . . . 0.0 110.863 -177.524 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -64.27 161.61 33.52 Favored 'Trans proline' 0 CA--C 1.537 0.653 0 C-N-CA 122.506 2.137 . . . . 0.0 112.277 -171.807 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -55.75 -29.1 59.02 Favored 'General case' 0 N--CA 1.476 0.83 0 CA-C-N 113.278 -1.783 . . . . 0.0 114.137 173.141 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -49.03 -33.55 11.52 Favored 'General case' 0 N--CA 1.48 1.033 0 N-CA-C 114.853 1.427 . . . . 0.0 114.853 172.941 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.763 HG12 HG22 ' A' ' 31' ' ' ILE . 30.2 m -112.15 -35.45 2.43 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.016 0 N-CA-C 113.789 1.033 . . . . 0.0 113.789 179.895 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.413 ' O ' ' HG ' ' A' ' 16' ' ' LEU . . . -64.57 -40.21 95.14 Favored 'General case' 0 N--CA 1.476 0.852 0 N-CA-C 113.651 0.982 . . . . 0.0 113.651 174.802 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -61.72 -40.67 99.09 Favored Glycine 0 CA--C 1.548 2.104 0 C-N-CA 124.172 0.891 . . . . 0.0 112.276 174.542 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.528 HG22 HD12 ' A' ' 28' ' ' ILE . 4.3 m -66.81 -40.99 88.25 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 125.139 1.376 . . . . 0.0 113.46 177.324 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.479 HG21 ' HE1' ' A' ' 1' ' ' MET . 54.4 t -52.54 -46.96 49.05 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.207 0 C-N-CA 123.126 0.57 . . . . 0.0 111.249 169.056 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.666 HD11 HG12 ' A' ' 68' ' ' ILE . 23.8 mt -57.28 -48.19 79.54 Favored 'General case' 0 N--CA 1.482 1.174 0 O-C-N 123.839 0.712 . . . . 0.0 112.904 179.205 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 11.8 t-20 -54.44 -44.68 72.67 Favored 'General case' 0 CA--C 1.542 0.665 0 CA-C-N 114.857 -1.065 . . . . 0.0 111.338 179.168 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.932 HG21 HD11 ' A' ' 28' ' ' ILE . 2.8 t -68.68 -40.96 82.35 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.762 0 CA-C-N 113.475 -1.693 . . . . 0.0 114.087 179.336 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.656 HG13 ' HA ' ' A' ' 56' ' ' LYS . 40.5 t -59.01 -52.48 60.16 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.357 0 O-C-N 124.392 1.058 . . . . 0.0 109.265 175.73 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 20' ' ' GLU . . . . . 0.542 ' HG3' ' HE2' ' A' ' 64' ' ' LYS . 36.0 mt-10 -55.01 -53.54 54.46 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 125.232 1.413 . . . . 0.0 113.35 178.099 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -77.24 -11.66 59.85 Favored 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 115.683 1.735 . . . . 0.0 115.683 -175.379 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 67.66 47.93 59.01 Favored Glycine 0 N--CA 1.478 1.472 0 C-N-CA 124.523 1.059 . . . . 0.0 111.424 -172.44 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -94.13 -160.1 34.44 Favored Glycine 0 N--CA 1.475 1.248 0 CA-C-O 123.163 1.424 . . . . 0.0 113.293 -173.958 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 9.1 m-90 -102.89 105.69 16.1 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-O 122.651 1.215 . . . . 0.0 113.305 179.16 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.48 HG23 ' HE3' ' A' ' 56' ' ' LYS . 77.4 t -55.67 -27.23 21.36 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.045 0 CA-C-N 114.057 -1.429 . . . . 0.0 112.899 168.338 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 3.1 t -60.28 -38.32 83.19 Favored 'General case' 0 N--CA 1.485 1.286 0 N-CA-C 113.349 0.87 . . . . 0.0 113.349 179.143 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 2.7 m -64.07 -41.03 97.49 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 125.09 1.356 . . . . 0.0 110.684 175.013 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.932 HD11 HG21 ' A' ' 18' ' ' VAL . 1.6 mm -73.65 -39.85 53.87 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.277 0 CA-C-N 115.508 -0.769 . . . . 0.0 111.411 -178.79 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 25.6 t -46.09 -44.77 5.5 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 C-N-CA 124.113 0.965 . . . . 0.0 111.639 175.589 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 20.0 m -57.1 -41.31 78.68 Favored 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 124.966 1.307 . . . . 0.0 114.472 174.287 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.763 HG22 HG12 ' A' ' 11' ' ' VAL . 16.4 mm -75.09 -37.62 40.79 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.272 0 C-N-CA 124.483 1.113 . . . . 0.0 110.196 -178.957 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.535 ' HB3' ' HA3' ' A' ' 39' ' ' GLY . 4.2 mm? -55.37 -41.17 72.23 Favored 'General case' 0 N--CA 1.49 1.573 0 C-N-CA 124.342 1.057 . . . . 0.0 110.926 168.805 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.597 HG23 ' HA2' ' A' ' 38' ' ' GLY . 25.5 m -68.53 -38.83 81.2 Favored 'General case' 0 N--CA 1.485 1.317 0 N-CA-C 114.232 1.197 . . . . 0.0 114.232 174.961 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -55.68 -30.12 60.53 Favored 'General case' 0 N--CA 1.481 1.115 0 O-C-N 124.7 1.25 . . . . 0.0 113.242 175.131 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.427 ' HB ' ' O ' ' A' ' 32' ' ' LEU . 54.5 t -57.32 -33.15 42.94 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.034 0 C-N-CA 125.838 1.655 . . . . 0.0 113.423 172.916 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 36' ' ' GLY . . . . . 0.452 ' C ' ' H ' ' A' ' 38' ' ' GLY . . . 111.78 169.5 18.48 Favored Glycine 0 CA--C 1.537 1.407 0 N-CA-C 107.633 -2.187 . . . . 0.0 107.633 -167.788 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 37' ' ' SER . . . . . 0.546 ' OG ' ' HB2' ' A' ' 40' ' ' LEU . 9.6 t 70.37 -39.47 0.44 Allowed 'General case' 0 N--CA 1.493 1.7 0 C-N-CA 126.039 1.735 . . . . 0.0 113.185 -173.763 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.597 ' HA2' HG23 ' A' ' 33' ' ' THR . . . 113.31 9.99 16.38 Favored Glycine 0 CA--C 1.537 1.455 0 C-N-CA 126.236 1.874 . . . . 0.0 112.133 -169.251 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.535 ' HA3' ' HB3' ' A' ' 32' ' ' LEU . . . 59.05 23.7 57.5 Favored Glycine 0 CA--C 1.546 1.977 0 C-N-CA 123.696 0.665 . . . . 0.0 111.899 -159.512 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.546 ' HB2' ' OG ' ' A' ' 37' ' ' SER . 9.4 mt -51.91 -40.03 60.07 Favored 'General case' 0 N--CA 1.485 1.303 0 N-CA-C 116.631 2.086 . . . . 0.0 116.631 -168.52 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 41' ' ' SER . . . . . 0.541 ' HB2' ' HD1' ' A' ' 5' ' ' PHE . 7.9 p -59.8 -49.04 79.26 Favored 'General case' 0 CA--C 1.546 0.792 0 N-CA-C 113.448 0.907 . . . . 0.0 113.448 178.792 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 15.8 tp -61.16 -47.36 86.56 Favored 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 122.968 0.507 . . . . 0.0 110.43 172.684 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 43.9 mt -66.19 -26.64 67.5 Favored 'General case' 0 N--CA 1.476 0.863 0 CA-C-N 114.605 -1.179 . . . . 0.0 114.062 -175.215 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -69.75 -45.16 68.71 Favored 'General case' 0 N--CA 1.475 0.823 0 CA-C-N 115.694 -0.685 . . . . 0.0 111.82 171.57 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -63.54 -35.81 81.7 Favored 'General case' 0 N--CA 1.479 0.976 0 CA-C-O 121.005 0.431 . . . . 0.0 111.875 173.845 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -66.13 -28.59 68.91 Favored 'General case' 0 N--CA 1.474 0.774 0 N-CA-C 116.193 1.923 . . . . 0.0 116.193 179.654 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -53.14 -35.05 48.37 Favored Glycine 0 N--CA 1.482 1.717 0 C-N-CA 124.818 1.199 . . . . 0.0 113.39 -178.433 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 42.2 ttp180 -57.24 -41.92 80.48 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 126.233 1.813 . . . . 0.0 113.929 -176.177 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -138.57 57.43 1.69 Allowed 'General case' 0 N--CA 1.476 0.839 0 CA-C-O 121.887 0.851 . . . . 0.0 110.149 178.197 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 9.0 t 30.33 114.32 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.225 0 N-CA-C 116.84 2.163 . . . . 0.0 116.84 -178.868 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 7.0 tp -26.99 -54.04 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.349 0 N-CA-C 118.023 2.601 . . . . 0.0 118.023 -177.273 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.449 ' HD2' ' HB ' ' A' ' 25' ' ' VAL . 24.1 tptp -57.65 -58.15 9.57 Favored 'General case' 0 N--CA 1.481 1.108 0 C-N-CA 124.494 1.118 . . . . 0.0 111.913 -177.762 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -72.01 -35.21 69.37 Favored 'General case' 0 N--CA 1.484 1.237 0 O-C-N 124.579 1.174 . . . . 0.0 113.831 177.847 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 67.8 t80 -45.78 -60.96 1.93 Allowed 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 125.445 1.498 . . . . 0.0 112.117 -179.695 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 59.4 mt -65.86 -36.14 82.61 Favored 'General case' 0 N--CA 1.475 0.811 0 N-CA-C 114.782 1.401 . . . . 0.0 114.782 -175.24 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.656 ' HA ' HG13 ' A' ' 19' ' ' VAL . 35.5 mmtp -57.67 -56.2 25.02 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-N 114.211 -1.359 . . . . 0.0 112.311 177.386 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.445 ' HE3' ' HE3' ' A' ' 61' ' ' LYS . 64.0 tttp -69.51 -51.15 38.4 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-N 115.054 -0.975 . . . . 0.0 111.968 175.673 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 58' ' ' GLU . . . . . 0.553 ' O ' ' HB2' ' A' ' 62' ' ' LYS . 3.6 mm-40 -54.93 -50.75 68.08 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-O 118.281 -0.866 . . . . 0.0 112.682 -173.377 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.606 HG23 HG21 ' A' ' 67' ' ' VAL . 2.7 mm -79.14 -25.68 12.94 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.077 0 CA-C-O 118.618 -0.706 . . . . 0.0 112.007 -175.824 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.414 ' HB2' ' O ' ' A' ' 56' ' ' LYS . 8.7 tppt? -62.1 -32.42 72.98 Favored 'General case' 0 N--CA 1.473 0.698 0 N-CA-C 114.416 1.265 . . . . 0.0 114.416 171.894 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.445 ' HE3' ' HE3' ' A' ' 57' ' ' LYS . 48.4 mttm -88.56 -45.7 9.68 Favored 'General case' 0 N--CA 1.476 0.838 0 CA-C-N 113.351 -1.75 . . . . 0.0 112.42 176.127 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.553 ' HB2' ' O ' ' A' ' 58' ' ' GLU . 2.9 tttm -64.41 -45.55 87.07 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 126.448 1.899 . . . . 0.0 112.96 -172.512 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 95.45 113.66 2.75 Favored Glycine 0 N--CA 1.479 1.546 0 O-C-N 124.958 1.411 . . . . 0.0 109.65 -175.546 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.622 ' HD2' ' H ' ' A' ' 64' ' ' LYS . 10.7 mptt -44.66 -43.7 8.5 Favored 'General case' 0 N--CA 1.484 1.234 0 N-CA-C 116.801 2.148 . . . . 0.0 116.801 -172.636 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.489 ' O ' ' HB ' ' A' ' 68' ' ' ILE . 0.0 OUTLIER -56.16 -48.53 76.11 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 125.381 1.472 . . . . 0.0 114.576 178.054 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -64.71 -28.05 69.33 Favored 'General case' 0 N--CA 1.473 0.718 0 N-CA-C 114.463 1.282 . . . . 0.0 114.463 172.526 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.606 HG21 HG23 ' A' ' 59' ' ' ILE . 95.3 t -72.96 -32.82 41.25 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.944 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.321 179.098 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.666 HG12 HD11 ' A' ' 16' ' ' LEU . 4.3 mm -50.05 -49.57 21.55 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.332 0 C-N-CA 123.494 0.718 . . . . 0.0 110.098 167.132 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -64.59 -50.0 68.92 Favored 'General case' 0 N--CA 1.481 1.076 0 CA-C-N 114.917 -1.038 . . . . 0.0 112.912 178.636 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 23.2 t90 . . . . . 0 CA--C 1.544 0.728 0 C-N-CA 126.489 1.915 . . . . 0.0 112.987 179.394 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.73 ' HE1' HG21 ' A' ' 15' ' ' VAL . 74.1 mtp . . . . . 0 N--CA 1.482 1.156 0 N-CA-C 113.327 0.862 . . . . 0.0 113.327 . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -65.18 -56.12 14.68 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-N 114.915 -1.039 . . . . 0.0 112.67 175.474 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 14.4 ttmm -71.09 -52.96 16.4 Favored 'General case' 0 CA--C 1.549 0.935 0 CA-C-N 114.361 -1.291 . . . . 0.0 114.118 -172.967 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' GLU . . . . . 0.434 ' HB2' ' O ' ' A' ' 70' ' ' TRP . 1.8 mp0 -79.77 -38.45 33.15 Favored 'General case' 0 N--CA 1.476 0.829 0 N-CA-C 115.052 1.501 . . . . 0.0 115.052 -174.559 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 5' ' ' PHE . . . . . 0.509 ' HD2' ' HA ' ' A' ' 1' ' ' MET . 73.9 m-85 -106.28 -9.72 16.71 Favored 'General case' 0 N--CA 1.484 1.253 0 N-CA-C 117.041 2.237 . . . . 0.0 117.041 -172.236 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 66.73 36.92 91.94 Favored Glycine 0 CA--C 1.54 1.632 0 CA-C-O 121.971 0.762 . . . . 0.0 112.917 -176.055 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.669 HG23 HG23 ' A' ' 11' ' ' VAL . 0.6 OUTLIER -116.12 112.87 41.81 Favored Pre-proline 0 N--CA 1.472 0.657 0 C-N-CA 124.327 1.051 . . . . 0.0 109.413 179.106 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_endo -63.86 164.05 23.02 Favored 'Trans proline' 0 N--CA 1.48 0.68 0 C-N-CA 121.184 1.256 . . . . 0.0 111.597 -174.471 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -55.76 -28.42 55.85 Favored 'General case' 0 N--CA 1.479 0.989 0 N-CA-C 114.674 1.361 . . . . 0.0 114.674 176.75 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -45.51 -43.98 12.21 Favored 'General case' 0 CA--C 1.549 0.917 0 C-N-CA 125.985 1.714 . . . . 0.0 113.753 174.628 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.952 HG12 HG22 ' A' ' 31' ' ' ILE . 33.6 m -100.24 -28.92 3.28 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.054 0 N-CA-C 114.766 1.395 . . . . 0.0 114.766 179.248 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -67.6 -34.97 78.07 Favored 'General case' 0 N--CA 1.477 0.895 0 N-CA-C 113.791 1.034 . . . . 0.0 113.791 176.76 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -61.47 -41.34 99.53 Favored Glycine 0 N--CA 1.478 1.44 0 CA-C-O 122.467 1.037 . . . . 0.0 112.304 172.357 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 3.1 m -64.1 -34.05 77.15 Favored 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 126.046 1.738 . . . . 0.0 112.893 175.524 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.73 HG21 ' HE1' ' A' ' 1' ' ' MET . 20.5 t -63.5 -36.64 77.06 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.065 0 C-N-CA 123.667 0.787 . . . . 0.0 112.083 172.039 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.631 HD13 ' HB3' ' A' ' 64' ' ' LYS . 31.6 mt -65.43 -40.36 93.21 Favored 'General case' 0 N--CA 1.485 1.305 0 N-CA-C 112.913 0.708 . . . . 0.0 112.913 174.234 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 74.1 m-20 -57.62 -43.99 85.18 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 124.976 1.31 . . . . 0.0 112.448 174.384 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.412 ' HB ' ' O ' ' A' ' 15' ' ' VAL . 4.1 t -48.11 -57.64 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.35 0 C-N-CA 123.835 0.854 . . . . 0.0 111.373 168.391 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.595 HG13 ' HA ' ' A' ' 56' ' ' LYS . 4.8 t -60.66 -44.78 97.76 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 123.935 0.772 . . . . 0.0 111.913 -176.16 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 27.6 mt-10 -63.93 -43.74 94.97 Favored 'General case' 0 N--CA 1.472 0.634 0 N-CA-C 115.301 1.593 . . . . 0.0 115.301 179.506 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -97.04 -11.51 24.39 Favored 'General case' 0 N--CA 1.478 0.934 0 N-CA-C 116.221 1.934 . . . . 0.0 116.221 -170.917 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 73.49 25.28 72.98 Favored Glycine 0 CA--C 1.544 1.866 0 O-C-N 123.521 0.513 . . . . 0.0 112.736 -169.002 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -78.76 149.94 33.8 Favored Glycine 0 N--CA 1.476 1.362 0 CA-C-O 122.419 1.01 . . . . 0.0 113.689 -171.054 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' TRP . . . . . 0.492 ' HB3' HG22 ' A' ' 26' ' ' THR . 2.9 m-90 -62.1 98.08 0.1 Allowed 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 125.31 1.444 . . . . 0.0 112.327 178.402 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 5.0 p -51.87 -27.84 9.19 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.868 0 CA-C-N 113.734 -1.575 . . . . 0.0 113.985 173.187 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.492 HG22 ' HB3' ' A' ' 24' ' ' TRP . 13.9 t -59.52 -40.72 88.05 Favored 'General case' 0 CA--C 1.546 0.827 0 C-N-CA 124.735 1.214 . . . . 0.0 112.937 -178.055 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -67.66 -47.07 70.57 Favored 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 124.101 0.96 . . . . 0.0 110.604 174.964 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 2.3 mp -60.21 -35.4 61.72 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.036 0 C-N-CA 125.259 1.424 . . . . 0.0 112.99 177.179 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.411 ' O ' ' HB2' ' A' ' 32' ' ' LEU . 15.9 t -48.97 -40.62 12.78 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.365 0 C-N-CA 124.403 1.081 . . . . 0.0 112.38 173.845 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 59.7 p -61.03 -30.3 70.22 Favored 'General case' 0 N--CA 1.477 0.888 0 N-CA-C 114.02 1.118 . . . . 0.0 114.02 176.255 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.952 HG22 HG12 ' A' ' 11' ' ' VAL . 42.6 mm -77.33 -36.47 23.96 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.989 0 C-N-CA 124.07 0.948 . . . . 0.0 109.191 179.965 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.561 ' HB3' ' HA3' ' A' ' 39' ' ' GLY . 3.9 mm? -60.13 -36.42 77.45 Favored 'General case' 0 N--CA 1.49 1.554 0 C-N-CA 123.741 0.817 . . . . 0.0 111.315 169.414 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.774 HG23 ' HA2' ' A' ' 38' ' ' GLY . 2.5 m -72.55 -34.31 67.42 Favored 'General case' 0 N--CA 1.483 1.176 0 N-CA-C 114.698 1.37 . . . . 0.0 114.698 175.403 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -54.49 -29.02 48.77 Favored 'General case' 0 N--CA 1.482 1.16 0 O-C-N 124.245 0.965 . . . . 0.0 113.459 174.317 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 70.5 t -56.65 -34.06 41.53 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.255 0 C-N-CA 126.313 1.845 . . . . 0.0 113.03 172.031 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 116.82 -51.24 0.74 Allowed Glycine 0 N--CA 1.482 1.757 0 O-C-N 123.221 0.326 . . . . 0.0 112.941 -178.392 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 62.8 p -62.04 5.74 0.09 Allowed 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 116.148 1.907 . . . . 0.0 116.148 173.883 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.774 ' HA2' HG23 ' A' ' 33' ' ' THR . . . 66.22 0.98 8.47 Favored Glycine 0 N--CA 1.483 1.806 0 C-N-CA 124.473 1.035 . . . . 0.0 115.511 -179.803 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.561 ' HA3' ' HB3' ' A' ' 32' ' ' LEU . . . 60.88 18.31 53.32 Favored Glycine 0 CA--C 1.543 1.815 0 C-N-CA 124.897 1.237 . . . . 0.0 113.404 -159.892 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 14.3 mt -53.23 -41.74 65.7 Favored 'General case' 0 N--CA 1.48 1.059 0 N-CA-C 116.459 2.022 . . . . 0.0 116.459 -171.127 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' SER . . . . . 0.469 ' HB2' ' HD1' ' A' ' 5' ' ' PHE . 11.5 p -59.47 -51.62 69.1 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 125.327 1.451 . . . . 0.0 113.86 175.26 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 14.5 tp -60.74 -43.48 97.87 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 123.676 0.79 . . . . 0.0 110.31 174.157 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 82.7 mt -65.68 -27.37 68.3 Favored 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 114.618 1.34 . . . . 0.0 114.618 -178.23 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -70.33 -48.26 57.32 Favored 'General case' 0 N--CA 1.478 0.953 0 CA-C-N 115.43 -0.805 . . . . 0.0 112.323 169.91 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -59.19 -37.16 76.74 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 123.446 0.699 . . . . 0.0 112.697 176.292 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -57.87 -28.95 64.62 Favored 'General case' 0 C--N 1.321 -0.63 0 C-N-CA 126.546 1.938 . . . . 0.0 115.642 177.76 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -47.81 -41.78 20.67 Favored Glycine 0 CA--C 1.536 1.371 0 C-N-CA 125.438 1.494 . . . . 0.0 114.608 -174.514 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 41.0 ttp-105 -53.81 -47.02 71.27 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 126.0 1.72 . . . . 0.0 113.81 -174.797 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 5.0 tt0 -127.14 31.01 5.32 Favored 'General case' 0 CA--C 1.547 0.854 0 N-CA-C 113.787 1.032 . . . . 0.0 113.787 -177.553 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 24.5 t 45.85 126.8 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 125.353 1.461 . . . . 0.0 113.809 -171.545 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 9.8 tp -37.44 -42.25 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 N-CA-C 117.239 2.311 . . . . 0.0 117.239 -173.437 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 8.4 mmtt -57.41 -72.05 0.09 Allowed 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 124.31 1.044 . . . . 0.0 112.05 174.393 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -62.49 -34.8 77.57 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 125.196 1.398 . . . . 0.0 113.853 -177.842 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 87.6 t80 -48.62 -59.45 3.51 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 125.497 1.519 . . . . 0.0 111.646 175.715 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.513 HD13 HG13 ' A' ' 15' ' ' VAL . 75.0 mt -67.86 -41.67 82.54 Favored 'General case' 0 N--CA 1.482 1.149 0 N-CA-C 114.448 1.277 . . . . 0.0 114.448 -177.873 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.595 ' HA ' HG13 ' A' ' 19' ' ' VAL . 33.2 mmtp -55.98 -42.16 75.92 Favored 'General case' 0 N--CA 1.479 0.993 0 CA-C-N 113.253 -1.794 . . . . 0.0 114.507 178.963 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 59.3 tttm -80.35 -54.97 5.23 Favored 'General case' 0 N--CA 1.473 0.715 0 O-C-N 124.843 1.34 . . . . 0.0 112.327 172.559 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 72.9 tt0 -58.68 -46.02 88.16 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-O 117.766 -1.111 . . . . 0.0 112.489 -168.694 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.676 HG23 HG21 ' A' ' 67' ' ' VAL . 3.7 mm -79.36 -20.02 12.59 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.895 0 C-N-CA 119.911 -0.716 . . . . 0.0 112.081 -173.814 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 22.9 tttp -72.55 -24.91 61.19 Favored 'General case' 0 CA--C 1.547 0.851 0 O-C-N 124.713 1.258 . . . . 0.0 114.147 172.638 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 45.3 mmtm -97.25 -38.8 9.54 Favored 'General case' 0 N--CA 1.477 0.886 0 CA-C-N 113.549 -1.66 . . . . 0.0 111.58 178.455 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.439 ' HD3' HG22 ' A' ' 67' ' ' VAL . 31.6 tttp -71.54 -52.65 17.1 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 126.282 1.833 . . . . 0.0 114.514 -177.938 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 102.17 114.62 3.88 Favored Glycine 0 N--CA 1.483 1.79 0 O-C-N 124.361 1.038 . . . . 0.0 111.022 -173.289 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.659 ' HD2' ' H ' ' A' ' 64' ' ' LYS . 9.0 mptt -41.44 -44.37 2.86 Favored 'General case' 0 N--CA 1.486 1.354 0 N-CA-C 117.548 2.425 . . . . 0.0 117.548 -176.043 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . 0.373 0.0 OUTLIER -53.08 -51.76 60.78 Favored 'General case' 0 C--N 1.315 -0.912 0 C-N-CA 127.801 2.44 . . . . 0.0 114.124 177.216 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -65.71 -27.62 68.47 Favored 'General case' 0 N--CA 1.475 0.788 0 N-CA-C 114.111 1.152 . . . . 0.0 114.111 173.436 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.676 HG21 HG23 ' A' ' 59' ' ' ILE . 21.7 t -71.08 -36.16 61.88 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.966 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.502 179.876 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.402 HG12 HD11 ' A' ' 16' ' ' LEU . 14.2 mm -49.01 -44.61 15.99 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.847 0 C-N-CA 124.243 1.017 . . . . 0.0 110.939 167.696 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -70.77 -51.76 25.01 Favored 'General case' 0 N--CA 1.477 0.877 0 CA-C-N 115.004 -0.998 . . . . 0.0 112.331 179.088 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' TRP . . . . . 0.434 ' O ' ' HB2' ' A' ' 4' ' ' GLU . 36.2 t90 . . . . . 0 CA--C 1.553 1.073 0 C-N-CA 125.303 1.441 . . . . 0.0 113.352 -177.277 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.418 ' HE1' HG21 ' A' ' 15' ' ' VAL . 34.3 mtp . . . . . 0 CA--C 1.533 0.294 0 CA-C-O 119.718 -0.182 . . . . 0.0 110.738 . . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 2' ' ' ALA . . . . . 0.412 ' HA ' ' O ' ' A' ' 7' ' ' ILE . . . -60.29 -50.39 73.84 Favored 'General case' 0 N--CA 1.478 0.966 0 CA-C-N 114.374 -1.285 . . . . 0.0 112.863 178.844 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 10.5 tptm -71.73 -58.92 3.05 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 113.543 -1.662 . . . . 0.0 114.55 -175.716 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -67.95 -43.58 78.77 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 116.263 1.949 . . . . 0.0 116.263 -170.209 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 5' ' ' PHE . . . . . 0.496 ' HB2' HD12 ' A' ' 7' ' ' ILE . 33.7 m-85 -102.0 -26.09 13.52 Favored 'General case' 0 N--CA 1.481 1.113 0 N-CA-C 116.665 2.098 . . . . 0.0 116.665 -170.408 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 92.47 58.64 1.34 Allowed Glycine 0 N--CA 1.477 1.384 0 O-C-N 124.931 1.394 . . . . 0.0 110.537 -174.975 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.496 HD12 ' HB2' ' A' ' 5' ' ' PHE . 0.7 OUTLIER -120.47 140.48 30.38 Favored Pre-proline 0 N--CA 1.476 0.831 0 CA-C-N 114.365 -0.918 . . . . 0.0 110.309 -179.12 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 68.3 Cg_endo -89.47 152.71 5.36 Favored 'Trans proline' 0 CA--C 1.534 0.495 0 C-N-CA 121.27 1.313 . . . . 0.0 109.069 166.828 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -44.65 -34.37 2.17 Favored 'General case' 0 N--CA 1.47 0.532 0 N-CA-C 116.108 1.892 . . . . 0.0 116.108 177.03 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -36.2 -43.29 0.35 Allowed 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 125.984 1.714 . . . . 0.0 115.108 168.687 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.921 HG12 HG22 ' A' ' 31' ' ' ILE . 10.4 m -103.66 -37.28 4.49 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.1 0 N-CA-C 115.192 1.553 . . . . 0.0 115.192 -177.442 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.489 ' O ' ' HG ' ' A' ' 16' ' ' LEU . . . -64.76 -36.28 83.8 Favored 'General case' 0 N--CA 1.482 1.15 0 N-CA-C 113.145 0.795 . . . . 0.0 113.145 177.758 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -64.12 -40.87 98.49 Favored Glycine 0 N--CA 1.479 1.567 0 C-N-CA 125.777 1.656 . . . . 0.0 112.35 176.13 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 2.1 m -63.98 -41.86 97.39 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 124.54 1.136 . . . . 0.0 112.404 174.308 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.663 HG13 HD13 ' A' ' 55' ' ' LEU . 32.1 t -53.75 -40.91 45.34 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.934 0 CA-C-O 121.174 0.512 . . . . 0.0 112.2 170.188 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.597 HD11 HG12 ' A' ' 68' ' ' ILE . 45.7 mt -64.99 -49.88 68.53 Favored 'General case' 0 N--CA 1.477 0.898 0 CA-C-N 115.699 -0.682 . . . . 0.0 112.725 178.825 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 1.7 t30 -42.8 -45.2 4.75 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-O 123.167 1.461 . . . . 0.0 113.839 172.657 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.739 HG13 ' O ' ' A' ' 23' ' ' GLY . 5.3 t -63.27 -50.99 76.72 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.746 0 CA-C-N 109.976 -3.284 . . . . 0.0 112.29 178.793 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.746 HG13 ' HA ' ' A' ' 56' ' ' LYS . 36.0 t -59.91 -46.39 93.98 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.889 0 O-C-N 124.77 1.294 . . . . 0.0 110.691 179.419 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -63.58 -39.82 95.37 Favored 'General case' 0 N--CA 1.466 0.369 0 N-CA-C 114.342 1.238 . . . . 0.0 114.342 -177.51 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -96.39 2.53 52.74 Favored 'General case' 0 N--CA 1.478 0.963 0 N-CA-C 115.616 1.71 . . . . 0.0 115.616 -177.593 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 56.97 47.08 89.95 Favored Glycine 0 CA--C 1.541 1.702 0 C-N-CA 123.644 0.64 . . . . 0.0 111.572 -174.39 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.739 ' O ' HG13 ' A' ' 18' ' ' VAL . . . -102.97 154.49 18.22 Favored Glycine 0 N--CA 1.476 1.313 0 CA-C-O 123.944 1.858 . . . . 0.0 112.594 -174.576 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 4.5 m-90 -73.43 101.11 3.4 Favored 'General case' 0 N--CA 1.473 0.689 0 CA-C-N 112.961 -1.619 . . . . 0.0 112.807 -175.69 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.682 ' HB ' HG11 ' A' ' 18' ' ' VAL . 7.6 p -62.37 -20.46 24.66 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 N-CA-C 114.171 1.174 . . . . 0.0 114.171 173.3 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 6.4 t -61.02 -28.62 69.18 Favored 'General case' 0 N--CA 1.481 1.09 0 N-CA-C 112.952 0.723 . . . . 0.0 112.952 178.942 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -74.91 -43.61 53.3 Favored 'General case' 0 N--CA 1.474 0.73 0 CA-C-O 119.625 -0.226 . . . . 0.0 111.118 174.669 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 3.2 mp -64.12 -30.93 51.4 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.053 0 C-N-CA 127.67 2.388 . . . . 0.0 112.853 178.15 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.578 HG13 HD11 ' A' ' 43' ' ' LEU . 31.2 t -44.96 -37.47 1.63 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.14 0 C-N-CA 124.616 1.166 . . . . 0.0 112.702 172.542 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 91.5 p -60.4 -35.39 75.65 Favored 'General case' 0 N--CA 1.476 0.873 0 N-CA-C 113.217 0.821 . . . . 0.0 113.217 176.415 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.921 HG22 HG12 ' A' ' 11' ' ' VAL . 33.8 mm -77.87 -34.08 19.28 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.775 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.304 -179.781 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.591 HD22 ' HB ' ' A' ' 11' ' ' VAL . 4.1 mm? -60.92 -50.03 75.08 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 124.127 0.971 . . . . 0.0 112.159 172.105 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -69.84 -26.14 64.08 Favored 'General case' 0 N--CA 1.482 1.132 0 N-CA-C 114.925 1.454 . . . . 0.0 114.925 -179.87 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -51.56 -38.38 54.09 Favored 'General case' 0 CA--C 1.545 0.758 0 O-C-N 124.139 0.899 . . . . 0.0 112.508 169.736 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 22.8 t -63.89 -32.4 56.95 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.081 0 C-N-CA 125.346 1.458 . . . . 0.0 111.607 174.852 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 105.56 -106.19 2.59 Favored Glycine 0 N--CA 1.476 1.34 0 N-CA-C 110.0 -1.24 . . . . 0.0 110.0 178.36 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 2.8 p -58.4 -45.86 87.55 Favored 'General case' 0 N--CA 1.474 0.761 0 CA-C-N 113.871 -1.165 . . . . 0.0 112.826 -174.615 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -49.98 -54.05 20.13 Favored Glycine 0 N--CA 1.476 1.357 0 O-C-N 125.547 1.779 . . . . 0.0 113.449 179.2 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.471 ' HA2' ' HB3' ' A' ' 32' ' ' LEU . . . -56.1 -51.84 53.13 Favored Glycine 0 CA--C 1.535 1.302 0 O-C-N 125.262 1.213 . . . . 0.0 110.788 177.836 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 66.4 mt -60.32 -52.41 65.38 Favored 'General case' 0 N--CA 1.47 0.565 0 N-CA-C 116.388 1.996 . . . . 0.0 116.388 -179.675 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 23.4 p -62.78 -35.15 78.91 Favored 'General case' 0 N--CA 1.479 0.997 0 CA-C-O 118.092 -0.956 . . . . 0.0 113.16 177.939 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 13.4 tp -61.05 -50.62 72.59 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 123.007 0.523 . . . . 0.0 111.12 170.56 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.578 HD11 HG13 ' A' ' 29' ' ' VAL . 59.1 mt -61.92 -34.45 76.08 Favored 'General case' 0 N--CA 1.479 0.985 0 O-C-N 124.222 0.951 . . . . 0.0 113.439 -179.532 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -63.24 -46.03 88.8 Favored 'General case' 0 N--CA 1.473 0.692 0 N-CA-C 112.995 0.739 . . . . 0.0 112.995 172.895 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -65.07 -35.72 82.06 Favored 'General case' 0 N--CA 1.487 1.388 0 CA-C-N 115.268 -0.878 . . . . 0.0 112.483 175.437 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -60.81 -28.31 68.69 Favored 'General case' 0 N--CA 1.475 0.779 0 N-CA-C 115.122 1.527 . . . . 0.0 115.122 179.837 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -44.85 -35.53 4.45 Favored Glycine 0 N--CA 1.48 1.601 0 C-N-CA 126.679 2.085 . . . . 0.0 114.193 -175.789 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' ARG . . . . . 0.517 ' HE ' ' HE1' ' A' ' 54' ' ' TYR . 63.3 ttp85 -51.61 -54.99 21.85 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-N 112.875 -1.663 . . . . 0.0 112.732 -176.692 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 25.4 tt0 -127.71 36.73 4.31 Favored 'General case' 0 N--CA 1.473 0.71 0 N-CA-C 114.154 1.168 . . . . 0.0 114.154 -173.14 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 75.8 p 50.4 121.69 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 125.221 1.408 . . . . 0.0 111.974 -171.387 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.473 ' O ' ' HB3' ' A' ' 54' ' ' TYR 0.276 6.3 tp -31.35 -53.86 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.483 1.223 0 N-CA-C 117.16 2.282 . . . . 0.0 117.16 -173.438 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.622 ' HG3' HG12 ' A' ' 25' ' ' VAL . 0.1 OUTLIER -59.11 -66.97 0.42 Allowed 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 115.561 1.689 . . . . 0.0 115.561 175.402 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -54.99 -34.17 63.15 Favored 'General case' 0 N--CA 1.475 0.788 0 O-C-N 124.776 1.298 . . . . 0.0 113.252 177.601 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' TYR . . . . . 0.517 ' HE1' ' HE ' ' A' ' 48' ' ' ARG . 87.5 t80 -54.36 -63.34 1.18 Allowed 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 126.141 1.776 . . . . 0.0 110.541 174.981 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.663 HD13 HG13 ' A' ' 15' ' ' VAL . 96.4 mt -66.98 -42.2 85.48 Favored 'General case' 0 N--CA 1.476 0.843 0 N-CA-C 115.379 1.622 . . . . 0.0 115.379 -177.453 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.746 ' HA ' HG13 ' A' ' 19' ' ' VAL . 96.4 mttt -56.52 -43.21 79.58 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 113.109 -1.859 . . . . 0.0 114.092 178.522 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.409 ' O ' ' HG3' ' A' ' 61' ' ' LYS . 15.6 tttt -82.64 -50.07 9.15 Favored 'General case' 0 C--N 1.318 -0.776 0 O-C-N 124.158 0.911 . . . . 0.0 112.997 174.306 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 58' ' ' GLU . . . . . 0.461 ' O ' ' HB2' ' A' ' 62' ' ' LYS . 31.1 tt0 -57.72 -47.49 82.26 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 118.2 -0.905 . . . . 0.0 112.397 -175.95 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.606 HG23 HG21 ' A' ' 67' ' ' VAL . 1.8 mm -75.84 -23.32 16.29 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.26 0 N-CA-C 112.266 0.469 . . . . 0.0 112.266 -175.49 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.441 ' HB2' ' O ' ' A' ' 56' ' ' LYS . 32.2 tptt -64.01 -38.55 91.5 Favored 'General case' 0 CA--C 1.544 0.717 0 O-C-N 124.695 1.247 . . . . 0.0 112.284 170.354 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.409 ' HG3' ' O ' ' A' ' 57' ' ' LYS . 26.5 mtpt -77.3 -45.44 26.25 Favored 'General case' 0 N--CA 1.481 1.108 0 CA-C-N 112.925 -1.943 . . . . 0.0 113.05 177.139 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.461 ' HB2' ' O ' ' A' ' 58' ' ' GLU . 10.4 tttm -70.25 -47.32 61.84 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 126.699 1.999 . . . . 0.0 113.352 -172.468 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 96.05 99.58 1.85 Allowed Glycine 0 N--CA 1.467 0.708 0 CA-C-N 114.46 -1.245 . . . . 0.0 110.658 179.067 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.748 ' HD2' ' H ' ' A' ' 64' ' ' LYS . 10.8 mptt -22.42 -47.6 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.838 0 N-CA-C 119.673 3.212 . . . . 0.0 119.673 -175.673 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.43 ' O ' ' HB ' ' A' ' 68' ' ' ILE . 0.1 OUTLIER -56.02 -49.5 73.5 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 124.687 1.195 . . . . 0.0 113.08 177.386 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -62.23 -26.12 68.2 Favored 'General case' 0 N--CA 1.471 0.61 0 N-CA-C 114.536 1.31 . . . . 0.0 114.536 174.514 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.606 HG21 HG23 ' A' ' 59' ' ' ILE . 99.1 t -72.97 -34.68 46.74 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.638 0 C-N-CA 123.094 0.558 . . . . 0.0 111.094 177.001 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.597 HG12 HD11 ' A' ' 16' ' ' LEU . 5.2 mm -51.06 -45.85 30.34 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.117 0 O-C-N 123.904 0.752 . . . . 0.0 110.468 169.689 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -64.83 -52.58 55.92 Favored 'General case' 0 CA--C 1.549 0.937 0 CA-C-N 114.368 -1.287 . . . . 0.0 113.033 175.906 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 35.3 t90 . . . . . 0 N--CA 1.484 1.228 0 C-N-CA 125.582 1.553 . . . . 0.0 115.007 -178.983 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.461 ' HE1' HD11 ' A' ' 32' ' ' LEU . 33.3 mtp . . . . . 0 N--CA 1.48 1.06 0 N-CA-C 111.988 0.366 . . . . 0.0 111.988 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . 0.451 ' HA ' ' O ' ' A' ' 7' ' ' ILE . . . -55.19 -50.75 68.57 Favored 'General case' 0 CA--C 1.543 0.68 0 O-C-N 124.475 1.109 . . . . 0.0 112.511 178.343 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 54.7 tttp -73.25 -59.95 2.47 Favored 'General case' 0 CA--C 1.543 0.7 0 CA-C-N 112.695 -2.048 . . . . 0.0 114.097 -176.717 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 14.0 tt0 -67.93 -42.54 80.85 Favored 'General case' 0 N--CA 1.481 1.075 0 N-CA-C 115.009 1.485 . . . . 0.0 115.009 -168.831 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . 0.409 ' HB2' HD12 ' A' ' 7' ' ' ILE . 70.4 m-85 -100.32 -18.71 16.67 Favored 'General case' 0 N--CA 1.468 0.467 0 N-CA-C 116.824 2.157 . . . . 0.0 116.824 -173.913 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 83.28 57.82 2.42 Favored Glycine 0 CA--C 1.544 1.892 0 O-C-N 124.688 1.242 . . . . 0.0 111.519 -173.652 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.451 ' O ' ' HA ' ' A' ' 2' ' ' ALA . 0.4 OUTLIER -115.67 150.17 44.31 Favored Pre-proline 0 N--CA 1.481 1.106 0 CA-C-N 113.384 -1.408 . . . . 0.0 110.638 177.888 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_endo -88.37 151.99 6.6 Favored 'Trans proline' 0 CA--C 1.53 0.312 0 N-CA-C 109.513 -0.995 . . . . 0.0 109.513 159.587 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -51.19 -26.97 7.73 Favored 'General case' 0 N--CA 1.476 0.86 0 N-CA-C 115.217 1.562 . . . . 0.0 115.217 176.156 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -41.94 -56.16 2.86 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 126.298 1.839 . . . . 0.0 112.312 169.948 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.797 HG12 HG22 ' A' ' 31' ' ' ILE . 21.3 m -88.91 -29.45 5.23 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.004 0 N-CA-C 114.371 1.249 . . . . 0.0 114.371 -173.7 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -64.92 -32.16 73.75 Favored 'General case' 0 N--CA 1.477 0.877 0 N-CA-C 112.964 0.727 . . . . 0.0 112.964 173.564 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -65.96 -40.37 95.29 Favored Glycine 0 CA--C 1.542 1.736 0 O-C-N 124.161 0.913 . . . . 0.0 112.809 173.581 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.639 HG22 HG13 ' A' ' 28' ' ' ILE . 1.0 OUTLIER -60.75 -40.6 93.07 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 123.969 0.908 . . . . 0.0 112.554 173.378 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.822 HG13 HD13 ' A' ' 55' ' ' LEU . 18.3 t -54.73 -43.34 66.05 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.086 0 C-N-CA 124.22 1.008 . . . . 0.0 112.86 168.776 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 81.5 mt -60.28 -38.72 84.46 Favored 'General case' 0 N--CA 1.481 1.096 0 N-CA-C 114.03 1.122 . . . . 0.0 114.03 177.115 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 24.7 t-20 -51.94 -48.64 64.17 Favored 'General case' 0 N--CA 1.481 1.077 0 O-C-N 124.512 1.132 . . . . 0.0 111.869 173.089 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -49.39 -49.39 18.08 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.182 0 CA-C-N 114.428 -1.26 . . . . 0.0 112.559 174.638 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.74 HG13 ' HA ' ' A' ' 56' ' ' LYS . 3.4 t -66.2 -51.27 61.16 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.975 0 O-C-N 125.071 1.482 . . . . 0.0 110.446 -177.069 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 25.3 mt-10 -60.45 -38.86 85.54 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 125.231 1.412 . . . . 0.0 114.215 -175.792 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -103.7 -16.21 15.53 Favored 'General case' 0 N--CA 1.472 0.645 0 N-CA-C 116.948 2.203 . . . . 0.0 116.948 -174.159 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 69.16 46.72 56.94 Favored Glycine 0 CA--C 1.545 1.926 0 N-CA-C 111.991 -0.443 . . . . 0.0 111.991 -169.885 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -102.71 167.82 17.82 Favored Glycine 0 CA--C 1.542 1.74 0 CA-C-N 114.036 -1.082 . . . . 0.0 114.384 -167.425 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' TRP . . . . . 0.461 ' HB3' HG22 ' A' ' 26' ' ' THR . 75.8 m95 -62.71 106.51 0.8 Allowed 'General case' 0 N--CA 1.476 0.84 0 CA-C-N 113.054 -1.573 . . . . 0.0 112.2 -178.849 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.49 HG21 HG22 ' A' ' 51' ' ' ILE . 2.6 p -57.46 -23.68 20.15 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.835 0 CA-C-N 113.624 -1.626 . . . . 0.0 113.723 168.698 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.461 HG22 ' HB3' ' A' ' 24' ' ' TRP . 1.7 t -55.4 -43.84 75.59 Favored 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 113.329 0.863 . . . . 0.0 113.329 -179.96 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . 0.439 ' O ' HG12 ' A' ' 31' ' ' ILE . 0.0 OUTLIER -65.46 -45.06 85.24 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 123.883 0.873 . . . . 0.0 112.242 174.868 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.639 HG13 HG22 ' A' ' 14' ' ' THR . 1.6 mp -59.78 -44.89 94.92 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.89 0 CA-C-N 114.598 -1.183 . . . . 0.0 111.796 177.398 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.487 HG13 HD11 ' A' ' 43' ' ' LEU . 53.2 t -53.77 -43.79 57.18 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.999 0 C-N-CA 124.126 0.97 . . . . 0.0 112.434 178.544 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 1.1 m -59.62 -43.08 93.93 Favored 'General case' 0 N--CA 1.485 1.317 0 N-CA-C 112.693 0.627 . . . . 0.0 112.693 176.078 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.797 HG22 HG12 ' A' ' 11' ' ' VAL . 35.5 mm -68.71 -38.8 79.4 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.138 0 CA-C-N 115.319 -0.855 . . . . 0.0 109.572 -176.544 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.679 HD22 ' HB ' ' A' ' 11' ' ' VAL . 3.7 mm? -63.89 -51.78 62.95 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 125.906 1.683 . . . . 0.0 112.624 176.35 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 27.7 p -70.19 -28.94 65.7 Favored 'General case' 0 N--CA 1.472 0.67 0 N-CA-C 114.28 1.215 . . . . 0.0 114.28 -179.733 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -52.57 -27.58 17.39 Favored 'General case' 0 N--CA 1.482 1.133 0 N-CA-C 113.951 1.093 . . . . 0.0 113.951 170.881 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 46.6 t . . . . . 0 N--CA 1.482 1.15 0 C-N-CA 125.433 1.493 . . . . 0.0 111.785 170.592 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . 0.458 ' O ' ' HG ' ' A' ' 43' ' ' LEU . . . . . . . . 0 CA--C 1.538 1.495 0 N-CA-C 112.271 -0.332 . . . . 0.0 112.271 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 12.2 mt -62.84 -44.16 96.89 Favored 'General case' 0 N--CA 1.478 0.93 0 CA-C-N 113.641 -1.28 . . . . 0.0 114.035 -178.065 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 28.6 p -61.53 -39.82 92.42 Favored 'General case' 0 N--CA 1.481 1.076 0 N-CA-C 113.234 0.827 . . . . 0.0 113.234 175.977 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 12.4 tp -62.21 -47.76 83.02 Favored 'General case' 0 N--CA 1.484 1.245 0 C-N-CA 122.863 0.465 . . . . 0.0 110.531 171.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.487 HD11 HG13 ' A' ' 29' ' ' VAL . 63.7 mt -60.5 -32.62 71.62 Favored 'General case' 0 N--CA 1.481 1.113 0 N-CA-C 114.86 1.43 . . . . 0.0 114.86 -179.606 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -66.53 -31.23 71.81 Favored 'General case' 0 N--CA 1.482 1.156 0 N-CA-C 113.732 1.012 . . . . 0.0 113.732 174.51 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -53.5 -48.52 68.88 Favored 'General case' 0 N--CA 1.477 0.875 0 N-CA-C 115.155 1.539 . . . . 0.0 115.155 -170.648 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -144.48 50.16 1.3 Allowed 'General case' 0 N--CA 1.482 1.129 0 CA-C-O 122.482 1.134 . . . . 0.0 113.503 174.271 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -51.37 -50.39 41.24 Favored Glycine 0 N--CA 1.487 2.076 0 CA-C-N 113.473 -1.694 . . . . 0.0 113.349 -176.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 79.4 ttt180 -58.83 -48.95 79.52 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 126.125 1.77 . . . . 0.0 113.974 -179.855 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 5.6 tm-20 -80.03 18.92 0.76 Allowed 'General case' 0 N--CA 1.476 0.838 0 N-CA-C 114.001 1.111 . . . . 0.0 114.001 -179.06 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 52.2 p 53.14 124.95 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 127.213 2.205 . . . . 0.0 111.911 -168.786 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.49 HG22 HG21 ' A' ' 25' ' ' VAL . 29.5 mm -52.44 -31.18 15.07 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.055 0 CA-C-N 115.081 -0.963 . . . . 0.0 112.816 170.419 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 71.1 tttt -57.14 -64.96 0.71 Allowed 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 124.36 1.064 . . . . 0.0 111.436 177.347 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -62.73 -35.17 78.89 Favored 'General case' 0 N--CA 1.472 0.659 0 N-CA-C 113.4 0.889 . . . . 0.0 113.4 178.694 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 15.7 t80 -51.17 -67.68 0.23 Allowed 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 124.984 1.314 . . . . 0.0 111.758 173.651 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.822 HD13 HG13 ' A' ' 15' ' ' VAL . 39.6 mt -61.97 -38.18 87.58 Favored 'General case' 0 N--CA 1.479 1.003 0 N-CA-C 113.084 0.772 . . . . 0.0 113.084 -177.115 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . 0.74 ' HA ' HG13 ' A' ' 19' ' ' VAL . 96.2 mttt -54.88 -52.3 63.27 Favored 'General case' 0 C--O 1.219 -0.502 0 CA-C-N 114.353 -1.294 . . . . 0.0 113.609 177.433 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 2.3 ttpm? -74.99 -45.22 43.52 Favored 'General case' 0 N--CA 1.476 0.828 0 CA-C-N 114.945 -1.025 . . . . 0.0 112.392 176.026 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . 0.431 ' O ' ' HB2' ' A' ' 62' ' ' LYS . 44.4 tt0 -58.67 -49.93 75.72 Favored 'General case' 0 N--CA 1.471 0.596 0 O-C-N 123.384 0.428 . . . . 0.0 111.199 -174.918 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.697 HG23 HG21 ' A' ' 67' ' ' VAL . 3.2 mm -76.33 -27.4 17.55 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.162 0 CA-C-O 118.934 -0.555 . . . . 0.0 112.258 -177.924 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.473 ' HB2' ' O ' ' A' ' 56' ' ' LYS . 19.9 ttmm -59.5 -27.83 66.5 Favored 'General case' 0 N--CA 1.469 0.508 0 N-CA-C 114.422 1.267 . . . . 0.0 114.422 172.005 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 75.0 mttt -93.92 -41.87 9.37 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-N 113.283 -1.781 . . . . 0.0 113.432 176.76 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . 0.431 ' HB2' ' O ' ' A' ' 58' ' ' GLU . 30.6 tttt -67.05 -60.94 2.2 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 126.511 1.924 . . . . 0.0 113.828 -175.301 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 104.09 110.21 3.46 Favored Glycine 0 CA--C 1.54 1.631 0 CA-C-N 114.795 -1.093 . . . . 0.0 112.448 -169.572 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.533 ' H ' ' HD2' ' A' ' 64' ' ' LYS . 0.0 OUTLIER -36.79 -43.36 0.43 Allowed 'General case' 0 N--CA 1.477 0.918 0 N-CA-C 119.577 3.177 . . . . 0.0 119.577 -175.668 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . 0.415 ' O ' ' HB ' ' A' ' 68' ' ' ILE . 1.8 ttp180 -56.56 -47.12 80.16 Favored 'General case' 0 N--CA 1.477 0.883 0 N-CA-C 114.146 1.165 . . . . 0.0 114.146 179.356 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -64.58 -26.13 68.27 Favored 'General case' 0 N--CA 1.475 0.798 0 CA-C-N 114.509 -1.223 . . . . 0.0 113.62 175.157 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.697 HG21 HG23 ' A' ' 59' ' ' ILE . 30.4 t -72.12 -36.9 58.15 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.042 0 C-N-CA 123.671 0.788 . . . . 0.0 110.707 179.95 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.415 ' HB ' ' O ' ' A' ' 65' ' ' ARG . 19.9 mm -51.76 -46.79 39.65 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.171 0 C-N-CA 124.12 0.968 . . . . 0.0 110.748 167.934 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -69.99 -49.46 51.3 Favored 'General case' 0 N--CA 1.477 0.913 0 N-CA-C 113.802 1.038 . . . . 0.0 113.802 177.019 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' TRP . . . . . 0.426 ' CE3' ' HG3' ' A' ' 1' ' ' MET . 32.2 t90 . . . . . 0 N--CA 1.48 1.031 0 C-N-CA 126.412 1.885 . . . . 0.0 112.98 -178.049 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.655 ' HE1' HG21 ' A' ' 15' ' ' VAL . 56.8 mtp . . . . . 0 CA--C 1.542 0.651 0 N-CA-C 112.238 0.459 . . . . 0.0 112.238 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . 0.407 ' HA ' ' O ' ' A' ' 7' ' ' ILE . . . -57.46 -52.37 65.66 Favored 'General case' 0 N--CA 1.488 1.471 0 CA-C-N 114.806 -1.088 . . . . 0.0 112.96 176.772 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . 0.413 ' HB2' ' O ' ' A' ' 69' ' ' ALA . 10.7 tptp -66.04 -58.35 5.68 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 127.491 2.316 . . . . 0.0 112.461 -177.425 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . 0.446 ' HB2' ' O ' ' A' ' 70' ' ' TRP . 0.7 OUTLIER -74.41 -47.54 33.22 Favored 'General case' 0 N--CA 1.477 0.883 0 N-CA-C 115.972 1.841 . . . . 0.0 115.972 -171.796 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . 0.636 ' HB2' HD12 ' A' ' 7' ' ' ILE . 47.8 m-85 -100.14 -11.2 20.67 Favored 'General case' 0 N--CA 1.473 0.683 0 N-CA-C 115.747 1.758 . . . . 0.0 115.747 -169.021 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 75.79 61.01 3.0 Favored Glycine 0 N--CA 1.478 1.443 0 O-C-N 124.614 1.197 . . . . 0.0 111.245 -173.413 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.636 HD12 ' HB2' ' A' ' 5' ' ' PHE . 1.0 OUTLIER -117.76 145.53 36.73 Favored Pre-proline 0 N--CA 1.478 0.951 0 C-N-CA 125.287 1.435 . . . . 0.0 111.941 179.696 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_endo -89.78 154.17 5.06 Favored 'Trans proline' 0 CA--C 1.535 0.548 0 N-CA-C 109.176 -1.125 . . . . 0.0 109.176 158.383 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -48.77 -29.78 4.92 Favored 'General case' 0 CA--C 1.544 0.73 0 N-CA-C 115.23 1.567 . . . . 0.0 115.23 176.774 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -39.67 -44.91 1.59 Allowed 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 126.388 1.875 . . . . 0.0 114.503 172.069 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.855 HG12 HG22 ' A' ' 31' ' ' ILE . 22.6 m -101.05 -29.51 3.17 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.93 0 N-CA-C 114.959 1.466 . . . . 0.0 114.959 -176.219 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 0.419 ' O ' ' HG ' ' A' ' 16' ' ' LEU . . . -68.48 -31.21 70.32 Favored 'General case' 0 CA--C 1.546 0.817 0 N-CA-C 112.547 0.573 . . . . 0.0 112.547 175.631 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -61.06 -42.87 99.94 Favored Glycine 0 CA--C 1.543 1.84 0 CA-C-O 122.186 0.881 . . . . 0.0 112.393 170.485 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.776 HG22 HG13 ' A' ' 28' ' ' ILE . 1.4 m -62.62 -36.89 84.22 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 124.928 1.291 . . . . 0.0 113.562 176.02 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.655 HG21 ' HE1' ' A' ' 1' ' ' MET . 2.4 t -58.05 -41.05 79.53 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 C-N-CA 124.03 0.932 . . . . 0.0 112.443 170.691 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.452 HD22 ' HG3' ' A' ' 64' ' ' LYS . 53.2 mt -60.04 -37.31 79.43 Favored 'General case' 0 N--CA 1.476 0.837 0 N-CA-C 112.73 0.641 . . . . 0.0 112.73 177.497 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 27.5 t-20 -56.96 -44.57 82.72 Favored 'General case' 0 N--CA 1.474 0.756 0 CA-C-N 115.765 -0.652 . . . . 0.0 112.527 175.864 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 3.7 t -48.49 -48.79 14.15 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.155 0 C-N-CA 123.086 0.555 . . . . 0.0 111.699 172.131 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.791 HG13 ' HA ' ' A' ' 56' ' ' LYS . 5.8 t -67.5 -50.46 61.5 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.389 0 CA-C-N 113.997 -1.456 . . . . 0.0 110.789 -176.351 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 29.2 mt-10 -65.81 -42.02 91.15 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 126.478 1.911 . . . . 0.0 115.606 -177.728 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -99.62 -22.91 15.23 Favored 'General case' 0 N--CA 1.477 0.919 0 N-CA-C 116.219 1.933 . . . . 0.0 116.219 -173.0 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . 0.53 ' HA2' ' NZ ' ' A' ' 56' ' ' LYS . . . 77.39 34.02 41.89 Favored Glycine 0 N--CA 1.481 1.68 0 N-CA-C 112.02 -0.432 . . . . 0.0 112.02 -171.248 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -99.85 172.53 24.8 Favored Glycine 0 N--CA 1.47 0.949 0 CA-C-N 113.263 -1.468 . . . . 0.0 114.102 -165.458 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 89.4 m95 -57.67 100.6 0.06 Allowed 'General case' 0 N--CA 1.476 0.866 0 CA-C-N 111.764 -2.218 . . . . 0.0 114.148 -176.967 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.593 HG21 HG13 ' A' ' 51' ' ' ILE . 4.3 p -56.72 -25.53 21.79 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 CA-C-N 112.553 -2.112 . . . . 0.0 113.779 169.244 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 11.5 p -61.34 -46.36 90.58 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 124.176 0.99 . . . . 0.0 112.277 -178.547 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . 0.427 ' O ' HG12 ' A' ' 31' ' ' ILE . 0.2 OUTLIER -60.8 -44.88 96.27 Favored 'General case' 0 N--CA 1.478 0.945 0 CA-C-N 114.01 -1.45 . . . . 0.0 110.994 175.039 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.776 HG13 HG22 ' A' ' 14' ' ' THR . 1.7 mp -62.63 -47.67 91.84 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.084 0 C-N-CA 124.073 0.949 . . . . 0.0 111.749 179.023 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.487 HG13 HD11 ' A' ' 43' ' ' LEU . 39.8 t -52.41 -43.5 41.34 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.067 0 C-N-CA 124.379 1.072 . . . . 0.0 111.325 179.064 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 90.4 p -65.79 -32.09 73.43 Favored 'General case' 0 N--CA 1.478 0.965 0 N-CA-C 115.391 1.626 . . . . 0.0 115.391 176.324 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.855 HG22 HG12 ' A' ' 11' ' ' VAL . 40.5 mm -70.9 -40.47 76.5 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.33 0 C-N-CA 123.7 0.8 . . . . 0.0 109.583 177.235 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.666 ' HB3' ' HA2' ' A' ' 39' ' ' GLY . 3.8 mm? -61.59 -52.07 65.94 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 125.365 1.466 . . . . 0.0 112.745 174.606 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 7.5 p -65.76 -27.1 68.05 Favored 'General case' 0 N--CA 1.484 1.243 0 N-CA-C 114.159 1.17 . . . . 0.0 114.159 179.317 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -53.0 -29.36 28.79 Favored 'General case' 0 N--CA 1.483 1.225 0 N-CA-C 113.892 1.071 . . . . 0.0 113.892 166.969 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 54.5 t . . . . . 0 N--CA 1.491 1.619 0 C-N-CA 124.238 1.015 . . . . 0.0 112.411 172.192 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . 0.666 ' HA2' ' HB3' ' A' ' 32' ' ' LEU . . . . . . . . 0 N--CA 1.475 1.25 0 N-CA-C 111.413 -0.675 . . . . 0.0 111.413 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 44.7 mt -58.86 -48.46 81.28 Favored 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 115.26 1.578 . . . . 0.0 115.26 -176.222 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . 0.426 ' HB2' ' HD1' ' A' ' 5' ' ' PHE . 29.6 p -60.69 -39.49 88.66 Favored 'General case' 0 N--CA 1.475 0.791 0 N-CA-C 114.488 1.292 . . . . 0.0 114.488 175.669 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 13.8 tp -63.79 -48.46 76.79 Favored 'General case' 0 N--CA 1.483 1.2 0 C-N-CA 122.505 0.322 . . . . 0.0 110.888 173.839 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.487 HD11 HG13 ' A' ' 29' ' ' VAL . 80.5 mt -61.98 -27.57 68.94 Favored 'General case' 0 N--CA 1.482 1.131 0 N-CA-C 114.843 1.423 . . . . 0.0 114.843 -176.344 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -70.81 -45.4 64.7 Favored 'General case' 0 CA--C 1.549 0.905 0 N-CA-C 112.839 0.681 . . . . 0.0 112.839 173.933 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -65.12 -40.47 94.53 Favored 'General case' 0 N--CA 1.477 0.917 0 CA-C-O 122.715 1.245 . . . . 0.0 111.999 179.902 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.446 ' HB1' ' HA ' ' A' ' 51' ' ' ILE . . . -59.18 -26.76 65.07 Favored 'General case' 0 CA--C 1.537 0.447 0 N-CA-C 116.438 2.014 . . . . 0.0 116.438 179.131 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -47.78 -40.62 18.81 Favored Glycine 0 N--CA 1.482 1.73 0 C-N-CA 125.598 1.57 . . . . 0.0 113.641 -177.942 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 35.4 ttp-105 -53.62 -47.78 69.91 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 125.184 1.394 . . . . 0.0 113.931 -173.937 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 11.8 tt0 -126.0 37.32 4.36 Favored 'General case' 0 N--CA 1.478 0.968 0 N-CA-C 114.285 1.217 . . . . 0.0 114.285 -177.962 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 72.0 p 50.77 127.49 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.502 0 C-N-CA 125.603 1.561 . . . . 0.0 112.792 -172.057 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.593 HG13 HG21 ' A' ' 25' ' ' VAL . 6.3 tp -39.04 -51.65 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 N-CA-C 117.728 2.492 . . . . 0.0 117.728 -172.791 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 56.3 tttt -65.95 -57.17 8.44 Favored 'General case' 0 N--CA 1.469 0.516 0 N-CA-C 113.618 0.97 . . . . 0.0 113.618 179.877 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -60.59 -38.17 83.75 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 124.591 1.156 . . . . 0.0 112.763 178.497 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . 0.401 ' HB3' ' O ' ' A' ' 51' ' ' ILE . 90.4 t80 -47.66 -63.51 1.04 Allowed 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 125.961 1.704 . . . . 0.0 109.861 170.233 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 79.1 mt -64.24 -41.98 96.74 Favored 'General case' 0 N--CA 1.473 0.721 0 N-CA-C 113.894 1.072 . . . . 0.0 113.894 -176.575 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . 0.791 ' HA ' HG13 ' A' ' 19' ' ' VAL . 29.2 mtpp -55.97 -44.73 78.79 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 114.653 -1.158 . . . . 0.0 113.447 177.466 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . 0.42 ' O ' ' HG2' ' A' ' 61' ' ' LYS . 66.7 tttt -77.3 -50.13 13.51 Favored 'General case' 0 N--CA 1.475 0.787 0 CA-C-N 115.292 -0.867 . . . . 0.0 112.051 172.947 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . 0.501 ' O ' ' HB2' ' A' ' 62' ' ' LYS . 4.2 tp10 -54.51 -51.38 65.29 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 123.979 0.912 . . . . 0.0 111.831 -173.51 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.683 HG23 HG21 ' A' ' 67' ' ' VAL . 1.3 mm -75.87 -26.32 17.69 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.05 0 CA-C-N 115.623 -0.717 . . . . 0.0 111.846 -175.255 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 6.7 mtpp -60.07 -39.05 84.72 Favored 'General case' 0 CA--C 1.538 0.487 0 N-CA-C 115.336 1.606 . . . . 0.0 115.336 170.285 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . 0.42 ' HG2' ' O ' ' A' ' 57' ' ' LYS . 70.4 mmtt -79.32 -46.24 18.09 Favored 'General case' 0 N--CA 1.476 0.834 0 O-C-N 126.188 2.18 . . . . 0.0 110.93 176.977 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . 0.501 ' HB2' ' O ' ' A' ' 58' ' ' GLU . 5.7 tptp -66.53 -52.22 48.17 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 126.728 2.011 . . . . 0.0 114.822 -175.561 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 96.6 117.87 3.47 Favored Glycine 0 N--CA 1.483 1.828 0 CA-C-N 114.593 -1.185 . . . . 0.0 110.332 -173.94 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.687 ' H ' ' HD2' ' A' ' 64' ' ' LYS . 9.8 mptt -36.18 -46.78 0.53 Allowed 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 117.782 2.512 . . . . 0.0 117.782 -177.422 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.22 -51.63 69.14 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 125.538 1.535 . . . . 0.0 114.958 176.89 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -64.83 -27.3 68.78 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-N 114.423 -1.262 . . . . 0.0 112.907 174.771 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.683 HG21 HG23 ' A' ' 59' ' ' ILE . 98.7 t -67.13 -41.78 87.43 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.251 0 C-N-CA 123.191 0.597 . . . . 0.0 110.942 175.19 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 35.1 mm -51.15 -42.66 25.87 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.856 0 O-C-N 124.18 0.925 . . . . 0.0 110.764 172.061 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.413 ' O ' ' HB2' ' A' ' 3' ' ' LYS . . . -71.38 -52.62 17.62 Favored 'General case' 0 N--CA 1.473 0.725 0 O-C-N 124.683 1.239 . . . . 0.0 112.585 176.117 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' TRP . . . . . 0.446 ' O ' ' HB2' ' A' ' 4' ' ' GLU . 30.9 t90 . . . . . 0 N--CA 1.485 1.277 0 C-N-CA 127.034 2.134 . . . . 0.0 112.646 -178.449 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.507 ' HE1' HG21 ' A' ' 15' ' ' VAL . 72.3 mtp . . . . . 0 N--CA 1.472 0.63 0 N-CA-C 112.184 0.439 . . . . 0.0 112.184 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -56.79 -49.6 74.83 Favored 'General case' 0 CA--C 1.547 0.828 0 CA-C-N 115.541 -0.754 . . . . 0.0 112.602 177.499 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 50.2 tttm -76.32 -51.65 11.54 Favored 'General case' 0 N--CA 1.475 0.799 0 CA-C-N 113.407 -1.724 . . . . 0.0 113.303 -173.195 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . 0.429 ' HB2' ' O ' ' A' ' 70' ' ' TRP . 1.8 mp0 -79.03 -33.33 44.91 Favored 'General case' 0 N--CA 1.47 0.536 0 N-CA-C 115.94 1.83 . . . . 0.0 115.94 -173.411 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . 0.41 ' HB2' HD12 ' A' ' 7' ' ' ILE . 26.7 m-85 -113.41 -14.13 12.79 Favored 'General case' 0 N--CA 1.474 0.774 0 N-CA-C 117.621 2.452 . . . . 0.0 117.621 -171.556 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 82.33 58.84 2.36 Favored Glycine 0 CA--C 1.538 1.506 0 C-N-CA 124.133 0.873 . . . . 0.0 111.159 -179.155 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.515 HG21 ' HB2' ' A' ' 12' ' ' ALA . 0.8 OUTLIER -120.39 146.71 43.51 Favored Pre-proline 0 N--CA 1.479 1.009 0 CA-C-N 112.747 -1.726 . . . . 0.0 113.307 -176.102 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -91.51 161.12 3.59 Favored 'Trans proline' 0 CA--C 1.537 0.662 0 C-N-CA 121.123 1.215 . . . . 0.0 110.745 160.535 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -52.75 -32.08 41.44 Favored 'General case' 0 CA--C 1.544 0.716 0 N-CA-C 114.07 1.137 . . . . 0.0 114.07 174.312 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -40.84 -39.46 1.13 Allowed 'General case' 0 N--CA 1.485 1.323 0 C-N-CA 126.784 2.033 . . . . 0.0 114.976 172.879 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.942 HG12 HG22 ' A' ' 31' ' ' ILE . 17.3 m -110.95 -31.63 2.25 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.354 0 N-CA-C 114.939 1.459 . . . . 0.0 114.939 -177.162 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 0.515 ' HB2' HG21 ' A' ' 7' ' ' ILE . . . -65.94 -36.91 84.65 Favored 'General case' 0 N--CA 1.476 0.864 0 N-CA-C 112.61 0.596 . . . . 0.0 112.61 174.016 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . 0.516 ' O ' ' HB2' ' A' ' 16' ' ' LEU . . . -58.18 -41.95 95.02 Favored Glycine 0 CA--C 1.54 1.603 0 C-N-CA 124.033 0.825 . . . . 0.0 112.563 171.813 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.775 HG22 HG13 ' A' ' 28' ' ' ILE . 0.2 OUTLIER -62.14 -34.05 75.65 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 125.546 1.538 . . . . 0.0 114.045 176.719 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.507 HG21 ' HE1' ' A' ' 1' ' ' MET . 5.2 t -58.15 -46.93 88.34 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.29 0 C-N-CA 123.846 0.858 . . . . 0.0 112.798 171.045 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.516 ' HB2' ' O ' ' A' ' 13' ' ' GLY . 9.5 mp -52.5 -38.61 59.94 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 124.912 1.285 . . . . 0.0 113.384 173.026 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 15.3 t-20 -57.4 -49.13 77.18 Favored 'General case' 0 N--CA 1.485 1.279 0 O-C-N 123.873 0.733 . . . . 0.0 110.815 177.768 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 2.4 t -50.19 -50.89 19.21 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.767 0 O-C-N 124.366 1.041 . . . . 0.0 112.77 173.31 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.564 HG13 ' HA ' ' A' ' 56' ' ' LYS . 9.0 t -65.34 -48.97 81.22 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.235 0 CA-C-N 114.647 -1.16 . . . . 0.0 112.411 -175.075 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -71.39 -46.72 59.59 Favored 'General case' 0 CA--C 1.548 0.872 0 N-CA-C 114.692 1.367 . . . . 0.0 114.692 -177.425 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -96.04 -9.18 31.59 Favored 'General case' 0 N--CA 1.475 0.807 0 N-CA-C 115.733 1.753 . . . . 0.0 115.733 -170.352 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 65.19 33.13 86.1 Favored Glycine 0 CA--C 1.542 1.773 0 C-N-CA 124.327 0.965 . . . . 0.0 112.494 -171.523 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -78.31 167.66 53.39 Favored Glycine 0 N--CA 1.476 1.357 0 C-N-CA 125.372 1.463 . . . . 0.0 115.698 -175.044 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' TRP . . . . . 0.409 ' HB3' HG22 ' A' ' 26' ' ' THR . 2.5 m-90 -68.2 106.39 2.42 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-N 113.454 -1.373 . . . . 0.0 111.999 -178.666 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 2.8 p -57.58 -24.84 23.14 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.781 0 CA-C-N 114.122 -1.399 . . . . 0.0 114.07 173.65 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.409 HG22 ' HB3' ' A' ' 24' ' ' TRP . 10.0 t -60.0 -44.54 94.48 Favored 'General case' 0 N--CA 1.483 1.214 0 C-N-CA 124.053 0.941 . . . . 0.0 113.239 -179.823 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . 0.452 ' O ' HG12 ' A' ' 31' ' ' ILE . 0.0 OUTLIER -65.28 -42.76 92.81 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 124.254 1.021 . . . . 0.0 111.787 175.657 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.775 HG13 HG22 ' A' ' 14' ' ' THR . 1.8 mp -62.3 -46.1 97.22 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 C-N-CA 124.427 1.091 . . . . 0.0 111.037 178.235 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.485 HG13 HD11 ' A' ' 43' ' ' LEU . 39.6 t -56.11 -45.27 80.62 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.837 0 C-N-CA 124.344 1.058 . . . . 0.0 111.978 174.009 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 36.9 m -58.34 -37.03 74.32 Favored 'General case' 0 N--CA 1.486 1.344 0 N-CA-C 113.855 1.057 . . . . 0.0 113.855 175.256 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.942 HG22 HG12 ' A' ' 11' ' ' VAL . 43.5 mm -75.9 -39.34 37.56 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.41 0 C-N-CA 123.926 0.891 . . . . 0.0 110.434 179.737 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.676 HD22 ' HB ' ' A' ' 11' ' ' VAL . 3.7 mm? -60.57 -50.94 71.51 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 125.564 1.546 . . . . 0.0 112.251 174.003 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 18.0 p -67.25 -30.55 70.47 Favored 'General case' 0 N--CA 1.484 1.229 0 N-CA-C 114.609 1.337 . . . . 0.0 114.609 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -49.1 -40.6 32.66 Favored 'General case' 0 N--CA 1.485 1.291 0 N-CA-C 113.52 0.933 . . . . 0.0 113.52 170.37 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 57.7 t . . . . . 0 N--CA 1.487 1.382 0 C-N-CA 125.139 1.376 . . . . 0.0 112.934 173.008 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . 0.543 ' HA2' ' HB3' ' A' ' 32' ' ' LEU . . . . . . . . 0 CA--C 1.535 1.307 0 N-CA-C 111.57 -0.612 . . . . 0.0 111.57 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 30.3 mt -59.34 -45.71 90.62 Favored 'General case' 0 N--CA 1.48 1.03 0 N-CA-C 114.983 1.475 . . . . 0.0 114.983 -177.789 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 51.9 p -66.2 -37.58 85.93 Favored 'General case' 0 N--CA 1.48 1.033 0 N-CA-C 113.926 1.084 . . . . 0.0 113.926 176.132 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 12.7 tp -65.98 -44.16 85.71 Favored 'General case' 0 N--CA 1.482 1.149 0 CA-C-O 120.963 0.411 . . . . 0.0 110.217 173.033 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.485 HD11 HG13 ' A' ' 29' ' ' VAL . 82.6 mt -64.9 -22.74 67.05 Favored 'General case' 0 N--CA 1.476 0.874 0 N-CA-C 115.031 1.493 . . . . 0.0 115.031 178.997 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -72.98 -47.85 41.69 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-N 115.706 -0.679 . . . . 0.0 112.16 170.15 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -60.22 -35.56 75.71 Favored 'General case' 0 N--CA 1.487 1.391 0 C-N-CA 124.221 1.009 . . . . 0.0 111.739 177.08 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -52.74 -26.87 15.43 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 127.209 2.204 . . . . 0.0 115.821 174.855 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -46.46 -43.22 14.62 Favored Glycine 0 N--CA 1.483 1.769 0 C-N-CA 125.676 1.608 . . . . 0.0 114.249 -175.5 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 66.6 ttp85 -47.48 -55.8 8.33 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 126.01 1.724 . . . . 0.0 113.486 -176.597 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 10.5 tt0 -136.38 38.54 2.69 Favored 'General case' 0 N--CA 1.483 1.198 0 N-CA-C 113.656 0.984 . . . . 0.0 113.656 -174.216 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 23.2 t 45.86 125.77 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 125.313 1.445 . . . . 0.0 114.096 -173.849 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 10.5 tp -31.3 -49.74 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.481 1.083 0 N-CA-C 118.355 2.724 . . . . 0.0 118.355 -174.32 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 52.2 tptt -55.77 -70.05 0.12 Allowed 'General case' 0 N--CA 1.483 1.215 0 C-N-CA 124.575 1.15 . . . . 0.0 111.848 176.525 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -61.3 -38.44 86.83 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 124.377 1.071 . . . . 0.0 113.525 179.709 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 85.9 t80 -46.8 -60.43 2.42 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 124.84 1.256 . . . . 0.0 111.587 173.359 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 67.4 mt -67.05 -43.81 81.76 Favored 'General case' 0 N--CA 1.478 0.952 0 N-CA-C 113.992 1.108 . . . . 0.0 113.992 -177.085 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . 0.564 ' HA ' HG13 ' A' ' 19' ' ' VAL . 6.5 mmmt -52.24 -43.37 64.29 Favored 'General case' 0 N--CA 1.478 0.947 0 CA-C-N 113.995 -1.457 . . . . 0.0 114.438 177.911 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 33.4 tttm -80.53 -55.25 4.99 Favored 'General case' 0 N--CA 1.476 0.847 0 CA-C-N 114.583 -1.189 . . . . 0.0 111.67 172.235 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . 0.555 ' O ' ' HB2' ' A' ' 62' ' ' LYS . 34.3 tt0 -54.06 -51.43 64.09 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-O 117.038 -1.458 . . . . 0.0 110.895 -170.478 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.765 HG23 HG21 ' A' ' 67' ' ' VAL . 3.4 mm -78.92 -23.51 12.86 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.349 0 CA-C-O 118.719 -0.658 . . . . 0.0 112.335 -174.707 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 1.2 tppm? -61.52 -37.64 84.47 Favored 'General case' 0 N--CA 1.466 0.368 0 N-CA-C 113.997 1.11 . . . . 0.0 113.997 172.436 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 45.1 mttt -90.93 -37.86 13.25 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-N 112.465 -2.152 . . . . 0.0 113.419 -178.453 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . 0.555 ' HB2' ' O ' ' A' ' 58' ' ' GLU . 24.1 tttm -67.51 -45.44 75.78 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 126.562 1.945 . . . . 0.0 113.574 -176.994 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 98.32 102.97 2.29 Favored Glycine 0 CA--C 1.534 1.229 0 CA-C-O 122.11 0.839 . . . . 0.0 111.409 -177.155 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.509 ' H ' ' HD2' ' A' ' 64' ' ' LYS . 2.2 mptp? -31.58 -47.6 0.12 Allowed 'General case' 0 N--CA 1.477 0.909 0 N-CA-C 119.136 3.013 . . . . 0.0 119.136 -178.076 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 4.8 ttp-105 -62.27 -47.81 82.68 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 124.76 1.224 . . . . 0.0 113.628 179.56 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -60.98 -26.95 67.94 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-N 114.642 -1.163 . . . . 0.0 113.952 172.489 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.765 HG21 HG23 ' A' ' 59' ' ' ILE . 63.9 t -68.6 -40.38 81.76 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.291 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.635 176.442 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 45.5 mm -53.52 -45.83 59.09 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.08 0 C-N-CA 123.485 0.714 . . . . 0.0 109.895 172.145 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -64.8 -52.58 56.05 Favored 'General case' 0 N--CA 1.482 1.134 0 N-CA-C 112.79 0.663 . . . . 0.0 112.79 176.111 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' TRP . . . . . 0.429 ' O ' ' HB2' ' A' ' 4' ' ' GLU . 33.9 t90 . . . . . 0 N--CA 1.479 1.018 0 C-N-CA 126.051 1.74 . . . . 0.0 112.336 178.36 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.59 ' HE1' HG21 ' A' ' 15' ' ' VAL . 46.1 mtp . . . . . 0 N--CA 1.471 0.577 0 N-CA-C 112.457 0.54 . . . . 0.0 112.457 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . 0.475 ' HA ' ' O ' ' A' ' 7' ' ' ILE . . . -52.22 -51.83 55.92 Favored 'General case' 0 N--CA 1.47 0.538 0 O-C-N 124.568 1.167 . . . . 0.0 112.73 176.708 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 14.7 tttt -79.93 -51.75 8.72 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 112.717 -2.038 . . . . 0.0 114.578 -173.555 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 10.6 mt-10 -73.04 -35.15 66.69 Favored 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 115.382 1.623 . . . . 0.0 115.382 -173.772 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 50.6 m-85 -109.04 -13.85 14.64 Favored 'General case' 0 N--CA 1.478 0.933 0 N-CA-C 117.356 2.354 . . . . 0.0 117.356 -173.997 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 82.75 60.49 2.07 Favored Glycine 0 CA--C 1.542 1.765 0 O-C-N 124.342 1.027 . . . . 0.0 110.65 -177.83 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.475 ' O ' ' HA ' ' A' ' 2' ' ' ALA . 0.8 OUTLIER -125.23 143.38 44.2 Favored Pre-proline 0 N--CA 1.481 1.12 0 CA-C-N 113.63 -1.285 . . . . 0.0 112.457 -175.924 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_endo -87.92 159.54 7.4 Favored 'Trans proline' 0 CA--C 1.538 0.675 0 C-N-CA 120.94 1.094 . . . . 0.0 109.376 163.797 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -50.58 -33.2 21.1 Favored 'General case' 0 N--CA 1.476 0.874 0 N-CA-C 114.253 1.205 . . . . 0.0 114.253 174.895 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -37.03 -41.85 0.38 Allowed 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 127.45 2.3 . . . . 0.0 115.917 169.725 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.9 HG12 HG22 ' A' ' 31' ' ' ILE . 19.0 m -111.37 -28.53 2.57 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 N-CA-C 115.395 1.628 . . . . 0.0 115.395 -176.749 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 0.463 ' O ' ' HG ' ' A' ' 16' ' ' LEU . . . -66.28 -33.61 76.14 Favored 'General case' 0 N--CA 1.477 0.891 0 N-CA-C 112.71 0.633 . . . . 0.0 112.71 171.433 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -59.62 -37.41 92.22 Favored Glycine 0 CA--C 1.539 1.59 0 C-N-CA 124.448 1.023 . . . . 0.0 112.674 171.349 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.65 HG22 HG13 ' A' ' 28' ' ' ILE . 0.2 OUTLIER -71.98 -37.15 69.93 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 125.188 1.395 . . . . 0.0 112.598 177.908 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.649 HG23 HD21 ' A' ' 32' ' ' LEU . 20.9 t -55.93 -41.65 68.23 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.237 0 C-N-CA 123.423 0.689 . . . . 0.0 111.88 166.366 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.463 ' HG ' ' O ' ' A' ' 12' ' ' ALA . 77.6 mt -61.25 -37.1 81.91 Favored 'General case' 0 N--CA 1.486 1.347 0 N-CA-C 114.518 1.303 . . . . 0.0 114.518 177.929 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 12.0 t-20 -52.35 -49.2 64.8 Favored 'General case' 0 CA--C 1.545 0.767 0 CA-C-N 114.395 -1.275 . . . . 0.0 112.065 173.424 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.449 ' HB ' ' O ' ' A' ' 15' ' ' VAL . 5.0 t -52.08 -50.57 34.8 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 CA-C-N 113.295 -1.775 . . . . 0.0 111.502 175.848 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.625 HG13 ' HA ' ' A' ' 56' ' ' LYS . 13.0 t -66.86 -48.62 79.21 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.255 0 O-C-N 123.991 0.807 . . . . 0.0 111.043 -176.124 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -63.73 -44.01 94.81 Favored 'General case' 0 CA--C 1.542 0.656 0 N-CA-C 114.446 1.276 . . . . 0.0 114.446 -176.638 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -103.06 -19.94 14.37 Favored 'General case' 0 N--CA 1.479 1.005 0 N-CA-C 115.559 1.689 . . . . 0.0 115.559 -171.194 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 71.17 39.69 62.33 Favored Glycine 0 N--CA 1.481 1.66 0 N-CA-C 109.905 -1.278 . . . . 0.0 109.905 -166.767 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -83.82 162.8 39.58 Favored Glycine 0 CA--C 1.527 0.806 0 N-CA-C 109.168 -1.573 . . . . 0.0 109.168 -178.96 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' TRP . . . . . 0.437 ' O ' HD13 ' A' ' 28' ' ' ILE . 31.5 m95 -64.76 104.6 0.85 Allowed 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 112.365 -1.918 . . . . 0.0 112.48 -175.132 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.578 HG21 HG13 ' A' ' 51' ' ' ILE . 3.1 p -57.35 -24.91 22.51 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.927 0 CA-C-N 113.147 -1.842 . . . . 0.0 113.39 171.395 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 3.1 p -61.34 -47.21 86.95 Favored 'General case' 0 N--CA 1.484 1.246 0 N-CA-C 113.786 1.032 . . . . 0.0 113.786 -179.516 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -62.4 -40.83 97.79 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 123.24 0.616 . . . . 0.0 111.357 173.862 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.65 HG13 HG22 ' A' ' 14' ' ' THR . 1.8 mp -60.02 -48.69 86.88 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 C-N-CA 124.878 1.271 . . . . 0.0 112.253 177.504 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.521 HG23 ' O ' ' A' ' 25' ' ' VAL . 53.5 t -49.59 -45.68 20.34 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 C-N-CA 124.406 1.082 . . . . 0.0 112.264 178.356 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -62.27 -41.72 98.71 Favored 'General case' 0 N--CA 1.485 1.314 0 N-CA-C 112.917 0.71 . . . . 0.0 112.917 178.38 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.9 HG22 HG12 ' A' ' 11' ' ' VAL . 36.7 mm -70.9 -38.86 74.19 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.145 0 C-N-CA 123.436 0.695 . . . . 0.0 109.805 -179.057 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.763 HD22 ' HB ' ' A' ' 11' ' ' VAL . 3.2 mm? -58.05 -53.44 58.18 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 125.475 1.51 . . . . 0.0 112.039 173.78 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 11.0 m -71.86 -21.19 61.7 Favored 'General case' 0 N--CA 1.477 0.916 0 N-CA-C 113.496 0.924 . . . . 0.0 113.496 179.473 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -58.89 -28.83 66.53 Favored 'General case' 0 N--CA 1.484 1.26 0 C-N-CA 123.967 0.907 . . . . 0.0 113.402 172.425 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 74.8 t . . . . . 0 N--CA 1.484 1.256 0 C-N-CA 124.045 0.938 . . . . 0.0 111.495 170.916 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . 0.431 ' O ' ' HG ' ' A' ' 43' ' ' LEU . . . . . . . . 0 N--CA 1.478 1.493 0 N-CA-C 114.901 0.72 . . . . 0.0 114.901 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 43.9 mt -67.05 -44.93 78.89 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 124.242 1.017 . . . . 0.0 113.42 -177.143 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -55.44 -39.79 70.74 Favored 'General case' 0 N--CA 1.481 1.082 0 O-C-N 124.079 0.862 . . . . 0.0 112.838 171.903 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 16.8 tp -64.09 -48.17 77.2 Favored 'General case' 0 N--CA 1.477 0.884 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.042 175.859 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.431 ' HG ' ' O ' ' A' ' 39' ' ' GLY . 44.1 mt -61.05 -30.94 70.62 Favored 'General case' 0 N--CA 1.479 0.999 0 N-CA-C 114.603 1.334 . . . . 0.0 114.603 179.078 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -66.62 -50.39 63.15 Favored 'General case' 0 N--CA 1.478 0.96 0 CA-C-N 115.882 -0.599 . . . . 0.0 112.211 171.402 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -61.16 -34.73 75.49 Favored 'General case' 0 N--CA 1.485 1.301 0 CA-C-O 121.743 0.782 . . . . 0.0 112.345 176.273 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -67.35 -22.57 65.58 Favored 'General case' 0 N--CA 1.478 0.934 0 N-CA-C 116.191 1.923 . . . . 0.0 116.191 179.993 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -49.42 -34.58 19.44 Favored Glycine 0 CA--C 1.549 2.208 0 C-N-CA 124.688 1.137 . . . . 0.0 112.741 177.123 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 18.5 ttm180 -52.32 -50.87 61.39 Favored 'General case' 0 CA--C 1.549 0.906 0 C-N-CA 126.455 1.902 . . . . 0.0 114.977 -175.427 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 16.0 tt0 -133.5 40.58 3.13 Favored 'General case' 0 N--CA 1.479 0.977 0 N-CA-C 113.283 0.846 . . . . 0.0 113.283 -175.529 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 89.0 p 44.86 115.14 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.499 0 C-N-CA 125.303 1.441 . . . . 0.0 113.727 -172.445 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.578 HG13 HG21 ' A' ' 25' ' ' VAL . 8.0 tp -23.88 -56.82 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.483 1.177 0 N-CA-C 119.131 3.012 . . . . 0.0 119.131 -175.484 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 54.2 tttt -64.11 -55.52 21.35 Favored 'General case' 0 N--CA 1.48 1.045 0 N-CA-C 112.835 0.68 . . . . 0.0 112.835 -179.86 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -62.9 -38.66 91.81 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 124.936 1.294 . . . . 0.0 112.158 177.759 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 69.1 t80 -51.75 -58.42 6.45 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 125.617 1.567 . . . . 0.0 111.18 174.791 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.601 HD13 HG13 ' A' ' 15' ' ' VAL . 60.6 mt -70.47 -41.12 73.19 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 114.811 1.411 . . . . 0.0 114.811 -179.346 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . 0.625 ' HA ' HG13 ' A' ' 19' ' ' VAL . 50.4 tptt -55.26 -49.96 70.72 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-N 114.004 -1.453 . . . . 0.0 113.174 178.076 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 52.8 tttp -74.55 -54.62 7.14 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-N 114.759 -1.109 . . . . 0.0 112.1 174.656 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . 0.409 ' O ' ' HB2' ' A' ' 62' ' ' LYS . 16.1 mt-10 -61.36 -41.78 97.63 Favored 'General case' 0 N--CA 1.472 0.625 0 N-CA-C 113.972 1.101 . . . . 0.0 113.972 -169.156 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.814 HG23 HG21 ' A' ' 67' ' ' VAL . 2.8 mm -78.09 -26.56 14.51 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.851 0 C-N-CA 120.13 -0.628 . . . . 0.0 112.192 -179.346 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 10.3 tppt? -61.94 -27.6 68.94 Favored 'General case' 0 CA--C 1.542 0.643 0 N-CA-C 114.332 1.234 . . . . 0.0 114.332 170.247 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 42.3 mmtm -89.18 -43.15 11.23 Favored 'General case' 0 N--CA 1.483 1.215 0 CA-C-N 113.647 -1.615 . . . . 0.0 111.387 178.475 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . 0.458 ' HD3' HG22 ' A' ' 67' ' ' VAL . 2.7 tttm -68.88 -51.02 44.66 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 125.965 1.706 . . . . 0.0 114.89 -176.274 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 100.46 112.79 3.49 Favored Glycine 0 CA--C 1.534 1.273 0 N-CA-C 110.547 -1.021 . . . . 0.0 110.547 -172.654 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.436 ' HB3' HD13 ' A' ' 16' ' ' LEU . 10.5 mptt -41.99 -43.84 3.29 Favored 'General case' 0 N--CA 1.479 1.015 0 N-CA-C 118.139 2.644 . . . . 0.0 118.139 -172.643 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . 0.437 ' O ' ' HB ' ' A' ' 68' ' ' ILE . 0.0 OUTLIER -61.3 -42.78 99.24 Favored 'General case' 0 N--CA 1.477 0.905 0 N-CA-C 114.995 1.48 . . . . 0.0 114.995 177.552 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -68.78 -22.33 64.29 Favored 'General case' 0 N--CA 1.479 1.022 0 CA-C-N 114.878 -1.055 . . . . 0.0 113.171 173.742 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.814 HG21 HG23 ' A' ' 59' ' ' ILE . 61.8 t -75.53 -32.71 25.5 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.919 0 C-N-CA 123.725 0.81 . . . . 0.0 111.34 176.72 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.437 ' HB ' ' O ' ' A' ' 65' ' ' ARG . 18.6 mm -51.78 -47.47 39.51 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.153 0 C-N-CA 123.639 0.776 . . . . 0.0 109.814 165.714 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -68.22 -48.83 64.11 Favored 'General case' 0 N--CA 1.472 0.641 0 O-C-N 124.225 0.953 . . . . 0.0 113.406 178.038 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 34.1 t90 . . . . . 0 N--CA 1.476 0.859 0 C-N-CA 125.587 1.555 . . . . 0.0 112.407 178.482 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.449 ' HB3' HG21 ' A' ' 7' ' ' ILE . 53.9 mtp . . . . . 0 N--CA 1.478 0.946 0 N-CA-C 112.367 0.506 . . . . 0.0 112.367 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -55.47 -50.82 68.87 Favored 'General case' 0 N--CA 1.472 0.643 0 O-C-N 124.67 1.231 . . . . 0.0 112.711 177.291 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 52.7 tttp -72.91 -58.81 3.06 Favored 'General case' 0 CA--C 1.543 0.686 0 CA-C-N 114.257 -1.338 . . . . 0.0 113.573 -178.78 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -66.16 -43.74 86.09 Favored 'General case' 0 N--CA 1.471 0.601 0 N-CA-C 116.474 2.027 . . . . 0.0 116.474 -168.901 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . 0.561 ' HB2' HD12 ' A' ' 7' ' ' ILE . 38.4 m-85 -101.41 -18.06 16.19 Favored 'General case' 0 N--CA 1.476 0.857 0 N-CA-C 115.953 1.835 . . . . 0.0 115.953 -170.509 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 81.41 63.06 1.89 Allowed Glycine 0 N--CA 1.484 1.855 0 O-C-N 124.532 1.145 . . . . 0.0 110.714 -169.464 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.561 HD12 ' HB2' ' A' ' 5' ' ' PHE . 0.4 OUTLIER -122.55 145.93 46.23 Favored Pre-proline 0 N--CA 1.471 0.613 0 C-N-CA 125.587 1.555 . . . . 0.0 108.998 179.775 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_endo -86.44 152.1 9.12 Favored 'Trans proline' 0 CA--C 1.537 0.645 0 N-CA-C 108.173 -1.51 . . . . 0.0 108.173 161.13 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -47.69 -33.94 7.54 Favored 'General case' 0 N--CA 1.47 0.55 0 N-CA-C 115.663 1.727 . . . . 0.0 115.663 175.486 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -37.69 -57.37 0.98 Allowed 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 126.964 2.106 . . . . 0.0 113.931 173.374 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.873 HG12 HG22 ' A' ' 31' ' ' ILE . 23.9 m -83.97 -33.16 9.01 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.214 0 N-CA-C 113.728 1.01 . . . . 0.0 113.728 -175.259 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -64.09 -32.39 73.93 Favored 'General case' 0 CA--C 1.545 0.787 0 N-CA-C 112.303 0.483 . . . . 0.0 112.303 173.38 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -59.36 -44.62 96.45 Favored Glycine 0 CA--C 1.538 1.473 0 CA-C-O 122.497 1.054 . . . . 0.0 113.071 171.277 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.7 HG22 HG13 ' A' ' 28' ' ' ILE . 0.3 OUTLIER -63.17 -35.7 81.17 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 125.276 1.43 . . . . 0.0 113.586 176.542 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.469 HG23 HD21 ' A' ' 32' ' ' LEU . 5.1 t -58.15 -41.53 80.97 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 C-N-CA 124.205 1.002 . . . . 0.0 111.992 170.747 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 24.6 mt -61.32 -38.93 88.64 Favored 'General case' 0 N--CA 1.472 0.638 0 N-CA-C 113.222 0.823 . . . . 0.0 113.222 178.681 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -52.81 -48.06 67.18 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 124.798 1.239 . . . . 0.0 112.526 173.038 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 1.1 t -54.4 -54.0 25.55 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.984 0 CA-C-N 115.057 -0.974 . . . . 0.0 111.501 174.735 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.795 HG13 ' HA ' ' A' ' 56' ' ' LYS . 6.8 t -59.87 -47.58 90.98 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.014 0 O-C-N 123.803 0.689 . . . . 0.0 110.458 -177.505 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . 0.595 ' HG3' ' HE2' ' A' ' 64' ' ' LYS . 17.4 mt-10 -60.34 -36.74 78.69 Favored 'General case' 0 CA--C 1.542 0.666 0 N-CA-C 115.992 1.849 . . . . 0.0 115.992 -178.49 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -106.8 -9.97 16.22 Favored 'General case' 0 N--CA 1.477 0.876 0 N-CA-C 116.303 1.964 . . . . 0.0 116.303 -175.409 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 64.42 42.01 97.8 Favored Glycine 0 CA--C 1.549 2.196 0 N-CA-C 110.298 -1.121 . . . . 0.0 110.298 -168.12 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -92.53 175.24 37.23 Favored Glycine 0 CA--C 1.534 1.275 0 C-N-CA 124.27 0.938 . . . . 0.0 113.872 -167.436 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' TRP . . . . . 0.546 ' HB3' HG22 ' A' ' 26' ' ' THR . 81.5 m95 -67.29 104.83 1.58 Allowed 'General case' 0 N--CA 1.468 0.464 0 CA-C-O 122.55 1.167 . . . . 0.0 113.3 179.763 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.565 HG21 HG13 ' A' ' 51' ' ' ILE . 2.2 p -60.74 -22.08 25.36 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.971 0 CA-C-N 113.665 -1.607 . . . . 0.0 113.693 170.795 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.546 HG22 ' HB3' ' A' ' 24' ' ' TRP . 4.4 t -56.57 -46.38 80.8 Favored 'General case' 0 N--CA 1.485 1.316 0 N-CA-C 113.811 1.041 . . . . 0.0 113.811 -179.982 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . 0.405 ' O ' HG12 ' A' ' 31' ' ' ILE . 0.0 OUTLIER -64.09 -41.01 97.45 Favored 'General case' 0 N--CA 1.479 1.016 0 O-C-N 123.972 0.795 . . . . 0.0 112.006 176.91 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.7 HG13 HG22 ' A' ' 14' ' ' THR . 2.0 mp -68.59 -44.37 82.8 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 C-N-CA 125.255 1.422 . . . . 0.0 111.904 -179.114 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.691 HG13 HD11 ' A' ' 43' ' ' LEU . 38.2 t -51.95 -48.88 39.74 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.349 0 C-N-CA 124.386 1.074 . . . . 0.0 111.069 174.52 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 42.3 m -52.34 -41.78 63.31 Favored 'General case' 0 N--CA 1.483 1.198 0 N-CA-C 114.555 1.317 . . . . 0.0 114.555 176.59 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.873 HG22 HG12 ' A' ' 11' ' ' VAL . 36.9 mm -75.35 -40.81 42.99 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.981 0 C-N-CA 124.407 1.083 . . . . 0.0 109.719 -177.766 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.651 HD22 ' HB ' ' A' ' 11' ' ' VAL . 3.9 mm? -55.96 -53.14 60.43 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 124.493 1.117 . . . . 0.0 112.294 171.565 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 1.2 p -66.4 -29.62 69.82 Favored 'General case' 0 N--CA 1.481 1.103 0 N-CA-C 115.974 1.842 . . . . 0.0 115.974 178.865 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -57.29 -27.94 62.59 Favored 'General case' 0 N--CA 1.477 0.882 0 O-C-N 124.303 1.002 . . . . 0.0 113.188 171.862 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 83.7 t . . . . . 0 N--CA 1.485 1.297 0 C-N-CA 124.019 0.928 . . . . 0.0 111.628 172.898 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . 0.447 ' HA2' ' HB3' ' A' ' 32' ' ' LEU . . . . . . . . 0 N--CA 1.477 1.38 0 N-CA-C 111.032 -0.827 . . . . 0.0 111.032 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 94.8 mt -65.02 -49.14 71.35 Favored 'General case' 0 N--CA 1.48 1.028 0 N-CA-C 114.291 1.219 . . . . 0.0 114.291 -179.22 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 27.8 p -59.2 -38.83 80.85 Favored 'General case' 0 N--CA 1.48 1.065 0 N-CA-C 114.167 1.173 . . . . 0.0 114.167 175.873 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 13.8 tp -62.32 -50.61 70.93 Favored 'General case' 0 N--CA 1.48 1.047 0 CA-C-O 120.853 0.358 . . . . 0.0 111.11 170.275 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.691 HD11 HG13 ' A' ' 29' ' ' VAL . 0.7 OUTLIER -61.43 -30.89 70.85 Favored 'General case' 0 N--CA 1.473 0.706 0 N-CA-C 114.835 1.421 . . . . 0.0 114.835 -179.284 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -70.36 -43.79 69.45 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 123.568 0.747 . . . . 0.0 112.562 173.239 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -64.77 -31.43 72.65 Favored 'General case' 0 N--CA 1.475 0.798 0 N-CA-C 112.977 0.732 . . . . 0.0 112.977 174.074 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -60.22 -21.24 61.56 Favored 'General case' 0 N--CA 1.476 0.842 0 N-CA-C 115.817 1.784 . . . . 0.0 115.817 177.124 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -49.63 -33.63 18.94 Favored Glycine 0 CA--C 1.542 1.781 0 C-N-CA 126.198 1.856 . . . . 0.0 114.423 179.631 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 66.3 ttp85 -49.61 -60.2 3.08 Favored 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 125.602 1.561 . . . . 0.0 112.339 179.84 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 12.5 tt0 -129.15 32.08 4.77 Favored 'General case' 0 N--CA 1.48 1.069 0 CA-C-N 114.61 -1.177 . . . . 0.0 113.586 -172.571 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 8.0 t 49.75 123.55 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.295 0 C-N-CA 124.642 1.177 . . . . 0.0 113.692 -173.458 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.565 HG13 HG21 ' A' ' 25' ' ' VAL . 8.7 tp -29.01 -49.8 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.482 1.136 0 N-CA-C 117.947 2.573 . . . . 0.0 117.947 -174.713 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 33.8 ttmt -57.97 -68.67 0.22 Allowed 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 123.849 0.86 . . . . 0.0 111.93 177.383 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -62.61 -33.96 76.05 Favored 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 124.743 1.217 . . . . 0.0 113.397 179.588 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 88.5 t80 -49.5 -63.48 1.09 Allowed 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 125.11 1.364 . . . . 0.0 111.786 175.15 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.423 HD13 HG13 ' A' ' 15' ' ' VAL . 59.9 mt -65.09 -39.87 93.78 Favored 'General case' 0 N--CA 1.475 0.802 0 N-CA-C 114.469 1.285 . . . . 0.0 114.469 -178.299 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . 0.795 ' HA ' HG13 ' A' ' 19' ' ' VAL . 97.8 mttt -58.66 -41.15 85.44 Favored 'General case' 0 N--CA 1.475 0.803 0 N-CA-C 114.34 1.237 . . . . 0.0 114.34 179.44 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 22.1 tttt -80.64 -49.66 10.96 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-N 114.628 -1.169 . . . . 0.0 111.983 173.753 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . 0.425 ' O ' ' HB2' ' A' ' 62' ' ' LYS . 31.2 tt0 -58.62 -49.29 78.05 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-N 115.672 -0.694 . . . . 0.0 112.421 -173.454 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.633 HD12 HG21 ' A' ' 67' ' ' VAL . 2.7 mm -75.53 -25.35 17.64 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.937 0 C-N-CA 120.658 -0.417 . . . . 0.0 111.91 -177.261 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.548 ' HB2' ' O ' ' A' ' 56' ' ' LYS . 2.5 tttt -62.85 -32.95 74.28 Favored 'General case' 0 N--CA 1.472 0.641 0 N-CA-C 114.599 1.333 . . . . 0.0 114.599 169.485 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 3.0 mptp? -81.36 -43.31 19.22 Favored 'General case' 0 N--CA 1.482 1.137 0 CA-C-N 114.132 -1.395 . . . . 0.0 112.373 173.271 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . 0.425 ' HB2' ' O ' ' A' ' 58' ' ' GLU . 17.4 tptt -71.59 -52.52 17.66 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 126.636 1.974 . . . . 0.0 114.038 -171.72 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 97.6 114.63 3.28 Favored Glycine 0 N--CA 1.475 1.246 0 CA-C-O 122.602 1.112 . . . . 0.0 110.895 -170.216 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.595 ' HE2' ' HG3' ' A' ' 20' ' ' GLU . 11.8 mptt -32.25 -52.11 0.27 Allowed 'General case' 0 N--CA 1.474 0.747 0 N-CA-C 119.251 3.056 . . . . 0.0 119.251 177.024 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . 1.045 HH21 HG13 ' A' ' 68' ' ' ILE . 0.0 OUTLIER -59.74 -45.31 92.59 Favored 'General case' 0 N--CA 1.476 0.827 0 N-CA-C 114.318 1.229 . . . . 0.0 114.318 -179.354 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -63.36 -29.85 71.08 Favored 'General case' 0 N--CA 1.474 0.751 0 CA-C-N 114.026 -1.443 . . . . 0.0 113.871 172.413 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.633 HG21 HD12 ' A' ' 59' ' ' ILE . 95.4 t -71.13 -33.12 50.06 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 N-CA-C 112.527 0.566 . . . . 0.0 112.527 178.175 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 1.045 HG13 HH21 ' A' ' 65' ' ' ARG . 27.0 mm -51.57 -47.49 37.05 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.333 0 O-C-N 123.902 0.751 . . . . 0.0 109.669 167.347 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -69.19 -51.48 37.59 Favored 'General case' 0 N--CA 1.483 1.21 0 CA-C-N 114.898 -1.046 . . . . 0.0 113.326 178.881 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 29.3 t90 . . . . . 0 N--CA 1.479 0.99 0 C-N-CA 124.657 1.183 . . . . 0.0 113.096 179.703 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.768 ' SD ' HD13 ' A' ' 42' ' ' LEU . 2.4 mmm . . . . . 0 CA--C 1.537 0.449 0 N-CA-C 111.442 0.164 . . . . 0.0 111.442 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -62.14 -58.78 6.5 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-N 113.65 -1.614 . . . . 0.0 112.261 177.871 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 15.5 ttpp -65.49 -54.05 33.73 Favored 'General case' 0 N--CA 1.476 0.832 0 CA-C-N 113.486 -1.688 . . . . 0.0 113.391 -173.478 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 12.1 tt0 -71.88 -37.47 70.16 Favored 'General case' 0 N--CA 1.477 0.911 0 N-CA-C 114.319 1.229 . . . . 0.0 114.319 -171.165 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . 0.436 ' HD1' ' HB2' ' A' ' 41' ' ' SER . 71.9 m-85 -102.84 -10.66 18.89 Favored 'General case' 0 N--CA 1.475 0.783 0 N-CA-C 117.473 2.397 . . . . 0.0 117.473 -172.944 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 74.36 50.9 9.13 Favored Glycine 0 CA--C 1.539 1.581 0 CA-C-O 122.459 1.033 . . . . 0.0 111.461 -174.604 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -113.86 146.84 36.43 Favored Pre-proline 0 N--CA 1.476 0.873 0 CA-C-N 112.998 -1.601 . . . . 0.0 109.767 179.405 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 97.4 Cg_endo -88.58 152.64 6.34 Favored 'Trans proline' 0 C--O 1.236 0.378 0 N-CA-C 109.733 -0.91 . . . . 0.0 109.733 165.498 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -48.77 -29.31 4.39 Favored 'General case' 0 N--CA 1.474 0.75 0 N-CA-C 115.119 1.525 . . . . 0.0 115.119 171.342 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -38.97 -47.75 1.5 Allowed 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 126.392 1.877 . . . . 0.0 114.498 170.092 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.729 HG12 HG22 ' A' ' 31' ' ' ILE . 33.0 m -99.04 -39.06 7.51 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.0 0 N-CA-C 113.791 1.034 . . . . 0.0 113.791 -176.892 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 0.402 ' O ' ' HG ' ' A' ' 16' ' ' LEU . . . -62.8 -38.02 89.02 Favored 'General case' 0 CA--C 1.547 0.865 0 N-CA-C 112.814 0.672 . . . . 0.0 112.814 176.982 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -58.5 -47.45 89.85 Favored Glycine 0 N--CA 1.486 1.995 0 O-C-N 124.535 1.147 . . . . 0.0 112.394 173.551 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 16.4 m -59.06 -39.57 82.48 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 124.625 1.17 . . . . 0.0 113.918 173.967 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.472 ' O ' HG23 ' A' ' 19' ' ' VAL . 40.6 t -57.04 -44.73 83.38 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.116 0 C-N-CA 123.682 0.793 . . . . 0.0 111.239 172.824 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.66 HD11 HG12 ' A' ' 68' ' ' ILE . 37.0 mt -60.97 -45.96 92.67 Favored 'General case' 0 N--CA 1.481 1.116 0 N-CA-C 112.831 0.678 . . . . 0.0 112.831 178.782 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 24.6 t-20 -50.14 -50.22 49.53 Favored 'General case' 0 N--CA 1.48 1.051 0 O-C-N 124.612 1.195 . . . . 0.0 111.067 174.475 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 56.5 t -57.65 -50.41 77.46 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 CA-C-N 113.056 -1.884 . . . . 0.0 111.841 178.624 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.611 HG11 ' HB ' ' A' ' 59' ' ' ILE . 24.3 t -59.31 -45.68 93.03 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.291 0 O-C-N 123.681 0.613 . . . . 0.0 110.943 -179.937 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . 0.558 ' HG3' ' HE2' ' A' ' 64' ' ' LYS . 14.3 mt-10 -57.69 -44.39 85.78 Favored 'General case' 0 N--CA 1.477 0.875 0 C-N-CA 125.153 1.381 . . . . 0.0 114.232 179.921 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -77.36 -17.46 58.22 Favored 'General case' 0 CA--C 1.541 0.609 0 N-CA-C 113.97 1.1 . . . . 0.0 113.97 178.35 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 71.61 51.45 16.06 Favored Glycine 0 N--CA 1.477 1.382 0 O-C-N 124.138 0.898 . . . . 0.0 111.86 -170.277 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -109.75 167.31 12.75 Favored Glycine 0 N--CA 1.48 1.597 0 CA-C-O 122.844 1.247 . . . . 0.0 112.634 -177.415 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' TRP . . . . . 0.669 ' HB3' HG22 ' A' ' 26' ' ' THR . 77.1 m95 -78.19 105.95 9.77 Favored 'General case' 0 N--CA 1.479 0.997 0 CA-C-N 113.252 -1.474 . . . . 0.0 111.818 -178.524 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.797 HG21 ' HB2' ' A' ' 55' ' ' LEU . 0.4 OUTLIER -62.58 -16.5 16.89 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.948 0 CA-C-N 113.897 -1.501 . . . . 0.0 112.825 171.021 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.669 HG22 ' HB3' ' A' ' 24' ' ' TRP . 15.3 t -67.74 -27.71 67.02 Favored 'General case' 0 N--CA 1.48 1.045 0 N-CA-C 114.513 1.301 . . . . 0.0 114.513 -178.993 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . 0.606 ' HB ' HD12 ' A' ' 28' ' ' ILE . 0.7 OUTLIER -71.11 -48.86 49.85 Favored 'General case' 0 N--CA 1.48 1.054 0 CA-C-O 121.445 0.64 . . . . 0.0 110.813 170.111 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.606 HD12 ' HB ' ' A' ' 27' ' ' THR . 3.4 mp -65.84 -25.36 36.08 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 C-N-CA 125.956 1.702 . . . . 0.0 112.86 -179.474 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.502 HG22 HD21 ' A' ' 43' ' ' LEU . 7.9 t -36.48 -44.21 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.409 0 C-N-CA 124.101 0.96 . . . . 0.0 112.013 162.255 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 85.2 p -59.01 -39.05 80.7 Favored 'General case' 0 N--CA 1.486 1.359 0 N-CA-C 113.831 1.048 . . . . 0.0 113.831 178.688 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.729 HG22 HG12 ' A' ' 11' ' ' VAL . 39.6 mm -76.65 -35.66 25.85 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.814 0 C-N-CA 124.51 1.124 . . . . 0.0 110.178 -177.557 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.701 HD22 ' HB ' ' A' ' 11' ' ' VAL . 3.8 mm? -59.71 -54.38 47.08 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 125.161 1.384 . . . . 0.0 112.973 170.884 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -68.83 -24.2 64.35 Favored 'General case' 0 N--CA 1.476 0.833 0 N-CA-C 114.765 1.394 . . . . 0.0 114.765 177.066 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -53.54 -28.17 30.0 Favored 'General case' 0 N--CA 1.482 1.131 0 N-CA-C 113.4 0.889 . . . . 0.0 113.4 167.092 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.404 ' HB ' ' O ' ' A' ' 32' ' ' LEU . 70.0 t . . . . . 0 N--CA 1.481 1.111 0 C-N-CA 125.087 1.355 . . . . 0.0 112.354 169.807 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . 0.441 ' O ' ' HG ' ' A' ' 43' ' ' LEU . . . . . . . . 0 CA--C 1.539 1.588 0 N-CA-C 111.433 -0.667 . . . . 0.0 111.433 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 79.4 mt -60.4 -49.7 76.52 Favored 'General case' 0 N--CA 1.479 1.022 0 N-CA-C 114.594 1.331 . . . . 0.0 114.594 179.594 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . 0.436 ' HB2' ' HD1' ' A' ' 5' ' ' PHE . 2.1 p -57.34 -37.33 72.38 Favored 'General case' 0 N--CA 1.479 1.021 0 N-CA-C 114.344 1.239 . . . . 0.0 114.344 177.337 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.768 HD13 ' SD ' ' A' ' 1' ' ' MET . 18.8 tp -62.94 -49.2 75.7 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 123.692 0.797 . . . . 0.0 110.436 171.396 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.502 HD21 HG22 ' A' ' 29' ' ' VAL . 49.5 mt -58.38 -33.74 69.95 Favored 'General case' 0 N--CA 1.476 0.855 0 N-CA-C 114.7 1.37 . . . . 0.0 114.7 178.087 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -65.1 -43.95 90.37 Favored 'General case' 0 N--CA 1.476 0.838 0 N-CA-C 112.324 0.491 . . . . 0.0 112.324 172.581 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -63.18 -43.17 98.98 Favored 'General case' 0 N--CA 1.484 1.251 0 C-N-CA 122.849 0.46 . . . . 0.0 111.729 173.276 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -57.34 -26.49 61.06 Favored 'General case' 0 N--CA 1.472 0.665 0 N-CA-C 115.645 1.72 . . . . 0.0 115.645 -176.597 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -45.86 -42.43 11.31 Favored Glycine 0 CA--C 1.546 2.029 0 C-N-CA 125.764 1.65 . . . . 0.0 114.052 178.589 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 29.0 ttm180 -48.54 -53.25 18.94 Favored 'General case' 0 N--CA 1.476 0.844 0 CA-C-N 112.558 -1.821 . . . . 0.0 113.673 -175.723 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 17.2 tt0 -126.84 36.72 4.41 Favored 'General case' 0 N--CA 1.474 0.77 0 N-CA-C 113.258 0.836 . . . . 0.0 113.258 178.024 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 18.4 t 48.33 120.96 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.421 0 C-N-CA 126.17 1.788 . . . . 0.0 113.821 -178.031 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 7.8 tp -31.31 -51.42 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 N-CA-C 116.595 2.072 . . . . 0.0 116.595 -176.319 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 70.3 mttt -48.68 -67.03 0.3 Allowed 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 125.477 1.511 . . . . 0.0 112.927 176.113 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -74.47 -30.86 62.03 Favored 'General case' 0 N--CA 1.466 0.352 0 N-CA-C 114.735 1.384 . . . . 0.0 114.735 -179.198 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . 0.504 ' HD2' ' HG ' ' A' ' 55' ' ' LEU . 72.9 t80 -49.0 -63.82 0.99 Allowed 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 124.933 1.293 . . . . 0.0 112.291 -178.133 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.797 ' HB2' HG21 ' A' ' 25' ' ' VAL . 42.4 mt -73.29 -34.44 65.76 Favored 'General case' 0 N--CA 1.477 0.885 0 N-CA-C 114.884 1.438 . . . . 0.0 114.884 -174.595 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . 0.578 ' HA ' HG13 ' A' ' 19' ' ' VAL . 57.8 mtpt -58.59 -46.17 87.53 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 114.438 -1.256 . . . . 0.0 112.67 177.052 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 61.6 tttm -77.44 -50.77 11.99 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 114.903 -1.044 . . . . 0.0 111.873 174.409 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 58.8 tt0 -59.1 -44.99 92.0 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-O 118.225 -0.893 . . . . 0.0 111.515 -170.404 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.748 HG23 HG21 ' A' ' 67' ' ' VAL . 4.0 mm -79.32 -20.08 12.61 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.789 0 C-N-CA 119.841 -0.744 . . . . 0.0 112.712 -175.262 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 23.1 tptt -65.57 -37.28 86.22 Favored 'General case' 0 CA--C 1.549 0.909 0 CA-C-O 122.449 1.119 . . . . 0.0 113.454 170.545 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 21.6 ttpp -84.53 -37.78 20.82 Favored 'General case' 0 CA--C 1.554 1.101 0 CA-C-N 112.355 -2.202 . . . . 0.0 111.415 -178.601 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 6.9 tttt -77.21 -43.62 33.0 Favored 'General case' 0 CA--C 1.541 0.626 0 N-CA-C 116.603 2.075 . . . . 0.0 116.603 -177.432 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 91.35 111.5 1.7 Allowed Glycine 0 N--CA 1.478 1.445 0 CA-C-O 122.584 1.102 . . . . 0.0 111.332 -177.48 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.635 ' H ' ' HD2' ' A' ' 64' ' ' LYS . 10.4 mptt -43.87 -41.21 4.99 Favored 'General case' 0 N--CA 1.487 1.377 0 N-CA-C 117.863 2.542 . . . . 0.0 117.863 -171.778 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . 0.485 ' O ' ' HB ' ' A' ' 68' ' ' ILE . 0.0 OUTLIER -56.16 -49.41 74.06 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 124.583 1.153 . . . . 0.0 113.386 178.402 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -67.65 -23.98 65.39 Favored 'General case' 0 N--CA 1.477 0.904 0 N-CA-C 114.61 1.337 . . . . 0.0 114.61 174.961 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.748 HG21 HG23 ' A' ' 59' ' ' ILE . 45.6 t -75.16 -32.23 26.05 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.083 0 CA-C-N 114.86 -1.064 . . . . 0.0 110.822 176.325 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.66 HG12 HD11 ' A' ' 16' ' ' LEU . 8.0 mm -51.7 -46.71 38.88 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.951 0 C-N-CA 123.355 0.662 . . . . 0.0 110.075 168.491 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -68.87 -48.91 62.24 Favored 'General case' 0 N--CA 1.482 1.143 0 O-C-N 124.542 1.152 . . . . 0.0 113.345 176.585 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 34.6 t90 . . . . . 0 N--CA 1.477 0.88 0 C-N-CA 124.799 1.24 . . . . 0.0 113.6 -178.846 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.536 ' HE3' HD13 ' A' ' 7' ' ' ILE . 22.5 mtp . . . . . 0 N--CA 1.48 1.036 0 N-CA-C 112.553 0.575 . . . . 0.0 112.553 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -60.56 -51.31 69.98 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-N 115.213 -0.903 . . . . 0.0 113.259 177.629 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 57.8 tttp -70.32 -51.44 30.15 Favored 'General case' 0 CA--C 1.551 0.987 0 CA-C-N 113.568 -1.651 . . . . 0.0 112.978 -173.42 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -77.22 -38.57 51.05 Favored 'General case' 0 N--CA 1.482 1.166 0 N-CA-C 116.577 2.065 . . . . 0.0 116.577 -170.361 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . 0.676 ' HD1' ' HB2' ' A' ' 41' ' ' SER . 53.3 m-85 -99.7 -30.99 11.78 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-N 112.914 -1.948 . . . . 0.0 115.356 -168.395 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 93.88 50.73 2.24 Favored Glycine 0 CA--C 1.541 1.682 0 O-C-N 125.277 1.611 . . . . 0.0 110.964 -171.174 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.536 HD13 ' HE3' ' A' ' 1' ' ' MET . 0.6 OUTLIER -117.83 147.76 41.82 Favored Pre-proline 0 N--CA 1.475 0.823 0 CA-C-N 113.4 -1.4 . . . . 0.0 109.287 -178.528 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_endo -89.42 155.04 5.42 Favored 'Trans proline' 0 C--N 1.332 -0.327 0 N-CA-C 108.861 -1.246 . . . . 0.0 108.861 161.307 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -50.18 -26.04 4.19 Favored 'General case' 0 CA--C 1.54 0.58 0 N-CA-C 115.208 1.558 . . . . 0.0 115.208 173.516 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -47.32 -59.38 3.23 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 125.237 1.415 . . . . 0.0 112.678 172.626 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.89 HG12 HG22 ' A' ' 31' ' ' ILE . 33.5 m -81.9 -27.6 9.61 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.988 0 N-CA-C 114.181 1.178 . . . . 0.0 114.181 -175.278 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -67.94 -33.84 75.44 Favored 'General case' 0 N--CA 1.478 0.932 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.651 172.863 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -61.24 -42.54 99.81 Favored Glycine 0 CA--C 1.537 1.451 0 C-N-CA 124.073 0.844 . . . . 0.0 112.833 173.263 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.476 HG22 HG13 ' A' ' 28' ' ' ILE . 0.8 OUTLIER -58.85 -41.63 87.41 Favored 'General case' 0 N--CA 1.478 0.966 0 N-CA-C 114.166 1.173 . . . . 0.0 114.166 173.792 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.539 HG13 HD13 ' A' ' 55' ' ' LEU . 22.2 t -53.87 -43.18 56.16 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.265 0 C-N-CA 123.514 0.725 . . . . 0.0 112.915 170.67 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 25.0 mt -60.74 -40.87 94.05 Favored 'General case' 0 N--CA 1.476 0.857 0 N-CA-C 113.278 0.844 . . . . 0.0 113.278 178.102 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -52.43 -45.5 66.0 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 124.405 1.082 . . . . 0.0 111.977 174.698 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -60.44 -51.65 70.57 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.682 0 CA-C-N 114.283 -1.326 . . . . 0.0 112.339 175.52 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.673 HG13 ' HA ' ' A' ' 56' ' ' LYS . 17.9 t -58.85 -45.0 91.82 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.388 0 O-C-N 124.265 0.978 . . . . 0.0 111.002 -178.876 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 21.0 mt-10 -66.88 -39.52 87.53 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 125.97 1.708 . . . . 0.0 115.418 -177.705 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -101.93 -24.19 14.04 Favored 'General case' 0 N--CA 1.474 0.753 0 N-CA-C 115.82 1.785 . . . . 0.0 115.82 -172.01 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . 0.618 ' HA2' ' HE2' ' A' ' 56' ' ' LYS . . . 77.7 44.21 13.1 Favored Glycine 0 N--CA 1.484 1.897 0 N-CA-C 110.742 -0.943 . . . . 0.0 110.742 -166.75 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -85.67 169.29 42.7 Favored Glycine 0 N--CA 1.474 1.208 0 C-N-CA 124.294 0.95 . . . . 0.0 112.995 -175.451 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 66.6 m95 -67.43 99.8 0.78 Allowed 'General case' 0 C--O 1.243 0.751 0 CA-C-O 123.257 1.503 . . . . 0.0 111.728 176.75 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.753 HG21 ' HA ' ' A' ' 52' ' ' LYS . 16.0 t -56.32 -24.46 18.38 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.939 0 CA-C-N 113.521 -1.672 . . . . 0.0 112.481 174.091 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 11.7 p -58.55 -45.68 88.42 Favored 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 123.735 0.814 . . . . 0.0 112.71 176.528 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -61.65 -45.22 94.96 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 124.095 0.958 . . . . 0.0 111.211 176.023 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.476 HG13 HG22 ' A' ' 14' ' ' THR . 1.7 mp -56.96 -48.43 81.62 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.915 0 CA-C-N 114.701 -1.136 . . . . 0.0 112.951 175.225 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.427 HG13 HD11 ' A' ' 43' ' ' LEU . 54.4 t -52.38 -41.83 36.34 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.059 0 C-N-CA 123.85 0.86 . . . . 0.0 111.937 176.948 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 73.2 m -55.96 -47.2 78.05 Favored 'General case' 0 N--CA 1.486 1.327 0 N-CA-C 113.625 0.972 . . . . 0.0 113.625 174.349 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.89 HG22 HG12 ' A' ' 11' ' ' VAL . 36.5 mm -69.47 -38.17 76.44 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.964 0 CA-C-N 115.149 -0.932 . . . . 0.0 109.349 -175.906 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.53 HD22 ' HB ' ' A' ' 11' ' ' VAL . 4.3 mm? -61.81 -52.66 63.29 Favored 'General case' 0 N--CA 1.48 1.026 0 CA-C-N 113.813 -1.54 . . . . 0.0 113.496 175.508 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 8.3 p -68.01 -31.72 71.6 Favored 'General case' 0 N--CA 1.476 0.834 0 N-CA-C 114.76 1.393 . . . . 0.0 114.76 177.36 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -52.46 -29.62 25.65 Favored 'General case' 0 N--CA 1.479 0.981 0 N-CA-C 113.714 1.005 . . . . 0.0 113.714 172.117 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 85.6 t . . . . . 0 N--CA 1.492 1.652 0 C-N-CA 124.179 0.992 . . . . 0.0 112.453 171.789 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . 0.433 ' O ' ' HG ' ' A' ' 43' ' ' LEU . . . . . . . . 0 N--CA 1.478 1.49 0 N-CA-C 110.875 -0.89 . . . . 0.0 110.875 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 18.9 mt -59.07 -48.94 79.77 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 124.594 1.157 . . . . 0.0 114.097 177.999 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . 0.676 ' HB2' ' HD1' ' A' ' 5' ' ' PHE . 0.0 OUTLIER -58.63 -41.46 86.03 Favored 'General case' 0 N--CA 1.479 1.014 0 N-CA-C 113.824 1.046 . . . . 0.0 113.824 174.927 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 15.3 tp -60.25 -44.44 95.26 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 122.477 0.311 . . . . 0.0 110.87 174.07 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.433 ' HG ' ' O ' ' A' ' 39' ' ' GLY . 79.6 mt -62.01 -36.25 80.97 Favored 'General case' 0 N--CA 1.477 0.891 0 N-CA-C 115.017 1.488 . . . . 0.0 115.017 178.103 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -63.12 -50.02 72.12 Favored 'General case' 0 N--CA 1.472 0.635 0 O-C-N 123.962 0.789 . . . . 0.0 112.076 172.2 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -62.67 -33.57 75.34 Favored 'General case' 0 N--CA 1.486 1.347 0 N-CA-C 112.571 0.582 . . . . 0.0 112.571 177.558 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -65.29 -19.72 66.09 Favored 'General case' 0 N--CA 1.474 0.732 0 N-CA-C 115.702 1.741 . . . . 0.0 115.702 178.289 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -52.61 -38.29 51.95 Favored Glycine 0 N--CA 1.477 1.412 0 O-C-N 124.665 1.228 . . . . 0.0 112.696 178.006 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 65.1 ttp85 -54.12 -47.03 72.29 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 125.541 1.536 . . . . 0.0 113.805 -174.744 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 15.8 tt0 -132.25 36.11 3.64 Favored 'General case' 0 N--CA 1.477 0.899 0 N-CA-C 114.903 1.446 . . . . 0.0 114.903 -174.722 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 78.2 p 49.37 116.99 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.823 0 C-N-CA 124.06 0.944 . . . . 0.0 113.073 -174.798 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.544 HG13 HG11 ' A' ' 25' ' ' VAL 0.256 8.2 tp -31.5 -49.54 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 N-CA-C 117.974 2.583 . . . . 0.0 117.974 -173.58 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 0.753 ' HA ' HG21 ' A' ' 25' ' ' VAL . 0.3 OUTLIER -64.98 -66.57 0.53 Allowed 'General case' 0 N--CA 1.489 1.518 0 CA-C-N 118.214 0.461 . . . . 0.0 111.885 178.132 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -50.74 -40.02 53.53 Favored 'General case' 0 C--O 1.236 0.349 0 O-C-N 124.868 1.355 . . . . 0.0 112.522 178.804 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 91.6 t80 -48.84 -62.82 1.32 Allowed 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 126.108 1.763 . . . . 0.0 111.23 174.212 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.539 HD13 HG13 ' A' ' 15' ' ' VAL . 92.4 mt -64.98 -39.62 93.74 Favored 'General case' 0 N--CA 1.478 0.956 0 N-CA-C 115.354 1.613 . . . . 0.0 115.354 -178.792 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . 0.673 ' HA ' HG13 ' A' ' 19' ' ' VAL . 29.1 mttt -58.78 -48.07 82.55 Favored 'General case' 0 C--N 1.319 -0.717 0 N-CA-C 115.444 1.646 . . . . 0.0 115.444 176.7 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 71.4 tttt -74.48 -50.71 17.18 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-N 115.039 -0.982 . . . . 0.0 112.039 173.547 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . 0.484 ' O ' ' HB2' ' A' ' 62' ' ' LYS . 31.3 tt0 -63.28 -47.37 82.63 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-O 118.433 -0.794 . . . . 0.0 111.549 -168.542 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.693 HG23 HG21 ' A' ' 67' ' ' VAL . 3.2 mm -77.66 -19.62 13.96 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.928 0 N-CA-C 112.117 0.414 . . . . 0.0 112.117 -176.334 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 2.7 ttmp? -68.62 -41.61 79.24 Favored 'General case' 0 CA--C 1.547 0.835 0 CA-C-N 115.511 -0.768 . . . . 0.0 112.643 170.069 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 25.4 ttpp -72.6 -41.91 65.1 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 125.651 1.58 . . . . 0.0 112.91 175.223 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . 0.484 ' HB2' ' O ' ' A' ' 58' ' ' GLU . 0.0 OUTLIER -70.68 -53.45 15.69 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 126.674 1.99 . . . . 0.0 113.855 -177.034 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 99.37 106.24 2.69 Favored Glycine 0 N--CA 1.477 1.405 0 N-CA-C 110.399 -1.08 . . . . 0.0 110.399 -174.246 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.786 ' H ' ' HD2' ' A' ' 64' ' ' LYS . 10.8 mptt -30.87 -50.21 0.14 Allowed 'General case' 0 N--CA 1.485 1.319 0 N-CA-C 118.769 2.878 . . . . 0.0 118.769 -175.738 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . 0.467 ' O ' ' HB ' ' A' ' 68' ' ' ILE . 0.0 OUTLIER -59.22 -42.1 90.2 Favored 'General case' 0 N--CA 1.474 0.73 0 N-CA-C 114.517 1.303 . . . . 0.0 114.517 178.759 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -69.56 -26.62 64.57 Favored 'General case' 0 N--CA 1.478 0.927 0 CA-C-N 114.55 -1.205 . . . . 0.0 113.65 174.729 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.693 HG21 HG23 ' A' ' 59' ' ' ILE . 72.6 t -69.63 -34.38 61.09 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.048 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.448 175.711 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.467 ' HB ' ' O ' ' A' ' 65' ' ' ARG . 19.8 mm -52.58 -41.57 37.52 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.941 0 O-C-N 124.223 0.952 . . . . 0.0 110.934 170.045 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -70.21 -53.84 15.37 Favored 'General case' 0 N--CA 1.48 1.042 0 N-CA-C 113.247 0.832 . . . . 0.0 113.247 174.535 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 46.7 t90 . . . . . 0 CA--C 1.545 0.76 0 C-N-CA 126.321 1.848 . . . . 0.0 114.325 -176.497 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.752 ' HE1' HG21 ' A' ' 15' ' ' VAL . 70.0 mtp . . . . . 0 N--CA 1.475 0.803 0 N-CA-C 112.98 0.733 . . . . 0.0 112.98 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . 0.418 ' HA ' ' O ' ' A' ' 7' ' ' ILE . . . -61.52 -56.28 21.78 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-N 114.546 -1.206 . . . . 0.0 112.112 172.685 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 95.1 mttt -64.06 -62.86 1.36 Allowed 'General case' 0 CA--C 1.541 0.621 0 CA-C-N 114.015 -1.448 . . . . 0.0 114.453 -177.555 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 3.9 mp0 -75.21 -40.54 59.1 Favored 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 115.016 1.488 . . . . 0.0 115.016 -170.065 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . 0.486 ' HD2' ' HA ' ' A' ' 1' ' ' MET . 41.3 m-85 -101.85 -11.68 18.85 Favored 'General case' 0 N--CA 1.476 0.851 0 N-CA-C 116.557 2.058 . . . . 0.0 116.557 -174.005 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 67.39 37.37 90.33 Favored Glycine 0 CA--C 1.538 1.528 0 CA-C-O 121.855 0.697 . . . . 0.0 111.359 -173.731 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.663 HG23 HG23 ' A' ' 11' ' ' VAL . 0.7 OUTLIER -110.06 115.31 55.06 Favored Pre-proline 0 N--CA 1.474 0.73 0 C-N-CA 124.547 1.139 . . . . 0.0 109.086 179.016 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 96.3 Cg_endo -65.2 154.92 71.22 Favored 'Trans proline' 0 CA--C 1.536 0.602 0 C-N-CA 120.614 0.876 . . . . 0.0 111.019 -177.165 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -46.49 -30.11 2.05 Favored 'General case' 0 N--CA 1.472 0.662 0 N-CA-C 115.833 1.79 . . . . 0.0 115.833 174.478 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -40.4 -60.76 1.03 Allowed 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 126.337 1.855 . . . . 0.0 112.875 171.116 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.98 HG12 HG22 ' A' ' 31' ' ' ILE . 34.6 m -86.86 -31.11 5.99 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.915 0 CA-C-N 114.58 -1.191 . . . . 0.0 113.679 -174.793 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -59.63 -33.81 71.98 Favored 'General case' 0 CA--C 1.547 0.843 0 N-CA-C 113.24 0.829 . . . . 0.0 113.24 171.611 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -63.68 -44.18 96.77 Favored Glycine 0 N--CA 1.481 1.69 0 C-N-CA 124.044 0.831 . . . . 0.0 112.229 174.641 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.915 HG22 HG13 ' A' ' 28' ' ' ILE . 1.7 m -61.33 -36.87 81.34 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 125.368 1.467 . . . . 0.0 113.674 174.175 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.752 HG21 ' HE1' ' A' ' 1' ' ' MET . 6.1 t -58.16 -45.36 88.7 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.359 0 N-CA-C 113.044 0.757 . . . . 0.0 113.044 170.187 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.404 HD13 ' HB3' ' A' ' 64' ' ' LYS . 39.0 mt -57.07 -38.56 73.47 Favored 'General case' 0 N--CA 1.482 1.173 0 CA-C-N 115.352 -0.84 . . . . 0.0 112.868 177.102 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -53.01 -46.17 68.25 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-N 113.355 -1.748 . . . . 0.0 113.384 176.268 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 1.7 t -55.52 -49.47 73.25 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.124 0 C-N-CA 124.696 1.198 . . . . 0.0 113.042 172.26 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.792 HG13 ' HA ' ' A' ' 56' ' ' LYS . 11.6 t -63.45 -45.44 97.9 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.227 0 C-N-CA 123.635 0.774 . . . . 0.0 111.483 -174.961 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . 0.432 ' HG3' ' HE2' ' A' ' 64' ' ' LYS . 19.0 mt-10 -65.14 -40.98 95.17 Favored 'General case' 0 CA--C 1.541 0.6 0 N-CA-C 115.843 1.794 . . . . 0.0 115.843 -179.6 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -101.12 -20.9 15.13 Favored 'General case' 0 N--CA 1.479 1.007 0 N-CA-C 116.287 1.958 . . . . 0.0 116.287 -174.716 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 71.57 39.63 60.5 Favored Glycine 0 N--CA 1.481 1.634 0 N-CA-C 110.894 -0.882 . . . . 0.0 110.894 -164.954 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -82.17 164.52 44.2 Favored Glycine 0 N--CA 1.478 1.444 0 C-N-CA 124.388 0.994 . . . . 0.0 113.006 -174.123 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' TRP . . . . . 0.499 ' HB3' HG22 ' A' ' 26' ' ' THR . 2.3 m-90 -62.33 103.9 0.44 Allowed 'General case' 0 N--CA 1.475 0.787 0 CA-C-O 123.166 1.46 . . . . 0.0 112.107 179.603 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 3.0 p -55.57 -24.56 16.36 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.718 0 CA-C-N 112.89 -1.959 . . . . 0.0 112.851 172.87 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.499 HG22 ' HB3' ' A' ' 24' ' ' TRP . 9.8 t -62.49 -45.92 90.82 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-O 118.002 -0.999 . . . . 0.0 113.441 177.951 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -60.09 -42.06 93.85 Favored 'General case' 0 N--CA 1.484 1.26 0 O-C-N 124.416 1.072 . . . . 0.0 110.454 175.642 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.915 HG13 HG22 ' A' ' 14' ' ' THR . 1.9 mp -65.62 -47.53 85.92 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.649 0 C-N-CA 124.634 1.174 . . . . 0.0 112.583 -179.534 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 72.7 t -50.37 -42.7 21.29 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 O-C-N 123.755 0.66 . . . . 0.0 111.232 174.426 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 5.5 m -55.55 -40.95 72.57 Favored 'General case' 0 N--CA 1.481 1.106 0 N-CA-C 113.919 1.081 . . . . 0.0 113.919 175.948 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.98 HG22 HG12 ' A' ' 11' ' ' VAL . 34.9 mm -71.45 -38.86 70.07 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.957 0 C-N-CA 124.14 0.976 . . . . 0.0 109.932 179.802 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.495 HD22 ' HB ' ' A' ' 11' ' ' VAL . 3.4 mm? -61.15 -40.42 93.77 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 124.716 1.207 . . . . 0.0 112.184 171.491 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 10.0 m -67.63 -36.88 81.61 Favored 'General case' 0 N--CA 1.476 0.84 0 N-CA-C 114.05 1.13 . . . . 0.0 114.05 175.813 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -53.64 -31.55 47.89 Favored 'General case' 0 N--CA 1.488 1.437 0 C-N-CA 124.325 1.05 . . . . 0.0 113.797 175.2 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 42.9 t . . . . . 0 N--CA 1.478 0.94 0 C-N-CA 125.802 1.641 . . . . 0.0 113.402 174.167 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . 0.433 ' HA3' ' HB3' ' A' ' 32' ' ' LEU . . . . . . . . 0 N--CA 1.484 1.837 0 N-CA-C 111.805 -0.518 . . . . 0.0 111.805 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 5.3 mt -56.97 -37.38 71.53 Favored 'General case' 0 N--CA 1.481 1.1 0 N-CA-C 115.954 1.835 . . . . 0.0 115.954 -167.869 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 12.3 p -59.15 -48.33 82.02 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 124.139 0.976 . . . . 0.0 112.661 176.335 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 15.0 tp -62.75 -49.39 75.21 Favored 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 122.983 0.513 . . . . 0.0 110.572 173.062 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 77.8 mt -60.47 -31.22 70.25 Favored 'General case' 0 N--CA 1.475 0.81 0 N-CA-C 113.972 1.101 . . . . 0.0 113.972 -177.462 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -69.36 -46.14 67.7 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 123.463 0.705 . . . . 0.0 111.826 173.94 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -60.74 -30.85 70.24 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 123.833 0.853 . . . . 0.0 112.563 177.317 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.426 ' HB1' ' HA ' ' A' ' 51' ' ' ILE . . . -67.38 -27.82 67.42 Favored 'General case' 0 N--CA 1.471 0.608 0 N-CA-C 115.931 1.826 . . . . 0.0 115.931 178.276 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -45.76 -45.54 13.23 Favored Glycine 0 CA--C 1.544 1.851 0 C-N-CA 126.105 1.812 . . . . 0.0 114.295 -170.811 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 24.6 tpt180 -45.79 -48.43 15.56 Favored 'General case' 0 CA--C 1.544 0.736 0 CA-C-N 111.948 -2.126 . . . . 0.0 114.328 -179.221 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 18.9 tt0 -123.74 25.89 7.91 Favored 'General case' 0 N--CA 1.481 1.107 0 N-CA-C 114.499 1.296 . . . . 0.0 114.499 -176.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 33.2 t 50.21 133.18 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.486 0 C-N-CA 125.626 1.57 . . . . 0.0 111.83 -167.971 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.426 ' HA ' ' HB1' ' A' ' 46' ' ' ALA . 7.4 tp -43.13 -45.4 1.36 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.027 0 N-CA-C 115.536 1.68 . . . . 0.0 115.536 -175.599 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 5.6 tmtm? -53.84 -71.2 0.08 Allowed 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 125.061 1.344 . . . . 0.0 111.941 177.733 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -65.47 -29.18 69.81 Favored 'General case' 0 N--CA 1.471 0.576 0 N-CA-C 115.135 1.531 . . . . 0.0 115.135 179.385 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . 0.459 ' O ' ' HB2' ' A' ' 58' ' ' GLU . 86.9 t80 -51.1 -64.64 0.75 Allowed 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 125.417 1.487 . . . . 0.0 111.579 176.565 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.461 HD13 HG13 ' A' ' 15' ' ' VAL . 75.4 mt -60.77 -37.86 83.3 Favored 'General case' 0 N--CA 1.478 0.95 0 N-CA-C 114.617 1.34 . . . . 0.0 114.617 -176.18 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . 0.792 ' HA ' HG13 ' A' ' 19' ' ' VAL . 94.0 mttt -61.3 -45.23 95.31 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 113.201 -1.818 . . . . 0.0 114.055 -179.335 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 81.4 tttt -77.25 -47.06 21.12 Favored 'General case' 0 CA--C 1.543 0.71 0 CA-C-N 115.275 -0.875 . . . . 0.0 112.703 171.463 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . 0.461 ' O ' ' HB2' ' A' ' 62' ' ' LYS . 4.1 mm-40 -57.22 -51.05 70.91 Favored 'General case' 0 C--O 1.219 -0.522 0 N-CA-C 113.743 1.016 . . . . 0.0 113.743 -175.105 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.697 HG23 HG21 ' A' ' 67' ' ' VAL . 2.6 mm -80.01 -21.1 11.91 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.484 0 N-CA-C 112.206 0.447 . . . . 0.0 112.206 -177.603 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.522 ' HB2' ' O ' ' A' ' 56' ' ' LYS . 6.9 tppt? -60.65 -42.79 97.71 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-O 123.783 1.754 . . . . 0.0 112.296 171.599 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . 0.277 19.5 tttm -81.32 -45.03 16.8 Favored 'General case' 0 CA--C 1.55 0.951 0 CA-C-N 111.132 -2.758 . . . . 0.0 111.74 -179.797 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . 0.461 ' HB2' ' O ' ' A' ' 58' ' ' GLU . 15.5 tptt -58.51 -50.66 72.95 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 126.036 1.734 . . . . 0.0 113.605 -179.135 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 86.66 108.31 0.82 Allowed Glycine 0 N--CA 1.478 1.47 0 CA-C-N 113.582 -1.644 . . . . 0.0 109.911 -169.079 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.71 ' H ' ' HD2' ' A' ' 64' ' ' LYS . 10.0 mptt -28.48 -48.38 0.06 Allowed 'General case' 0 N--CA 1.481 1.083 0 N-CA-C 119.776 3.25 . . . . 0.0 119.776 -176.625 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . 0.406 ' O ' ' HB ' ' A' ' 68' ' ' ILE . 1.2 ttp85 -54.5 -44.03 72.35 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 125.625 1.57 . . . . 0.0 113.321 178.804 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -69.25 -23.25 63.84 Favored 'General case' 0 N--CA 1.474 0.761 0 N-CA-C 114.702 1.371 . . . . 0.0 114.702 176.116 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.697 HG21 HG23 ' A' ' 59' ' ' ILE . 63.9 t -75.67 -35.88 32.48 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.31 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.893 178.752 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.406 ' HB ' ' O ' ' A' ' 65' ' ' ARG . 17.3 mm -50.39 -42.56 21.2 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 C-N-CA 124.124 0.969 . . . . 0.0 111.107 169.304 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -74.9 -52.8 10.35 Favored 'General case' 0 N--CA 1.484 1.238 0 N-CA-C 113.718 1.007 . . . . 0.0 113.718 174.789 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 33.3 t90 . . . . . 0 N--CA 1.488 1.47 0 C-N-CA 125.704 1.602 . . . . 0.0 114.118 -178.301 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.548 ' HB3' HG22 ' A' ' 7' ' ' ILE . 68.1 mtp . . . . . 0 N--CA 1.478 0.969 0 N-CA-C 112.137 0.421 . . . . 0.0 112.137 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . 0.54 ' HA ' ' O ' ' A' ' 7' ' ' ILE . . . -58.26 -52.78 64.14 Favored 'General case' 0 N--CA 1.475 0.825 0 CA-C-N 114.819 -1.082 . . . . 0.0 112.129 173.902 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.99 -65.11 0.84 Allowed 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 112.518 -2.128 . . . . 0.0 115.997 -174.962 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . 0.421 ' HB2' ' O ' ' A' ' 70' ' ' TRP . 1.8 mp0 -73.79 -26.34 60.58 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-N 112.877 -1.965 . . . . 0.0 113.496 -170.718 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . 0.413 ' HD1' ' HB2' ' A' ' 41' ' ' SER . 31.6 m-85 -118.02 -6.92 10.92 Favored 'General case' 0 N--CA 1.478 0.937 0 N-CA-C 118.025 2.602 . . . . 0.0 118.025 -174.167 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 63.13 37.22 94.56 Favored Glycine 0 CA--C 1.543 1.806 0 O-C-N 124.007 0.817 . . . . 0.0 112.551 -175.866 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.548 HG22 ' HB3' ' A' ' 1' ' ' MET . 0.5 OUTLIER -114.0 121.51 36.63 Favored Pre-proline 0 N--CA 1.475 0.778 0 CA-C-N 114.448 -0.876 . . . . 0.0 108.708 -179.833 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 96.6 Cg_endo -67.28 160.87 45.59 Favored 'Trans proline' 0 CA--C 1.532 0.411 0 C-N-CA 120.971 1.114 . . . . 0.0 111.334 -177.558 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -53.62 -27.62 28.05 Favored 'General case' 0 CA--C 1.545 0.772 0 N-CA-C 114.713 1.375 . . . . 0.0 114.713 173.048 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -45.43 -43.9 11.7 Favored 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 126.191 1.796 . . . . 0.0 114.357 174.216 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.531 HG23 HG23 ' A' ' 7' ' ' ILE . 34.5 m -102.65 -33.59 3.36 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.893 0 N-CA-C 114.306 1.225 . . . . 0.0 114.306 -176.947 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 0.412 ' O ' ' HG ' ' A' ' 16' ' ' LEU . . . -61.45 -34.17 74.97 Favored 'General case' 0 N--CA 1.475 0.776 0 CA-C-N 114.8 -1.091 . . . . 0.0 112.181 173.686 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -59.71 -49.97 72.82 Favored Glycine 0 N--CA 1.478 1.434 0 C-N-CA 124.799 1.19 . . . . 0.0 112.775 173.57 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 9.1 m -62.13 -36.39 81.65 Favored 'General case' 0 N--CA 1.479 1.001 0 N-CA-C 114.612 1.338 . . . . 0.0 114.612 175.596 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.438 ' O ' HG23 ' A' ' 19' ' ' VAL . 72.0 t -56.94 -40.11 69.96 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.133 0 C-N-CA 123.213 0.605 . . . . 0.0 111.481 173.109 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.622 HD13 ' HB3' ' A' ' 64' ' ' LYS . 27.6 mt -61.36 -43.57 98.65 Favored 'General case' 0 N--CA 1.479 1.023 0 N-CA-C 113.418 0.896 . . . . 0.0 113.418 178.636 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 56.6 t-20 -54.77 -49.77 70.08 Favored 'General case' 0 CA--C 1.548 0.901 0 O-C-N 124.614 1.197 . . . . 0.0 111.055 173.443 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 96.8 t -54.9 -52.35 44.0 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.954 0 CA-C-N 114.6 -1.182 . . . . 0.0 111.204 175.823 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.643 HG11 ' HB ' ' A' ' 59' ' ' ILE . 81.7 t -53.88 -56.14 10.61 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.307 0 O-C-N 124.05 0.844 . . . . 0.0 111.124 179.788 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 14.5 tt0 -57.13 -37.69 72.38 Favored 'General case' 0 N--CA 1.476 0.829 0 O-C-N 124.972 1.42 . . . . 0.0 113.191 -176.825 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -88.12 -16.64 32.91 Favored 'General case' 0 N--CA 1.473 0.699 0 N-CA-C 116.294 1.961 . . . . 0.0 116.294 179.15 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 70.58 33.65 67.36 Favored Glycine 0 N--CA 1.487 2.099 0 C-N-CA 124.5 1.048 . . . . 0.0 112.143 -170.012 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -77.32 -177.12 45.69 Favored Glycine 0 CA--C 1.539 1.583 0 CA-C-O 124.155 1.975 . . . . 0.0 115.542 -170.954 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' TRP . . . . . 0.419 ' HB3' ' OG1' ' A' ' 26' ' ' THR . 74.0 m95 -63.7 122.65 16.9 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 110.717 -2.741 . . . . 0.0 116.73 -176.296 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 11.9 p -42.76 -37.75 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.379 0 CA-C-N 112.492 -2.14 . . . . 0.0 113.802 164.561 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.419 ' OG1' ' HB3' ' A' ' 24' ' ' TRP . 8.4 p -60.1 -44.26 94.97 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 123.782 0.833 . . . . 0.0 111.483 176.927 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -60.72 -29.54 69.42 Favored 'General case' 0 N--CA 1.485 1.317 0 N-CA-C 112.835 0.68 . . . . 0.0 112.835 176.321 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.488 ' O ' HD23 ' A' ' 32' ' ' LEU . 30.4 mt -72.75 -68.28 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.028 0 N-CA-C 109.36 -0.607 . . . . 0.0 109.36 167.239 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 85.7 t -54.39 -48.49 68.57 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.054 0 CA-C-O 118.159 -0.924 . . . . 0.0 112.896 -170.45 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 67.2 m -64.83 -26.15 68.21 Favored 'General case' 0 N--CA 1.477 0.897 0 N-CA-C 115.172 1.545 . . . . 0.0 115.172 179.349 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.49 HG22 HG12 ' A' ' 11' ' ' VAL . 35.7 mm -85.23 -42.41 16.3 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.921 0 C-N-CA 123.047 0.539 . . . . 0.0 110.166 174.659 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.527 HD22 ' HB ' ' A' ' 11' ' ' VAL . 3.5 mm? -62.18 -30.12 70.84 Favored 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 125.107 1.363 . . . . 0.0 114.328 176.015 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 2.8 p -68.54 -30.84 69.72 Favored 'General case' 0 N--CA 1.488 1.448 0 N-CA-C 116.424 2.009 . . . . 0.0 116.424 170.472 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -58.63 -25.46 62.71 Favored 'General case' 0 N--CA 1.475 0.82 0 O-C-N 124.654 1.221 . . . . 0.0 112.868 177.16 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.43 HG23 HG11 ' A' ' 11' ' ' VAL . 98.4 t . . . . . 0 N--CA 1.481 1.077 0 C-N-CA 126.592 1.957 . . . . 0.0 112.597 175.408 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . 0.511 ' HA3' ' HB3' ' A' ' 32' ' ' LEU . . . . . . . . 0 CA--C 1.541 1.686 0 CA-C-O 119.109 -0.828 . . . . 0.0 113.48 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 20.8 mt -55.79 -43.16 76.54 Favored 'General case' 0 N--CA 1.477 0.908 0 N-CA-C 115.15 1.537 . . . . 0.0 115.15 -173.442 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . 0.413 ' HB2' ' HD1' ' A' ' 5' ' ' PHE . 8.8 p -60.0 -46.39 89.61 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 123.861 0.864 . . . . 0.0 113.063 173.937 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 12.0 tp -60.91 -51.3 69.88 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 124.002 0.921 . . . . 0.0 110.366 172.096 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.406 ' HG ' ' O ' ' A' ' 39' ' ' GLY . 52.1 mt -57.8 -33.06 68.17 Favored 'General case' 0 N--CA 1.476 0.84 0 N-CA-C 114.345 1.239 . . . . 0.0 114.345 -179.692 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -65.39 -48.43 72.9 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-N 115.765 -0.652 . . . . 0.0 112.529 172.697 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -64.7 -36.63 84.9 Favored 'General case' 0 N--CA 1.482 1.155 0 CA-C-O 121.892 0.853 . . . . 0.0 111.829 177.595 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.466 ' HB1' ' HA ' ' A' ' 51' ' ' ILE . . . -65.16 -15.74 62.75 Favored 'General case' 0 N--CA 1.476 0.843 0 N-CA-C 116.107 1.891 . . . . 0.0 116.107 179.071 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -51.77 -42.81 53.51 Favored Glycine 0 CA--C 1.544 1.87 0 C-N-CA 124.725 1.155 . . . . 0.0 112.988 177.914 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 44.9 ttp180 -49.58 -49.89 44.68 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 125.123 1.369 . . . . 0.0 113.817 -174.158 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.404 ' HB3' ' HD1' ' A' ' 54' ' ' TYR . 29.1 tt0 -129.64 36.06 4.13 Favored 'General case' 0 CA--C 1.547 0.849 0 N-CA-C 113.605 0.965 . . . . 0.0 113.605 -174.518 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 96.0 p 50.31 123.68 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.372 0 C-N-CA 126.527 1.931 . . . . 0.0 113.877 -175.524 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.466 ' HA ' ' HB1' ' A' ' 46' ' ' ALA 0.274 3.9 tp -35.23 -63.99 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.545 0.779 0 N-CA-C 117.547 2.425 . . . . 0.0 117.547 -170.134 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 16.0 ttpp -52.52 -58.49 6.6 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 123.387 0.675 . . . . 0.0 112.791 177.359 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -64.05 -38.37 90.83 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 124.518 1.127 . . . . 0.0 113.485 -178.147 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . 0.404 ' HD1' ' HB3' ' A' ' 49' ' ' GLU . 72.8 t80 -51.9 -65.6 0.53 Allowed 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 126.056 1.742 . . . . 0.0 109.625 175.441 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 48.1 mt -64.36 -37.27 86.93 Favored 'General case' 0 N--CA 1.474 0.765 0 N-CA-C 114.33 1.233 . . . . 0.0 114.33 -177.8 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . 0.612 ' HA ' HG13 ' A' ' 19' ' ' VAL . 9.0 tmtm? -57.58 -48.86 78.21 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 114.594 -1.185 . . . . 0.0 112.598 178.602 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 41.2 tttm -77.88 -49.83 13.44 Favored 'General case' 0 N--CA 1.476 0.854 0 CA-C-N 115.18 -0.918 . . . . 0.0 112.601 175.171 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . 0.442 ' O ' ' HB2' ' A' ' 62' ' ' LYS . 39.5 tt0 -58.25 -49.2 77.93 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-O 118.523 -0.751 . . . . 0.0 110.53 -173.164 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.741 HG23 HG21 ' A' ' 67' ' ' VAL . 2.8 mm -75.89 -25.53 17.22 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.893 0 CA-C-O 119.18 -0.438 . . . . 0.0 111.902 -176.503 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.567 ' HB2' ' O ' ' A' ' 56' ' ' LYS . 0.9 OUTLIER -61.38 -34.03 74.65 Favored 'General case' 0 CA--C 1.546 0.796 0 O-C-N 124.56 1.162 . . . . 0.0 113.812 171.867 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -86.26 -43.34 13.02 Favored 'General case' 0 N--CA 1.481 1.098 0 CA-C-N 113.094 -1.866 . . . . 0.0 112.228 179.02 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . 0.442 ' HB2' ' O ' ' A' ' 58' ' ' GLU . 22.8 tttm -67.06 -51.06 59.17 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 127.507 2.323 . . . . 0.0 112.34 -173.742 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 102.42 108.38 3.2 Favored Glycine 0 N--CA 1.476 1.325 0 N-CA-C 109.621 -1.392 . . . . 0.0 109.621 -173.048 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.622 ' HB3' HD13 ' A' ' 16' ' ' LEU . 10.9 mptt -40.04 -43.57 1.6 Allowed 'General case' 0 N--CA 1.487 1.375 0 N-CA-C 117.558 2.429 . . . . 0.0 117.558 -175.171 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . 0.446 ' O ' ' HB ' ' A' ' 68' ' ' ILE . 11.2 mmp_? -57.4 -43.39 83.66 Favored 'General case' 0 N--CA 1.478 0.931 0 N-CA-C 116.003 1.853 . . . . 0.0 116.003 178.749 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -67.65 -27.7 67.09 Favored 'General case' 0 N--CA 1.482 1.157 0 CA-C-N 114.15 -1.386 . . . . 0.0 113.209 173.104 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.741 HG21 HG23 ' A' ' 59' ' ' ILE . 78.8 t -70.92 -33.18 51.06 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.048 0 C-N-CA 123.337 0.655 . . . . 0.0 111.972 177.794 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.446 ' HB ' ' O ' ' A' ' 65' ' ' ARG . 14.1 mm -51.07 -44.38 28.23 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.022 0 C-N-CA 123.805 0.842 . . . . 0.0 110.894 166.831 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -71.96 -48.61 43.93 Favored 'General case' 0 N--CA 1.478 0.957 0 O-C-N 124.263 0.977 . . . . 0.0 112.697 176.727 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' TRP . . . . . 0.421 ' O ' ' HB2' ' A' ' 4' ' ' GLU . 40.6 t90 . . . . . 0 N--CA 1.48 1.041 0 C-N-CA 126.045 1.738 . . . . 0.0 113.519 -178.469 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.605 ' HE3' HD13 ' A' ' 7' ' ' ILE . 67.2 mtp . . . . . 0 N--CA 1.479 1.013 0 N-CA-C 112.615 0.598 . . . . 0.0 112.615 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . 0.531 ' HA ' ' O ' ' A' ' 7' ' ' ILE . . . -53.67 -52.53 59.68 Favored 'General case' 0 CA--C 1.542 0.653 0 O-C-N 124.658 1.224 . . . . 0.0 112.691 172.407 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 39.7 ttmt -73.76 -55.32 6.37 Favored 'General case' 0 N--CA 1.472 0.675 0 CA-C-N 112.617 -2.083 . . . . 0.0 114.765 -175.637 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -74.86 -35.83 62.33 Favored 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 114.804 1.409 . . . . 0.0 114.804 -170.154 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . 0.533 ' HB2' HD12 ' A' ' 7' ' ' ILE . 61.1 m-85 -113.89 -23.23 9.73 Favored 'General case' 0 N--CA 1.48 1.045 0 N-CA-C 116.92 2.192 . . . . 0.0 116.92 -170.999 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 87.23 59.12 1.79 Allowed Glycine 0 N--CA 1.488 2.121 0 O-C-N 125.151 1.532 . . . . 0.0 111.878 -176.472 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.605 HD13 ' HE3' ' A' ' 1' ' ' MET . 1.0 OUTLIER -119.07 139.74 27.81 Favored Pre-proline 0 N--CA 1.48 1.031 0 C-N-CA 125.061 1.344 . . . . 0.0 110.412 178.85 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_endo -83.2 151.86 13.93 Favored 'Trans proline' 0 N--CA 1.455 -0.757 0 N-CA-C 108.714 -1.302 . . . . 0.0 108.714 162.978 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -42.76 -38.28 2.05 Favored 'General case' 0 N--CA 1.471 0.597 0 N-CA-C 116.403 2.001 . . . . 0.0 116.403 -179.629 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -30.62 -59.26 0.2 Allowed 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 127.081 2.153 . . . . 0.0 113.99 168.594 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.894 HG12 HG22 ' A' ' 31' ' ' ILE . 17.2 m -87.98 -31.01 5.61 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.668 0 N-CA-C 114.627 1.344 . . . . 0.0 114.627 -170.903 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -67.3 -29.27 68.81 Favored 'General case' 0 CA--C 1.549 0.927 0 CA-C-N 116.302 -0.408 . . . . 0.0 112.092 169.757 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . 0.523 ' HA2' HD12 ' A' ' 16' ' ' LEU . . . -67.56 -41.81 89.42 Favored Glycine 0 CA--C 1.545 1.908 0 C-N-CA 125.368 1.461 . . . . 0.0 112.936 171.209 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.529 HG22 HG13 ' A' ' 28' ' ' ILE . 8.6 m -65.84 -35.87 81.87 Favored 'General case' 0 N--CA 1.475 0.778 0 N-CA-C 113.046 0.758 . . . . 0.0 113.046 173.503 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.673 HG23 HD21 ' A' ' 32' ' ' LEU . 2.3 t -49.24 -38.48 11.75 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.066 0 C-N-CA 124.47 1.108 . . . . 0.0 113.599 166.126 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.643 HD22 ' HG3' ' A' ' 64' ' ' LYS . 84.6 mt -61.0 -38.12 84.91 Favored 'General case' 0 N--CA 1.475 0.822 0 N-CA-C 113.602 0.964 . . . . 0.0 113.602 178.648 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 35.2 t-20 -52.23 -42.72 63.83 Favored 'General case' 0 CA--C 1.547 0.838 0 O-C-N 124.0 0.813 . . . . 0.0 111.421 172.983 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.409 HG23 HD13 ' A' ' 28' ' ' ILE . 1.0 OUTLIER -60.43 -56.3 18.61 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.816 0 CA-C-N 115.046 -0.979 . . . . 0.0 113.045 173.14 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.779 HG13 ' HA ' ' A' ' 56' ' ' LYS . 5.5 t -58.96 -49.69 82.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 124.026 0.829 . . . . 0.0 112.698 -177.53 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . 0.443 ' OE1' ' HB3' ' A' ' 16' ' ' LEU . 24.5 mt-10 -72.35 -42.4 65.38 Favored 'General case' 0 N--CA 1.473 0.696 0 N-CA-C 116.57 2.063 . . . . 0.0 116.57 -175.236 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -103.92 -25.87 12.88 Favored 'General case' 0 N--CA 1.481 1.125 0 N-CA-C 115.231 1.567 . . . . 0.0 115.231 -173.022 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 77.4 41.23 21.36 Favored Glycine 0 CA--C 1.541 1.699 0 N-CA-C 110.467 -1.053 . . . . 0.0 110.467 -165.71 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -76.44 173.86 54.01 Favored Glycine 0 CA--C 1.535 1.316 0 C-N-CA 124.914 1.245 . . . . 0.0 112.689 -173.439 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 3.6 m-90 -69.16 101.79 1.53 Allowed 'General case' 0 N--CA 1.473 0.72 0 CA-C-O 123.341 1.544 . . . . 0.0 110.93 -178.92 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 9.8 p -48.51 -29.44 2.53 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.821 0 CA-C-N 112.658 -2.064 . . . . 0.0 114.86 172.736 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 11.1 t -60.04 -46.62 88.93 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 123.73 0.812 . . . . 0.0 112.929 179.745 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . 0.536 ' O ' HG12 ' A' ' 31' ' ' ILE . 2.0 m -60.09 -48.13 82.98 Favored 'General case' 0 N--CA 1.481 1.08 0 CA-C-N 114.144 -1.389 . . . . 0.0 109.992 175.913 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.529 HG13 HG22 ' A' ' 14' ' ' THR . 1.8 mp -58.32 -53.03 51.81 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.023 0 C-N-CA 123.912 0.885 . . . . 0.0 110.771 179.301 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 65.5 t -53.98 -47.81 64.62 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.744 0 CA-C-O 118.118 -0.944 . . . . 0.0 111.474 177.551 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 20.9 m -61.04 -36.91 80.83 Favored 'General case' 0 N--CA 1.481 1.119 0 N-CA-C 114.446 1.276 . . . . 0.0 114.446 178.672 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.894 HG22 HG12 ' A' ' 11' ' ' VAL . 42.2 mm -72.98 -42.44 59.77 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.93 0 C-N-CA 124.246 1.018 . . . . 0.0 109.463 178.88 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.673 HD21 HG23 ' A' ' 15' ' ' VAL . 4.2 mm? -57.83 -53.06 62.48 Favored 'General case' 0 N--CA 1.484 1.259 0 C-N-CA 125.097 1.359 . . . . 0.0 112.897 173.796 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -65.57 -28.11 68.91 Favored 'General case' 0 N--CA 1.481 1.104 0 N-CA-C 115.406 1.632 . . . . 0.0 115.406 178.329 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -52.37 -32.0 36.48 Favored 'General case' 0 N--CA 1.486 1.358 0 N-CA-C 113.907 1.077 . . . . 0.0 113.907 171.949 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 50.7 t . . . . . 0 N--CA 1.49 1.561 0 C-N-CA 126.169 1.788 . . . . 0.0 112.41 173.816 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . 0.5 ' HA2' ' HB3' ' A' ' 32' ' ' LEU . . . . . . . . 0 N--CA 1.482 1.765 0 N-CA-C 111.435 -0.666 . . . . 0.0 111.435 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 72.0 mt -57.54 -45.6 84.88 Favored 'General case' 0 N--CA 1.476 0.861 0 N-CA-C 115.937 1.828 . . . . 0.0 115.937 -176.297 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 79.5 p -62.54 -42.36 99.47 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-N 115.384 -0.825 . . . . 0.0 112.938 176.148 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 11.9 tp -63.59 -43.42 96.98 Favored 'General case' 0 N--CA 1.474 0.762 0 N-CA-C 110.026 -0.361 . . . . 0.0 110.026 175.731 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 94.7 mt -62.95 -35.97 81.91 Favored 'General case' 0 N--CA 1.475 0.784 0 N-CA-C 114.414 1.265 . . . . 0.0 114.414 -179.808 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -69.68 -40.69 76.24 Favored 'General case' 0 N--CA 1.473 0.691 0 O-C-N 123.83 0.706 . . . . 0.0 112.782 174.176 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -68.57 -36.17 78.39 Favored 'General case' 0 N--CA 1.475 0.817 0 CA-C-O 121.286 0.565 . . . . 0.0 112.128 177.508 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -53.95 -21.76 8.71 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 126.58 1.952 . . . . 0.0 115.587 173.197 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -50.01 -32.89 20.42 Favored Glycine 0 N--CA 1.478 1.49 0 C-N-CA 125.144 1.354 . . . . 0.0 114.007 178.936 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 68.0 ttp85 -55.36 -55.32 32.9 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 124.918 1.287 . . . . 0.0 113.33 178.573 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 8.2 tt0 -133.29 34.79 3.5 Favored 'General case' 0 CA--C 1.548 0.869 0 N-CA-C 114.803 1.408 . . . . 0.0 114.803 -173.931 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 32.8 t 44.31 127.09 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.041 0 N-CA-C 114.147 1.165 . . . . 0.0 114.147 -172.646 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . 0.266 8.8 tp -30.47 -57.28 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 N-CA-C 119.036 2.976 . . . . 0.0 119.036 -169.812 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 81.9 tttt -60.99 -56.0 26.25 Favored 'General case' 0 N--CA 1.478 0.927 0 N-CA-C 112.065 0.394 . . . . 0.0 112.065 -179.477 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -61.16 -38.44 86.44 Favored 'General case' 0 N--CA 1.486 1.363 0 C-N-CA 123.94 0.896 . . . . 0.0 113.203 177.603 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 89.9 t80 -52.41 -60.24 3.47 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 125.618 1.567 . . . . 0.0 112.253 175.479 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 64.5 mt -65.9 -38.88 89.89 Favored 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 114.053 1.131 . . . . 0.0 114.053 -179.929 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . 0.779 ' HA ' HG13 ' A' ' 19' ' ' VAL . 30.9 mttm -53.81 -54.04 43.92 Favored 'General case' 0 N--CA 1.48 1.039 0 CA-C-N 114.029 -1.441 . . . . 0.0 113.377 178.482 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 55.2 tttp -68.93 -47.23 66.23 Favored 'General case' 0 CA--C 1.541 0.621 0 CA-C-N 115.294 -0.866 . . . . 0.0 112.537 176.981 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . 0.467 ' O ' ' HB2' ' A' ' 62' ' ' LYS . 66.8 mt-10 -56.61 -51.66 67.8 Favored 'General case' 0 N--CA 1.477 0.898 0 N-CA-C 112.26 0.467 . . . . 0.0 112.26 -175.351 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.468 ' HA ' ' HB2' ' A' ' 62' ' ' LYS . 6.3 mm -81.02 -20.61 11.21 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.258 0 N-CA-C 112.99 0.737 . . . . 0.0 112.99 -176.218 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.413 ' HB2' ' O ' ' A' ' 56' ' ' LYS . 10.2 tppt? -62.44 -34.02 75.95 Favored 'General case' 0 CA--C 1.542 0.657 0 CA-C-O 121.985 0.898 . . . . 0.0 112.865 170.234 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 93.0 mttt -84.95 -44.67 12.91 Favored 'General case' 0 CA--C 1.546 0.806 0 CA-C-N 112.814 -1.994 . . . . 0.0 113.556 175.507 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . 0.468 ' HB2' ' HA ' ' A' ' 59' ' ' ILE . 0.2 OUTLIER -65.06 -45.04 86.98 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-N 113.529 -1.669 . . . . 0.0 115.329 -172.929 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 85.91 111.72 0.79 Allowed Glycine 0 N--CA 1.47 0.949 0 N-CA-C 108.356 -1.898 . . . . 0.0 108.356 -172.964 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.866 ' H ' ' HD2' ' A' ' 64' ' ' LYS . 9.9 mptt -23.41 -46.53 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.437 0 N-CA-C 119.516 3.154 . . . . 0.0 119.516 -174.829 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . 0.284 8.9 ttt180 -48.92 -44.22 40.14 Favored 'General case' 0 N--CA 1.471 0.618 0 N-CA-C 115.365 1.617 . . . . 0.0 115.365 173.052 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -58.74 -31.25 68.15 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 116.243 -1.837 . . . . 0.0 113.124 174.575 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.523 HG12 ' O ' ' A' ' 64' ' ' LYS . 0.5 OUTLIER -64.06 -41.84 93.76 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.259 0 CA-C-N 119.393 0.997 . . . . 0.0 111.573 178.766 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 35.8 mm -57.82 -39.06 69.16 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.887 0 CA-C-N 113.251 -1.795 . . . . 0.0 110.471 177.141 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -80.24 -49.18 11.96 Favored 'General case' 0 N--CA 1.475 0.805 0 N-CA-C 114.288 1.218 . . . . 0.0 114.288 175.05 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 24.3 t90 . . . . . 0 N--CA 1.484 1.265 0 C-N-CA 127.055 2.142 . . . . 0.0 112.708 -179.363 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.761 ' HE1' HG21 ' A' ' 15' ' ' VAL . 52.3 mtp . . . . . 0 N--CA 1.479 0.979 0 N-CA-C 113.417 0.895 . . . . 0.0 113.417 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -61.31 -49.27 77.68 Favored 'General case' 0 N--CA 1.474 0.757 0 CA-C-N 115.018 -0.992 . . . . 0.0 112.287 173.974 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 57.4 tttm -75.82 -60.46 2.31 Favored 'General case' 0 N--CA 1.478 0.948 0 CA-C-N 114.046 -1.434 . . . . 0.0 114.085 -176.428 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . 0.402 ' HB2' ' O ' ' A' ' 70' ' ' TRP . 2.1 mp0 -75.96 -29.07 58.16 Favored 'General case' 0 N--CA 1.474 0.744 0 N-CA-C 115.656 1.724 . . . . 0.0 115.656 -169.751 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . 0.409 ' HD1' ' HB2' ' A' ' 41' ' ' SER . 43.4 m-85 -115.11 -18.21 11.23 Favored 'General case' 0 N--CA 1.48 1.051 0 N-CA-C 117.496 2.406 . . . . 0.0 117.496 -173.243 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 72.82 40.67 51.94 Favored Glycine 0 CA--C 1.542 1.756 0 O-C-N 124.543 1.152 . . . . 0.0 112.11 -171.126 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.789 HG23 HG23 ' A' ' 11' ' ' VAL . 0.6 OUTLIER -121.91 106.23 36.89 Favored Pre-proline 0 N--CA 1.474 0.73 0 C-N-CA 124.566 1.146 . . . . 0.0 110.288 179.425 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_endo -63.93 168.23 12.5 Favored 'Trans proline' 0 CA--C 1.54 0.791 0 C-N-CA 122.567 2.178 . . . . 0.0 112.582 -172.825 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -51.34 -33.32 28.91 Favored 'General case' 0 N--CA 1.477 0.914 0 CA-C-N 113.617 -1.629 . . . . 0.0 114.212 172.493 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -49.87 -34.45 20.13 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 125.9 1.68 . . . . 0.0 114.567 176.099 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 1.084 HG12 HG22 ' A' ' 31' ' ' ILE . 30.4 m -112.0 -29.4 2.37 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.407 0 N-CA-C 114.145 1.165 . . . . 0.0 114.145 179.819 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -66.77 -37.35 84.41 Favored 'General case' 0 N--CA 1.475 0.794 0 N-CA-C 113.393 0.886 . . . . 0.0 113.393 174.791 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -61.09 -37.9 94.68 Favored Glycine 0 CA--C 1.544 1.871 0 C-N-CA 123.92 0.771 . . . . 0.0 112.287 170.62 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -70.32 -32.91 70.87 Favored 'General case' 0 N--CA 1.487 1.407 0 C-N-CA 125.051 1.34 . . . . 0.0 113.363 179.44 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.761 HG21 ' HE1' ' A' ' 1' ' ' MET . 10.4 t -61.2 -36.11 70.47 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.255 0 C-N-CA 123.895 0.878 . . . . 0.0 111.982 169.469 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.57 HD13 ' HB3' ' A' ' 64' ' ' LYS . 48.3 mt -66.09 -37.73 86.5 Favored 'General case' 0 N--CA 1.471 0.61 0 N-CA-C 113.242 0.83 . . . . 0.0 113.242 177.423 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 11.0 t30 -55.12 -44.59 75.13 Favored 'General case' 0 N--CA 1.478 0.934 0 CA-C-N 115.341 -0.845 . . . . 0.0 111.339 172.798 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.526 ' HB ' ' O ' ' A' ' 15' ' ' VAL . 12.8 t -50.64 -52.56 15.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 C-N-CA 124.642 1.177 . . . . 0.0 112.182 171.67 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.758 HG13 ' HA ' ' A' ' 56' ' ' LYS . 11.4 t -61.91 -52.66 57.88 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.191 0 C-N-CA 124.568 1.147 . . . . 0.0 111.479 -178.452 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 10.1 mt-10 -54.82 -44.04 73.51 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 125.692 1.597 . . . . 0.0 115.057 -178.401 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -93.17 -17.1 24.13 Favored 'General case' 0 CA--C 1.546 0.822 0 N-CA-C 115.701 1.741 . . . . 0.0 115.701 -175.376 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 68.39 40.96 86.69 Favored Glycine 0 CA--C 1.544 1.889 0 N-CA-C 110.438 -1.065 . . . . 0.0 110.438 -165.489 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -100.46 164.11 18.95 Favored Glycine 0 CA--C 1.537 1.428 0 C-N-CA 124.827 1.203 . . . . 0.0 114.145 -167.259 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 5.8 m-90 -67.69 104.53 1.66 Allowed 'General case' 0 C--O 1.24 0.583 0 CA-C-O 122.577 1.179 . . . . 0.0 113.831 -175.341 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.46 HG11 HG13 ' A' ' 51' ' ' ILE . 5.5 p -55.59 -25.13 17.43 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.825 0 CA-C-N 113.369 -1.741 . . . . 0.0 113.847 169.191 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 1.7 t -60.51 -40.33 91.04 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 114.305 1.224 . . . . 0.0 114.305 179.727 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 1.9 m -68.54 -39.1 81.26 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 122.928 0.491 . . . . 0.0 110.653 175.811 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 2.8 mp -72.23 -31.07 37.9 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.077 0 C-N-CA 124.854 1.262 . . . . 0.0 112.576 177.9 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.447 HG23 ' O ' ' A' ' 25' ' ' VAL . 55.6 t -55.54 -36.42 41.74 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.826 0 C-N-CA 123.104 0.562 . . . . 0.0 112.201 171.737 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 29.8 p -60.98 -26.15 67.37 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 114.813 1.412 . . . . 0.0 114.813 173.788 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 1.084 HG22 HG12 ' A' ' 11' ' ' VAL . 34.7 mm -85.01 -37.84 12.69 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.914 0 C-N-CA 123.901 0.88 . . . . 0.0 109.85 176.493 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.59 HD22 ' HB ' ' A' ' 11' ' ' VAL . 4.3 mm? -60.54 -34.49 74.21 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 124.835 1.254 . . . . 0.0 112.255 172.636 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 9.1 p -75.2 -36.24 61.43 Favored 'General case' 0 N--CA 1.474 0.775 0 N-CA-C 115.413 1.634 . . . . 0.0 115.413 174.057 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -52.88 -25.24 11.04 Favored 'General case' 0 N--CA 1.482 1.155 0 O-C-N 124.64 1.212 . . . . 0.0 114.183 172.236 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 93.0 t . . . . . 0 N--CA 1.482 1.133 0 C-N-CA 126.32 1.848 . . . . 0.0 113.238 171.225 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . 0.508 ' HA3' ' HB3' ' A' ' 32' ' ' LEU . . . . . . . . 0 N--CA 1.487 2.069 0 CA-C-O 119.6 -0.555 . . . . 0.0 113.461 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 9.7 mt -54.6 -46.83 73.88 Favored 'General case' 0 N--CA 1.481 1.106 0 N-CA-C 116.563 2.06 . . . . 0.0 116.563 -168.501 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . 0.409 ' HB2' ' HD1' ' A' ' 5' ' ' PHE . 11.6 p -60.11 -44.83 94.56 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 114.823 -1.08 . . . . 0.0 113.397 177.636 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 10.8 tp -63.09 -50.31 71.04 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 123.887 0.875 . . . . 0.0 110.287 171.923 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 82.9 mt -60.77 -28.64 68.88 Favored 'General case' 0 N--CA 1.477 0.887 0 N-CA-C 114.875 1.435 . . . . 0.0 114.875 -177.23 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -67.3 -47.64 69.99 Favored 'General case' 0 N--CA 1.474 0.736 0 O-C-N 123.805 0.691 . . . . 0.0 112.798 170.785 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -62.46 -33.61 75.18 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 123.375 0.67 . . . . 0.0 112.44 179.247 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -57.18 -23.75 49.75 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 126.885 2.074 . . . . 0.0 115.546 174.655 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -52.11 -35.03 40.64 Favored Glycine 0 CA--C 1.538 1.486 0 C-N-CA 125.068 1.318 . . . . 0.0 113.91 -177.904 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 40.0 ttp180 -51.57 -53.51 37.33 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 125.0 1.32 . . . . 0.0 112.958 -176.233 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 20.6 tt0 -128.76 36.8 4.18 Favored 'General case' 0 N--CA 1.478 0.963 0 CA-C-N 115.166 -0.924 . . . . 0.0 113.153 -176.247 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 8.0 t 43.36 128.4 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 125.68 1.592 . . . . 0.0 114.474 -172.07 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.46 HG13 HG11 ' A' ' 25' ' ' VAL . 8.0 tp -32.25 -52.47 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.258 0 N-CA-C 118.156 2.65 . . . . 0.0 118.156 -171.161 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 2.3 ttmt -60.37 -67.46 0.39 Allowed 'General case' 0 N--CA 1.472 0.631 0 N-CA-C 114.461 1.282 . . . . 0.0 114.461 178.441 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -56.62 -34.64 67.46 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 124.276 1.03 . . . . 0.0 113.667 177.817 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 66.7 t80 -50.86 -62.27 1.71 Allowed 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 124.875 1.27 . . . . 0.0 110.589 174.541 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.62 HD13 HG13 ' A' ' 15' ' ' VAL . 60.7 mt -65.26 -37.91 88.66 Favored 'General case' 0 N--CA 1.475 0.783 0 N-CA-C 115.001 1.482 . . . . 0.0 115.001 -176.123 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . 0.758 ' HA ' HG13 ' A' ' 19' ' ' VAL . 93.9 mttt -61.94 -37.15 83.62 Favored 'General case' 0 N--CA 1.473 0.7 0 CA-C-N 113.445 -1.707 . . . . 0.0 114.732 178.523 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . 0.469 ' HE3' ' HE3' ' A' ' 61' ' ' LYS . 80.2 tttt -85.64 -52.55 5.73 Favored 'General case' 0 CA--C 1.535 0.395 0 O-C-N 124.514 1.134 . . . . 0.0 111.241 173.03 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . 0.415 ' O ' ' HB2' ' A' ' 62' ' ' LYS . 29.0 tt0 -55.19 -51.08 67.67 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-O 118.687 -0.673 . . . . 0.0 111.771 -173.014 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.71 HG23 HG21 ' A' ' 67' ' ' VAL . 3.7 mm -75.96 -27.1 17.99 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.281 0 N-CA-C 112.769 0.655 . . . . 0.0 112.769 -173.64 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.457 ' HB2' ' O ' ' A' ' 56' ' ' LYS . 14.9 tttp -60.28 -36.32 77.56 Favored 'General case' 0 CA--C 1.544 0.749 0 CA-C-O 122.643 1.211 . . . . 0.0 113.496 174.02 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . 0.469 ' HE3' ' HE3' ' A' ' 57' ' ' LYS . 9.7 mttm -85.01 -33.17 22.6 Favored 'General case' 0 N--CA 1.474 0.757 0 CA-C-N 112.023 -2.353 . . . . 0.0 112.236 -179.412 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . 0.415 ' HB2' ' O ' ' A' ' 58' ' ' GLU . 66.8 tttt -85.33 -60.13 2.12 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-N 112.744 -2.026 . . . . 0.0 111.561 -168.484 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . 0.46 ' O ' HG23 ' A' ' 67' ' ' VAL . . . 113.11 126.03 4.45 Favored Glycine 0 CA--C 1.532 1.122 0 N-CA-C 110.08 -1.208 . . . . 0.0 110.08 -172.297 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.57 ' HB3' HD13 ' A' ' 16' ' ' LEU . 0.0 OUTLIER -59.4 -42.04 90.81 Favored 'General case' 0 N--CA 1.482 1.135 0 N-CA-C 115.59 1.7 . . . . 0.0 115.59 -173.128 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -58.13 -47.3 83.73 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 125.251 1.42 . . . . 0.0 113.648 179.353 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -62.94 -32.05 73.28 Favored 'General case' 0 N--CA 1.475 0.777 0 CA-C-N 114.534 -1.212 . . . . 0.0 113.769 173.002 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.71 HG21 HG23 ' A' ' 59' ' ' ILE . 48.5 t -68.8 -35.97 72.07 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.989 0 C-N-CA 122.872 0.469 . . . . 0.0 111.179 179.497 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 18.0 mt -53.42 -48.5 57.08 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.01 0 C-N-CA 124.267 1.027 . . . . 0.0 109.722 169.385 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -67.08 -47.49 71.1 Favored 'General case' 0 N--CA 1.477 0.907 0 CA-C-N 115.581 -0.736 . . . . 0.0 112.901 178.808 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' TRP . . . . . 0.402 ' O ' ' HB2' ' A' ' 4' ' ' GLU . 43.0 t90 . . . . . 0 N--CA 1.477 0.891 0 C-N-CA 125.78 1.632 . . . . 0.0 112.22 -179.512 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.497 ' HB3' HG21 ' A' ' 7' ' ' ILE . 76.6 mtp . . . . . 0 C--O 1.238 0.487 0 N-CA-C 113.039 0.755 . . . . 0.0 113.039 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . 0.436 ' HA ' ' O ' ' A' ' 7' ' ' ILE . . . -55.78 -54.13 48.14 Favored 'General case' 0 N--CA 1.475 0.814 0 CA-C-N 114.988 -1.005 . . . . 0.0 111.649 172.882 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 51.1 tttp -72.86 -61.02 1.96 Allowed 'General case' 0 N--CA 1.481 1.08 0 CA-C-N 113.952 -1.476 . . . . 0.0 113.982 -174.246 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -71.0 -37.25 72.66 Favored 'General case' 0 N--CA 1.475 0.815 0 N-CA-C 115.48 1.659 . . . . 0.0 115.48 -171.388 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . 0.422 ' HD2' ' HA ' ' A' ' 1' ' ' MET . 52.1 m-85 -107.95 -15.92 14.42 Favored 'General case' 0 N--CA 1.477 0.885 0 N-CA-C 116.532 2.049 . . . . 0.0 116.532 -172.063 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 79.65 54.25 4.02 Favored Glycine 0 CA--C 1.541 1.701 0 CA-C-O 122.311 0.95 . . . . 0.0 112.508 -176.023 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.497 HG21 ' HB3' ' A' ' 1' ' ' MET . 0.5 OUTLIER -112.73 147.99 38.34 Favored Pre-proline 0 N--CA 1.482 1.128 0 CA-C-N 113.526 -1.337 . . . . 0.0 111.645 -178.839 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 91.0 Cg_endo -86.06 153.39 9.69 Favored 'Trans proline' 0 CA--C 1.538 0.723 0 C-N-CA 121.685 1.59 . . . . 0.0 109.365 163.309 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -49.7 -33.67 16.55 Favored 'General case' 0 N--CA 1.47 0.574 0 N-CA-C 114.966 1.469 . . . . 0.0 114.966 176.346 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -39.08 -43.73 1.06 Allowed 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 127.792 2.437 . . . . 0.0 115.174 171.626 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.981 HG12 HG22 ' A' ' 31' ' ' ILE . 20.0 m -102.31 -29.09 3.04 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.914 0 N-CA-C 114.269 1.211 . . . . 0.0 114.269 -173.626 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -67.48 -30.65 70.41 Favored 'General case' 0 N--CA 1.489 1.483 0 CA-C-N 115.727 -0.67 . . . . 0.0 112.197 171.526 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . 0.446 ' O ' ' HB2' ' A' ' 16' ' ' LEU . . . -63.57 -43.05 98.6 Favored Glycine 0 CA--C 1.553 2.44 0 C-N-CA 124.278 0.942 . . . . 0.0 112.625 168.814 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.806 HG22 HG13 ' A' ' 28' ' ' ILE . 3.9 m -62.78 -37.49 86.87 Favored 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 113.371 0.878 . . . . 0.0 113.371 176.792 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.463 HG21 ' HE1' ' A' ' 1' ' ' MET . 2.4 t -50.52 -37.73 15.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 C-N-CA 124.155 0.982 . . . . 0.0 113.337 168.254 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.716 HD22 ' HG3' ' A' ' 64' ' ' LYS . 84.8 mt -61.98 -37.28 84.22 Favored 'General case' 0 N--CA 1.479 0.996 0 N-CA-C 113.989 1.107 . . . . 0.0 113.989 177.446 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 14.6 t-20 -53.99 -47.06 71.82 Favored 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 123.223 0.609 . . . . 0.0 110.864 173.417 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 3.1 t -52.01 -56.26 6.87 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.256 0 CA-C-N 114.996 -1.002 . . . . 0.0 112.67 170.556 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.754 HG13 ' HA ' ' A' ' 56' ' ' LYS . 3.8 t -60.11 -51.17 76.04 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 O-C-N 124.549 1.156 . . . . 0.0 111.523 -176.307 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -66.49 -44.37 82.83 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 126.166 1.786 . . . . 0.0 115.705 -175.636 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -101.59 -12.41 18.49 Favored 'General case' 0 CA--C 1.548 0.891 0 N-CA-C 115.413 1.635 . . . . 0.0 115.413 -170.492 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . 0.424 ' HA2' ' HE2' ' A' ' 56' ' ' LYS . . . 66.69 41.53 93.79 Favored Glycine 0 N--CA 1.482 1.762 0 N-CA-C 110.137 -1.185 . . . . 0.0 110.137 -161.734 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -74.53 158.92 51.98 Favored Glycine 0 N--CA 1.471 0.984 0 C-N-CA 125.151 1.358 . . . . 0.0 114.266 -169.3 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 88.7 m95 -61.68 102.99 0.29 Allowed 'General case' 0 N--CA 1.473 0.724 0 CA-C-N 113.277 -1.462 . . . . 0.0 111.785 175.538 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.564 HG21 HG13 ' A' ' 51' ' ' ILE . 2.7 p -54.49 -24.19 12.25 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.625 0 CA-C-N 114.279 -1.328 . . . . 0.0 114.58 175.331 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 3.6 t -60.29 -44.24 95.55 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 124.261 1.024 . . . . 0.0 113.632 -179.915 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . 0.566 ' O ' HG12 ' A' ' 31' ' ' ILE . 0.8 OUTLIER -65.68 -46.34 79.43 Favored 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 123.799 0.84 . . . . 0.0 110.212 176.49 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.806 HG13 HG22 ' A' ' 14' ' ' THR . 2.0 mp -58.98 -51.49 71.87 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.979 0 C-N-CA 124.438 1.095 . . . . 0.0 111.622 177.375 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 50.6 t -53.11 -48.73 53.07 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.826 0 CA-C-O 117.037 -1.459 . . . . 0.0 111.556 176.59 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . 0.284 1.5 p -61.99 -29.85 70.54 Favored 'General case' 0 N--CA 1.479 1.016 0 N-CA-C 115.438 1.644 . . . . 0.0 115.438 179.712 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.981 HG22 HG12 ' A' ' 11' ' ' VAL . 21.2 mm -76.65 -43.26 34.51 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.006 0 C-N-CA 124.174 0.99 . . . . 0.0 110.115 176.38 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.63 HD22 ' HB ' ' A' ' 11' ' ' VAL . 4.2 mm? -55.52 -56.02 25.06 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 124.951 1.3 . . . . 0.0 112.427 172.796 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 3.1 p -64.0 -30.88 71.92 Favored 'General case' 0 N--CA 1.475 0.814 0 N-CA-C 114.825 1.417 . . . . 0.0 114.825 177.599 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -53.31 -25.41 14.74 Favored 'General case' 0 N--CA 1.482 1.134 0 N-CA-C 114.649 1.351 . . . . 0.0 114.649 172.355 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 61.7 t . . . . . 0 N--CA 1.486 1.356 0 C-N-CA 124.547 1.139 . . . . 0.0 111.574 172.669 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . 0.468 ' HA2' ' HB3' ' A' ' 32' ' ' LEU . . . . . . . . 0 N--CA 1.479 1.507 0 N-CA-C 111.76 -0.536 . . . . 0.0 111.76 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 78.4 mt -60.25 -41.65 93.65 Favored 'General case' 0 N--CA 1.482 1.142 0 N-CA-C 115.434 1.642 . . . . 0.0 115.434 -177.754 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 42.7 p -63.69 -43.28 97.1 Favored 'General case' 0 N--CA 1.476 0.863 0 N-CA-C 113.294 0.85 . . . . 0.0 113.294 174.922 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 12.4 tp -61.7 -46.8 88.13 Favored 'General case' 0 N--CA 1.474 0.741 0 CA-C-O 121.22 0.534 . . . . 0.0 110.435 174.002 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 94.8 mt -59.96 -39.15 84.64 Favored 'General case' 0 N--CA 1.482 1.153 0 CA-C-N 114.457 -1.247 . . . . 0.0 114.328 179.983 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -61.93 -44.94 95.73 Favored 'General case' 0 N--CA 1.477 0.911 0 N-CA-C 112.362 0.504 . . . . 0.0 112.362 173.289 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -65.96 -33.29 75.47 Favored 'General case' 0 N--CA 1.479 0.992 0 N-CA-C 113.564 0.95 . . . . 0.0 113.564 177.339 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -75.65 -21.56 57.57 Favored 'General case' 0 CA--C 1.543 0.698 0 N-CA-C 116.888 2.181 . . . . 0.0 116.888 179.766 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -50.99 -39.8 41.57 Favored Glycine 0 N--CA 1.474 1.185 0 O-C-N 124.308 1.005 . . . . 0.0 113.914 -173.031 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . 0.515 ' HA ' ' HD2' ' A' ' 48' ' ' ARG . 0.3 OUTLIER -59.51 -49.74 76.61 Favored 'General case' 0 CA--C 1.542 0.643 0 CA-C-N 111.239 -2.48 . . . . 0.0 115.876 -176.479 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 5.4 tt0 -114.5 28.86 8.43 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-N 115.29 -0.868 . . . . 0.0 112.982 -175.242 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 94.2 p 48.33 121.45 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 125.9 1.68 . . . . 0.0 113.373 -172.796 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.564 HG13 HG21 ' A' ' 25' ' ' VAL . 7.6 tp -41.47 -46.14 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.42 0 N-CA-C 117.298 2.332 . . . . 0.0 117.298 -173.64 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 34.6 tttm -60.36 -62.6 1.75 Allowed 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 124.582 1.153 . . . . 0.0 112.266 177.035 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -59.66 -38.7 82.17 Favored 'General case' 0 N--CA 1.48 1.044 0 N-CA-C 113.96 1.096 . . . . 0.0 113.96 177.598 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 84.3 t80 -49.84 -62.11 1.75 Allowed 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 125.432 1.493 . . . . 0.0 111.071 177.343 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.41 HD22 HG13 ' A' ' 15' ' ' VAL . 45.0 mt -61.87 -38.98 90.28 Favored 'General case' 0 N--CA 1.484 1.234 0 N-CA-C 114.477 1.288 . . . . 0.0 114.477 -176.829 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . 0.754 ' HA ' HG13 ' A' ' 19' ' ' VAL . 92.3 mttt -55.19 -54.64 40.73 Favored 'General case' 0 N--CA 1.472 0.638 0 O-C-N 124.83 1.331 . . . . 0.0 112.483 177.705 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . 0.572 ' HG2' ' HD2' ' A' ' 61' ' ' LYS . 78.0 tttt -71.76 -45.75 60.66 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-N 114.622 -1.172 . . . . 0.0 112.575 178.452 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 7.7 mm-40 -52.55 -55.36 22.73 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 122.824 0.45 . . . . 0.0 111.087 -177.617 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 5.9 mm -80.1 -23.51 11.68 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 CA-C-N 114.652 -1.158 . . . . 0.0 112.957 -172.635 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.452 ' HB2' ' O ' ' A' ' 56' ' ' LYS . 16.7 tttp -59.08 -38.0 78.43 Favored 'General case' 0 CA--C 1.544 0.73 0 N-CA-C 114.195 1.183 . . . . 0.0 114.195 170.362 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . 0.572 ' HD2' ' HG2' ' A' ' 57' ' ' LYS . 23.4 mtpt -86.2 -43.59 12.87 Favored 'General case' 0 N--CA 1.479 0.994 0 CA-C-N 113.681 -1.599 . . . . 0.0 111.174 -179.518 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 17.3 tttt -72.14 -40.34 68.13 Favored 'General case' 0 N--CA 1.473 0.709 0 CA-C-N 112.664 -2.062 . . . . 0.0 115.048 -173.391 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 85.49 130.22 2.34 Favored Glycine 0 CA--C 1.538 1.5 0 N-CA-C 109.743 -1.343 . . . . 0.0 109.743 -171.817 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.733 ' H ' ' HD2' ' A' ' 64' ' ' LYS . 11.9 mptt -40.7 -45.16 2.33 Favored 'General case' 0 N--CA 1.486 1.348 0 N-CA-C 116.501 2.038 . . . . 0.0 116.501 -179.496 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -53.64 -43.89 69.14 Favored 'General case' 0 N--CA 1.468 0.441 0 N-CA-C 112.174 0.435 . . . . 0.0 112.174 179.391 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -64.55 -29.73 70.76 Favored 'General case' 0 N--CA 1.48 1.044 0 CA-C-N 113.632 -1.622 . . . . 0.0 114.566 174.787 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.661 HG12 ' O ' ' A' ' 64' ' ' LYS . 1.4 p -64.57 -43.07 96.76 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.342 0 CA-C-N 119.629 1.104 . . . . 0.0 111.759 175.137 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 45.1 mm -55.86 -42.64 71.51 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.276 0 CA-C-N 114.082 -1.417 . . . . 0.0 110.023 176.148 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -72.63 -51.43 19.6 Favored 'General case' 0 N--CA 1.48 1.056 0 N-CA-C 113.951 1.093 . . . . 0.0 113.951 175.573 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 25.9 t90 . . . . . 0 N--CA 1.478 0.952 0 C-N-CA 126.752 2.021 . . . . 0.0 112.176 -178.305 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.61 ' HE3' HD13 ' A' ' 7' ' ' ILE . 53.1 mtp . . . . . 0 N--CA 1.469 0.479 0 N-CA-C 112.592 0.59 . . . . 0.0 112.592 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . 0.503 ' HA ' ' O ' ' A' ' 7' ' ' ILE . . . -56.51 -57.05 14.01 Favored 'General case' 0 N--CA 1.473 0.695 0 CA-C-N 114.823 -1.081 . . . . 0.0 112.12 175.873 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 18.6 ttpp -67.37 -49.2 64.94 Favored 'General case' 0 CA--C 1.547 0.841 0 CA-C-N 112.985 -1.916 . . . . 0.0 113.385 -172.014 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 10.2 tt0 -81.17 -48.08 12.58 Favored 'General case' 0 N--CA 1.477 0.903 0 N-CA-C 114.203 1.186 . . . . 0.0 114.203 -170.088 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . 0.615 ' HB2' HD12 ' A' ' 7' ' ' ILE . 48.0 m-85 -95.86 -17.06 21.41 Favored 'General case' 0 N--CA 1.474 0.733 0 N-CA-C 117.402 2.371 . . . . 0.0 117.402 -170.717 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 83.97 54.9 2.92 Favored Glycine 0 CA--C 1.539 1.564 0 CA-C-O 122.575 1.097 . . . . 0.0 111.052 -174.671 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.615 HD12 ' HB2' ' A' ' 5' ' ' PHE . 1.0 OUTLIER -117.65 142.65 30.91 Favored Pre-proline 0 N--CA 1.475 0.811 0 CA-C-N 113.665 -1.268 . . . . 0.0 110.777 -178.092 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 90.9 Cg_endo -87.82 158.98 7.53 Favored 'Trans proline' 0 CA--C 1.541 0.845 0 C-N-CA 121.26 1.307 . . . . 0.0 109.164 164.844 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -49.09 -32.33 9.55 Favored 'General case' 0 N--CA 1.48 1.07 0 N-CA-C 114.297 1.221 . . . . 0.0 114.297 171.829 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -43.8 -37.1 2.58 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 127.047 2.139 . . . . 0.0 115.615 174.618 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.934 HG12 HG22 ' A' ' 31' ' ' ILE . 26.9 m -109.22 -31.6 2.37 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.074 0 N-CA-C 114.13 1.159 . . . . 0.0 114.13 -179.537 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -69.39 -32.1 70.91 Favored 'General case' 0 N--CA 1.483 1.198 0 N-CA-C 113.354 0.872 . . . . 0.0 113.354 178.301 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -65.81 -36.67 92.52 Favored Glycine 0 N--CA 1.484 1.855 0 CA-C-O 122.717 1.176 . . . . 0.0 112.232 173.953 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.53 HG22 HG13 ' A' ' 28' ' ' ILE . 0.2 OUTLIER -68.44 -36.19 78.68 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 126.557 1.943 . . . . 0.0 113.356 176.877 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.558 HG21 ' HE1' ' A' ' 1' ' ' MET . 17.4 t -56.11 -39.82 60.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 C-N-CA 124.093 0.957 . . . . 0.0 112.065 168.167 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 39.6 mt -65.59 -41.18 93.11 Favored 'General case' 0 N--CA 1.476 0.829 0 N-CA-C 113.398 0.888 . . . . 0.0 113.398 179.599 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 25.5 t-20 -50.34 -47.54 55.85 Favored 'General case' 0 N--CA 1.475 0.783 0 O-C-N 124.317 1.011 . . . . 0.0 111.593 171.469 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.412 ' HB ' ' O ' ' A' ' 15' ' ' VAL . 2.4 t -50.79 -48.69 27.87 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.993 0 C-N-CA 123.991 0.916 . . . . 0.0 112.106 177.183 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.812 HG13 ' HA ' ' A' ' 56' ' ' LYS . 9.7 t -64.84 -55.56 20.31 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.116 0 O-C-N 124.139 0.9 . . . . 0.0 109.806 -179.13 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 37.7 mt-10 -58.75 -49.71 76.62 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 125.897 1.679 . . . . 0.0 114.585 -177.586 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -77.66 -17.99 57.15 Favored 'General case' 0 N--CA 1.473 0.724 0 N-CA-C 114.904 1.446 . . . . 0.0 114.904 -176.282 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . 0.532 ' HA2' ' HE3' ' A' ' 56' ' ' LYS . . . 67.0 44.78 87.78 Favored Glycine 0 N--CA 1.486 1.969 0 N-CA-C 109.588 -1.405 . . . . 0.0 109.588 -162.309 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -96.79 157.65 21.24 Favored Glycine 0 N--CA 1.474 1.22 0 CA-C-N 113.661 -1.27 . . . . 0.0 114.777 -161.701 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 85.4 m95 -68.47 100.56 1.11 Allowed 'General case' 0 N--CA 1.473 0.691 0 CA-C-N 113.004 -1.598 . . . . 0.0 110.581 -178.562 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.526 HG21 HG13 ' A' ' 51' ' ' ILE . 0.6 OUTLIER -53.48 -26.15 12.3 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.799 0 CA-C-N 113.828 -1.533 . . . . 0.0 113.609 172.39 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 4.7 t -59.44 -43.92 93.03 Favored 'General case' 0 N--CA 1.481 1.076 0 CA-C-O 118.715 -0.659 . . . . 0.0 112.71 -176.364 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . 0.452 ' HB ' HD12 ' A' ' 28' ' ' ILE . 2.7 m -57.82 -42.46 84.33 Favored 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 124.144 0.978 . . . . 0.0 111.855 174.218 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.53 HG13 HG22 ' A' ' 14' ' ' THR . 2.0 mp -73.73 -42.54 54.55 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.058 0 C-N-CA 125.98 1.712 . . . . 0.0 112.59 -178.124 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.582 HG13 HD11 ' A' ' 43' ' ' LEU . 40.1 t -49.64 -46.35 21.1 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.322 0 C-N-CA 124.815 1.246 . . . . 0.0 110.719 178.625 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -55.46 -35.86 65.95 Favored 'General case' 0 N--CA 1.486 1.364 0 C-N-CA 124.749 1.219 . . . . 0.0 113.906 176.366 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.934 HG22 HG12 ' A' ' 11' ' ' VAL . 22.3 mm -78.96 -39.36 21.65 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.071 0 C-N-CA 124.171 0.988 . . . . 0.0 109.083 -176.477 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.684 ' HB3' ' HA2' ' A' ' 39' ' ' GLY . 4.3 mm? -57.04 -49.38 75.98 Favored 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 124.553 1.141 . . . . 0.0 111.804 171.506 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 1.4 p -67.71 -27.38 66.77 Favored 'General case' 0 N--CA 1.474 0.734 0 N-CA-C 115.371 1.619 . . . . 0.0 115.371 178.018 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -55.71 -29.45 59.46 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 113.098 0.777 . . . . 0.0 113.098 169.95 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 23.0 t . . . . . 0 N--CA 1.483 1.187 0 C-N-CA 125.166 1.386 . . . . 0.0 111.065 174.486 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . 0.684 ' HA2' ' HB3' ' A' ' 32' ' ' LEU . . . . . . . . 0 N--CA 1.472 1.05 0 CA-C-O 121.287 0.382 . . . . 0.0 113.542 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 14.6 mt -62.53 -44.71 95.69 Favored 'General case' 0 N--CA 1.477 0.892 0 CA-C-N 113.149 -1.525 . . . . 0.0 113.96 -178.46 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 6.9 m -55.9 -47.12 77.99 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 123.745 0.818 . . . . 0.0 112.174 173.65 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 12.3 tp -63.23 -45.22 92.63 Favored 'General case' 0 N--CA 1.48 1.035 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.763 177.691 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.582 HD11 HG13 ' A' ' 29' ' ' VAL . 46.8 mt -64.15 -21.46 66.56 Favored 'General case' 0 N--CA 1.477 0.909 0 N-CA-C 115.732 1.753 . . . . 0.0 115.732 -178.987 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -78.35 -42.4 30.62 Favored 'General case' 0 CA--C 1.545 0.767 0 CA-C-N 115.493 -0.776 . . . . 0.0 112.954 171.33 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -61.77 -29.48 70.16 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 123.752 0.821 . . . . 0.0 112.245 172.874 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -59.03 -23.87 62.34 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 125.581 1.552 . . . . 0.0 115.011 177.709 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -52.76 -34.42 44.39 Favored Glycine 0 CA--C 1.543 1.83 0 C-N-CA 125.474 1.512 . . . . 0.0 113.763 -176.147 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 65.5 ttp85 -55.04 -52.64 62.55 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 124.662 1.185 . . . . 0.0 112.937 -178.974 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.409 ' HB3' ' HA ' ' A' ' 54' ' ' TYR . 12.5 tt0 -137.37 38.13 2.49 Favored 'General case' 0 N--CA 1.477 0.906 0 N-CA-C 115.404 1.631 . . . . 0.0 115.404 -175.621 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 21.0 t 42.15 121.26 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.293 0 C-N-CA 125.325 1.45 . . . . 0.0 114.846 -174.08 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.526 HG13 HG21 ' A' ' 25' ' ' VAL 0.278 9.8 tp -27.42 -57.75 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.481 1.096 0 N-CA-C 118.654 2.835 . . . . 0.0 118.654 -169.231 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 39.4 tttm -57.75 -61.11 2.76 Favored 'General case' 0 N--CA 1.486 1.344 0 C-N-CA 123.703 0.801 . . . . 0.0 111.771 178.56 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -63.47 -39.17 93.75 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 124.843 1.257 . . . . 0.0 112.836 178.236 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . 0.409 ' HA ' ' HB3' ' A' ' 49' ' ' GLU . 79.3 t80 -48.22 -59.35 3.48 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 125.203 1.401 . . . . 0.0 111.932 176.684 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 64.0 mt -65.74 -39.61 91.3 Favored 'General case' 0 N--CA 1.478 0.973 0 CA-C-N 114.597 -1.183 . . . . 0.0 114.123 -179.883 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . 0.812 ' HA ' HG13 ' A' ' 19' ' ' VAL . 43.7 mttp -57.9 -42.76 85.37 Favored 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 114.955 1.465 . . . . 0.0 114.955 179.869 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 55.7 tttp -78.9 -52.55 8.14 Favored 'General case' 0 N--CA 1.478 0.941 0 CA-C-N 115.256 -0.884 . . . . 0.0 111.54 170.984 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . 0.466 ' O ' ' HB2' ' A' ' 62' ' ' LYS . 28.0 tt0 -56.57 -49.94 73.39 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-O 118.558 -0.734 . . . . 0.0 111.975 -171.051 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.71 HG23 HG21 ' A' ' 67' ' ' VAL . 2.8 mm -75.86 -27.91 18.79 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 O-C-N 121.306 -0.872 . . . . 0.0 112.683 -175.959 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.469 ' HB2' ' O ' ' A' ' 56' ' ' LYS . 11.9 mttt -62.51 -34.12 76.24 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 116.935 2.198 . . . . 0.0 116.935 171.008 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 62.3 pttt -92.96 -25.36 18.05 Favored 'General case' 0 CA--C 1.546 0.825 0 CA-C-N 113.879 -1.51 . . . . 0.0 112.515 176.358 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . 0.466 ' HB2' ' O ' ' A' ' 58' ' ' GLU . 29.1 tttm -80.27 -46.14 16.71 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 125.967 1.707 . . . . 0.0 113.594 -176.573 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 93.89 105.6 1.83 Allowed Glycine 0 N--CA 1.477 1.405 0 N-CA-C 110.589 -1.004 . . . . 0.0 110.589 -177.818 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.608 ' H ' ' HD2' ' A' ' 64' ' ' LYS . 5.6 mptt -32.01 -45.57 0.1 Allowed 'General case' 0 N--CA 1.489 1.479 0 C-N-CA 127.587 2.355 . . . . 0.0 116.266 -178.131 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . 0.3 0.0 OUTLIER -46.94 -56.11 6.94 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 127.568 2.347 . . . . 0.0 114.105 175.781 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -71.12 -23.24 62.05 Favored 'General case' 0 N--CA 1.478 0.957 0 CA-C-N 113.994 -1.457 . . . . 0.0 114.298 175.072 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.71 HG21 HG23 ' A' ' 59' ' ' ILE . 61.1 t -70.82 -39.11 75.08 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.174 0 C-N-CA 123.423 0.689 . . . . 0.0 110.838 177.91 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 19.0 mm -51.15 -44.24 28.94 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.87 0 C-N-CA 123.902 0.881 . . . . 0.0 111.089 169.682 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -68.91 -51.4 40.46 Favored 'General case' 0 N--CA 1.481 1.097 0 N-CA-C 113.559 0.948 . . . . 0.0 113.559 174.574 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 31.1 t90 . . . . . 0 N--CA 1.479 1.0 0 C-N-CA 125.419 1.487 . . . . 0.0 112.621 -179.302 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.403 ' HE3' HD13 ' A' ' 7' ' ' ILE . 62.9 mtp . . . . . 0 N--CA 1.477 0.879 0 N-CA-C 113.321 0.86 . . . . 0.0 113.321 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -60.19 -48.92 79.71 Favored 'General case' 0 N--CA 1.477 0.89 0 O-C-N 124.104 0.877 . . . . 0.0 112.959 177.269 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 42.2 tttm -72.5 -58.36 3.44 Favored 'General case' 0 N--CA 1.479 0.998 0 CA-C-N 114.404 -1.271 . . . . 0.0 113.624 -174.59 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . 0.46 ' HB2' ' O ' ' A' ' 70' ' ' TRP . 0.8 OUTLIER -70.29 -36.24 74.24 Favored 'General case' 0 CA--C 1.538 0.485 0 N-CA-C 114.327 1.232 . . . . 0.0 114.327 -171.658 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . 0.55 ' HB2' HD12 ' A' ' 7' ' ' ILE . 29.8 m-85 -108.86 -10.09 15.12 Favored 'General case' 0 N--CA 1.47 0.55 0 N-CA-C 117.014 2.227 . . . . 0.0 117.014 -170.36 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 68.08 56.65 10.08 Favored Glycine 0 CA--C 1.541 1.678 0 O-C-N 123.965 0.791 . . . . 0.0 111.351 -174.634 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.55 HD12 ' HB2' ' A' ' 5' ' ' PHE . 0.4 OUTLIER -111.95 140.37 23.34 Favored Pre-proline 0 N--CA 1.476 0.874 0 CA-C-N 113.466 -1.367 . . . . 0.0 110.149 -179.841 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -85.27 160.78 11.31 Favored 'Trans proline' 0 C--O 1.243 0.752 0 C-N-CA 121.161 1.241 . . . . 0.0 110.057 166.551 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -52.21 -32.76 38.0 Favored 'General case' 0 N--CA 1.484 1.225 0 N-CA-C 115.262 1.579 . . . . 0.0 115.262 175.807 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -41.0 -38.26 0.95 Allowed 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 126.688 1.995 . . . . 0.0 115.815 172.412 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.701 ' HB ' HD22 ' A' ' 32' ' ' LEU . 33.6 m -105.4 -41.24 6.24 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.95 0 N-CA-C 114.754 1.391 . . . . 0.0 114.754 -176.67 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 0.432 ' HB2' HG21 ' A' ' 7' ' ' ILE . . . -67.29 -39.85 86.03 Favored 'General case' 0 N--CA 1.479 1.023 0 N-CA-C 112.992 0.738 . . . . 0.0 112.992 178.541 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -58.52 -41.9 95.69 Favored Glycine 0 CA--C 1.547 2.048 0 C-N-CA 123.923 0.773 . . . . 0.0 111.877 175.532 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 10.4 m -66.52 -39.88 88.88 Favored 'General case' 0 N--CA 1.484 1.232 0 CA-C-N 113.644 -1.278 . . . . 0.0 114.158 176.986 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 71.4 t -52.77 -43.36 44.86 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.017 0 N-CA-C 112.042 0.386 . . . . 0.0 112.042 169.445 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.595 HD11 HG12 ' A' ' 68' ' ' ILE . 38.3 mt -60.63 -43.84 97.07 Favored 'General case' 0 N--CA 1.481 1.095 0 N-CA-C 113.161 0.8 . . . . 0.0 113.161 179.75 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 20.4 t-20 -52.95 -50.78 63.35 Favored 'General case' 0 N--CA 1.48 1.05 0 O-C-N 124.934 1.396 . . . . 0.0 110.731 173.909 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.56 HG11 HD11 ' A' ' 28' ' ' ILE . 70.6 t -63.05 -41.62 93.54 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.088 0 CA-C-N 114.306 -1.315 . . . . 0.0 113.746 178.24 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.685 HG13 ' HA ' ' A' ' 56' ' ' LYS . 37.0 t -61.25 -45.75 97.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 123.845 0.716 . . . . 0.0 110.427 175.689 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . 0.42 ' HG3' ' HE2' ' A' ' 64' ' ' LYS . 31.3 mt-10 -60.67 -39.54 88.77 Favored 'General case' 0 CA--C 1.551 0.981 0 C-N-CA 124.914 1.286 . . . . 0.0 113.744 177.605 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -87.06 -15.98 36.97 Favored 'General case' 0 CA--C 1.543 0.68 0 N-CA-C 117.398 2.37 . . . . 0.0 117.398 -178.551 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 63.6 37.14 94.3 Favored Glycine 0 N--CA 1.484 1.851 0 C-N-CA 124.216 0.912 . . . . 0.0 112.219 -172.021 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -90.01 -166.23 41.29 Favored Glycine 0 N--CA 1.482 1.712 0 CA-C-O 122.808 1.227 . . . . 0.0 113.365 -172.694 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' TRP . . . . . 0.602 ' HB3' HG22 ' A' ' 26' ' ' THR . 5.4 m-90 -82.74 111.44 18.68 Favored 'General case' 0 N--CA 1.478 0.957 0 CA-C-O 122.328 1.061 . . . . 0.0 111.032 -179.891 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.41 ' HB ' ' HG2' ' A' ' 52' ' ' LYS . 39.6 t -65.02 -20.18 27.07 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.209 0 CA-C-N 114.669 -1.15 . . . . 0.0 112.307 168.278 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.602 HG22 ' HB3' ' A' ' 24' ' ' TRP . 10.9 t -64.26 -32.96 74.75 Favored 'General case' 0 N--CA 1.482 1.129 0 N-CA-C 113.96 1.096 . . . . 0.0 113.96 179.587 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -66.74 -33.68 76.16 Favored 'General case' 0 N--CA 1.485 1.313 0 N-CA-C 113.672 0.99 . . . . 0.0 113.672 173.875 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.56 HD11 HG11 ' A' ' 18' ' ' VAL . 0.0 OUTLIER -87.4 -38.0 11.57 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.165 0 CA-C-O 118.737 -0.649 . . . . 0.0 111.363 -178.798 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 14.0 t -44.82 -44.23 2.63 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.213 0 C-N-CA 124.225 1.01 . . . . 0.0 111.981 175.288 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 6.4 p -63.28 -31.76 72.99 Favored 'General case' 0 N--CA 1.484 1.229 0 N-CA-C 114.706 1.373 . . . . 0.0 114.706 175.92 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.699 HG22 HG12 ' A' ' 11' ' ' VAL . 15.3 mm -82.44 -37.94 14.83 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.152 0 C-N-CA 123.661 0.784 . . . . 0.0 109.732 179.006 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.701 HD22 ' HB ' ' A' ' 11' ' ' VAL . 3.7 mm? -53.72 -52.97 58.39 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 125.341 1.456 . . . . 0.0 111.283 170.356 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 17.2 p -70.18 -30.87 68.1 Favored 'General case' 0 N--CA 1.475 0.825 0 N-CA-C 114.277 1.214 . . . . 0.0 114.277 179.159 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -53.64 -33.47 55.27 Favored 'General case' 0 N--CA 1.483 1.184 0 N-CA-C 113.554 0.946 . . . . 0.0 113.554 170.022 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.476 ' HB ' ' O ' ' A' ' 32' ' ' LEU . 74.7 t . . . . . 0 N--CA 1.488 1.426 0 C-N-CA 124.675 1.19 . . . . 0.0 112.899 170.934 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . 0.499 ' HA2' ' HB3' ' A' ' 32' ' ' LEU . . . . . . . . 0 N--CA 1.479 1.527 0 N-CA-C 111.753 -0.539 . . . . 0.0 111.753 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 52.5 mt -60.21 -47.38 86.23 Favored 'General case' 0 N--CA 1.478 0.949 0 N-CA-C 115.126 1.528 . . . . 0.0 115.126 -176.529 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 75.5 p -61.76 -41.29 97.5 Favored 'General case' 0 CA--C 1.544 0.715 0 N-CA-C 113.139 0.792 . . . . 0.0 113.139 176.665 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 9.8 tp -63.88 -47.37 80.91 Favored 'General case' 0 N--CA 1.482 1.135 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.405 173.87 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.477 ' HG ' ' O ' ' A' ' 39' ' ' GLY . 75.8 mt -60.6 -30.48 69.85 Favored 'General case' 0 N--CA 1.474 0.768 0 N-CA-C 114.783 1.401 . . . . 0.0 114.783 -178.916 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -70.3 -44.68 67.83 Favored 'General case' 0 N--CA 1.477 0.917 0 O-C-N 123.842 0.714 . . . . 0.0 112.724 172.897 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -68.64 -37.14 79.45 Favored 'General case' 0 N--CA 1.479 0.994 0 CA-C-O 121.607 0.717 . . . . 0.0 112.305 177.242 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.423 ' HB1' ' HA ' ' A' ' 51' ' ' ILE . . . -60.74 -25.24 66.33 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 126.45 1.9 . . . . 0.0 115.371 176.364 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -48.77 -36.83 20.05 Favored Glycine 0 CA--C 1.545 1.934 0 O-C-N 124.657 1.223 . . . . 0.0 113.564 176.642 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 25.0 ttm180 -43.64 -52.57 6.31 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 128.256 2.622 . . . . 0.0 113.228 -177.698 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 11.2 tt0 -128.55 36.12 4.29 Favored 'General case' 0 CA--C 1.545 0.761 0 N-CA-C 112.957 0.725 . . . . 0.0 112.957 -178.599 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 60.3 p 51.5 123.62 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.664 0 C-N-CA 125.065 1.346 . . . . 0.0 112.17 -169.101 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.423 ' HA ' ' HB1' ' A' ' 46' ' ' ALA . 5.8 tp -33.57 -50.51 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.164 0 N-CA-C 117.082 2.253 . . . . 0.0 117.082 -176.952 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 0.41 ' HG2' ' HB ' ' A' ' 25' ' ' VAL . 7.1 mttt -59.76 -62.86 1.56 Allowed 'General case' 0 N--CA 1.471 0.623 0 N-CA-C 114.388 1.255 . . . . 0.0 114.388 178.123 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -63.28 -34.1 76.94 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 113.24 -1.8 . . . . 0.0 112.662 -179.388 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 72.4 t80 -51.52 -63.61 1.08 Allowed 'General case' 0 C--O 1.224 -0.277 0 C-N-CA 125.955 1.702 . . . . 0.0 110.654 176.969 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 43.5 mt -65.96 -39.62 90.59 Favored 'General case' 0 N--CA 1.477 0.925 0 N-CA-C 115.265 1.58 . . . . 0.0 115.265 -175.859 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . 0.685 ' HA ' HG13 ' A' ' 19' ' ' VAL . 1.8 mptm? -58.94 -44.38 91.41 Favored 'General case' 0 N--CA 1.472 0.644 0 N-CA-C 114.859 1.429 . . . . 0.0 114.859 177.767 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 15.6 tttm -79.39 -52.68 7.76 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-N 114.467 -1.242 . . . . 0.0 112.542 173.284 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . 0.546 ' O ' ' HB2' ' A' ' 62' ' ' LYS . 0.8 OUTLIER -59.22 -45.17 91.82 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-O 116.488 -1.72 . . . . 0.0 113.039 -171.62 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.653 HG23 HG21 ' A' ' 67' ' ' VAL . 3.2 mm -76.37 -26.64 17.05 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.04 0 C-N-CA 119.994 -0.682 . . . . 0.0 111.697 -179.637 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.523 ' HB2' ' O ' ' A' ' 56' ' ' LYS . 0.7 OUTLIER -59.22 -34.51 72.27 Favored 'General case' 0 CA--C 1.543 0.7 0 CA-C-O 122.162 0.982 . . . . 0.0 113.566 173.144 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 5.0 mttm -87.97 -44.97 10.62 Favored 'General case' 0 N--CA 1.479 0.985 0 CA-C-N 112.536 -2.12 . . . . 0.0 110.853 179.363 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . 0.546 ' HB2' ' O ' ' A' ' 58' ' ' GLU . 19.9 tttt -68.51 -41.23 80.27 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 127.348 2.259 . . . . 0.0 114.41 -171.554 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 93.24 110.57 2.02 Favored Glycine 0 CA--C 1.534 1.231 0 N-CA-C 110.358 -1.097 . . . . 0.0 110.358 -177.719 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.714 ' H ' ' HD2' ' A' ' 64' ' ' LYS . 10.0 mptt -39.3 -47.61 1.73 Allowed 'General case' 0 N--CA 1.481 1.093 0 N-CA-C 117.395 2.369 . . . . 0.0 117.395 -176.189 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . 0.485 ' O ' ' HB ' ' A' ' 68' ' ' ILE . 4.6 ttp180 -58.51 -50.22 74.55 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 124.18 0.992 . . . . 0.0 113.436 179.448 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -61.96 -28.03 69.26 Favored 'General case' 0 N--CA 1.476 0.843 0 N-CA-C 114.118 1.155 . . . . 0.0 114.118 173.669 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.653 HG21 HG23 ' A' ' 59' ' ' ILE . 90.3 t -70.62 -33.15 51.98 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 N-CA-C 112.333 0.494 . . . . 0.0 112.333 176.509 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.595 HG12 HD11 ' A' ' 16' ' ' LEU . 4.1 mm -49.5 -47.28 20.38 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.332 0 C-N-CA 123.28 0.632 . . . . 0.0 109.718 167.719 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -66.95 -51.81 50.59 Favored 'General case' 0 N--CA 1.485 1.286 0 CA-C-N 114.811 -1.086 . . . . 0.0 112.751 177.807 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' TRP . . . . . 0.46 ' O ' ' HB2' ' A' ' 4' ' ' GLU . 39.6 t90 . . . . . 0 N--CA 1.484 1.263 0 C-N-CA 125.055 1.342 . . . . 0.0 113.121 -179.201 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.552 ' HE1' HG21 ' A' ' 15' ' ' VAL . 72.4 mtp . . . . . 0 N--CA 1.476 0.832 0 N-CA-C 112.814 0.672 . . . . 0.0 112.814 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . 0.611 ' HA ' ' O ' ' A' ' 7' ' ' ILE . . . -60.91 -54.84 40.15 Favored 'General case' 0 N--CA 1.471 0.601 0 N-CA-C 113.584 0.957 . . . . 0.0 113.584 173.961 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 9.7 tptp -74.08 -57.05 4.22 Favored 'General case' 0 CA--C 1.543 0.711 0 CA-C-N 113.559 -1.655 . . . . 0.0 114.456 -174.597 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 11.3 tt0 -77.88 -43.74 29.27 Favored 'General case' 0 N--CA 1.477 0.88 0 N-CA-C 113.631 0.974 . . . . 0.0 113.631 -171.967 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 41.7 m-85 -95.35 -8.08 36.75 Favored 'General case' 0 CA--C 1.542 0.652 0 N-CA-C 117.396 2.369 . . . . 0.0 117.396 -173.749 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 63.48 38.53 96.48 Favored Glycine 0 N--CA 1.478 1.47 0 O-C-N 124.38 1.05 . . . . 0.0 112.848 -177.773 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.611 ' O ' ' HA ' ' A' ' 2' ' ' ALA . 0.8 OUTLIER -114.06 128.6 25.62 Favored Pre-proline 0 N--CA 1.479 1.005 0 C-N-CA 124.51 1.124 . . . . 0.0 108.474 -179.808 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -66.89 156.37 66.46 Favored 'Trans proline' 0 CA--C 1.54 0.785 0 CA-C-N 120.169 1.096 . . . . 0.0 110.943 179.721 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -51.8 -30.0 21.4 Favored 'General case' 0 N--CA 1.483 1.177 0 N-CA-C 115.077 1.51 . . . . 0.0 115.077 173.988 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -44.64 -46.98 10.44 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 126.332 1.853 . . . . 0.0 114.007 175.159 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.973 HG12 HG22 ' A' ' 31' ' ' ILE . 34.9 m -96.14 -32.43 4.31 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.345 0 N-CA-C 114.016 1.117 . . . . 0.0 114.016 -177.824 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 0.41 ' O ' ' HG ' ' A' ' 16' ' ' LEU . . . -59.99 -34.61 73.55 Favored 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 112.483 0.549 . . . . 0.0 112.483 173.43 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -58.69 -46.73 92.95 Favored Glycine 0 CA--C 1.546 1.978 0 C-N-CA 124.823 1.201 . . . . 0.0 113.048 169.463 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -62.32 -39.98 94.82 Favored 'General case' 0 N--CA 1.487 1.391 0 C-N-CA 124.46 1.104 . . . . 0.0 113.633 176.822 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.558 HG13 HD13 ' A' ' 55' ' ' LEU . 30.9 t -51.76 -39.37 24.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 C-N-CA 124.286 1.034 . . . . 0.0 112.768 169.338 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.581 HD22 ' HG3' ' A' ' 64' ' ' LYS . 56.3 mt -62.75 -38.35 90.23 Favored 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 113.773 1.027 . . . . 0.0 113.773 177.408 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 18.2 t-20 -51.84 -47.48 64.36 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 123.792 0.837 . . . . 0.0 111.762 173.338 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.407 HG21 ' HA ' ' A' ' 25' ' ' VAL . 2.1 t -52.33 -51.49 32.03 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.118 0 CA-C-N 115.366 -0.833 . . . . 0.0 113.039 173.507 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.603 HG13 ' HA ' ' A' ' 56' ' ' LYS . 4.1 t -63.28 -46.41 95.73 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.065 0 O-C-N 124.299 0.999 . . . . 0.0 110.982 -179.116 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 33.0 mt-10 -62.21 -45.72 92.08 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 125.075 1.35 . . . . 0.0 114.279 -178.09 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -94.9 -22.01 18.28 Favored 'General case' 0 N--CA 1.48 1.056 0 N-CA-C 116.34 1.978 . . . . 0.0 116.34 -172.035 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 73.89 45.54 26.73 Favored Glycine 0 N--CA 1.481 1.663 0 N-CA-C 109.042 -1.623 . . . . 0.0 109.042 -163.352 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -94.71 164.13 25.13 Favored Glycine 0 N--CA 1.477 1.401 0 C-N-CA 124.898 1.237 . . . . 0.0 113.829 -169.438 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 2.8 m-90 -66.86 102.12 0.92 Allowed 'General case' 0 N--CA 1.475 0.818 0 CA-C-O 122.568 1.175 . . . . 0.0 112.045 -178.542 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.637 HG21 HG13 ' A' ' 51' ' ' ILE . 5.5 p -53.45 -25.59 11.1 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.996 0 CA-C-N 112.979 -1.918 . . . . 0.0 115.225 170.881 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 10.6 t -62.42 -36.42 82.33 Favored 'General case' 0 N--CA 1.478 0.951 0 N-CA-C 113.434 0.902 . . . . 0.0 113.434 179.756 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 1.3 m -67.11 -42.7 84.07 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 124.082 0.953 . . . . 0.0 110.65 173.226 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.448 ' O ' HD23 ' A' ' 32' ' ' LEU . 1.6 mp -63.34 -44.7 99.16 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.759 0 C-N-CA 124.227 1.011 . . . . 0.0 112.633 178.272 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 77.2 t -52.38 -44.17 42.58 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.152 0 C-N-CA 123.816 0.846 . . . . 0.0 111.049 174.842 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 20.3 p -60.83 -33.59 73.27 Favored 'General case' 0 N--CA 1.482 1.15 0 N-CA-C 114.999 1.481 . . . . 0.0 114.999 175.944 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.973 HG22 HG12 ' A' ' 11' ' ' VAL . 27.7 mm -75.18 -40.73 44.1 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.692 0 C-N-CA 124.226 1.01 . . . . 0.0 109.319 178.891 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.619 ' HB3' ' HA3' ' A' ' 39' ' ' GLY . 3.6 mm? -59.68 -32.89 70.91 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 124.743 1.217 . . . . 0.0 111.391 169.236 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 2.9 m -73.38 -35.88 65.98 Favored 'General case' 0 N--CA 1.475 0.801 0 N-CA-C 113.984 1.105 . . . . 0.0 113.984 174.532 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -53.8 -30.38 44.64 Favored 'General case' 0 N--CA 1.487 1.383 0 N-CA-C 113.374 0.879 . . . . 0.0 113.374 175.94 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 55.5 t . . . . . 0 N--CA 1.481 1.093 0 C-N-CA 126.823 2.049 . . . . 0.0 113.213 173.567 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . 0.619 ' HA3' ' HB3' ' A' ' 32' ' ' LEU . . . . . . . . 0 CA--C 1.55 2.28 0 N-CA-C 110.784 -0.926 . . . . 0.0 110.784 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 10.8 mt -55.81 -37.34 68.52 Favored 'General case' 0 N--CA 1.483 1.216 0 N-CA-C 116.363 1.986 . . . . 0.0 116.363 -169.657 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 16.6 p -56.87 -43.64 81.44 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 124.376 1.07 . . . . 0.0 113.652 176.506 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.41 HD22 ' HE1' ' A' ' 1' ' ' MET . 14.9 tp -66.68 -45.8 77.7 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 123.12 0.568 . . . . 0.0 110.845 175.316 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 88.4 mt -60.65 -30.77 70.09 Favored 'General case' 0 N--CA 1.477 0.89 0 CA-C-N 114.293 -1.321 . . . . 0.0 114.19 179.116 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -66.79 -48.18 69.82 Favored 'General case' 0 N--CA 1.474 0.726 0 N-CA-C 112.943 0.72 . . . . 0.0 112.943 173.546 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -64.36 -29.21 70.29 Favored 'General case' 0 N--CA 1.485 1.316 0 N-CA-C 113.029 0.752 . . . . 0.0 113.029 176.815 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -77.99 -9.53 59.15 Favored 'General case' 0 CA--C 1.543 0.683 0 N-CA-C 117.259 2.318 . . . . 0.0 117.259 -177.236 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -56.6 -57.06 21.41 Favored Glycine 0 CA--C 1.542 1.75 0 C-N-CA 124.321 0.962 . . . . 0.0 113.216 -166.881 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.71 -44.93 90.5 Favored 'General case' 0 CA--C 1.541 0.601 0 N-CA-C 115.681 1.734 . . . . 0.0 115.681 -177.321 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.502 ' OE1' ' HA ' ' A' ' 54' ' ' TYR . 13.0 tt0 -103.1 25.49 9.37 Favored 'General case' 0 N--CA 1.478 0.947 0 N-CA-C 114.749 1.389 . . . . 0.0 114.749 -175.058 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 91.8 p 46.63 118.85 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 125.756 1.622 . . . . 0.0 112.919 -174.594 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.637 HG13 HG21 ' A' ' 25' ' ' VAL . 8.0 tp -35.86 -52.18 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.263 0 N-CA-C 116.883 2.179 . . . . 0.0 116.883 -174.134 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 23.6 tptp -55.51 -67.98 0.24 Allowed 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 124.703 1.201 . . . . 0.0 112.863 174.518 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -57.73 -36.31 71.86 Favored 'General case' 0 N--CA 1.482 1.16 0 N-CA-C 113.993 1.108 . . . . 0.0 113.993 179.586 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . 0.502 ' HA ' ' OE1' ' A' ' 49' ' ' GLU . 94.3 t80 -50.0 -64.6 0.76 Allowed 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 125.533 1.533 . . . . 0.0 111.738 173.641 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.558 HD13 HG13 ' A' ' 15' ' ' VAL . 46.2 mt -63.16 -41.2 99.21 Favored 'General case' 0 N--CA 1.472 0.675 0 N-CA-C 114.023 1.12 . . . . 0.0 114.023 -178.357 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . 0.603 ' HA ' HG13 ' A' ' 19' ' ' VAL . 54.1 tptt -53.57 -54.15 41.56 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-N 113.751 -1.568 . . . . 0.0 112.303 179.076 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 58.9 tttp -68.79 -54.42 15.96 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 115.127 -0.942 . . . . 0.0 111.943 173.895 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 8.9 tt0 -59.25 -48.23 82.4 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-N 115.655 -0.702 . . . . 0.0 111.845 -167.34 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.716 HG23 HG21 ' A' ' 67' ' ' VAL . 3.1 mm -75.99 -23.95 16.35 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.124 0 O-C-N 123.288 0.367 . . . . 0.0 111.359 -176.051 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.421 ' HB2' ' O ' ' A' ' 56' ' ' LYS . 24.3 mttt -65.92 -21.6 66.45 Favored 'General case' 0 C--O 1.222 -0.362 0 N-CA-C 117.3 2.333 . . . . 0.0 117.3 169.095 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 60.4 mtpt -91.26 -50.24 5.93 Favored 'General case' 0 N--CA 1.481 1.091 0 CA-C-N 112.831 -1.986 . . . . 0.0 110.614 172.481 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 36.9 tttp -65.19 -50.29 66.49 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 126.957 2.103 . . . . 0.0 114.909 -171.957 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 95.77 121.61 3.84 Favored Glycine 0 CA--C 1.533 1.181 0 CA-C-O 122.384 0.991 . . . . 0.0 110.888 -171.86 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.581 ' HG3' HD22 ' A' ' 16' ' ' LEU . 12.3 mptt -45.08 -39.38 5.8 Favored 'General case' 0 N--CA 1.48 1.054 0 N-CA-C 117.396 2.369 . . . . 0.0 117.396 -175.777 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . 0.418 ' O ' ' HB ' ' A' ' 68' ' ' ILE . 0.0 OUTLIER -59.66 -46.97 87.42 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 124.545 1.138 . . . . 0.0 112.805 178.208 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -63.26 -28.27 69.91 Favored 'General case' 0 N--CA 1.479 1.023 0 N-CA-C 114.54 1.311 . . . . 0.0 114.54 174.723 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.716 HG21 HG23 ' A' ' 59' ' ' ILE . 26.2 t -70.75 -36.9 66.82 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.868 0 C-N-CA 123.594 0.758 . . . . 0.0 111.282 178.536 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.418 ' HB ' ' O ' ' A' ' 65' ' ' ARG . 21.6 mm -52.95 -46.75 53.55 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.95 0 C-N-CA 123.926 0.89 . . . . 0.0 110.384 170.781 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -70.37 -50.88 34.3 Favored 'General case' 0 N--CA 1.479 1.009 0 CA-C-N 114.783 -1.099 . . . . 0.0 113.172 177.072 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 31.6 t90 . . . . . 0 N--CA 1.484 1.248 0 C-N-CA 125.611 1.564 . . . . 0.0 112.77 -179.494 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.45 ' HE1' HG21 ' A' ' 15' ' ' VAL . 74.2 mtp . . . . . 0 N--CA 1.471 0.577 0 N-CA-C 112.215 0.45 . . . . 0.0 112.215 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . 0.425 ' HA ' ' O ' ' A' ' 7' ' ' ILE . . . -54.96 -58.38 7.85 Favored 'General case' 0 N--CA 1.472 0.664 0 O-C-N 124.734 1.271 . . . . 0.0 113.255 173.395 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 22.1 tptm -71.81 -50.75 26.91 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 113.684 -1.598 . . . . 0.0 113.104 -173.763 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 8.3 tt0 -78.1 -42.76 31.03 Favored 'General case' 0 N--CA 1.479 0.99 0 N-CA-C 114.674 1.361 . . . . 0.0 114.674 -170.254 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . 0.457 ' HD1' ' HB2' ' A' ' 41' ' ' SER . 58.3 m-85 -105.76 -15.15 15.03 Favored 'General case' 0 N--CA 1.474 0.738 0 N-CA-C 116.987 2.218 . . . . 0.0 116.987 -172.101 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 85.75 61.21 1.71 Allowed Glycine 0 N--CA 1.482 1.73 0 O-C-N 124.352 1.033 . . . . 0.0 112.331 -176.922 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.538 HG21 ' HB2' ' A' ' 12' ' ' ALA . 1.0 OUTLIER -111.48 137.14 21.04 Favored Pre-proline 0 N--CA 1.475 0.789 0 CA-C-N 114.365 -0.918 . . . . 0.0 109.771 173.47 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.416 ' C ' ' H ' ' A' ' 10' ' ' ALA . 47.5 Cg_endo -82.04 38.45 0.75 Allowed 'Trans proline' 0 CA--C 1.537 0.673 0 C-N-CA 122.861 2.374 . . . . 0.0 113.2 175.522 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . 53.85 -34.04 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.518 0 C-N-CA 129.69 3.196 . . . . 0.0 117.243 -169.959 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.416 ' H ' ' C ' ' A' ' 8' ' ' PRO . . . -37.23 -63.53 0.43 Allowed 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 128.735 2.814 . . . . 0.0 113.564 174.023 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.537 HG12 HG22 ' A' ' 31' ' ' ILE . 26.9 m -74.77 -21.43 16.99 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.862 0 N-CA-C 113.896 1.073 . . . . 0.0 113.896 -176.248 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 0.538 ' HB2' HG21 ' A' ' 7' ' ' ILE . . . -67.6 -32.88 73.91 Favored 'General case' 0 N--CA 1.475 0.785 0 N-CA-C 112.356 0.502 . . . . 0.0 112.356 169.991 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -59.37 -38.04 92.84 Favored Glycine 0 CA--C 1.541 1.706 0 C-N-CA 123.836 0.731 . . . . 0.0 113.44 172.284 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.541 HG22 HG13 ' A' ' 28' ' ' ILE . 0.2 OUTLIER -69.79 -27.67 65.1 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 126.189 1.796 . . . . 0.0 115.124 176.329 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.484 ' O ' ' HB ' ' A' ' 18' ' ' VAL . 2.8 t -67.01 -44.07 88.62 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.169 0 C-N-CA 124.884 1.273 . . . . 0.0 110.691 171.501 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.451 HD13 ' HB3' ' A' ' 64' ' ' LYS . 60.2 mt -63.44 -42.83 98.67 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 114.408 -1.269 . . . . 0.0 112.348 179.076 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . 0.41 ' HB2' ' O ' ' A' ' 14' ' ' THR 0.444 0.6 OUTLIER -48.33 -52.86 19.63 Favored 'General case' 0 C--N 1.31 -1.123 0 CA-C-N 114.484 -1.235 . . . . 0.0 114.161 169.281 . . . . . . . . 4 4 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.484 ' HB ' ' O ' ' A' ' 15' ' ' VAL . 2.9 t -46.17 -54.2 2.09 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.416 0 O-C-N 125.629 1.831 . . . . 0.0 110.342 173.434 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.823 HG13 ' HA ' ' A' ' 56' ' ' LYS . 4.1 t -62.33 -49.99 81.73 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.08 0 CA-C-N 115.011 -0.995 . . . . 0.0 111.16 -174.453 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 25.8 mt-10 -66.28 -38.59 88.14 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 126.128 1.771 . . . . 0.0 115.012 -171.959 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -99.63 -11.45 20.93 Favored 'General case' 0 N--CA 1.473 0.688 0 N-CA-C 114.473 1.286 . . . . 0.0 114.473 -175.044 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 68.03 39.83 88.81 Favored Glycine 0 CA--C 1.545 1.912 0 N-CA-C 111.423 -0.671 . . . . 0.0 111.423 -166.903 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -91.69 159.45 25.85 Favored Glycine 0 CA--C 1.541 1.689 0 CA-C-O 122.948 1.304 . . . . 0.0 113.776 -173.251 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 83.8 m95 -63.81 108.03 1.35 Allowed 'General case' 0 N--CA 1.47 0.558 0 CA-C-N 112.863 -1.668 . . . . 0.0 113.564 -179.512 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.614 HG21 HG13 ' A' ' 51' ' ' ILE . 5.5 p -58.46 -26.86 31.87 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 CA-C-N 111.741 -2.481 . . . . 0.0 113.864 168.653 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 10.1 t -65.09 -36.51 84.53 Favored 'General case' 0 N--CA 1.482 1.125 0 N-CA-C 113.431 0.901 . . . . 0.0 113.431 -173.867 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -70.45 -43.7 69.33 Favored 'General case' 0 N--CA 1.47 0.544 0 N-CA-C 112.367 0.506 . . . . 0.0 112.367 172.029 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.541 HG13 HG22 ' A' ' 14' ' ' THR . 1.6 mp -61.27 -44.0 97.59 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.564 0 C-N-CA 124.92 1.288 . . . . 0.0 112.539 -179.214 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.527 HG13 HD11 ' A' ' 43' ' ' LEU . 23.7 t -46.04 -47.54 5.76 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.703 0 C-N-CA 124.632 1.173 . . . . 0.0 111.594 171.572 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 22.7 p -60.52 -33.98 73.43 Favored 'General case' 0 N--CA 1.482 1.128 0 N-CA-C 114.606 1.335 . . . . 0.0 114.606 177.808 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.537 HG22 HG12 ' A' ' 11' ' ' VAL . 21.7 mm -77.28 -35.66 22.87 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 C-N-CA 124.142 0.977 . . . . 0.0 109.235 -178.951 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.611 ' HB3' ' HA2' ' A' ' 39' ' ' GLY . 4.0 mm? -60.66 -52.38 65.36 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 124.198 0.999 . . . . 0.0 111.587 173.5 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 1.7 p -60.84 -30.05 69.87 Favored 'General case' 0 N--CA 1.482 1.169 0 N-CA-C 115.37 1.619 . . . . 0.0 115.37 177.156 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -53.62 -33.51 55.28 Favored 'General case' 0 N--CA 1.479 1.009 0 N-CA-C 114.81 1.411 . . . . 0.0 114.81 175.251 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 68.8 t . . . . . 0 N--CA 1.484 1.265 0 C-N-CA 125.916 1.686 . . . . 0.0 111.912 175.889 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . 0.611 ' HA2' ' HB3' ' A' ' 32' ' ' LEU . . . . . . . . 0 N--CA 1.473 1.143 0 N-CA-C 111.467 -0.653 . . . . 0.0 111.467 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 58.8 mt -57.89 -48.94 78.39 Favored 'General case' 0 N--CA 1.474 0.742 0 N-CA-C 115.452 1.649 . . . . 0.0 115.452 -175.971 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . 0.457 ' HB2' ' HD1' ' A' ' 5' ' ' PHE . 13.1 p -61.91 -37.88 86.3 Favored 'General case' 0 CA--C 1.544 0.732 0 N-CA-C 114.828 1.418 . . . . 0.0 114.828 177.66 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 10.0 tp -69.74 -42.12 74.34 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 124.251 1.02 . . . . 0.0 111.005 175.183 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.527 HD11 HG13 ' A' ' 29' ' ' VAL . 51.2 mt -63.26 -25.79 68.48 Favored 'General case' 0 N--CA 1.469 0.506 0 N-CA-C 114.968 1.47 . . . . 0.0 114.968 178.516 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -72.09 -49.52 35.61 Favored 'General case' 0 N--CA 1.481 1.106 0 CA-C-N 115.909 -0.587 . . . . 0.0 112.286 171.273 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -60.9 -35.75 77.46 Favored 'General case' 0 N--CA 1.49 1.529 0 C-N-CA 124.847 1.259 . . . . 0.0 112.933 -179.229 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -52.4 -25.7 10.6 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 126.844 2.058 . . . . 0.0 114.347 174.293 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -45.7 -37.97 7.27 Favored Glycine 0 CA--C 1.539 1.561 0 C-N-CA 126.514 2.007 . . . . 0.0 114.101 178.868 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 4.5 tmm_? -62.96 -39.35 94.39 Favored 'General case' 0 CA--C 1.544 0.738 0 N-CA-C 114.802 1.408 . . . . 0.0 114.802 -173.079 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 11.5 tt0 -141.15 38.7 1.76 Allowed 'General case' 0 N--CA 1.479 0.981 0 N-CA-C 116.365 1.987 . . . . 0.0 116.365 -178.51 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 59.5 p 53.47 119.34 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.874 0 C-N-CA 125.184 1.394 . . . . 0.0 112.643 -177.131 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.614 HG13 HG21 ' A' ' 25' ' ' VAL 0.276 8.6 tp -36.7 -46.55 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 N-CA-C 117.89 2.552 . . . . 0.0 117.89 -171.945 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 24.7 tptt -55.86 -68.93 0.16 Allowed 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 126.107 1.763 . . . . 0.0 112.895 174.767 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -62.96 -32.3 73.59 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 124.904 1.282 . . . . 0.0 113.865 177.317 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 91.2 t80 -53.81 -62.91 1.35 Allowed 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 125.894 1.677 . . . . 0.0 110.88 -178.948 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 65.8 mt -65.09 -35.39 81.0 Favored 'General case' 0 N--CA 1.469 0.483 0 N-CA-C 114.134 1.161 . . . . 0.0 114.134 179.928 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . 0.823 ' HA ' HG13 ' A' ' 19' ' ' VAL . 58.7 mttp -61.36 -47.96 83.46 Favored 'General case' 0 N--CA 1.477 0.904 0 CA-C-N 113.982 -1.463 . . . . 0.0 114.445 178.476 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 85.7 tttt -76.78 -50.64 13.02 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-N 114.764 -1.107 . . . . 0.0 111.695 175.406 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . 0.434 ' O ' ' HB2' ' A' ' 62' ' ' LYS . 28.8 tt0 -59.08 -49.21 78.75 Favored 'General case' 0 N--CA 1.471 0.596 0 N-CA-C 111.922 0.341 . . . . 0.0 111.922 -173.152 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.739 HD12 HG21 ' A' ' 67' ' ' VAL . 2.7 mm -72.09 -25.03 23.08 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.038 0 CA-C-O 118.428 -0.796 . . . . 0.0 112.391 -178.669 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 63.9 tttm -62.77 -33.17 74.62 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 114.682 1.364 . . . . 0.0 114.682 172.045 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 55.1 mtmt -80.91 -48.58 12.14 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-N 114.055 -1.429 . . . . 0.0 110.729 173.941 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . 0.434 ' HB2' ' O ' ' A' ' 58' ' ' GLU . 5.9 tttm -64.51 -50.6 66.74 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 126.131 1.772 . . . . 0.0 115.77 -172.053 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 91.66 108.58 1.59 Allowed Glycine 0 N--CA 1.482 1.749 0 CA-C-N 114.932 -1.031 . . . . 0.0 110.747 -175.941 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.707 ' H ' ' HD2' ' A' ' 64' ' ' LYS . 8.6 mptt -31.95 -43.83 0.08 Allowed 'General case' 0 N--CA 1.482 1.153 0 N-CA-C 119.277 3.066 . . . . 0.0 119.277 -173.713 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.44 -47.94 82.34 Favored 'General case' 0 N--CA 1.475 0.78 0 N-CA-C 113.396 0.888 . . . . 0.0 113.396 178.865 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -60.77 -28.12 68.49 Favored 'General case' 0 N--CA 1.473 0.723 0 CA-C-N 115.015 -0.993 . . . . 0.0 113.402 172.937 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.739 HG21 HD12 ' A' ' 59' ' ' ILE . 96.2 t -72.95 -36.09 50.56 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.662 0 N-CA-C 112.877 0.695 . . . . 0.0 112.877 179.276 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 33.5 mm -53.21 -46.77 56.63 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.996 0 O-C-N 123.637 0.586 . . . . 0.0 109.952 168.721 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -68.6 -43.15 77.05 Favored 'General case' 0 N--CA 1.476 0.844 0 N-CA-C 113.598 0.962 . . . . 0.0 113.598 178.57 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 29.3 t90 . . . . . 0 N--CA 1.477 0.886 0 CA-C-N 114.816 -1.084 . . . . 0.0 113.069 178.337 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.624 ' HE3' HD13 ' A' ' 7' ' ' ILE . 39.7 mtp . . . . . 0 N--CA 1.477 0.918 0 N-CA-C 111.8 0.296 . . . . 0.0 111.8 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . 0.423 ' HA ' ' O ' ' A' ' 7' ' ' ILE . . . -53.64 -55.19 28.04 Favored 'General case' 0 N--CA 1.475 0.789 0 CA-C-N 113.714 -1.585 . . . . 0.0 113.415 177.625 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -74.24 -44.11 54.32 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 113.639 -1.619 . . . . 0.0 114.156 -174.758 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 13.6 tt0 -78.52 -43.19 27.45 Favored 'General case' 0 N--CA 1.472 0.652 0 N-CA-C 114.241 1.2 . . . . 0.0 114.241 -170.898 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . 0.6 ' HB2' HD12 ' A' ' 7' ' ' ILE . 46.3 m-85 -105.34 -23.99 12.76 Favored 'General case' 0 N--CA 1.484 1.233 0 N-CA-C 116.258 1.947 . . . . 0.0 116.258 -170.16 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 95.72 58.38 1.12 Allowed Glycine 0 CA--C 1.534 1.276 0 C-N-CA 124.225 0.917 . . . . 0.0 111.77 -175.083 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.624 HD13 ' HE3' ' A' ' 1' ' ' MET . 1.3 mt -125.77 151.11 70.46 Favored Pre-proline 0 N--CA 1.478 0.944 0 C-N-CA 124.764 1.225 . . . . 0.0 111.069 -173.57 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo -97.27 162.63 0.97 Allowed 'Trans proline' 0 C--O 1.24 0.597 0 C-N-CA 121.162 1.241 . . . . 0.0 109.703 161.596 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -53.44 -29.38 35.11 Favored 'General case' 0 CA--C 1.538 0.481 0 N-CA-C 114.719 1.377 . . . . 0.0 114.719 177.176 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -43.61 -59.87 2.0 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 126.196 1.799 . . . . 0.0 112.953 173.146 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.779 HG12 HG22 ' A' ' 31' ' ' ILE . 29.6 m -84.42 -29.89 7.13 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.195 0 N-CA-C 114.321 1.23 . . . . 0.0 114.321 -175.231 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -67.26 -29.79 69.5 Favored 'General case' 0 N--CA 1.48 1.064 0 N-CA-C 112.759 0.651 . . . . 0.0 112.759 172.943 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -66.66 -40.01 93.89 Favored Glycine 0 CA--C 1.536 1.374 0 C-N-CA 124.317 0.96 . . . . 0.0 112.401 170.616 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.756 HG22 HD12 ' A' ' 28' ' ' ILE . 1.0 OUTLIER -67.7 -34.13 76.29 Favored 'General case' 0 N--CA 1.487 1.404 0 C-N-CA 124.183 0.993 . . . . 0.0 112.937 177.232 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.569 HG21 ' HE1' ' A' ' 1' ' ' MET . 10.8 t -54.15 -40.58 47.3 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 C-N-CA 124.707 1.203 . . . . 0.0 112.879 165.772 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.478 HD22 ' HG3' ' A' ' 64' ' ' LYS . 83.2 mt -61.27 -37.13 82.03 Favored 'General case' 0 N--CA 1.472 0.645 0 N-CA-C 114.261 1.208 . . . . 0.0 114.261 176.494 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 48.2 t-20 -53.62 -47.9 69.8 Favored 'General case' 0 N--CA 1.481 1.076 0 CA-C-N 115.179 -0.919 . . . . 0.0 111.355 173.353 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.574 HG23 HG13 ' A' ' 28' ' ' ILE . 22.6 t -48.11 -51.61 9.0 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.213 0 CA-C-N 115.28 -0.873 . . . . 0.0 112.021 174.596 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.829 HG13 ' HA ' ' A' ' 56' ' ' LYS . 5.1 t -64.3 -48.16 86.62 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.144 0 C-N-CA 124.155 0.982 . . . . 0.0 111.327 -176.774 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -74.13 -43.11 58.72 Favored 'General case' 0 N--CA 1.469 0.519 0 N-CA-C 116.767 2.136 . . . . 0.0 116.767 -176.127 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -103.17 -22.45 13.74 Favored 'General case' 0 N--CA 1.481 1.107 0 N-CA-C 115.814 1.783 . . . . 0.0 115.814 -169.796 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 68.87 39.61 85.34 Favored Glycine 0 N--CA 1.477 1.413 0 N-CA-C 110.639 -0.984 . . . . 0.0 110.639 -165.928 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -86.55 142.82 18.91 Favored Glycine 0 N--CA 1.48 1.57 0 N-CA-C 108.815 -1.714 . . . . 0.0 108.815 -177.513 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 9.2 m-90 -49.6 103.15 0.04 OUTLIER 'General case' 0 N--CA 1.477 0.883 0 CA-C-N 113.624 -1.288 . . . . 0.0 112.71 -172.498 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.402 ' O ' HG23 ' A' ' 29' ' ' VAL . 3.2 p -56.44 -23.41 16.68 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.758 0 CA-C-N 114.028 -1.442 . . . . 0.0 114.414 176.368 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 5.0 t -62.43 -44.42 96.47 Favored 'General case' 0 N--CA 1.484 1.225 0 CA-C-N 115.648 -0.705 . . . . 0.0 112.558 178.389 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 1.6 m -60.86 -45.76 93.25 Favored 'General case' 0 N--CA 1.485 1.287 0 C-N-CA 123.871 0.868 . . . . 0.0 110.937 172.998 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.756 HD12 HG22 ' A' ' 14' ' ' THR . 8.4 mm -62.37 -46.58 96.09 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.152 0 C-N-CA 124.394 1.078 . . . . 0.0 111.867 -179.09 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.402 HG23 ' O ' ' A' ' 25' ' ' VAL . 48.7 t -50.31 -45.77 25.02 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.386 0 C-N-CA 124.757 1.223 . . . . 0.0 111.129 176.964 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 64.8 m -63.81 -27.31 69.09 Favored 'General case' 0 N--CA 1.481 1.095 0 N-CA-C 115.867 1.802 . . . . 0.0 115.867 177.825 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.779 HG22 HG12 ' A' ' 11' ' ' VAL . 34.9 mm -82.21 -39.81 16.67 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.032 0 C-N-CA 123.857 0.863 . . . . 0.0 109.07 178.967 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.773 HD22 ' HB ' ' A' ' 11' ' ' VAL . 3.4 mm? -56.64 -50.58 71.61 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 125.142 1.377 . . . . 0.0 112.204 172.171 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 1.4 p -70.89 -29.69 65.83 Favored 'General case' 0 N--CA 1.481 1.079 0 N-CA-C 114.683 1.364 . . . . 0.0 114.683 177.837 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -52.4 -25.63 10.43 Favored 'General case' 0 N--CA 1.477 0.918 0 N-CA-C 114.006 1.113 . . . . 0.0 114.006 170.456 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 58.5 t . . . . . 0 N--CA 1.485 1.322 0 C-N-CA 124.327 1.051 . . . . 0.0 112.051 173.753 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . 0.526 ' O ' ' HG ' ' A' ' 43' ' ' LEU . . . . . . . . 0 N--CA 1.48 1.58 0 CA-C-O 120.34 -0.144 . . . . 0.0 113.018 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 22.3 mt -61.45 -48.27 81.91 Favored 'General case' 0 N--CA 1.479 0.981 0 CA-C-N 113.589 -1.306 . . . . 0.0 113.5 -178.845 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 17.0 m -57.92 -41.25 82.3 Favored 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 123.658 0.783 . . . . 0.0 112.758 176.188 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 13.7 tp -60.5 -45.76 92.6 Favored 'General case' 0 N--CA 1.478 0.961 0 CA-C-N 115.554 -0.748 . . . . 0.0 111.393 173.969 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.526 ' HG ' ' O ' ' A' ' 39' ' ' GLY . 69.2 mt -61.85 -32.84 73.21 Favored 'General case' 0 N--CA 1.473 0.697 0 N-CA-C 113.66 0.985 . . . . 0.0 113.66 -179.269 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -63.9 -48.99 74.43 Favored 'General case' 0 N--CA 1.476 0.851 0 O-C-N 123.985 0.803 . . . . 0.0 112.102 171.802 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -62.52 -33.34 74.7 Favored 'General case' 0 N--CA 1.485 1.284 0 CA-C-O 122.239 1.019 . . . . 0.0 112.753 178.12 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -61.77 -14.33 31.64 Favored 'General case' 0 N--CA 1.478 0.933 0 N-CA-C 116.11 1.893 . . . . 0.0 116.11 176.559 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -48.54 -37.22 19.24 Favored Glycine 0 CA--C 1.542 1.771 0 O-C-N 124.718 1.261 . . . . 0.0 113.511 177.833 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 40.2 ttp180 -50.71 -50.76 54.46 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 125.671 1.588 . . . . 0.0 113.647 -173.602 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -145.52 37.98 1.12 Allowed 'General case' 0 N--CA 1.476 0.841 0 N-CA-C 114.064 1.135 . . . . 0.0 114.064 -175.013 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 27.6 t 52.96 133.37 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.504 0 C-N-CA 125.175 1.39 . . . . 0.0 112.855 -175.71 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.419 ' O ' ' HB3' ' A' ' 54' ' ' TYR 0.259 9.9 tp -37.79 -54.04 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.822 0 N-CA-C 117.89 2.552 . . . . 0.0 117.89 -168.186 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 38.4 tttt -61.98 -57.23 12.48 Favored 'General case' 0 CA--C 1.543 0.694 0 N-CA-C 114.096 1.147 . . . . 0.0 114.096 178.232 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -66.17 -30.0 70.39 Favored 'General case' 0 N--CA 1.479 1.011 0 O-C-N 123.925 0.765 . . . . 0.0 112.936 179.766 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . 0.419 ' HB3' ' O ' ' A' ' 51' ' ' ILE . 64.4 t80 -53.98 -61.42 2.31 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 124.893 1.277 . . . . 0.0 110.716 170.592 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.431 HD13 HG13 ' A' ' 15' ' ' VAL . 51.2 mt -65.01 -35.81 82.4 Favored 'General case' 0 N--CA 1.482 1.165 0 N-CA-C 113.622 0.971 . . . . 0.0 113.622 -174.662 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . 0.829 ' HA ' HG13 ' A' ' 19' ' ' VAL . 55.6 mttm -54.41 -56.58 17.26 Favored 'General case' 0 N--CA 1.473 0.693 0 O-C-N 125.34 1.65 . . . . 0.0 112.065 173.024 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 57.1 tttm -68.43 -45.47 72.47 Favored 'General case' 0 CA--C 1.542 0.635 0 CA-C-N 115.411 -0.813 . . . . 0.0 112.113 176.799 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . 0.451 ' O ' ' HB2' ' A' ' 62' ' ' LYS . 4.1 tp10 -56.81 -52.37 65.31 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-N 114.969 -1.014 . . . . 0.0 112.962 -175.969 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.532 HG23 HG21 ' A' ' 67' ' ' VAL . 1.2 mm -74.8 -26.7 19.75 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.261 0 CA-C-N 116.04 -0.527 . . . . 0.0 112.1 -177.713 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.472 ' HB2' ' O ' ' A' ' 56' ' ' LYS . 3.8 tppt? -62.06 -42.2 98.94 Favored 'General case' 0 CA--C 1.539 0.543 0 O-C-N 124.383 1.052 . . . . 0.0 112.525 176.596 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 61.2 pttt -86.39 -26.99 24.49 Favored 'General case' 0 CA--C 1.547 0.86 0 CA-C-N 113.447 -1.706 . . . . 0.0 113.193 177.935 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . 0.451 ' HB2' ' O ' ' A' ' 58' ' ' GLU . 35.7 tptt -76.16 -58.37 3.32 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 125.714 1.606 . . . . 0.0 114.542 -178.008 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 103.32 110.72 3.48 Favored Glycine 0 CA--C 1.543 1.803 0 CA-C-N 114.628 -1.169 . . . . 0.0 112.189 -174.304 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.517 ' H ' ' HD2' ' A' ' 64' ' ' LYS . 11.2 mptt -34.75 -52.27 0.52 Allowed 'General case' 0 N--CA 1.481 1.077 0 N-CA-C 119.784 3.253 . . . . 0.0 119.784 -172.641 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -61.55 -45.59 93.52 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 123.779 0.831 . . . . 0.0 112.993 -179.778 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -65.48 -25.82 67.65 Favored 'General case' 0 N--CA 1.478 0.97 0 CA-C-N 113.924 -1.489 . . . . 0.0 112.949 174.12 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.532 HG21 HG23 ' A' ' 59' ' ' ILE . 71.7 t -63.77 -43.86 98.09 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.314 0 C-N-CA 123.319 0.648 . . . . 0.0 110.411 174.864 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -51.78 -44.48 36.52 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.966 0 C-N-CA 123.339 0.656 . . . . 0.0 111.671 173.562 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -70.43 -47.64 59.79 Favored 'General case' 0 N--CA 1.481 1.077 0 N-CA-C 113.222 0.823 . . . . 0.0 113.222 177.629 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 30.7 t90 . . . . . 0 N--CA 1.481 1.083 0 C-N-CA 126.382 1.873 . . . . 0.0 112.433 -178.69 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.668 ' HB3' HG22 ' A' ' 7' ' ' ILE . 68.4 mtp . . . . . 0 N--CA 1.474 0.757 0 N-CA-C 113.471 0.915 . . . . 0.0 113.471 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -64.37 -38.83 92.42 Favored 'General case' 0 N--CA 1.475 0.813 0 N-CA-C 114.111 1.152 . . . . 0.0 114.111 176.562 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 35.6 ttmt -91.25 -68.54 0.79 Allowed 'General case' 0 N--CA 1.471 0.605 0 N-CA-C 114.125 1.157 . . . . 0.0 114.125 -176.89 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 8.5 tt0 -61.66 -31.14 71.23 Favored 'General case' 0 CA--C 1.55 0.974 0 C-N-CA 125.188 1.395 . . . . 0.0 113.796 -173.623 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . 0.541 ' HD1' ' HB2' ' A' ' 41' ' ' SER . 45.1 m-85 -109.77 -11.93 14.67 Favored 'General case' 0 N--CA 1.474 0.74 0 N-CA-C 116.948 2.203 . . . . 0.0 116.948 -179.94 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 64.44 31.62 81.47 Favored Glycine 0 CA--C 1.538 1.511 0 C-N-CA 124.176 0.893 . . . . 0.0 113.856 -174.228 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.668 HG22 ' HB3' ' A' ' 1' ' ' MET . 0.7 OUTLIER -104.21 118.01 57.97 Favored Pre-proline 0 N--CA 1.478 0.939 0 C-N-CA 123.418 0.687 . . . . 0.0 110.863 -177.524 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -64.27 161.61 33.52 Favored 'Trans proline' 0 CA--C 1.537 0.653 0 C-N-CA 122.506 2.137 . . . . 0.0 112.277 -171.807 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -55.75 -29.1 59.02 Favored 'General case' 0 N--CA 1.476 0.83 0 CA-C-N 113.278 -1.783 . . . . 0.0 114.137 173.141 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -49.03 -33.55 11.52 Favored 'General case' 0 N--CA 1.48 1.033 0 N-CA-C 114.853 1.427 . . . . 0.0 114.853 172.941 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.763 HG12 HG22 ' A' ' 31' ' ' ILE . 30.2 m -112.15 -35.45 2.43 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.016 0 N-CA-C 113.789 1.033 . . . . 0.0 113.789 179.895 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 0.413 ' O ' ' HG ' ' A' ' 16' ' ' LEU . . . -64.57 -40.21 95.14 Favored 'General case' 0 N--CA 1.476 0.852 0 N-CA-C 113.651 0.982 . . . . 0.0 113.651 174.802 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -61.72 -40.67 99.09 Favored Glycine 0 CA--C 1.548 2.104 0 C-N-CA 124.172 0.891 . . . . 0.0 112.276 174.542 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.528 HG22 HD12 ' A' ' 28' ' ' ILE . 4.3 m -66.81 -40.99 88.25 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 125.139 1.376 . . . . 0.0 113.46 177.324 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.479 HG21 ' HE1' ' A' ' 1' ' ' MET . 54.4 t -52.54 -46.96 49.05 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.207 0 C-N-CA 123.126 0.57 . . . . 0.0 111.249 169.056 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.666 HD11 HG12 ' A' ' 68' ' ' ILE . 23.8 mt -57.28 -48.19 79.54 Favored 'General case' 0 N--CA 1.482 1.174 0 O-C-N 123.839 0.712 . . . . 0.0 112.904 179.205 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 11.8 t-20 -54.44 -44.68 72.67 Favored 'General case' 0 CA--C 1.542 0.665 0 CA-C-N 114.857 -1.065 . . . . 0.0 111.338 179.168 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.932 HG21 HD11 ' A' ' 28' ' ' ILE . 2.8 t -68.68 -40.96 82.35 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.762 0 CA-C-N 113.475 -1.693 . . . . 0.0 114.087 179.336 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.656 HG13 ' HA ' ' A' ' 56' ' ' LYS . 40.5 t -59.01 -52.48 60.16 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.357 0 O-C-N 124.392 1.058 . . . . 0.0 109.265 175.73 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . 0.542 ' HG3' ' HE2' ' A' ' 64' ' ' LYS . 36.0 mt-10 -55.01 -53.54 54.46 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 125.232 1.413 . . . . 0.0 113.35 178.099 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -77.24 -11.66 59.85 Favored 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 115.683 1.735 . . . . 0.0 115.683 -175.379 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 67.66 47.93 59.01 Favored Glycine 0 N--CA 1.478 1.472 0 C-N-CA 124.523 1.059 . . . . 0.0 111.424 -172.44 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -94.13 -160.1 34.44 Favored Glycine 0 N--CA 1.475 1.248 0 CA-C-O 123.163 1.424 . . . . 0.0 113.293 -173.958 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 9.1 m-90 -102.89 105.69 16.1 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-O 122.651 1.215 . . . . 0.0 113.305 179.16 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.48 HG23 ' HE3' ' A' ' 56' ' ' LYS . 77.4 t -55.67 -27.23 21.36 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.045 0 CA-C-N 114.057 -1.429 . . . . 0.0 112.899 168.338 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 3.1 t -60.28 -38.32 83.19 Favored 'General case' 0 N--CA 1.485 1.286 0 N-CA-C 113.349 0.87 . . . . 0.0 113.349 179.143 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 2.7 m -64.07 -41.03 97.49 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 125.09 1.356 . . . . 0.0 110.684 175.013 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.932 HD11 HG21 ' A' ' 18' ' ' VAL . 1.6 mm -73.65 -39.85 53.87 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.277 0 CA-C-N 115.508 -0.769 . . . . 0.0 111.411 -178.79 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 25.6 t -46.09 -44.77 5.5 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 C-N-CA 124.113 0.965 . . . . 0.0 111.639 175.589 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 20.0 m -57.1 -41.31 78.68 Favored 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 124.966 1.307 . . . . 0.0 114.472 174.287 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.763 HG22 HG12 ' A' ' 11' ' ' VAL . 16.4 mm -75.09 -37.62 40.79 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.272 0 C-N-CA 124.483 1.113 . . . . 0.0 110.196 -178.957 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.535 ' HB3' ' HA3' ' A' ' 39' ' ' GLY . 4.2 mm? -55.37 -41.17 72.23 Favored 'General case' 0 N--CA 1.49 1.573 0 C-N-CA 124.342 1.057 . . . . 0.0 110.926 168.805 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 25.5 m -68.53 -38.83 81.2 Favored 'General case' 0 N--CA 1.485 1.317 0 N-CA-C 114.232 1.197 . . . . 0.0 114.232 174.961 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -55.68 -30.12 60.53 Favored 'General case' 0 N--CA 1.481 1.115 0 O-C-N 124.7 1.25 . . . . 0.0 113.242 175.131 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.427 ' HB ' ' O ' ' A' ' 32' ' ' LEU . 54.5 t . . . . . 0 N--CA 1.48 1.034 0 C-N-CA 125.838 1.655 . . . . 0.0 113.423 172.916 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . 0.535 ' HA3' ' HB3' ' A' ' 32' ' ' LEU . . . . . . . . 0 CA--C 1.546 1.977 0 N-CA-C 111.899 -0.481 . . . . 0.0 111.899 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 9.4 mt -51.91 -40.03 60.07 Favored 'General case' 0 N--CA 1.485 1.303 0 N-CA-C 116.631 2.086 . . . . 0.0 116.631 -168.52 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . 0.541 ' HB2' ' HD1' ' A' ' 5' ' ' PHE . 7.9 p -59.8 -49.04 79.26 Favored 'General case' 0 CA--C 1.546 0.792 0 N-CA-C 113.448 0.907 . . . . 0.0 113.448 178.792 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 15.8 tp -61.16 -47.36 86.56 Favored 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 122.968 0.507 . . . . 0.0 110.43 172.684 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 43.9 mt -66.19 -26.64 67.5 Favored 'General case' 0 N--CA 1.476 0.863 0 CA-C-N 114.605 -1.179 . . . . 0.0 114.062 -175.215 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -69.75 -45.16 68.71 Favored 'General case' 0 N--CA 1.475 0.823 0 CA-C-N 115.694 -0.685 . . . . 0.0 111.82 171.57 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -63.54 -35.81 81.7 Favored 'General case' 0 N--CA 1.479 0.976 0 CA-C-O 121.005 0.431 . . . . 0.0 111.875 173.845 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -66.13 -28.59 68.91 Favored 'General case' 0 N--CA 1.474 0.774 0 N-CA-C 116.193 1.923 . . . . 0.0 116.193 179.654 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -53.14 -35.05 48.37 Favored Glycine 0 N--CA 1.482 1.717 0 C-N-CA 124.818 1.199 . . . . 0.0 113.39 -178.433 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 42.2 ttp180 -57.24 -41.92 80.48 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 126.233 1.813 . . . . 0.0 113.929 -176.177 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -138.57 57.43 1.69 Allowed 'General case' 0 N--CA 1.476 0.839 0 CA-C-O 121.887 0.851 . . . . 0.0 110.149 178.197 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 9.0 t 30.33 114.32 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.225 0 N-CA-C 116.84 2.163 . . . . 0.0 116.84 -178.868 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 7.0 tp -26.99 -54.04 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.349 0 N-CA-C 118.023 2.601 . . . . 0.0 118.023 -177.273 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 0.449 ' HD2' ' HB ' ' A' ' 25' ' ' VAL . 24.1 tptp -57.65 -58.15 9.57 Favored 'General case' 0 N--CA 1.481 1.108 0 C-N-CA 124.494 1.118 . . . . 0.0 111.913 -177.762 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -72.01 -35.21 69.37 Favored 'General case' 0 N--CA 1.484 1.237 0 O-C-N 124.579 1.174 . . . . 0.0 113.831 177.847 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 67.8 t80 -45.78 -60.96 1.93 Allowed 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 125.445 1.498 . . . . 0.0 112.117 -179.695 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 59.4 mt -65.86 -36.14 82.61 Favored 'General case' 0 N--CA 1.475 0.811 0 N-CA-C 114.782 1.401 . . . . 0.0 114.782 -175.24 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . 0.656 ' HA ' HG13 ' A' ' 19' ' ' VAL . 35.5 mmtp -57.67 -56.2 25.02 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-N 114.211 -1.359 . . . . 0.0 112.311 177.386 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . 0.445 ' HE3' ' HE3' ' A' ' 61' ' ' LYS . 64.0 tttp -69.51 -51.15 38.4 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-N 115.054 -0.975 . . . . 0.0 111.968 175.673 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . 0.553 ' O ' ' HB2' ' A' ' 62' ' ' LYS . 3.6 mm-40 -54.93 -50.75 68.08 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-O 118.281 -0.866 . . . . 0.0 112.682 -173.377 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.606 HG23 HG21 ' A' ' 67' ' ' VAL . 2.7 mm -79.14 -25.68 12.94 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.077 0 CA-C-O 118.618 -0.706 . . . . 0.0 112.007 -175.824 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.414 ' HB2' ' O ' ' A' ' 56' ' ' LYS . 8.7 tppt? -62.1 -32.42 72.98 Favored 'General case' 0 N--CA 1.473 0.698 0 N-CA-C 114.416 1.265 . . . . 0.0 114.416 171.894 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . 0.445 ' HE3' ' HE3' ' A' ' 57' ' ' LYS . 48.4 mttm -88.56 -45.7 9.68 Favored 'General case' 0 N--CA 1.476 0.838 0 CA-C-N 113.351 -1.75 . . . . 0.0 112.42 176.127 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . 0.553 ' HB2' ' O ' ' A' ' 58' ' ' GLU . 2.9 tttm -64.41 -45.55 87.07 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 126.448 1.899 . . . . 0.0 112.96 -172.512 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 95.45 113.66 2.75 Favored Glycine 0 N--CA 1.479 1.546 0 O-C-N 124.958 1.411 . . . . 0.0 109.65 -175.546 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.622 ' H ' ' HD2' ' A' ' 64' ' ' LYS . 10.7 mptt -44.66 -43.7 8.5 Favored 'General case' 0 N--CA 1.484 1.234 0 N-CA-C 116.801 2.148 . . . . 0.0 116.801 -172.636 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . 0.489 ' O ' ' HB ' ' A' ' 68' ' ' ILE . 0.0 OUTLIER -56.16 -48.53 76.11 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 125.381 1.472 . . . . 0.0 114.576 178.054 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -64.71 -28.05 69.33 Favored 'General case' 0 N--CA 1.473 0.718 0 N-CA-C 114.463 1.282 . . . . 0.0 114.463 172.526 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.606 HG21 HG23 ' A' ' 59' ' ' ILE . 95.3 t -72.96 -32.82 41.25 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.944 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.321 179.098 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.666 HG12 HD11 ' A' ' 16' ' ' LEU . 4.3 mm -50.05 -49.57 21.55 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.332 0 C-N-CA 123.494 0.718 . . . . 0.0 110.098 167.132 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -64.59 -50.0 68.92 Favored 'General case' 0 N--CA 1.481 1.076 0 CA-C-N 114.917 -1.038 . . . . 0.0 112.912 178.636 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 23.2 t90 . . . . . 0 CA--C 1.544 0.728 0 C-N-CA 126.489 1.915 . . . . 0.0 112.987 179.394 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.73 ' HE1' HG21 ' A' ' 15' ' ' VAL . 74.1 mtp . . . . . 0 N--CA 1.482 1.156 0 N-CA-C 113.327 0.862 . . . . 0.0 113.327 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -65.18 -56.12 14.68 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-N 114.915 -1.039 . . . . 0.0 112.67 175.474 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 14.4 ttmm -71.09 -52.96 16.4 Favored 'General case' 0 CA--C 1.549 0.935 0 CA-C-N 114.361 -1.291 . . . . 0.0 114.118 -172.967 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . 0.434 ' HB2' ' O ' ' A' ' 70' ' ' TRP . 1.8 mp0 -79.77 -38.45 33.15 Favored 'General case' 0 N--CA 1.476 0.829 0 N-CA-C 115.052 1.501 . . . . 0.0 115.052 -174.559 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . 0.509 ' HD2' ' HA ' ' A' ' 1' ' ' MET . 73.9 m-85 -106.28 -9.72 16.71 Favored 'General case' 0 N--CA 1.484 1.253 0 N-CA-C 117.041 2.237 . . . . 0.0 117.041 -172.236 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 66.73 36.92 91.94 Favored Glycine 0 CA--C 1.54 1.632 0 CA-C-O 121.971 0.762 . . . . 0.0 112.917 -176.055 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.669 HG23 HG23 ' A' ' 11' ' ' VAL . 0.6 OUTLIER -116.12 112.87 41.81 Favored Pre-proline 0 N--CA 1.472 0.657 0 C-N-CA 124.327 1.051 . . . . 0.0 109.413 179.106 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_endo -63.86 164.05 23.02 Favored 'Trans proline' 0 N--CA 1.48 0.68 0 C-N-CA 121.184 1.256 . . . . 0.0 111.597 -174.471 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -55.76 -28.42 55.85 Favored 'General case' 0 N--CA 1.479 0.989 0 N-CA-C 114.674 1.361 . . . . 0.0 114.674 176.75 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -45.51 -43.98 12.21 Favored 'General case' 0 CA--C 1.549 0.917 0 C-N-CA 125.985 1.714 . . . . 0.0 113.753 174.628 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.952 HG12 HG22 ' A' ' 31' ' ' ILE . 33.6 m -100.24 -28.92 3.28 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.054 0 N-CA-C 114.766 1.395 . . . . 0.0 114.766 179.248 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -67.6 -34.97 78.07 Favored 'General case' 0 N--CA 1.477 0.895 0 N-CA-C 113.791 1.034 . . . . 0.0 113.791 176.76 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -61.47 -41.34 99.53 Favored Glycine 0 N--CA 1.478 1.44 0 CA-C-O 122.467 1.037 . . . . 0.0 112.304 172.357 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 3.1 m -64.1 -34.05 77.15 Favored 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 126.046 1.738 . . . . 0.0 112.893 175.524 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.73 HG21 ' HE1' ' A' ' 1' ' ' MET . 20.5 t -63.5 -36.64 77.06 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.065 0 C-N-CA 123.667 0.787 . . . . 0.0 112.083 172.039 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.631 HD13 ' HB3' ' A' ' 64' ' ' LYS . 31.6 mt -65.43 -40.36 93.21 Favored 'General case' 0 N--CA 1.485 1.305 0 N-CA-C 112.913 0.708 . . . . 0.0 112.913 174.234 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 4.6 m120 -57.62 -43.99 85.18 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 124.976 1.31 . . . . 0.0 112.448 174.384 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.412 ' HB ' ' O ' ' A' ' 15' ' ' VAL . 4.1 t -48.11 -57.64 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.35 0 C-N-CA 123.835 0.854 . . . . 0.0 111.373 168.391 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.595 HG13 ' HA ' ' A' ' 56' ' ' LYS . 4.8 t -60.66 -44.78 97.76 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 123.935 0.772 . . . . 0.0 111.913 -176.16 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 27.6 mt-10 -63.93 -43.74 94.97 Favored 'General case' 0 N--CA 1.472 0.634 0 N-CA-C 115.301 1.593 . . . . 0.0 115.301 179.506 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -97.04 -11.51 24.39 Favored 'General case' 0 N--CA 1.478 0.934 0 N-CA-C 116.221 1.934 . . . . 0.0 116.221 -170.917 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 73.49 25.28 72.98 Favored Glycine 0 CA--C 1.544 1.866 0 O-C-N 123.521 0.513 . . . . 0.0 112.736 -169.002 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -78.76 149.94 33.8 Favored Glycine 0 N--CA 1.476 1.362 0 CA-C-O 122.419 1.01 . . . . 0.0 113.689 -171.054 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' TRP . . . . . 0.492 ' HB3' HG22 ' A' ' 26' ' ' THR . 2.9 m-90 -62.1 98.08 0.1 Allowed 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 125.31 1.444 . . . . 0.0 112.327 178.402 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 5.0 p -51.87 -27.84 9.19 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.868 0 CA-C-N 113.734 -1.575 . . . . 0.0 113.985 173.187 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.492 HG22 ' HB3' ' A' ' 24' ' ' TRP . 13.9 t -59.52 -40.72 88.05 Favored 'General case' 0 CA--C 1.546 0.827 0 C-N-CA 124.735 1.214 . . . . 0.0 112.937 -178.055 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -67.66 -47.07 70.57 Favored 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 124.101 0.96 . . . . 0.0 110.604 174.964 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 2.3 mp -60.21 -35.4 61.72 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.036 0 C-N-CA 125.259 1.424 . . . . 0.0 112.99 177.179 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.411 ' O ' ' HB2' ' A' ' 32' ' ' LEU . 15.9 t -48.97 -40.62 12.78 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.365 0 C-N-CA 124.403 1.081 . . . . 0.0 112.38 173.845 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 59.7 p -61.03 -30.3 70.22 Favored 'General case' 0 N--CA 1.477 0.888 0 N-CA-C 114.02 1.118 . . . . 0.0 114.02 176.255 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.952 HG22 HG12 ' A' ' 11' ' ' VAL . 42.6 mm -77.33 -36.47 23.96 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.989 0 C-N-CA 124.07 0.948 . . . . 0.0 109.191 179.965 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.561 ' HB3' ' HA3' ' A' ' 39' ' ' GLY . 3.9 mm? -60.13 -36.42 77.45 Favored 'General case' 0 N--CA 1.49 1.554 0 C-N-CA 123.741 0.817 . . . . 0.0 111.315 169.414 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 2.5 m -72.55 -34.31 67.42 Favored 'General case' 0 N--CA 1.483 1.176 0 N-CA-C 114.698 1.37 . . . . 0.0 114.698 175.403 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -54.49 -29.02 48.77 Favored 'General case' 0 N--CA 1.482 1.16 0 O-C-N 124.245 0.965 . . . . 0.0 113.459 174.317 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 70.5 t . . . . . 0 N--CA 1.484 1.255 0 C-N-CA 126.313 1.845 . . . . 0.0 113.03 172.031 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . 0.561 ' HA3' ' HB3' ' A' ' 32' ' ' LEU . . . . . . . . 0 CA--C 1.543 1.815 0 N-CA-C 113.404 0.121 . . . . 0.0 113.404 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 14.3 mt -53.23 -41.74 65.7 Favored 'General case' 0 N--CA 1.48 1.059 0 N-CA-C 116.459 2.022 . . . . 0.0 116.459 -171.127 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . 0.469 ' HB2' ' HD1' ' A' ' 5' ' ' PHE . 11.5 p -59.47 -51.62 69.1 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 125.327 1.451 . . . . 0.0 113.86 175.26 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 14.5 tp -60.74 -43.48 97.87 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 123.676 0.79 . . . . 0.0 110.31 174.157 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 82.7 mt -65.68 -27.37 68.3 Favored 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 114.618 1.34 . . . . 0.0 114.618 -178.23 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -70.33 -48.26 57.32 Favored 'General case' 0 N--CA 1.478 0.953 0 CA-C-N 115.43 -0.805 . . . . 0.0 112.323 169.91 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -59.19 -37.16 76.74 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 123.446 0.699 . . . . 0.0 112.697 176.292 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -57.87 -28.95 64.62 Favored 'General case' 0 C--N 1.321 -0.63 0 C-N-CA 126.546 1.938 . . . . 0.0 115.642 177.76 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -47.81 -41.78 20.67 Favored Glycine 0 CA--C 1.536 1.371 0 C-N-CA 125.438 1.494 . . . . 0.0 114.608 -174.514 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 41.0 ttp-105 -53.81 -47.02 71.27 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 126.0 1.72 . . . . 0.0 113.81 -174.797 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 5.0 tt0 -127.14 31.01 5.32 Favored 'General case' 0 CA--C 1.547 0.854 0 N-CA-C 113.787 1.032 . . . . 0.0 113.787 -177.553 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 24.5 t 45.85 126.8 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 125.353 1.461 . . . . 0.0 113.809 -171.545 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 9.8 tp -37.44 -42.25 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 N-CA-C 117.239 2.311 . . . . 0.0 117.239 -173.437 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 8.4 mmtt -57.41 -72.05 0.09 Allowed 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 124.31 1.044 . . . . 0.0 112.05 174.393 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -62.49 -34.8 77.57 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 125.196 1.398 . . . . 0.0 113.853 -177.842 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 87.6 t80 -48.62 -59.45 3.51 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 125.497 1.519 . . . . 0.0 111.646 175.715 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.513 HD13 HG13 ' A' ' 15' ' ' VAL . 75.0 mt -67.86 -41.67 82.54 Favored 'General case' 0 N--CA 1.482 1.149 0 N-CA-C 114.448 1.277 . . . . 0.0 114.448 -177.873 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . 0.595 ' HA ' HG13 ' A' ' 19' ' ' VAL . 33.2 mmtp -55.98 -42.16 75.92 Favored 'General case' 0 N--CA 1.479 0.993 0 CA-C-N 113.253 -1.794 . . . . 0.0 114.507 178.963 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 59.3 tttm -80.35 -54.97 5.23 Favored 'General case' 0 N--CA 1.473 0.715 0 O-C-N 124.843 1.34 . . . . 0.0 112.327 172.559 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 72.9 tt0 -58.68 -46.02 88.16 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-O 117.766 -1.111 . . . . 0.0 112.489 -168.694 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.676 HG23 HG21 ' A' ' 67' ' ' VAL . 3.7 mm -79.36 -20.02 12.59 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.895 0 C-N-CA 119.911 -0.716 . . . . 0.0 112.081 -173.814 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 22.9 tttp -72.55 -24.91 61.19 Favored 'General case' 0 CA--C 1.547 0.851 0 O-C-N 124.713 1.258 . . . . 0.0 114.147 172.638 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 45.3 mmtm -97.25 -38.8 9.54 Favored 'General case' 0 N--CA 1.477 0.886 0 CA-C-N 113.549 -1.66 . . . . 0.0 111.58 178.455 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . 0.439 ' HD3' HG22 ' A' ' 67' ' ' VAL . 31.6 tttp -71.54 -52.65 17.1 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 126.282 1.833 . . . . 0.0 114.514 -177.938 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 102.17 114.62 3.88 Favored Glycine 0 N--CA 1.483 1.79 0 O-C-N 124.361 1.038 . . . . 0.0 111.022 -173.289 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.659 ' H ' ' HD2' ' A' ' 64' ' ' LYS . 9.0 mptt -41.44 -44.37 2.86 Favored 'General case' 0 N--CA 1.486 1.354 0 N-CA-C 117.548 2.425 . . . . 0.0 117.548 -176.043 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . 0.373 0.0 OUTLIER -53.08 -51.76 60.78 Favored 'General case' 0 C--N 1.315 -0.912 0 C-N-CA 127.801 2.44 . . . . 0.0 114.124 177.216 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -65.71 -27.62 68.47 Favored 'General case' 0 N--CA 1.475 0.788 0 N-CA-C 114.111 1.152 . . . . 0.0 114.111 173.436 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.676 HG21 HG23 ' A' ' 59' ' ' ILE . 21.7 t -71.08 -36.16 61.88 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.966 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.502 179.876 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.402 HG12 HD11 ' A' ' 16' ' ' LEU . 14.2 mm -49.01 -44.61 15.99 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.847 0 C-N-CA 124.243 1.017 . . . . 0.0 110.939 167.696 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -70.77 -51.76 25.01 Favored 'General case' 0 N--CA 1.477 0.877 0 CA-C-N 115.004 -0.998 . . . . 0.0 112.331 179.088 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' TRP . . . . . 0.434 ' O ' ' HB2' ' A' ' 4' ' ' GLU . 36.2 t90 . . . . . 0 CA--C 1.553 1.073 0 C-N-CA 125.303 1.441 . . . . 0.0 113.352 -177.277 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.418 ' HE1' HG21 ' A' ' 15' ' ' VAL . 34.3 mtp . . . . . 0 CA--C 1.533 0.294 0 CA-C-O 119.718 -0.182 . . . . 0.0 110.738 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . 0.412 ' HA ' ' O ' ' A' ' 7' ' ' ILE . . . -60.29 -50.39 73.84 Favored 'General case' 0 N--CA 1.478 0.966 0 CA-C-N 114.374 -1.285 . . . . 0.0 112.863 178.844 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 10.5 tptm -71.73 -58.92 3.05 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 113.543 -1.662 . . . . 0.0 114.55 -175.716 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -67.95 -43.58 78.77 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 116.263 1.949 . . . . 0.0 116.263 -170.209 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . 0.496 ' HB2' HD12 ' A' ' 7' ' ' ILE . 33.7 m-85 -102.0 -26.09 13.52 Favored 'General case' 0 N--CA 1.481 1.113 0 N-CA-C 116.665 2.098 . . . . 0.0 116.665 -170.408 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 92.47 58.64 1.34 Allowed Glycine 0 N--CA 1.477 1.384 0 O-C-N 124.931 1.394 . . . . 0.0 110.537 -174.975 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.496 HD12 ' HB2' ' A' ' 5' ' ' PHE . 0.7 OUTLIER -120.47 140.48 30.38 Favored Pre-proline 0 N--CA 1.476 0.831 0 CA-C-N 114.365 -0.918 . . . . 0.0 110.309 -179.12 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 68.3 Cg_endo -89.47 152.71 5.36 Favored 'Trans proline' 0 CA--C 1.534 0.495 0 C-N-CA 121.27 1.313 . . . . 0.0 109.069 166.828 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -44.65 -34.37 2.17 Favored 'General case' 0 N--CA 1.47 0.532 0 N-CA-C 116.108 1.892 . . . . 0.0 116.108 177.03 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -36.2 -43.29 0.35 Allowed 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 125.984 1.714 . . . . 0.0 115.108 168.687 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.921 HG12 HG22 ' A' ' 31' ' ' ILE . 10.4 m -103.66 -37.28 4.49 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.1 0 N-CA-C 115.192 1.553 . . . . 0.0 115.192 -177.442 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 0.489 ' O ' ' HG ' ' A' ' 16' ' ' LEU . . . -64.76 -36.28 83.8 Favored 'General case' 0 N--CA 1.482 1.15 0 N-CA-C 113.145 0.795 . . . . 0.0 113.145 177.758 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -64.12 -40.87 98.49 Favored Glycine 0 N--CA 1.479 1.567 0 C-N-CA 125.777 1.656 . . . . 0.0 112.35 176.13 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 2.1 m -63.98 -41.86 97.39 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 124.54 1.136 . . . . 0.0 112.404 174.308 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.663 HG13 HD13 ' A' ' 55' ' ' LEU . 32.1 t -53.75 -40.91 45.34 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.934 0 CA-C-O 121.174 0.512 . . . . 0.0 112.2 170.188 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.597 HD11 HG12 ' A' ' 68' ' ' ILE . 45.7 mt -64.99 -49.88 68.53 Favored 'General case' 0 N--CA 1.477 0.898 0 CA-C-N 115.699 -0.682 . . . . 0.0 112.725 178.825 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 1.7 t30 -42.8 -45.2 4.75 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-O 123.167 1.461 . . . . 0.0 113.839 172.657 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.739 HG13 ' O ' ' A' ' 23' ' ' GLY . 5.3 t -63.27 -50.99 76.72 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.746 0 CA-C-N 109.976 -3.284 . . . . 0.0 112.29 178.793 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.746 HG13 ' HA ' ' A' ' 56' ' ' LYS . 36.0 t -59.91 -46.39 93.98 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.889 0 O-C-N 124.77 1.294 . . . . 0.0 110.691 179.419 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -63.58 -39.82 95.37 Favored 'General case' 0 N--CA 1.466 0.369 0 N-CA-C 114.342 1.238 . . . . 0.0 114.342 -177.51 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -96.39 2.53 52.74 Favored 'General case' 0 N--CA 1.478 0.963 0 N-CA-C 115.616 1.71 . . . . 0.0 115.616 -177.593 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 56.97 47.08 89.95 Favored Glycine 0 CA--C 1.541 1.702 0 C-N-CA 123.644 0.64 . . . . 0.0 111.572 -174.39 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.739 ' O ' HG13 ' A' ' 18' ' ' VAL . . . -102.97 154.49 18.22 Favored Glycine 0 N--CA 1.476 1.313 0 CA-C-O 123.944 1.858 . . . . 0.0 112.594 -174.576 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 4.5 m-90 -73.43 101.11 3.4 Favored 'General case' 0 N--CA 1.473 0.689 0 CA-C-N 112.961 -1.619 . . . . 0.0 112.807 -175.69 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.682 ' HB ' HG11 ' A' ' 18' ' ' VAL . 7.6 p -62.37 -20.46 24.66 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 N-CA-C 114.171 1.174 . . . . 0.0 114.171 173.3 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 6.4 t -61.02 -28.62 69.18 Favored 'General case' 0 N--CA 1.481 1.09 0 N-CA-C 112.952 0.723 . . . . 0.0 112.952 178.942 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -74.91 -43.61 53.3 Favored 'General case' 0 N--CA 1.474 0.73 0 CA-C-O 119.625 -0.226 . . . . 0.0 111.118 174.669 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 3.2 mp -64.12 -30.93 51.4 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.053 0 C-N-CA 127.67 2.388 . . . . 0.0 112.853 178.15 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.578 HG13 HD11 ' A' ' 43' ' ' LEU . 31.2 t -44.96 -37.47 1.63 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.14 0 C-N-CA 124.616 1.166 . . . . 0.0 112.702 172.542 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 91.5 p -60.4 -35.39 75.65 Favored 'General case' 0 N--CA 1.476 0.873 0 N-CA-C 113.217 0.821 . . . . 0.0 113.217 176.415 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.921 HG22 HG12 ' A' ' 11' ' ' VAL . 33.8 mm -77.87 -34.08 19.28 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.775 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.304 -179.781 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.591 HD22 ' HB ' ' A' ' 11' ' ' VAL . 4.1 mm? -60.92 -50.03 75.08 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 124.127 0.971 . . . . 0.0 112.159 172.105 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -69.84 -26.14 64.08 Favored 'General case' 0 N--CA 1.482 1.132 0 N-CA-C 114.925 1.454 . . . . 0.0 114.925 -179.87 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -51.56 -38.38 54.09 Favored 'General case' 0 CA--C 1.545 0.758 0 O-C-N 124.139 0.899 . . . . 0.0 112.508 169.736 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 22.8 t . . . . . 0 N--CA 1.481 1.081 0 C-N-CA 125.346 1.458 . . . . 0.0 111.607 174.852 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . 0.471 ' HA2' ' HB3' ' A' ' 32' ' ' LEU . . . . . . . . 0 CA--C 1.535 1.302 0 N-CA-C 110.788 -0.925 . . . . 0.0 110.788 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 66.4 mt -60.32 -52.41 65.38 Favored 'General case' 0 N--CA 1.47 0.565 0 N-CA-C 116.388 1.996 . . . . 0.0 116.388 -179.675 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 23.4 p -62.78 -35.15 78.91 Favored 'General case' 0 N--CA 1.479 0.997 0 CA-C-O 118.092 -0.956 . . . . 0.0 113.16 177.939 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 13.4 tp -61.05 -50.62 72.59 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 123.007 0.523 . . . . 0.0 111.12 170.56 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.578 HD11 HG13 ' A' ' 29' ' ' VAL . 59.1 mt -61.92 -34.45 76.08 Favored 'General case' 0 N--CA 1.479 0.985 0 O-C-N 124.222 0.951 . . . . 0.0 113.439 -179.532 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -63.24 -46.03 88.8 Favored 'General case' 0 N--CA 1.473 0.692 0 N-CA-C 112.995 0.739 . . . . 0.0 112.995 172.895 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -65.07 -35.72 82.06 Favored 'General case' 0 N--CA 1.487 1.388 0 CA-C-N 115.268 -0.878 . . . . 0.0 112.483 175.437 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -60.81 -28.31 68.69 Favored 'General case' 0 N--CA 1.475 0.779 0 N-CA-C 115.122 1.527 . . . . 0.0 115.122 179.837 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -44.85 -35.53 4.45 Favored Glycine 0 N--CA 1.48 1.601 0 C-N-CA 126.679 2.085 . . . . 0.0 114.193 -175.789 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . 0.517 ' HE ' ' HE1' ' A' ' 54' ' ' TYR . 63.3 ttp85 -51.61 -54.99 21.85 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-N 112.875 -1.663 . . . . 0.0 112.732 -176.692 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 25.4 tt0 -127.71 36.73 4.31 Favored 'General case' 0 N--CA 1.473 0.71 0 N-CA-C 114.154 1.168 . . . . 0.0 114.154 -173.14 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 75.8 p 50.4 121.69 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 125.221 1.408 . . . . 0.0 111.974 -171.387 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.473 ' O ' ' HB3' ' A' ' 54' ' ' TYR 0.276 6.3 tp -31.35 -53.86 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.483 1.223 0 N-CA-C 117.16 2.282 . . . . 0.0 117.16 -173.438 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 0.622 ' HG3' HG12 ' A' ' 25' ' ' VAL . 0.1 OUTLIER -59.11 -66.97 0.42 Allowed 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 115.561 1.689 . . . . 0.0 115.561 175.402 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -54.99 -34.17 63.15 Favored 'General case' 0 N--CA 1.475 0.788 0 O-C-N 124.776 1.298 . . . . 0.0 113.252 177.601 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . 0.517 ' HE1' ' HE ' ' A' ' 48' ' ' ARG . 87.5 t80 -54.36 -63.34 1.18 Allowed 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 126.141 1.776 . . . . 0.0 110.541 174.981 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.663 HD13 HG13 ' A' ' 15' ' ' VAL . 96.4 mt -66.98 -42.2 85.48 Favored 'General case' 0 N--CA 1.476 0.843 0 N-CA-C 115.379 1.622 . . . . 0.0 115.379 -177.453 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . 0.746 ' HA ' HG13 ' A' ' 19' ' ' VAL . 96.4 mttt -56.52 -43.21 79.58 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 113.109 -1.859 . . . . 0.0 114.092 178.522 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . 0.409 ' O ' ' HG3' ' A' ' 61' ' ' LYS . 15.6 tttt -82.64 -50.07 9.15 Favored 'General case' 0 C--N 1.318 -0.776 0 O-C-N 124.158 0.911 . . . . 0.0 112.997 174.306 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . 0.461 ' O ' ' HB2' ' A' ' 62' ' ' LYS . 31.1 tt0 -57.72 -47.49 82.26 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 118.2 -0.905 . . . . 0.0 112.397 -175.95 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.606 HG23 HG21 ' A' ' 67' ' ' VAL . 1.8 mm -75.84 -23.32 16.29 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.26 0 N-CA-C 112.266 0.469 . . . . 0.0 112.266 -175.49 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.441 ' HB2' ' O ' ' A' ' 56' ' ' LYS . 32.2 tptt -64.01 -38.55 91.5 Favored 'General case' 0 CA--C 1.544 0.717 0 O-C-N 124.695 1.247 . . . . 0.0 112.284 170.354 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . 0.409 ' HG3' ' O ' ' A' ' 57' ' ' LYS . 26.5 mtpt -77.3 -45.44 26.25 Favored 'General case' 0 N--CA 1.481 1.108 0 CA-C-N 112.925 -1.943 . . . . 0.0 113.05 177.139 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . 0.461 ' HB2' ' O ' ' A' ' 58' ' ' GLU . 10.4 tttm -70.25 -47.32 61.84 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 126.699 1.999 . . . . 0.0 113.352 -172.468 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 96.05 99.58 1.85 Allowed Glycine 0 N--CA 1.467 0.708 0 CA-C-N 114.46 -1.245 . . . . 0.0 110.658 179.067 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.748 ' H ' ' HD2' ' A' ' 64' ' ' LYS . 10.8 mptt -22.42 -47.6 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.838 0 N-CA-C 119.673 3.212 . . . . 0.0 119.673 -175.673 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . 0.43 ' O ' ' HB ' ' A' ' 68' ' ' ILE . 0.1 OUTLIER -56.02 -49.5 73.5 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 124.687 1.195 . . . . 0.0 113.08 177.386 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -62.23 -26.12 68.2 Favored 'General case' 0 N--CA 1.471 0.61 0 N-CA-C 114.536 1.31 . . . . 0.0 114.536 174.514 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.606 HG21 HG23 ' A' ' 59' ' ' ILE . 99.1 t -72.97 -34.68 46.74 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.638 0 C-N-CA 123.094 0.558 . . . . 0.0 111.094 177.001 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.597 HG12 HD11 ' A' ' 16' ' ' LEU . 5.2 mm -51.06 -45.85 30.34 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.117 0 O-C-N 123.904 0.752 . . . . 0.0 110.468 169.689 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -64.83 -52.58 55.92 Favored 'General case' 0 CA--C 1.549 0.937 0 CA-C-N 114.368 -1.287 . . . . 0.0 113.033 175.906 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 35.3 t90 . . . . . 0 N--CA 1.484 1.228 0 C-N-CA 125.582 1.553 . . . . 0.0 115.007 -178.983 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.461 ' HE1' HD11 ' A' ' 32' ' ' LEU . 33.3 mtp . . . . . 0 N--CA 1.48 1.06 0 N-CA-C 111.988 0.366 . . . . 0.0 111.988 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . 0.451 ' HA ' ' O ' ' A' ' 7' ' ' ILE . . . -55.19 -50.75 68.57 Favored 'General case' 0 CA--C 1.543 0.68 0 O-C-N 124.475 1.109 . . . . 0.0 112.511 178.343 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 54.7 tttp -73.25 -59.95 2.47 Favored 'General case' 0 CA--C 1.543 0.7 0 CA-C-N 112.695 -2.048 . . . . 0.0 114.097 -176.717 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 14.0 tt0 -67.93 -42.54 80.85 Favored 'General case' 0 N--CA 1.481 1.075 0 N-CA-C 115.009 1.485 . . . . 0.0 115.009 -168.831 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . 0.409 ' HB2' HD12 ' A' ' 7' ' ' ILE . 70.4 m-85 -100.32 -18.71 16.67 Favored 'General case' 0 N--CA 1.468 0.467 0 N-CA-C 116.824 2.157 . . . . 0.0 116.824 -173.913 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 83.28 57.82 2.42 Favored Glycine 0 CA--C 1.544 1.892 0 O-C-N 124.688 1.242 . . . . 0.0 111.519 -173.652 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.451 ' O ' ' HA ' ' A' ' 2' ' ' ALA . 0.4 OUTLIER -115.67 150.17 44.31 Favored Pre-proline 0 N--CA 1.481 1.106 0 CA-C-N 113.384 -1.408 . . . . 0.0 110.638 177.888 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_endo -88.37 151.99 6.6 Favored 'Trans proline' 0 CA--C 1.53 0.312 0 N-CA-C 109.513 -0.995 . . . . 0.0 109.513 159.587 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -51.19 -26.97 7.73 Favored 'General case' 0 N--CA 1.476 0.86 0 N-CA-C 115.217 1.562 . . . . 0.0 115.217 176.156 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -41.94 -56.16 2.86 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 126.298 1.839 . . . . 0.0 112.312 169.948 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.797 HG12 HG22 ' A' ' 31' ' ' ILE . 21.3 m -88.91 -29.45 5.23 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.004 0 N-CA-C 114.371 1.249 . . . . 0.0 114.371 -173.7 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -64.92 -32.16 73.75 Favored 'General case' 0 N--CA 1.477 0.877 0 N-CA-C 112.964 0.727 . . . . 0.0 112.964 173.564 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -65.96 -40.37 95.29 Favored Glycine 0 CA--C 1.542 1.736 0 O-C-N 124.161 0.913 . . . . 0.0 112.809 173.581 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.639 HG22 HG13 ' A' ' 28' ' ' ILE . 1.0 OUTLIER -60.75 -40.6 93.07 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 123.969 0.908 . . . . 0.0 112.554 173.378 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.822 HG13 HD13 ' A' ' 55' ' ' LEU . 18.3 t -54.73 -43.34 66.05 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.086 0 C-N-CA 124.22 1.008 . . . . 0.0 112.86 168.776 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 81.5 mt -60.28 -38.72 84.46 Favored 'General case' 0 N--CA 1.481 1.096 0 N-CA-C 114.03 1.122 . . . . 0.0 114.03 177.115 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 24.7 t-20 -51.94 -48.64 64.17 Favored 'General case' 0 N--CA 1.481 1.077 0 O-C-N 124.512 1.132 . . . . 0.0 111.869 173.089 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -49.39 -49.39 18.08 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.182 0 CA-C-N 114.428 -1.26 . . . . 0.0 112.559 174.638 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.74 HG13 ' HA ' ' A' ' 56' ' ' LYS . 3.4 t -66.2 -51.27 61.16 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.975 0 O-C-N 125.071 1.482 . . . . 0.0 110.446 -177.069 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 25.3 mt-10 -60.45 -38.86 85.54 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 125.231 1.412 . . . . 0.0 114.215 -175.792 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -103.7 -16.21 15.53 Favored 'General case' 0 N--CA 1.472 0.645 0 N-CA-C 116.948 2.203 . . . . 0.0 116.948 -174.159 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 69.16 46.72 56.94 Favored Glycine 0 CA--C 1.545 1.926 0 N-CA-C 111.991 -0.443 . . . . 0.0 111.991 -169.885 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -102.71 167.82 17.82 Favored Glycine 0 CA--C 1.542 1.74 0 CA-C-N 114.036 -1.082 . . . . 0.0 114.384 -167.425 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' TRP . . . . . 0.461 ' HB3' HG22 ' A' ' 26' ' ' THR . 75.8 m95 -62.71 106.51 0.8 Allowed 'General case' 0 N--CA 1.476 0.84 0 CA-C-N 113.054 -1.573 . . . . 0.0 112.2 -178.849 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.49 HG21 HG22 ' A' ' 51' ' ' ILE . 2.6 p -57.46 -23.68 20.15 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.835 0 CA-C-N 113.624 -1.626 . . . . 0.0 113.723 168.698 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.461 HG22 ' HB3' ' A' ' 24' ' ' TRP . 1.7 t -55.4 -43.84 75.59 Favored 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 113.329 0.863 . . . . 0.0 113.329 -179.96 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.439 ' O ' HG12 ' A' ' 31' ' ' ILE . 0.0 OUTLIER -65.46 -45.06 85.24 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 123.883 0.873 . . . . 0.0 112.242 174.868 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.639 HG13 HG22 ' A' ' 14' ' ' THR . 1.6 mp -59.78 -44.89 94.92 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.89 0 CA-C-N 114.598 -1.183 . . . . 0.0 111.796 177.398 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.487 HG13 HD11 ' A' ' 43' ' ' LEU . 53.2 t -53.77 -43.79 57.18 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.999 0 C-N-CA 124.126 0.97 . . . . 0.0 112.434 178.544 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 1.1 m -59.62 -43.08 93.93 Favored 'General case' 0 N--CA 1.485 1.317 0 N-CA-C 112.693 0.627 . . . . 0.0 112.693 176.078 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.797 HG22 HG12 ' A' ' 11' ' ' VAL . 35.5 mm -68.71 -38.8 79.4 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.138 0 CA-C-N 115.319 -0.855 . . . . 0.0 109.572 -176.544 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.679 HD22 ' HB ' ' A' ' 11' ' ' VAL . 3.7 mm? -63.89 -51.78 62.95 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 125.906 1.683 . . . . 0.0 112.624 176.35 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 27.7 p -70.19 -28.94 65.7 Favored 'General case' 0 N--CA 1.472 0.67 0 N-CA-C 114.28 1.215 . . . . 0.0 114.28 -179.733 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -52.57 -27.58 17.39 Favored 'General case' 0 N--CA 1.482 1.133 0 N-CA-C 113.951 1.093 . . . . 0.0 113.951 170.881 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 46.6 t -68.36 -38.73 79.84 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.15 0 C-N-CA 125.433 1.493 . . . . 0.0 111.785 170.592 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 118.68 -123.53 5.72 Favored Glycine 0 N--CA 1.478 1.454 0 C-N-CA 124.77 1.176 . . . . 0.0 110.421 -175.472 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 13.3 p -59.26 -38.64 80.59 Favored 'General case' 0 N--CA 1.478 0.964 0 CA-C-N 112.739 -1.731 . . . . 0.0 115.181 -174.381 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -50.07 -43.13 40.82 Favored Glycine 0 N--CA 1.484 1.886 0 O-C-N 124.525 1.141 . . . . 0.0 114.209 177.308 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.458 ' O ' ' HG ' ' A' ' 43' ' ' LEU . . . -62.73 -49.78 69.97 Favored Glycine 0 CA--C 1.538 1.495 0 C-N-CA 123.393 0.52 . . . . 0.0 112.271 176.842 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 12.2 mt -62.84 -44.16 96.89 Favored 'General case' 0 N--CA 1.478 0.93 0 CA-C-N 113.641 -1.28 . . . . 0.0 114.035 -178.065 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 28.6 p -61.53 -39.82 92.42 Favored 'General case' 0 N--CA 1.481 1.076 0 N-CA-C 113.234 0.827 . . . . 0.0 113.234 175.977 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 12.4 tp -62.21 -47.76 83.02 Favored 'General case' 0 N--CA 1.484 1.245 0 C-N-CA 122.863 0.465 . . . . 0.0 110.531 171.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.487 HD11 HG13 ' A' ' 29' ' ' VAL . 63.7 mt -60.5 -32.62 71.62 Favored 'General case' 0 N--CA 1.481 1.113 0 N-CA-C 114.86 1.43 . . . . 0.0 114.86 -179.606 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -66.53 -31.23 71.81 Favored 'General case' 0 N--CA 1.482 1.156 0 N-CA-C 113.732 1.012 . . . . 0.0 113.732 174.51 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -53.5 -48.52 68.88 Favored 'General case' 0 N--CA 1.477 0.875 0 N-CA-C 115.155 1.539 . . . . 0.0 115.155 -170.648 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -144.48 50.16 1.3 Allowed 'General case' 0 N--CA 1.482 1.129 0 CA-C-O 122.482 1.134 . . . . 0.0 113.503 174.271 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -51.37 -50.39 41.24 Favored Glycine 0 N--CA 1.487 2.076 0 CA-C-N 113.473 -1.694 . . . . 0.0 113.349 -176.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 79.4 ttt180 -58.83 -48.95 79.52 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 126.125 1.77 . . . . 0.0 113.974 -179.855 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 5.6 tm-20 -80.03 18.92 0.76 Allowed 'General case' 0 N--CA 1.476 0.838 0 N-CA-C 114.001 1.111 . . . . 0.0 114.001 -179.06 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 52.2 p 53.14 124.95 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 127.213 2.205 . . . . 0.0 111.911 -168.786 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.49 HG22 HG21 ' A' ' 25' ' ' VAL . 29.5 mm -52.44 -31.18 15.07 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.055 0 CA-C-N 115.081 -0.963 . . . . 0.0 112.816 170.419 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 71.1 tttt -57.14 -64.96 0.71 Allowed 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 124.36 1.064 . . . . 0.0 111.436 177.347 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -62.73 -35.17 78.89 Favored 'General case' 0 N--CA 1.472 0.659 0 N-CA-C 113.4 0.889 . . . . 0.0 113.4 178.694 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 15.7 t80 -51.17 -67.68 0.23 Allowed 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 124.984 1.314 . . . . 0.0 111.758 173.651 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.822 HD13 HG13 ' A' ' 15' ' ' VAL . 39.6 mt -61.97 -38.18 87.58 Favored 'General case' 0 N--CA 1.479 1.003 0 N-CA-C 113.084 0.772 . . . . 0.0 113.084 -177.115 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.74 ' HA ' HG13 ' A' ' 19' ' ' VAL . 96.2 mttt -54.88 -52.3 63.27 Favored 'General case' 0 C--O 1.219 -0.502 0 CA-C-N 114.353 -1.294 . . . . 0.0 113.609 177.433 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 2.3 ttpm? -74.99 -45.22 43.52 Favored 'General case' 0 N--CA 1.476 0.828 0 CA-C-N 114.945 -1.025 . . . . 0.0 112.392 176.026 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . 0.431 ' O ' ' HB2' ' A' ' 62' ' ' LYS . 44.4 tt0 -58.67 -49.93 75.72 Favored 'General case' 0 N--CA 1.471 0.596 0 O-C-N 123.384 0.428 . . . . 0.0 111.199 -174.918 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.697 HG23 HG21 ' A' ' 67' ' ' VAL . 3.2 mm -76.33 -27.4 17.55 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.162 0 CA-C-O 118.934 -0.555 . . . . 0.0 112.258 -177.924 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.473 ' HB2' ' O ' ' A' ' 56' ' ' LYS . 19.9 ttmm -59.5 -27.83 66.5 Favored 'General case' 0 N--CA 1.469 0.508 0 N-CA-C 114.422 1.267 . . . . 0.0 114.422 172.005 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 75.0 mttt -93.92 -41.87 9.37 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-N 113.283 -1.781 . . . . 0.0 113.432 176.76 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.431 ' HB2' ' O ' ' A' ' 58' ' ' GLU . 30.6 tttt -67.05 -60.94 2.2 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 126.511 1.924 . . . . 0.0 113.828 -175.301 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 104.09 110.21 3.46 Favored Glycine 0 CA--C 1.54 1.631 0 CA-C-N 114.795 -1.093 . . . . 0.0 112.448 -169.572 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.533 ' H ' ' HD2' ' A' ' 64' ' ' LYS . 0.0 OUTLIER -36.79 -43.36 0.43 Allowed 'General case' 0 N--CA 1.477 0.918 0 N-CA-C 119.577 3.177 . . . . 0.0 119.577 -175.668 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.415 ' O ' ' HB ' ' A' ' 68' ' ' ILE . 1.8 ttp180 -56.56 -47.12 80.16 Favored 'General case' 0 N--CA 1.477 0.883 0 N-CA-C 114.146 1.165 . . . . 0.0 114.146 179.356 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -64.58 -26.13 68.27 Favored 'General case' 0 N--CA 1.475 0.798 0 CA-C-N 114.509 -1.223 . . . . 0.0 113.62 175.157 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.697 HG21 HG23 ' A' ' 59' ' ' ILE . 30.4 t -72.12 -36.9 58.15 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.042 0 C-N-CA 123.671 0.788 . . . . 0.0 110.707 179.95 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.415 ' HB ' ' O ' ' A' ' 65' ' ' ARG . 19.9 mm -51.76 -46.79 39.65 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.171 0 C-N-CA 124.12 0.968 . . . . 0.0 110.748 167.934 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -69.99 -49.46 51.3 Favored 'General case' 0 N--CA 1.477 0.913 0 N-CA-C 113.802 1.038 . . . . 0.0 113.802 177.019 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' TRP . . . . . 0.426 ' CE3' ' HG3' ' A' ' 1' ' ' MET . 32.2 t90 . . . . . 0 N--CA 1.48 1.031 0 C-N-CA 126.412 1.885 . . . . 0.0 112.98 -178.049 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.655 ' HE1' HG21 ' A' ' 15' ' ' VAL . 56.8 mtp . . . . . 0 CA--C 1.542 0.651 0 N-CA-C 112.238 0.459 . . . . 0.0 112.238 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . 0.407 ' HA ' ' O ' ' A' ' 7' ' ' ILE . . . -57.46 -52.37 65.66 Favored 'General case' 0 N--CA 1.488 1.471 0 CA-C-N 114.806 -1.088 . . . . 0.0 112.96 176.772 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.413 ' HB2' ' O ' ' A' ' 69' ' ' ALA . 10.7 tptp -66.04 -58.35 5.68 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 127.491 2.316 . . . . 0.0 112.461 -177.425 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . 0.446 ' HB2' ' O ' ' A' ' 70' ' ' TRP . 0.7 OUTLIER -74.41 -47.54 33.22 Favored 'General case' 0 N--CA 1.477 0.883 0 N-CA-C 115.972 1.841 . . . . 0.0 115.972 -171.796 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . 0.636 ' HB2' HD12 ' A' ' 7' ' ' ILE . 47.8 m-85 -100.14 -11.2 20.67 Favored 'General case' 0 N--CA 1.473 0.683 0 N-CA-C 115.747 1.758 . . . . 0.0 115.747 -169.021 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 75.79 61.01 3.0 Favored Glycine 0 N--CA 1.478 1.443 0 O-C-N 124.614 1.197 . . . . 0.0 111.245 -173.413 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.636 HD12 ' HB2' ' A' ' 5' ' ' PHE . 1.0 OUTLIER -117.76 145.53 36.73 Favored Pre-proline 0 N--CA 1.478 0.951 0 C-N-CA 125.287 1.435 . . . . 0.0 111.941 179.696 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_endo -89.78 154.17 5.06 Favored 'Trans proline' 0 CA--C 1.535 0.548 0 N-CA-C 109.176 -1.125 . . . . 0.0 109.176 158.383 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -48.77 -29.78 4.92 Favored 'General case' 0 CA--C 1.544 0.73 0 N-CA-C 115.23 1.567 . . . . 0.0 115.23 176.774 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -39.67 -44.91 1.59 Allowed 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 126.388 1.875 . . . . 0.0 114.503 172.069 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.855 HG12 HG22 ' A' ' 31' ' ' ILE . 22.6 m -101.05 -29.51 3.17 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.93 0 N-CA-C 114.959 1.466 . . . . 0.0 114.959 -176.219 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.419 ' O ' ' HG ' ' A' ' 16' ' ' LEU . . . -68.48 -31.21 70.32 Favored 'General case' 0 CA--C 1.546 0.817 0 N-CA-C 112.547 0.573 . . . . 0.0 112.547 175.631 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -61.06 -42.87 99.94 Favored Glycine 0 CA--C 1.543 1.84 0 CA-C-O 122.186 0.881 . . . . 0.0 112.393 170.485 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.776 HG22 HG13 ' A' ' 28' ' ' ILE . 1.4 m -62.62 -36.89 84.22 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 124.928 1.291 . . . . 0.0 113.562 176.02 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.655 HG21 ' HE1' ' A' ' 1' ' ' MET . 2.4 t -58.05 -41.05 79.53 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 C-N-CA 124.03 0.932 . . . . 0.0 112.443 170.691 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.452 HD22 ' HG3' ' A' ' 64' ' ' LYS . 53.2 mt -60.04 -37.31 79.43 Favored 'General case' 0 N--CA 1.476 0.837 0 N-CA-C 112.73 0.641 . . . . 0.0 112.73 177.497 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 27.5 t-20 -56.96 -44.57 82.72 Favored 'General case' 0 N--CA 1.474 0.756 0 CA-C-N 115.765 -0.652 . . . . 0.0 112.527 175.864 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 3.7 t -48.49 -48.79 14.15 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.155 0 C-N-CA 123.086 0.555 . . . . 0.0 111.699 172.131 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.791 HG13 ' HA ' ' A' ' 56' ' ' LYS . 5.8 t -67.5 -50.46 61.5 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.389 0 CA-C-N 113.997 -1.456 . . . . 0.0 110.789 -176.351 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 29.2 mt-10 -65.81 -42.02 91.15 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 126.478 1.911 . . . . 0.0 115.606 -177.728 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -99.62 -22.91 15.23 Favored 'General case' 0 N--CA 1.477 0.919 0 N-CA-C 116.219 1.933 . . . . 0.0 116.219 -173.0 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.53 ' HA2' ' NZ ' ' A' ' 56' ' ' LYS . . . 77.39 34.02 41.89 Favored Glycine 0 N--CA 1.481 1.68 0 N-CA-C 112.02 -0.432 . . . . 0.0 112.02 -171.248 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -99.85 172.53 24.8 Favored Glycine 0 N--CA 1.47 0.949 0 CA-C-N 113.263 -1.468 . . . . 0.0 114.102 -165.458 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 89.4 m95 -57.67 100.6 0.06 Allowed 'General case' 0 N--CA 1.476 0.866 0 CA-C-N 111.764 -2.218 . . . . 0.0 114.148 -176.967 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.593 HG21 HG13 ' A' ' 51' ' ' ILE . 4.3 p -56.72 -25.53 21.79 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 CA-C-N 112.553 -2.112 . . . . 0.0 113.779 169.244 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 11.5 p -61.34 -46.36 90.58 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 124.176 0.99 . . . . 0.0 112.277 -178.547 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.427 ' O ' HG12 ' A' ' 31' ' ' ILE . 0.2 OUTLIER -60.8 -44.88 96.27 Favored 'General case' 0 N--CA 1.478 0.945 0 CA-C-N 114.01 -1.45 . . . . 0.0 110.994 175.039 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.776 HG13 HG22 ' A' ' 14' ' ' THR . 1.7 mp -62.63 -47.67 91.84 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.084 0 C-N-CA 124.073 0.949 . . . . 0.0 111.749 179.023 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.487 HG13 HD11 ' A' ' 43' ' ' LEU . 39.8 t -52.41 -43.5 41.34 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.067 0 C-N-CA 124.379 1.072 . . . . 0.0 111.325 179.064 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 90.4 p -65.79 -32.09 73.43 Favored 'General case' 0 N--CA 1.478 0.965 0 N-CA-C 115.391 1.626 . . . . 0.0 115.391 176.324 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.855 HG22 HG12 ' A' ' 11' ' ' VAL . 40.5 mm -70.9 -40.47 76.5 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.33 0 C-N-CA 123.7 0.8 . . . . 0.0 109.583 177.235 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.666 ' HB3' ' HA2' ' A' ' 39' ' ' GLY . 3.8 mm? -61.59 -52.07 65.94 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 125.365 1.466 . . . . 0.0 112.745 174.606 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 7.5 p -65.76 -27.1 68.05 Favored 'General case' 0 N--CA 1.484 1.243 0 N-CA-C 114.159 1.17 . . . . 0.0 114.159 179.317 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -53.0 -29.36 28.79 Favored 'General case' 0 N--CA 1.483 1.225 0 N-CA-C 113.892 1.071 . . . . 0.0 113.892 166.969 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 54.5 t -75.34 -27.16 19.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 C-N-CA 124.238 1.015 . . . . 0.0 112.411 172.192 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 97.88 -100.4 2.37 Favored Glycine 0 N--CA 1.481 1.658 0 C-N-CA 124.727 1.156 . . . . 0.0 111.015 -176.797 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 2.7 p -55.41 -47.34 76.07 Favored 'General case' 0 N--CA 1.483 1.21 0 CA-C-N 113.628 -1.286 . . . . 0.0 113.569 -177.014 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.406 ' HA3' HG13 ' A' ' 7' ' ' ILE . . . -54.28 -40.97 69.7 Favored Glycine 0 CA--C 1.539 1.592 0 C-N-CA 124.875 1.226 . . . . 0.0 115.106 -178.58 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.666 ' HA2' ' HB3' ' A' ' 32' ' ' LEU . . . -60.18 -58.56 13.44 Favored Glycine 0 N--CA 1.475 1.25 0 O-C-N 124.604 0.826 . . . . 0.0 111.413 173.595 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 44.7 mt -58.86 -48.46 81.28 Favored 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 115.26 1.578 . . . . 0.0 115.26 -176.222 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . 0.426 ' HB2' ' HD1' ' A' ' 5' ' ' PHE . 29.6 p -60.69 -39.49 88.66 Favored 'General case' 0 N--CA 1.475 0.791 0 N-CA-C 114.488 1.292 . . . . 0.0 114.488 175.669 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 13.8 tp -63.79 -48.46 76.79 Favored 'General case' 0 N--CA 1.483 1.2 0 C-N-CA 122.505 0.322 . . . . 0.0 110.888 173.839 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.487 HD11 HG13 ' A' ' 29' ' ' VAL . 80.5 mt -61.98 -27.57 68.94 Favored 'General case' 0 N--CA 1.482 1.131 0 N-CA-C 114.843 1.423 . . . . 0.0 114.843 -176.344 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -70.81 -45.4 64.7 Favored 'General case' 0 CA--C 1.549 0.905 0 N-CA-C 112.839 0.681 . . . . 0.0 112.839 173.933 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -65.12 -40.47 94.53 Favored 'General case' 0 N--CA 1.477 0.917 0 CA-C-O 122.715 1.245 . . . . 0.0 111.999 179.902 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.446 ' HB1' ' HA ' ' A' ' 51' ' ' ILE . . . -59.18 -26.76 65.07 Favored 'General case' 0 CA--C 1.537 0.447 0 N-CA-C 116.438 2.014 . . . . 0.0 116.438 179.131 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -47.78 -40.62 18.81 Favored Glycine 0 N--CA 1.482 1.73 0 C-N-CA 125.598 1.57 . . . . 0.0 113.641 -177.942 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 35.4 ttp-105 -53.62 -47.78 69.91 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 125.184 1.394 . . . . 0.0 113.931 -173.937 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 11.8 tt0 -126.0 37.32 4.36 Favored 'General case' 0 N--CA 1.478 0.968 0 N-CA-C 114.285 1.217 . . . . 0.0 114.285 -177.962 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 72.0 p 50.77 127.49 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.502 0 C-N-CA 125.603 1.561 . . . . 0.0 112.792 -172.057 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.593 HG13 HG21 ' A' ' 25' ' ' VAL . 6.3 tp -39.04 -51.65 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 N-CA-C 117.728 2.492 . . . . 0.0 117.728 -172.791 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 56.3 tttt -65.95 -57.17 8.44 Favored 'General case' 0 N--CA 1.469 0.516 0 N-CA-C 113.618 0.97 . . . . 0.0 113.618 179.877 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -60.59 -38.17 83.75 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 124.591 1.156 . . . . 0.0 112.763 178.497 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . 0.401 ' HB3' ' O ' ' A' ' 51' ' ' ILE . 90.4 t80 -47.66 -63.51 1.04 Allowed 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 125.961 1.704 . . . . 0.0 109.861 170.233 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 79.1 mt -64.24 -41.98 96.74 Favored 'General case' 0 N--CA 1.473 0.721 0 N-CA-C 113.894 1.072 . . . . 0.0 113.894 -176.575 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.791 ' HA ' HG13 ' A' ' 19' ' ' VAL . 29.2 mtpp -55.97 -44.73 78.79 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 114.653 -1.158 . . . . 0.0 113.447 177.466 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.42 ' O ' ' HG2' ' A' ' 61' ' ' LYS . 66.7 tttt -77.3 -50.13 13.51 Favored 'General case' 0 N--CA 1.475 0.787 0 CA-C-N 115.292 -0.867 . . . . 0.0 112.051 172.947 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . 0.501 ' O ' ' HB2' ' A' ' 62' ' ' LYS . 4.2 tp10 -54.51 -51.38 65.29 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 123.979 0.912 . . . . 0.0 111.831 -173.51 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.683 HG23 HG21 ' A' ' 67' ' ' VAL . 1.3 mm -75.87 -26.32 17.69 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.05 0 CA-C-N 115.623 -0.717 . . . . 0.0 111.846 -175.255 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 6.7 mtpp -60.07 -39.05 84.72 Favored 'General case' 0 CA--C 1.538 0.487 0 N-CA-C 115.336 1.606 . . . . 0.0 115.336 170.285 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.42 ' HG2' ' O ' ' A' ' 57' ' ' LYS . 70.4 mmtt -79.32 -46.24 18.09 Favored 'General case' 0 N--CA 1.476 0.834 0 O-C-N 126.188 2.18 . . . . 0.0 110.93 176.977 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.501 ' HB2' ' O ' ' A' ' 58' ' ' GLU . 5.7 tptp -66.53 -52.22 48.17 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 126.728 2.011 . . . . 0.0 114.822 -175.561 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 96.6 117.87 3.47 Favored Glycine 0 N--CA 1.483 1.828 0 CA-C-N 114.593 -1.185 . . . . 0.0 110.332 -173.94 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.687 ' H ' ' HD2' ' A' ' 64' ' ' LYS . 9.8 mptt -36.18 -46.78 0.53 Allowed 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 117.782 2.512 . . . . 0.0 117.782 -177.422 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.22 -51.63 69.14 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 125.538 1.535 . . . . 0.0 114.958 176.89 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -64.83 -27.3 68.78 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-N 114.423 -1.262 . . . . 0.0 112.907 174.771 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.683 HG21 HG23 ' A' ' 59' ' ' ILE . 98.7 t -67.13 -41.78 87.43 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.251 0 C-N-CA 123.191 0.597 . . . . 0.0 110.942 175.19 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 35.1 mm -51.15 -42.66 25.87 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.856 0 O-C-N 124.18 0.925 . . . . 0.0 110.764 172.061 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.413 ' O ' ' HB2' ' A' ' 3' ' ' LYS . . . -71.38 -52.62 17.62 Favored 'General case' 0 N--CA 1.473 0.725 0 O-C-N 124.683 1.239 . . . . 0.0 112.585 176.117 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' TRP . . . . . 0.446 ' O ' ' HB2' ' A' ' 4' ' ' GLU . 30.9 t90 . . . . . 0 N--CA 1.485 1.277 0 C-N-CA 127.034 2.134 . . . . 0.0 112.646 -178.449 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.507 ' HE1' HG21 ' A' ' 15' ' ' VAL . 72.3 mtp . . . . . 0 N--CA 1.472 0.63 0 N-CA-C 112.184 0.439 . . . . 0.0 112.184 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -56.79 -49.6 74.83 Favored 'General case' 0 CA--C 1.547 0.828 0 CA-C-N 115.541 -0.754 . . . . 0.0 112.602 177.499 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 50.2 tttm -76.32 -51.65 11.54 Favored 'General case' 0 N--CA 1.475 0.799 0 CA-C-N 113.407 -1.724 . . . . 0.0 113.303 -173.195 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . 0.429 ' HB2' ' O ' ' A' ' 70' ' ' TRP . 1.8 mp0 -79.03 -33.33 44.91 Favored 'General case' 0 N--CA 1.47 0.536 0 N-CA-C 115.94 1.83 . . . . 0.0 115.94 -173.411 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . 0.41 ' HB2' HD12 ' A' ' 7' ' ' ILE . 26.7 m-85 -113.41 -14.13 12.79 Favored 'General case' 0 N--CA 1.474 0.774 0 N-CA-C 117.621 2.452 . . . . 0.0 117.621 -171.556 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 82.33 58.84 2.36 Favored Glycine 0 CA--C 1.538 1.506 0 C-N-CA 124.133 0.873 . . . . 0.0 111.159 -179.155 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.515 HG21 ' HB2' ' A' ' 12' ' ' ALA . 0.8 OUTLIER -120.39 146.71 43.51 Favored Pre-proline 0 N--CA 1.479 1.009 0 CA-C-N 112.747 -1.726 . . . . 0.0 113.307 -176.102 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -91.51 161.12 3.59 Favored 'Trans proline' 0 CA--C 1.537 0.662 0 C-N-CA 121.123 1.215 . . . . 0.0 110.745 160.535 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -52.75 -32.08 41.44 Favored 'General case' 0 CA--C 1.544 0.716 0 N-CA-C 114.07 1.137 . . . . 0.0 114.07 174.312 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -40.84 -39.46 1.13 Allowed 'General case' 0 N--CA 1.485 1.323 0 C-N-CA 126.784 2.033 . . . . 0.0 114.976 172.879 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.942 HG12 HG22 ' A' ' 31' ' ' ILE . 17.3 m -110.95 -31.63 2.25 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.354 0 N-CA-C 114.939 1.459 . . . . 0.0 114.939 -177.162 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.515 ' HB2' HG21 ' A' ' 7' ' ' ILE . . . -65.94 -36.91 84.65 Favored 'General case' 0 N--CA 1.476 0.864 0 N-CA-C 112.61 0.596 . . . . 0.0 112.61 174.016 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . 0.516 ' O ' ' HB2' ' A' ' 16' ' ' LEU . . . -58.18 -41.95 95.02 Favored Glycine 0 CA--C 1.54 1.603 0 C-N-CA 124.033 0.825 . . . . 0.0 112.563 171.813 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.775 HG22 HG13 ' A' ' 28' ' ' ILE . 0.2 OUTLIER -62.14 -34.05 75.65 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 125.546 1.538 . . . . 0.0 114.045 176.719 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.507 HG21 ' HE1' ' A' ' 1' ' ' MET . 5.2 t -58.15 -46.93 88.34 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.29 0 C-N-CA 123.846 0.858 . . . . 0.0 112.798 171.045 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.516 ' HB2' ' O ' ' A' ' 13' ' ' GLY . 9.5 mp -52.5 -38.61 59.94 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 124.912 1.285 . . . . 0.0 113.384 173.026 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 15.3 t-20 -57.4 -49.13 77.18 Favored 'General case' 0 N--CA 1.485 1.279 0 O-C-N 123.873 0.733 . . . . 0.0 110.815 177.768 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 2.4 t -50.19 -50.89 19.21 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.767 0 O-C-N 124.366 1.041 . . . . 0.0 112.77 173.31 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.564 HG13 ' HA ' ' A' ' 56' ' ' LYS . 9.0 t -65.34 -48.97 81.22 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.235 0 CA-C-N 114.647 -1.16 . . . . 0.0 112.411 -175.075 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -71.39 -46.72 59.59 Favored 'General case' 0 CA--C 1.548 0.872 0 N-CA-C 114.692 1.367 . . . . 0.0 114.692 -177.425 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -96.04 -9.18 31.59 Favored 'General case' 0 N--CA 1.475 0.807 0 N-CA-C 115.733 1.753 . . . . 0.0 115.733 -170.352 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 65.19 33.13 86.1 Favored Glycine 0 CA--C 1.542 1.773 0 C-N-CA 124.327 0.965 . . . . 0.0 112.494 -171.523 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -78.31 167.66 53.39 Favored Glycine 0 N--CA 1.476 1.357 0 C-N-CA 125.372 1.463 . . . . 0.0 115.698 -175.044 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' TRP . . . . . 0.409 ' HB3' HG22 ' A' ' 26' ' ' THR . 2.5 m-90 -68.2 106.39 2.42 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-N 113.454 -1.373 . . . . 0.0 111.999 -178.666 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 2.8 p -57.58 -24.84 23.14 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.781 0 CA-C-N 114.122 -1.399 . . . . 0.0 114.07 173.65 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.409 HG22 ' HB3' ' A' ' 24' ' ' TRP . 10.0 t -60.0 -44.54 94.48 Favored 'General case' 0 N--CA 1.483 1.214 0 C-N-CA 124.053 0.941 . . . . 0.0 113.239 -179.823 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.452 ' O ' HG12 ' A' ' 31' ' ' ILE . 0.0 OUTLIER -65.28 -42.76 92.81 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 124.254 1.021 . . . . 0.0 111.787 175.657 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.775 HG13 HG22 ' A' ' 14' ' ' THR . 1.8 mp -62.3 -46.1 97.22 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 C-N-CA 124.427 1.091 . . . . 0.0 111.037 178.235 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.485 HG13 HD11 ' A' ' 43' ' ' LEU . 39.6 t -56.11 -45.27 80.62 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.837 0 C-N-CA 124.344 1.058 . . . . 0.0 111.978 174.009 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 36.9 m -58.34 -37.03 74.32 Favored 'General case' 0 N--CA 1.486 1.344 0 N-CA-C 113.855 1.057 . . . . 0.0 113.855 175.256 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.942 HG22 HG12 ' A' ' 11' ' ' VAL . 43.5 mm -75.9 -39.34 37.56 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.41 0 C-N-CA 123.926 0.891 . . . . 0.0 110.434 179.737 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.676 HD22 ' HB ' ' A' ' 11' ' ' VAL . 3.7 mm? -60.57 -50.94 71.51 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 125.564 1.546 . . . . 0.0 112.251 174.003 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 18.0 p -67.25 -30.55 70.47 Favored 'General case' 0 N--CA 1.484 1.229 0 N-CA-C 114.609 1.337 . . . . 0.0 114.609 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -49.1 -40.6 32.66 Favored 'General case' 0 N--CA 1.485 1.291 0 N-CA-C 113.52 0.933 . . . . 0.0 113.52 170.37 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 57.7 t -63.74 -20.32 26.18 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.382 0 C-N-CA 125.139 1.376 . . . . 0.0 112.934 173.008 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 91.38 -102.12 2.88 Favored Glycine 0 N--CA 1.473 1.141 0 C-N-CA 125.091 1.329 . . . . 0.0 110.416 -179.463 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 11.9 p -56.62 -45.3 81.58 Favored 'General case' 0 N--CA 1.479 0.992 0 CA-C-N 112.306 -1.947 . . . . 0.0 113.904 -175.774 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -51.02 -48.17 46.69 Favored Glycine 0 N--CA 1.477 1.401 0 C-N-CA 124.898 1.237 . . . . 0.0 114.76 179.345 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.543 ' HA2' ' HB3' ' A' ' 32' ' ' LEU . . . -60.04 -52.99 49.48 Favored Glycine 0 CA--C 1.535 1.307 0 N-CA-C 111.57 -0.612 . . . . 0.0 111.57 176.269 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 30.3 mt -59.34 -45.71 90.62 Favored 'General case' 0 N--CA 1.48 1.03 0 N-CA-C 114.983 1.475 . . . . 0.0 114.983 -177.789 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 51.9 p -66.2 -37.58 85.93 Favored 'General case' 0 N--CA 1.48 1.033 0 N-CA-C 113.926 1.084 . . . . 0.0 113.926 176.132 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 12.7 tp -65.98 -44.16 85.71 Favored 'General case' 0 N--CA 1.482 1.149 0 CA-C-O 120.963 0.411 . . . . 0.0 110.217 173.033 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.485 HD11 HG13 ' A' ' 29' ' ' VAL . 82.6 mt -64.9 -22.74 67.05 Favored 'General case' 0 N--CA 1.476 0.874 0 N-CA-C 115.031 1.493 . . . . 0.0 115.031 178.997 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -72.98 -47.85 41.69 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-N 115.706 -0.679 . . . . 0.0 112.16 170.15 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -60.22 -35.56 75.71 Favored 'General case' 0 N--CA 1.487 1.391 0 C-N-CA 124.221 1.009 . . . . 0.0 111.739 177.08 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -52.74 -26.87 15.43 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 127.209 2.204 . . . . 0.0 115.821 174.855 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -46.46 -43.22 14.62 Favored Glycine 0 N--CA 1.483 1.769 0 C-N-CA 125.676 1.608 . . . . 0.0 114.249 -175.5 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 66.6 ttp85 -47.48 -55.8 8.33 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 126.01 1.724 . . . . 0.0 113.486 -176.597 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 10.5 tt0 -136.38 38.54 2.69 Favored 'General case' 0 N--CA 1.483 1.198 0 N-CA-C 113.656 0.984 . . . . 0.0 113.656 -174.216 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 23.2 t 45.86 125.77 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 125.313 1.445 . . . . 0.0 114.096 -173.849 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 10.5 tp -31.3 -49.74 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.481 1.083 0 N-CA-C 118.355 2.724 . . . . 0.0 118.355 -174.32 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 52.2 tptt -55.77 -70.05 0.12 Allowed 'General case' 0 N--CA 1.483 1.215 0 C-N-CA 124.575 1.15 . . . . 0.0 111.848 176.525 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -61.3 -38.44 86.83 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 124.377 1.071 . . . . 0.0 113.525 179.709 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 85.9 t80 -46.8 -60.43 2.42 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 124.84 1.256 . . . . 0.0 111.587 173.359 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 67.4 mt -67.05 -43.81 81.76 Favored 'General case' 0 N--CA 1.478 0.952 0 N-CA-C 113.992 1.108 . . . . 0.0 113.992 -177.085 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.564 ' HA ' HG13 ' A' ' 19' ' ' VAL . 6.5 mmmt -52.24 -43.37 64.29 Favored 'General case' 0 N--CA 1.478 0.947 0 CA-C-N 113.995 -1.457 . . . . 0.0 114.438 177.911 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 33.4 tttm -80.53 -55.25 4.99 Favored 'General case' 0 N--CA 1.476 0.847 0 CA-C-N 114.583 -1.189 . . . . 0.0 111.67 172.235 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . 0.555 ' O ' ' HB2' ' A' ' 62' ' ' LYS . 34.3 tt0 -54.06 -51.43 64.09 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-O 117.038 -1.458 . . . . 0.0 110.895 -170.478 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.765 HG23 HG21 ' A' ' 67' ' ' VAL . 3.4 mm -78.92 -23.51 12.86 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.349 0 CA-C-O 118.719 -0.658 . . . . 0.0 112.335 -174.707 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 1.2 tppm? -61.52 -37.64 84.47 Favored 'General case' 0 N--CA 1.466 0.368 0 N-CA-C 113.997 1.11 . . . . 0.0 113.997 172.436 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 45.1 mttt -90.93 -37.86 13.25 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-N 112.465 -2.152 . . . . 0.0 113.419 -178.453 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.555 ' HB2' ' O ' ' A' ' 58' ' ' GLU . 24.1 tttm -67.51 -45.44 75.78 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 126.562 1.945 . . . . 0.0 113.574 -176.994 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 98.32 102.97 2.29 Favored Glycine 0 CA--C 1.534 1.229 0 CA-C-O 122.11 0.839 . . . . 0.0 111.409 -177.155 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.509 ' H ' ' HD2' ' A' ' 64' ' ' LYS . 2.2 mptp? -31.58 -47.6 0.12 Allowed 'General case' 0 N--CA 1.477 0.909 0 N-CA-C 119.136 3.013 . . . . 0.0 119.136 -178.076 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 4.8 ttp-105 -62.27 -47.81 82.68 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 124.76 1.224 . . . . 0.0 113.628 179.56 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -60.98 -26.95 67.94 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-N 114.642 -1.163 . . . . 0.0 113.952 172.489 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.765 HG21 HG23 ' A' ' 59' ' ' ILE . 63.9 t -68.6 -40.38 81.76 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.291 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.635 176.442 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 45.5 mm -53.52 -45.83 59.09 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.08 0 C-N-CA 123.485 0.714 . . . . 0.0 109.895 172.145 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -64.8 -52.58 56.05 Favored 'General case' 0 N--CA 1.482 1.134 0 N-CA-C 112.79 0.663 . . . . 0.0 112.79 176.111 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' TRP . . . . . 0.429 ' O ' ' HB2' ' A' ' 4' ' ' GLU . 33.9 t90 . . . . . 0 N--CA 1.479 1.018 0 C-N-CA 126.051 1.74 . . . . 0.0 112.336 178.36 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.59 ' HE1' HG21 ' A' ' 15' ' ' VAL . 46.1 mtp . . . . . 0 N--CA 1.471 0.577 0 N-CA-C 112.457 0.54 . . . . 0.0 112.457 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . 0.475 ' HA ' ' O ' ' A' ' 7' ' ' ILE . . . -52.22 -51.83 55.92 Favored 'General case' 0 N--CA 1.47 0.538 0 O-C-N 124.568 1.167 . . . . 0.0 112.73 176.708 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 14.7 tttt -79.93 -51.75 8.72 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 112.717 -2.038 . . . . 0.0 114.578 -173.555 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 10.6 mt-10 -73.04 -35.15 66.69 Favored 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 115.382 1.623 . . . . 0.0 115.382 -173.772 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 50.6 m-85 -109.04 -13.85 14.64 Favored 'General case' 0 N--CA 1.478 0.933 0 N-CA-C 117.356 2.354 . . . . 0.0 117.356 -173.997 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 82.75 60.49 2.07 Favored Glycine 0 CA--C 1.542 1.765 0 O-C-N 124.342 1.027 . . . . 0.0 110.65 -177.83 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.475 ' O ' ' HA ' ' A' ' 2' ' ' ALA . 0.8 OUTLIER -125.23 143.38 44.2 Favored Pre-proline 0 N--CA 1.481 1.12 0 CA-C-N 113.63 -1.285 . . . . 0.0 112.457 -175.924 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_endo -87.92 159.54 7.4 Favored 'Trans proline' 0 CA--C 1.538 0.675 0 C-N-CA 120.94 1.094 . . . . 0.0 109.376 163.797 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -50.58 -33.2 21.1 Favored 'General case' 0 N--CA 1.476 0.874 0 N-CA-C 114.253 1.205 . . . . 0.0 114.253 174.895 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -37.03 -41.85 0.38 Allowed 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 127.45 2.3 . . . . 0.0 115.917 169.725 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.9 HG12 HG22 ' A' ' 31' ' ' ILE . 19.0 m -111.37 -28.53 2.57 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 N-CA-C 115.395 1.628 . . . . 0.0 115.395 -176.749 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.463 ' O ' ' HG ' ' A' ' 16' ' ' LEU . . . -66.28 -33.61 76.14 Favored 'General case' 0 N--CA 1.477 0.891 0 N-CA-C 112.71 0.633 . . . . 0.0 112.71 171.433 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -59.62 -37.41 92.22 Favored Glycine 0 CA--C 1.539 1.59 0 C-N-CA 124.448 1.023 . . . . 0.0 112.674 171.349 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.65 HG22 HG13 ' A' ' 28' ' ' ILE . 0.2 OUTLIER -71.98 -37.15 69.93 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 125.188 1.395 . . . . 0.0 112.598 177.908 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.649 HG23 HD21 ' A' ' 32' ' ' LEU . 20.9 t -55.93 -41.65 68.23 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.237 0 C-N-CA 123.423 0.689 . . . . 0.0 111.88 166.366 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.463 ' HG ' ' O ' ' A' ' 12' ' ' ALA . 77.6 mt -61.25 -37.1 81.91 Favored 'General case' 0 N--CA 1.486 1.347 0 N-CA-C 114.518 1.303 . . . . 0.0 114.518 177.929 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 12.0 t-20 -52.35 -49.2 64.8 Favored 'General case' 0 CA--C 1.545 0.767 0 CA-C-N 114.395 -1.275 . . . . 0.0 112.065 173.424 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.449 ' HB ' ' O ' ' A' ' 15' ' ' VAL . 5.0 t -52.08 -50.57 34.8 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 CA-C-N 113.295 -1.775 . . . . 0.0 111.502 175.848 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.625 HG13 ' HA ' ' A' ' 56' ' ' LYS . 13.0 t -66.86 -48.62 79.21 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.255 0 O-C-N 123.991 0.807 . . . . 0.0 111.043 -176.124 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -63.73 -44.01 94.81 Favored 'General case' 0 CA--C 1.542 0.656 0 N-CA-C 114.446 1.276 . . . . 0.0 114.446 -176.638 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -103.06 -19.94 14.37 Favored 'General case' 0 N--CA 1.479 1.005 0 N-CA-C 115.559 1.689 . . . . 0.0 115.559 -171.194 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 71.17 39.69 62.33 Favored Glycine 0 N--CA 1.481 1.66 0 N-CA-C 109.905 -1.278 . . . . 0.0 109.905 -166.767 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -83.82 162.8 39.58 Favored Glycine 0 CA--C 1.527 0.806 0 N-CA-C 109.168 -1.573 . . . . 0.0 109.168 -178.96 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' TRP . . . . . 0.437 ' O ' HD13 ' A' ' 28' ' ' ILE . 31.5 m95 -64.76 104.6 0.85 Allowed 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 112.365 -1.918 . . . . 0.0 112.48 -175.132 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.578 HG21 HG13 ' A' ' 51' ' ' ILE . 3.1 p -57.35 -24.91 22.51 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.927 0 CA-C-N 113.147 -1.842 . . . . 0.0 113.39 171.395 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 3.1 p -61.34 -47.21 86.95 Favored 'General case' 0 N--CA 1.484 1.246 0 N-CA-C 113.786 1.032 . . . . 0.0 113.786 -179.516 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -62.4 -40.83 97.79 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 123.24 0.616 . . . . 0.0 111.357 173.862 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.65 HG13 HG22 ' A' ' 14' ' ' THR . 1.8 mp -60.02 -48.69 86.88 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 C-N-CA 124.878 1.271 . . . . 0.0 112.253 177.504 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.521 HG23 ' O ' ' A' ' 25' ' ' VAL . 53.5 t -49.59 -45.68 20.34 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 C-N-CA 124.406 1.082 . . . . 0.0 112.264 178.356 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -62.27 -41.72 98.71 Favored 'General case' 0 N--CA 1.485 1.314 0 N-CA-C 112.917 0.71 . . . . 0.0 112.917 178.38 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.9 HG22 HG12 ' A' ' 11' ' ' VAL . 36.7 mm -70.9 -38.86 74.19 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.145 0 C-N-CA 123.436 0.695 . . . . 0.0 109.805 -179.057 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.763 HD22 ' HB ' ' A' ' 11' ' ' VAL . 3.2 mm? -58.05 -53.44 58.18 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 125.475 1.51 . . . . 0.0 112.039 173.78 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 11.0 m -71.86 -21.19 61.7 Favored 'General case' 0 N--CA 1.477 0.916 0 N-CA-C 113.496 0.924 . . . . 0.0 113.496 179.473 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -58.89 -28.83 66.53 Favored 'General case' 0 N--CA 1.484 1.26 0 C-N-CA 123.967 0.907 . . . . 0.0 113.402 172.425 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 74.8 t -59.16 -38.28 73.35 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.256 0 C-N-CA 124.045 0.938 . . . . 0.0 111.495 170.916 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 89.86 109.28 1.3 Allowed Glycine 0 CA--C 1.537 1.412 0 N-CA-C 110.313 -1.115 . . . . 0.0 110.313 -175.482 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 50.4 m 76.05 -38.55 0.34 Allowed 'General case' 0 N--CA 1.494 1.738 0 C-N-CA 127.649 2.379 . . . . 0.0 113.959 -176.557 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -51.76 -53.16 30.79 Favored Glycine 0 N--CA 1.485 1.953 0 C-N-CA 124.732 1.158 . . . . 0.0 113.262 -175.586 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.431 ' O ' ' HG ' ' A' ' 43' ' ' LEU . . . -58.19 -41.33 94.72 Favored Glycine 0 N--CA 1.478 1.493 0 CA-C-N 114.316 -0.942 . . . . 0.0 114.901 176.087 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 43.9 mt -67.05 -44.93 78.89 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 124.242 1.017 . . . . 0.0 113.42 -177.143 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -55.44 -39.79 70.74 Favored 'General case' 0 N--CA 1.481 1.082 0 O-C-N 124.079 0.862 . . . . 0.0 112.838 171.903 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 16.8 tp -64.09 -48.17 77.2 Favored 'General case' 0 N--CA 1.477 0.884 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.042 175.859 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.431 ' HG ' ' O ' ' A' ' 39' ' ' GLY . 44.1 mt -61.05 -30.94 70.62 Favored 'General case' 0 N--CA 1.479 0.999 0 N-CA-C 114.603 1.334 . . . . 0.0 114.603 179.078 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -66.62 -50.39 63.15 Favored 'General case' 0 N--CA 1.478 0.96 0 CA-C-N 115.882 -0.599 . . . . 0.0 112.211 171.402 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -61.16 -34.73 75.49 Favored 'General case' 0 N--CA 1.485 1.301 0 CA-C-O 121.743 0.782 . . . . 0.0 112.345 176.273 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -67.35 -22.57 65.58 Favored 'General case' 0 N--CA 1.478 0.934 0 N-CA-C 116.191 1.923 . . . . 0.0 116.191 179.993 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -49.42 -34.58 19.44 Favored Glycine 0 CA--C 1.549 2.208 0 C-N-CA 124.688 1.137 . . . . 0.0 112.741 177.123 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 18.5 ttm180 -52.32 -50.87 61.39 Favored 'General case' 0 CA--C 1.549 0.906 0 C-N-CA 126.455 1.902 . . . . 0.0 114.977 -175.427 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 16.0 tt0 -133.5 40.58 3.13 Favored 'General case' 0 N--CA 1.479 0.977 0 N-CA-C 113.283 0.846 . . . . 0.0 113.283 -175.529 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 89.0 p 44.86 115.14 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.499 0 C-N-CA 125.303 1.441 . . . . 0.0 113.727 -172.445 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.578 HG13 HG21 ' A' ' 25' ' ' VAL . 8.0 tp -23.88 -56.82 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.483 1.177 0 N-CA-C 119.131 3.012 . . . . 0.0 119.131 -175.484 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 54.2 tttt -64.11 -55.52 21.35 Favored 'General case' 0 N--CA 1.48 1.045 0 N-CA-C 112.835 0.68 . . . . 0.0 112.835 -179.86 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -62.9 -38.66 91.81 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 124.936 1.294 . . . . 0.0 112.158 177.759 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 69.1 t80 -51.75 -58.42 6.45 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 125.617 1.567 . . . . 0.0 111.18 174.791 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.601 HD13 HG13 ' A' ' 15' ' ' VAL . 60.6 mt -70.47 -41.12 73.19 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 114.811 1.411 . . . . 0.0 114.811 -179.346 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.625 ' HA ' HG13 ' A' ' 19' ' ' VAL . 50.4 tptt -55.26 -49.96 70.72 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-N 114.004 -1.453 . . . . 0.0 113.174 178.076 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 52.8 tttp -74.55 -54.62 7.14 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-N 114.759 -1.109 . . . . 0.0 112.1 174.656 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . 0.409 ' O ' ' HB2' ' A' ' 62' ' ' LYS . 16.1 mt-10 -61.36 -41.78 97.63 Favored 'General case' 0 N--CA 1.472 0.625 0 N-CA-C 113.972 1.101 . . . . 0.0 113.972 -169.156 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.814 HG23 HG21 ' A' ' 67' ' ' VAL . 2.8 mm -78.09 -26.56 14.51 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.851 0 C-N-CA 120.13 -0.628 . . . . 0.0 112.192 -179.346 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 10.3 tppt? -61.94 -27.6 68.94 Favored 'General case' 0 CA--C 1.542 0.643 0 N-CA-C 114.332 1.234 . . . . 0.0 114.332 170.247 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 42.3 mmtm -89.18 -43.15 11.23 Favored 'General case' 0 N--CA 1.483 1.215 0 CA-C-N 113.647 -1.615 . . . . 0.0 111.387 178.475 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.458 ' HD3' HG22 ' A' ' 67' ' ' VAL . 2.7 tttm -68.88 -51.02 44.66 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 125.965 1.706 . . . . 0.0 114.89 -176.274 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 100.46 112.79 3.49 Favored Glycine 0 CA--C 1.534 1.273 0 N-CA-C 110.547 -1.021 . . . . 0.0 110.547 -172.654 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.436 ' HB3' HD13 ' A' ' 16' ' ' LEU . 10.5 mptt -41.99 -43.84 3.29 Favored 'General case' 0 N--CA 1.479 1.015 0 N-CA-C 118.139 2.644 . . . . 0.0 118.139 -172.643 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.437 ' O ' ' HB ' ' A' ' 68' ' ' ILE . 0.0 OUTLIER -61.3 -42.78 99.24 Favored 'General case' 0 N--CA 1.477 0.905 0 N-CA-C 114.995 1.48 . . . . 0.0 114.995 177.552 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -68.78 -22.33 64.29 Favored 'General case' 0 N--CA 1.479 1.022 0 CA-C-N 114.878 -1.055 . . . . 0.0 113.171 173.742 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.814 HG21 HG23 ' A' ' 59' ' ' ILE . 61.8 t -75.53 -32.71 25.5 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.919 0 C-N-CA 123.725 0.81 . . . . 0.0 111.34 176.72 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.437 ' HB ' ' O ' ' A' ' 65' ' ' ARG . 18.6 mm -51.78 -47.47 39.51 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.153 0 C-N-CA 123.639 0.776 . . . . 0.0 109.814 165.714 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -68.22 -48.83 64.11 Favored 'General case' 0 N--CA 1.472 0.641 0 O-C-N 124.225 0.953 . . . . 0.0 113.406 178.038 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 34.1 t90 . . . . . 0 N--CA 1.476 0.859 0 C-N-CA 125.587 1.555 . . . . 0.0 112.407 178.482 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.449 ' HB3' HG21 ' A' ' 7' ' ' ILE . 53.9 mtp . . . . . 0 N--CA 1.478 0.946 0 N-CA-C 112.367 0.506 . . . . 0.0 112.367 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -55.47 -50.82 68.87 Favored 'General case' 0 N--CA 1.472 0.643 0 O-C-N 124.67 1.231 . . . . 0.0 112.711 177.291 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 52.7 tttp -72.91 -58.81 3.06 Favored 'General case' 0 CA--C 1.543 0.686 0 CA-C-N 114.257 -1.338 . . . . 0.0 113.573 -178.78 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -66.16 -43.74 86.09 Favored 'General case' 0 N--CA 1.471 0.601 0 N-CA-C 116.474 2.027 . . . . 0.0 116.474 -168.901 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . 0.561 ' HB2' HD12 ' A' ' 7' ' ' ILE . 38.4 m-85 -101.41 -18.06 16.19 Favored 'General case' 0 N--CA 1.476 0.857 0 N-CA-C 115.953 1.835 . . . . 0.0 115.953 -170.509 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 81.41 63.06 1.89 Allowed Glycine 0 N--CA 1.484 1.855 0 O-C-N 124.532 1.145 . . . . 0.0 110.714 -169.464 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.561 HD12 ' HB2' ' A' ' 5' ' ' PHE . 0.4 OUTLIER -122.55 145.93 46.23 Favored Pre-proline 0 N--CA 1.471 0.613 0 C-N-CA 125.587 1.555 . . . . 0.0 108.998 179.775 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_endo -86.44 152.1 9.12 Favored 'Trans proline' 0 CA--C 1.537 0.645 0 N-CA-C 108.173 -1.51 . . . . 0.0 108.173 161.13 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -47.69 -33.94 7.54 Favored 'General case' 0 N--CA 1.47 0.55 0 N-CA-C 115.663 1.727 . . . . 0.0 115.663 175.486 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -37.69 -57.37 0.98 Allowed 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 126.964 2.106 . . . . 0.0 113.931 173.374 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.873 HG12 HG22 ' A' ' 31' ' ' ILE . 23.9 m -83.97 -33.16 9.01 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.214 0 N-CA-C 113.728 1.01 . . . . 0.0 113.728 -175.259 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -64.09 -32.39 73.93 Favored 'General case' 0 CA--C 1.545 0.787 0 N-CA-C 112.303 0.483 . . . . 0.0 112.303 173.38 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -59.36 -44.62 96.45 Favored Glycine 0 CA--C 1.538 1.473 0 CA-C-O 122.497 1.054 . . . . 0.0 113.071 171.277 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.7 HG22 HG13 ' A' ' 28' ' ' ILE . 0.3 OUTLIER -63.17 -35.7 81.17 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 125.276 1.43 . . . . 0.0 113.586 176.542 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.469 HG23 HD21 ' A' ' 32' ' ' LEU . 5.1 t -58.15 -41.53 80.97 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 C-N-CA 124.205 1.002 . . . . 0.0 111.992 170.747 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 24.6 mt -61.32 -38.93 88.64 Favored 'General case' 0 N--CA 1.472 0.638 0 N-CA-C 113.222 0.823 . . . . 0.0 113.222 178.681 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -52.81 -48.06 67.18 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 124.798 1.239 . . . . 0.0 112.526 173.038 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 1.1 t -54.4 -54.0 25.55 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.984 0 CA-C-N 115.057 -0.974 . . . . 0.0 111.501 174.735 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.795 HG13 ' HA ' ' A' ' 56' ' ' LYS . 6.8 t -59.87 -47.58 90.98 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.014 0 O-C-N 123.803 0.689 . . . . 0.0 110.458 -177.505 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . 0.595 ' HG3' ' HE2' ' A' ' 64' ' ' LYS . 17.4 mt-10 -60.34 -36.74 78.69 Favored 'General case' 0 CA--C 1.542 0.666 0 N-CA-C 115.992 1.849 . . . . 0.0 115.992 -178.49 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -106.8 -9.97 16.22 Favored 'General case' 0 N--CA 1.477 0.876 0 N-CA-C 116.303 1.964 . . . . 0.0 116.303 -175.409 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 64.42 42.01 97.8 Favored Glycine 0 CA--C 1.549 2.196 0 N-CA-C 110.298 -1.121 . . . . 0.0 110.298 -168.12 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -92.53 175.24 37.23 Favored Glycine 0 CA--C 1.534 1.275 0 C-N-CA 124.27 0.938 . . . . 0.0 113.872 -167.436 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' TRP . . . . . 0.546 ' HB3' HG22 ' A' ' 26' ' ' THR . 81.5 m95 -67.29 104.83 1.58 Allowed 'General case' 0 N--CA 1.468 0.464 0 CA-C-O 122.55 1.167 . . . . 0.0 113.3 179.763 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.565 HG21 HG13 ' A' ' 51' ' ' ILE . 2.2 p -60.74 -22.08 25.36 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.971 0 CA-C-N 113.665 -1.607 . . . . 0.0 113.693 170.795 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.546 HG22 ' HB3' ' A' ' 24' ' ' TRP . 4.4 t -56.57 -46.38 80.8 Favored 'General case' 0 N--CA 1.485 1.316 0 N-CA-C 113.811 1.041 . . . . 0.0 113.811 -179.982 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.405 ' O ' HG12 ' A' ' 31' ' ' ILE . 0.0 OUTLIER -64.09 -41.01 97.45 Favored 'General case' 0 N--CA 1.479 1.016 0 O-C-N 123.972 0.795 . . . . 0.0 112.006 176.91 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.7 HG13 HG22 ' A' ' 14' ' ' THR . 2.0 mp -68.59 -44.37 82.8 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 C-N-CA 125.255 1.422 . . . . 0.0 111.904 -179.114 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.691 HG13 HD11 ' A' ' 43' ' ' LEU . 38.2 t -51.95 -48.88 39.74 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.349 0 C-N-CA 124.386 1.074 . . . . 0.0 111.069 174.52 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 42.3 m -52.34 -41.78 63.31 Favored 'General case' 0 N--CA 1.483 1.198 0 N-CA-C 114.555 1.317 . . . . 0.0 114.555 176.59 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.873 HG22 HG12 ' A' ' 11' ' ' VAL . 36.9 mm -75.35 -40.81 42.99 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.981 0 C-N-CA 124.407 1.083 . . . . 0.0 109.719 -177.766 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.651 HD22 ' HB ' ' A' ' 11' ' ' VAL . 3.9 mm? -55.96 -53.14 60.43 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 124.493 1.117 . . . . 0.0 112.294 171.565 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 1.2 p -66.4 -29.62 69.82 Favored 'General case' 0 N--CA 1.481 1.103 0 N-CA-C 115.974 1.842 . . . . 0.0 115.974 178.865 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -57.29 -27.94 62.59 Favored 'General case' 0 N--CA 1.477 0.882 0 O-C-N 124.303 1.002 . . . . 0.0 113.188 171.862 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 83.7 t -68.73 -32.85 56.64 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.297 0 C-N-CA 124.019 0.928 . . . . 0.0 111.628 172.898 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 108.45 -116.02 4.6 Favored Glycine 0 N--CA 1.47 0.928 0 C-N-CA 124.462 1.029 . . . . 0.0 111.825 -178.162 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 23.5 p -49.16 -47.78 45.48 Favored 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 115.754 1.761 . . . . 0.0 115.754 -175.982 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -60.65 -41.14 98.8 Favored Glycine 0 N--CA 1.474 1.193 0 C-N-CA 125.562 1.553 . . . . 0.0 114.251 -177.513 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.447 ' HA2' ' HB3' ' A' ' 32' ' ' LEU . . . -54.86 -52.35 46.89 Favored Glycine 0 N--CA 1.477 1.38 0 N-CA-C 111.032 -0.827 . . . . 0.0 111.032 173.328 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 94.8 mt -65.02 -49.14 71.35 Favored 'General case' 0 N--CA 1.48 1.028 0 N-CA-C 114.291 1.219 . . . . 0.0 114.291 -179.22 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 27.8 p -59.2 -38.83 80.85 Favored 'General case' 0 N--CA 1.48 1.065 0 N-CA-C 114.167 1.173 . . . . 0.0 114.167 175.873 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 13.8 tp -62.32 -50.61 70.93 Favored 'General case' 0 N--CA 1.48 1.047 0 CA-C-O 120.853 0.358 . . . . 0.0 111.11 170.275 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.691 HD11 HG13 ' A' ' 29' ' ' VAL . 0.7 OUTLIER -61.43 -30.89 70.85 Favored 'General case' 0 N--CA 1.473 0.706 0 N-CA-C 114.835 1.421 . . . . 0.0 114.835 -179.284 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -70.36 -43.79 69.45 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 123.568 0.747 . . . . 0.0 112.562 173.239 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -64.77 -31.43 72.65 Favored 'General case' 0 N--CA 1.475 0.798 0 N-CA-C 112.977 0.732 . . . . 0.0 112.977 174.074 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -60.22 -21.24 61.56 Favored 'General case' 0 N--CA 1.476 0.842 0 N-CA-C 115.817 1.784 . . . . 0.0 115.817 177.124 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -49.63 -33.63 18.94 Favored Glycine 0 CA--C 1.542 1.781 0 C-N-CA 126.198 1.856 . . . . 0.0 114.423 179.631 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 66.3 ttp85 -49.61 -60.2 3.08 Favored 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 125.602 1.561 . . . . 0.0 112.339 179.84 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 12.5 tt0 -129.15 32.08 4.77 Favored 'General case' 0 N--CA 1.48 1.069 0 CA-C-N 114.61 -1.177 . . . . 0.0 113.586 -172.571 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 8.0 t 49.75 123.55 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.295 0 C-N-CA 124.642 1.177 . . . . 0.0 113.692 -173.458 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.565 HG13 HG21 ' A' ' 25' ' ' VAL . 8.7 tp -29.01 -49.8 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.482 1.136 0 N-CA-C 117.947 2.573 . . . . 0.0 117.947 -174.713 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 33.8 ttmt -57.97 -68.67 0.22 Allowed 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 123.849 0.86 . . . . 0.0 111.93 177.383 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -62.61 -33.96 76.05 Favored 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 124.743 1.217 . . . . 0.0 113.397 179.588 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 88.5 t80 -49.5 -63.48 1.09 Allowed 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 125.11 1.364 . . . . 0.0 111.786 175.15 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.423 HD13 HG13 ' A' ' 15' ' ' VAL . 59.9 mt -65.09 -39.87 93.78 Favored 'General case' 0 N--CA 1.475 0.802 0 N-CA-C 114.469 1.285 . . . . 0.0 114.469 -178.299 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.795 ' HA ' HG13 ' A' ' 19' ' ' VAL . 97.8 mttt -58.66 -41.15 85.44 Favored 'General case' 0 N--CA 1.475 0.803 0 N-CA-C 114.34 1.237 . . . . 0.0 114.34 179.44 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 22.1 tttt -80.64 -49.66 10.96 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-N 114.628 -1.169 . . . . 0.0 111.983 173.753 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . 0.425 ' O ' ' HB2' ' A' ' 62' ' ' LYS . 31.2 tt0 -58.62 -49.29 78.05 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-N 115.672 -0.694 . . . . 0.0 112.421 -173.454 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.633 HD12 HG21 ' A' ' 67' ' ' VAL . 2.7 mm -75.53 -25.35 17.64 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.937 0 C-N-CA 120.658 -0.417 . . . . 0.0 111.91 -177.261 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.548 ' HB2' ' O ' ' A' ' 56' ' ' LYS . 2.5 tttt -62.85 -32.95 74.28 Favored 'General case' 0 N--CA 1.472 0.641 0 N-CA-C 114.599 1.333 . . . . 0.0 114.599 169.485 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 3.0 mptp? -81.36 -43.31 19.22 Favored 'General case' 0 N--CA 1.482 1.137 0 CA-C-N 114.132 -1.395 . . . . 0.0 112.373 173.271 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.425 ' HB2' ' O ' ' A' ' 58' ' ' GLU . 17.4 tptt -71.59 -52.52 17.66 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 126.636 1.974 . . . . 0.0 114.038 -171.72 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 97.6 114.63 3.28 Favored Glycine 0 N--CA 1.475 1.246 0 CA-C-O 122.602 1.112 . . . . 0.0 110.895 -170.216 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.595 ' HE2' ' HG3' ' A' ' 20' ' ' GLU . 11.8 mptt -32.25 -52.11 0.27 Allowed 'General case' 0 N--CA 1.474 0.747 0 N-CA-C 119.251 3.056 . . . . 0.0 119.251 177.024 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 1.045 HH21 HG13 ' A' ' 68' ' ' ILE . 0.0 OUTLIER -59.74 -45.31 92.59 Favored 'General case' 0 N--CA 1.476 0.827 0 N-CA-C 114.318 1.229 . . . . 0.0 114.318 -179.354 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -63.36 -29.85 71.08 Favored 'General case' 0 N--CA 1.474 0.751 0 CA-C-N 114.026 -1.443 . . . . 0.0 113.871 172.413 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.633 HG21 HD12 ' A' ' 59' ' ' ILE . 95.4 t -71.13 -33.12 50.06 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 N-CA-C 112.527 0.566 . . . . 0.0 112.527 178.175 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 1.045 HG13 HH21 ' A' ' 65' ' ' ARG . 27.0 mm -51.57 -47.49 37.05 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.333 0 O-C-N 123.902 0.751 . . . . 0.0 109.669 167.347 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -69.19 -51.48 37.59 Favored 'General case' 0 N--CA 1.483 1.21 0 CA-C-N 114.898 -1.046 . . . . 0.0 113.326 178.881 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 29.3 t90 . . . . . 0 N--CA 1.479 0.99 0 C-N-CA 124.657 1.183 . . . . 0.0 113.096 179.703 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.768 ' SD ' HD13 ' A' ' 42' ' ' LEU . 2.4 mmm . . . . . 0 CA--C 1.537 0.449 0 N-CA-C 111.442 0.164 . . . . 0.0 111.442 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -62.14 -58.78 6.5 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-N 113.65 -1.614 . . . . 0.0 112.261 177.871 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 15.5 ttpp -65.49 -54.05 33.73 Favored 'General case' 0 N--CA 1.476 0.832 0 CA-C-N 113.486 -1.688 . . . . 0.0 113.391 -173.478 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 12.1 tt0 -71.88 -37.47 70.16 Favored 'General case' 0 N--CA 1.477 0.911 0 N-CA-C 114.319 1.229 . . . . 0.0 114.319 -171.165 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . 0.436 ' HD1' ' HB2' ' A' ' 41' ' ' SER . 71.9 m-85 -102.84 -10.66 18.89 Favored 'General case' 0 N--CA 1.475 0.783 0 N-CA-C 117.473 2.397 . . . . 0.0 117.473 -172.944 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 74.36 50.9 9.13 Favored Glycine 0 CA--C 1.539 1.581 0 CA-C-O 122.459 1.033 . . . . 0.0 111.461 -174.604 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -113.86 146.84 36.43 Favored Pre-proline 0 N--CA 1.476 0.873 0 CA-C-N 112.998 -1.601 . . . . 0.0 109.767 179.405 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 97.4 Cg_endo -88.58 152.64 6.34 Favored 'Trans proline' 0 C--O 1.236 0.378 0 N-CA-C 109.733 -0.91 . . . . 0.0 109.733 165.498 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -48.77 -29.31 4.39 Favored 'General case' 0 N--CA 1.474 0.75 0 N-CA-C 115.119 1.525 . . . . 0.0 115.119 171.342 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -38.97 -47.75 1.5 Allowed 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 126.392 1.877 . . . . 0.0 114.498 170.092 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.729 HG12 HG22 ' A' ' 31' ' ' ILE . 33.0 m -99.04 -39.06 7.51 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.0 0 N-CA-C 113.791 1.034 . . . . 0.0 113.791 -176.892 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.402 ' O ' ' HG ' ' A' ' 16' ' ' LEU . . . -62.8 -38.02 89.02 Favored 'General case' 0 CA--C 1.547 0.865 0 N-CA-C 112.814 0.672 . . . . 0.0 112.814 176.982 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -58.5 -47.45 89.85 Favored Glycine 0 N--CA 1.486 1.995 0 O-C-N 124.535 1.147 . . . . 0.0 112.394 173.551 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 16.4 m -59.06 -39.57 82.48 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 124.625 1.17 . . . . 0.0 113.918 173.967 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.472 ' O ' HG23 ' A' ' 19' ' ' VAL . 40.6 t -57.04 -44.73 83.38 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.116 0 C-N-CA 123.682 0.793 . . . . 0.0 111.239 172.824 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.66 HD11 HG12 ' A' ' 68' ' ' ILE . 37.0 mt -60.97 -45.96 92.67 Favored 'General case' 0 N--CA 1.481 1.116 0 N-CA-C 112.831 0.678 . . . . 0.0 112.831 178.782 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 24.6 t-20 -50.14 -50.22 49.53 Favored 'General case' 0 N--CA 1.48 1.051 0 O-C-N 124.612 1.195 . . . . 0.0 111.067 174.475 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 56.5 t -57.65 -50.41 77.46 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 CA-C-N 113.056 -1.884 . . . . 0.0 111.841 178.624 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.611 HG11 ' HB ' ' A' ' 59' ' ' ILE . 24.3 t -59.31 -45.68 93.03 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.291 0 O-C-N 123.681 0.613 . . . . 0.0 110.943 -179.937 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . 0.558 ' HG3' ' HE2' ' A' ' 64' ' ' LYS . 14.3 mt-10 -57.69 -44.39 85.78 Favored 'General case' 0 N--CA 1.477 0.875 0 C-N-CA 125.153 1.381 . . . . 0.0 114.232 179.921 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -77.36 -17.46 58.22 Favored 'General case' 0 CA--C 1.541 0.609 0 N-CA-C 113.97 1.1 . . . . 0.0 113.97 178.35 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 71.61 51.45 16.06 Favored Glycine 0 N--CA 1.477 1.382 0 O-C-N 124.138 0.898 . . . . 0.0 111.86 -170.277 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -109.75 167.31 12.75 Favored Glycine 0 N--CA 1.48 1.597 0 CA-C-O 122.844 1.247 . . . . 0.0 112.634 -177.415 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' TRP . . . . . 0.669 ' HB3' HG22 ' A' ' 26' ' ' THR . 77.1 m95 -78.19 105.95 9.77 Favored 'General case' 0 N--CA 1.479 0.997 0 CA-C-N 113.252 -1.474 . . . . 0.0 111.818 -178.524 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.797 HG21 ' HB2' ' A' ' 55' ' ' LEU . 0.4 OUTLIER -62.58 -16.5 16.89 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.948 0 CA-C-N 113.897 -1.501 . . . . 0.0 112.825 171.021 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.669 HG22 ' HB3' ' A' ' 24' ' ' TRP . 15.3 t -67.74 -27.71 67.02 Favored 'General case' 0 N--CA 1.48 1.045 0 N-CA-C 114.513 1.301 . . . . 0.0 114.513 -178.993 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.606 ' HB ' HD12 ' A' ' 28' ' ' ILE . 0.7 OUTLIER -71.11 -48.86 49.85 Favored 'General case' 0 N--CA 1.48 1.054 0 CA-C-O 121.445 0.64 . . . . 0.0 110.813 170.111 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.606 HD12 ' HB ' ' A' ' 27' ' ' THR . 3.4 mp -65.84 -25.36 36.08 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 C-N-CA 125.956 1.702 . . . . 0.0 112.86 -179.474 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.502 HG22 HD21 ' A' ' 43' ' ' LEU . 7.9 t -36.48 -44.21 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.409 0 C-N-CA 124.101 0.96 . . . . 0.0 112.013 162.255 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 85.2 p -59.01 -39.05 80.7 Favored 'General case' 0 N--CA 1.486 1.359 0 N-CA-C 113.831 1.048 . . . . 0.0 113.831 178.688 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.729 HG22 HG12 ' A' ' 11' ' ' VAL . 39.6 mm -76.65 -35.66 25.85 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.814 0 C-N-CA 124.51 1.124 . . . . 0.0 110.178 -177.557 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.701 HD22 ' HB ' ' A' ' 11' ' ' VAL . 3.8 mm? -59.71 -54.38 47.08 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 125.161 1.384 . . . . 0.0 112.973 170.884 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -68.83 -24.2 64.35 Favored 'General case' 0 N--CA 1.476 0.833 0 N-CA-C 114.765 1.394 . . . . 0.0 114.765 177.066 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -53.54 -28.17 30.0 Favored 'General case' 0 N--CA 1.482 1.131 0 N-CA-C 113.4 0.889 . . . . 0.0 113.4 167.092 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.404 ' HB ' ' O ' ' A' ' 32' ' ' LEU . 70.0 t -69.92 -32.46 51.72 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.111 0 C-N-CA 125.087 1.355 . . . . 0.0 112.354 169.807 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 109.16 -114.64 4.06 Favored Glycine 0 N--CA 1.477 1.39 0 C-N-CA 125.435 1.493 . . . . 0.0 111.201 179.747 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 12.4 p -56.54 -39.92 74.22 Favored 'General case' 0 N--CA 1.481 1.076 0 CA-C-N 112.628 -1.786 . . . . 0.0 115.265 -178.784 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -56.52 -50.84 60.26 Favored Glycine 0 CA--C 1.538 1.528 0 O-C-N 124.739 1.274 . . . . 0.0 113.155 -179.335 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.441 ' O ' ' HG ' ' A' ' 43' ' ' LEU . . . -54.63 -46.9 72.95 Favored Glycine 0 CA--C 1.539 1.588 0 N-CA-C 111.433 -0.667 . . . . 0.0 111.433 173.998 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 79.4 mt -60.4 -49.7 76.52 Favored 'General case' 0 N--CA 1.479 1.022 0 N-CA-C 114.594 1.331 . . . . 0.0 114.594 179.594 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . 0.436 ' HB2' ' HD1' ' A' ' 5' ' ' PHE . 2.1 p -57.34 -37.33 72.38 Favored 'General case' 0 N--CA 1.479 1.021 0 N-CA-C 114.344 1.239 . . . . 0.0 114.344 177.337 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.768 HD13 ' SD ' ' A' ' 1' ' ' MET . 18.8 tp -62.94 -49.2 75.7 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 123.692 0.797 . . . . 0.0 110.436 171.396 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.502 HD21 HG22 ' A' ' 29' ' ' VAL . 49.5 mt -58.38 -33.74 69.95 Favored 'General case' 0 N--CA 1.476 0.855 0 N-CA-C 114.7 1.37 . . . . 0.0 114.7 178.087 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -65.1 -43.95 90.37 Favored 'General case' 0 N--CA 1.476 0.838 0 N-CA-C 112.324 0.491 . . . . 0.0 112.324 172.581 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -63.18 -43.17 98.98 Favored 'General case' 0 N--CA 1.484 1.251 0 C-N-CA 122.849 0.46 . . . . 0.0 111.729 173.276 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -57.34 -26.49 61.06 Favored 'General case' 0 N--CA 1.472 0.665 0 N-CA-C 115.645 1.72 . . . . 0.0 115.645 -176.597 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -45.86 -42.43 11.31 Favored Glycine 0 CA--C 1.546 2.029 0 C-N-CA 125.764 1.65 . . . . 0.0 114.052 178.589 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 29.0 ttm180 -48.54 -53.25 18.94 Favored 'General case' 0 N--CA 1.476 0.844 0 CA-C-N 112.558 -1.821 . . . . 0.0 113.673 -175.723 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 17.2 tt0 -126.84 36.72 4.41 Favored 'General case' 0 N--CA 1.474 0.77 0 N-CA-C 113.258 0.836 . . . . 0.0 113.258 178.024 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 18.4 t 48.33 120.96 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.421 0 C-N-CA 126.17 1.788 . . . . 0.0 113.821 -178.031 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 7.8 tp -31.31 -51.42 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 N-CA-C 116.595 2.072 . . . . 0.0 116.595 -176.319 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 70.3 mttt -48.68 -67.03 0.3 Allowed 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 125.477 1.511 . . . . 0.0 112.927 176.113 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -74.47 -30.86 62.03 Favored 'General case' 0 N--CA 1.466 0.352 0 N-CA-C 114.735 1.384 . . . . 0.0 114.735 -179.198 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . 0.504 ' HD2' ' HG ' ' A' ' 55' ' ' LEU . 72.9 t80 -49.0 -63.82 0.99 Allowed 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 124.933 1.293 . . . . 0.0 112.291 -178.133 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.797 ' HB2' HG21 ' A' ' 25' ' ' VAL . 42.4 mt -73.29 -34.44 65.76 Favored 'General case' 0 N--CA 1.477 0.885 0 N-CA-C 114.884 1.438 . . . . 0.0 114.884 -174.595 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.578 ' HA ' HG13 ' A' ' 19' ' ' VAL . 57.8 mtpt -58.59 -46.17 87.53 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 114.438 -1.256 . . . . 0.0 112.67 177.052 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 61.6 tttm -77.44 -50.77 11.99 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 114.903 -1.044 . . . . 0.0 111.873 174.409 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 58.8 tt0 -59.1 -44.99 92.0 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-O 118.225 -0.893 . . . . 0.0 111.515 -170.404 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.748 HG23 HG21 ' A' ' 67' ' ' VAL . 4.0 mm -79.32 -20.08 12.61 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.789 0 C-N-CA 119.841 -0.744 . . . . 0.0 112.712 -175.262 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 23.1 tptt -65.57 -37.28 86.22 Favored 'General case' 0 CA--C 1.549 0.909 0 CA-C-O 122.449 1.119 . . . . 0.0 113.454 170.545 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 21.6 ttpp -84.53 -37.78 20.82 Favored 'General case' 0 CA--C 1.554 1.101 0 CA-C-N 112.355 -2.202 . . . . 0.0 111.415 -178.601 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 6.9 tttt -77.21 -43.62 33.0 Favored 'General case' 0 CA--C 1.541 0.626 0 N-CA-C 116.603 2.075 . . . . 0.0 116.603 -177.432 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 91.35 111.5 1.7 Allowed Glycine 0 N--CA 1.478 1.445 0 CA-C-O 122.584 1.102 . . . . 0.0 111.332 -177.48 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.635 ' H ' ' HD2' ' A' ' 64' ' ' LYS . 10.4 mptt -43.87 -41.21 4.99 Favored 'General case' 0 N--CA 1.487 1.377 0 N-CA-C 117.863 2.542 . . . . 0.0 117.863 -171.778 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.485 ' O ' ' HB ' ' A' ' 68' ' ' ILE . 0.0 OUTLIER -56.16 -49.41 74.06 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 124.583 1.153 . . . . 0.0 113.386 178.402 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -67.65 -23.98 65.39 Favored 'General case' 0 N--CA 1.477 0.904 0 N-CA-C 114.61 1.337 . . . . 0.0 114.61 174.961 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.748 HG21 HG23 ' A' ' 59' ' ' ILE . 45.6 t -75.16 -32.23 26.05 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.083 0 CA-C-N 114.86 -1.064 . . . . 0.0 110.822 176.325 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.66 HG12 HD11 ' A' ' 16' ' ' LEU . 8.0 mm -51.7 -46.71 38.88 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.951 0 C-N-CA 123.355 0.662 . . . . 0.0 110.075 168.491 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -68.87 -48.91 62.24 Favored 'General case' 0 N--CA 1.482 1.143 0 O-C-N 124.542 1.152 . . . . 0.0 113.345 176.585 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 34.6 t90 . . . . . 0 N--CA 1.477 0.88 0 C-N-CA 124.799 1.24 . . . . 0.0 113.6 -178.846 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.536 ' HE3' HD13 ' A' ' 7' ' ' ILE . 22.5 mtp . . . . . 0 N--CA 1.48 1.036 0 N-CA-C 112.553 0.575 . . . . 0.0 112.553 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -60.56 -51.31 69.98 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-N 115.213 -0.903 . . . . 0.0 113.259 177.629 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 57.8 tttp -70.32 -51.44 30.15 Favored 'General case' 0 CA--C 1.551 0.987 0 CA-C-N 113.568 -1.651 . . . . 0.0 112.978 -173.42 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -77.22 -38.57 51.05 Favored 'General case' 0 N--CA 1.482 1.166 0 N-CA-C 116.577 2.065 . . . . 0.0 116.577 -170.361 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . 0.676 ' HD1' ' HB2' ' A' ' 41' ' ' SER . 53.3 m-85 -99.7 -30.99 11.78 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-N 112.914 -1.948 . . . . 0.0 115.356 -168.395 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 93.88 50.73 2.24 Favored Glycine 0 CA--C 1.541 1.682 0 O-C-N 125.277 1.611 . . . . 0.0 110.964 -171.174 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.536 HD13 ' HE3' ' A' ' 1' ' ' MET . 0.6 OUTLIER -117.83 147.76 41.82 Favored Pre-proline 0 N--CA 1.475 0.823 0 CA-C-N 113.4 -1.4 . . . . 0.0 109.287 -178.528 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_endo -89.42 155.04 5.42 Favored 'Trans proline' 0 C--N 1.332 -0.327 0 N-CA-C 108.861 -1.246 . . . . 0.0 108.861 161.307 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -50.18 -26.04 4.19 Favored 'General case' 0 CA--C 1.54 0.58 0 N-CA-C 115.208 1.558 . . . . 0.0 115.208 173.516 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -47.32 -59.38 3.23 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 125.237 1.415 . . . . 0.0 112.678 172.626 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.89 HG12 HG22 ' A' ' 31' ' ' ILE . 33.5 m -81.9 -27.6 9.61 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.988 0 N-CA-C 114.181 1.178 . . . . 0.0 114.181 -175.278 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -67.94 -33.84 75.44 Favored 'General case' 0 N--CA 1.478 0.932 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.651 172.863 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -61.24 -42.54 99.81 Favored Glycine 0 CA--C 1.537 1.451 0 C-N-CA 124.073 0.844 . . . . 0.0 112.833 173.263 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.476 HG22 HG13 ' A' ' 28' ' ' ILE . 0.8 OUTLIER -58.85 -41.63 87.41 Favored 'General case' 0 N--CA 1.478 0.966 0 N-CA-C 114.166 1.173 . . . . 0.0 114.166 173.792 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.539 HG13 HD13 ' A' ' 55' ' ' LEU . 22.2 t -53.87 -43.18 56.16 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.265 0 C-N-CA 123.514 0.725 . . . . 0.0 112.915 170.67 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 25.0 mt -60.74 -40.87 94.05 Favored 'General case' 0 N--CA 1.476 0.857 0 N-CA-C 113.278 0.844 . . . . 0.0 113.278 178.102 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -52.43 -45.5 66.0 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 124.405 1.082 . . . . 0.0 111.977 174.698 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -60.44 -51.65 70.57 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.682 0 CA-C-N 114.283 -1.326 . . . . 0.0 112.339 175.52 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.673 HG13 ' HA ' ' A' ' 56' ' ' LYS . 17.9 t -58.85 -45.0 91.82 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.388 0 O-C-N 124.265 0.978 . . . . 0.0 111.002 -178.876 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 21.0 mt-10 -66.88 -39.52 87.53 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 125.97 1.708 . . . . 0.0 115.418 -177.705 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -101.93 -24.19 14.04 Favored 'General case' 0 N--CA 1.474 0.753 0 N-CA-C 115.82 1.785 . . . . 0.0 115.82 -172.01 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.618 ' HA2' ' HE2' ' A' ' 56' ' ' LYS . . . 77.7 44.21 13.1 Favored Glycine 0 N--CA 1.484 1.897 0 N-CA-C 110.742 -0.943 . . . . 0.0 110.742 -166.75 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -85.67 169.29 42.7 Favored Glycine 0 N--CA 1.474 1.208 0 C-N-CA 124.294 0.95 . . . . 0.0 112.995 -175.451 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 66.6 m95 -67.43 99.8 0.78 Allowed 'General case' 0 C--O 1.243 0.751 0 CA-C-O 123.257 1.503 . . . . 0.0 111.728 176.75 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.753 HG21 ' HA ' ' A' ' 52' ' ' LYS . 16.0 t -56.32 -24.46 18.38 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.939 0 CA-C-N 113.521 -1.672 . . . . 0.0 112.481 174.091 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 11.7 p -58.55 -45.68 88.42 Favored 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 123.735 0.814 . . . . 0.0 112.71 176.528 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -61.65 -45.22 94.96 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 124.095 0.958 . . . . 0.0 111.211 176.023 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.476 HG13 HG22 ' A' ' 14' ' ' THR . 1.7 mp -56.96 -48.43 81.62 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.915 0 CA-C-N 114.701 -1.136 . . . . 0.0 112.951 175.225 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.427 HG13 HD11 ' A' ' 43' ' ' LEU . 54.4 t -52.38 -41.83 36.34 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.059 0 C-N-CA 123.85 0.86 . . . . 0.0 111.937 176.948 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 73.2 m -55.96 -47.2 78.05 Favored 'General case' 0 N--CA 1.486 1.327 0 N-CA-C 113.625 0.972 . . . . 0.0 113.625 174.349 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.89 HG22 HG12 ' A' ' 11' ' ' VAL . 36.5 mm -69.47 -38.17 76.44 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.964 0 CA-C-N 115.149 -0.932 . . . . 0.0 109.349 -175.906 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.53 HD22 ' HB ' ' A' ' 11' ' ' VAL . 4.3 mm? -61.81 -52.66 63.29 Favored 'General case' 0 N--CA 1.48 1.026 0 CA-C-N 113.813 -1.54 . . . . 0.0 113.496 175.508 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 8.3 p -68.01 -31.72 71.6 Favored 'General case' 0 N--CA 1.476 0.834 0 N-CA-C 114.76 1.393 . . . . 0.0 114.76 177.36 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -52.46 -29.62 25.65 Favored 'General case' 0 N--CA 1.479 0.981 0 N-CA-C 113.714 1.005 . . . . 0.0 113.714 172.117 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 85.6 t -69.11 -33.42 58.48 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 C-N-CA 124.179 0.992 . . . . 0.0 112.453 171.789 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 117.04 -118.08 4.03 Favored Glycine 0 N--CA 1.473 1.152 0 C-N-CA 124.396 0.998 . . . . 0.0 111.235 179.898 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 5.2 p -62.12 -38.97 90.96 Favored 'General case' 0 N--CA 1.473 0.711 0 N-CA-C 115.831 1.789 . . . . 0.0 115.831 -173.577 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -52.64 -47.58 57.62 Favored Glycine 0 CA--C 1.542 1.761 0 O-C-N 124.83 1.331 . . . . 0.0 113.729 176.187 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.433 ' O ' ' HG ' ' A' ' 43' ' ' LEU . . . -56.73 -51.25 58.01 Favored Glycine 0 N--CA 1.478 1.49 0 N-CA-C 110.875 -0.89 . . . . 0.0 110.875 177.727 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 18.9 mt -59.07 -48.94 79.77 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 124.594 1.157 . . . . 0.0 114.097 177.999 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . 0.676 ' HB2' ' HD1' ' A' ' 5' ' ' PHE . 0.0 OUTLIER -58.63 -41.46 86.03 Favored 'General case' 0 N--CA 1.479 1.014 0 N-CA-C 113.824 1.046 . . . . 0.0 113.824 174.927 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 15.3 tp -60.25 -44.44 95.26 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 122.477 0.311 . . . . 0.0 110.87 174.07 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.433 ' HG ' ' O ' ' A' ' 39' ' ' GLY . 79.6 mt -62.01 -36.25 80.97 Favored 'General case' 0 N--CA 1.477 0.891 0 N-CA-C 115.017 1.488 . . . . 0.0 115.017 178.103 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -63.12 -50.02 72.12 Favored 'General case' 0 N--CA 1.472 0.635 0 O-C-N 123.962 0.789 . . . . 0.0 112.076 172.2 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -62.67 -33.57 75.34 Favored 'General case' 0 N--CA 1.486 1.347 0 N-CA-C 112.571 0.582 . . . . 0.0 112.571 177.558 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -65.29 -19.72 66.09 Favored 'General case' 0 N--CA 1.474 0.732 0 N-CA-C 115.702 1.741 . . . . 0.0 115.702 178.289 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -52.61 -38.29 51.95 Favored Glycine 0 N--CA 1.477 1.412 0 O-C-N 124.665 1.228 . . . . 0.0 112.696 178.006 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 65.1 ttp85 -54.12 -47.03 72.29 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 125.541 1.536 . . . . 0.0 113.805 -174.744 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 15.8 tt0 -132.25 36.11 3.64 Favored 'General case' 0 N--CA 1.477 0.899 0 N-CA-C 114.903 1.446 . . . . 0.0 114.903 -174.722 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 78.2 p 49.37 116.99 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.823 0 C-N-CA 124.06 0.944 . . . . 0.0 113.073 -174.798 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.544 HG13 HG11 ' A' ' 25' ' ' VAL 0.256 8.2 tp -31.5 -49.54 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 N-CA-C 117.974 2.583 . . . . 0.0 117.974 -173.58 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.753 ' HA ' HG21 ' A' ' 25' ' ' VAL . 0.3 OUTLIER -64.98 -66.57 0.53 Allowed 'General case' 0 N--CA 1.489 1.518 0 CA-C-N 118.214 0.461 . . . . 0.0 111.885 178.132 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -50.74 -40.02 53.53 Favored 'General case' 0 C--O 1.236 0.349 0 O-C-N 124.868 1.355 . . . . 0.0 112.522 178.804 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 91.6 t80 -48.84 -62.82 1.32 Allowed 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 126.108 1.763 . . . . 0.0 111.23 174.212 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.539 HD13 HG13 ' A' ' 15' ' ' VAL . 92.4 mt -64.98 -39.62 93.74 Favored 'General case' 0 N--CA 1.478 0.956 0 N-CA-C 115.354 1.613 . . . . 0.0 115.354 -178.792 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.673 ' HA ' HG13 ' A' ' 19' ' ' VAL . 29.1 mttt -58.78 -48.07 82.55 Favored 'General case' 0 C--N 1.319 -0.717 0 N-CA-C 115.444 1.646 . . . . 0.0 115.444 176.7 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 71.4 tttt -74.48 -50.71 17.18 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-N 115.039 -0.982 . . . . 0.0 112.039 173.547 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . 0.484 ' O ' ' HB2' ' A' ' 62' ' ' LYS . 31.3 tt0 -63.28 -47.37 82.63 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-O 118.433 -0.794 . . . . 0.0 111.549 -168.542 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.693 HG23 HG21 ' A' ' 67' ' ' VAL . 3.2 mm -77.66 -19.62 13.96 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.928 0 N-CA-C 112.117 0.414 . . . . 0.0 112.117 -176.334 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 2.7 ttmp? -68.62 -41.61 79.24 Favored 'General case' 0 CA--C 1.547 0.835 0 CA-C-N 115.511 -0.768 . . . . 0.0 112.643 170.069 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 25.4 ttpp -72.6 -41.91 65.1 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 125.651 1.58 . . . . 0.0 112.91 175.223 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.484 ' HB2' ' O ' ' A' ' 58' ' ' GLU . 0.0 OUTLIER -70.68 -53.45 15.69 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 126.674 1.99 . . . . 0.0 113.855 -177.034 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 99.37 106.24 2.69 Favored Glycine 0 N--CA 1.477 1.405 0 N-CA-C 110.399 -1.08 . . . . 0.0 110.399 -174.246 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.786 ' H ' ' HD2' ' A' ' 64' ' ' LYS . 10.8 mptt -30.87 -50.21 0.14 Allowed 'General case' 0 N--CA 1.485 1.319 0 N-CA-C 118.769 2.878 . . . . 0.0 118.769 -175.738 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.467 ' O ' ' HB ' ' A' ' 68' ' ' ILE . 0.0 OUTLIER -59.22 -42.1 90.2 Favored 'General case' 0 N--CA 1.474 0.73 0 N-CA-C 114.517 1.303 . . . . 0.0 114.517 178.759 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -69.56 -26.62 64.57 Favored 'General case' 0 N--CA 1.478 0.927 0 CA-C-N 114.55 -1.205 . . . . 0.0 113.65 174.729 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.693 HG21 HG23 ' A' ' 59' ' ' ILE . 72.6 t -69.63 -34.38 61.09 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.048 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.448 175.711 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.467 ' HB ' ' O ' ' A' ' 65' ' ' ARG . 19.8 mm -52.58 -41.57 37.52 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.941 0 O-C-N 124.223 0.952 . . . . 0.0 110.934 170.045 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -70.21 -53.84 15.37 Favored 'General case' 0 N--CA 1.48 1.042 0 N-CA-C 113.247 0.832 . . . . 0.0 113.247 174.535 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 46.7 t90 . . . . . 0 CA--C 1.545 0.76 0 C-N-CA 126.321 1.848 . . . . 0.0 114.325 -176.497 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.752 ' HE1' HG21 ' A' ' 15' ' ' VAL . 70.0 mtp . . . . . 0 N--CA 1.475 0.803 0 N-CA-C 112.98 0.733 . . . . 0.0 112.98 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . 0.418 ' HA ' ' O ' ' A' ' 7' ' ' ILE . . . -61.52 -56.28 21.78 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-N 114.546 -1.206 . . . . 0.0 112.112 172.685 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 95.1 mttt -64.06 -62.86 1.36 Allowed 'General case' 0 CA--C 1.541 0.621 0 CA-C-N 114.015 -1.448 . . . . 0.0 114.453 -177.555 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 3.9 mp0 -75.21 -40.54 59.1 Favored 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 115.016 1.488 . . . . 0.0 115.016 -170.065 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . 0.486 ' HD2' ' HA ' ' A' ' 1' ' ' MET . 41.3 m-85 -101.85 -11.68 18.85 Favored 'General case' 0 N--CA 1.476 0.851 0 N-CA-C 116.557 2.058 . . . . 0.0 116.557 -174.005 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 67.39 37.37 90.33 Favored Glycine 0 CA--C 1.538 1.528 0 CA-C-O 121.855 0.697 . . . . 0.0 111.359 -173.731 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.663 HG23 HG23 ' A' ' 11' ' ' VAL . 0.7 OUTLIER -110.06 115.31 55.06 Favored Pre-proline 0 N--CA 1.474 0.73 0 C-N-CA 124.547 1.139 . . . . 0.0 109.086 179.016 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 96.3 Cg_endo -65.2 154.92 71.22 Favored 'Trans proline' 0 CA--C 1.536 0.602 0 C-N-CA 120.614 0.876 . . . . 0.0 111.019 -177.165 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -46.49 -30.11 2.05 Favored 'General case' 0 N--CA 1.472 0.662 0 N-CA-C 115.833 1.79 . . . . 0.0 115.833 174.478 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -40.4 -60.76 1.03 Allowed 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 126.337 1.855 . . . . 0.0 112.875 171.116 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.98 HG12 HG22 ' A' ' 31' ' ' ILE . 34.6 m -86.86 -31.11 5.99 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.915 0 CA-C-N 114.58 -1.191 . . . . 0.0 113.679 -174.793 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -59.63 -33.81 71.98 Favored 'General case' 0 CA--C 1.547 0.843 0 N-CA-C 113.24 0.829 . . . . 0.0 113.24 171.611 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -63.68 -44.18 96.77 Favored Glycine 0 N--CA 1.481 1.69 0 C-N-CA 124.044 0.831 . . . . 0.0 112.229 174.641 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.915 HG22 HG13 ' A' ' 28' ' ' ILE . 1.7 m -61.33 -36.87 81.34 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 125.368 1.467 . . . . 0.0 113.674 174.175 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.752 HG21 ' HE1' ' A' ' 1' ' ' MET . 6.1 t -58.16 -45.36 88.7 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.359 0 N-CA-C 113.044 0.757 . . . . 0.0 113.044 170.187 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.404 HD13 ' HB3' ' A' ' 64' ' ' LYS . 39.0 mt -57.07 -38.56 73.47 Favored 'General case' 0 N--CA 1.482 1.173 0 CA-C-N 115.352 -0.84 . . . . 0.0 112.868 177.102 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -53.01 -46.17 68.25 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-N 113.355 -1.748 . . . . 0.0 113.384 176.268 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 1.7 t -55.52 -49.47 73.25 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.124 0 C-N-CA 124.696 1.198 . . . . 0.0 113.042 172.26 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.792 HG13 ' HA ' ' A' ' 56' ' ' LYS . 11.6 t -63.45 -45.44 97.9 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.227 0 C-N-CA 123.635 0.774 . . . . 0.0 111.483 -174.961 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . 0.432 ' HG3' ' HE2' ' A' ' 64' ' ' LYS . 19.0 mt-10 -65.14 -40.98 95.17 Favored 'General case' 0 CA--C 1.541 0.6 0 N-CA-C 115.843 1.794 . . . . 0.0 115.843 -179.6 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -101.12 -20.9 15.13 Favored 'General case' 0 N--CA 1.479 1.007 0 N-CA-C 116.287 1.958 . . . . 0.0 116.287 -174.716 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 71.57 39.63 60.5 Favored Glycine 0 N--CA 1.481 1.634 0 N-CA-C 110.894 -0.882 . . . . 0.0 110.894 -164.954 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -82.17 164.52 44.2 Favored Glycine 0 N--CA 1.478 1.444 0 C-N-CA 124.388 0.994 . . . . 0.0 113.006 -174.123 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' TRP . . . . . 0.499 ' HB3' HG22 ' A' ' 26' ' ' THR . 2.3 m-90 -62.33 103.9 0.44 Allowed 'General case' 0 N--CA 1.475 0.787 0 CA-C-O 123.166 1.46 . . . . 0.0 112.107 179.603 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 3.0 p -55.57 -24.56 16.36 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.718 0 CA-C-N 112.89 -1.959 . . . . 0.0 112.851 172.87 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.499 HG22 ' HB3' ' A' ' 24' ' ' TRP . 9.8 t -62.49 -45.92 90.82 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-O 118.002 -0.999 . . . . 0.0 113.441 177.951 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -60.09 -42.06 93.85 Favored 'General case' 0 N--CA 1.484 1.26 0 O-C-N 124.416 1.072 . . . . 0.0 110.454 175.642 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.915 HG13 HG22 ' A' ' 14' ' ' THR . 1.9 mp -65.62 -47.53 85.92 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.649 0 C-N-CA 124.634 1.174 . . . . 0.0 112.583 -179.534 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 72.7 t -50.37 -42.7 21.29 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 O-C-N 123.755 0.66 . . . . 0.0 111.232 174.426 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 5.5 m -55.55 -40.95 72.57 Favored 'General case' 0 N--CA 1.481 1.106 0 N-CA-C 113.919 1.081 . . . . 0.0 113.919 175.948 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.98 HG22 HG12 ' A' ' 11' ' ' VAL . 34.9 mm -71.45 -38.86 70.07 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.957 0 C-N-CA 124.14 0.976 . . . . 0.0 109.932 179.802 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.495 HD22 ' HB ' ' A' ' 11' ' ' VAL . 3.4 mm? -61.15 -40.42 93.77 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 124.716 1.207 . . . . 0.0 112.184 171.491 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.734 HG23 ' HA2' ' A' ' 38' ' ' GLY . 10.0 m -67.63 -36.88 81.61 Favored 'General case' 0 N--CA 1.476 0.84 0 N-CA-C 114.05 1.13 . . . . 0.0 114.05 175.813 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -53.64 -31.55 47.89 Favored 'General case' 0 N--CA 1.488 1.437 0 C-N-CA 124.325 1.05 . . . . 0.0 113.797 175.2 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 42.9 t -58.78 -36.81 62.66 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.94 0 C-N-CA 125.802 1.641 . . . . 0.0 113.402 174.167 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 118.06 160.6 11.65 Favored Glycine 0 CA--C 1.535 1.286 0 N-CA-C 108.982 -1.647 . . . . 0.0 108.982 -168.971 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . 0.59 ' OG ' ' HB2' ' A' ' 40' ' ' LEU . 8.3 t 73.39 -37.77 0.39 Allowed 'General case' 0 N--CA 1.493 1.708 0 C-N-CA 126.376 1.87 . . . . 0.0 112.928 -175.914 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.734 ' HA2' HG23 ' A' ' 33' ' ' THR . . . 116.97 14.43 7.23 Favored Glycine 0 CA--C 1.54 1.608 0 C-N-CA 125.978 1.751 . . . . 0.0 112.459 -174.337 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.433 ' HA3' ' HB3' ' A' ' 32' ' ' LEU . . . 57.14 27.68 57.73 Favored Glycine 0 N--CA 1.484 1.837 0 N-CA-C 111.805 -0.518 . . . . 0.0 111.805 -159.765 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.59 ' HB2' ' OG ' ' A' ' 37' ' ' SER . 5.3 mt -56.97 -37.38 71.53 Favored 'General case' 0 N--CA 1.481 1.1 0 N-CA-C 115.954 1.835 . . . . 0.0 115.954 -167.869 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 12.3 p -59.15 -48.33 82.02 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 124.139 0.976 . . . . 0.0 112.661 176.335 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 15.0 tp -62.75 -49.39 75.21 Favored 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 122.983 0.513 . . . . 0.0 110.572 173.062 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 77.8 mt -60.47 -31.22 70.25 Favored 'General case' 0 N--CA 1.475 0.81 0 N-CA-C 113.972 1.101 . . . . 0.0 113.972 -177.462 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -69.36 -46.14 67.7 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 123.463 0.705 . . . . 0.0 111.826 173.94 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -60.74 -30.85 70.24 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 123.833 0.853 . . . . 0.0 112.563 177.317 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.426 ' HB1' ' HA ' ' A' ' 51' ' ' ILE . . . -67.38 -27.82 67.42 Favored 'General case' 0 N--CA 1.471 0.608 0 N-CA-C 115.931 1.826 . . . . 0.0 115.931 178.276 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -45.76 -45.54 13.23 Favored Glycine 0 CA--C 1.544 1.851 0 C-N-CA 126.105 1.812 . . . . 0.0 114.295 -170.811 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 24.6 tpt180 -45.79 -48.43 15.56 Favored 'General case' 0 CA--C 1.544 0.736 0 CA-C-N 111.948 -2.126 . . . . 0.0 114.328 -179.221 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 18.9 tt0 -123.74 25.89 7.91 Favored 'General case' 0 N--CA 1.481 1.107 0 N-CA-C 114.499 1.296 . . . . 0.0 114.499 -176.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 33.2 t 50.21 133.18 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.486 0 C-N-CA 125.626 1.57 . . . . 0.0 111.83 -167.971 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.426 ' HA ' ' HB1' ' A' ' 46' ' ' ALA . 7.4 tp -43.13 -45.4 1.36 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.027 0 N-CA-C 115.536 1.68 . . . . 0.0 115.536 -175.599 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 5.6 tmtm? -53.84 -71.2 0.08 Allowed 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 125.061 1.344 . . . . 0.0 111.941 177.733 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -65.47 -29.18 69.81 Favored 'General case' 0 N--CA 1.471 0.576 0 N-CA-C 115.135 1.531 . . . . 0.0 115.135 179.385 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . 0.459 ' O ' ' HB2' ' A' ' 58' ' ' GLU . 86.9 t80 -51.1 -64.64 0.75 Allowed 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 125.417 1.487 . . . . 0.0 111.579 176.565 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.461 HD13 HG13 ' A' ' 15' ' ' VAL . 75.4 mt -60.77 -37.86 83.3 Favored 'General case' 0 N--CA 1.478 0.95 0 N-CA-C 114.617 1.34 . . . . 0.0 114.617 -176.18 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.792 ' HA ' HG13 ' A' ' 19' ' ' VAL . 94.0 mttt -61.3 -45.23 95.31 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 113.201 -1.818 . . . . 0.0 114.055 -179.335 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 81.4 tttt -77.25 -47.06 21.12 Favored 'General case' 0 CA--C 1.543 0.71 0 CA-C-N 115.275 -0.875 . . . . 0.0 112.703 171.463 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . 0.461 ' O ' ' HB2' ' A' ' 62' ' ' LYS . 4.1 mm-40 -57.22 -51.05 70.91 Favored 'General case' 0 C--O 1.219 -0.522 0 N-CA-C 113.743 1.016 . . . . 0.0 113.743 -175.105 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.697 HG23 HG21 ' A' ' 67' ' ' VAL . 2.6 mm -80.01 -21.1 11.91 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.484 0 N-CA-C 112.206 0.447 . . . . 0.0 112.206 -177.603 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.522 ' HB2' ' O ' ' A' ' 56' ' ' LYS . 6.9 tppt? -60.65 -42.79 97.71 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-O 123.783 1.754 . . . . 0.0 112.296 171.599 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . 0.277 19.5 tttm -81.32 -45.03 16.8 Favored 'General case' 0 CA--C 1.55 0.951 0 CA-C-N 111.132 -2.758 . . . . 0.0 111.74 -179.797 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.461 ' HB2' ' O ' ' A' ' 58' ' ' GLU . 15.5 tptt -58.51 -50.66 72.95 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 126.036 1.734 . . . . 0.0 113.605 -179.135 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 86.66 108.31 0.82 Allowed Glycine 0 N--CA 1.478 1.47 0 CA-C-N 113.582 -1.644 . . . . 0.0 109.911 -169.079 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.71 ' H ' ' HD2' ' A' ' 64' ' ' LYS . 10.0 mptt -28.48 -48.38 0.06 Allowed 'General case' 0 N--CA 1.481 1.083 0 N-CA-C 119.776 3.25 . . . . 0.0 119.776 -176.625 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.406 ' O ' ' HB ' ' A' ' 68' ' ' ILE . 1.2 ttp85 -54.5 -44.03 72.35 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 125.625 1.57 . . . . 0.0 113.321 178.804 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -69.25 -23.25 63.84 Favored 'General case' 0 N--CA 1.474 0.761 0 N-CA-C 114.702 1.371 . . . . 0.0 114.702 176.116 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.697 HG21 HG23 ' A' ' 59' ' ' ILE . 63.9 t -75.67 -35.88 32.48 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.31 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.893 178.752 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.406 ' HB ' ' O ' ' A' ' 65' ' ' ARG . 17.3 mm -50.39 -42.56 21.2 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 C-N-CA 124.124 0.969 . . . . 0.0 111.107 169.304 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -74.9 -52.8 10.35 Favored 'General case' 0 N--CA 1.484 1.238 0 N-CA-C 113.718 1.007 . . . . 0.0 113.718 174.789 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 33.3 t90 . . . . . 0 N--CA 1.488 1.47 0 C-N-CA 125.704 1.602 . . . . 0.0 114.118 -178.301 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.548 ' HB3' HG22 ' A' ' 7' ' ' ILE . 68.1 mtp . . . . . 0 N--CA 1.478 0.969 0 N-CA-C 112.137 0.421 . . . . 0.0 112.137 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . 0.54 ' HA ' ' O ' ' A' ' 7' ' ' ILE . . . -58.26 -52.78 64.14 Favored 'General case' 0 N--CA 1.475 0.825 0 CA-C-N 114.819 -1.082 . . . . 0.0 112.129 173.902 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.99 -65.11 0.84 Allowed 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 112.518 -2.128 . . . . 0.0 115.997 -174.962 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . 0.421 ' HB2' ' O ' ' A' ' 70' ' ' TRP . 1.8 mp0 -73.79 -26.34 60.58 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-N 112.877 -1.965 . . . . 0.0 113.496 -170.718 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . 0.413 ' HD1' ' HB2' ' A' ' 41' ' ' SER . 31.6 m-85 -118.02 -6.92 10.92 Favored 'General case' 0 N--CA 1.478 0.937 0 N-CA-C 118.025 2.602 . . . . 0.0 118.025 -174.167 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 63.13 37.22 94.56 Favored Glycine 0 CA--C 1.543 1.806 0 O-C-N 124.007 0.817 . . . . 0.0 112.551 -175.866 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.548 HG22 ' HB3' ' A' ' 1' ' ' MET . 0.5 OUTLIER -114.0 121.51 36.63 Favored Pre-proline 0 N--CA 1.475 0.778 0 CA-C-N 114.448 -0.876 . . . . 0.0 108.708 -179.833 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 96.6 Cg_endo -67.28 160.87 45.59 Favored 'Trans proline' 0 CA--C 1.532 0.411 0 C-N-CA 120.971 1.114 . . . . 0.0 111.334 -177.558 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -53.62 -27.62 28.05 Favored 'General case' 0 CA--C 1.545 0.772 0 N-CA-C 114.713 1.375 . . . . 0.0 114.713 173.048 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -45.43 -43.9 11.7 Favored 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 126.191 1.796 . . . . 0.0 114.357 174.216 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.531 HG23 HG23 ' A' ' 7' ' ' ILE . 34.5 m -102.65 -33.59 3.36 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.893 0 N-CA-C 114.306 1.225 . . . . 0.0 114.306 -176.947 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.412 ' O ' ' HG ' ' A' ' 16' ' ' LEU . . . -61.45 -34.17 74.97 Favored 'General case' 0 N--CA 1.475 0.776 0 CA-C-N 114.8 -1.091 . . . . 0.0 112.181 173.686 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -59.71 -49.97 72.82 Favored Glycine 0 N--CA 1.478 1.434 0 C-N-CA 124.799 1.19 . . . . 0.0 112.775 173.57 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 9.1 m -62.13 -36.39 81.65 Favored 'General case' 0 N--CA 1.479 1.001 0 N-CA-C 114.612 1.338 . . . . 0.0 114.612 175.596 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.438 ' O ' HG23 ' A' ' 19' ' ' VAL . 72.0 t -56.94 -40.11 69.96 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.133 0 C-N-CA 123.213 0.605 . . . . 0.0 111.481 173.109 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.622 HD13 ' HB3' ' A' ' 64' ' ' LYS . 27.6 mt -61.36 -43.57 98.65 Favored 'General case' 0 N--CA 1.479 1.023 0 N-CA-C 113.418 0.896 . . . . 0.0 113.418 178.636 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 56.6 t-20 -54.77 -49.77 70.08 Favored 'General case' 0 CA--C 1.548 0.901 0 O-C-N 124.614 1.197 . . . . 0.0 111.055 173.443 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 96.8 t -54.9 -52.35 44.0 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.954 0 CA-C-N 114.6 -1.182 . . . . 0.0 111.204 175.823 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.643 HG11 ' HB ' ' A' ' 59' ' ' ILE . 81.7 t -53.88 -56.14 10.61 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.307 0 O-C-N 124.05 0.844 . . . . 0.0 111.124 179.788 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 14.5 tt0 -57.13 -37.69 72.38 Favored 'General case' 0 N--CA 1.476 0.829 0 O-C-N 124.972 1.42 . . . . 0.0 113.191 -176.825 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -88.12 -16.64 32.91 Favored 'General case' 0 N--CA 1.473 0.699 0 N-CA-C 116.294 1.961 . . . . 0.0 116.294 179.15 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 70.58 33.65 67.36 Favored Glycine 0 N--CA 1.487 2.099 0 C-N-CA 124.5 1.048 . . . . 0.0 112.143 -170.012 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -77.32 -177.12 45.69 Favored Glycine 0 CA--C 1.539 1.583 0 CA-C-O 124.155 1.975 . . . . 0.0 115.542 -170.954 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' TRP . . . . . 0.419 ' HB3' ' OG1' ' A' ' 26' ' ' THR . 74.0 m95 -63.7 122.65 16.9 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 110.717 -2.741 . . . . 0.0 116.73 -176.296 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 11.9 p -42.76 -37.75 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.379 0 CA-C-N 112.492 -2.14 . . . . 0.0 113.802 164.561 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.419 ' OG1' ' HB3' ' A' ' 24' ' ' TRP . 8.4 p -60.1 -44.26 94.97 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 123.782 0.833 . . . . 0.0 111.483 176.927 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -60.72 -29.54 69.42 Favored 'General case' 0 N--CA 1.485 1.317 0 N-CA-C 112.835 0.68 . . . . 0.0 112.835 176.321 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.488 ' O ' HD23 ' A' ' 32' ' ' LEU . 30.4 mt -72.75 -68.28 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.028 0 N-CA-C 109.36 -0.607 . . . . 0.0 109.36 167.239 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 85.7 t -54.39 -48.49 68.57 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.054 0 CA-C-O 118.159 -0.924 . . . . 0.0 112.896 -170.45 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 67.2 m -64.83 -26.15 68.21 Favored 'General case' 0 N--CA 1.477 0.897 0 N-CA-C 115.172 1.545 . . . . 0.0 115.172 179.349 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.49 HG22 HG12 ' A' ' 11' ' ' VAL . 35.7 mm -85.23 -42.41 16.3 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.921 0 C-N-CA 123.047 0.539 . . . . 0.0 110.166 174.659 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.527 HD22 ' HB ' ' A' ' 11' ' ' VAL . 3.5 mm? -62.18 -30.12 70.84 Favored 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 125.107 1.363 . . . . 0.0 114.328 176.015 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.727 ' HA ' ' HA2' ' A' ' 38' ' ' GLY . 2.8 p -68.54 -30.84 69.72 Favored 'General case' 0 N--CA 1.488 1.448 0 N-CA-C 116.424 2.009 . . . . 0.0 116.424 170.472 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -58.63 -25.46 62.71 Favored 'General case' 0 N--CA 1.475 0.82 0 O-C-N 124.654 1.221 . . . . 0.0 112.868 177.16 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.43 HG23 HG11 ' A' ' 11' ' ' VAL . 98.4 t -69.17 -31.7 51.04 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.077 0 C-N-CA 126.592 1.957 . . . . 0.0 112.597 175.408 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 109.8 -51.14 0.72 Allowed Glycine 0 CA--C 1.542 1.738 0 N-CA-C 111.178 -0.769 . . . . 0.0 111.178 -175.24 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 16.3 p -61.66 -4.28 1.37 Allowed 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 114.574 1.324 . . . . 0.0 114.574 174.615 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.727 ' HA2' ' HA ' ' A' ' 33' ' ' THR . . . 63.94 16.11 59.09 Favored Glycine 0 N--CA 1.487 2.097 0 C-N-CA 124.073 0.844 . . . . 0.0 114.62 173.886 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.511 ' HA3' ' HB3' ' A' ' 32' ' ' LEU . . . 51.8 27.33 20.03 Favored Glycine 0 CA--C 1.541 1.686 0 C-N-CA 125.408 1.48 . . . . 0.0 113.48 -163.423 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 20.8 mt -55.79 -43.16 76.54 Favored 'General case' 0 N--CA 1.477 0.908 0 N-CA-C 115.15 1.537 . . . . 0.0 115.15 -173.442 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . 0.413 ' HB2' ' HD1' ' A' ' 5' ' ' PHE . 8.8 p -60.0 -46.39 89.61 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 123.861 0.864 . . . . 0.0 113.063 173.937 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 12.0 tp -60.91 -51.3 69.88 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 124.002 0.921 . . . . 0.0 110.366 172.096 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.406 ' HG ' ' O ' ' A' ' 39' ' ' GLY . 52.1 mt -57.8 -33.06 68.17 Favored 'General case' 0 N--CA 1.476 0.84 0 N-CA-C 114.345 1.239 . . . . 0.0 114.345 -179.692 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -65.39 -48.43 72.9 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-N 115.765 -0.652 . . . . 0.0 112.529 172.697 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -64.7 -36.63 84.9 Favored 'General case' 0 N--CA 1.482 1.155 0 CA-C-O 121.892 0.853 . . . . 0.0 111.829 177.595 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.466 ' HB1' ' HA ' ' A' ' 51' ' ' ILE . . . -65.16 -15.74 62.75 Favored 'General case' 0 N--CA 1.476 0.843 0 N-CA-C 116.107 1.891 . . . . 0.0 116.107 179.071 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -51.77 -42.81 53.51 Favored Glycine 0 CA--C 1.544 1.87 0 C-N-CA 124.725 1.155 . . . . 0.0 112.988 177.914 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 44.9 ttp180 -49.58 -49.89 44.68 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 125.123 1.369 . . . . 0.0 113.817 -174.158 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.404 ' HB3' ' HD1' ' A' ' 54' ' ' TYR . 29.1 tt0 -129.64 36.06 4.13 Favored 'General case' 0 CA--C 1.547 0.849 0 N-CA-C 113.605 0.965 . . . . 0.0 113.605 -174.518 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 96.0 p 50.31 123.68 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.372 0 C-N-CA 126.527 1.931 . . . . 0.0 113.877 -175.524 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.466 ' HA ' ' HB1' ' A' ' 46' ' ' ALA 0.274 3.9 tp -35.23 -63.99 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.545 0.779 0 N-CA-C 117.547 2.425 . . . . 0.0 117.547 -170.134 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 16.0 ttpp -52.52 -58.49 6.6 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 123.387 0.675 . . . . 0.0 112.791 177.359 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -64.05 -38.37 90.83 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 124.518 1.127 . . . . 0.0 113.485 -178.147 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . 0.404 ' HD1' ' HB3' ' A' ' 49' ' ' GLU . 72.8 t80 -51.9 -65.6 0.53 Allowed 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 126.056 1.742 . . . . 0.0 109.625 175.441 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 48.1 mt -64.36 -37.27 86.93 Favored 'General case' 0 N--CA 1.474 0.765 0 N-CA-C 114.33 1.233 . . . . 0.0 114.33 -177.8 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.612 ' HA ' HG13 ' A' ' 19' ' ' VAL . 9.0 tmtm? -57.58 -48.86 78.21 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 114.594 -1.185 . . . . 0.0 112.598 178.602 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 41.2 tttm -77.88 -49.83 13.44 Favored 'General case' 0 N--CA 1.476 0.854 0 CA-C-N 115.18 -0.918 . . . . 0.0 112.601 175.171 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . 0.442 ' O ' ' HB2' ' A' ' 62' ' ' LYS . 39.5 tt0 -58.25 -49.2 77.93 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-O 118.523 -0.751 . . . . 0.0 110.53 -173.164 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.741 HG23 HG21 ' A' ' 67' ' ' VAL . 2.8 mm -75.89 -25.53 17.22 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.893 0 CA-C-O 119.18 -0.438 . . . . 0.0 111.902 -176.503 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.567 ' HB2' ' O ' ' A' ' 56' ' ' LYS . 0.9 OUTLIER -61.38 -34.03 74.65 Favored 'General case' 0 CA--C 1.546 0.796 0 O-C-N 124.56 1.162 . . . . 0.0 113.812 171.867 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -86.26 -43.34 13.02 Favored 'General case' 0 N--CA 1.481 1.098 0 CA-C-N 113.094 -1.866 . . . . 0.0 112.228 179.02 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.442 ' HB2' ' O ' ' A' ' 58' ' ' GLU . 22.8 tttm -67.06 -51.06 59.17 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 127.507 2.323 . . . . 0.0 112.34 -173.742 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 102.42 108.38 3.2 Favored Glycine 0 N--CA 1.476 1.325 0 N-CA-C 109.621 -1.392 . . . . 0.0 109.621 -173.048 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.622 ' HB3' HD13 ' A' ' 16' ' ' LEU . 10.9 mptt -40.04 -43.57 1.6 Allowed 'General case' 0 N--CA 1.487 1.375 0 N-CA-C 117.558 2.429 . . . . 0.0 117.558 -175.171 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.446 ' O ' ' HB ' ' A' ' 68' ' ' ILE . 11.2 mmp_? -57.4 -43.39 83.66 Favored 'General case' 0 N--CA 1.478 0.931 0 N-CA-C 116.003 1.853 . . . . 0.0 116.003 178.749 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -67.65 -27.7 67.09 Favored 'General case' 0 N--CA 1.482 1.157 0 CA-C-N 114.15 -1.386 . . . . 0.0 113.209 173.104 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.741 HG21 HG23 ' A' ' 59' ' ' ILE . 78.8 t -70.92 -33.18 51.06 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.048 0 C-N-CA 123.337 0.655 . . . . 0.0 111.972 177.794 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.446 ' HB ' ' O ' ' A' ' 65' ' ' ARG . 14.1 mm -51.07 -44.38 28.23 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.022 0 C-N-CA 123.805 0.842 . . . . 0.0 110.894 166.831 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -71.96 -48.61 43.93 Favored 'General case' 0 N--CA 1.478 0.957 0 O-C-N 124.263 0.977 . . . . 0.0 112.697 176.727 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' TRP . . . . . 0.421 ' O ' ' HB2' ' A' ' 4' ' ' GLU . 40.6 t90 . . . . . 0 N--CA 1.48 1.041 0 C-N-CA 126.045 1.738 . . . . 0.0 113.519 -178.469 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.605 ' HE3' HD13 ' A' ' 7' ' ' ILE . 67.2 mtp . . . . . 0 N--CA 1.479 1.013 0 N-CA-C 112.615 0.598 . . . . 0.0 112.615 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . 0.531 ' HA ' ' O ' ' A' ' 7' ' ' ILE . . . -53.67 -52.53 59.68 Favored 'General case' 0 CA--C 1.542 0.653 0 O-C-N 124.658 1.224 . . . . 0.0 112.691 172.407 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 39.7 ttmt -73.76 -55.32 6.37 Favored 'General case' 0 N--CA 1.472 0.675 0 CA-C-N 112.617 -2.083 . . . . 0.0 114.765 -175.637 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -74.86 -35.83 62.33 Favored 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 114.804 1.409 . . . . 0.0 114.804 -170.154 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . 0.533 ' HB2' HD12 ' A' ' 7' ' ' ILE . 61.1 m-85 -113.89 -23.23 9.73 Favored 'General case' 0 N--CA 1.48 1.045 0 N-CA-C 116.92 2.192 . . . . 0.0 116.92 -170.999 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 87.23 59.12 1.79 Allowed Glycine 0 N--CA 1.488 2.121 0 O-C-N 125.151 1.532 . . . . 0.0 111.878 -176.472 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.605 HD13 ' HE3' ' A' ' 1' ' ' MET . 1.0 OUTLIER -119.07 139.74 27.81 Favored Pre-proline 0 N--CA 1.48 1.031 0 C-N-CA 125.061 1.344 . . . . 0.0 110.412 178.85 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_endo -83.2 151.86 13.93 Favored 'Trans proline' 0 N--CA 1.455 -0.757 0 N-CA-C 108.714 -1.302 . . . . 0.0 108.714 162.978 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -42.76 -38.28 2.05 Favored 'General case' 0 N--CA 1.471 0.597 0 N-CA-C 116.403 2.001 . . . . 0.0 116.403 -179.629 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -30.62 -59.26 0.2 Allowed 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 127.081 2.153 . . . . 0.0 113.99 168.594 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.894 HG12 HG22 ' A' ' 31' ' ' ILE . 17.2 m -87.98 -31.01 5.61 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.668 0 N-CA-C 114.627 1.344 . . . . 0.0 114.627 -170.903 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -67.3 -29.27 68.81 Favored 'General case' 0 CA--C 1.549 0.927 0 CA-C-N 116.302 -0.408 . . . . 0.0 112.092 169.757 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . 0.523 ' HA2' HD12 ' A' ' 16' ' ' LEU . . . -67.56 -41.81 89.42 Favored Glycine 0 CA--C 1.545 1.908 0 C-N-CA 125.368 1.461 . . . . 0.0 112.936 171.209 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.529 HG22 HG13 ' A' ' 28' ' ' ILE . 8.6 m -65.84 -35.87 81.87 Favored 'General case' 0 N--CA 1.475 0.778 0 N-CA-C 113.046 0.758 . . . . 0.0 113.046 173.503 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.673 HG23 HD21 ' A' ' 32' ' ' LEU . 2.3 t -49.24 -38.48 11.75 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.066 0 C-N-CA 124.47 1.108 . . . . 0.0 113.599 166.126 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.643 HD22 ' HG3' ' A' ' 64' ' ' LYS . 84.6 mt -61.0 -38.12 84.91 Favored 'General case' 0 N--CA 1.475 0.822 0 N-CA-C 113.602 0.964 . . . . 0.0 113.602 178.648 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 35.2 t-20 -52.23 -42.72 63.83 Favored 'General case' 0 CA--C 1.547 0.838 0 O-C-N 124.0 0.813 . . . . 0.0 111.421 172.983 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.409 HG23 HD13 ' A' ' 28' ' ' ILE . 1.0 OUTLIER -60.43 -56.3 18.61 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.816 0 CA-C-N 115.046 -0.979 . . . . 0.0 113.045 173.14 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.779 HG13 ' HA ' ' A' ' 56' ' ' LYS . 5.5 t -58.96 -49.69 82.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 124.026 0.829 . . . . 0.0 112.698 -177.53 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . 0.443 ' OE1' ' HB3' ' A' ' 16' ' ' LEU . 24.5 mt-10 -72.35 -42.4 65.38 Favored 'General case' 0 N--CA 1.473 0.696 0 N-CA-C 116.57 2.063 . . . . 0.0 116.57 -175.236 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -103.92 -25.87 12.88 Favored 'General case' 0 N--CA 1.481 1.125 0 N-CA-C 115.231 1.567 . . . . 0.0 115.231 -173.022 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 77.4 41.23 21.36 Favored Glycine 0 CA--C 1.541 1.699 0 N-CA-C 110.467 -1.053 . . . . 0.0 110.467 -165.71 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -76.44 173.86 54.01 Favored Glycine 0 CA--C 1.535 1.316 0 C-N-CA 124.914 1.245 . . . . 0.0 112.689 -173.439 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 3.6 m-90 -69.16 101.79 1.53 Allowed 'General case' 0 N--CA 1.473 0.72 0 CA-C-O 123.341 1.544 . . . . 0.0 110.93 -178.92 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 9.8 p -48.51 -29.44 2.53 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.821 0 CA-C-N 112.658 -2.064 . . . . 0.0 114.86 172.736 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 11.1 t -60.04 -46.62 88.93 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 123.73 0.812 . . . . 0.0 112.929 179.745 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.536 ' O ' HG12 ' A' ' 31' ' ' ILE . 2.0 m -60.09 -48.13 82.98 Favored 'General case' 0 N--CA 1.481 1.08 0 CA-C-N 114.144 -1.389 . . . . 0.0 109.992 175.913 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.529 HG13 HG22 ' A' ' 14' ' ' THR . 1.8 mp -58.32 -53.03 51.81 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.023 0 C-N-CA 123.912 0.885 . . . . 0.0 110.771 179.301 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 65.5 t -53.98 -47.81 64.62 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.744 0 CA-C-O 118.118 -0.944 . . . . 0.0 111.474 177.551 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 20.9 m -61.04 -36.91 80.83 Favored 'General case' 0 N--CA 1.481 1.119 0 N-CA-C 114.446 1.276 . . . . 0.0 114.446 178.672 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.894 HG22 HG12 ' A' ' 11' ' ' VAL . 42.2 mm -72.98 -42.44 59.77 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.93 0 C-N-CA 124.246 1.018 . . . . 0.0 109.463 178.88 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.673 HD21 HG23 ' A' ' 15' ' ' VAL . 4.2 mm? -57.83 -53.06 62.48 Favored 'General case' 0 N--CA 1.484 1.259 0 C-N-CA 125.097 1.359 . . . . 0.0 112.897 173.796 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -65.57 -28.11 68.91 Favored 'General case' 0 N--CA 1.481 1.104 0 N-CA-C 115.406 1.632 . . . . 0.0 115.406 178.329 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -52.37 -32.0 36.48 Favored 'General case' 0 N--CA 1.486 1.358 0 N-CA-C 113.907 1.077 . . . . 0.0 113.907 171.949 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 50.7 t -70.26 -28.04 34.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 C-N-CA 126.169 1.788 . . . . 0.0 112.41 173.816 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 105.58 -106.37 2.62 Favored Glycine 0 CA--C 1.532 1.125 0 C-N-CA 124.851 1.215 . . . . 0.0 110.678 179.344 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 8.9 p -60.64 -39.65 89.1 Favored 'General case' 0 N--CA 1.472 0.654 0 CA-C-N 113.431 -1.384 . . . . 0.0 114.116 -177.93 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -51.42 -45.08 53.49 Favored Glycine 0 CA--C 1.542 1.744 0 O-C-N 124.354 1.033 . . . . 0.0 113.8 177.232 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.5 ' HA2' ' HB3' ' A' ' 32' ' ' LEU . . . -59.53 -58.48 14.13 Favored Glycine 0 N--CA 1.482 1.765 0 N-CA-C 111.435 -0.666 . . . . 0.0 111.435 173.836 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 72.0 mt -57.54 -45.6 84.88 Favored 'General case' 0 N--CA 1.476 0.861 0 N-CA-C 115.937 1.828 . . . . 0.0 115.937 -176.297 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 79.5 p -62.54 -42.36 99.47 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-N 115.384 -0.825 . . . . 0.0 112.938 176.148 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 11.9 tp -63.59 -43.42 96.98 Favored 'General case' 0 N--CA 1.474 0.762 0 N-CA-C 110.026 -0.361 . . . . 0.0 110.026 175.731 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 94.7 mt -62.95 -35.97 81.91 Favored 'General case' 0 N--CA 1.475 0.784 0 N-CA-C 114.414 1.265 . . . . 0.0 114.414 -179.808 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -69.68 -40.69 76.24 Favored 'General case' 0 N--CA 1.473 0.691 0 O-C-N 123.83 0.706 . . . . 0.0 112.782 174.176 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -68.57 -36.17 78.39 Favored 'General case' 0 N--CA 1.475 0.817 0 CA-C-O 121.286 0.565 . . . . 0.0 112.128 177.508 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -53.95 -21.76 8.71 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 126.58 1.952 . . . . 0.0 115.587 173.197 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -50.01 -32.89 20.42 Favored Glycine 0 N--CA 1.478 1.49 0 C-N-CA 125.144 1.354 . . . . 0.0 114.007 178.936 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 68.0 ttp85 -55.36 -55.32 32.9 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 124.918 1.287 . . . . 0.0 113.33 178.573 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 8.2 tt0 -133.29 34.79 3.5 Favored 'General case' 0 CA--C 1.548 0.869 0 N-CA-C 114.803 1.408 . . . . 0.0 114.803 -173.931 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 32.8 t 44.31 127.09 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.041 0 N-CA-C 114.147 1.165 . . . . 0.0 114.147 -172.646 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . 0.266 8.8 tp -30.47 -57.28 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 N-CA-C 119.036 2.976 . . . . 0.0 119.036 -169.812 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 81.9 tttt -60.99 -56.0 26.25 Favored 'General case' 0 N--CA 1.478 0.927 0 N-CA-C 112.065 0.394 . . . . 0.0 112.065 -179.477 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -61.16 -38.44 86.44 Favored 'General case' 0 N--CA 1.486 1.363 0 C-N-CA 123.94 0.896 . . . . 0.0 113.203 177.603 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 89.9 t80 -52.41 -60.24 3.47 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 125.618 1.567 . . . . 0.0 112.253 175.479 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 64.5 mt -65.9 -38.88 89.89 Favored 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 114.053 1.131 . . . . 0.0 114.053 -179.929 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.779 ' HA ' HG13 ' A' ' 19' ' ' VAL . 30.9 mttm -53.81 -54.04 43.92 Favored 'General case' 0 N--CA 1.48 1.039 0 CA-C-N 114.029 -1.441 . . . . 0.0 113.377 178.482 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 55.2 tttp -68.93 -47.23 66.23 Favored 'General case' 0 CA--C 1.541 0.621 0 CA-C-N 115.294 -0.866 . . . . 0.0 112.537 176.981 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . 0.467 ' O ' ' HB2' ' A' ' 62' ' ' LYS . 66.8 mt-10 -56.61 -51.66 67.8 Favored 'General case' 0 N--CA 1.477 0.898 0 N-CA-C 112.26 0.467 . . . . 0.0 112.26 -175.351 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.468 ' HA ' ' HB2' ' A' ' 62' ' ' LYS . 6.3 mm -81.02 -20.61 11.21 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.258 0 N-CA-C 112.99 0.737 . . . . 0.0 112.99 -176.218 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.413 ' HB2' ' O ' ' A' ' 56' ' ' LYS . 10.2 tppt? -62.44 -34.02 75.95 Favored 'General case' 0 CA--C 1.542 0.657 0 CA-C-O 121.985 0.898 . . . . 0.0 112.865 170.234 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 93.0 mttt -84.95 -44.67 12.91 Favored 'General case' 0 CA--C 1.546 0.806 0 CA-C-N 112.814 -1.994 . . . . 0.0 113.556 175.507 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.468 ' HB2' ' HA ' ' A' ' 59' ' ' ILE . 0.2 OUTLIER -65.06 -45.04 86.98 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-N 113.529 -1.669 . . . . 0.0 115.329 -172.929 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 85.91 111.72 0.79 Allowed Glycine 0 N--CA 1.47 0.949 0 N-CA-C 108.356 -1.898 . . . . 0.0 108.356 -172.964 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.866 ' H ' ' HD2' ' A' ' 64' ' ' LYS . 9.9 mptt -23.41 -46.53 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.437 0 N-CA-C 119.516 3.154 . . . . 0.0 119.516 -174.829 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . 0.284 8.9 ttt180 -48.92 -44.22 40.14 Favored 'General case' 0 N--CA 1.471 0.618 0 N-CA-C 115.365 1.617 . . . . 0.0 115.365 173.052 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -58.74 -31.25 68.15 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 116.243 -1.837 . . . . 0.0 113.124 174.575 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.523 HG12 ' O ' ' A' ' 64' ' ' LYS . 0.5 OUTLIER -64.06 -41.84 93.76 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.259 0 CA-C-N 119.393 0.997 . . . . 0.0 111.573 178.766 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 35.8 mm -57.82 -39.06 69.16 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.887 0 CA-C-N 113.251 -1.795 . . . . 0.0 110.471 177.141 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -80.24 -49.18 11.96 Favored 'General case' 0 N--CA 1.475 0.805 0 N-CA-C 114.288 1.218 . . . . 0.0 114.288 175.05 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 24.3 t90 . . . . . 0 N--CA 1.484 1.265 0 C-N-CA 127.055 2.142 . . . . 0.0 112.708 -179.363 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.761 ' HE1' HG21 ' A' ' 15' ' ' VAL . 52.3 mtp . . . . . 0 N--CA 1.479 0.979 0 N-CA-C 113.417 0.895 . . . . 0.0 113.417 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -61.31 -49.27 77.68 Favored 'General case' 0 N--CA 1.474 0.757 0 CA-C-N 115.018 -0.992 . . . . 0.0 112.287 173.974 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 57.4 tttm -75.82 -60.46 2.31 Favored 'General case' 0 N--CA 1.478 0.948 0 CA-C-N 114.046 -1.434 . . . . 0.0 114.085 -176.428 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . 0.402 ' HB2' ' O ' ' A' ' 70' ' ' TRP . 2.1 mp0 -75.96 -29.07 58.16 Favored 'General case' 0 N--CA 1.474 0.744 0 N-CA-C 115.656 1.724 . . . . 0.0 115.656 -169.751 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . 0.409 ' HD1' ' HB2' ' A' ' 41' ' ' SER . 43.4 m-85 -115.11 -18.21 11.23 Favored 'General case' 0 N--CA 1.48 1.051 0 N-CA-C 117.496 2.406 . . . . 0.0 117.496 -173.243 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 72.82 40.67 51.94 Favored Glycine 0 CA--C 1.542 1.756 0 O-C-N 124.543 1.152 . . . . 0.0 112.11 -171.126 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.789 HG23 HG23 ' A' ' 11' ' ' VAL . 0.6 OUTLIER -121.91 106.23 36.89 Favored Pre-proline 0 N--CA 1.474 0.73 0 C-N-CA 124.566 1.146 . . . . 0.0 110.288 179.425 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_endo -63.93 168.23 12.5 Favored 'Trans proline' 0 CA--C 1.54 0.791 0 C-N-CA 122.567 2.178 . . . . 0.0 112.582 -172.825 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -51.34 -33.32 28.91 Favored 'General case' 0 N--CA 1.477 0.914 0 CA-C-N 113.617 -1.629 . . . . 0.0 114.212 172.493 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -49.87 -34.45 20.13 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 125.9 1.68 . . . . 0.0 114.567 176.099 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 1.084 HG12 HG22 ' A' ' 31' ' ' ILE . 30.4 m -112.0 -29.4 2.37 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.407 0 N-CA-C 114.145 1.165 . . . . 0.0 114.145 179.819 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -66.77 -37.35 84.41 Favored 'General case' 0 N--CA 1.475 0.794 0 N-CA-C 113.393 0.886 . . . . 0.0 113.393 174.791 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -61.09 -37.9 94.68 Favored Glycine 0 CA--C 1.544 1.871 0 C-N-CA 123.92 0.771 . . . . 0.0 112.287 170.62 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -70.32 -32.91 70.87 Favored 'General case' 0 N--CA 1.487 1.407 0 C-N-CA 125.051 1.34 . . . . 0.0 113.363 179.44 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.761 HG21 ' HE1' ' A' ' 1' ' ' MET . 10.4 t -61.2 -36.11 70.47 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.255 0 C-N-CA 123.895 0.878 . . . . 0.0 111.982 169.469 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.57 HD13 ' HB3' ' A' ' 64' ' ' LYS . 48.3 mt -66.09 -37.73 86.5 Favored 'General case' 0 N--CA 1.471 0.61 0 N-CA-C 113.242 0.83 . . . . 0.0 113.242 177.423 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 11.0 t30 -55.12 -44.59 75.13 Favored 'General case' 0 N--CA 1.478 0.934 0 CA-C-N 115.341 -0.845 . . . . 0.0 111.339 172.798 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.526 ' HB ' ' O ' ' A' ' 15' ' ' VAL . 12.8 t -50.64 -52.56 15.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 C-N-CA 124.642 1.177 . . . . 0.0 112.182 171.67 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.758 HG13 ' HA ' ' A' ' 56' ' ' LYS . 11.4 t -61.91 -52.66 57.88 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.191 0 C-N-CA 124.568 1.147 . . . . 0.0 111.479 -178.452 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 10.1 mt-10 -54.82 -44.04 73.51 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 125.692 1.597 . . . . 0.0 115.057 -178.401 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -93.17 -17.1 24.13 Favored 'General case' 0 CA--C 1.546 0.822 0 N-CA-C 115.701 1.741 . . . . 0.0 115.701 -175.376 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 68.39 40.96 86.69 Favored Glycine 0 CA--C 1.544 1.889 0 N-CA-C 110.438 -1.065 . . . . 0.0 110.438 -165.489 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -100.46 164.11 18.95 Favored Glycine 0 CA--C 1.537 1.428 0 C-N-CA 124.827 1.203 . . . . 0.0 114.145 -167.259 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 5.8 m-90 -67.69 104.53 1.66 Allowed 'General case' 0 C--O 1.24 0.583 0 CA-C-O 122.577 1.179 . . . . 0.0 113.831 -175.341 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.46 HG11 HG13 ' A' ' 51' ' ' ILE . 5.5 p -55.59 -25.13 17.43 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.825 0 CA-C-N 113.369 -1.741 . . . . 0.0 113.847 169.191 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 1.7 t -60.51 -40.33 91.04 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 114.305 1.224 . . . . 0.0 114.305 179.727 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 1.9 m -68.54 -39.1 81.26 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 122.928 0.491 . . . . 0.0 110.653 175.811 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 2.8 mp -72.23 -31.07 37.9 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.077 0 C-N-CA 124.854 1.262 . . . . 0.0 112.576 177.9 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.447 HG23 ' O ' ' A' ' 25' ' ' VAL . 55.6 t -55.54 -36.42 41.74 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.826 0 C-N-CA 123.104 0.562 . . . . 0.0 112.201 171.737 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 29.8 p -60.98 -26.15 67.37 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 114.813 1.412 . . . . 0.0 114.813 173.788 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 1.084 HG22 HG12 ' A' ' 11' ' ' VAL . 34.7 mm -85.01 -37.84 12.69 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.914 0 C-N-CA 123.901 0.88 . . . . 0.0 109.85 176.493 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.59 HD22 ' HB ' ' A' ' 11' ' ' VAL . 4.3 mm? -60.54 -34.49 74.21 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 124.835 1.254 . . . . 0.0 112.255 172.636 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.48 ' HA ' ' HA2' ' A' ' 38' ' ' GLY . 9.1 p -75.2 -36.24 61.43 Favored 'General case' 0 N--CA 1.474 0.775 0 N-CA-C 115.413 1.634 . . . . 0.0 115.413 174.057 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -52.88 -25.24 11.04 Favored 'General case' 0 N--CA 1.482 1.155 0 O-C-N 124.64 1.212 . . . . 0.0 114.183 172.236 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 93.0 t -60.82 -31.38 49.36 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.133 0 C-N-CA 126.32 1.848 . . . . 0.0 113.238 171.225 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 112.58 -53.68 0.58 Allowed Glycine 0 CA--C 1.541 1.688 0 N-CA-C 112.093 -0.403 . . . . 0.0 112.093 -179.209 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 9.8 p -66.58 15.59 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.564 0 C-N-CA 125.572 1.549 . . . . 0.0 114.968 174.555 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.48 ' HA2' ' HA ' ' A' ' 33' ' ' THR . . . 54.28 15.9 6.05 Favored Glycine 0 N--CA 1.486 2.025 0 C-N-CA 126.266 1.888 . . . . 0.0 116.548 174.835 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.508 ' HA3' ' HB3' ' A' ' 32' ' ' LEU . . . 53.5 16.35 5.07 Favored Glycine 0 N--CA 1.487 2.069 0 C-N-CA 124.323 0.964 . . . . 0.0 113.461 -163.118 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 9.7 mt -54.6 -46.83 73.88 Favored 'General case' 0 N--CA 1.481 1.106 0 N-CA-C 116.563 2.06 . . . . 0.0 116.563 -168.501 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . 0.409 ' HB2' ' HD1' ' A' ' 5' ' ' PHE . 11.6 p -60.11 -44.83 94.56 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 114.823 -1.08 . . . . 0.0 113.397 177.636 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 10.8 tp -63.09 -50.31 71.04 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 123.887 0.875 . . . . 0.0 110.287 171.923 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 82.9 mt -60.77 -28.64 68.88 Favored 'General case' 0 N--CA 1.477 0.887 0 N-CA-C 114.875 1.435 . . . . 0.0 114.875 -177.23 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -67.3 -47.64 69.99 Favored 'General case' 0 N--CA 1.474 0.736 0 O-C-N 123.805 0.691 . . . . 0.0 112.798 170.785 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -62.46 -33.61 75.18 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 123.375 0.67 . . . . 0.0 112.44 179.247 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -57.18 -23.75 49.75 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 126.885 2.074 . . . . 0.0 115.546 174.655 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -52.11 -35.03 40.64 Favored Glycine 0 CA--C 1.538 1.486 0 C-N-CA 125.068 1.318 . . . . 0.0 113.91 -177.904 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 40.0 ttp180 -51.57 -53.51 37.33 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 125.0 1.32 . . . . 0.0 112.958 -176.233 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 20.6 tt0 -128.76 36.8 4.18 Favored 'General case' 0 N--CA 1.478 0.963 0 CA-C-N 115.166 -0.924 . . . . 0.0 113.153 -176.247 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 8.0 t 43.36 128.4 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 125.68 1.592 . . . . 0.0 114.474 -172.07 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.46 HG13 HG11 ' A' ' 25' ' ' VAL . 8.0 tp -32.25 -52.47 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.258 0 N-CA-C 118.156 2.65 . . . . 0.0 118.156 -171.161 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 2.3 ttmt -60.37 -67.46 0.39 Allowed 'General case' 0 N--CA 1.472 0.631 0 N-CA-C 114.461 1.282 . . . . 0.0 114.461 178.441 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -56.62 -34.64 67.46 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 124.276 1.03 . . . . 0.0 113.667 177.817 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 66.7 t80 -50.86 -62.27 1.71 Allowed 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 124.875 1.27 . . . . 0.0 110.589 174.541 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.62 HD13 HG13 ' A' ' 15' ' ' VAL . 60.7 mt -65.26 -37.91 88.66 Favored 'General case' 0 N--CA 1.475 0.783 0 N-CA-C 115.001 1.482 . . . . 0.0 115.001 -176.123 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.758 ' HA ' HG13 ' A' ' 19' ' ' VAL . 93.9 mttt -61.94 -37.15 83.62 Favored 'General case' 0 N--CA 1.473 0.7 0 CA-C-N 113.445 -1.707 . . . . 0.0 114.732 178.523 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.469 ' HE3' ' HE3' ' A' ' 61' ' ' LYS . 80.2 tttt -85.64 -52.55 5.73 Favored 'General case' 0 CA--C 1.535 0.395 0 O-C-N 124.514 1.134 . . . . 0.0 111.241 173.03 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . 0.415 ' O ' ' HB2' ' A' ' 62' ' ' LYS . 29.0 tt0 -55.19 -51.08 67.67 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-O 118.687 -0.673 . . . . 0.0 111.771 -173.014 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.71 HG23 HG21 ' A' ' 67' ' ' VAL . 3.7 mm -75.96 -27.1 17.99 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.281 0 N-CA-C 112.769 0.655 . . . . 0.0 112.769 -173.64 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.457 ' HB2' ' O ' ' A' ' 56' ' ' LYS . 14.9 tttp -60.28 -36.32 77.56 Favored 'General case' 0 CA--C 1.544 0.749 0 CA-C-O 122.643 1.211 . . . . 0.0 113.496 174.02 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.469 ' HE3' ' HE3' ' A' ' 57' ' ' LYS . 9.7 mttm -85.01 -33.17 22.6 Favored 'General case' 0 N--CA 1.474 0.757 0 CA-C-N 112.023 -2.353 . . . . 0.0 112.236 -179.412 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.415 ' HB2' ' O ' ' A' ' 58' ' ' GLU . 66.8 tttt -85.33 -60.13 2.12 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-N 112.744 -2.026 . . . . 0.0 111.561 -168.484 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . 0.46 ' O ' HG23 ' A' ' 67' ' ' VAL . . . 113.11 126.03 4.45 Favored Glycine 0 CA--C 1.532 1.122 0 N-CA-C 110.08 -1.208 . . . . 0.0 110.08 -172.297 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.57 ' HB3' HD13 ' A' ' 16' ' ' LEU . 0.0 OUTLIER -59.4 -42.04 90.81 Favored 'General case' 0 N--CA 1.482 1.135 0 N-CA-C 115.59 1.7 . . . . 0.0 115.59 -173.128 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -58.13 -47.3 83.73 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 125.251 1.42 . . . . 0.0 113.648 179.353 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -62.94 -32.05 73.28 Favored 'General case' 0 N--CA 1.475 0.777 0 CA-C-N 114.534 -1.212 . . . . 0.0 113.769 173.002 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.71 HG21 HG23 ' A' ' 59' ' ' ILE . 48.5 t -68.8 -35.97 72.07 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.989 0 C-N-CA 122.872 0.469 . . . . 0.0 111.179 179.497 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 18.0 mt -53.42 -48.5 57.08 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.01 0 C-N-CA 124.267 1.027 . . . . 0.0 109.722 169.385 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -67.08 -47.49 71.1 Favored 'General case' 0 N--CA 1.477 0.907 0 CA-C-N 115.581 -0.736 . . . . 0.0 112.901 178.808 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' TRP . . . . . 0.402 ' O ' ' HB2' ' A' ' 4' ' ' GLU . 43.0 t90 . . . . . 0 N--CA 1.477 0.891 0 C-N-CA 125.78 1.632 . . . . 0.0 112.22 -179.512 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.497 ' HB3' HG21 ' A' ' 7' ' ' ILE . 76.6 mtp . . . . . 0 C--O 1.238 0.487 0 N-CA-C 113.039 0.755 . . . . 0.0 113.039 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . 0.436 ' HA ' ' O ' ' A' ' 7' ' ' ILE . . . -55.78 -54.13 48.14 Favored 'General case' 0 N--CA 1.475 0.814 0 CA-C-N 114.988 -1.005 . . . . 0.0 111.649 172.882 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 51.1 tttp -72.86 -61.02 1.96 Allowed 'General case' 0 N--CA 1.481 1.08 0 CA-C-N 113.952 -1.476 . . . . 0.0 113.982 -174.246 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -71.0 -37.25 72.66 Favored 'General case' 0 N--CA 1.475 0.815 0 N-CA-C 115.48 1.659 . . . . 0.0 115.48 -171.388 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . 0.422 ' HD2' ' HA ' ' A' ' 1' ' ' MET . 52.1 m-85 -107.95 -15.92 14.42 Favored 'General case' 0 N--CA 1.477 0.885 0 N-CA-C 116.532 2.049 . . . . 0.0 116.532 -172.063 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 79.65 54.25 4.02 Favored Glycine 0 CA--C 1.541 1.701 0 CA-C-O 122.311 0.95 . . . . 0.0 112.508 -176.023 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.497 HG21 ' HB3' ' A' ' 1' ' ' MET . 0.5 OUTLIER -112.73 147.99 38.34 Favored Pre-proline 0 N--CA 1.482 1.128 0 CA-C-N 113.526 -1.337 . . . . 0.0 111.645 -178.839 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 91.0 Cg_endo -86.06 153.39 9.69 Favored 'Trans proline' 0 CA--C 1.538 0.723 0 C-N-CA 121.685 1.59 . . . . 0.0 109.365 163.309 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -49.7 -33.67 16.55 Favored 'General case' 0 N--CA 1.47 0.574 0 N-CA-C 114.966 1.469 . . . . 0.0 114.966 176.346 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -39.08 -43.73 1.06 Allowed 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 127.792 2.437 . . . . 0.0 115.174 171.626 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.981 HG12 HG22 ' A' ' 31' ' ' ILE . 20.0 m -102.31 -29.09 3.04 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.914 0 N-CA-C 114.269 1.211 . . . . 0.0 114.269 -173.626 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -67.48 -30.65 70.41 Favored 'General case' 0 N--CA 1.489 1.483 0 CA-C-N 115.727 -0.67 . . . . 0.0 112.197 171.526 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . 0.446 ' O ' ' HB2' ' A' ' 16' ' ' LEU . . . -63.57 -43.05 98.6 Favored Glycine 0 CA--C 1.553 2.44 0 C-N-CA 124.278 0.942 . . . . 0.0 112.625 168.814 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.806 HG22 HG13 ' A' ' 28' ' ' ILE . 3.9 m -62.78 -37.49 86.87 Favored 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 113.371 0.878 . . . . 0.0 113.371 176.792 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.463 HG21 ' HE1' ' A' ' 1' ' ' MET . 2.4 t -50.52 -37.73 15.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 C-N-CA 124.155 0.982 . . . . 0.0 113.337 168.254 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.716 HD22 ' HG3' ' A' ' 64' ' ' LYS . 84.8 mt -61.98 -37.28 84.22 Favored 'General case' 0 N--CA 1.479 0.996 0 N-CA-C 113.989 1.107 . . . . 0.0 113.989 177.446 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 14.6 t-20 -53.99 -47.06 71.82 Favored 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 123.223 0.609 . . . . 0.0 110.864 173.417 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 3.1 t -52.01 -56.26 6.87 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.256 0 CA-C-N 114.996 -1.002 . . . . 0.0 112.67 170.556 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.754 HG13 ' HA ' ' A' ' 56' ' ' LYS . 3.8 t -60.11 -51.17 76.04 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 O-C-N 124.549 1.156 . . . . 0.0 111.523 -176.307 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -66.49 -44.37 82.83 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 126.166 1.786 . . . . 0.0 115.705 -175.636 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -101.59 -12.41 18.49 Favored 'General case' 0 CA--C 1.548 0.891 0 N-CA-C 115.413 1.635 . . . . 0.0 115.413 -170.492 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.424 ' HA2' ' HE2' ' A' ' 56' ' ' LYS . . . 66.69 41.53 93.79 Favored Glycine 0 N--CA 1.482 1.762 0 N-CA-C 110.137 -1.185 . . . . 0.0 110.137 -161.734 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -74.53 158.92 51.98 Favored Glycine 0 N--CA 1.471 0.984 0 C-N-CA 125.151 1.358 . . . . 0.0 114.266 -169.3 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 88.7 m95 -61.68 102.99 0.29 Allowed 'General case' 0 N--CA 1.473 0.724 0 CA-C-N 113.277 -1.462 . . . . 0.0 111.785 175.538 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.564 HG21 HG13 ' A' ' 51' ' ' ILE . 2.7 p -54.49 -24.19 12.25 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.625 0 CA-C-N 114.279 -1.328 . . . . 0.0 114.58 175.331 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 3.6 t -60.29 -44.24 95.55 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 124.261 1.024 . . . . 0.0 113.632 -179.915 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.566 ' O ' HG12 ' A' ' 31' ' ' ILE . 0.8 OUTLIER -65.68 -46.34 79.43 Favored 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 123.799 0.84 . . . . 0.0 110.212 176.49 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.806 HG13 HG22 ' A' ' 14' ' ' THR . 2.0 mp -58.98 -51.49 71.87 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.979 0 C-N-CA 124.438 1.095 . . . . 0.0 111.622 177.375 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 50.6 t -53.11 -48.73 53.07 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.826 0 CA-C-O 117.037 -1.459 . . . . 0.0 111.556 176.59 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . 0.284 1.5 p -61.99 -29.85 70.54 Favored 'General case' 0 N--CA 1.479 1.016 0 N-CA-C 115.438 1.644 . . . . 0.0 115.438 179.712 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.981 HG22 HG12 ' A' ' 11' ' ' VAL . 21.2 mm -76.65 -43.26 34.51 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.006 0 C-N-CA 124.174 0.99 . . . . 0.0 110.115 176.38 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.63 HD22 ' HB ' ' A' ' 11' ' ' VAL . 4.2 mm? -55.52 -56.02 25.06 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 124.951 1.3 . . . . 0.0 112.427 172.796 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 3.1 p -64.0 -30.88 71.92 Favored 'General case' 0 N--CA 1.475 0.814 0 N-CA-C 114.825 1.417 . . . . 0.0 114.825 177.599 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -53.31 -25.41 14.74 Favored 'General case' 0 N--CA 1.482 1.134 0 N-CA-C 114.649 1.351 . . . . 0.0 114.649 172.355 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 61.7 t -74.13 -29.08 24.36 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.356 0 C-N-CA 124.547 1.139 . . . . 0.0 111.574 172.669 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 108.78 -116.97 4.83 Favored Glycine 0 N--CA 1.47 0.963 0 C-N-CA 125.0 1.286 . . . . 0.0 111.022 -176.421 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 33.8 p -54.72 -40.22 69.02 Favored 'General case' 0 N--CA 1.485 1.314 0 CA-C-N 113.487 -1.357 . . . . 0.0 114.494 -178.643 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -51.72 -46.2 54.32 Favored Glycine 0 CA--C 1.54 1.616 0 C-N-CA 124.851 1.215 . . . . 0.0 113.608 179.324 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.468 ' HA2' ' HB3' ' A' ' 32' ' ' LEU . . . -57.11 -54.96 32.94 Favored Glycine 0 N--CA 1.479 1.507 0 CA-C-N 115.034 -0.583 . . . . 0.0 111.76 174.129 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 78.4 mt -60.25 -41.65 93.65 Favored 'General case' 0 N--CA 1.482 1.142 0 N-CA-C 115.434 1.642 . . . . 0.0 115.434 -177.754 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 42.7 p -63.69 -43.28 97.1 Favored 'General case' 0 N--CA 1.476 0.863 0 N-CA-C 113.294 0.85 . . . . 0.0 113.294 174.922 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 12.4 tp -61.7 -46.8 88.13 Favored 'General case' 0 N--CA 1.474 0.741 0 CA-C-O 121.22 0.534 . . . . 0.0 110.435 174.002 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 94.8 mt -59.96 -39.15 84.64 Favored 'General case' 0 N--CA 1.482 1.153 0 CA-C-N 114.457 -1.247 . . . . 0.0 114.328 179.983 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -61.93 -44.94 95.73 Favored 'General case' 0 N--CA 1.477 0.911 0 N-CA-C 112.362 0.504 . . . . 0.0 112.362 173.289 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -65.96 -33.29 75.47 Favored 'General case' 0 N--CA 1.479 0.992 0 N-CA-C 113.564 0.95 . . . . 0.0 113.564 177.339 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -75.65 -21.56 57.57 Favored 'General case' 0 CA--C 1.543 0.698 0 N-CA-C 116.888 2.181 . . . . 0.0 116.888 179.766 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -50.99 -39.8 41.57 Favored Glycine 0 N--CA 1.474 1.185 0 O-C-N 124.308 1.005 . . . . 0.0 113.914 -173.031 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . 0.515 ' HA ' ' HD2' ' A' ' 48' ' ' ARG . 0.3 OUTLIER -59.51 -49.74 76.61 Favored 'General case' 0 CA--C 1.542 0.643 0 CA-C-N 111.239 -2.48 . . . . 0.0 115.876 -176.479 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 5.4 tt0 -114.5 28.86 8.43 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-N 115.29 -0.868 . . . . 0.0 112.982 -175.242 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 94.2 p 48.33 121.45 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 125.9 1.68 . . . . 0.0 113.373 -172.796 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.564 HG13 HG21 ' A' ' 25' ' ' VAL . 7.6 tp -41.47 -46.14 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.42 0 N-CA-C 117.298 2.332 . . . . 0.0 117.298 -173.64 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 34.6 tttm -60.36 -62.6 1.75 Allowed 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 124.582 1.153 . . . . 0.0 112.266 177.035 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -59.66 -38.7 82.17 Favored 'General case' 0 N--CA 1.48 1.044 0 N-CA-C 113.96 1.096 . . . . 0.0 113.96 177.598 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 84.3 t80 -49.84 -62.11 1.75 Allowed 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 125.432 1.493 . . . . 0.0 111.071 177.343 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.41 HD22 HG13 ' A' ' 15' ' ' VAL . 45.0 mt -61.87 -38.98 90.28 Favored 'General case' 0 N--CA 1.484 1.234 0 N-CA-C 114.477 1.288 . . . . 0.0 114.477 -176.829 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.754 ' HA ' HG13 ' A' ' 19' ' ' VAL . 92.3 mttt -55.19 -54.64 40.73 Favored 'General case' 0 N--CA 1.472 0.638 0 O-C-N 124.83 1.331 . . . . 0.0 112.483 177.705 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.572 ' HG2' ' HD2' ' A' ' 61' ' ' LYS . 78.0 tttt -71.76 -45.75 60.66 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-N 114.622 -1.172 . . . . 0.0 112.575 178.452 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 7.7 mm-40 -52.55 -55.36 22.73 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 122.824 0.45 . . . . 0.0 111.087 -177.617 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 5.9 mm -80.1 -23.51 11.68 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 CA-C-N 114.652 -1.158 . . . . 0.0 112.957 -172.635 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.452 ' HB2' ' O ' ' A' ' 56' ' ' LYS . 16.7 tttp -59.08 -38.0 78.43 Favored 'General case' 0 CA--C 1.544 0.73 0 N-CA-C 114.195 1.183 . . . . 0.0 114.195 170.362 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.572 ' HD2' ' HG2' ' A' ' 57' ' ' LYS . 23.4 mtpt -86.2 -43.59 12.87 Favored 'General case' 0 N--CA 1.479 0.994 0 CA-C-N 113.681 -1.599 . . . . 0.0 111.174 -179.518 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 17.3 tttt -72.14 -40.34 68.13 Favored 'General case' 0 N--CA 1.473 0.709 0 CA-C-N 112.664 -2.062 . . . . 0.0 115.048 -173.391 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 85.49 130.22 2.34 Favored Glycine 0 CA--C 1.538 1.5 0 N-CA-C 109.743 -1.343 . . . . 0.0 109.743 -171.817 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.733 ' H ' ' HD2' ' A' ' 64' ' ' LYS . 11.9 mptt -40.7 -45.16 2.33 Favored 'General case' 0 N--CA 1.486 1.348 0 N-CA-C 116.501 2.038 . . . . 0.0 116.501 -179.496 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -53.64 -43.89 69.14 Favored 'General case' 0 N--CA 1.468 0.441 0 N-CA-C 112.174 0.435 . . . . 0.0 112.174 179.391 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -64.55 -29.73 70.76 Favored 'General case' 0 N--CA 1.48 1.044 0 CA-C-N 113.632 -1.622 . . . . 0.0 114.566 174.787 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.661 HG12 ' O ' ' A' ' 64' ' ' LYS . 1.4 p -64.57 -43.07 96.76 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.342 0 CA-C-N 119.629 1.104 . . . . 0.0 111.759 175.137 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 45.1 mm -55.86 -42.64 71.51 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.276 0 CA-C-N 114.082 -1.417 . . . . 0.0 110.023 176.148 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -72.63 -51.43 19.6 Favored 'General case' 0 N--CA 1.48 1.056 0 N-CA-C 113.951 1.093 . . . . 0.0 113.951 175.573 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 25.9 t90 . . . . . 0 N--CA 1.478 0.952 0 C-N-CA 126.752 2.021 . . . . 0.0 112.176 -178.305 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.61 ' HE3' HD13 ' A' ' 7' ' ' ILE . 53.1 mtp . . . . . 0 N--CA 1.469 0.479 0 N-CA-C 112.592 0.59 . . . . 0.0 112.592 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . 0.503 ' HA ' ' O ' ' A' ' 7' ' ' ILE . . . -56.51 -57.05 14.01 Favored 'General case' 0 N--CA 1.473 0.695 0 CA-C-N 114.823 -1.081 . . . . 0.0 112.12 175.873 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 18.6 ttpp -67.37 -49.2 64.94 Favored 'General case' 0 CA--C 1.547 0.841 0 CA-C-N 112.985 -1.916 . . . . 0.0 113.385 -172.014 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 10.2 tt0 -81.17 -48.08 12.58 Favored 'General case' 0 N--CA 1.477 0.903 0 N-CA-C 114.203 1.186 . . . . 0.0 114.203 -170.088 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . 0.615 ' HB2' HD12 ' A' ' 7' ' ' ILE . 48.0 m-85 -95.86 -17.06 21.41 Favored 'General case' 0 N--CA 1.474 0.733 0 N-CA-C 117.402 2.371 . . . . 0.0 117.402 -170.717 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 83.97 54.9 2.92 Favored Glycine 0 CA--C 1.539 1.564 0 CA-C-O 122.575 1.097 . . . . 0.0 111.052 -174.671 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.615 HD12 ' HB2' ' A' ' 5' ' ' PHE . 1.0 OUTLIER -117.65 142.65 30.91 Favored Pre-proline 0 N--CA 1.475 0.811 0 CA-C-N 113.665 -1.268 . . . . 0.0 110.777 -178.092 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 90.9 Cg_endo -87.82 158.98 7.53 Favored 'Trans proline' 0 CA--C 1.541 0.845 0 C-N-CA 121.26 1.307 . . . . 0.0 109.164 164.844 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -49.09 -32.33 9.55 Favored 'General case' 0 N--CA 1.48 1.07 0 N-CA-C 114.297 1.221 . . . . 0.0 114.297 171.829 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -43.8 -37.1 2.58 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 127.047 2.139 . . . . 0.0 115.615 174.618 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.934 HG12 HG22 ' A' ' 31' ' ' ILE . 26.9 m -109.22 -31.6 2.37 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.074 0 N-CA-C 114.13 1.159 . . . . 0.0 114.13 -179.537 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -69.39 -32.1 70.91 Favored 'General case' 0 N--CA 1.483 1.198 0 N-CA-C 113.354 0.872 . . . . 0.0 113.354 178.301 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -65.81 -36.67 92.52 Favored Glycine 0 N--CA 1.484 1.855 0 CA-C-O 122.717 1.176 . . . . 0.0 112.232 173.953 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.53 HG22 HG13 ' A' ' 28' ' ' ILE . 0.2 OUTLIER -68.44 -36.19 78.68 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 126.557 1.943 . . . . 0.0 113.356 176.877 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.558 HG21 ' HE1' ' A' ' 1' ' ' MET . 17.4 t -56.11 -39.82 60.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 C-N-CA 124.093 0.957 . . . . 0.0 112.065 168.167 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 39.6 mt -65.59 -41.18 93.11 Favored 'General case' 0 N--CA 1.476 0.829 0 N-CA-C 113.398 0.888 . . . . 0.0 113.398 179.599 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 25.5 t-20 -50.34 -47.54 55.85 Favored 'General case' 0 N--CA 1.475 0.783 0 O-C-N 124.317 1.011 . . . . 0.0 111.593 171.469 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.412 ' HB ' ' O ' ' A' ' 15' ' ' VAL . 2.4 t -50.79 -48.69 27.87 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.993 0 C-N-CA 123.991 0.916 . . . . 0.0 112.106 177.183 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.812 HG13 ' HA ' ' A' ' 56' ' ' LYS . 9.7 t -64.84 -55.56 20.31 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.116 0 O-C-N 124.139 0.9 . . . . 0.0 109.806 -179.13 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 37.7 mt-10 -58.75 -49.71 76.62 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 125.897 1.679 . . . . 0.0 114.585 -177.586 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -77.66 -17.99 57.15 Favored 'General case' 0 N--CA 1.473 0.724 0 N-CA-C 114.904 1.446 . . . . 0.0 114.904 -176.282 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.532 ' HA2' ' HE3' ' A' ' 56' ' ' LYS . . . 67.0 44.78 87.78 Favored Glycine 0 N--CA 1.486 1.969 0 N-CA-C 109.588 -1.405 . . . . 0.0 109.588 -162.309 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -96.79 157.65 21.24 Favored Glycine 0 N--CA 1.474 1.22 0 CA-C-N 113.661 -1.27 . . . . 0.0 114.777 -161.701 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 85.4 m95 -68.47 100.56 1.11 Allowed 'General case' 0 N--CA 1.473 0.691 0 CA-C-N 113.004 -1.598 . . . . 0.0 110.581 -178.562 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.526 HG21 HG13 ' A' ' 51' ' ' ILE . 0.6 OUTLIER -53.48 -26.15 12.3 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.799 0 CA-C-N 113.828 -1.533 . . . . 0.0 113.609 172.39 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 4.7 t -59.44 -43.92 93.03 Favored 'General case' 0 N--CA 1.481 1.076 0 CA-C-O 118.715 -0.659 . . . . 0.0 112.71 -176.364 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.452 ' HB ' HD12 ' A' ' 28' ' ' ILE . 2.7 m -57.82 -42.46 84.33 Favored 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 124.144 0.978 . . . . 0.0 111.855 174.218 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.53 HG13 HG22 ' A' ' 14' ' ' THR . 2.0 mp -73.73 -42.54 54.55 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.058 0 C-N-CA 125.98 1.712 . . . . 0.0 112.59 -178.124 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.582 HG13 HD11 ' A' ' 43' ' ' LEU . 40.1 t -49.64 -46.35 21.1 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.322 0 C-N-CA 124.815 1.246 . . . . 0.0 110.719 178.625 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -55.46 -35.86 65.95 Favored 'General case' 0 N--CA 1.486 1.364 0 C-N-CA 124.749 1.219 . . . . 0.0 113.906 176.366 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.934 HG22 HG12 ' A' ' 11' ' ' VAL . 22.3 mm -78.96 -39.36 21.65 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.071 0 C-N-CA 124.171 0.988 . . . . 0.0 109.083 -176.477 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.684 ' HB3' ' HA2' ' A' ' 39' ' ' GLY . 4.3 mm? -57.04 -49.38 75.98 Favored 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 124.553 1.141 . . . . 0.0 111.804 171.506 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 1.4 p -67.71 -27.38 66.77 Favored 'General case' 0 N--CA 1.474 0.734 0 N-CA-C 115.371 1.619 . . . . 0.0 115.371 178.018 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -55.71 -29.45 59.46 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 113.098 0.777 . . . . 0.0 113.098 169.95 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 23.0 t -71.61 -21.44 21.34 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.187 0 C-N-CA 125.166 1.386 . . . . 0.0 111.065 174.486 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 95.49 -102.13 2.79 Favored Glycine 0 N--CA 1.477 1.374 0 N-CA-C 109.416 -1.474 . . . . 0.0 109.416 -177.201 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 12.9 p -64.11 -44.48 92.11 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-N 113.115 -1.542 . . . . 0.0 114.973 -175.325 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -46.63 -49.26 16.53 Favored Glycine 0 N--CA 1.478 1.441 0 C-N-CA 124.496 1.046 . . . . 0.0 114.52 179.577 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.684 ' HA2' ' HB3' ' A' ' 32' ' ' LEU . . . -55.58 -53.55 40.65 Favored Glycine 0 N--CA 1.472 1.05 0 C-N-CA 124.291 0.948 . . . . 0.0 113.542 177.023 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 14.6 mt -62.53 -44.71 95.69 Favored 'General case' 0 N--CA 1.477 0.892 0 CA-C-N 113.149 -1.525 . . . . 0.0 113.96 -178.46 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 6.9 m -55.9 -47.12 77.99 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 123.745 0.818 . . . . 0.0 112.174 173.65 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 12.3 tp -63.23 -45.22 92.63 Favored 'General case' 0 N--CA 1.48 1.035 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.763 177.691 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.582 HD11 HG13 ' A' ' 29' ' ' VAL . 46.8 mt -64.15 -21.46 66.56 Favored 'General case' 0 N--CA 1.477 0.909 0 N-CA-C 115.732 1.753 . . . . 0.0 115.732 -178.987 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -78.35 -42.4 30.62 Favored 'General case' 0 CA--C 1.545 0.767 0 CA-C-N 115.493 -0.776 . . . . 0.0 112.954 171.33 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -61.77 -29.48 70.16 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 123.752 0.821 . . . . 0.0 112.245 172.874 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -59.03 -23.87 62.34 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 125.581 1.552 . . . . 0.0 115.011 177.709 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -52.76 -34.42 44.39 Favored Glycine 0 CA--C 1.543 1.83 0 C-N-CA 125.474 1.512 . . . . 0.0 113.763 -176.147 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 65.5 ttp85 -55.04 -52.64 62.55 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 124.662 1.185 . . . . 0.0 112.937 -178.974 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.409 ' HB3' ' HA ' ' A' ' 54' ' ' TYR . 12.5 tt0 -137.37 38.13 2.49 Favored 'General case' 0 N--CA 1.477 0.906 0 N-CA-C 115.404 1.631 . . . . 0.0 115.404 -175.621 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 21.0 t 42.15 121.26 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.293 0 C-N-CA 125.325 1.45 . . . . 0.0 114.846 -174.08 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.526 HG13 HG21 ' A' ' 25' ' ' VAL 0.278 9.8 tp -27.42 -57.75 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.481 1.096 0 N-CA-C 118.654 2.835 . . . . 0.0 118.654 -169.231 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 39.4 tttm -57.75 -61.11 2.76 Favored 'General case' 0 N--CA 1.486 1.344 0 C-N-CA 123.703 0.801 . . . . 0.0 111.771 178.56 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -63.47 -39.17 93.75 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 124.843 1.257 . . . . 0.0 112.836 178.236 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . 0.409 ' HA ' ' HB3' ' A' ' 49' ' ' GLU . 79.3 t80 -48.22 -59.35 3.48 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 125.203 1.401 . . . . 0.0 111.932 176.684 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 64.0 mt -65.74 -39.61 91.3 Favored 'General case' 0 N--CA 1.478 0.973 0 CA-C-N 114.597 -1.183 . . . . 0.0 114.123 -179.883 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.812 ' HA ' HG13 ' A' ' 19' ' ' VAL . 43.7 mttp -57.9 -42.76 85.37 Favored 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 114.955 1.465 . . . . 0.0 114.955 179.869 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 55.7 tttp -78.9 -52.55 8.14 Favored 'General case' 0 N--CA 1.478 0.941 0 CA-C-N 115.256 -0.884 . . . . 0.0 111.54 170.984 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . 0.466 ' O ' ' HB2' ' A' ' 62' ' ' LYS . 28.0 tt0 -56.57 -49.94 73.39 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-O 118.558 -0.734 . . . . 0.0 111.975 -171.051 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.71 HG23 HG21 ' A' ' 67' ' ' VAL . 2.8 mm -75.86 -27.91 18.79 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 O-C-N 121.306 -0.872 . . . . 0.0 112.683 -175.959 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.469 ' HB2' ' O ' ' A' ' 56' ' ' LYS . 11.9 mttt -62.51 -34.12 76.24 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 116.935 2.198 . . . . 0.0 116.935 171.008 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 62.3 pttt -92.96 -25.36 18.05 Favored 'General case' 0 CA--C 1.546 0.825 0 CA-C-N 113.879 -1.51 . . . . 0.0 112.515 176.358 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.466 ' HB2' ' O ' ' A' ' 58' ' ' GLU . 29.1 tttm -80.27 -46.14 16.71 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 125.967 1.707 . . . . 0.0 113.594 -176.573 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 93.89 105.6 1.83 Allowed Glycine 0 N--CA 1.477 1.405 0 N-CA-C 110.589 -1.004 . . . . 0.0 110.589 -177.818 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.608 ' H ' ' HD2' ' A' ' 64' ' ' LYS . 5.6 mptt -32.01 -45.57 0.1 Allowed 'General case' 0 N--CA 1.489 1.479 0 C-N-CA 127.587 2.355 . . . . 0.0 116.266 -178.131 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . 0.3 0.0 OUTLIER -46.94 -56.11 6.94 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 127.568 2.347 . . . . 0.0 114.105 175.781 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -71.12 -23.24 62.05 Favored 'General case' 0 N--CA 1.478 0.957 0 CA-C-N 113.994 -1.457 . . . . 0.0 114.298 175.072 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.71 HG21 HG23 ' A' ' 59' ' ' ILE . 61.1 t -70.82 -39.11 75.08 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.174 0 C-N-CA 123.423 0.689 . . . . 0.0 110.838 177.91 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 19.0 mm -51.15 -44.24 28.94 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.87 0 C-N-CA 123.902 0.881 . . . . 0.0 111.089 169.682 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -68.91 -51.4 40.46 Favored 'General case' 0 N--CA 1.481 1.097 0 N-CA-C 113.559 0.948 . . . . 0.0 113.559 174.574 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 31.1 t90 . . . . . 0 N--CA 1.479 1.0 0 C-N-CA 125.419 1.487 . . . . 0.0 112.621 -179.302 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.403 ' HE3' HD13 ' A' ' 7' ' ' ILE . 62.9 mtp . . . . . 0 N--CA 1.477 0.879 0 N-CA-C 113.321 0.86 . . . . 0.0 113.321 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -60.19 -48.92 79.71 Favored 'General case' 0 N--CA 1.477 0.89 0 O-C-N 124.104 0.877 . . . . 0.0 112.959 177.269 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 42.2 tttm -72.5 -58.36 3.44 Favored 'General case' 0 N--CA 1.479 0.998 0 CA-C-N 114.404 -1.271 . . . . 0.0 113.624 -174.59 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . 0.46 ' HB2' ' O ' ' A' ' 70' ' ' TRP . 0.8 OUTLIER -70.29 -36.24 74.24 Favored 'General case' 0 CA--C 1.538 0.485 0 N-CA-C 114.327 1.232 . . . . 0.0 114.327 -171.658 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . 0.55 ' HB2' HD12 ' A' ' 7' ' ' ILE . 29.8 m-85 -108.86 -10.09 15.12 Favored 'General case' 0 N--CA 1.47 0.55 0 N-CA-C 117.014 2.227 . . . . 0.0 117.014 -170.36 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 68.08 56.65 10.08 Favored Glycine 0 CA--C 1.541 1.678 0 O-C-N 123.965 0.791 . . . . 0.0 111.351 -174.634 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.55 HD12 ' HB2' ' A' ' 5' ' ' PHE . 0.4 OUTLIER -111.95 140.37 23.34 Favored Pre-proline 0 N--CA 1.476 0.874 0 CA-C-N 113.466 -1.367 . . . . 0.0 110.149 -179.841 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -85.27 160.78 11.31 Favored 'Trans proline' 0 C--O 1.243 0.752 0 C-N-CA 121.161 1.241 . . . . 0.0 110.057 166.551 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -52.21 -32.76 38.0 Favored 'General case' 0 N--CA 1.484 1.225 0 N-CA-C 115.262 1.579 . . . . 0.0 115.262 175.807 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -41.0 -38.26 0.95 Allowed 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 126.688 1.995 . . . . 0.0 115.815 172.412 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.701 ' HB ' HD22 ' A' ' 32' ' ' LEU . 33.6 m -105.4 -41.24 6.24 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.95 0 N-CA-C 114.754 1.391 . . . . 0.0 114.754 -176.67 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.432 ' HB2' HG21 ' A' ' 7' ' ' ILE . . . -67.29 -39.85 86.03 Favored 'General case' 0 N--CA 1.479 1.023 0 N-CA-C 112.992 0.738 . . . . 0.0 112.992 178.541 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -58.52 -41.9 95.69 Favored Glycine 0 CA--C 1.547 2.048 0 C-N-CA 123.923 0.773 . . . . 0.0 111.877 175.532 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 10.4 m -66.52 -39.88 88.88 Favored 'General case' 0 N--CA 1.484 1.232 0 CA-C-N 113.644 -1.278 . . . . 0.0 114.158 176.986 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 71.4 t -52.77 -43.36 44.86 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.017 0 N-CA-C 112.042 0.386 . . . . 0.0 112.042 169.445 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.595 HD11 HG12 ' A' ' 68' ' ' ILE . 38.3 mt -60.63 -43.84 97.07 Favored 'General case' 0 N--CA 1.481 1.095 0 N-CA-C 113.161 0.8 . . . . 0.0 113.161 179.75 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 20.4 t-20 -52.95 -50.78 63.35 Favored 'General case' 0 N--CA 1.48 1.05 0 O-C-N 124.934 1.396 . . . . 0.0 110.731 173.909 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.56 HG11 HD11 ' A' ' 28' ' ' ILE . 70.6 t -63.05 -41.62 93.54 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.088 0 CA-C-N 114.306 -1.315 . . . . 0.0 113.746 178.24 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.685 HG13 ' HA ' ' A' ' 56' ' ' LYS . 37.0 t -61.25 -45.75 97.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 123.845 0.716 . . . . 0.0 110.427 175.689 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . 0.42 ' HG3' ' HE2' ' A' ' 64' ' ' LYS . 31.3 mt-10 -60.67 -39.54 88.77 Favored 'General case' 0 CA--C 1.551 0.981 0 C-N-CA 124.914 1.286 . . . . 0.0 113.744 177.605 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -87.06 -15.98 36.97 Favored 'General case' 0 CA--C 1.543 0.68 0 N-CA-C 117.398 2.37 . . . . 0.0 117.398 -178.551 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 63.6 37.14 94.3 Favored Glycine 0 N--CA 1.484 1.851 0 C-N-CA 124.216 0.912 . . . . 0.0 112.219 -172.021 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -90.01 -166.23 41.29 Favored Glycine 0 N--CA 1.482 1.712 0 CA-C-O 122.808 1.227 . . . . 0.0 113.365 -172.694 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' TRP . . . . . 0.602 ' HB3' HG22 ' A' ' 26' ' ' THR . 5.4 m-90 -82.74 111.44 18.68 Favored 'General case' 0 N--CA 1.478 0.957 0 CA-C-O 122.328 1.061 . . . . 0.0 111.032 -179.891 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.41 ' HB ' ' HG2' ' A' ' 52' ' ' LYS . 39.6 t -65.02 -20.18 27.07 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.209 0 CA-C-N 114.669 -1.15 . . . . 0.0 112.307 168.278 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.602 HG22 ' HB3' ' A' ' 24' ' ' TRP . 10.9 t -64.26 -32.96 74.75 Favored 'General case' 0 N--CA 1.482 1.129 0 N-CA-C 113.96 1.096 . . . . 0.0 113.96 179.587 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -66.74 -33.68 76.16 Favored 'General case' 0 N--CA 1.485 1.313 0 N-CA-C 113.672 0.99 . . . . 0.0 113.672 173.875 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.56 HD11 HG11 ' A' ' 18' ' ' VAL . 0.0 OUTLIER -87.4 -38.0 11.57 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.165 0 CA-C-O 118.737 -0.649 . . . . 0.0 111.363 -178.798 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 14.0 t -44.82 -44.23 2.63 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.213 0 C-N-CA 124.225 1.01 . . . . 0.0 111.981 175.288 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 6.4 p -63.28 -31.76 72.99 Favored 'General case' 0 N--CA 1.484 1.229 0 N-CA-C 114.706 1.373 . . . . 0.0 114.706 175.92 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.699 HG22 HG12 ' A' ' 11' ' ' VAL . 15.3 mm -82.44 -37.94 14.83 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.152 0 C-N-CA 123.661 0.784 . . . . 0.0 109.732 179.006 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.701 HD22 ' HB ' ' A' ' 11' ' ' VAL . 3.7 mm? -53.72 -52.97 58.39 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 125.341 1.456 . . . . 0.0 111.283 170.356 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 17.2 p -70.18 -30.87 68.1 Favored 'General case' 0 N--CA 1.475 0.825 0 N-CA-C 114.277 1.214 . . . . 0.0 114.277 179.159 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -53.64 -33.47 55.27 Favored 'General case' 0 N--CA 1.483 1.184 0 N-CA-C 113.554 0.946 . . . . 0.0 113.554 170.022 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.476 ' HB ' ' O ' ' A' ' 32' ' ' LEU . 74.7 t -61.77 -26.98 41.29 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.426 0 C-N-CA 124.675 1.19 . . . . 0.0 112.899 170.934 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 103.3 -105.45 2.69 Favored Glycine 0 N--CA 1.472 1.073 0 N-CA-C 110.337 -1.105 . . . . 0.0 110.337 -178.923 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 30.2 p -61.28 -44.1 97.79 Favored 'General case' 0 N--CA 1.479 1.021 0 N-CA-C 114.08 1.141 . . . . 0.0 114.08 -176.521 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -52.16 -50.74 44.7 Favored Glycine 0 N--CA 1.474 1.181 0 C-N-CA 125.733 1.635 . . . . 0.0 113.96 -175.761 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.499 ' HA2' ' HB3' ' A' ' 32' ' ' LEU . . . -54.38 -55.27 27.61 Favored Glycine 0 N--CA 1.479 1.527 0 CA-C-N 114.336 -0.932 . . . . 0.0 111.753 175.2 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 52.5 mt -60.21 -47.38 86.23 Favored 'General case' 0 N--CA 1.478 0.949 0 N-CA-C 115.126 1.528 . . . . 0.0 115.126 -176.529 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 75.5 p -61.76 -41.29 97.5 Favored 'General case' 0 CA--C 1.544 0.715 0 N-CA-C 113.139 0.792 . . . . 0.0 113.139 176.665 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 9.8 tp -63.88 -47.37 80.91 Favored 'General case' 0 N--CA 1.482 1.135 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.405 173.87 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.477 ' HG ' ' O ' ' A' ' 39' ' ' GLY . 75.8 mt -60.6 -30.48 69.85 Favored 'General case' 0 N--CA 1.474 0.768 0 N-CA-C 114.783 1.401 . . . . 0.0 114.783 -178.916 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -70.3 -44.68 67.83 Favored 'General case' 0 N--CA 1.477 0.917 0 O-C-N 123.842 0.714 . . . . 0.0 112.724 172.897 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -68.64 -37.14 79.45 Favored 'General case' 0 N--CA 1.479 0.994 0 CA-C-O 121.607 0.717 . . . . 0.0 112.305 177.242 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.423 ' HB1' ' HA ' ' A' ' 51' ' ' ILE . . . -60.74 -25.24 66.33 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 126.45 1.9 . . . . 0.0 115.371 176.364 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -48.77 -36.83 20.05 Favored Glycine 0 CA--C 1.545 1.934 0 O-C-N 124.657 1.223 . . . . 0.0 113.564 176.642 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 25.0 ttm180 -43.64 -52.57 6.31 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 128.256 2.622 . . . . 0.0 113.228 -177.698 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 11.2 tt0 -128.55 36.12 4.29 Favored 'General case' 0 CA--C 1.545 0.761 0 N-CA-C 112.957 0.725 . . . . 0.0 112.957 -178.599 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 60.3 p 51.5 123.62 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.664 0 C-N-CA 125.065 1.346 . . . . 0.0 112.17 -169.101 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.423 ' HA ' ' HB1' ' A' ' 46' ' ' ALA . 5.8 tp -33.57 -50.51 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.164 0 N-CA-C 117.082 2.253 . . . . 0.0 117.082 -176.952 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.41 ' HG2' ' HB ' ' A' ' 25' ' ' VAL . 7.1 mttt -59.76 -62.86 1.56 Allowed 'General case' 0 N--CA 1.471 0.623 0 N-CA-C 114.388 1.255 . . . . 0.0 114.388 178.123 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -63.28 -34.1 76.94 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 113.24 -1.8 . . . . 0.0 112.662 -179.388 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 72.4 t80 -51.52 -63.61 1.08 Allowed 'General case' 0 C--O 1.224 -0.277 0 C-N-CA 125.955 1.702 . . . . 0.0 110.654 176.969 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 43.5 mt -65.96 -39.62 90.59 Favored 'General case' 0 N--CA 1.477 0.925 0 N-CA-C 115.265 1.58 . . . . 0.0 115.265 -175.859 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.685 ' HA ' HG13 ' A' ' 19' ' ' VAL . 1.8 mptm? -58.94 -44.38 91.41 Favored 'General case' 0 N--CA 1.472 0.644 0 N-CA-C 114.859 1.429 . . . . 0.0 114.859 177.767 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 15.6 tttm -79.39 -52.68 7.76 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-N 114.467 -1.242 . . . . 0.0 112.542 173.284 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . 0.546 ' O ' ' HB2' ' A' ' 62' ' ' LYS . 0.8 OUTLIER -59.22 -45.17 91.82 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-O 116.488 -1.72 . . . . 0.0 113.039 -171.62 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.653 HG23 HG21 ' A' ' 67' ' ' VAL . 3.2 mm -76.37 -26.64 17.05 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.04 0 C-N-CA 119.994 -0.682 . . . . 0.0 111.697 -179.637 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.523 ' HB2' ' O ' ' A' ' 56' ' ' LYS . 0.7 OUTLIER -59.22 -34.51 72.27 Favored 'General case' 0 CA--C 1.543 0.7 0 CA-C-O 122.162 0.982 . . . . 0.0 113.566 173.144 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 5.0 mttm -87.97 -44.97 10.62 Favored 'General case' 0 N--CA 1.479 0.985 0 CA-C-N 112.536 -2.12 . . . . 0.0 110.853 179.363 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.546 ' HB2' ' O ' ' A' ' 58' ' ' GLU . 19.9 tttt -68.51 -41.23 80.27 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 127.348 2.259 . . . . 0.0 114.41 -171.554 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 93.24 110.57 2.02 Favored Glycine 0 CA--C 1.534 1.231 0 N-CA-C 110.358 -1.097 . . . . 0.0 110.358 -177.719 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.714 ' H ' ' HD2' ' A' ' 64' ' ' LYS . 10.0 mptt -39.3 -47.61 1.73 Allowed 'General case' 0 N--CA 1.481 1.093 0 N-CA-C 117.395 2.369 . . . . 0.0 117.395 -176.189 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.485 ' O ' ' HB ' ' A' ' 68' ' ' ILE . 4.6 ttp180 -58.51 -50.22 74.55 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 124.18 0.992 . . . . 0.0 113.436 179.448 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -61.96 -28.03 69.26 Favored 'General case' 0 N--CA 1.476 0.843 0 N-CA-C 114.118 1.155 . . . . 0.0 114.118 173.669 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.653 HG21 HG23 ' A' ' 59' ' ' ILE . 90.3 t -70.62 -33.15 51.98 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 N-CA-C 112.333 0.494 . . . . 0.0 112.333 176.509 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.595 HG12 HD11 ' A' ' 16' ' ' LEU . 4.1 mm -49.5 -47.28 20.38 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.332 0 C-N-CA 123.28 0.632 . . . . 0.0 109.718 167.719 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -66.95 -51.81 50.59 Favored 'General case' 0 N--CA 1.485 1.286 0 CA-C-N 114.811 -1.086 . . . . 0.0 112.751 177.807 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' TRP . . . . . 0.46 ' O ' ' HB2' ' A' ' 4' ' ' GLU . 39.6 t90 . . . . . 0 N--CA 1.484 1.263 0 C-N-CA 125.055 1.342 . . . . 0.0 113.121 -179.201 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.552 ' HE1' HG21 ' A' ' 15' ' ' VAL . 72.4 mtp . . . . . 0 N--CA 1.476 0.832 0 N-CA-C 112.814 0.672 . . . . 0.0 112.814 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . 0.611 ' HA ' ' O ' ' A' ' 7' ' ' ILE . . . -60.91 -54.84 40.15 Favored 'General case' 0 N--CA 1.471 0.601 0 N-CA-C 113.584 0.957 . . . . 0.0 113.584 173.961 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 9.7 tptp -74.08 -57.05 4.22 Favored 'General case' 0 CA--C 1.543 0.711 0 CA-C-N 113.559 -1.655 . . . . 0.0 114.456 -174.597 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 11.3 tt0 -77.88 -43.74 29.27 Favored 'General case' 0 N--CA 1.477 0.88 0 N-CA-C 113.631 0.974 . . . . 0.0 113.631 -171.967 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 41.7 m-85 -95.35 -8.08 36.75 Favored 'General case' 0 CA--C 1.542 0.652 0 N-CA-C 117.396 2.369 . . . . 0.0 117.396 -173.749 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 63.48 38.53 96.48 Favored Glycine 0 N--CA 1.478 1.47 0 O-C-N 124.38 1.05 . . . . 0.0 112.848 -177.773 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.611 ' O ' ' HA ' ' A' ' 2' ' ' ALA . 0.8 OUTLIER -114.06 128.6 25.62 Favored Pre-proline 0 N--CA 1.479 1.005 0 C-N-CA 124.51 1.124 . . . . 0.0 108.474 -179.808 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -66.89 156.37 66.46 Favored 'Trans proline' 0 CA--C 1.54 0.785 0 CA-C-N 120.169 1.096 . . . . 0.0 110.943 179.721 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -51.8 -30.0 21.4 Favored 'General case' 0 N--CA 1.483 1.177 0 N-CA-C 115.077 1.51 . . . . 0.0 115.077 173.988 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -44.64 -46.98 10.44 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 126.332 1.853 . . . . 0.0 114.007 175.159 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.973 HG12 HG22 ' A' ' 31' ' ' ILE . 34.9 m -96.14 -32.43 4.31 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.345 0 N-CA-C 114.016 1.117 . . . . 0.0 114.016 -177.824 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.41 ' O ' ' HG ' ' A' ' 16' ' ' LEU . . . -59.99 -34.61 73.55 Favored 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 112.483 0.549 . . . . 0.0 112.483 173.43 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -58.69 -46.73 92.95 Favored Glycine 0 CA--C 1.546 1.978 0 C-N-CA 124.823 1.201 . . . . 0.0 113.048 169.463 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -62.32 -39.98 94.82 Favored 'General case' 0 N--CA 1.487 1.391 0 C-N-CA 124.46 1.104 . . . . 0.0 113.633 176.822 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.558 HG13 HD13 ' A' ' 55' ' ' LEU . 30.9 t -51.76 -39.37 24.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 C-N-CA 124.286 1.034 . . . . 0.0 112.768 169.338 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.581 HD22 ' HG3' ' A' ' 64' ' ' LYS . 56.3 mt -62.75 -38.35 90.23 Favored 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 113.773 1.027 . . . . 0.0 113.773 177.408 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 18.2 t-20 -51.84 -47.48 64.36 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 123.792 0.837 . . . . 0.0 111.762 173.338 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.407 HG21 ' HA ' ' A' ' 25' ' ' VAL . 2.1 t -52.33 -51.49 32.03 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.118 0 CA-C-N 115.366 -0.833 . . . . 0.0 113.039 173.507 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.603 HG13 ' HA ' ' A' ' 56' ' ' LYS . 4.1 t -63.28 -46.41 95.73 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.065 0 O-C-N 124.299 0.999 . . . . 0.0 110.982 -179.116 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 33.0 mt-10 -62.21 -45.72 92.08 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 125.075 1.35 . . . . 0.0 114.279 -178.09 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -94.9 -22.01 18.28 Favored 'General case' 0 N--CA 1.48 1.056 0 N-CA-C 116.34 1.978 . . . . 0.0 116.34 -172.035 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 73.89 45.54 26.73 Favored Glycine 0 N--CA 1.481 1.663 0 N-CA-C 109.042 -1.623 . . . . 0.0 109.042 -163.352 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -94.71 164.13 25.13 Favored Glycine 0 N--CA 1.477 1.401 0 C-N-CA 124.898 1.237 . . . . 0.0 113.829 -169.438 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 2.8 m-90 -66.86 102.12 0.92 Allowed 'General case' 0 N--CA 1.475 0.818 0 CA-C-O 122.568 1.175 . . . . 0.0 112.045 -178.542 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.637 HG21 HG13 ' A' ' 51' ' ' ILE . 5.5 p -53.45 -25.59 11.1 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.996 0 CA-C-N 112.979 -1.918 . . . . 0.0 115.225 170.881 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 10.6 t -62.42 -36.42 82.33 Favored 'General case' 0 N--CA 1.478 0.951 0 N-CA-C 113.434 0.902 . . . . 0.0 113.434 179.756 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 1.3 m -67.11 -42.7 84.07 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 124.082 0.953 . . . . 0.0 110.65 173.226 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.448 ' O ' HD23 ' A' ' 32' ' ' LEU . 1.6 mp -63.34 -44.7 99.16 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.759 0 C-N-CA 124.227 1.011 . . . . 0.0 112.633 178.272 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 77.2 t -52.38 -44.17 42.58 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.152 0 C-N-CA 123.816 0.846 . . . . 0.0 111.049 174.842 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 20.3 p -60.83 -33.59 73.27 Favored 'General case' 0 N--CA 1.482 1.15 0 N-CA-C 114.999 1.481 . . . . 0.0 114.999 175.944 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.973 HG22 HG12 ' A' ' 11' ' ' VAL . 27.7 mm -75.18 -40.73 44.1 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.692 0 C-N-CA 124.226 1.01 . . . . 0.0 109.319 178.891 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.619 ' HB3' ' HA3' ' A' ' 39' ' ' GLY . 3.6 mm? -59.68 -32.89 70.91 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 124.743 1.217 . . . . 0.0 111.391 169.236 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.545 HG23 ' HA2' ' A' ' 38' ' ' GLY . 2.9 m -73.38 -35.88 65.98 Favored 'General case' 0 N--CA 1.475 0.801 0 N-CA-C 113.984 1.105 . . . . 0.0 113.984 174.532 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -53.8 -30.38 44.64 Favored 'General case' 0 N--CA 1.487 1.383 0 N-CA-C 113.374 0.879 . . . . 0.0 113.374 175.94 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 55.5 t -65.14 -36.32 77.49 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.093 0 C-N-CA 126.823 2.049 . . . . 0.0 113.213 173.567 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 114.39 155.68 11.33 Favored Glycine 0 CA--C 1.535 1.339 0 N-CA-C 110.218 -1.153 . . . . 0.0 110.218 -166.224 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 56.9 p 77.27 -40.38 0.34 Allowed 'General case' 0 N--CA 1.49 1.541 0 C-N-CA 127.95 2.5 . . . . 0.0 113.158 -177.527 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.545 ' HA2' HG23 ' A' ' 33' ' ' THR . . . 118.46 6.17 12.05 Favored Glycine 0 CA--C 1.537 1.432 0 CA-C-N 114.208 -1.36 . . . . 0.0 113.05 -169.197 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.619 ' HA3' ' HB3' ' A' ' 32' ' ' LEU . . . 60.03 36.52 90.63 Favored Glycine 0 CA--C 1.55 2.28 0 N-CA-C 110.784 -0.926 . . . . 0.0 110.784 -155.892 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 10.8 mt -55.81 -37.34 68.52 Favored 'General case' 0 N--CA 1.483 1.216 0 N-CA-C 116.363 1.986 . . . . 0.0 116.363 -169.657 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 16.6 p -56.87 -43.64 81.44 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 124.376 1.07 . . . . 0.0 113.652 176.506 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.41 HD22 ' HE1' ' A' ' 1' ' ' MET . 14.9 tp -66.68 -45.8 77.7 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 123.12 0.568 . . . . 0.0 110.845 175.316 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 88.4 mt -60.65 -30.77 70.09 Favored 'General case' 0 N--CA 1.477 0.89 0 CA-C-N 114.293 -1.321 . . . . 0.0 114.19 179.116 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -66.79 -48.18 69.82 Favored 'General case' 0 N--CA 1.474 0.726 0 N-CA-C 112.943 0.72 . . . . 0.0 112.943 173.546 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -64.36 -29.21 70.29 Favored 'General case' 0 N--CA 1.485 1.316 0 N-CA-C 113.029 0.752 . . . . 0.0 113.029 176.815 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -77.99 -9.53 59.15 Favored 'General case' 0 CA--C 1.543 0.683 0 N-CA-C 117.259 2.318 . . . . 0.0 117.259 -177.236 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -56.6 -57.06 21.41 Favored Glycine 0 CA--C 1.542 1.75 0 C-N-CA 124.321 0.962 . . . . 0.0 113.216 -166.881 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.71 -44.93 90.5 Favored 'General case' 0 CA--C 1.541 0.601 0 N-CA-C 115.681 1.734 . . . . 0.0 115.681 -177.321 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.502 ' OE1' ' HA ' ' A' ' 54' ' ' TYR . 13.0 tt0 -103.1 25.49 9.37 Favored 'General case' 0 N--CA 1.478 0.947 0 N-CA-C 114.749 1.389 . . . . 0.0 114.749 -175.058 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 91.8 p 46.63 118.85 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 125.756 1.622 . . . . 0.0 112.919 -174.594 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.637 HG13 HG21 ' A' ' 25' ' ' VAL . 8.0 tp -35.86 -52.18 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.263 0 N-CA-C 116.883 2.179 . . . . 0.0 116.883 -174.134 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 23.6 tptp -55.51 -67.98 0.24 Allowed 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 124.703 1.201 . . . . 0.0 112.863 174.518 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -57.73 -36.31 71.86 Favored 'General case' 0 N--CA 1.482 1.16 0 N-CA-C 113.993 1.108 . . . . 0.0 113.993 179.586 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . 0.502 ' HA ' ' OE1' ' A' ' 49' ' ' GLU . 94.3 t80 -50.0 -64.6 0.76 Allowed 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 125.533 1.533 . . . . 0.0 111.738 173.641 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.558 HD13 HG13 ' A' ' 15' ' ' VAL . 46.2 mt -63.16 -41.2 99.21 Favored 'General case' 0 N--CA 1.472 0.675 0 N-CA-C 114.023 1.12 . . . . 0.0 114.023 -178.357 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.603 ' HA ' HG13 ' A' ' 19' ' ' VAL . 54.1 tptt -53.57 -54.15 41.56 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-N 113.751 -1.568 . . . . 0.0 112.303 179.076 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 58.9 tttp -68.79 -54.42 15.96 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 115.127 -0.942 . . . . 0.0 111.943 173.895 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 8.9 tt0 -59.25 -48.23 82.4 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-N 115.655 -0.702 . . . . 0.0 111.845 -167.34 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.716 HG23 HG21 ' A' ' 67' ' ' VAL . 3.1 mm -75.99 -23.95 16.35 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.124 0 O-C-N 123.288 0.367 . . . . 0.0 111.359 -176.051 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.421 ' HB2' ' O ' ' A' ' 56' ' ' LYS . 24.3 mttt -65.92 -21.6 66.45 Favored 'General case' 0 C--O 1.222 -0.362 0 N-CA-C 117.3 2.333 . . . . 0.0 117.3 169.095 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 60.4 mtpt -91.26 -50.24 5.93 Favored 'General case' 0 N--CA 1.481 1.091 0 CA-C-N 112.831 -1.986 . . . . 0.0 110.614 172.481 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 36.9 tttp -65.19 -50.29 66.49 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 126.957 2.103 . . . . 0.0 114.909 -171.957 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 95.77 121.61 3.84 Favored Glycine 0 CA--C 1.533 1.181 0 CA-C-O 122.384 0.991 . . . . 0.0 110.888 -171.86 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.581 ' HG3' HD22 ' A' ' 16' ' ' LEU . 12.3 mptt -45.08 -39.38 5.8 Favored 'General case' 0 N--CA 1.48 1.054 0 N-CA-C 117.396 2.369 . . . . 0.0 117.396 -175.777 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.418 ' O ' ' HB ' ' A' ' 68' ' ' ILE . 0.0 OUTLIER -59.66 -46.97 87.42 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 124.545 1.138 . . . . 0.0 112.805 178.208 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -63.26 -28.27 69.91 Favored 'General case' 0 N--CA 1.479 1.023 0 N-CA-C 114.54 1.311 . . . . 0.0 114.54 174.723 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.716 HG21 HG23 ' A' ' 59' ' ' ILE . 26.2 t -70.75 -36.9 66.82 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.868 0 C-N-CA 123.594 0.758 . . . . 0.0 111.282 178.536 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.418 ' HB ' ' O ' ' A' ' 65' ' ' ARG . 21.6 mm -52.95 -46.75 53.55 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.95 0 C-N-CA 123.926 0.89 . . . . 0.0 110.384 170.781 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -70.37 -50.88 34.3 Favored 'General case' 0 N--CA 1.479 1.009 0 CA-C-N 114.783 -1.099 . . . . 0.0 113.172 177.072 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 31.6 t90 . . . . . 0 N--CA 1.484 1.248 0 C-N-CA 125.611 1.564 . . . . 0.0 112.77 -179.494 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.45 ' HE1' HG21 ' A' ' 15' ' ' VAL . 74.2 mtp . . . . . 0 N--CA 1.471 0.577 0 N-CA-C 112.215 0.45 . . . . 0.0 112.215 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . 0.425 ' HA ' ' O ' ' A' ' 7' ' ' ILE . . . -54.96 -58.38 7.85 Favored 'General case' 0 N--CA 1.472 0.664 0 O-C-N 124.734 1.271 . . . . 0.0 113.255 173.395 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 22.1 tptm -71.81 -50.75 26.91 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 113.684 -1.598 . . . . 0.0 113.104 -173.763 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 8.3 tt0 -78.1 -42.76 31.03 Favored 'General case' 0 N--CA 1.479 0.99 0 N-CA-C 114.674 1.361 . . . . 0.0 114.674 -170.254 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . 0.457 ' HD1' ' HB2' ' A' ' 41' ' ' SER . 58.3 m-85 -105.76 -15.15 15.03 Favored 'General case' 0 N--CA 1.474 0.738 0 N-CA-C 116.987 2.218 . . . . 0.0 116.987 -172.101 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 85.75 61.21 1.71 Allowed Glycine 0 N--CA 1.482 1.73 0 O-C-N 124.352 1.033 . . . . 0.0 112.331 -176.922 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.538 HG21 ' HB2' ' A' ' 12' ' ' ALA . 1.0 OUTLIER -111.48 137.14 21.04 Favored Pre-proline 0 N--CA 1.475 0.789 0 CA-C-N 114.365 -0.918 . . . . 0.0 109.771 173.47 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.416 ' C ' ' H ' ' A' ' 10' ' ' ALA . 47.5 Cg_endo -82.04 38.45 0.75 Allowed 'Trans proline' 0 CA--C 1.537 0.673 0 C-N-CA 122.861 2.374 . . . . 0.0 113.2 175.522 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . 53.85 -34.04 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.518 0 C-N-CA 129.69 3.196 . . . . 0.0 117.243 -169.959 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.416 ' H ' ' C ' ' A' ' 8' ' ' PRO . . . -37.23 -63.53 0.43 Allowed 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 128.735 2.814 . . . . 0.0 113.564 174.023 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.537 HG12 HG22 ' A' ' 31' ' ' ILE . 26.9 m -74.77 -21.43 16.99 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.862 0 N-CA-C 113.896 1.073 . . . . 0.0 113.896 -176.248 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.538 ' HB2' HG21 ' A' ' 7' ' ' ILE . . . -67.6 -32.88 73.91 Favored 'General case' 0 N--CA 1.475 0.785 0 N-CA-C 112.356 0.502 . . . . 0.0 112.356 169.991 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -59.37 -38.04 92.84 Favored Glycine 0 CA--C 1.541 1.706 0 C-N-CA 123.836 0.731 . . . . 0.0 113.44 172.284 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.541 HG22 HG13 ' A' ' 28' ' ' ILE . 0.2 OUTLIER -69.79 -27.67 65.1 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 126.189 1.796 . . . . 0.0 115.124 176.329 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.484 ' O ' ' HB ' ' A' ' 18' ' ' VAL . 2.8 t -67.01 -44.07 88.62 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.169 0 C-N-CA 124.884 1.273 . . . . 0.0 110.691 171.501 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.451 HD13 ' HB3' ' A' ' 64' ' ' LYS . 60.2 mt -63.44 -42.83 98.67 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 114.408 -1.269 . . . . 0.0 112.348 179.076 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . 0.41 ' HB2' ' O ' ' A' ' 14' ' ' THR 0.444 0.6 OUTLIER -48.33 -52.86 19.63 Favored 'General case' 0 C--N 1.31 -1.123 0 CA-C-N 114.484 -1.235 . . . . 0.0 114.161 169.281 . . . . . . . . 4 4 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.484 ' HB ' ' O ' ' A' ' 15' ' ' VAL . 2.9 t -46.17 -54.2 2.09 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.416 0 O-C-N 125.629 1.831 . . . . 0.0 110.342 173.434 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.823 HG13 ' HA ' ' A' ' 56' ' ' LYS . 4.1 t -62.33 -49.99 81.73 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.08 0 CA-C-N 115.011 -0.995 . . . . 0.0 111.16 -174.453 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 25.8 mt-10 -66.28 -38.59 88.14 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 126.128 1.771 . . . . 0.0 115.012 -171.959 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -99.63 -11.45 20.93 Favored 'General case' 0 N--CA 1.473 0.688 0 N-CA-C 114.473 1.286 . . . . 0.0 114.473 -175.044 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 68.03 39.83 88.81 Favored Glycine 0 CA--C 1.545 1.912 0 N-CA-C 111.423 -0.671 . . . . 0.0 111.423 -166.903 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -91.69 159.45 25.85 Favored Glycine 0 CA--C 1.541 1.689 0 CA-C-O 122.948 1.304 . . . . 0.0 113.776 -173.251 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 83.8 m95 -63.81 108.03 1.35 Allowed 'General case' 0 N--CA 1.47 0.558 0 CA-C-N 112.863 -1.668 . . . . 0.0 113.564 -179.512 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.614 HG21 HG13 ' A' ' 51' ' ' ILE . 5.5 p -58.46 -26.86 31.87 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 CA-C-N 111.741 -2.481 . . . . 0.0 113.864 168.653 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 10.1 t -65.09 -36.51 84.53 Favored 'General case' 0 N--CA 1.482 1.125 0 N-CA-C 113.431 0.901 . . . . 0.0 113.431 -173.867 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -70.45 -43.7 69.33 Favored 'General case' 0 N--CA 1.47 0.544 0 N-CA-C 112.367 0.506 . . . . 0.0 112.367 172.029 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.541 HG13 HG22 ' A' ' 14' ' ' THR . 1.6 mp -61.27 -44.0 97.59 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.564 0 C-N-CA 124.92 1.288 . . . . 0.0 112.539 -179.214 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.527 HG13 HD11 ' A' ' 43' ' ' LEU . 23.7 t -46.04 -47.54 5.76 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.703 0 C-N-CA 124.632 1.173 . . . . 0.0 111.594 171.572 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 22.7 p -60.52 -33.98 73.43 Favored 'General case' 0 N--CA 1.482 1.128 0 N-CA-C 114.606 1.335 . . . . 0.0 114.606 177.808 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.537 HG22 HG12 ' A' ' 11' ' ' VAL . 21.7 mm -77.28 -35.66 22.87 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 C-N-CA 124.142 0.977 . . . . 0.0 109.235 -178.951 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.611 ' HB3' ' HA2' ' A' ' 39' ' ' GLY . 4.0 mm? -60.66 -52.38 65.36 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 124.198 0.999 . . . . 0.0 111.587 173.5 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 1.7 p -60.84 -30.05 69.87 Favored 'General case' 0 N--CA 1.482 1.169 0 N-CA-C 115.37 1.619 . . . . 0.0 115.37 177.156 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -53.62 -33.51 55.28 Favored 'General case' 0 N--CA 1.479 1.009 0 N-CA-C 114.81 1.411 . . . . 0.0 114.81 175.251 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 68.8 t -68.69 -21.88 26.31 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.265 0 C-N-CA 125.916 1.686 . . . . 0.0 111.912 175.889 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 97.35 -96.74 1.88 Allowed Glycine 0 N--CA 1.477 1.377 0 N-CA-C 108.301 -1.919 . . . . 0.0 108.301 179.47 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 6.2 p -58.52 -48.57 80.4 Favored 'General case' 0 N--CA 1.487 1.413 0 CA-C-N 112.707 -1.746 . . . . 0.0 114.885 -174.255 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -54.69 -41.3 74.17 Favored Glycine 0 N--CA 1.479 1.544 0 O-C-N 125.941 2.025 . . . . 0.0 115.325 -175.442 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.611 ' HA2' ' HB3' ' A' ' 32' ' ' LEU . . . -62.6 -55.26 28.21 Favored Glycine 0 N--CA 1.473 1.143 0 N-CA-C 111.467 -0.653 . . . . 0.0 111.467 172.621 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 58.8 mt -57.89 -48.94 78.39 Favored 'General case' 0 N--CA 1.474 0.742 0 N-CA-C 115.452 1.649 . . . . 0.0 115.452 -175.971 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . 0.457 ' HB2' ' HD1' ' A' ' 5' ' ' PHE . 13.1 p -61.91 -37.88 86.3 Favored 'General case' 0 CA--C 1.544 0.732 0 N-CA-C 114.828 1.418 . . . . 0.0 114.828 177.66 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 10.0 tp -69.74 -42.12 74.34 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 124.251 1.02 . . . . 0.0 111.005 175.183 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.527 HD11 HG13 ' A' ' 29' ' ' VAL . 51.2 mt -63.26 -25.79 68.48 Favored 'General case' 0 N--CA 1.469 0.506 0 N-CA-C 114.968 1.47 . . . . 0.0 114.968 178.516 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -72.09 -49.52 35.61 Favored 'General case' 0 N--CA 1.481 1.106 0 CA-C-N 115.909 -0.587 . . . . 0.0 112.286 171.273 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -60.9 -35.75 77.46 Favored 'General case' 0 N--CA 1.49 1.529 0 C-N-CA 124.847 1.259 . . . . 0.0 112.933 -179.229 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -52.4 -25.7 10.6 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 126.844 2.058 . . . . 0.0 114.347 174.293 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -45.7 -37.97 7.27 Favored Glycine 0 CA--C 1.539 1.561 0 C-N-CA 126.514 2.007 . . . . 0.0 114.101 178.868 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 4.5 tmm_? -62.96 -39.35 94.39 Favored 'General case' 0 CA--C 1.544 0.738 0 N-CA-C 114.802 1.408 . . . . 0.0 114.802 -173.079 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 11.5 tt0 -141.15 38.7 1.76 Allowed 'General case' 0 N--CA 1.479 0.981 0 N-CA-C 116.365 1.987 . . . . 0.0 116.365 -178.51 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 59.5 p 53.47 119.34 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.874 0 C-N-CA 125.184 1.394 . . . . 0.0 112.643 -177.131 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.614 HG13 HG21 ' A' ' 25' ' ' VAL 0.276 8.6 tp -36.7 -46.55 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 N-CA-C 117.89 2.552 . . . . 0.0 117.89 -171.945 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 24.7 tptt -55.86 -68.93 0.16 Allowed 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 126.107 1.763 . . . . 0.0 112.895 174.767 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -62.96 -32.3 73.59 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 124.904 1.282 . . . . 0.0 113.865 177.317 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 91.2 t80 -53.81 -62.91 1.35 Allowed 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 125.894 1.677 . . . . 0.0 110.88 -178.948 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 65.8 mt -65.09 -35.39 81.0 Favored 'General case' 0 N--CA 1.469 0.483 0 N-CA-C 114.134 1.161 . . . . 0.0 114.134 179.928 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.823 ' HA ' HG13 ' A' ' 19' ' ' VAL . 58.7 mttp -61.36 -47.96 83.46 Favored 'General case' 0 N--CA 1.477 0.904 0 CA-C-N 113.982 -1.463 . . . . 0.0 114.445 178.476 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 85.7 tttt -76.78 -50.64 13.02 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-N 114.764 -1.107 . . . . 0.0 111.695 175.406 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . 0.434 ' O ' ' HB2' ' A' ' 62' ' ' LYS . 28.8 tt0 -59.08 -49.21 78.75 Favored 'General case' 0 N--CA 1.471 0.596 0 N-CA-C 111.922 0.341 . . . . 0.0 111.922 -173.152 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.739 HD12 HG21 ' A' ' 67' ' ' VAL . 2.7 mm -72.09 -25.03 23.08 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.038 0 CA-C-O 118.428 -0.796 . . . . 0.0 112.391 -178.669 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 63.9 tttm -62.77 -33.17 74.62 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 114.682 1.364 . . . . 0.0 114.682 172.045 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 55.1 mtmt -80.91 -48.58 12.14 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-N 114.055 -1.429 . . . . 0.0 110.729 173.941 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.434 ' HB2' ' O ' ' A' ' 58' ' ' GLU . 5.9 tttm -64.51 -50.6 66.74 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 126.131 1.772 . . . . 0.0 115.77 -172.053 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 91.66 108.58 1.59 Allowed Glycine 0 N--CA 1.482 1.749 0 CA-C-N 114.932 -1.031 . . . . 0.0 110.747 -175.941 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.707 ' H ' ' HD2' ' A' ' 64' ' ' LYS . 8.6 mptt -31.95 -43.83 0.08 Allowed 'General case' 0 N--CA 1.482 1.153 0 N-CA-C 119.277 3.066 . . . . 0.0 119.277 -173.713 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.44 -47.94 82.34 Favored 'General case' 0 N--CA 1.475 0.78 0 N-CA-C 113.396 0.888 . . . . 0.0 113.396 178.865 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -60.77 -28.12 68.49 Favored 'General case' 0 N--CA 1.473 0.723 0 CA-C-N 115.015 -0.993 . . . . 0.0 113.402 172.937 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.739 HG21 HD12 ' A' ' 59' ' ' ILE . 96.2 t -72.95 -36.09 50.56 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.662 0 N-CA-C 112.877 0.695 . . . . 0.0 112.877 179.276 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 33.5 mm -53.21 -46.77 56.63 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.996 0 O-C-N 123.637 0.586 . . . . 0.0 109.952 168.721 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -68.6 -43.15 77.05 Favored 'General case' 0 N--CA 1.476 0.844 0 N-CA-C 113.598 0.962 . . . . 0.0 113.598 178.57 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 29.3 t90 . . . . . 0 N--CA 1.477 0.886 0 CA-C-N 114.816 -1.084 . . . . 0.0 113.069 178.337 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.624 ' HE3' HD13 ' A' ' 7' ' ' ILE . 39.7 mtp . . . . . 0 N--CA 1.477 0.918 0 N-CA-C 111.8 0.296 . . . . 0.0 111.8 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . 0.423 ' HA ' ' O ' ' A' ' 7' ' ' ILE . . . -53.64 -55.19 28.04 Favored 'General case' 0 N--CA 1.475 0.789 0 CA-C-N 113.714 -1.585 . . . . 0.0 113.415 177.625 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -74.24 -44.11 54.32 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 113.639 -1.619 . . . . 0.0 114.156 -174.758 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 13.6 tt0 -78.52 -43.19 27.45 Favored 'General case' 0 N--CA 1.472 0.652 0 N-CA-C 114.241 1.2 . . . . 0.0 114.241 -170.898 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . 0.6 ' HB2' HD12 ' A' ' 7' ' ' ILE . 46.3 m-85 -105.34 -23.99 12.76 Favored 'General case' 0 N--CA 1.484 1.233 0 N-CA-C 116.258 1.947 . . . . 0.0 116.258 -170.16 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 95.72 58.38 1.12 Allowed Glycine 0 CA--C 1.534 1.276 0 C-N-CA 124.225 0.917 . . . . 0.0 111.77 -175.083 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.624 HD13 ' HE3' ' A' ' 1' ' ' MET . 1.3 mt -125.77 151.11 70.46 Favored Pre-proline 0 N--CA 1.478 0.944 0 C-N-CA 124.764 1.225 . . . . 0.0 111.069 -173.57 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo -97.27 162.63 0.97 Allowed 'Trans proline' 0 C--O 1.24 0.597 0 C-N-CA 121.162 1.241 . . . . 0.0 109.703 161.596 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -53.44 -29.38 35.11 Favored 'General case' 0 CA--C 1.538 0.481 0 N-CA-C 114.719 1.377 . . . . 0.0 114.719 177.176 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -43.61 -59.87 2.0 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 126.196 1.799 . . . . 0.0 112.953 173.146 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.779 HG12 HG22 ' A' ' 31' ' ' ILE . 29.6 m -84.42 -29.89 7.13 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.195 0 N-CA-C 114.321 1.23 . . . . 0.0 114.321 -175.231 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -67.26 -29.79 69.5 Favored 'General case' 0 N--CA 1.48 1.064 0 N-CA-C 112.759 0.651 . . . . 0.0 112.759 172.943 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -66.66 -40.01 93.89 Favored Glycine 0 CA--C 1.536 1.374 0 C-N-CA 124.317 0.96 . . . . 0.0 112.401 170.616 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.756 HG22 HD12 ' A' ' 28' ' ' ILE . 1.0 OUTLIER -67.7 -34.13 76.29 Favored 'General case' 0 N--CA 1.487 1.404 0 C-N-CA 124.183 0.993 . . . . 0.0 112.937 177.232 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.569 HG21 ' HE1' ' A' ' 1' ' ' MET . 10.8 t -54.15 -40.58 47.3 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 C-N-CA 124.707 1.203 . . . . 0.0 112.879 165.772 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.478 HD22 ' HG3' ' A' ' 64' ' ' LYS . 83.2 mt -61.27 -37.13 82.03 Favored 'General case' 0 N--CA 1.472 0.645 0 N-CA-C 114.261 1.208 . . . . 0.0 114.261 176.494 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 48.2 t-20 -53.62 -47.9 69.8 Favored 'General case' 0 N--CA 1.481 1.076 0 CA-C-N 115.179 -0.919 . . . . 0.0 111.355 173.353 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.574 HG23 HG13 ' A' ' 28' ' ' ILE . 22.6 t -48.11 -51.61 9.0 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.213 0 CA-C-N 115.28 -0.873 . . . . 0.0 112.021 174.596 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.829 HG13 ' HA ' ' A' ' 56' ' ' LYS . 5.1 t -64.3 -48.16 86.62 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.144 0 C-N-CA 124.155 0.982 . . . . 0.0 111.327 -176.774 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -74.13 -43.11 58.72 Favored 'General case' 0 N--CA 1.469 0.519 0 N-CA-C 116.767 2.136 . . . . 0.0 116.767 -176.127 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -103.17 -22.45 13.74 Favored 'General case' 0 N--CA 1.481 1.107 0 N-CA-C 115.814 1.783 . . . . 0.0 115.814 -169.796 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 68.87 39.61 85.34 Favored Glycine 0 N--CA 1.477 1.413 0 N-CA-C 110.639 -0.984 . . . . 0.0 110.639 -165.928 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -86.55 142.82 18.91 Favored Glycine 0 N--CA 1.48 1.57 0 N-CA-C 108.815 -1.714 . . . . 0.0 108.815 -177.513 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 9.2 m-90 -49.6 103.15 0.04 OUTLIER 'General case' 0 N--CA 1.477 0.883 0 CA-C-N 113.624 -1.288 . . . . 0.0 112.71 -172.498 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.402 ' O ' HG23 ' A' ' 29' ' ' VAL . 3.2 p -56.44 -23.41 16.68 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.758 0 CA-C-N 114.028 -1.442 . . . . 0.0 114.414 176.368 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 5.0 t -62.43 -44.42 96.47 Favored 'General case' 0 N--CA 1.484 1.225 0 CA-C-N 115.648 -0.705 . . . . 0.0 112.558 178.389 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 1.6 m -60.86 -45.76 93.25 Favored 'General case' 0 N--CA 1.485 1.287 0 C-N-CA 123.871 0.868 . . . . 0.0 110.937 172.998 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.756 HD12 HG22 ' A' ' 14' ' ' THR . 8.4 mm -62.37 -46.58 96.09 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.152 0 C-N-CA 124.394 1.078 . . . . 0.0 111.867 -179.09 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.402 HG23 ' O ' ' A' ' 25' ' ' VAL . 48.7 t -50.31 -45.77 25.02 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.386 0 C-N-CA 124.757 1.223 . . . . 0.0 111.129 176.964 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 64.8 m -63.81 -27.31 69.09 Favored 'General case' 0 N--CA 1.481 1.095 0 N-CA-C 115.867 1.802 . . . . 0.0 115.867 177.825 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.779 HG22 HG12 ' A' ' 11' ' ' VAL . 34.9 mm -82.21 -39.81 16.67 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.032 0 C-N-CA 123.857 0.863 . . . . 0.0 109.07 178.967 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.773 HD22 ' HB ' ' A' ' 11' ' ' VAL . 3.4 mm? -56.64 -50.58 71.61 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 125.142 1.377 . . . . 0.0 112.204 172.171 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 1.4 p -70.89 -29.69 65.83 Favored 'General case' 0 N--CA 1.481 1.079 0 N-CA-C 114.683 1.364 . . . . 0.0 114.683 177.837 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -52.4 -25.63 10.43 Favored 'General case' 0 N--CA 1.477 0.918 0 N-CA-C 114.006 1.113 . . . . 0.0 114.006 170.456 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 58.5 t -70.9 -26.25 27.42 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.322 0 C-N-CA 124.327 1.051 . . . . 0.0 112.051 173.753 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 114.35 -118.78 4.5 Favored Glycine 0 CA--C 1.527 0.794 0 C-N-CA 125.21 1.386 . . . . 0.0 110.201 -176.813 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 17.8 p -61.44 -37.38 83.35 Favored 'General case' 0 N--CA 1.478 0.943 0 CA-C-N 112.979 -1.61 . . . . 0.0 114.259 -179.596 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -46.65 -54.75 8.69 Favored Glycine 0 N--CA 1.482 1.745 0 C-N-CA 124.789 1.185 . . . . 0.0 114.586 -175.729 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.526 ' O ' ' HG ' ' A' ' 43' ' ' LEU . . . -55.3 -49.23 64.82 Favored Glycine 0 N--CA 1.48 1.58 0 O-C-N 125.172 1.16 . . . . 0.0 113.018 176.922 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 22.3 mt -61.45 -48.27 81.91 Favored 'General case' 0 N--CA 1.479 0.981 0 CA-C-N 113.589 -1.306 . . . . 0.0 113.5 -178.845 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 17.0 m -57.92 -41.25 82.3 Favored 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 123.658 0.783 . . . . 0.0 112.758 176.188 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 13.7 tp -60.5 -45.76 92.6 Favored 'General case' 0 N--CA 1.478 0.961 0 CA-C-N 115.554 -0.748 . . . . 0.0 111.393 173.969 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.526 ' HG ' ' O ' ' A' ' 39' ' ' GLY . 69.2 mt -61.85 -32.84 73.21 Favored 'General case' 0 N--CA 1.473 0.697 0 N-CA-C 113.66 0.985 . . . . 0.0 113.66 -179.269 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -63.9 -48.99 74.43 Favored 'General case' 0 N--CA 1.476 0.851 0 O-C-N 123.985 0.803 . . . . 0.0 112.102 171.802 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -62.52 -33.34 74.7 Favored 'General case' 0 N--CA 1.485 1.284 0 CA-C-O 122.239 1.019 . . . . 0.0 112.753 178.12 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -61.77 -14.33 31.64 Favored 'General case' 0 N--CA 1.478 0.933 0 N-CA-C 116.11 1.893 . . . . 0.0 116.11 176.559 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -48.54 -37.22 19.24 Favored Glycine 0 CA--C 1.542 1.771 0 O-C-N 124.718 1.261 . . . . 0.0 113.511 177.833 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 40.2 ttp180 -50.71 -50.76 54.46 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 125.671 1.588 . . . . 0.0 113.647 -173.602 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -145.52 37.98 1.12 Allowed 'General case' 0 N--CA 1.476 0.841 0 N-CA-C 114.064 1.135 . . . . 0.0 114.064 -175.013 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 27.6 t 52.96 133.37 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.504 0 C-N-CA 125.175 1.39 . . . . 0.0 112.855 -175.71 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.419 ' O ' ' HB3' ' A' ' 54' ' ' TYR 0.259 9.9 tp -37.79 -54.04 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.822 0 N-CA-C 117.89 2.552 . . . . 0.0 117.89 -168.186 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 38.4 tttt -61.98 -57.23 12.48 Favored 'General case' 0 CA--C 1.543 0.694 0 N-CA-C 114.096 1.147 . . . . 0.0 114.096 178.232 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -66.17 -30.0 70.39 Favored 'General case' 0 N--CA 1.479 1.011 0 O-C-N 123.925 0.765 . . . . 0.0 112.936 179.766 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . 0.419 ' HB3' ' O ' ' A' ' 51' ' ' ILE . 64.4 t80 -53.98 -61.42 2.31 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 124.893 1.277 . . . . 0.0 110.716 170.592 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.431 HD13 HG13 ' A' ' 15' ' ' VAL . 51.2 mt -65.01 -35.81 82.4 Favored 'General case' 0 N--CA 1.482 1.165 0 N-CA-C 113.622 0.971 . . . . 0.0 113.622 -174.662 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.829 ' HA ' HG13 ' A' ' 19' ' ' VAL . 55.6 mttm -54.41 -56.58 17.26 Favored 'General case' 0 N--CA 1.473 0.693 0 O-C-N 125.34 1.65 . . . . 0.0 112.065 173.024 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 57.1 tttm -68.43 -45.47 72.47 Favored 'General case' 0 CA--C 1.542 0.635 0 CA-C-N 115.411 -0.813 . . . . 0.0 112.113 176.799 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . 0.451 ' O ' ' HB2' ' A' ' 62' ' ' LYS . 4.1 tp10 -56.81 -52.37 65.31 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-N 114.969 -1.014 . . . . 0.0 112.962 -175.969 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.532 HG23 HG21 ' A' ' 67' ' ' VAL . 1.2 mm -74.8 -26.7 19.75 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.261 0 CA-C-N 116.04 -0.527 . . . . 0.0 112.1 -177.713 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.472 ' HB2' ' O ' ' A' ' 56' ' ' LYS . 3.8 tppt? -62.06 -42.2 98.94 Favored 'General case' 0 CA--C 1.539 0.543 0 O-C-N 124.383 1.052 . . . . 0.0 112.525 176.596 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 61.2 pttt -86.39 -26.99 24.49 Favored 'General case' 0 CA--C 1.547 0.86 0 CA-C-N 113.447 -1.706 . . . . 0.0 113.193 177.935 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.451 ' HB2' ' O ' ' A' ' 58' ' ' GLU . 35.7 tptt -76.16 -58.37 3.32 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 125.714 1.606 . . . . 0.0 114.542 -178.008 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 103.32 110.72 3.48 Favored Glycine 0 CA--C 1.543 1.803 0 CA-C-N 114.628 -1.169 . . . . 0.0 112.189 -174.304 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.517 ' H ' ' HD2' ' A' ' 64' ' ' LYS . 11.2 mptt -34.75 -52.27 0.52 Allowed 'General case' 0 N--CA 1.481 1.077 0 N-CA-C 119.784 3.253 . . . . 0.0 119.784 -172.641 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -61.55 -45.59 93.52 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 123.779 0.831 . . . . 0.0 112.993 -179.778 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -65.48 -25.82 67.65 Favored 'General case' 0 N--CA 1.478 0.97 0 CA-C-N 113.924 -1.489 . . . . 0.0 112.949 174.12 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.532 HG21 HG23 ' A' ' 59' ' ' ILE . 71.7 t -63.77 -43.86 98.09 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.314 0 C-N-CA 123.319 0.648 . . . . 0.0 110.411 174.864 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -51.78 -44.48 36.52 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.966 0 C-N-CA 123.339 0.656 . . . . 0.0 111.671 173.562 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -70.43 -47.64 59.79 Favored 'General case' 0 N--CA 1.481 1.077 0 N-CA-C 113.222 0.823 . . . . 0.0 113.222 177.629 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 30.7 t90 . . . . . 0 N--CA 1.481 1.083 0 C-N-CA 126.382 1.873 . . . . 0.0 112.433 -178.69 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.668 ' HB3' HG22 ' A' ' 7' ' ' ILE . 68.4 mtp . . . . . 0 N--CA 1.474 0.757 0 N-CA-C 113.471 0.915 . . . . 0.0 113.471 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -64.37 -38.83 92.42 Favored 'General case' 0 N--CA 1.475 0.813 0 N-CA-C 114.111 1.152 . . . . 0.0 114.111 176.562 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 35.6 ttmt -91.25 -68.54 0.79 Allowed 'General case' 0 N--CA 1.471 0.605 0 N-CA-C 114.125 1.157 . . . . 0.0 114.125 -176.89 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 8.5 tt0 -61.66 -31.14 71.23 Favored 'General case' 0 CA--C 1.55 0.974 0 C-N-CA 125.188 1.395 . . . . 0.0 113.796 -173.623 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . 0.541 ' HD1' ' HB2' ' A' ' 41' ' ' SER . 45.1 m-85 -109.77 -11.93 14.67 Favored 'General case' 0 N--CA 1.474 0.74 0 N-CA-C 116.948 2.203 . . . . 0.0 116.948 -179.94 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 64.44 31.62 81.47 Favored Glycine 0 CA--C 1.538 1.511 0 C-N-CA 124.176 0.893 . . . . 0.0 113.856 -174.228 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.668 HG22 ' HB3' ' A' ' 1' ' ' MET . 0.7 OUTLIER -104.21 118.01 57.97 Favored Pre-proline 0 N--CA 1.478 0.939 0 C-N-CA 123.418 0.687 . . . . 0.0 110.863 -177.524 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -64.27 161.61 33.52 Favored 'Trans proline' 0 CA--C 1.537 0.653 0 C-N-CA 122.506 2.137 . . . . 0.0 112.277 -171.807 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -55.75 -29.1 59.02 Favored 'General case' 0 N--CA 1.476 0.83 0 CA-C-N 113.278 -1.783 . . . . 0.0 114.137 173.141 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -49.03 -33.55 11.52 Favored 'General case' 0 N--CA 1.48 1.033 0 N-CA-C 114.853 1.427 . . . . 0.0 114.853 172.941 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.763 HG12 HG22 ' A' ' 31' ' ' ILE . 30.2 m -112.15 -35.45 2.43 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.016 0 N-CA-C 113.789 1.033 . . . . 0.0 113.789 179.895 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.413 ' O ' ' HG ' ' A' ' 16' ' ' LEU . . . -64.57 -40.21 95.14 Favored 'General case' 0 N--CA 1.476 0.852 0 N-CA-C 113.651 0.982 . . . . 0.0 113.651 174.802 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -61.72 -40.67 99.09 Favored Glycine 0 CA--C 1.548 2.104 0 C-N-CA 124.172 0.891 . . . . 0.0 112.276 174.542 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.528 HG22 HD12 ' A' ' 28' ' ' ILE . 4.3 m -66.81 -40.99 88.25 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 125.139 1.376 . . . . 0.0 113.46 177.324 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.479 HG21 ' HE1' ' A' ' 1' ' ' MET . 54.4 t -52.54 -46.96 49.05 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.207 0 C-N-CA 123.126 0.57 . . . . 0.0 111.249 169.056 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.666 HD11 HG12 ' A' ' 68' ' ' ILE . 23.8 mt -57.28 -48.19 79.54 Favored 'General case' 0 N--CA 1.482 1.174 0 O-C-N 123.839 0.712 . . . . 0.0 112.904 179.205 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 11.8 t-20 -54.44 -44.68 72.67 Favored 'General case' 0 CA--C 1.542 0.665 0 CA-C-N 114.857 -1.065 . . . . 0.0 111.338 179.168 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.932 HG21 HD11 ' A' ' 28' ' ' ILE . 2.8 t -68.68 -40.96 82.35 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.762 0 CA-C-N 113.475 -1.693 . . . . 0.0 114.087 179.336 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.656 HG13 ' HA ' ' A' ' 56' ' ' LYS . 40.5 t -59.01 -52.48 60.16 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.357 0 O-C-N 124.392 1.058 . . . . 0.0 109.265 175.73 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . 0.542 ' HG3' ' HE2' ' A' ' 64' ' ' LYS . 36.0 mt-10 -55.01 -53.54 54.46 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 125.232 1.413 . . . . 0.0 113.35 178.099 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -77.24 -11.66 59.85 Favored 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 115.683 1.735 . . . . 0.0 115.683 -175.379 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 67.66 47.93 59.01 Favored Glycine 0 N--CA 1.478 1.472 0 C-N-CA 124.523 1.059 . . . . 0.0 111.424 -172.44 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -94.13 -160.1 34.44 Favored Glycine 0 N--CA 1.475 1.248 0 CA-C-O 123.163 1.424 . . . . 0.0 113.293 -173.958 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 9.1 m-90 -102.89 105.69 16.1 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-O 122.651 1.215 . . . . 0.0 113.305 179.16 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.48 HG23 ' HE3' ' A' ' 56' ' ' LYS . 77.4 t -55.67 -27.23 21.36 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.045 0 CA-C-N 114.057 -1.429 . . . . 0.0 112.899 168.338 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 3.1 t -60.28 -38.32 83.19 Favored 'General case' 0 N--CA 1.485 1.286 0 N-CA-C 113.349 0.87 . . . . 0.0 113.349 179.143 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 2.7 m -64.07 -41.03 97.49 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 125.09 1.356 . . . . 0.0 110.684 175.013 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.932 HD11 HG21 ' A' ' 18' ' ' VAL . 1.6 mm -73.65 -39.85 53.87 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.277 0 CA-C-N 115.508 -0.769 . . . . 0.0 111.411 -178.79 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 25.6 t -46.09 -44.77 5.5 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 C-N-CA 124.113 0.965 . . . . 0.0 111.639 175.589 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 20.0 m -57.1 -41.31 78.68 Favored 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 124.966 1.307 . . . . 0.0 114.472 174.287 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.763 HG22 HG12 ' A' ' 11' ' ' VAL . 16.4 mm -75.09 -37.62 40.79 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.272 0 C-N-CA 124.483 1.113 . . . . 0.0 110.196 -178.957 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.535 ' HB3' ' HA3' ' A' ' 39' ' ' GLY . 4.2 mm? -55.37 -41.17 72.23 Favored 'General case' 0 N--CA 1.49 1.573 0 C-N-CA 124.342 1.057 . . . . 0.0 110.926 168.805 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.597 HG23 ' HA2' ' A' ' 38' ' ' GLY . 25.5 m -68.53 -38.83 81.2 Favored 'General case' 0 N--CA 1.485 1.317 0 N-CA-C 114.232 1.197 . . . . 0.0 114.232 174.961 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -55.68 -30.12 60.53 Favored 'General case' 0 N--CA 1.481 1.115 0 O-C-N 124.7 1.25 . . . . 0.0 113.242 175.131 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.427 ' HB ' ' O ' ' A' ' 32' ' ' LEU . 54.5 t -57.32 -33.15 42.94 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.034 0 C-N-CA 125.838 1.655 . . . . 0.0 113.423 172.916 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.452 ' C ' ' H ' ' A' ' 38' ' ' GLY . . . 111.78 169.5 18.48 Favored Glycine 0 CA--C 1.537 1.407 0 N-CA-C 107.633 -2.187 . . . . 0.0 107.633 -167.788 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . 0.546 ' OG ' ' HB2' ' A' ' 40' ' ' LEU . 9.6 t 70.37 -39.47 0.44 Allowed 'General case' 0 N--CA 1.493 1.7 0 C-N-CA 126.039 1.735 . . . . 0.0 113.185 -173.763 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.597 ' HA2' HG23 ' A' ' 33' ' ' THR . . . 113.31 9.99 16.38 Favored Glycine 0 CA--C 1.537 1.455 0 C-N-CA 126.236 1.874 . . . . 0.0 112.133 -169.251 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.535 ' HA3' ' HB3' ' A' ' 32' ' ' LEU . . . 59.05 23.7 57.5 Favored Glycine 0 CA--C 1.546 1.977 0 C-N-CA 123.696 0.665 . . . . 0.0 111.899 -159.512 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.546 ' HB2' ' OG ' ' A' ' 37' ' ' SER . 9.4 mt -51.91 -40.03 60.07 Favored 'General case' 0 N--CA 1.485 1.303 0 N-CA-C 116.631 2.086 . . . . 0.0 116.631 -168.52 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . 0.541 ' HB2' ' HD1' ' A' ' 5' ' ' PHE . 7.9 p -59.8 -49.04 79.26 Favored 'General case' 0 CA--C 1.546 0.792 0 N-CA-C 113.448 0.907 . . . . 0.0 113.448 178.792 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 15.8 tp -61.16 -47.36 86.56 Favored 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 122.968 0.507 . . . . 0.0 110.43 172.684 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 43.9 mt -66.19 -26.64 67.5 Favored 'General case' 0 N--CA 1.476 0.863 0 CA-C-N 114.605 -1.179 . . . . 0.0 114.062 -175.215 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -69.75 -45.16 68.71 Favored 'General case' 0 N--CA 1.475 0.823 0 CA-C-N 115.694 -0.685 . . . . 0.0 111.82 171.57 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -63.54 -35.81 81.7 Favored 'General case' 0 N--CA 1.479 0.976 0 CA-C-O 121.005 0.431 . . . . 0.0 111.875 173.845 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -66.13 -28.59 68.91 Favored 'General case' 0 N--CA 1.474 0.774 0 N-CA-C 116.193 1.923 . . . . 0.0 116.193 179.654 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -53.14 -35.05 48.37 Favored Glycine 0 N--CA 1.482 1.717 0 C-N-CA 124.818 1.199 . . . . 0.0 113.39 -178.433 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 42.2 ttp180 -57.24 -41.92 80.48 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 126.233 1.813 . . . . 0.0 113.929 -176.177 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -138.57 57.43 1.69 Allowed 'General case' 0 N--CA 1.476 0.839 0 CA-C-O 121.887 0.851 . . . . 0.0 110.149 178.197 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 9.0 t 30.33 114.32 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.225 0 N-CA-C 116.84 2.163 . . . . 0.0 116.84 -178.868 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 7.0 tp -26.99 -54.04 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.349 0 N-CA-C 118.023 2.601 . . . . 0.0 118.023 -177.273 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.449 ' HD2' ' HB ' ' A' ' 25' ' ' VAL . 24.1 tptp -57.65 -58.15 9.57 Favored 'General case' 0 N--CA 1.481 1.108 0 C-N-CA 124.494 1.118 . . . . 0.0 111.913 -177.762 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -72.01 -35.21 69.37 Favored 'General case' 0 N--CA 1.484 1.237 0 O-C-N 124.579 1.174 . . . . 0.0 113.831 177.847 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 67.8 t80 -45.78 -60.96 1.93 Allowed 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 125.445 1.498 . . . . 0.0 112.117 -179.695 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 59.4 mt -65.86 -36.14 82.61 Favored 'General case' 0 N--CA 1.475 0.811 0 N-CA-C 114.782 1.401 . . . . 0.0 114.782 -175.24 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.656 ' HA ' HG13 ' A' ' 19' ' ' VAL . 35.5 mmtp -57.67 -56.2 25.02 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-N 114.211 -1.359 . . . . 0.0 112.311 177.386 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.445 ' HE3' ' HE3' ' A' ' 61' ' ' LYS . 64.0 tttp -69.51 -51.15 38.4 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-N 115.054 -0.975 . . . . 0.0 111.968 175.673 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . 0.553 ' O ' ' HB2' ' A' ' 62' ' ' LYS . 3.6 mm-40 -54.93 -50.75 68.08 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-O 118.281 -0.866 . . . . 0.0 112.682 -173.377 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.606 HG23 HG21 ' A' ' 67' ' ' VAL . 2.7 mm -79.14 -25.68 12.94 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.077 0 CA-C-O 118.618 -0.706 . . . . 0.0 112.007 -175.824 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.414 ' HB2' ' O ' ' A' ' 56' ' ' LYS . 8.7 tppt? -62.1 -32.42 72.98 Favored 'General case' 0 N--CA 1.473 0.698 0 N-CA-C 114.416 1.265 . . . . 0.0 114.416 171.894 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.445 ' HE3' ' HE3' ' A' ' 57' ' ' LYS . 48.4 mttm -88.56 -45.7 9.68 Favored 'General case' 0 N--CA 1.476 0.838 0 CA-C-N 113.351 -1.75 . . . . 0.0 112.42 176.127 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.553 ' HB2' ' O ' ' A' ' 58' ' ' GLU . 2.9 tttm -64.41 -45.55 87.07 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 126.448 1.899 . . . . 0.0 112.96 -172.512 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 95.45 113.66 2.75 Favored Glycine 0 N--CA 1.479 1.546 0 O-C-N 124.958 1.411 . . . . 0.0 109.65 -175.546 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.622 ' H ' ' HD2' ' A' ' 64' ' ' LYS . 10.7 mptt -44.66 -43.7 8.5 Favored 'General case' 0 N--CA 1.484 1.234 0 N-CA-C 116.801 2.148 . . . . 0.0 116.801 -172.636 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.489 ' O ' ' HB ' ' A' ' 68' ' ' ILE . 0.0 OUTLIER -56.16 -48.53 76.11 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 125.381 1.472 . . . . 0.0 114.576 178.054 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -64.71 -28.05 69.33 Favored 'General case' 0 N--CA 1.473 0.718 0 N-CA-C 114.463 1.282 . . . . 0.0 114.463 172.526 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.606 HG21 HG23 ' A' ' 59' ' ' ILE . 95.3 t -72.96 -32.82 41.25 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.944 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.321 179.098 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.666 HG12 HD11 ' A' ' 16' ' ' LEU . 4.3 mm -50.05 -49.57 21.55 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.332 0 C-N-CA 123.494 0.718 . . . . 0.0 110.098 167.132 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -64.59 -50.0 68.92 Favored 'General case' 0 N--CA 1.481 1.076 0 CA-C-N 114.917 -1.038 . . . . 0.0 112.912 178.636 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 23.2 t90 . . . . . 0 CA--C 1.544 0.728 0 C-N-CA 126.489 1.915 . . . . 0.0 112.987 179.394 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.73 ' HE1' HG21 ' A' ' 15' ' ' VAL . 74.1 mtp . . . . . 0 N--CA 1.482 1.156 0 N-CA-C 113.327 0.862 . . . . 0.0 113.327 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -65.18 -56.12 14.68 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-N 114.915 -1.039 . . . . 0.0 112.67 175.474 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 14.4 ttmm -71.09 -52.96 16.4 Favored 'General case' 0 CA--C 1.549 0.935 0 CA-C-N 114.361 -1.291 . . . . 0.0 114.118 -172.967 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . 0.434 ' HB2' ' O ' ' A' ' 70' ' ' TRP . 1.8 mp0 -79.77 -38.45 33.15 Favored 'General case' 0 N--CA 1.476 0.829 0 N-CA-C 115.052 1.501 . . . . 0.0 115.052 -174.559 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . 0.509 ' HD2' ' HA ' ' A' ' 1' ' ' MET . 73.9 m-85 -106.28 -9.72 16.71 Favored 'General case' 0 N--CA 1.484 1.253 0 N-CA-C 117.041 2.237 . . . . 0.0 117.041 -172.236 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 66.73 36.92 91.94 Favored Glycine 0 CA--C 1.54 1.632 0 CA-C-O 121.971 0.762 . . . . 0.0 112.917 -176.055 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.669 HG23 HG23 ' A' ' 11' ' ' VAL . 0.6 OUTLIER -116.12 112.87 41.81 Favored Pre-proline 0 N--CA 1.472 0.657 0 C-N-CA 124.327 1.051 . . . . 0.0 109.413 179.106 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_endo -63.86 164.05 23.02 Favored 'Trans proline' 0 N--CA 1.48 0.68 0 C-N-CA 121.184 1.256 . . . . 0.0 111.597 -174.471 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -55.76 -28.42 55.85 Favored 'General case' 0 N--CA 1.479 0.989 0 N-CA-C 114.674 1.361 . . . . 0.0 114.674 176.75 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -45.51 -43.98 12.21 Favored 'General case' 0 CA--C 1.549 0.917 0 C-N-CA 125.985 1.714 . . . . 0.0 113.753 174.628 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.952 HG12 HG22 ' A' ' 31' ' ' ILE . 33.6 m -100.24 -28.92 3.28 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.054 0 N-CA-C 114.766 1.395 . . . . 0.0 114.766 179.248 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -67.6 -34.97 78.07 Favored 'General case' 0 N--CA 1.477 0.895 0 N-CA-C 113.791 1.034 . . . . 0.0 113.791 176.76 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -61.47 -41.34 99.53 Favored Glycine 0 N--CA 1.478 1.44 0 CA-C-O 122.467 1.037 . . . . 0.0 112.304 172.357 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 3.1 m -64.1 -34.05 77.15 Favored 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 126.046 1.738 . . . . 0.0 112.893 175.524 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.73 HG21 ' HE1' ' A' ' 1' ' ' MET . 20.5 t -63.5 -36.64 77.06 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.065 0 C-N-CA 123.667 0.787 . . . . 0.0 112.083 172.039 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.631 HD13 ' HB3' ' A' ' 64' ' ' LYS . 31.6 mt -65.43 -40.36 93.21 Favored 'General case' 0 N--CA 1.485 1.305 0 N-CA-C 112.913 0.708 . . . . 0.0 112.913 174.234 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 4.6 m120 -57.62 -43.99 85.18 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 124.976 1.31 . . . . 0.0 112.448 174.384 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.412 ' HB ' ' O ' ' A' ' 15' ' ' VAL . 4.1 t -48.11 -57.64 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.35 0 C-N-CA 123.835 0.854 . . . . 0.0 111.373 168.391 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.595 HG13 ' HA ' ' A' ' 56' ' ' LYS . 4.8 t -60.66 -44.78 97.76 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 123.935 0.772 . . . . 0.0 111.913 -176.16 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 27.6 mt-10 -63.93 -43.74 94.97 Favored 'General case' 0 N--CA 1.472 0.634 0 N-CA-C 115.301 1.593 . . . . 0.0 115.301 179.506 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -97.04 -11.51 24.39 Favored 'General case' 0 N--CA 1.478 0.934 0 N-CA-C 116.221 1.934 . . . . 0.0 116.221 -170.917 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 73.49 25.28 72.98 Favored Glycine 0 CA--C 1.544 1.866 0 O-C-N 123.521 0.513 . . . . 0.0 112.736 -169.002 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -78.76 149.94 33.8 Favored Glycine 0 N--CA 1.476 1.362 0 CA-C-O 122.419 1.01 . . . . 0.0 113.689 -171.054 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' TRP . . . . . 0.492 ' HB3' HG22 ' A' ' 26' ' ' THR . 2.9 m-90 -62.1 98.08 0.1 Allowed 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 125.31 1.444 . . . . 0.0 112.327 178.402 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 5.0 p -51.87 -27.84 9.19 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.868 0 CA-C-N 113.734 -1.575 . . . . 0.0 113.985 173.187 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.492 HG22 ' HB3' ' A' ' 24' ' ' TRP . 13.9 t -59.52 -40.72 88.05 Favored 'General case' 0 CA--C 1.546 0.827 0 C-N-CA 124.735 1.214 . . . . 0.0 112.937 -178.055 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -67.66 -47.07 70.57 Favored 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 124.101 0.96 . . . . 0.0 110.604 174.964 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 2.3 mp -60.21 -35.4 61.72 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.036 0 C-N-CA 125.259 1.424 . . . . 0.0 112.99 177.179 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.411 ' O ' ' HB2' ' A' ' 32' ' ' LEU . 15.9 t -48.97 -40.62 12.78 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.365 0 C-N-CA 124.403 1.081 . . . . 0.0 112.38 173.845 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 59.7 p -61.03 -30.3 70.22 Favored 'General case' 0 N--CA 1.477 0.888 0 N-CA-C 114.02 1.118 . . . . 0.0 114.02 176.255 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.952 HG22 HG12 ' A' ' 11' ' ' VAL . 42.6 mm -77.33 -36.47 23.96 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.989 0 C-N-CA 124.07 0.948 . . . . 0.0 109.191 179.965 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.561 ' HB3' ' HA3' ' A' ' 39' ' ' GLY . 3.9 mm? -60.13 -36.42 77.45 Favored 'General case' 0 N--CA 1.49 1.554 0 C-N-CA 123.741 0.817 . . . . 0.0 111.315 169.414 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.774 HG23 ' HA2' ' A' ' 38' ' ' GLY . 2.5 m -72.55 -34.31 67.42 Favored 'General case' 0 N--CA 1.483 1.176 0 N-CA-C 114.698 1.37 . . . . 0.0 114.698 175.403 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -54.49 -29.02 48.77 Favored 'General case' 0 N--CA 1.482 1.16 0 O-C-N 124.245 0.965 . . . . 0.0 113.459 174.317 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 70.5 t -56.65 -34.06 41.53 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.255 0 C-N-CA 126.313 1.845 . . . . 0.0 113.03 172.031 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 116.82 -51.24 0.74 Allowed Glycine 0 N--CA 1.482 1.757 0 O-C-N 123.221 0.326 . . . . 0.0 112.941 -178.392 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 62.8 p -62.04 5.74 0.09 Allowed 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 116.148 1.907 . . . . 0.0 116.148 173.883 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.774 ' HA2' HG23 ' A' ' 33' ' ' THR . . . 66.22 0.98 8.47 Favored Glycine 0 N--CA 1.483 1.806 0 C-N-CA 124.473 1.035 . . . . 0.0 115.511 -179.803 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.561 ' HA3' ' HB3' ' A' ' 32' ' ' LEU . . . 60.88 18.31 53.32 Favored Glycine 0 CA--C 1.543 1.815 0 C-N-CA 124.897 1.237 . . . . 0.0 113.404 -159.892 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 14.3 mt -53.23 -41.74 65.7 Favored 'General case' 0 N--CA 1.48 1.059 0 N-CA-C 116.459 2.022 . . . . 0.0 116.459 -171.127 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . 0.469 ' HB2' ' HD1' ' A' ' 5' ' ' PHE . 11.5 p -59.47 -51.62 69.1 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 125.327 1.451 . . . . 0.0 113.86 175.26 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 14.5 tp -60.74 -43.48 97.87 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 123.676 0.79 . . . . 0.0 110.31 174.157 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 82.7 mt -65.68 -27.37 68.3 Favored 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 114.618 1.34 . . . . 0.0 114.618 -178.23 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -70.33 -48.26 57.32 Favored 'General case' 0 N--CA 1.478 0.953 0 CA-C-N 115.43 -0.805 . . . . 0.0 112.323 169.91 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -59.19 -37.16 76.74 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 123.446 0.699 . . . . 0.0 112.697 176.292 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -57.87 -28.95 64.62 Favored 'General case' 0 C--N 1.321 -0.63 0 C-N-CA 126.546 1.938 . . . . 0.0 115.642 177.76 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -47.81 -41.78 20.67 Favored Glycine 0 CA--C 1.536 1.371 0 C-N-CA 125.438 1.494 . . . . 0.0 114.608 -174.514 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 41.0 ttp-105 -53.81 -47.02 71.27 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 126.0 1.72 . . . . 0.0 113.81 -174.797 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 5.0 tt0 -127.14 31.01 5.32 Favored 'General case' 0 CA--C 1.547 0.854 0 N-CA-C 113.787 1.032 . . . . 0.0 113.787 -177.553 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 24.5 t 45.85 126.8 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 125.353 1.461 . . . . 0.0 113.809 -171.545 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 9.8 tp -37.44 -42.25 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 N-CA-C 117.239 2.311 . . . . 0.0 117.239 -173.437 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 8.4 mmtt -57.41 -72.05 0.09 Allowed 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 124.31 1.044 . . . . 0.0 112.05 174.393 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -62.49 -34.8 77.57 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 125.196 1.398 . . . . 0.0 113.853 -177.842 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 87.6 t80 -48.62 -59.45 3.51 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 125.497 1.519 . . . . 0.0 111.646 175.715 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.513 HD13 HG13 ' A' ' 15' ' ' VAL . 75.0 mt -67.86 -41.67 82.54 Favored 'General case' 0 N--CA 1.482 1.149 0 N-CA-C 114.448 1.277 . . . . 0.0 114.448 -177.873 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.595 ' HA ' HG13 ' A' ' 19' ' ' VAL . 33.2 mmtp -55.98 -42.16 75.92 Favored 'General case' 0 N--CA 1.479 0.993 0 CA-C-N 113.253 -1.794 . . . . 0.0 114.507 178.963 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 59.3 tttm -80.35 -54.97 5.23 Favored 'General case' 0 N--CA 1.473 0.715 0 O-C-N 124.843 1.34 . . . . 0.0 112.327 172.559 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 72.9 tt0 -58.68 -46.02 88.16 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-O 117.766 -1.111 . . . . 0.0 112.489 -168.694 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.676 HG23 HG21 ' A' ' 67' ' ' VAL . 3.7 mm -79.36 -20.02 12.59 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.895 0 C-N-CA 119.911 -0.716 . . . . 0.0 112.081 -173.814 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 22.9 tttp -72.55 -24.91 61.19 Favored 'General case' 0 CA--C 1.547 0.851 0 O-C-N 124.713 1.258 . . . . 0.0 114.147 172.638 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 45.3 mmtm -97.25 -38.8 9.54 Favored 'General case' 0 N--CA 1.477 0.886 0 CA-C-N 113.549 -1.66 . . . . 0.0 111.58 178.455 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.439 ' HD3' HG22 ' A' ' 67' ' ' VAL . 31.6 tttp -71.54 -52.65 17.1 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 126.282 1.833 . . . . 0.0 114.514 -177.938 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 102.17 114.62 3.88 Favored Glycine 0 N--CA 1.483 1.79 0 O-C-N 124.361 1.038 . . . . 0.0 111.022 -173.289 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.659 ' H ' ' HD2' ' A' ' 64' ' ' LYS . 9.0 mptt -41.44 -44.37 2.86 Favored 'General case' 0 N--CA 1.486 1.354 0 N-CA-C 117.548 2.425 . . . . 0.0 117.548 -176.043 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . 0.373 0.0 OUTLIER -53.08 -51.76 60.78 Favored 'General case' 0 C--N 1.315 -0.912 0 C-N-CA 127.801 2.44 . . . . 0.0 114.124 177.216 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -65.71 -27.62 68.47 Favored 'General case' 0 N--CA 1.475 0.788 0 N-CA-C 114.111 1.152 . . . . 0.0 114.111 173.436 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.676 HG21 HG23 ' A' ' 59' ' ' ILE . 21.7 t -71.08 -36.16 61.88 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.966 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.502 179.876 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.402 HG12 HD11 ' A' ' 16' ' ' LEU . 14.2 mm -49.01 -44.61 15.99 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.847 0 C-N-CA 124.243 1.017 . . . . 0.0 110.939 167.696 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -70.77 -51.76 25.01 Favored 'General case' 0 N--CA 1.477 0.877 0 CA-C-N 115.004 -0.998 . . . . 0.0 112.331 179.088 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' TRP . . . . . 0.434 ' O ' ' HB2' ' A' ' 4' ' ' GLU . 36.2 t90 . . . . . 0 CA--C 1.553 1.073 0 C-N-CA 125.303 1.441 . . . . 0.0 113.352 -177.277 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.418 ' HE1' HG21 ' A' ' 15' ' ' VAL . 34.3 mtp . . . . . 0 CA--C 1.533 0.294 0 CA-C-O 119.718 -0.182 . . . . 0.0 110.738 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . 0.412 ' HA ' ' O ' ' A' ' 7' ' ' ILE . . . -60.29 -50.39 73.84 Favored 'General case' 0 N--CA 1.478 0.966 0 CA-C-N 114.374 -1.285 . . . . 0.0 112.863 178.844 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 10.5 tptm -71.73 -58.92 3.05 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 113.543 -1.662 . . . . 0.0 114.55 -175.716 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -67.95 -43.58 78.77 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 116.263 1.949 . . . . 0.0 116.263 -170.209 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . 0.496 ' HB2' HD12 ' A' ' 7' ' ' ILE . 33.7 m-85 -102.0 -26.09 13.52 Favored 'General case' 0 N--CA 1.481 1.113 0 N-CA-C 116.665 2.098 . . . . 0.0 116.665 -170.408 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 92.47 58.64 1.34 Allowed Glycine 0 N--CA 1.477 1.384 0 O-C-N 124.931 1.394 . . . . 0.0 110.537 -174.975 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.496 HD12 ' HB2' ' A' ' 5' ' ' PHE . 0.7 OUTLIER -120.47 140.48 30.38 Favored Pre-proline 0 N--CA 1.476 0.831 0 CA-C-N 114.365 -0.918 . . . . 0.0 110.309 -179.12 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 68.3 Cg_endo -89.47 152.71 5.36 Favored 'Trans proline' 0 CA--C 1.534 0.495 0 C-N-CA 121.27 1.313 . . . . 0.0 109.069 166.828 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -44.65 -34.37 2.17 Favored 'General case' 0 N--CA 1.47 0.532 0 N-CA-C 116.108 1.892 . . . . 0.0 116.108 177.03 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -36.2 -43.29 0.35 Allowed 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 125.984 1.714 . . . . 0.0 115.108 168.687 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.921 HG12 HG22 ' A' ' 31' ' ' ILE . 10.4 m -103.66 -37.28 4.49 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.1 0 N-CA-C 115.192 1.553 . . . . 0.0 115.192 -177.442 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.489 ' O ' ' HG ' ' A' ' 16' ' ' LEU . . . -64.76 -36.28 83.8 Favored 'General case' 0 N--CA 1.482 1.15 0 N-CA-C 113.145 0.795 . . . . 0.0 113.145 177.758 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -64.12 -40.87 98.49 Favored Glycine 0 N--CA 1.479 1.567 0 C-N-CA 125.777 1.656 . . . . 0.0 112.35 176.13 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 2.1 m -63.98 -41.86 97.39 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 124.54 1.136 . . . . 0.0 112.404 174.308 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.663 HG13 HD13 ' A' ' 55' ' ' LEU . 32.1 t -53.75 -40.91 45.34 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.934 0 CA-C-O 121.174 0.512 . . . . 0.0 112.2 170.188 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.597 HD11 HG12 ' A' ' 68' ' ' ILE . 45.7 mt -64.99 -49.88 68.53 Favored 'General case' 0 N--CA 1.477 0.898 0 CA-C-N 115.699 -0.682 . . . . 0.0 112.725 178.825 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 1.7 t30 -42.8 -45.2 4.75 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-O 123.167 1.461 . . . . 0.0 113.839 172.657 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.739 HG13 ' O ' ' A' ' 23' ' ' GLY . 5.3 t -63.27 -50.99 76.72 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.746 0 CA-C-N 109.976 -3.284 . . . . 0.0 112.29 178.793 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.746 HG13 ' HA ' ' A' ' 56' ' ' LYS . 36.0 t -59.91 -46.39 93.98 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.889 0 O-C-N 124.77 1.294 . . . . 0.0 110.691 179.419 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -63.58 -39.82 95.37 Favored 'General case' 0 N--CA 1.466 0.369 0 N-CA-C 114.342 1.238 . . . . 0.0 114.342 -177.51 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -96.39 2.53 52.74 Favored 'General case' 0 N--CA 1.478 0.963 0 N-CA-C 115.616 1.71 . . . . 0.0 115.616 -177.593 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 56.97 47.08 89.95 Favored Glycine 0 CA--C 1.541 1.702 0 C-N-CA 123.644 0.64 . . . . 0.0 111.572 -174.39 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.739 ' O ' HG13 ' A' ' 18' ' ' VAL . . . -102.97 154.49 18.22 Favored Glycine 0 N--CA 1.476 1.313 0 CA-C-O 123.944 1.858 . . . . 0.0 112.594 -174.576 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 4.5 m-90 -73.43 101.11 3.4 Favored 'General case' 0 N--CA 1.473 0.689 0 CA-C-N 112.961 -1.619 . . . . 0.0 112.807 -175.69 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.682 ' HB ' HG11 ' A' ' 18' ' ' VAL . 7.6 p -62.37 -20.46 24.66 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 N-CA-C 114.171 1.174 . . . . 0.0 114.171 173.3 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 6.4 t -61.02 -28.62 69.18 Favored 'General case' 0 N--CA 1.481 1.09 0 N-CA-C 112.952 0.723 . . . . 0.0 112.952 178.942 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -74.91 -43.61 53.3 Favored 'General case' 0 N--CA 1.474 0.73 0 CA-C-O 119.625 -0.226 . . . . 0.0 111.118 174.669 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 3.2 mp -64.12 -30.93 51.4 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.053 0 C-N-CA 127.67 2.388 . . . . 0.0 112.853 178.15 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.578 HG13 HD11 ' A' ' 43' ' ' LEU . 31.2 t -44.96 -37.47 1.63 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.14 0 C-N-CA 124.616 1.166 . . . . 0.0 112.702 172.542 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 91.5 p -60.4 -35.39 75.65 Favored 'General case' 0 N--CA 1.476 0.873 0 N-CA-C 113.217 0.821 . . . . 0.0 113.217 176.415 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.921 HG22 HG12 ' A' ' 11' ' ' VAL . 33.8 mm -77.87 -34.08 19.28 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.775 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.304 -179.781 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.591 HD22 ' HB ' ' A' ' 11' ' ' VAL . 4.1 mm? -60.92 -50.03 75.08 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 124.127 0.971 . . . . 0.0 112.159 172.105 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -69.84 -26.14 64.08 Favored 'General case' 0 N--CA 1.482 1.132 0 N-CA-C 114.925 1.454 . . . . 0.0 114.925 -179.87 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -51.56 -38.38 54.09 Favored 'General case' 0 CA--C 1.545 0.758 0 O-C-N 124.139 0.899 . . . . 0.0 112.508 169.736 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 22.8 t -63.89 -32.4 56.95 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.081 0 C-N-CA 125.346 1.458 . . . . 0.0 111.607 174.852 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 105.56 -106.19 2.59 Favored Glycine 0 N--CA 1.476 1.34 0 N-CA-C 110.0 -1.24 . . . . 0.0 110.0 178.36 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 2.8 p -58.4 -45.86 87.55 Favored 'General case' 0 N--CA 1.474 0.761 0 CA-C-N 113.871 -1.165 . . . . 0.0 112.826 -174.615 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -49.98 -54.05 20.13 Favored Glycine 0 N--CA 1.476 1.357 0 O-C-N 125.547 1.779 . . . . 0.0 113.449 179.2 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.471 ' HA2' ' HB3' ' A' ' 32' ' ' LEU . . . -56.1 -51.84 53.13 Favored Glycine 0 CA--C 1.535 1.302 0 O-C-N 125.262 1.213 . . . . 0.0 110.788 177.836 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 66.4 mt -60.32 -52.41 65.38 Favored 'General case' 0 N--CA 1.47 0.565 0 N-CA-C 116.388 1.996 . . . . 0.0 116.388 -179.675 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 23.4 p -62.78 -35.15 78.91 Favored 'General case' 0 N--CA 1.479 0.997 0 CA-C-O 118.092 -0.956 . . . . 0.0 113.16 177.939 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 13.4 tp -61.05 -50.62 72.59 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 123.007 0.523 . . . . 0.0 111.12 170.56 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.578 HD11 HG13 ' A' ' 29' ' ' VAL . 59.1 mt -61.92 -34.45 76.08 Favored 'General case' 0 N--CA 1.479 0.985 0 O-C-N 124.222 0.951 . . . . 0.0 113.439 -179.532 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -63.24 -46.03 88.8 Favored 'General case' 0 N--CA 1.473 0.692 0 N-CA-C 112.995 0.739 . . . . 0.0 112.995 172.895 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -65.07 -35.72 82.06 Favored 'General case' 0 N--CA 1.487 1.388 0 CA-C-N 115.268 -0.878 . . . . 0.0 112.483 175.437 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -60.81 -28.31 68.69 Favored 'General case' 0 N--CA 1.475 0.779 0 N-CA-C 115.122 1.527 . . . . 0.0 115.122 179.837 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -44.85 -35.53 4.45 Favored Glycine 0 N--CA 1.48 1.601 0 C-N-CA 126.679 2.085 . . . . 0.0 114.193 -175.789 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . 0.517 ' HE ' ' HE1' ' A' ' 54' ' ' TYR . 63.3 ttp85 -51.61 -54.99 21.85 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-N 112.875 -1.663 . . . . 0.0 112.732 -176.692 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 25.4 tt0 -127.71 36.73 4.31 Favored 'General case' 0 N--CA 1.473 0.71 0 N-CA-C 114.154 1.168 . . . . 0.0 114.154 -173.14 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 75.8 p 50.4 121.69 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 125.221 1.408 . . . . 0.0 111.974 -171.387 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.473 ' O ' ' HB3' ' A' ' 54' ' ' TYR 0.276 6.3 tp -31.35 -53.86 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.483 1.223 0 N-CA-C 117.16 2.282 . . . . 0.0 117.16 -173.438 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.622 ' HG3' HG12 ' A' ' 25' ' ' VAL . 0.1 OUTLIER -59.11 -66.97 0.42 Allowed 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 115.561 1.689 . . . . 0.0 115.561 175.402 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -54.99 -34.17 63.15 Favored 'General case' 0 N--CA 1.475 0.788 0 O-C-N 124.776 1.298 . . . . 0.0 113.252 177.601 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . 0.517 ' HE1' ' HE ' ' A' ' 48' ' ' ARG . 87.5 t80 -54.36 -63.34 1.18 Allowed 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 126.141 1.776 . . . . 0.0 110.541 174.981 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.663 HD13 HG13 ' A' ' 15' ' ' VAL . 96.4 mt -66.98 -42.2 85.48 Favored 'General case' 0 N--CA 1.476 0.843 0 N-CA-C 115.379 1.622 . . . . 0.0 115.379 -177.453 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.746 ' HA ' HG13 ' A' ' 19' ' ' VAL . 96.4 mttt -56.52 -43.21 79.58 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 113.109 -1.859 . . . . 0.0 114.092 178.522 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.409 ' O ' ' HG3' ' A' ' 61' ' ' LYS . 15.6 tttt -82.64 -50.07 9.15 Favored 'General case' 0 C--N 1.318 -0.776 0 O-C-N 124.158 0.911 . . . . 0.0 112.997 174.306 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . 0.461 ' O ' ' HB2' ' A' ' 62' ' ' LYS . 31.1 tt0 -57.72 -47.49 82.26 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 118.2 -0.905 . . . . 0.0 112.397 -175.95 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.606 HG23 HG21 ' A' ' 67' ' ' VAL . 1.8 mm -75.84 -23.32 16.29 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.26 0 N-CA-C 112.266 0.469 . . . . 0.0 112.266 -175.49 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.441 ' HB2' ' O ' ' A' ' 56' ' ' LYS . 32.2 tptt -64.01 -38.55 91.5 Favored 'General case' 0 CA--C 1.544 0.717 0 O-C-N 124.695 1.247 . . . . 0.0 112.284 170.354 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.409 ' HG3' ' O ' ' A' ' 57' ' ' LYS . 26.5 mtpt -77.3 -45.44 26.25 Favored 'General case' 0 N--CA 1.481 1.108 0 CA-C-N 112.925 -1.943 . . . . 0.0 113.05 177.139 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.461 ' HB2' ' O ' ' A' ' 58' ' ' GLU . 10.4 tttm -70.25 -47.32 61.84 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 126.699 1.999 . . . . 0.0 113.352 -172.468 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 96.05 99.58 1.85 Allowed Glycine 0 N--CA 1.467 0.708 0 CA-C-N 114.46 -1.245 . . . . 0.0 110.658 179.067 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.748 ' H ' ' HD2' ' A' ' 64' ' ' LYS . 10.8 mptt -22.42 -47.6 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.838 0 N-CA-C 119.673 3.212 . . . . 0.0 119.673 -175.673 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.43 ' O ' ' HB ' ' A' ' 68' ' ' ILE . 0.1 OUTLIER -56.02 -49.5 73.5 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 124.687 1.195 . . . . 0.0 113.08 177.386 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -62.23 -26.12 68.2 Favored 'General case' 0 N--CA 1.471 0.61 0 N-CA-C 114.536 1.31 . . . . 0.0 114.536 174.514 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.606 HG21 HG23 ' A' ' 59' ' ' ILE . 99.1 t -72.97 -34.68 46.74 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.638 0 C-N-CA 123.094 0.558 . . . . 0.0 111.094 177.001 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.597 HG12 HD11 ' A' ' 16' ' ' LEU . 5.2 mm -51.06 -45.85 30.34 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.117 0 O-C-N 123.904 0.752 . . . . 0.0 110.468 169.689 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -64.83 -52.58 55.92 Favored 'General case' 0 CA--C 1.549 0.937 0 CA-C-N 114.368 -1.287 . . . . 0.0 113.033 175.906 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 35.3 t90 . . . . . 0 N--CA 1.484 1.228 0 C-N-CA 125.582 1.553 . . . . 0.0 115.007 -178.983 . . . . . . . . 0 0 . 1 stop_ save_